PAGEANT Report

1st Q

This section reports quality control (QC) statistics for the personal genotype data, as well as for the reference genotype data.

Sample QC

  • The genetically determined sex is: Female
  • 7 of 295,702 variants are missing, missing rate is: 0.00%

Variants count in each chromosome:

Variants count in each chromosome

Minor allele frequency in sample based on MAF reference data:

  • 292805 of 296237 variants were found in MAF reference data.
Minor allele frequency of each variants in sample

Population stratification analysis:

PCA

Principal Components of Sample based on reference

UMAP

UMAP result of Sample based on reference

Concordance check:

  • In the current genotype file, 296184 of 296237 (99.98%) variants were found in previous genotype file.
  • In these common variants, 200739 of 296184 (67.78%) variants were identical.
Venn diagram of genotype files' variants

Population QC

Minor allele frequency:

Minor allele frequency of each variant

Missing genotype rates:

Missing genotype rates per variant Missing genotype rates per sample

Sex discrepancy:

F value (X chromosome homozygosity estimate) of each sample

Cryptic relatedness:

Pihat value of each sample-sample pair

Hardy-Weinberg equilibrium:

Hardy-Weinberg equilibrium p-value in each variant

Heterozygosity rate:

Heterozygosity rate in each sample

2nd Q

The traits listed in this section are almost definitely determined by genetics. However, the association with relevant disease outcome is certainly not definite. For example, “FTO related obesity” simply reports one widely cited FTO SNP that is associated with obesity, but obesity itself is certainly not determined by a single SNP.

Qualitative traits

Name Result
ABO blood type A
APOE type ε3/ε3: the most common
Alcohol flush A-
Altruism More likely
Caffeine metabolism Normal
Earwax Type Wet
FTO related obesity None allele mutated: wild type
Folic Acid metabolism Slow
HIV resistance Susceptible
Lactose metabolism Lactose tolerance
Marital satisfaction Higher levels of satisfaction
Muscle fiber type Slow muscle type
Nicotineaddiction Wild type
Perception of fish odor Insensitive

Scientific detail:

ABO blood type

Description:

ABO blood typepicture

The ABO blood types were discovered by Karl Landsteiner in 1901. He received the Nobel Prize in Physiology or Medicine in 1930 for this discovery. ABO blood types are also present in other primates such as apes and Old World monkeys. The ABO blood group system is used to denote the presence of one, both, or neither of the A and B antigens on erythrocytes. In human blood transfusions it is the most important of the 38 different blood type (or group) classification systems currently recognized. A mismatch in this, or any other serotype, can cause a potentially fatal adverse reaction after a transfusion, or an unwanted immune response to an organ transplant. The associated anti-A and anti-B antibodies are usually IgM antibodies, produced in the first years of life by sensitization to environmental substances such as food, bacteria, and viruses. Usually, four tag SNPs were used for the main ABO blood group antigens (rs8176746 for B, rs687289 for O, rs507666 for A1 and rs8176704 for A2).

Result:

A

Distribution plot:

ABO_blood_type Distribution Plot

Scientific detail:

  • rs41302905: C/C
  • rs8176719: TC/T
  • rs8176746: G/G

Reference:

  • PMID: 18604267

APOE type

Description:

APOE typepicture

The APOE gene provides instructions for making a protein called apolipoprotein E. This protein combines with fats (lipids) in the body to form molecules called lipoproteins. Lipoproteins are responsible for packaging cholesterol and other fats and carrying them through the bloodstream. Maintaining normal levels of cholesterol is essential for the prevention of disorders that affect the heart and blood vessels (cardiovascular diseases), including heart attack and stroke.

Result:

ε3/ε3: the most common

Distribution plot:

APOE_type Distribution Plot

Scientific detail:

  • rs429358: T/T
  • rs7412: C/C

Reference:

  • PMID: 9343467

Alcohol flush

Description:

Alcohol flushpicture

In African and European populations, acetaldehyde is broken down quickly enough to maintain tolerably low concentrations in drinkers. In east Asian populations, there is a common loss-of-function variant of the ALDH2 gene on chromosome 12 (rs671). Even a single copy decreases acetaldehyde breakdown enough for the concentration to become uncomfortably high after drinking alcohol. This variant is an important determinant of the east Asian flushing reaction to alcohol, and of alcohol intake. Less importantly, a genetic variant of the ADH1B gene on chromosome 4 (rs1229984) that is common in east Asia increases alcohol clearance rates. Together, these two single nucleotide polymorphisms strongly affect alcohol exposure, and each has been shown to decrease substantially the incidence of alcoholism. Both variants involve a G→A mutation, with the A allele decreasing alcohol exposure. Each variant has three possible genotypes, AA, AG, and GG, so the two variants define nine possible genotypes. Alcohol intake is affected more by the decreased rate of breakdown of acetaldehyde than by the increased alcohol clearance rate. Hence, when describing these nine genotypes the rs671 genotype is given first and the rs1229984 genotype second, and alphabetic order corresponds to increasing alcohol intake: AA/AA, AA/AG, AA/GG; then AG/AA, AG/AG, AG/GG; then GG/AA, GG/AG, GG/GG. We denote this 9 genotype as A+, A, A-, B+, B, B-, C+, C, C-, respectively.

Result:

A-

Distribution plot:

Alcohol_flush Distribution Plot

Scientific detail:

  • rs671: G/G
  • rs1229984: C/C

Reference:

  • PMID: 30955975
  • PMID 6582480

Altruism

Description:

Altruismpicture

William D. Hamilton postulated the existence of ‘genes underlying altruism’, under the rubric of inclusive fitness theory, a half-century ago. Humans are by nature prosocial. Nevertheless, prosocial behavior is greatly variable among individuals. By far the best-studied polymorphism within COMT is the Val158Met polymorphism (rs4680). It has long been known that there is a trimodal distribution of COMT activity in human populations (Floderus et al., 1981), which was subsequently shown to be due to the presence of this polymorphism (Lachman et al., 1996). The polymorphism is an A to G single nucleotide change that results in a valine to methionine substitution at position 158 of the MB-COMT amino acid sequence (position 108 in S-COMT Bertocci et al., 1991; Lundstrom et al., 1991). The Met158 form of COMT has a lower thermostability and therefore a lower activity at 37˚C, compared to the Val158 form (Chen et al., 2004; Lotta et al., 1995). The apparent differences in the magnitude of the Val158Met effect on activity are likely due in part to methodological factors, but could plausibly also be due to tissue-specific effects of other polymorphisms/haplotypes in COMT.

Result:

More likely

Distribution plot:

Altruism Distribution Plot

Scientific detail:

  • rs4680: G/A

Reference:

  • PMID: 21030481

Caffeine metabolism

Description:

Caffeine metabolismpicture

Caffeine (1,3,7-trimethylxanthine) is one of the most widely used drugs in the world and is available in many mediums for consumption. The pharmacokinetics and pharmacodynamics of caffeine have been well studied. Caffeine metabolism occurs primarily in the liver via the cytochrome P450 system (CYP1A2). The CYP1A2 proteins are encoded by the CYP1A2 gene, and CYP1A2 activity is induced when aromatic hydrocarbons bind the aryl hydrocarbon receptor. The CYP1A2 gene encodes a member of the cytochrome p450 family of proteins, which metabolize nutrients and drugs. One well known substrate of CYP1A2 is caffeine. The same amount of caffeine will therefore tend to have more stimulating effect on CYP1A2 slow metabolizers than on CYP1A2 fast metabolizers. The SNP rs762551, also known as -164A>C or -163C>A, encodes the CYP1A2*1F allele of the CYP1A2 gene. The C allele is considered the wild-type, even though it is the rarer allele in most populations. AA = CYP1A2*1F = Fast Metabolizer. CC, AC = CYP1A2*1C = Slow Metabolizer.

Result:

Normal

Distribution plot:

Caffeine_metabolism Distribution Plot

Scientific detail:

  • rs762551: A/A

Earwax Type

Description:

Earwax Typepicture

Description is unavailable.

Result:

Wet

Distribution plot:

Earwax_Type Distribution Plot

Scientific detail:

  • rs17822931: C/C

Reference:

  • PMID: 16444273

Folic Acid metabolism

Description:

Folic Acid metabolismpicture

The methylenetetrahydrofolate reductase gene, more commonly known as MTHFR, is the most asked-about gene by DTC customers. Some websites and products have made bold claims that common genetic variants in MTHFR can cause a wide array of health conditions, ranging from blood clots and cancer to autism and migraines. The MTHFR gene contains instructions for making an enzyme that’s important for metabolizing folate (also called folic acid or vitamin B9). MTHFR also helps our cells recycle homocysteine, a chemical in the blood, into methionine, a building block for proteins. there are two common naturally occurring variants in the MTHFR gene, called C677T (rs1801133) and A1298C. When the MTHFR gene has either of these two variants, the resulting MTHFR enzyme is slightly less active, and this can lead to decreased levels of folate and increased levels of homocysteine in the blood. Homozygous rs1801133(T;T) individuals have ~30% of the expected MTHFR enzyme activity, and rs1801133(C;T) heterozygotes have ~65% activity, compared to the most common genotype, rs1801133(C;C).

Result:

Slow

Distribution plot:

Folic_Acid_metabolism Distribution Plot

Scientific detail:

  • rs1801133: G/A

Reference:

  • PMID: 8789576

HIV resistance

Description:

HIV resistancepicture

Host genetic factors are involved in resistance/susceptibility to HIV-1 infection and progression. The most relevant genetic variant of the gene encoding HIV-1 major co- receptor, CCR5 (chemokine receptor type 5). The CCR5 gene codes for a protein on the cell membrane of white blood cells, specifically T-cells, macrophages, dendritic cells, eosinophils, and microglial cells. It is a part of your immune system’s response to foreign invaders, and it is also an essential part of the way that the HIV virus is able to hijack immune cells. A mutation in CCR5, named Delta 32 (rs333), causes a change in the protein that makes it non-functional. Carrying two copies of the mutation protects most carriers from HIV. The first person in the world to be cured of HIV, the “Berlin Patient“, was Timothy Ray Brown, an American living in Berlin. While HIV positive, he contracted leukemia, and in 2007 he was given a bone marrow transplant from a donor with two copies of the CCR5 Delta32 mutation. After 3 months, he no longer had detectable HIV in his blood. The Delta32 variant is well studied on a variety of immune system topics. It is thought that the mutation first arose in Northern Europe and was preferentially passed on in Caucasian populations due to increasing resistance to smallpox.

Result:

Susceptible

Distribution plot:

HIV_resistance Distribution Plot

Scientific detail:

  • Snp (rs333) cannot be found in your genotype file!
  • rs113010081: T/T

Reference:

  • PMID: 31873311
  • PMID: 8898752

Lactose metabolism

Description:

Lactose metabolismpicture

Lactose, a sugar in milk, is broken down by the enzyme lactase which our bodies produce in the small intestines. For some people, the production of the lactase enzyme stops when they become an adult, driven by a genetic variation near the LCT gene. This means some adults are genetically predisposed to not be able to digest larger quantities of milk. Producing lactase as an adult is the most common genotype for Caucasian populations, while in Asian populations, the majority do not produce lactase as an adult. A theory for this occurrence seems to be an adaptation by Caucasian populations in Europe who relied on dairy products as a source of protein. For people with European Caucasian ancestry, the main variant to look at is rs4988235. It is located in the MCM6 gene, which influences the LCT gene. Approximately 90% of Caucasians will have A/A or A/G and still produce lactase to break down milk as an adult. In Asian populations, less than one percent will carry the G allele. People with African ancestry may find that they carry a different variant (rs145946881) in the MCM6 gene that also causes lactase persistence as an adult.

Result:

Lactose tolerance

Distribution plot:

Lactose_metabolism Distribution Plot

Scientific detail:

  • rs4988235: A/A

Reference:

  • PMID: 11788828

Marital satisfaction

Description:

Marital satisfactionpicture

Based on a study from Makhanova, A. at el. published in February 2021, a research team from the University of Arkansas, Florida State University, and McGill University collected data from 71 heterosexual newlywed couples (N = 142 participants) in their early 30s. Within three months of getting married, couples completed a series of baseline measures. Over the next three years, both partners completed measures of marital satisfaction every four months, along with saliva samples for DNA extraction. Those who had the rs3796863 CC genotype reported greater marital satisfaction, compared to those with the AC/AA type. In addition, those with the CC genotype also reported more trust, forgiveness, and gratitude toward their relationship partner. These associations were the same for men and women. It’s also important to realize that any genetic marker associated with a behavior — in this case marital satisfaction — isn’t causal. That is, every person with this CC genotype won’t be great at relationships. And every person without it won’t be hopeless when it comes to love. Genes aren’t destiny. But this research does show that there are genetic underpinnings to our behavior.

Result:

Higher levels of satisfaction

Distribution plot:

Marital_satisfaction Distribution Plot

Scientific detail:

  • rs3796863: G/G

Reference:

  • PMID: 33536489

Muscle fiber type

Description:

Muscle fiber typepicture

Over the last couple of decades, research has focused on attempting to understand the genetic influence on sports performance. This has led to the identification of a number of candidate genes which may help differentiate between elite and non-elite athletes. One of the most promising genes in that regard is ACTN3, which has commonly been referred to as “a gene for speed”. Recent research has examined the influence of this gene on other performance phenotypes, including exercise adaptation, exercise recovery, and sporting injury risk. ACTN3 is a gene that encodes for alpha-actinin-3, a protein expressed only in type-II muscle fibers (North et al., 1999). A common polymorphism in this gene is R577X (rs1815739), where a C-to-T base substitution results in the transformation of an arginine base (R) to a premature stop codon (X). X allele homozygotes are deficient in the alpha-actinin-3 protein, which is associated with a lower fast-twitch fiber percentage (Vincent et al., 2007), but does not result in disease (MacArthur and North, 2004). The XX genotype frequency differs across ethnic groups, with approximately 25% of Asians, 18% of Caucasians, 11% of Ethiopians, 3% of Jamaican and US African Americans, and 1% of Kenyans and Nigerians possessing the XX genotype (Yang et al., 2007; MacArthur et al., 2008; Scott et al., 2010). ACTN3 genotype is associated with speed and power phenotypes.

Result:

Slow muscle type

Distribution plot:

Muscle_fiber_type Distribution Plot

Scientific detail:

  • rs1815739: T/T

Reference:

  • PMID: 17828264

Nicotineaddiction

Description:

Nicotineaddictionpicture

Abundant data from twin and adoption studies provide evidence for the heritability of habitual cigarette smoking. Hall et al. reviewed twin and adoption data in smoking studies, including five studies of twins reared apart. Taken together, these twin studies suggest that a majority of NA risk is attributable to genetic factors. More recent twin smoking research suggests that the heritability of NA is ∼75%. In 2008, Berrettini et al. described a GWAS of ∼7000 individuals of European origin for CPD, with a P-value ∼10−5, at a CHRNA3 SNP allele. They studied a second population of equal size, for the same phenotype (CPD), reporting association to a second allele in the same haplotype, establishing the common European haplotype as conferring risk for Nicotine addition. The CHRNA5/A3/B4 is a gene cluster on chromosome 15 that encodes the α5, α3, and β4 of the nicotinic acetylcholine receptor subunits (nAChR) (Duga et al., 2001; Eng, Kozak, Beaudet, & Zoghbi, 1991). Genome-wide association studies have shown strong associations between tobacco smoking dependence and genetic variations in the CHRNA5/A3/B4 gene cluster (Saccone et al., 2007; Wen, Yang, Cui, & Li, 2016). One single nucleotide polymorphisms (SNP) that showed strong relation to tobacco smoking behavior/dependence is rs16969968 in exon 5 of CHRNA5.

Result:

Wild type

Distribution plot:

Nicotineaddiction Distribution Plot

Scientific detail:

  • rs429358: T/T
  • rs16969968: G/A

Reference:

  • https://www.nature.com/articles/nature06846
  • PMID: 18519524

Perception of fish odor

Description:

Perception of fish odorpicture

The perception of smell is enabled by olfactory receptors, which are proteins that bind odor molecules. Olfactory senses are one of the oldest and most critical senses for the organism survival that helps in identifying food, potential mating partners, as well as dangers. Due to the variation in the number of olfactory receptors in the species, different species have different olfactory abilities. These olfactory receptors (OR) are encoded by OR genes. In humans out of 855 OR genes, only ~400 were functionally coded for ORs. The genetic variation in the OR genes among individuals provides the personalized olfaction behaviour among individuals. A number of association studies for odor perception with genetic OR loci are reported. Also, a recent genome-wide association study was performed by Gisladottir et al. for odor perception on 9,122 Icelanders. They found three genetic variants i.e. p.Ser95Pro in TAAR5 gene (rs41286168), p.Lys233Asn in OR6C70 (rs60683621) and intergenic variant rs317787 associated with aversion to fish odor, increased intensity of licorice, and cinnamon odor respectively.

Result:

Insensitive

Distribution plot:

Perception_of_fish_odor Distribution Plot

Scientific detail:

  • rs41286168: A/A

Reference:

  • PMID: 33035477

3rd Q

The risk assessment is purely based on polygenic risk score, whose association with various diseases is usually very limited. Furthermore, the information provided here should be in no way treated similarly as information from your physician. Most complex traits are determined by both genetics, lifestyle factors, and many other environmental factors.

According to SNPedia , “population statistics are a bit hard to come by, and furthermore, the more interesting ‘personal genomics’ statistic might be residual lifetime risk in light of your own genome and your current age ... but there isn't enough medical and epidemiological data to actually calculate this yet for any complex disease”. Nevertheless, we list the average lifetime risk for various traits based on SNPedia, unless otherwise specified.

Quantitative traits

Name Risk
Age related macular degeneration Normal
Atrial fibrillation Low risk
Breast cancer Normal
COVID-19 susceptibility Normal
Colorectal cancer Normal
Coronary artery disease Low risk
Lung cancer Normal
Migraine Low risk
Schizophrenia Low risk

Scientific detail:

Atrial fibrillation

Description:

Atrial fibrillationpicture

Atrial fibrillation (AF) is the most common heart rhythm disorder worldwide and may have serious cardiovascular health consequences. AF is associated with increased risk of stroke, dementia, heart failure, and death. There are several known robust, clinical risk predictors for AF, such as male sex, increasing age, and hypertension; however, during the last couple of decades, a substantive genetic component has also been established. Over the last 10 years, the discovery of novel AF-related genetic variants has accelerated, increasing our understanding of mechanisms behind AF. Current studies are focusing on mapping the polygenic structure of AF, improving risk prediction, therapeutic development, and patient-specific management. Nevertheless, it is still difficult for clinicians to interpret the role of genetics in AF prediction and management.

Standardized genetic risk score:

Mean - 1.46 * SD

Distribution:

N of reference population: 503

N below this sample: 30 (5.96%)

N above this sample: 473 (94.04%)

Distribution plot:

Atrial_fibrillation Distribution Plot

Scientific detail:

  • rs11264280: C/C, effect allele: T, beta: 1.12
  • rs1152591: G/A, effect allele: A, beta: 1.09
  • rs11598047: A/A, effect allele: G, beta: 1.18
  • rs11718898: T/C, effect allele: C, beta: 1.08
  • rs12664873: G/T, effect allele: T, beta: 1.08
  • rs1997572: A/A, effect allele: G, beta: 1.1
  • rs2106261: C/C, effect allele: T, beta: 1.2
  • rs2288327: A/A, effect allele: G, beta: 1.09
  • rs2540949: A/A, effect allele: A, beta: 1.08
  • rs2967791: C/C, effect allele: T, beta: 1.07
  • rs337711: C/C, effect allele: T, beta: 1.07
  • rs35176054: T/T, effect allele: A, beta: 1.14
  • rs3771537: C/C, effect allele: A, beta: 1.09
  • rs4499262: C/C, effect allele: A, beta: 1.14
  • rs4946333: G/A, effect allele: G, beta: 1.08
  • rs520525: G/A, effect allele: A, beta: 1.12
  • rs60848348: C/C, effect allele: T, beta: 1.13
  • rs6843082: G/A, effect allele: G, beta: 1.45
  • rs7026071: C/C, effect allele: T, beta: 1.09
  • rs72700118: C/C, effect allele: A, beta: 1.14
  • rs7394190: G/G, effect allele: G, beta: 1.15
  • rs74022964: C/C, effect allele: T, beta: 1.12
  • rs7508: G/A, effect allele: A, beta: 1.09
  • rs75190942: C/C, effect allele: A, beta: 1.17
  • rs7915134: C/C, effect allele: C, beta: 1.12
  • rs883079: T/T, effect allele: T, beta: 1.11

Reference:

  • Multi-ethnic genome-wide association study for atrial fibrillation

Breast cancer

Description:

Breast cancerpicture

Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer risk remains unknown.

Standardized genetic risk score:

Mean - 0.32 * SD

Distribution:

N of reference population: 503

N below this sample: 175 (34.79%)

N above this sample: 328 (65.21%)

Distribution plot:

Breast_cancer Distribution Plot

Scientific detail:

  • Snp (rs2992756) cannot be found in your genotype file! Using reference population average: 1.0334317891373774
  • Snp (rs4233486) cannot be found in your genotype file! Using reference population average: 0.9589735623003371
  • Snp (rs79724016) cannot be found in your genotype file! Using reference population average: 0.7260223642172805
  • Snp (rs1707302) cannot be found in your genotype file! Using reference population average: 0.9628855431310027
  • Snp (rs140850326) cannot be found in your genotype file! Using reference population average: 1.0
  • Snp (rs17426269) cannot be found in your genotype file! Using reference population average: 1.1129035143769395
  • Snp (rs7529522) cannot be found in your genotype file! Using reference population average: 1.083614217252348
  • Snp (rs4971059) cannot be found in your genotype file! Using reference population average: 1.081641972843436
  • Snp (rs35383942) cannot be found in your genotype file! Using reference population average: 1.1632677316294282
  • Snp (rs11117758) cannot be found in your genotype file! Using reference population average: 0.9187969249201129
  • Snp (rs113577745) cannot be found in your genotype file! Using reference population average: 1.155537380191719
  • Snp (rs6725517) cannot be found in your genotype file! Using reference population average: 0.9511491613418529
  • Snp (rs71801447) cannot be found in your genotype file!
  • Snp (rs12479355) cannot be found in your genotype file! Using reference population average: 0.9069477635782623
  • Snp (rs6805189) cannot be found in your genotype file! Using reference population average: 0.9451884984025519
  • Snp (rs13066793) cannot be found in your genotype file! Using reference population average: 0.8367671725239362
  • Snp (rs9833888) cannot be found in your genotype file! Using reference population average: 1.101887380191636
  • Snp (rs34207738) cannot be found in your genotype file!
  • Snp (rs58058861) cannot be found in your genotype file! Using reference population average: 1.0794668530351308
  • Snp (rs6815814) cannot be found in your genotype file! Using reference population average: 1.0442362220447294
  • Snp (4:84370124) cannot be found in your genotype file!
  • Snp (rs10022462) cannot be found in your genotype file! Using reference population average: 1.1025896964856043
  • Snp (rs77528541) cannot be found in your genotype file! Using reference population average: 0.8431771565494999
  • Snp (rs116095464) cannot be found in your genotype file!
  • Snp (rs72749841) cannot be found in your genotype file! Using reference population average: 0.8730825079872432
  • Snp (rs35951924) cannot be found in your genotype file! Using reference population average: 0.9392945686900891
  • Snp (rs6882649) cannot be found in your genotype file! Using reference population average: 0.9536480830671081
  • Snp (rs6596100) cannot be found in your genotype file! Using reference population average: 0.9531382987220692
  • Snp (rs4562056) cannot be found in your genotype file! Using reference population average: 1.0493833865814504
  • rs3819405: C/C, effect allele: C, beta: 0.93
  • Snp (rs2223621) cannot be found in your genotype file! Using reference population average: 1.068766972843443
  • Snp (rs71557345) cannot be found in your genotype file! Using reference population average: 0.8488396166133758
  • Snp (rs12207986) cannot be found in your genotype file! Using reference population average: 0.9764736421725224
  • Snp (rs6569648) cannot be found in your genotype file! Using reference population average: 0.8445896964856018
  • Snp (rs7971) cannot be found in your genotype file! Using reference population average: 0.9534873003195139
  • rs17156577: T/T, effect allele: T, beta: 1.11
  • Snp (rs17268829) cannot be found in your genotype file! Using reference population average: 1.1084440894568466
  • Snp (rs71559437) cannot be found in your genotype file! Using reference population average: 0.9270670926517366
  • Snp (rs514192) cannot be found in your genotype file! Using reference population average: 1.0632127795526785
  • Snp (rs12546444) cannot be found in your genotype file! Using reference population average: 0.8936226837060419
  • Snp (rs58847541) cannot be found in your genotype file! Using reference population average: 1.1283795527156582
  • Snp (rs1895062) cannot be found in your genotype file! Using reference population average: 0.9566287939297338
  • Snp (rs10760444) cannot be found in your genotype file! Using reference population average: 1.0753648562300204
  • Snp (rs8176636) cannot be found in your genotype file!
  • Snp (rs67958007) cannot be found in your genotype file! Using reference population average: 1.1121314696485036
  • Snp (rs140936696) cannot be found in your genotype file! Using reference population average: 1.1059907348242641
  • Snp (rs6597981) cannot be found in your genotype file! Using reference population average: 0.9753233226837154
  • Snp (rs202049448) cannot be found in your genotype file! Using reference population average: 0.9557201277955363
  • Snp (rs206966) cannot be found in your genotype file! Using reference population average: 1.0688996805111626
  • Snp (rs10623258) cannot be found in your genotype file! Using reference population average: 1.0449779552715384
  • Snp (rs28539243) cannot be found in your genotype file! Using reference population average: 1.0340764776357831
  • Snp (rs2432539) cannot be found in your genotype file! Using reference population average: 1.0727875399360927
  • Snp (rs4496150) cannot be found in your genotype file! Using reference population average: 0.9413840255590948
  • Snp (rs72826962) cannot be found in your genotype file! Using reference population average: 0.9801434904153662
  • Snp (rs2532263) cannot be found in your genotype file!
  • Snp (rs117618124) cannot be found in your genotype file! Using reference population average: 0.7437507987220884
  • Snp (rs78269692) cannot be found in your genotype file! Using reference population average: 1.1641597444089813
  • Snp (rs2594714) cannot be found in your genotype file! Using reference population average: 0.9321204472843492
  • Snp (rs2965183) cannot be found in your genotype file! Using reference population average: 1.0530301517571885
  • Snp (rs71338792) cannot be found in your genotype file!
  • rs16991615: G/G, effect allele: G, beta: 1.09
  • Snp (rs6122906) cannot be found in your genotype file! Using reference population average: 1.11911693290735
  • Snp (rs738321) cannot be found in your genotype file! Using reference population average: 0.9304579872204548
  • Snp (rs73161324) cannot be found in your genotype file! Using reference population average: 1.2939507987220076
  • Snp (rs28512361) cannot be found in your genotype file! Using reference population average: 1.1055137380191156

Reference:

  • Association analysis identifies 65 new breast cancer risk loci

COVID-19 susceptibility

Description:

COVID-19 susceptibilitypicture

While environmental, clinical and social factors play a role in exposure to SARS-CoV-2 and COVID-19 disease severity, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We derive personal susceptibility based on GWAS released by the COVID-19 host genetics initiative. This initiative brings together the human genetics community to generate, share, and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity, and outcomes. Such discoveries could help to generate hypotheses for drug repurposing, identify individuals at unusually high or low risk, and contribute to global knowledge of the biology of SARS-CoV-2 infection and disease.

Standardized genetic risk score:

Mean + 0.44 * SD

Distribution:

N of reference population: 503

N below this sample: 325 (64.61%)

N above this sample: 178 (35.39%)

Distribution plot:

COVID-19_susceptibility Distribution Plot

Scientific detail:

  • Snp (rs2271616) cannot be found in your genotype file! Using reference population average: 1.3052131988818636
  • Snp (rs10490770) cannot be found in your genotype file! Using reference population average: 1.315690734824335
  • Snp (rs11919389) cannot be found in your genotype file! Using reference population average: 0.9177937967252382
  • Snp (rs1886814) cannot be found in your genotype file! Using reference population average: 1.1869673210862484
  • Snp (rs912805253) cannot be found in your genotype file!
  • rs10774671: G/G, effect allele: G, beta: 1.059
  • Snp (rs2109069) cannot be found in your genotype file! Using reference population average: 1.0788328202875401
  • Snp (rs4801778) cannot be found in your genotype file! Using reference population average: 0.9080582284344927
  • Snp (rs72711165) cannot be found in your genotype file! Using reference population average: 1.1523330299520391
  • Snp (rs1819040) cannot be found in your genotype file! Using reference population average: 0.9240992815495079
  • Snp (rs77534576) cannot be found in your genotype file! Using reference population average: 1.1687035335463538
  • Snp (rs74956615) cannot be found in your genotype file! Using reference population average: 1.1114028953674755
  • Snp (rs13050728) cannot be found in your genotype file! Using reference population average: 0.9739275223642436

Reference:

  • PMID:34237774

Colorectal cancer

Description:

Colorectal cancerpicture

Colorectal cancer (CRC) is the third and fourth most common cancer in women and men worldwide, respectively, and the fourth most common cause of cancer death. CRC exhibits global geographic variations in its incidence with multiple factors (social, demographic, environmental, and genetic) playing different roles in its pathogenesis. Diet rich in fat and low in fiber, high levels of triglycerides, physical inactivity, diabetes, alcohol, obesity, and smoking are the identified risk factors of colorectal cancer. Hereditary factors play a definite role as well. CRC is generally sporadic but approximately 25% of the patients have a genetic predisposition. Instability in chromosomes, CpG island methylation, and microsatellite instability have been reported in key genes leading to the developing of CRC. Gene–environment interactions are also important in the pathogenesis.

Standardized genetic risk score:

Mean + 0.09 * SD

Distribution:

N of reference population: 503

N below this sample: 274 (54.47%)

N above this sample: 229 (45.53%)

Distribution plot:

Colorectal_cancer Distribution Plot

Scientific detail:

  • Using "clump" and "score" function in plink to calculate PRS.
     
  • There are 4791 variants for this trait in raw GWAS data.
     
  • After clumping, there are 4792 valid variants for PRS.
     
  • In this sample, there are 4790 loaded to calculate PRS.
     

Reference:

  • Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Coronary artery disease

Description:

Coronary artery diseasepicture

Coronary artery disease (CAD) is a leading cause of death worldwide. The major sequelae of CAD include angina, myocardial infarction (MI), arrhythmias, heart failure, and sudden cardiac death. CAD has a complex aetiology, and various environmental factors, including cigarette smoking, sedentary lifestyle, unhealthy diet and obesity, and disease predisposition. These lifestyle-related factors can lead to type 2 diabetes, hypercholesterolaemia and arterial hypertension, which are key risk factors for CAD. In addition, the influence of heritability on CAD susceptibility has been recognized for many years and accounts for 40–50% of cases. Although the inherited CAD risk is particularly evident in large families with multiple affected members, decade ago only mutations in the LDL receptor gene were reproducibly linked to the disease. However, with the emergence of genome-wide association studies (GWAS), large number of common variants displayed strongly reproducible yet small effects and substantially broadened the spectrum of genetic factors recognized as contributing to CAD aetiology.

Standardized genetic risk score:

Mean - 2.04 * SD

Distribution:

N of reference population: 503

N below this sample: 7 (1.39%)

N above this sample: 496 (98.61%)

Distribution plot:

Coronary_artery_disease Distribution Plot

Scientific detail:

  • rs10840293: G/A, effect allele: A, beta: 1.06
  • rs10947789: T/C, effect allele: T, beta: 1.05
  • rs10953541: C/C, effect allele: C, beta: 1.05
  • rs11203042: T/C, effect allele: T, beta: 1.04
  • rs11206510: T/T, effect allele: T, beta: 1.08
  • rs1122608: G/T, effect allele: G, beta: 1.08
  • rs11556924: C/C, effect allele: C, beta: 1.08
  • rs11830157: T/T, effect allele: G, beta: 1.04
  • rs12190287: G/C, effect allele: C, beta: 1.06
  • rs12413409: G/G, effect allele: G, beta: 1.08
  • rs12526453: C/C, effect allele: C, beta: 1.1
  • rs12936587: G/A, effect allele: G, beta: 1.03
  • rs12976411: A/A, effect allele: T, beta: 0.95
  • rs1412444: T/T, effect allele: T, beta: 1.07
  • rs1561198: T/C, effect allele: T, beta: 1.06
  • rs16986953: G/G, effect allele: A, beta: 1.09
  • rs17087335: G/G, effect allele: T, beta: 1.06
  • rs17114036: G/A, effect allele: A, beta: 1.13
  • rs17464857: T/T, effect allele: T, beta: 1.06
  • rs17465637: C/C, effect allele: C, beta: 1.08
  • rs17514846: C/C, effect allele: A, beta: 1.05
  • rs180803: G/G, effect allele: G, beta: 1.2
  • rs1878406: C/C, effect allele: T, beta: 1.06
  • rs2023938: T/T, effect allele: C, beta: 1.06
  • rs2047009: G/T, effect allele: G, beta: 1.06
  • rs2048327: T/T, effect allele: C, beta: 1.06
  • rs2075650: A/A, effect allele: G, beta: 1.07
  • rs216172: G/G, effect allele: C, beta: 1.05
  • rs2252641: C/C, effect allele: C, beta: 1.03
  • rs2505083: T/C, effect allele: C, beta: 1.06
  • rs264: G/G, effect allele: G, beta: 1.06
  • rs273909: A/A, effect allele: G, beta: 1.06
  • rs2895811: T/C, effect allele: C, beta: 1.04
  • rs2954029: T/T, effect allele: A, beta: 1.04
  • rs3184504: T/C, effect allele: T, beta: 1.07
  • rs3217992: C/C, effect allele: T, beta: 1.14
  • rs3798220: T/T, effect allele: C, beta: 1.42
  • rs3918226: C/C, effect allele: T, beta: 1.14
  • rs4252120: C/C, effect allele: T, beta: 1.03
  • rs445925: G/G, effect allele: G, beta: 1.09
  • rs46522: C/C, effect allele: T, beta: 1.04
  • rs4773144: A/A, effect allele: G, beta: 1.05
  • rs4845625: C/C, effect allele: T, beta: 1.05
  • rs4977574: A/A, effect allele: G, beta: 1.21
  • rs501120: T/T, effect allele: T, beta: 1.08
  • rs515135: C/C, effect allele: C, beta: 1.07
  • rs56062135: T/C, effect allele: C, beta: 1.07
  • rs579459: T/C, effect allele: C, beta: 1.08
  • rs646776: T/C, effect allele: T, beta: 1.11
  • rs6544713: C/C, effect allele: T, beta: 1.05
  • rs663129: G/A, effect allele: A, beta: 1.06
  • rs6725887: T/T, effect allele: C, beta: 1.14
  • rs7136259: T/C, effect allele: T, beta: 1.04
  • rs7173743: T/C, effect allele: T, beta: 1.08
  • rs7212798: T/T, effect allele: C, beta: 1.08
  • rs7692387: G/A, effect allele: G, beta: 1.07
  • rs8042271: G/G, effect allele: G, beta: 1.1
  • rs9319428: G/G, effect allele: A, beta: 1.04
  • rs9515203: T/T, effect allele: T, beta: 1.07
  • rs964184: C/C, effect allele: G, beta: 1.05
  • rs974819: C/C, effect allele: T, beta: 1.07
  • rs9818870: C/C, effect allele: T, beta: 1.07
  • rs9982601: C/C, effect allele: T, beta: 1.12

Reference:

  • Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease

Lung cancer

Description:

Lung cancerpicture

Lung cancer is the leading cause of cancer-related deaths worldwide in both men and women. Although it has long been recognized that lung cancer runs strongly in families, the specific genes that are responsible for enhanced risk are just starting to be revealed. Identifying genes responsible for lung cancer before the era of GWAS has been limited. Candidate susceptibility genes coding for enzymes involved in the activation, detoxification and repair of damages caused by tobacco smoke as well as genes in inflammatory and cell-cycle pathways have been extensively studied. Many of these candidate gene studies are either preliminary or controversial. GWAS have evolved from finding lung cancer loci per se, to a more refined search strategy focused on specific subgroups of lung cancer patients. Advances in analysis strategies were also achieved moving from single marker analyses to pathway-based and variant prioritization approaches. GWAS have also been performed to find genetic loci associated with lung cancer survival, response to conventional therapies, and multiple sites of cancer. GWAS by environmental exposures and genome-wide epistasis analyses are also emerging.

Standardized genetic risk score:

Mean - 0.13 * SD

Distribution:

N of reference population: 503

N below this sample: 223 (44.33%)

N above this sample: 280 (55.67%)

Distribution plot:

Lung_cancer Distribution Plot

Scientific detail:

  • rs1056562: C/C, effect allele: T, beta: 1.11
  • rs11571833: A/A, effect allele: T, beta: 1.6
  • rs11591710: A/A, effect allele: C, beta: 1.16
  • Snp (rs116822326) cannot be found in your genotype file!
  • rs11780471: G/G, effect allele: A, beta: 0.87
  • rs13080835: G/T, effect allele: T, beta: 0.9
  • rs17879961: A/A, effect allele: G, beta: 0.41
  • rs41309931: G/G, effect allele: T, beta: 1.17
  • rs4236709: G/A, effect allele: G, beta: 1.13
  • rs55781567: G/C, effect allele: G, beta: 1.3
  • rs56113850: C/C, effect allele: T, beta: 0.88
  • rs66759488: G/G, effect allele: A, beta: 1.07
  • rs6920364: G/G, effect allele: C, beta: 1.07
  • rs71658797: T/T, effect allele: A, beta: 1.13
  • rs7705526: C/C, effect allele: A, beta: 1.25
  • rs77468143: T/T, effect allele: G, beta: 0.86
  • rs7953330: G/C, effect allele: C, beta: 0.86
  • rs885518: G/A, effect allele: G, beta: 1.17

Reference:

  • Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

Migraine

Description:

Migrainepicture

Migraine affects up to one-fifth of the world population. It persistently ranks among the top 10 causes of disability, and accounts for more than half of the years lived with disability from neurological causes. As such, migraine has a tremendous socioeconomic impact, not to mention lost productivity and human suffering. Despite decades of research, the complex pathophysiology of migraine is still poorly understood. Without understanding the molecular mechanisms, existing therapies are empirical, serendipitous, and of limited efficacy. It has long been recognised that migraine is a disease with a strong genetic component. Migraine runs in families, and epidemiological studies in twins and families have indicated that risk for migraine is conferred by a combination of genetic and environmental factors, both contributing equally. These studies also indicated that the genetic contribution seems stronger in migraine with aura than the more common migraine without aura subtype.

Standardized genetic risk score:

Mean - 0.69 * SD

Distribution:

N of reference population: 503

N below this sample: 120 (23.86%)

N above this sample: 383 (76.14%)

Distribution plot:

Migraine Distribution Plot

Scientific detail:

  • rs10155855: A/A, effect allele: T, beta: 1.08
  • rs10166942: T/C, effect allele: C, beta: 0.94
  • rs10218452: A/A, effect allele: G, beta: 1.11
  • rs1024905: G/G, effect allele: G, beta: 1.06
  • rs10456100: C/C, effect allele: T, beta: 1.06
  • rs10786156: C/C, effect allele: G, beta: 0.95
  • rs10895275: A/A, effect allele: A, beta: 1.04
  • rs11031122: T/T, effect allele: C, beta: 1.04
  • Snp (rs111404218) cannot be found in your genotype file!
  • rs11172113: T/C, effect allele: C, beta: 0.9
  • rs11624776: A/C, effect allele: C, beta: 0.96
  • rs12260159: G/A, effect allele: A, beta: 0.92
  • rs1268083: T/T, effect allele: C, beta: 0.96
  • rs12845494: C/C, effect allele: G, beta: 0.96
  • rs13078967: A/A, effect allele: C, beta: 0.87
  • rs138556413: C/C, effect allele: T, beta: 0.88
  • Snp (rs140002913) cannot be found in your genotype file!
  • rs144017103: C/C, effect allele: T, beta: 0.85
  • rs1572668: A/A, effect allele: G, beta: 1.04
  • rs17857135: T/T, effect allele: C, beta: 1.06
  • rs186166891: A/A, effect allele: T, beta: 1.09
  • rs1925950: A/A, effect allele: G, beta: 1.07
  • rs2078371: T/T, effect allele: C, beta: 1.11
  • rs2223089: G/G, effect allele: C, beta: 0.93
  • rs2506142: A/A, effect allele: G, beta: 1.06
  • rs28455731: G/G, effect allele: T, beta: 1.06
  • rs4081947: G/G, effect allele: G, beta: 1.03
  • rs4814864: G/C, effect allele: C, beta: 1.07
  • rs4910165: G/C, effect allele: C, beta: 0.94
  • rs561561: A/A, effect allele: T, beta: 0.94
  • rs6478241: G/A, effect allele: A, beta: 1.05
  • rs6693567: T/T, effect allele: C, beta: 1.05
  • Snp (rs67338227) cannot be found in your genotype file!
  • rs6791480: C/C, effect allele: T, beta: 1.04
  • rs75213074: C/C, effect allele: T, beta: 0.89
  • rs7684253: T/T, effect allele: C, beta: 0.96
  • Snp (rs77505915) cannot be found in your genotype file!
  • rs9349379: G/G, effect allele: G, beta: 0.93
  • rs10514168: C/C, effect allele: C, beta: 1.05
  • rs10752212: G/A, effect allele: G, beta: 1.03
  • rs10970305: A/C, effect allele: C, beta: 1.06
  • rs11129078: G/A, effect allele: G, beta: 1.06
  • rs11713169: A/A, effect allele: C, beta: 1.05
  • rs1195218: G/G, effect allele: G, beta: 1.1
  • rs1378552: T/C, effect allele: T, beta: 1.03
  • rs149951341: C/C, effect allele: C, beta: 1.05
  • rs17515225: T/C, effect allele: T, beta: 1.03
  • rs1782032: G/G, effect allele: G, beta: 1.03
  • rs1847202: T/T, effect allele: T, beta: 1.03
  • rs1858111: A/A, effect allele: G, beta: 1.04
  • rs2150864: G/A, effect allele: G, beta: 1.04
  • rs2153535: G/G, effect allele: G, beta: 1.05
  • rs2318131: A/C, effect allele: C, beta: 1.04
  • rs2360806: A/A, effect allele: C, beta: 1.05
  • rs2551802: G/G, effect allele: G, beta: 1.04
  • rs34311235: T/T, effect allele: T, beta: 1.03
  • rs34912216: G/A, effect allele: G, beta: 1.04
  • rs4076764: T/T, effect allele: T, beta: 1.03
  • rs4343996: A/A, effect allele: G, beta: 1.03
  • rs56051278: A/A, effect allele: G, beta: 1.07
  • rs60464047: T/T, effect allele: T, beta: 1.04
  • rs6069325: T/T, effect allele: T, beta: 1.07
  • rs61759167: C/C, effect allele: T, beta: 1.05
  • rs62018380: A/C, effect allele: C, beta: 1.05
  • rs66800491: A/A, effect allele: G, beta: 1.08
  • rs6833641: G/G, effect allele: G, beta: 1.05
  • rs6946969: G/A, effect allele: G, beta: 1.03
  • rs705145: A/C, effect allele: C, beta: 1.05
  • rs7170668: T/T, effect allele: T, beta: 1.04
  • rs7957589: A/T, effect allele: T, beta: 1.05
  • rs9834560: A/C, effect allele: C, beta: 1.04
  • rs9906289: C/C, effect allele: T, beta: 1.09
  • rs997295: T/T, effect allele: T, beta: 1.03

Reference:

  • Meta-analysis of 375
  • 000 individuals identifies 38 susceptibility loci for migraine

Schizophrenia

Description:

Schizophreniapicture

Schizophrenia is a common and serious psychiatric illness affecting 0.5–1% of the population in early adulthood. The disease remains incurable, with the best outcome being the control of symptoms and preservation of sufficient functionality and independence. Schizophrenia is a disease with remarkable phenotypic heterogeneity. The symptoms are generally divided into three categories: positive symptoms, negative symptoms, and cognitive symptoms. Each patient can have a different mix of the three types of symptoms leading to an overall highly heterogeneous phenotype. Affective symptoms may combine with the classic symptoms of schizophrenia leading to schizoaffective disorder, which some genetic researchers categorize with schizophrenia and others with bipolar disorder (BD). It has long been recognized that schizophrenia runs in families, noted in the first detailed description of the disease by Bleuler in 1911. Formally, the heritability of the disease has been calculated at > 80%, making genetic makeup the most important factor for developing the disease.

Standardized genetic risk score:

Mean - 1.24 * SD

Distribution:

N of reference population: 503

N below this sample: 57 (11.33%)

N above this sample: 446 (88.67%)

Average lifetime risk: 15.2/100,000 persons

Distribution plot:

Schizophrenia Distribution Plot

Scientific detail:

  • Snp (chr1_243881945_I) cannot be found in your genotype file!
  • Snp (chr1_8424984_D) cannot be found in your genotype file!
  • Snp (chr10_104957618_I) cannot be found in your genotype file!
  • Snp (chr11_46350213_D) cannot be found in your genotype file!
  • Snp (chr18_52749216_D) cannot be found in your genotype file!
  • Snp (chr2_146436222_I) cannot be found in your genotype file!
  • Snp (chr2_149429178_D) cannot be found in your genotype file!
  • Snp (chr2_200825237_I) cannot be found in your genotype file!
  • Snp (chr22_39987017_D) cannot be found in your genotype file!
  • Snp (chr3_180594593_I) cannot be found in your genotype file!
  • Snp (chr5_140143664_I) cannot be found in your genotype file!
  • Snp (chr6_84280274_D) cannot be found in your genotype file!
  • Snp (chr7_2025096_I) cannot be found in your genotype file!
  • Snp (chr7_24747494_D) cannot be found in your genotype file!
  • rs10043984: C/C, effect allele: T, beta: 1.069
  • rs1023500: T/T, effect allele: T, beta: 1.076
  • rs10503253: A/C, effect allele: A, beta: 1.073
  • rs10520163: T/T, effect allele: T, beta: 1.065
  • rs10791097: T/T, effect allele: T, beta: 1.076
  • rs10803138: G/A, effect allele: A, beta: 0.933
  • rs10860964: C/C, effect allele: T, beta: 1.06
  • rs11027857: G/A, effect allele: A, beta: 1.064
  • rs1106568: A/A, effect allele: A, beta: 0.934
  • rs111294930: G/G, effect allele: A, beta: 1.094
  • rs11139497: A/A, effect allele: A, beta: 1.069
  • rs11191419: T/T, effect allele: A, beta: 0.906
  • rs11210892: A/A, effect allele: A, beta: 0.934
  • Snp (rs115329265) cannot be found in your genotype file!
  • rs11682175: T/C, effect allele: T, beta: 0.933
  • rs11685299: A/A, effect allele: A, beta: 0.939
  • rs11693094: T/C, effect allele: T, beta: 0.929
  • rs117074560: C/C, effect allele: T, beta: 0.849
  • rs11740474: A/A, effect allele: A, beta: 0.942
  • rs12129573: A/C, effect allele: A, beta: 1.078
  • rs12148337: T/T, effect allele: T, beta: 1.06
  • rs12325245: A/A, effect allele: A, beta: 0.92
  • rs12421382: T/C, effect allele: T, beta: 0.941
  • rs12522290: C/C, effect allele: C, beta: 1.084
  • rs12691307: G/A, effect allele: A, beta: 1.073
  • rs12704290: G/A, effect allele: A, beta: 0.904
  • rs12826178: G/G, effect allele: T, beta: 0.846
  • rs12845396: A/A, effect allele: A, beta: 0.947
  • rs12887734: G/G, effect allele: T, beta: 1.088
  • rs12903146: A/A, effect allele: A, beta: 1.067
  • rs13240464: T/T, effect allele: T, beta: 1.083
  • rs1339227: T/C, effect allele: T, beta: 0.942
  • rs1378559: T/T, effect allele: T, beta: 1.09
  • rs140505938: T/C, effect allele: T, beta: 0.914
  • rs14403: T/C, effect allele: T, beta: 0.934
  • rs1498232: C/C, effect allele: T, beta: 1.069
  • rs1501357: T/T, effect allele: T, beta: 0.926
  • rs16867576: A/A, effect allele: A, beta: 1.101
  • rs1702294: C/C, effect allele: T, beta: 0.887
  • rs17194490: G/G, effect allele: T, beta: 1.101
  • Snp (rs190065944) cannot be found in your genotype file!
  • rs2007044: G/A, effect allele: A, beta: 0.912
  • rs2053079: A/A, effect allele: A, beta: 0.931
  • rs2068012: T/C, effect allele: T, beta: 0.933
  • rs211829: T/T, effect allele: T, beta: 1.061
  • rs215411: A/T, effect allele: A, beta: 1.064
  • rs2239063: A/A, effect allele: A, beta: 1.067
  • rs2332700: G/C, effect allele: C, beta: 1.073
  • rs2514218: T/C, effect allele: T, beta: 0.927
  • rs2535627: T/T, effect allele: T, beta: 1.071
  • rs2693698: G/G, effect allele: A, beta: 0.939
  • rs2851447: G/C, effect allele: C, beta: 0.915
  • rs2905426: G/T, effect allele: T, beta: 0.934
  • rs2909457: G/A, effect allele: A, beta: 0.944
  • rs2973155: T/C, effect allele: T, beta: 0.933
  • rs324017: A/C, effect allele: A, beta: 0.938
  • rs35518360: A/A, effect allele: A, beta: 0.857
  • rs36068923: A/A, effect allele: A, beta: 0.919
  • rs3735025: C/C, effect allele: T, beta: 1.066
  • rs3768644: G/G, effect allele: A, beta: 0.904
  • rs3849046: T/C, effect allele: T, beta: 1.063
  • rs4129585: C/C, effect allele: A, beta: 1.087
  • rs4240748: C/C, effect allele: C, beta: 0.943
  • rs4330281: T/C, effect allele: T, beta: 0.94
  • rs4388249: C/C, effect allele: T, beta: 1.076
  • rs4391122: G/A, effect allele: A, beta: 0.922
  • rs4523957: T/T, effect allele: T, beta: 1.071
  • rs4648845: C/C, effect allele: T, beta: 1.072
  • rs4702: A/A, effect allele: A, beta: 0.922
  • rs4766428: C/C, effect allele: T, beta: 1.068
  • rs55661361: G/G, effect allele: A, beta: 0.926
  • rs55833108: G/G, effect allele: T, beta: 1.075
  • rs56205728: G/A, effect allele: A, beta: 1.074
  • rs56873913: T/T, effect allele: T, beta: 1.071
  • rs5937157: T/T, effect allele: T, beta: 0.938
  • rs59979824: A/A, effect allele: A, beta: 0.937
  • rs6002655: T/C, effect allele: T, beta: 1.066
  • rs6065094: G/A, effect allele: A, beta: 0.928
  • rs6434928: G/A, effect allele: A, beta: 0.929
  • rs6466055: C/C, effect allele: A, beta: 1.068
  • rs6670165: T/C, effect allele: T, beta: 1.075
  • rs6704641: A/A, effect allele: A, beta: 1.081
  • rs6704768: A/A, effect allele: A, beta: 0.93
  • rs679087: C/C, effect allele: A, beta: 0.941
  • rs6984242: G/A, effect allele: A, beta: 0.941
  • rs715170: C/C, effect allele: T, beta: 0.935
  • rs7267348: T/T, effect allele: T, beta: 0.937
  • rs72934570: T/C, effect allele: T, beta: 0.873
  • rs73229090: A/C, effect allele: A, beta: 0.908
  • rs7405404: T/C, effect allele: T, beta: 1.077
  • rs7432375: G/A, effect allele: A, beta: 0.933
  • rs75059851: A/A, effect allele: A, beta: 1.091
  • rs7523273: A/A, effect allele: A, beta: 1.063
  • rs75575209: A/A, effect allele: A, beta: 0.902
  • rs75968099: C/C, effect allele: T, beta: 1.085
  • rs76869799: C/C, effect allele: C, beta: 0.846
  • rs77149735: G/G, effect allele: A, beta: 1.317
  • rs77502336: G/G, effect allele: C, beta: 1.066
  • rs7801375: G/G, effect allele: A, beta: 0.924
  • rs7819570: G/G, effect allele: T, beta: 1.079
  • rs78322266: G/G, effect allele: T, beta: 1.188
  • rs7893279: T/T, effect allele: T, beta: 1.125
  • Snp (rs7907645) cannot be found in your genotype file!
  • rs79212538: G/G, effect allele: T, beta: 1.155
  • rs8042374: G/A, effect allele: A, beta: 1.093
  • rs8044995: G/G, effect allele: A, beta: 1.081
  • rs8082590: A/A, effect allele: A, beta: 0.939
  • rs832187: C/C, effect allele: T, beta: 0.941
  • rs9420: G/G, effect allele: A, beta: 1.068
  • rs950169: T/C, effect allele: T, beta: 0.923
  • rs9607782: T/T, effect allele: A, beta: 1.087
  • rs9636107: A/A, effect allele: A, beta: 0.93
  • rs9841616: T/T, effect allele: A, beta: 0.925
  • rs9922678: A/A, effect allele: A, beta: 1.067

Reference:

  • Biological insights from 108 schizophrenia-associated genetic loci

4th Q

This section uses PharmGKB and ClinVAR as an example, to illustrate how PAGEMENT could query third party genotype-based databases. Right now, only VCF file format is supported. By default, the first five INFO fields are displayed in the output table, unless specified otherwise by the user.

Clinvar

Page:
Variant Allele Allele type Genotype Clinvar ID
rs10246939 C Drug response TC 2906
rs1042713 A Drug response GA 225937
rs10509305 C Conflicting interpretations of pathogenicity AC 1720
rs10509681 C Drug response TC 375654
rs1051740 C Drug response TC 16604
rs16969968 A Drug response GA 17497
rs1800629 A Drug response GA 225964
rs1801131 G Conflicting interpretations of pathogenicity GT 3521
rs1801133 A Drug response GA 3520
rs1801274 G Drug response GA 14823
rs1801278 T Risk factor TC 29761
rs1801394 G Drug response GA 7029
rs1801700 A Conflicting interpretations of pathogenicity GA 255981
rs2214102 C Drug response TC 829326
rs2228001 T Drug response GT 190215
rs3738888 A Conflicting interpretations of pathogenicity GA 136500
rs405509 G Drug response GT 619951
rs4680 A Drug response GA 17591
rs4961 T Drug response GT 18274
rs5174 T Risk factor TT 6996
rs6025 C Drug response CC 226007
rs716274 G Drug response GG 226013
rs9332131 G Drug response GAGA 285601
rs10066882 A Conflicting interpretations of pathogenicity CC 414373
rs1041983 T Drug response CC 375653
rs10979599 T Conflicting interpretations of pathogenicity GG 245634
rs11078699 T Conflicting interpretations of pathogenicity CC 387361
rs11104729 C Conflicting interpretations of pathogenicity TT 261849
rs11466016 A Conflicting interpretations of pathogenicity CC 36516
rs11541998 T Conflicting interpretations of pathogenicity CC 732303
rs11549709 A Conflicting interpretations of pathogenicity GG 136294
rs11568360 A Conflicting interpretations of pathogenicity GG 284547
rs11569534 T Conflicting interpretations of pathogenicity CC 330292
rs11569541 G Conflicting interpretations of pathogenicity AA 636934
rs11570255 A Conflicting interpretations of pathogenicity GG 16646
rs11571640 C Conflicting interpretations of pathogenicity AA 38258
rs11575936 T Conflicting interpretations of pathogenicity CC 723758
rs11807956 A Conflicting interpretations of pathogenicity GG 256741
rs11840224 A Conflicting interpretations of pathogenicity GG 35723
rs11893228 T Conflicting interpretations of pathogenicity CC 178627
rs11971167 A Drug response GG 7164
rs12161733 A Conflicting interpretations of pathogenicity GG 536220
rs12324002 G Conflicting interpretations of pathogenicity AA 36133
rs12562058 A Conflicting interpretations of pathogenicity CC 710715
rs12713843 T Conflicting interpretations of pathogenicity CC 281142
rs12720763 A Conflicting interpretations of pathogenicity CC 334059
rs13098532 G Conflicting interpretations of pathogenicity TT 343746
rs13171868 C Conflicting interpretations of pathogenicity TT 163597
rs13306187 T Conflicting interpretations of pathogenicity CC 334146
rs13306505 T Conflicting interpretations of pathogenicity CC 374957
rs13306523 T Conflicting interpretations of pathogenicity CC 297984
rs16024 T Conflicting interpretations of pathogenicity CC 194928
rs16881446 C Risk factor TT 441163
rs16904791 A Conflicting interpretations of pathogenicity CC 709941
rs16937932 T Conflicting interpretations of pathogenicity CC 178767
rs16955859 G Conflicting interpretations of pathogenicity AA 707596
rs16978578 C Conflicting interpretations of pathogenicity TT 226712
rs17006082 G Conflicting interpretations of pathogenicity TT 462965
rs17027133 C Conflicting interpretations of pathogenicity TT 540408
rs17028450 T Conflicting interpretations of pathogenicity CC 12707
rs17071686 A Conflicting interpretations of pathogenicity CC 774331
rs17089782 A Conflicting interpretations of pathogenicity GG 217689
rs17102066 T Conflicting interpretations of pathogenicity CC 281057
rs17107315 C Conflicting interpretations of pathogenicity TT 13760
rs17158558 T Conflicting interpretations of pathogenicity CC 13938
rs17222674 G Conflicting interpretations of pathogenicity AA 499389
rs17235409 A Risk factor GG 9233
rs17354992 T Conflicting interpretations of pathogenicity CC 46987
rs17500494 G Conflicting interpretations of pathogenicity TT 359958
rs17514281 G Conflicting interpretations of pathogenicity AA 294581
rs1762111 G Conflicting interpretations of pathogenicity AA 99311
rs17860530 A Conflicting interpretations of pathogenicity GG 196346
rs17878854 A Conflicting interpretations of pathogenicity GG 366730
rs17879685 T Drug response CC 633846
rs17879961 G Conflicting interpretations of pathogenicity AA 5591
rs17883718 A Conflicting interpretations of pathogenicity GG 618661
rs17885240 T Conflicting interpretations of pathogenicity CC 134361
rs1799802 T Conflicting interpretations of pathogenicity CC 134148
rs1799978 C Drug response TT 225963
rs1800056 C Conflicting interpretations of pathogenicity TT 132736
rs1800059 C Conflicting interpretations of pathogenicity AA 127399
rs1800120 T Conflicting interpretations of pathogenicity GG 256253
rs1800556 T Conflicting interpretations of pathogenicity CC 3830
rs1800562 A Conflicting interpretations of pathogenicity GG 9
rs1800888 T Drug response CC 17744
rs1805007 T Conflicting interpretations of pathogenicity CC 14312
rs1805008 T Conflicting interpretations of pathogenicity CC 14310
rs1805322 T Conflicting interpretations of pathogenicity GG 135946
rs2070074 G Conflicting interpretations of pathogenicity AA 3613
rs2219594 A Conflicting interpretations of pathogenicity CC 51695
rs2227434 T Conflicting interpretations of pathogenicity CC 696149
rs2228241 A Conflicting interpretations of pathogenicity GG 42334
rs2229152 T Conflicting interpretations of pathogenicity CC 712435
rs2229843 T Conflicting interpretations of pathogenicity GG 12690
rs2230234 T Conflicting interpretations of pathogenicity AA 36014
rs2230516 T Conflicting interpretations of pathogenicity CC 194960
rs2232078 T Conflicting interpretations of pathogenicity CC 339211
rs2233218 A Conflicting interpretations of pathogenicity GG 218640
rs2233328 G Conflicting interpretations of pathogenicity TT 188374
rs2235019 A Drug response CC 828595
rs2235075 G Drug response AA 828561
rs2271305 C Conflicting interpretations of pathogenicity TT 197782
rs2272707 A Conflicting interpretations of pathogenicity GG 737320
rs2275601 C Conflicting interpretations of pathogenicity TT 715943
rs2276263 A Conflicting interpretations of pathogenicity GG 374733
rs2276278 T Conflicting interpretations of pathogenicity GG 517205
rs2287617 T Conflicting interpretations of pathogenicity CC 594929
rs2288326 T Conflicting interpretations of pathogenicity GG 47548
rs2295947 A Conflicting interpretations of pathogenicity GG 165063
rs2296928 G Conflicting interpretations of pathogenicity TT 692098
rs2303603 A Conflicting interpretations of pathogenicity GG 290657
rs2303834 G Conflicting interpretations of pathogenicity AA 47086
rs2307440 A Conflicting interpretations of pathogenicity GG 21313
rs2491080 A Conflicting interpretations of pathogenicity GG 626489
rs268 G Conflicting interpretations of pathogenicity AA 1550
rs28363595 T Conflicting interpretations of pathogenicity CC 713884
rs28364364 A Conflicting interpretations of pathogenicity GG 92419
rs28364528 A Conflicting interpretations of pathogenicity GG 468645
rs28364537 T Conflicting interpretations of pathogenicity CC 254868
rs28369776 A Conflicting interpretations of pathogenicity GG 377876
rs28377085 G Conflicting interpretations of pathogenicity AA 236819
rs28383481 A Conflicting interpretations of pathogenicity GG 38794
rs28399504 G Drug response AA 16900
rs28562785 T Conflicting interpretations of pathogenicity CC 159460
rs288326 A Risk factor GG 5221
rs2884737 C Drug response AA 225983
rs28897680 G Conflicting interpretations of pathogenicity TT 37443
rs28903085 C Conflicting interpretations of pathogenicity AA 128012
rs28903091 A Conflicting interpretations of pathogenicity GG 37380
rs28909989 A Conflicting interpretations of pathogenicity GG 331219
rs28910612 A Conflicting interpretations of pathogenicity GG 786476
rs28990974 C Conflicting interpretations of pathogenicity TT 302744
rs28990975 C Conflicting interpretations of pathogenicity AA 302740
rs28991292 A Conflicting interpretations of pathogenicity GG 256612
rs29000285 T Conflicting interpretations of pathogenicity CC 361175
rs2915960 T Conflicting interpretations of pathogenicity CC 329088
rs3087376 T Conflicting interpretations of pathogenicity CC 317310
rs3087378 A Conflicting interpretations of pathogenicity GG 317337
rs3092859 C Conflicting interpretations of pathogenicity TT 135748
rs3212986 A Drug response CC 225987
rs3212989 G Conflicting interpretations of pathogenicity AA 235480
rs3213408 T Conflicting interpretations of pathogenicity CC 464097
rs3218690 C Conflicting interpretations of pathogenicity TT 132757
rs3219488 A Conflicting interpretations of pathogenicity GG 132703
rs339097 G Drug response AA 225988
rs34044544 A Conflicting interpretations of pathogenicity GG 352970
rs34360255 A Conflicting interpretations of pathogenicity GG 763904
rs34391943 T Conflicting interpretations of pathogenicity CC 167378
rs34723289 G Conflicting interpretations of pathogenicity AA 198818
rs34819316 A Conflicting interpretations of pathogenicity GG 445491
rs34832477 A Conflicting interpretations of pathogenicity GG 691859
rs35152987 A Conflicting interpretations of pathogenicity CC 15070
rs35313315 A Conflicting interpretations of pathogenicity TT 129596
rs35350960 A Conflicting interpretations of pathogenicity CC 12274
rs35554630 A Conflicting interpretations of pathogenicity GG 196576
rs35625882 T Conflicting interpretations of pathogenicity CC 739302
rs35691292 A Conflicting interpretations of pathogenicity GG 13135
rs35759430 A Conflicting interpretations of pathogenicity GG 283585
rs36022183 T Conflicting interpretations of pathogenicity CC 94111
rs363824 G Conflicting interpretations of pathogenicity TT 42408
rs3729732 A Conflicting interpretations of pathogenicity GG 631966
rs3729841 T Conflicting interpretations of pathogenicity CC 43391
rs3735971 A Conflicting interpretations of pathogenicity GG 363868
rs3736497 C Conflicting interpretations of pathogenicity AA 437080
rs3737274 A Conflicting interpretations of pathogenicity GG 299646
rs3737311 A Conflicting interpretations of pathogenicity GG 285240
rs3738497 T Conflicting interpretations of pathogenicity GG 468979
rs3739274 T Conflicting interpretations of pathogenicity CC 361923
rs3740654 A Conflicting interpretations of pathogenicity GG 514270
rs3741050 C Conflicting interpretations of pathogenicity GG 769322
rs3741447 A Conflicting interpretations of pathogenicity GG 434780
rs3743808 G Conflicting interpretations of pathogenicity AA 632946
rs3744824 T Conflicting interpretations of pathogenicity CC 159870
rs3747835 T Conflicting interpretations of pathogenicity CC 100583
rs3751369 C Conflicting interpretations of pathogenicity TT 311551
rs3761169 A Conflicting interpretations of pathogenicity GG 288545
rs3764873 A Conflicting interpretations of pathogenicity CC 310137
rs3766317 A Conflicting interpretations of pathogenicity GG 21357
rs3782356 T Conflicting interpretations of pathogenicity CC 134730
rs3795339 T Conflicting interpretations of pathogenicity CC 129318
rs3796241 A Conflicting interpretations of pathogenicity TT 730216
rs3810796 T Conflicting interpretations of pathogenicity CC 378702
rs3918290 T Drug response CC 432
rs41428447 A Conflicting interpretations of pathogenicity GG 214786
rs4148323 A Drug response GG 12280
rs4148327 C Conflicting interpretations of pathogenicity TT 160241
rs4148725 T Conflicting interpretations of pathogenicity CC 411121
rs4149584 T Conflicting interpretations of pathogenicity CC 217017
rs4150521 A Conflicting interpretations of pathogenicity GG 134120
rs4151031 A Conflicting interpretations of pathogenicity GG 256188
rs4253046 G Conflicting interpretations of pathogenicity TT 300083
rs429358 C Conflicting interpretations of pathogenicity TT 17864
rs4977574 G Risk factor AA 812644
rs4986761 C Conflicting interpretations of pathogenicity TT 128454
rs4987050 G Conflicting interpretations of pathogenicity AA 136580
rs4988460 A Conflicting interpretations of pathogenicity GG 597988
rs5029941 T Conflicting interpretations of pathogenicity CC 135332
rs5122 A Conflicting interpretations of pathogenicity GG 2582
rs5346 A Conflicting interpretations of pathogenicity GG 226623
rs5350 A Conflicting interpretations of pathogenicity GG 255141
rs5352 T Conflicting interpretations of pathogenicity CC 16638
rs5452 A Conflicting interpretations of pathogenicity GG 329805
rs5744739 A Conflicting interpretations of pathogenicity GG 240452
rs5744948 G Conflicting interpretations of pathogenicity TT 240537
rs5964007 G Conflicting interpretations of pathogenicity AA 287834
rs5969 G Conflicting interpretations of pathogenicity AA 627369
rs6035 C Conflicting interpretations of pathogenicity TT 255189
rs6063 T Conflicting interpretations of pathogenicity CC 16378
rs6068812 G Conflicting interpretations of pathogenicity AA 29680
rs607969 T Conflicting interpretations of pathogenicity CC 41854
rs6161 T Conflicting interpretations of pathogenicity CC 372354
rs6170 T Conflicting interpretations of pathogenicity GG 304276
rs6177 A Conflicting interpretations of pathogenicity GG 281656
rs6267 T Drug response GG 17592
rs6413438 T Drug response CC 39353
rs6413500 T Conflicting interpretations of pathogenicity CC 626118
rs6672843 A Conflicting interpretations of pathogenicity GG 260015
rs6755258 A Conflicting interpretations of pathogenicity GG 528460
rs7190978 T Conflicting interpretations of pathogenicity GG 320070
rs7196804 T Conflicting interpretations of pathogenicity CC 201068
rs7244681 C Conflicting interpretations of pathogenicity GG 196054
rs7262506 C Conflicting interpretations of pathogenicity AA 338234
rs730254 T Conflicting interpretations of pathogenicity CC 48422
rs7334118 C Conflicting interpretations of pathogenicity TT 35724
rs7412 T Drug response CC 17848
rs8099917 G Drug response TT 226027
rs8187798 G Conflicting interpretations of pathogenicity AA 256159
rs8187808 G Conflicting interpretations of pathogenicity AA 498331
rs8190976 T Conflicting interpretations of pathogenicity CC 810272
rs8191498 C Conflicting interpretations of pathogenicity TT 321155
rs8191996 C Conflicting interpretations of pathogenicity TT 736719
rs9282564 C Drug response TT 829327
rs9332604 C Conflicting interpretations of pathogenicity TT 293616
Page:

PharmGKB

Variants which affect phenotypes:

Page:
Variant Alleles Associations Genotype PMID
rs10030044 G Allele G is associated with increased risk of occurence of breast cancer during SERM (selective estrogen receptor modulators) therapy when treated with raloxifene or tamoxifen in people with Breast Neoplasms as compared to allele T. GT 23764426
rs1017860 CC Genotype CC is associated with increased risk of Graft vs Host Disease when treated with cyclosporine and methotrexate in people with hemopoietic stem cell transplant as compared to genotypes CT + TT. CC 25425682
rs10248420 G Allele G is associated with increased likelihood of remission when treated with amitriptyline, citalopram, paroxetine or venlafaxine in people with Depression as compared to allele A. GA 18215618
rs10267099 G Allele G is associated with increased risk of Hypercholesterolemia due to atenolol in people with Hypertension as compared to allele A. GG 24116192
rs1042713 G Allele G is associated with increased likelihood of Sexual adverse events when treated with risperidone in people with Schizophrenia as compared to allele A. GA 22212732
rs1049353 C Allele C is associated with increased risk of Weight gain when exposed to risperidone in children with Autism Spectrum Disorder as compared to allele T. TC 23799528
rs10509681 C Allele C is associated with increased risk of Peripheral Nervous System Diseases when treated with paclitaxel in women with Breast Neoplasms as compared to allele T. TC 23413280
rs1051740 T Allele T is associated with increased risk of Craniofacial Abnormalities when exposed to phenytoin in people with first trimester pregnancy as compared to allele C. TC 19952982
rs10875989 T Allele T is associated with increased severity of Anemia, Leukopenia, Neutropenia and Thrombocytopenia when treated with platinum in people with Lung Neoplasms as compared to allele C. TC 26358256
rs10876844 A Allele A is associated with increased likelihood of Diarrhea when treated with fluorouracil in people with Colorectal Neoplasms as compared to allele C. AC 22310351
rs1138272 T Allele T is associated with increased non-inducible thiotepa clearance and decreased tepa clearance when treated with thiotepa. TC 19076156
rs1138272 CT + TT Genotypes CT + TT is associated with decreased event-free survival and overall survival when treated with cisplatin in people with Osteosarcoma as compared to genotype CC. TC 25592234
rs1143634 AA Genotype AA is associated with decreased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to genotypes AG + GG. GA 25560300
rs1152003 CC Genotype CC is associated with increased risk of developing osteonecrosis of the jaw when treated with zoledronate in people with Multiple Myeloma as compared to genotypes CG + GG. CC 21517810
rs11549467 AG Genotype AG is associated with decreased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to genotype GG. GG 21576632
rs11549467 AG Genotype AG is associated with decreased progression-free survival as compared to genotype GG. GG 26641474
rs11563250 AG + GG Genotypes AG + GG is associated with decreased risk of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype AA. AA 25778466
rs11587213 AA Genotype AA is associated with increased risk of aspirin-intolerant asthma when exposed to aspirin in people with Asthma as compared to genotypes AG + GG. AA 18595682
rs11739136 CT + TT Genotypes CT + TT are associated with decreased risk of Hypertension as compared to genotype CC. CC 18496125
rs11739136 CT + TT Genotypes CT + TT are associated with decreased blood pressure in men as compared to genotype CC. CC 18854753
rs12036333 AA + AG Genotypes AA + AG is associated with decreased event-free survival when treated with cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG. GG 28570300
rs12210538 G Allele G is associated with increased likelihood of Drug Toxicity when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A. GA 20179710
rs1229984 T Allele T is associated with decreased risk of Alcoholism due to ethanol as compared to allele C. CC 32451486
rs1229984 T Allele T is associated with decreased risk of Alcoholism due to ethanol as compared to allele C. CC 15902904
rs1229984 T Allele T is associated with decreased risk of Alcoholism due to ethanol as compared to allele C. CC 31090166
rs12720067 T Allele T is associated with increased likelihood of remission when treated with amitriptyline, citalopram, paroxetine or venlafaxine in people with Depression as compared to allele C. TC 18215618
rs12721655 AG Genotype AG is associated with decreased survival when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to genotype AA. AA 20179710
rs12762549 G Allele G is associated with increased risk of Leukopenia when treated with docetaxel. GC 18294295
rs13181 GG + GT Genotypes GG + GT are associated with increased risk of Recurrence when treated with fluorouracil and leucovorin in people with Colorectal Neoplasms as compared to genotype TT. GT 18267032
rs13181 GT Genotype GT is associated with increased progression-free survival when treated with fluorouracil and oxaliplatin in people with Colorectal Neoplasms as compared to genotypes GG + TT. GT 21449681
rs13181 GG Genotype GG is associated with decreased progression-free survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT. GT 22026922
rs13181 G Allele G is associated with increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to allele T. GT 19620936
rs13181 GG + GT Genotypes GG + GT are associated with increased risk of Alopecia due to bleomycin, cisplatin and etoposide in men with Testicular Neoplasms as compared to genotype TT. GT 30914949
rs13181 GG Genotype GG is associated with decreased overall survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT. GT 22026922
rs13181 G Allele G is associated with increased risk of Drug Toxicity when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT. GT 20385995
rs1409314 A Allele A is associated with increased risk of Anemia, Leukopenia, Thrombocytopenia, Toxic liver disease or Vomiting when exposed to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G. GA 25732572
rs1611115 T Allele T is associated with decreased likelihood of Headache Disorders and Substance Withdrawal Syndrome in people not taking Analgesics, Antiinflammatory agents, non-steroids, Ergot alkaloids, opioids and sumatriptan as compared to allele C. CC 25096645
rs1634776 T Allele T is associated with increased likelihood of severe cutaneous adverse reactions when treated with allopurinol as compared to allele C. TC 33356553
rs16969968 A Allele A is associated with increased likelihood of Tobacco Use Disorder when exposed to nicotine as compared to allele G. GA 19706762
rs16969968 A Allele A is associated with increased risk of Tobacco Use Disorder. GA 18618000
rs16969968 A Allele A is associated with increased likelihood of Schizophrenia. GA 21418140
rs16969968 A Allele A is associated with increased risk of Tobacco Use Disorder when exposed to nicotine as compared to allele G. GA 20886544
rs16969968 A Allele A is associated with increased severity of smoking when exposed to nicotine in people with smoking as compared to allele G. GA 21418140
rs16969968 G Allele G is not associated with increased Tobacco Use Disorder when treated with Opium alkaloids and derivatives in people with Pain as compared to allele A. GA 20725741
rs16969968 A Allele A is associated with increased severity of smoking when exposed to nicotine in people with Schizophrenia who are smokers as compared to allele G. GA 21418140
rs16969968 A Allele A is associated with increased severity of Substance-Related Disorders due to Opium alkaloids and derivatives in people with Pain as compared to allele G. GA 20725741
rs16969968 A Allele A is associated with increased likelihood of Tobacco Use Disorder due to nicotine as compared to allele G. GA 19132693
rs16969968 A Allele A is associated with increased likelihood of Tobacco Use Disorder as compared to allele G. GA 27355804
rs16969968 A Allele A is associated with increased risk of Tobacco Use Disorder when exposed to nicotine as compared to allele G. GA 30453884
rs16969968 A Allele A is associated with increased Tobacco Use Disorder when exposed to nicotine as compared to allele G. GA 29196725
rs16969968 G Allele G is associated with increased likelihood of Alcoholism due to ethanol as compared to allele A. GA 19132693
rs17024608 A Allele A is associated with increased likelihood of Osteonecrosis when treated with Bisphosphonates as compared to allele G. AA 22267851
rs17128809 AA Genotype AA is associated with increased risk of adverse events when treated with ritodrine as compared to genotypes AT + TT. AA 31324945
rs17221417 G Allele G is associated with increased risk of Crohn Disease. GC 20362271
rs17501011 AA + AG Genotypes AA + AG is associated with decreased overall survival when treated with FOLFIRI in people with Colorectal Neoplasms as compared to genotype GG. GG 31698983
rs17501331 AG + GG Genotypes AG + GG are associated with decreased severity of Neutropenia when exposed to irinotecan in people with Colorectal Neoplasms as compared to genotype AA. AA 27845419
rs17574269 AG Genotype AG is associated with decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to genotype AA. AA 23478653
rs17587029 G Allele G is associated with decreased likelihood of Amenorrhea when treated with docetaxel, FEC100, gemcitabine, trastuzumab and zoledronate in women with Breast Neoplasms as compared to allele A. AA 31371054
rs17655652 CC Genotype CC is associated with decreased reduction in LDL-C when treated with pravastatin in women as compared to genotypes CT + TT. TT 19752398
rs17661089 AG + GG Genotypes AG + GG are associated with decreased overall survival due to carboplatin, cisplatin, docetaxel or paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA. GA 21636554
rs1799722 T Allele T is associated with increased risk of Cough when treated with Ace Inhibitors, Plain in people with Hypertension as compared to allele C. TC 10904024
rs1799836 CC Genotype CC is associated with increased risk of Tobacco Use Disorder in women as compared to genotypes CT + TT. CC 28858992
rs1799978 C Allele C is associated with decreased time until response when treated with olanzapine and risperidone in people with Schizophrenia as compared to genotype TT. TT 16513877
rs1800629 A Allele A is associated with increased likelihood of serious hypersensitivity when treated with carbamazepine as compared to allele G. GA 11294926
rs1800629 A Allele A is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele G. GA 31616045
rs1801131 GG Genotype GG is associated with decreased event-free survival when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT. GT 23652803
rs1801131 G Allele G is associated with increased progression free survival in people with Leukemia, Lymphocytic, Chronic, B-Cell as compared to genotype TT. GT 15385937
rs1801131 G Allele G is associated with increased likelihood of clinical response when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT. GT 20863444
rs1801131 T Allele T is associated with increased likelihood of adverse events when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele G. GT 16439441
rs1801131 GG + GT Genotypes GG + GT are associated with increased overall survival when treated with bevacizumab, cyanocobalamin, folic acid and pemetrexed in people with Head and Neck Neoplasms as compared to genotype TT. GT 21343546
rs1801131 G Allele G is associated with increased likelihood of neurotoxicity when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele T. GT 19858780
rs1801131 TT Genotype TT is associated with decreased Drug Toxicity when treated with capecitabine in people with Colorectal Neoplasms as compared to genotypes GG + GT. GT 18245544
rs1801131 GG Genotype GG is associated with decreased risk of Myelosuppression when treated with mercaptopurine and methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes GT + TT. GT 17323057
rs1801131 G Allele G is associated with increased risk of side effects when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele T. GT 16572443
rs1801131 G Allele G is associated with increased risk of Graft vs Host Disease when treated with methotrexate in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT. GT 16920564
rs1801131 GG Genotype GG is associated with decreased severity of oral mucositis when treated with methotrexate in people with hematopoietic-cell-transplantation as compared to genotype TT. GT 16501586
rs1801131 GG Genotype GG is associated with decreased risk of relapse when treated with methotrexate in people with allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia. as compared to genotype TT. GT 15569990
rs1801131 GG Genotype GG is associated with decreased event-free survival and overall survival when treated with capecitabine, fluorouracil or oxaliplatin in people with Colorectal Neoplasms as compared to genotypes GT + TT. GT 25331073
rs1801131 GT + TT Genotypes GT + TT is associated with increased risk of mucositis when treated with asparaginase, daunorubicin, methotrexate, prednisolone and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GT 25065700
rs1801131 G Allele G is associated with increased likelihood of elevated transaminases when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele T. GT 20514079
rs1801133 A Allele A is associated with increased likelihood of Drug Toxicity when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele G. GA 27992285
rs1801133 AA + AG Genotypes AA + AG are associated with decreased severity of Leukopenia when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 16870553
rs1801133 AA + AG Genotypes AA + AG is associated with decreased survival when treated with methotrexate in children with Lymphoma, Non-Hodgkin as compared to genotype GG. GA 23488607
rs1801133 GG Genotype GG is associated with decreased risk of Drug Toxicity when treated with methotrexate in children with Neoplasms as compared to genotypes AA + AG. GA 28696419
rs1801133 A Allele A is associated with graft vs host disease when treated with cyclosporine and methotrexate in people with recipients of HLA-identical hematopoietic stem cell transplantation. GA 19005482
rs1801133 A Allele A is associated with increased likelihood of Metabolic Syndrome when treated with antipsychotics in people with Schizophrenia. GA 17976958
rs1801133 A Allele A is associated with increased likelihood of adverse events when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 20863444
rs1801133 A Allele A is associated with increased risk of Recurrence when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G. GA 15781665
rs1801133 AA Genotype AA is associated with decreased risk of Graft vs Host Disease when treated with methotrexate in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG. GA 16920564
rs1801133 A Allele A is associated with increased likelihood of Drug Toxicity when treated with cyclophosphamide and fluorouracil in people with Breast Neoplasms as compared to allele G. GA 20638924
rs1801133 GG Genotype GG is associated with decreased severity of Drug Toxicity when treated with fluorouracil and leucovorin in people with Colorectal Neoplasms as compared to genotypes AA + AG. GA 19384296
rs1801133 A Allele A is associated with increased risk of prolonged high concentrations of methotrexate in children with Leukemia as compared to allele G. GA 24241962
rs1801133 G Allele G is associated with increased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele A. GA 24725652
rs1801133 AA Genotype AA is associated with decreased overall survival when treated with azacitidine in people with Myelodysplastic Syndromes as compared to genotypes AG + GG. GA 29205204
rs1801133 AG + GG Genotypes AG + GG are associated with decreased severity of Pain when treated with folic acid and vitamin b-complex, plain in women with Migraine with Aura as compared to genotype AA. GA 22926161
rs1801133 GG Genotype GG is associated with decreased likelihood of Coronary Artery Disease and Myocardial Infarction when treated with pravastatin in people with Hypertension. GA 18622257
rs1801133 AA + AG Genotypes AA + AG is associated with decreased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to genotype GG. GA 24732178
rs1801133 AA + AG Genotypes AA + AG is associated with decreased risk of Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to genotype GG. GA 18299612
rs1801274 AG Genotype AG is associated with decreased disease activity score 28 joint in rheumatoid arthritis when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA. GA 28112584
rs1801394 AA + AG Genotypes AA + AG are associated with decreased severity of Pain when treated with folic acid and vitamin b-complex, plain in women with Migraine with Aura as compared to genotype GG. GA 22926161
rs1801394 G Allele G is associated with increased likelihood of Drug Toxicity when treated with methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele A. GA 29589488
rs1883112 AG + GG Genotypes AG + GG are associated with decreased risk of toxicity when treated with cyclophosphamide, doxorubicin, prednisone, rituximab and vincristine in people with Lymphoma, Large B-Cell, Diffuse as compared to genotype AA. GA 19448608
rs1978153 C Allele C is associated with increased severity of Respiratory Insufficiency when treated with morphine in children with Sleep Apnea Syndromes and tonsillectomy as compared to allele G. GC 26810133
rs2016848 A Allele A is associated with increased risk of Cough when treated with Ace Inhibitors, Plain in people with Hypertension as compared to allele G. GA 21052031
rs2144297 T Allele T is associated with Hypercholesterolemia due to atenolol in people with Hypertension as compared to allele C. TC 24116192
rs2207396 A Allele A is associated with increased risk of Oligospermia when treated with Alkylating Agents and cisplatin in people with childhood cancer as compared to genotype GG. GA 21430602
rs2227956 G Allele G is associated with decreased severity of Hypersensitivity when treated with carbamazepine as compared to allele A. AA 16538175
rs2228001 GG + GT Genotypes GG + GT are associated with increased risk of Neutropenia when treated with cisplatin in people with Urinary Bladder Neoplasms as compared to genotype TT. GT 21047201
rs2228001 G Allele G is associated with increased risk of Ototoxicity when treated with cisplatin in people with Osteosarcoma as compared to allele T. GT 19434073
rs2228001 GG + GT Genotypes GG + GT are associated with increased risk of Drug Toxicity when treated with cisplatin in people with Urinary Bladder Neoplasms as compared to genotype TT. GT 21047201
rs2229109 CC Genotype CC is associated with increased intracellular and blood concentration of cyclosporine in people with Transplantation as compared to genotypes CT + TT. CC 18334915
rs2233406 AG + GG Genotypes AG + GG are associated with decreased risk of Diarrhea due to gefitinib in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA. GA 31664190
rs2236418 AG + GG Genotypes AG + GG is associated with increased likelihood of methamphetamine dependence, Psychotic Disorders and Substance-Related Disorders when exposed to methamphetamine as compared to genotype AA. GG 27967329
rs2246709 G Allele G is associated with increased severity of side effects when treated with methadone in people with Heroin Dependence as compared to allele A. GA 21902501
rs2273697 GG Genotype GG is associated with increased risk of Anemia when treated with cyclophosphamide, doxorubicin and fluorouracil in women with Breast Neoplasms as compared to genotypes AA + AG. GG 29507678
rs2278294 T Allele T is associated with increased risk of Leukopenia when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to allele C. TT 20679962
rs2305948 C Allele C is associated with increased severity of Drug Toxicity when treated with sunitinib in people with Carcinoma, Renal Cell and Gastrointestinal Stromal Tumors as compared to allele T. CC 19667267
rs2305948 CC Genotype CC is associated with increased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to genotypes CT + TT. CC 24510746
rs2562519 T Allele T is associated with increased risk of Exanthema when treated with nevirapine in people with HIV Infections as compared to allele C. TT 21810746
rs2720376 C Allele C is associated with increased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to allele T. TC 25829401
rs2748249 A Allele A is associated with increased severity of Drug Toxicity when treated with platinum in people with Carcinoma, Non-Small-Cell Lung as compared to allele C. AC 24220096
rs28371685 CT Genotype CT is associated with decreased warfarin dose when treated with warfarin as compared to genotype CC. CC 15970795
rs28399504 G Allele G is associated with decreased platelet inhibition after a clopidogrel 600-mg loading dose when treated with clopidogrel in people with Coronary Artery Disease as compared to allele A. AA 19463375
rs2884737 CC Genotype CC is associated with decreased warfarin dose requirements on day 14 when treated with warfarin as compared to genotype AA. AA 18030307
rs2884737 AC + CC Genotypes AC + CC is associated with decreased time to the first INR within the therapeutic range when treated with warfarin as compared to genotype AA. AA 18322281
rs2963155 G Allele G is associated with increased pain crisis in people with Anemia, Sickle Cell as compared to allele A. GA 30079801
rs307826 CC + CT Genotypes CC + CT is associated with decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to genotype TT. TT 23462807
rs3094188 A Allele A is associated with increased risk of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with allopurinol as compared to allele C. AC 21801394
rs3094188 A Allele A is associated with increased risk of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with allopurinol, carbamazepine or phenytoin as compared to allele C. AC 21801394
rs3212986 CC Genotype CC is associated with increased progression-free survival when treated with Platinum compounds in people with Ovarian Neoplasms as compared to genotypes AA + AC. CC 19203783
rs3212986 AA Genotype AA is associated with decreased likelihood of nephrotoxicity when treated with cisplatin in people with Neoplasms as compared to genotypes AC + CC. CC 21902499
rs3212986 CC Genotype CC is associated with increased risk of mucositis when treated with docetaxel in women with Breast Neoplasms as compared to genotypes AA + AC. CC 25495407
rs3212986 AC Genotype AC is associated with decreased disease-free survival and overall survival in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC. CC 19361884
rs3219484 CT Genotype CT is associated with decreased risk of neutropenia grade 3-4 when treated with cisplatin and cyclophosphamide in women with Ovarian Neoplasms as compared to genotype CC. CC 24533712
rs34399035 T Allele T is associated with decreased metformin uptake in HEK-293 cells and reduction in protein expression levels when exposed to metformin as compared to allele C. CC 21956618
rs3732218 GG Genotype GG is associated with increased glucuronidation of anastrozole in human liver microsomes as compared to genotypes AA + AG. GG 23371966
rs3736228 T Allele T is associated with increased risk of osteoporotic fracture as compared to allele C. TC 18455228
rs3736228 T Allele T is associated with increased risk of Osteoporosis. TC 18455228
rs3780126 G Allele G are associated with increased overall survival when treated with bevacizumab and pemetrexed in people with Lung Neoplasms as compared to allele A. GA 19841321
rs3786362 A Allele A is associated with increased risk of Hyperprolactinemia when treated with risperidone in children with Autism Spectrum Disorder as compared to allele G. AA 29955115
rs3798220 CT Genotype CT is associated with decreased risk of Myocardial Infarction when treated with aspirin in women. TT 18775538
rs3815087 A Allele A is associated with increased risk of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with allopurinol as compared to allele G. GA 21801394
rs3815087 A Allele A is associated with increased risk of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with allopurinol, carbamazepine or phenytoin as compared to allele G. GA 21801394
rs4133101 T Allele T is associated with increased risk of gastrointestinal toxicities when treated with celecoxib in people with Colorectal Neoplasms as compared to allele C. TT 23778325
rs4141964 CT + TT Genotypes CT + TT is associated with increased risk of Postoperative Nausea and Vomiting when treated with morphine in children as compared to genotype CC. TT 25558980
rs4148323 AA Genotype AA is associated with decreased progression-free survival when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 16636344
rs4148323 AA Genotype AA is associated with decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 16636344
rs4148412 T Allele T is associated with increased severity of Respiratory Insufficiency when treated with morphine in children with Sleep Apnea Syndromes and tonsillectomy as compared to allele C. TT 26810133
rs4149000 T Allele T is associated with increased risk of Muscular Diseases when treated with hmg coa reductase inhibitors as compared to allele C. TC 31220337
rs4149118 G Allele G is associated with increased AUC of docetaxel in people with Nasopharyngeal Neoplasms. GA 21995462
rs429358 T Allele T is associated with LDL-C response when treated with atorvastatin in people with Coronary Disease. TT 20031582
rs429358 TT Genotype TT is associated with increased time to achieve stable dose when treated with warfarin as compared to genotypes CC + CT. TT 21923605
rs463312 AC Genotype AC is associated with decreased progression-free survival when treated with cabazitaxel in people with Carcinoma, Transitional Cell as compared to genotype AA. AA 27020167
rs4680 AA Genotype AA is associated with decreased risk of Death due to opioids in people with Opioid-Related Disorders as compared to genotypes AG + GG. GA 27061230
rs4680 AG + GG Genotypes AG + GG are associated with decreased likelihood of treatment with methadone or morphine in infants with Neonatal Abstinence Syndrome as compared to genotype AA. GA 23632726
rs4680 A Allele A is associated with increased risk of Toxic liver disease when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G. GA 32265697
rs4680 AG Genotype AG is associated with decreased likelihood of Exanthema when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotypes AA + GG. GA 30549211
rs4680 AA + AG Genotypes AA + AG are associated with decreased risk of tardive dyskinesia when treated with antipsychotics in people with Schizophrenia as compared to genotype GG. GA 18180754
rs4680 AG Genotype AG is associated with decreased reaction time when treated with tolcapone in abstinent smokers. GA 24095246
rs4680 A Allele A is associated with increased methylation at sites 1 and 2 in the COMT promoter when treated with antipsychotics in people with Schizophrenia as compared to allele G. GA 22391769
rs4680 AG + GG Genotypes AG + GG are associated with decreased length of hospital stay in infants with Neonatal Abstinence Syndrome as compared to genotype AA. GA 23632726
rs4680 AA + GG Genotypes AA + GG is associated with decreased libido when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotype AG. GA 30549211
rs4680 G Allele G is associated with increased severity of Pain when treated with propranolol in women with Temporomandibular Joint Disorders and Pain as compared to allele A. GA 20216107
rs4680 AA Genotype AA is associated with decreased likelihood of Headache Disorders and Substance Withdrawal Syndrome in people not taking Analgesics, Antiinflammatory agents, non-steroids, Ergot alkaloids, opioids and sumatriptan as compared to genotypes AG + GG. GA 25096645
rs4693570 C Allele C is associated with increased risk of Myalgia unspecified when treated with hmg coa reductase inhibitors in people with Hyperlipidemias as compared to allele T. CC 21868014
rs4790694 C Allele C is associated with increased likelihood of Substance-Related Disorders when exposed to methamphetamine as compared to allele A. CC 17233643
rs4888024 G Allele G is associated with end-of-induction minimal risidual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) and is also associated with greater methotrexate clearance when treated with methotrexate as compared to allele A. GG 19176441
rs4961 GT + TT Genotypes GT + TT are associated with increased reduction in blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to genotype GG. GT 18591455
rs4961 GT + TT Genotypes GT + TT are associated with increased reduction in mean blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to genotype GG. GT 11882573
rs4961 GT + TT Genotypes GT + TT are associated with increased ambulatory blood pressure in people with Hypertension as compared to genotype GG. GT 18591455
rs4961 GT + TT Genotypes GT + TT are associated with increased likelihood of Hypertension as compared to genotype GG. GT 9149697
rs4961 GT + TT Genotypes GT + TT are associated with increased likelihood of diuretic unresponsiveness when treated with furosemide and spironolactone in people with Liver Cirrhosis as compared to genotype GG. GT 21692745
rs4961 GT Genotype GT is associated with increased reduction in mean arterial pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to genotype GG. GT 9149697
rs4961 GT + TT Genotypes GT + TT are associated with increased reduction in mean blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to genotype GG. GT 10523341
rs4961 GG Genotype GG is associated with decreased risk of Myocardial Infarction when treated with Thiazides, plain in people with Hypertension. GT 19145769
rs508448 GG Genotype GG is associated with decreased age at onset of Heroin Dependence due to heroin as compared to genotypes AA + AG. GA 28692418
rs50872 GG Genotype GG is associated with increased risk of Drug Toxicity when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG. GG 27498158
rs55781567 G Allele G is associated with increased Tobacco Use Disorder when exposed to nicotine as compared to allele C. GC 29196725
rs5925720 T Allele T is associated with decreased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele G. GG 26378035
rs598961 AA Genotype AA is associated with decreased time to delivery when treated with ritodrine as compared to genotypes AG + GG. GG 31324945
rs6002674 C Allele C is associated with decreased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to allele T. TT 23508266
rs6088638 T Allele T is associated with increased risk of Alcoholism due to ethanol as compared to allele C. TT 28550509
rs6090041 G Allele G is associated with increased risk of Opioid-Related Disorders when exposed to opioids as compared to allele A. GG 20032820
rs6090043 C Allele C is associated with increased risk of Opioid-Related Disorders when exposed to opioids as compared to allele T. CC 20032820
rs6130615 CC Genotype CC is associated with increased risk of Hemorrhage when treated with warfarin as compared to genotypes CT + TT. CC 31461081
rs6347 TT Genotype TT is associated with increased risk of Death when exposed to cocaine in people with Cocaine-Related Disorders as compared to genotypes CC + CT. TT 23340505
rs6500843 G Allele G is associated with increased risk of Death when treated with antineoplastic agents in women with Breast Neoplasms as compared to allele A. GG 25823661
rs6511720 T Allele T is associated with baseline LDL cholesterol in people with Vascular Diseases. GT 21977987
rs652888 G Allele G is associated with increased likelihood of Agranulocytosis when treated with Antithyroid Preparations as compared to allele A. GA 27157822
rs671 GG Genotype GG is associated with increased risk of Alcoholism due to ethanol as compared to genotypes AA + AG. GG 16679777
rs671 A Allele A is associated with decreased risk of Alcoholism due to ethanol as compared to allele G. GG 15902904
rs683369 CG + GG Genotypes CG + GG is associated with decreased event-free survival when treated with imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype CC. CC 24589908
rs6920220 A Allele A is associated with increased likelihood of discontinuation of methotrexate in people with Arthritis as compared to allele G. GA 20921970
rs6962291 AA Genotype AA is associated with decreased risk of intolerance when treated with aspirin in people with Asthma as compared to genotype TT. TT 21449675
rs7131056 CC Genotype CC is associated with decreased likelihood of Weight gain when treated with antipsychotics as compared to genotypes AA + AC. AC 27217270
rs716274 AG + GG Genotypes AG + GG are associated with increased risk of Death when treated with etoposide and Platinum compounds in people with Carcinoma, Small Cell as compared to genotype AA. GG 21118971
rs7242 T Allele T is associated with increased likelihood of Depressive Disorder, Major as compared to allele G. TT 18794724
rs7259857 C Allele C is associated with decreased risk of Esophagitis when treated with radiotherapy as compared to allele T. TT 25054431
rs7412 CC Genotype CC is associated with increased time to achieve stable dose when treated with warfarin as compared to genotypes CT + TT. CC 21923605
rs762551 CC Genotype CC is associated with decreased risk of Parkinson Disease when exposed to caffeine in people with coffee consumption as compared to genotype AA. AA 21281405
rs762551 AA Genotype AA is associated with increased likelihood of insomnia due to caffeine as compared to genotypes AC + CC. AA 29668752
rs762551 AC + CC Genotypes AC + CC are associated with decreased risk of Breast Neoplasms when exposed to caffeine in people with BRCA1 mutations. AA 17507615
rs762551 A Allele A is associated with increased risk of Fatigue when treated with paroxetine in people with Depressive Disorder, Major as compared to allele C. AA 21121774
rs762551 AA Genotype AA is associated with increased likelihood of Metabolic Syndrome when treated with clozapine in people with Schizophrenia and Tobacco Use Disorder as compared to genotypes AC + CC. AA 27681143
rs762551 AA Genotype AA is associated with increased likelihood of Neural Tube Defects when exposed to caffeine in women who are pregnant as compared to genotypes AC + CC. AA 20641098
rs778293 C Allele C is associated with increased likelihood of Psychotic Disorders due to methamphetamine as compared to allele T. TC 19482054
rs7945189 CT + TT Genotypes CT + TT are associated with decreased likelihood of Acute coronary syndrome when exposed to Antiinflammatory agents, non-steroids in people with Acute coronary syndrome as compared to genotype CC. CC 20538124
rs8099917 TT Genotype TT is associated with increased baseline viral load in people with Hepatitis as compared to genotypes GG + GT. TT 21628662
rs8099917 T Allele T is associated with increased response (SVR and RVR) in HCV-HIV coinfected patients when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin as compared to allele G. TT 23133602
rs8099917 TT Genotype TT is associated with increased response (SVR) in HCV genotype 1 patients when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 22438096
rs8099917 TT Genotype TT is associated with increased response (SVR) to interferon monotherapy in HCV genotype 1 patients when treated with interferons in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 22438096
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 28261382
rs8099917 TT Genotype TT is associated with increased likelihood of cryoglobulinemia when treated with peginterferon alfa-2a in people with. TT 28453396
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 29104462
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with daclatasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 30431653
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 27514956
rs8099917 TT Genotype TT is associated with increased likelihood of sustained virological response (SVR) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis as compared to genotypes GG + GT. TT 21628662
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 24362944
rs8099917 TT Genotype TT is associated with increased rapid virological response (rvr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 26699619
rs8099917 TT Genotype TT is associated with increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype GT. TT 27561198
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 27027531
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with as compared to genotypes GG + GT. TT 25918016
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with ledipasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 27357737
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 27833958
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 28261382
rs8099917 G Allele G is associated with decreased likelihood of sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T. TT 28261910
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 28739427
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 28506030
rs8099917 TT Genotype TT is associated with increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 24308755
rs8099917 TT Genotype TT is associated with increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 31803800
rs8124728 A Allele A is associated with decreased risk of Peripheral Nervous System Diseases due to stavudine in people with HIV Infections as compared to allele G. GG 30273369
rs8176719 C Allele C is associated with increased risk of Venous Thrombosis when treated with hormonal contraceptives for systemic use in women as compared to allele del. TCT 28750087
rs877087 TT Genotype TT is associated with increased risk of Heart Failure when treated with amlodipine in people with Hypertension. TT 22664477
rs894160 CT + TT Genotypes CT + TT are associated with decreased Weight gain due to rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC. TC 16732015
rs9282564 CC + CT Genotypes CC + CT are associated with decreased risk of Death due to opioids in people with Opioid-Related Disorders as compared to genotype TT. TT 27061230
rs928655 A Allele A is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G. AA 18615156
rs9554320 AA Genotype AA is associated with decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AC + CC. AC 23421954
rs9554320 AA Genotype AA is associated with decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AC + CC. AC 27417418
rs962369 C Allele C is associated with increased likelihood of suicidal ideation when treated with escitalopram or nortriptyline in people with Depressive Disorder, Major as compared to allele T. TC 19641488
rs9981861 TT Genotype TT is associated with decreased survival when treated with carboplatin and paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT. TC 21079520
rs1021737 TT Genotype TT is associated with increased risk of Hepatic Veno-Occlusive Disease when treated with busulfan and cyclophosphamide in children with hemopoietic stem cell transplant as compared to genotypes GG + GT. GG 27779248
rs1041983 T Allele T is associated with increased risk of Toxic liver disease when treated with isoniazid, pyrazinamide and rifampin in people with Tuberculosis. CC 18421452
rs1041983 TT Genotype TT is associated with increased risk of Toxic liver disease when treated with ethambutol, isoniazid, pyrazinamide and rifampin in people with Tuberculosis as compared to genotype CC. CC 22506592
rs1041983 T Allele T is associated with increased risk of drug-induced liver injury when treated with isoniazid in people with Tuberculosis as compared to allele C. CC 29036176
rs1041983 T Allele T is associated with increased risk of Drug Toxicity due to isoniazid and phenytoin in people with Tuberculoma of brain or Tuberculous meningitis NOS as compared to allele C. CC 27488001
rs1042713 AA Genotype AA is associated with increased risk of asthma exacerbations when exposed to salmeterol in children with Asthma as compared to genotype GG. GA 16772309
rs1042713 AA Genotype AA is associated with increased risk of asthma exacerbations when exposed to salbutamol or salmeterol in children with Asthma as compared to genotype GG. GA 19800676
rs1042713 AA Genotype AA is associated with increased risk of uncontrolled asthma when treated with corticosteroids in children with Asthma as compared to genotype GG. GA 24279851
rs1042713 GG Genotype GG is not associated with increased risk of Hypertriglyceridemia due to atenolol or metoprolol in people with Hypertension as compared to genotypes AA + AG. GA 16027735
rs1042713 GG Genotype GG is associated with increased risk of emergency department and hospital utliization when treated with Ace Inhibitors, Plain, Angiotensin II Antagonists, Beta Blocking Agents, digoxin, diuretics or spironolactone in people with Heart Failure as compared to genotypes AA + AG. GA 22543981
rs1042713 AA Genotype AA is associated with increased risk of exacerbations when treated with corticosteroids and salmeterol in children with Asthma as compared to genotype GG. GA 24279851
rs1045644 CG + GG Genotypes CG + GG are associated with decreased likelihood of Peripheral Nervous System Diseases when treated with vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC. GG 30506673
rs10491684 A Allele A is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele G. GG 31616045
rs10517 GG Genotype GG is associated with decreased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AG. GG 30237583
rs1051740 CC Genotype CC is associated with increased time above therapeutic range when treated with phenprocoumon as compared to genotype TT. TC 21057703
rs1051740 CC Genotype CC is associated with increased likelihood of being overanticoagulated due to phenprocoumon as compared to genotypes CT + TT. TC 21057703
rs1051740 CT Genotype CT is associated with increased risk of nephrotoxicity grades 1-4 when treated with cisplatin and cyclophosphamide in women with Ovarian Neoplasms as compared to genotype TT. TC 24533712
rs10792367 G Allele G is associated with decreased blood pressure (BP) reduction when treated with hydrochlorothiazide in people with Hypertension as compared to genotype CC. GC 21164499
rs10841661 T Allele T is associated with increased likelihood of severe myelosuppression when treated with irinotecan in people with Neoplasms as compared to allele C. CC 19696792
rs10846744 GG Genotype GG is associated with decreased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG. GG 27561198
rs10981694 GG + GT Genotypes GG + GT are associated with increased severity of Ototoxicity when treated with cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT. TT 22516052
rs11212570 AA + AG Genotypes AA + AG is associated with increased likelihood of Pain when treated with Iodine (131I) compounds and radiotherapy in people with Thyroid Neoplasms as compared to genotype GG. GA 30430914
rs11252394 A Allele A is associated with increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to allele G. GG 23508266
rs11587213 AG + GG Genotypes AG + GG are associated with increased likelihood of atopy in patients with aspirin-intolerant chronic urticaria as compared to genotype AA. AA 18534082
rs11591147 T Allele T is associated with LDL-C response when treated with atorvastatin in people with Coronary Disease. GG 20031582
rs11600347 A Allele A is associated with increased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele C. CC 22907731
rs11710163 AG Genotype AG is associated with increased overall survival due to carboplatin, cisplatin, docetaxel, gemcitabine or paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA. AA 21636554
rs12119882 AG Genotype AG is associated with increased likelihood of Hyperbilirubinemia when treated with capecitabine in people with Colorectal Neoplasms as compared to genotype AA. AA 28347776
rs1229984 TT Genotype TT is associated with increased Vmax of ethanol in healthy individuals as compared to genotypes CC + CT. CC 23240771
rs12720066 AC + CC Genotypes AC + CC are associated with increased severity of Neutropenia when exposed to irinotecan in people with Colorectal Neoplasms as compared to genotype AA. AA 27845419
rs13181 GG Genotype GG is associated with increased risk of dying when treated with Platinum compounds in people with Colorectal Neoplasms as compared to genotype TT. GT 15213713
rs13181 G Allele G is associated with decreased event free survival when treated with cisplatin in people with Osteosarcoma as compared to genotype TT. GT 19434073
rs13181 GG Genotype GG is associated with increased event free survival when treated with cisplatin, doxorubicin, ifosfamide and methotrexate in people with Osteosarcoma as compared to genotype TT. GT 21826087
rs13181 TT Genotype TT is associated with increased risk of Neutropenia when treated with docetaxel in women with Breast Neoplasms as compared to genotypes GG + GT. GT 25495407
rs13181 GG Genotype GG is associated with increased likelihood of pneumonitis when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes GT + TT. GT 25069034
rs13181 GG + GT Genotypes GG + GT is associated with decreased overall survival and progression-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT. GT 27636246
rs13432159 G Allele G is associated with increased general side-effects when treated with sertraline in people with Depressive Disorder, Major as compared to allele T. TT 22041458
rs135543 TT Genotype TT is associated with increased reduction in fasting LDL-C when treated with fenofibrate as compared to genotypes CC + CT. CC 22547144
rs1522113 A Allele A is associated with increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to allele G. GG 23508266
rs16969968 A Allele A is associated with decreased likelihood of abstinence of nicotine in people with Tobacco Use Disorder. GA 22648373
rs16969968 GG Genotype GG is associated with increased functional MRI reactivity to smoking images due to nicotine in women with nicotine dependence as compared to genotypes AA + AG. GA 21764527
rs16969968 A Allele A is associated with decreased variance in Tobacco Use Disorder associated with peer smoking when exposed to nicotine as compared to allele G. GA 20840187
rs17091162 AC + CC Genotypes AC + CC are associated with decreased survival when treated with antineoplastic agents in people with Pancreatic Neoplasms as compared to genotype AA. AC 21487324
rs17135437 T Allele T is associated with increased hearing and vision-related side-effects when treated with citalopram in people with Depressive Disorder, Major as compared to allele C. CC 22760553
rs17655652 CC Genotype CC is associated with increased reduction in LDL-C when treated with pravastatin in men as compared to genotypes CT + TT. TT 19752398
rs1799722 CT + TT Genotypes CT + TT are associated with increased risk of Cough when treated with enalapril, imidapril and lisinopril in people with Essential hypertension as compared to genotype CC. TC 12522467
rs1799807 C Allele C is associated with postanesthesia apnea when exposed to succinylcholine as compared to allele T. TT 12724618
rs1799978 CT Genotype CT is associated with increased likelihood of Insulin Resistance when treated with risperidone in children with Child Behavior Disorders and Mental Disorders as compared to genotype TT. TT 26880915
rs1799978 C Allele C is associated with increased risk of Hyperprolactinemia when treated with risperidone as compared to allele T. TT 19339912
rs1800629 GG Genotype GG is associated with increased bone marrow density in the lumbar spine when treated with atorvastatin in people with Acute coronary syndrome. GA 18997459
rs1800629 AA + AG Genotypes AA + AG are associated with increased risk of transplant rejection when treated with cyclosporine and mycophenolate mofetil in people with Kidney Transplantation as compared to genotype GG. GA 18444945
rs1800629 AA + AG Genotypes AA + AG are associated with increased likelihood of Toxic liver disease when treated with ethambutol, isoniazid, pyrazinamide and rifampin in people with Tuberculosis as compared to genotype GG. GA 22151084
rs1800629 GG Genotype GG is associated with increased risk of hand-foot syndrome when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to genotype AG. GA 22736425
rs1800629 AG Genotype AG is associated with increased likelihood of Pain when treated with Iodine (131I) compounds and radiotherapy in people with Thyroid Neoplasms as compared to genotype GG. GA 30430914
rs1800872 TT Genotype TT is associated with increased risk of transplant rejection when treated with cyclosporine and mycophenolate mofetil in people with Kidney Transplantation as compared to genotypes GG + GT. GG 18444945
rs1800888 TT Genotype TT is not associated with increased risk of Hypertriglyceridemia due to atenolol or metoprolol in people with Hypertension as compared to genotypes CC + CT. CC 16027735
rs1801123 C Allele C is associated with lymph node involvement when treated with in women with Breast Neoplasms as compared to allele T. TT 23459444
rs1801131 GG Genotype GG is associated with increased risk of mucositis when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotypes GT + TT. GT 17488658
rs1801131 TT Genotype TT is associated with increased response base on Disease Activity Score in 44 joints improvement at 6 months of treatment when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotypes GG + GT. GT 16572443
rs1801131 TT Genotype TT is associated with increased likelihood of red blood cell transfusions when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes GG + GT. GT 18368069
rs1801131 GG + GT Genotypes GG + GT are associated with decreased overall survival when treated with cisplatin and pemetrexed in people with Stomach Neoplasms as compared to genotype TT. GT 20634689
rs1801131 GG Genotype GG is associated with increased likelihood of Drug Toxicity when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotypes GT + TT. GT 17700593
rs1801131 TT Genotype TT is associated with increased risk of Drug Toxicity when treated with fluorouracil in people with Rectal Neoplasms as compared to genotypes GG + GT. GT 22045187
rs1801131 GG Genotype GG is associated with increased risk of hand-foot syndrome when treated with capecitabine in people with Neoplasms. GT 23736036
rs1801131 TT Genotype TT is associated with increased event free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes GG + GT. GT 21747412
rs1801131 GG Genotype GG is associated with increased plasma total homocysteine concentrations when exposed to nitrous oxide in people with surgery as compared to genotype TT. GT 18580170
rs1801131 GG Genotype GG is associated with increased risk of hand-foot syndrome when treated with capecitabine in people with Gastrointestinal Neoplasms as compared to genotypes GT + TT. GT 27864592
rs1801131 GG Genotype GG is associated with increased risk of Drug Toxicity when treated with capecitabine, fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms. GT 20819423
rs1801131 GG Genotype GG is associated with increased Weight gain when treated with clozapine or olanzapine in people with schizoaffective disorder and Schizophrenia as compared to genotype GT. GT 24725652
rs1801133 AA + AG Genotypes AA + AG are associated with increased likelihood of treatment interruptions when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 18458567
rs1801133 AA Genotype AA is associated with increased risk of gastrointestinal toxicity, Leukopenia and Toxic liver disease when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 19648163
rs1801133 AA + AG Genotypes AA + AG are associated with increased risk of discontinuation when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 11710708
rs1801133 AA Genotype AA is associated with increased progression-free survival when treated with carboplatin and pemetrexed in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GA 19307503
rs1801133 AA Genotype AA is associated with increased risk of Drug Toxicity when treated with methotrexate in people with Leukemia as compared to genotypes AG + GG. GA 12453860
rs1801133 AA Genotype AA is associated with increased likelihood of Drug Toxicity when treated with cisplatin, cyclophosphamide, dactinomycin, doxorubicin, methotrexate and vincristine in children with Osteosarcoma as compared to genotypes AG + GG. GA 19159907
rs1801133 AA + AG Genotypes AA + AG is associated with increased risk of Toxic liver disease when treated with methotrexate in children with Neoplasms as compared to genotype GG. GA 23648444
rs1801133 AA + AG Genotypes AA + AG is associated with increased risk of Drug Toxicity when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25007187
rs1801133 AA Genotype AA is associated with increased likelihood of Recurrence when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG. GA 21644011
rs1801133 AA + AG Genotypes AA + AG is associated with increased Drug Toxicity when treated with methotrexate in children with as compared to genotype GG. GA 21644011
rs1801133 AA + AG Genotypes AA + AG is associated with increased severity of Folic Acid Deficiency when treated with asparaginase, daunorubicin, methotrexate, prednisolone and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25065700
rs1801133 AA + AG Genotypes AA + AG are associated with increased risk of Leukopenia when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25110820
rs1801133 AA + AG Genotypes AA + AG are associated with increased risk of Neutropenia when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25110820
rs1801133 AA Genotype AA is associated with increased likelihood of Recurrence when treated with methotrexate in children with Osteosarcoma as compared to genotypes AG + GG. GA 28592186
rs1801133 AA + AG Genotypes AA + AG is associated with increased likelihood of Drug Toxicity when treated with methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotype GG. GA 29589488
rs1801133 AA Genotype AA is associated with increased risk of Thrombocytopenia when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotypes AG + GG. GA 17488658
rs1801133 AA Genotype AA is associated with increased risk of Toxic liver disease when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotypes AG + GG. GA 17488658
rs1801133 AG Genotype AG is associated with increased risk of Drug Toxicity when treated with capecitabine, fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms. GA 20819423
rs1801133 AA + AG Genotypes AA + AG are not associated with increased risk of Osteonecrosis when treated with dexamethasone in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 18285546
rs1801133 AA Genotype AA is associated with increased likelihood of response to chemotherapy when treated with carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel and vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GA 21605004
rs1801133 AA Genotype AA is associated with increased risk of toxicity when treated with methotrexate as compared to genotype GG. GA 22143415
rs1801133 AA + AG Genotypes AA + AG is associated with increased risk of hematological toxicity when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotype GG. GA 23488607
rs1801133 GG Genotype GG is associated with increased risk of Toxic liver disease when treated with methotrexate in people with Osteosarcoma as compared to genotypes AA + AG. GA 25778468
rs1801133 GG Genotype GG is associated with increased likelihood of treatment interruptions when treated with capecitabine in people with Colorectal Neoplasms as compared to genotypes AA + AG. GA 28745575
rs1801133 AA + AG Genotypes AA + AG is associated with increased risk of Diarrhea, mucositis and Neutropenia when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype GG. GA 29134491
rs1801133 AA Genotype AA is associated with increased risk of Toxic liver disease when treated with methotrexate as compared to genotype GG. GA 22143415
rs1801133 AA Genotype AA is associated with increased risk of Toxic liver disease when treated with methotrexate in people with Arthritis, Psoriatic as compared to genotypes AG + GG. GA 20472929
rs1801133 AA Genotype AA is associated with increased overall survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 17512587
rs1801133 AA Genotype AA is associated with increased risk of mucositis when treated with busulfan, cyclophosphamide and methotrexate as compared to genotype GG. GA 15051775
rs1801133 A Allele A is associated with decreased likelihood of event-free survival when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotype GG. GA 17488658
rs1801133 GG Genotype GG is associated with increased progression free survival when treated with antineoplastic agents in people with Leukemia, Lymphocytic, Chronic, B-Cell as compared to genotypes AA + AG. GA 15385937
rs1801133 AA Genotype AA is associated with increased risk of mucositis when treated with methotrexate in people with Lymphoma, Non-Hodgkin as compared to genotypes AG + GG. GA 17488658
rs1801133 AA + AG Genotypes AA + AG are associated with increased likelihood of treatment interruptions when treated with mercaptopurine in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 18458567
rs1801133 AA Genotype AA is associated with increased risk of mucositis when treated with methotrexate in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG. GA 11418485
rs1801133 AA Genotype AA is associated with increased risk of Drug Toxicity when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG. GA 17512587
rs1801133 AG Genotype AG is associated with increased risk of Alopecia when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 18381794
rs1801133 AA Genotype AA is associated with increased severity of mucositis when treated with methotrexate in people with hematopoietic stem cell transplantation as compared to genotype GG. GA 16501586
rs1801133 GG Genotype GG is associated with increased event-free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AG. GA 21747412
rs1801133 AA Genotype AA is associated with increased risk of Drug Toxicity when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 23095111
rs1801133 AA Genotype AA is associated with increased risk of Neutropenia when treated with fluorouracil, leucovorin and oxaliplatin in people with Colonic Neoplasms as compared to genotypes AG + GG. GA 23314736
rs1801133 GG Genotype GG is associated with increased event-free survival and overall survival when treated with fluorouracil in people with Rectal Neoplasms as compared to genotype AA. GA 25041994
rs1801133 AA Genotype AA is associated with increased risk of Drug Toxicity when treated with methotrexate in people with Burkitt Lymphoma, Lymphoma, T-Cell or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25303299
rs1801133 AA Genotype AA is associated with increased plasma total homocysteine concentrations when exposed to nitrous oxide in people with surgery as compared to genotype GG. GA 18580170
rs1801133 AA Genotype AA is associated with increased likelihood of adverse events when treated with methotrexate in people with Arthritis, Juvenile Rheumatoid as compared to genotype GG. GA 20595278
rs1801274 GG Genotype GG is associated with increased overall survival when treated with cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG. GA 23296156
rs1801274 AA Genotype AA is associated with increased progression free survival when treated with trastuzumab in women with Breast Neoplasms as compared to genotypes AG + GG. GA 21109570
rs1801274 AA Genotype AA is associated with increased progression-free survival when treated with trastuzumab in women Breast Neoplasms as compared to genotype GG. GA 18347005
rs1801394 AG + GG Genotypes AG + GG are associated with increased likelihood of mucositis when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma. GA 18368069
rs1801394 AA Genotype AA is associated with increased red blood cell folate when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 20386493
rs1801394 GG Genotype GG is associated with increased severity of Stomatitis when treated with leucovorin and tegafur in people with Colorectal Neoplasms as compared to genotypes AA + AG. GA 20647221
rs1801394 AG Genotype AG is associated with increased speed of platelet recovery when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + GG. GA 18368069
rs1804645 CT Genotype CT is associated with increased severity of change in Lumbar Bone Mineral Density when treated with tamoxifen as compared to genotype CC. CC 22174377
rs1805034 C Allele C is associated with increased risk of Angioedema and Urticaria when treated with acetaminophen, aspirin, diclofenac, propionic acid derivatives and Pyrazolones as compared to genotype TT. TT 26398624
rs1883112 AA Genotype AA is associated with increased risk of cardiotoxicity when treated with doxorubicin in people with Lymphoma, Non-Hodgkin as compared to genotypes AG + GG. GA 16330681
rs1883112 AA Genotype AA is associated with increased risk of cardiotoxicity when treated with idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG. GA 28485375
rs2066713 A Allele A is associated with increased risk of Alcoholism due to ethanol as compared to allele G. GG 31595439
rs2070401 GG Genotype GG is associated with increased likelihood of Toxic liver disease when treated with isoniazid and rifampin in people with Tuberculosis as compared to genotypes AA + AG. AA 22341855
rs2229109 CT Genotype CT is associated with increased risk of Diarrhea and Vomiting when treated with bleomycin, cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine and vindesine in people with Lymphoma, Non-Hodgkin as compared to genotype CC. CC 25637052
rs2229109 CT Genotype CT is associated with increased likelihood of progression-free survival when treated with dexamethasone and lenalidomide in people with Multiple Myeloma as compared to genotype CC. CC 29177954
rs2229109 CT Genotype CT is associated with increased risk of Neutropenia when treated with valganciclovir in people with Kidney Transplantation as compared to genotype CC. CC 27402191
rs2229109 CT + TT Genotypes CT + TT is associated with increased risk of renal transplant failure when treated with tacrolimus in people with Kidney Transplantation as compared to genotype CC. CC 29689130
rs2241716 TT Genotype TT is associated with increased likelihood of Pain when treated with Iodine (131I) compounds and radiotherapy in people with Thyroid Neoplasms as compared to genotypes CC + CT. CC 30430914
rs2246709 A Allele A is associated with decreased severity of opioid withdrawal symptoms when treated with methadone in people with Heroin Dependence as compared to allele G. GA 21902501
rs2273697 A Allele A is associated with increased probability of antiepileptic drug response when treated with antiepileptics in children with Epilepsy as compared to allele G. GG 21799461
rs2273697 A Allele A is associated with increased risk of Bone Marrow Diseases when treated with methotrexate in children with Osteosarcoma as compared to allele G. GG 27566582
rs2273697 A Allele A is associated with increased residual clearance of intravenous talinolol and lower bioavailablilty of orally administered talinolol when exposed to talinolol as compared to allele G. GG 18334920
rs2273697 AA + AG Genotypes AA + AG are associated with increased risk of neurological ADR when treated with carbamazepine in people with Epilepsy as compared to genotype GG. GG 20216337
rs2273697 AA Genotype AA is associated with increased likelihood of Drug Toxicity when treated with methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AG + GG. GG 18381794
rs2273697 A Allele A is associated with increased risk of renal proximal tubulopathy due to tenofovir in people with HIV Infections as compared to allele G. GG 17083032
rs2273697 AG Genotype AG is associated with increased area under the concentration versus time curve (AUC6-12) level of the acyl glucuronide of mycophenolic acid when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to genotype GG. GG 18946804
rs2273697 GG Genotype GG is associated with decreased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AG. GG 30237583
rs2274924 C Allele C is associated with increased risk of hypomagnesemia primary when treated with Proton pump inhibitors as compared to allele T. TT 27926584
rs2278294 CT + TT Genotypes CT + TT is associated with decreased likelihood of Lymphopenia when treated with azathioprine in children with Inflammatory Bowel Diseases as compared to genotype CC. TT 26332308
rs2278294 CT + TT Genotypes CT + TT are associated with decreased risk of biopsy-proven acute rejection when treated with mycophenolate mofetil in people with kidney transplant as compared to genotype CC. TT 17851563
rs2278294 T Allele T is associated with decreased risk of transplant rejection when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to allele C. TT 20679962
rs2281617 CC Genotype CC is associated with increased Euphoric and Energetic after amphetamine (10 mg) when exposed to amphetamine in healthy individuals as compared to genotypes CT + TT. TC 21029375
rs2291075 CT + TT Genotypes CT + TT are associated with increased event-free survival and overall survival when treated with cytarabine, daunorubicin, etoposide and mitoxantrone in children with Leukemia, Myeloid, Acute as compared to genotype CC. TC 26663398
rs2302821 C Allele C is associated with increased risk of cardiovascular toxicity and symptoms when treated with celecoxib in people with Colorectal Neoplasms as compared to allele A. AA 23778325
rs2302948 T Allele T is associated with decreased likelihood of Fever when treated with cytarabine, fludarabine, gemtuzumab ozogamicin and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C. TC 22584460
rs2305799 CT + TT Genotypes CT + TT are not associated with increased risk of Osteonecrosis when treated with dexamethasone in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC. CC 18285546
rs2305948 TT Genotype TT is associated with increased risk of Angina Pectoris and Myocardial Infarction when treated with clopidogrel in people with Coronary Disease as compared to genotypes CC + CT. CC 25738571
rs2305948 CC Genotype CC is associated with decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell. CC 21882181
rs2307441 C Allele C is associated with increased risk of Toxic liver disease when treated with valproic acid as compared to allele T. TT 21038416
rs2366929 C Allele C is associated with increased risk of Opioid-Related Disorders due to opioids in men as compared to allele T. TT 31792237
rs2440390 T Allele T is associated with increased Weight gain when treated with olanzapine in people with Mental Disorders as compared to allele C. CC 22967772
rs2476601 AA Genotype AA is associated with increased likelihood of discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GG 20921970
rs2476601 A Allele A is associated with increased risk of drug-induced liver injury when treated with amoxicillin and clavulanate as compared to allele G. GG 30664875
rs2501873 CC Genotype CC is associated with decreased severity of Anemia when treated with docetaxel in people with Nasopharyngeal Neoplasms as compared to genotypes CT + TT. CC 24193570
rs2514218 CC Genotype CC is associated with increased severity of Psychomotor Agitation due to aripiprazole in people with Psychotic Disorders, schizoaffective disorder or Schizophrenia as compared to genotypes CT + TT. TC 26320194
rs2518224 CC Genotype CC is associated with increased risk of treatment-emergent suicidal ideation when treated with citalopram in people with Depression. AC 17898344
rs28362731 AG Genotype AG is associated with increased risk of Thrombocytopenia due to cisplatin in people with Mesothelioma as compared to genotype GG. GA 30840592
rs28399504 G Allele G is associated with increased risk of Death when treated with clopidogrel in people with Acute coronary syndrome as compared to allele A. AA 19106084
rs28399504 G Allele G is associated with increased risk of cardiovascular events when treated with clopidogrel in people with Myocardial Infarction as compared to genotype AA. AA 19106083
rs28399504 G Allele G is associated with increased risk of ischaemic events when treated with clopidogrel in people with Acute coronary syndrome as compared to allele A. AA 20801498
rs2884737 CC Genotype CC is associated with increased risk of over-anticoagulation when treated with warfarin as compared to genotype AA. AA 20354686
rs301927 G Allele G is associated with increased likelihood of Peripheral Nervous System Diseases when treated with cyclophosphamide, epirubicin and paclitaxel in women with Breast Neoplasms as compared to allele A. AA 24599932
rs301927 AA Genotype AA is associated with decreased risk of Peripheral Nervous System Diseases when treated with paclitaxel in women with Breast Neoplasms as compared to genotypes AG + GG. AA 26133777
rs3087374 A Allele A is associated with increased risk of Toxic liver disease when treated with valproic acid as compared to allele C. CC 21038416
rs3136228 GG Genotype GG is associated with increased severity of Neutropenia when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to genotypes GT + TT. TT 22868256
rs3212191 TT Genotype TT is associated with increased risk of Hemorrhage when treated with warfarin as compared to genotypes CC + CT. TC 31461081
rs3212986 AC Genotype AC is associated with increased risk of nephrotoxicity when treated with cisplatin and cyclophosphamide in people with Ovarian Neoplasms as compared to genotype AA. CC 19786980
rs3212986 AA + AC Genotypes AA + AC are associated with increased overall survival when treated with platinum in people with Carcinoma, Non-Small-Cell Lung as compared to allele C. CC 19362955
rs3212986 AA + AC Genotypes AA + AC are not associated with increased risk of recurrence of disease when treated with Platinum compounds in women Ovarian Neoplasms as compared to genotype CC. CC 22329723
rs3212986 AA + AC Genotypes AA + AC are not associated with increased risk of Death when treated with Platinum compounds in women Ovarian Neoplasms as compared to genotype CC. CC 22329723
rs3212986 A Allele A is associated with increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to allele C. CC 19620936
rs3212986 AA + AC Genotypes AA + AC is associated with increased risk of Peripheral Nervous System Diseases when treated with paclitaxel in women with Breast Neoplasms as compared to genotype CC. CC 25495407
rs3212986 AA Genotype AA is associated with increased risk of Neutropenia when treated with cyclophosphamide, doxorubicin and fluorouracil in women with Breast Neoplasms as compared to genotypes AC + CC. CC 29507678
rs3212986 AC + CC Genotypes AC + CC are associated with decreased risk of Vomiting due to bleomycin, cisplatin and etoposide in men with Testicular Neoplasms as compared to genotype AA. CC 30914949
rs3212986 AA + AC Genotypes AA + AC are associated with increased overall survival when treated with cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to genotype CC. CC 23962907
rs363341 TT Genotype TT is associated with increased risk of Drug Toxicity when treated with antipsychotics in people with Psychotic Disorders as compared to genotypes CC + CT. TC 27272046
rs3736228 T Allele T is associated with decreased Bone Mineral Density as compared to allele C. TC 18455228
rs3764043 CC Genotype CC is associated with decreased imatinib clearance when treated with imatinib as compared to genotypes CT + TT. CC 21633340
rs3780412 C Allele C is associated with increased risk of obsessive-compulsive symptoms when treated with clozapine, olanzapine and risperidone in people with Schizophrenia. TT 19884611
rs3784867 T Allele T is associated with increased risk of Peripheral Nervous System Diseases when treated with vincristine as compared to allele C. CC 29999516
rs3787186 TT Genotype TT is associated with increased risk of Graft vs Host Disease when treated with cyclosporine and methotrexate in people with hemopoietic stem cell transplant as compared to genotypes CC + CT. TC 25425682
rs3789243 G Allele G is associated with increased risk of drug resistance when treated with antiepileptics in people with Epilepsy. AA 19450124
rs3789243 G Allele G is associated with increased risk of drug resistance when treated with antiepileptics in men with Epilepsy. AA 19450124
rs3856806 TT Genotype TT is associated with increased decline in FEV 1 after aspirin provocation when exposed to aspirin in people with Asthma as compared to genotypes CC + CT. TC 20224667
rs3856806 TT Genotype TT is associated with increased risk of aspirin hypersensitivity when treated with aspirin in people with Asthma as compared to genotypes CC + CT. TC 20224667
rs3918290 CT Genotype CT is associated with increased likelihood of Drug Toxicity when treated with fluorouracil in people with Colorectal Neoplasms. CC 17700593
rs3918290 CT Genotype CT is associated with increased Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 30114658
rs3918290 CT + TT Genotypes CT + TT is associated with increased severity of hand-foot syndrome when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 24817302
rs3918290 CT Genotype CT is associated with increased severity of Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to genotype CC. CC 26099996
rs3918290 T Allele T is associated with increased risk of Drug Toxicity when treated with capecitabine, fluorouracil or tegafur in people with Neoplasms. CC 23930673
rs3918290 CT + TT Genotypes CT + TT is associated with increased severity of Myelosuppression when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 24817302
rs3918290 CT Genotype CT is associated with increased Infection and Toxic liver disease when treated with fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC. CC 26846104
rs3918290 CT Genotype CT is associated with increased likelihood of mucositis when treated with fluorouracil in women with Neoplasms as compared to genotype CC. CC 19473056
rs3918290 CT Genotype CT is associated with increased likelihood of Thrombocytopenia when treated with fluorouracil in women with Neoplasms as compared to genotype CC. CC 19473056
rs3918290 CT + TT Genotypes CT + TT is associated with increased likelihood of Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to genotype CC. CC 12360106
rs3918290 T Allele T is associated with increased risk of Drug Toxicity when treated with capecitabine in women with Breast Neoplasms as compared to allele C. CC 28481884
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 20819423
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity, Leukopenia and mucositis when treated with fluorouracil in people with Neoplasms as compared to genotype CC. CC 18299612
rs3918290 CT Genotype CT is associated with increased likelihood of Drug Toxicity when treated with capecitabine in people with Colorectal Neoplasms as compared to genotype CC. CC 21498394
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 24167597
rs3918290 CT + TT Genotypes CT + TT is associated with increased severity of Diarrhea when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 24817302
rs3918290 CT + TT Genotypes CT + TT are associated with increased risk of Drug Toxicity when treated with capecitabine or fluorouracil in people with Neoplasms as compared to genotype CC. CC 30723313
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity when treated with capecitabine in women with Breast Neoplasms as compared to genotype CC. CC 27454530
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity when treated with fluorouracil in people with Colonic Neoplasms as compared to genotype CC. CC 25381393
rs3918290 CT Genotype CT is associated with increased risk of Drug Toxicity when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 29134491
rs3918290 CT + TT Genotypes CT + TT are associated with increased risk of Drug Toxicity when treated with capecitabine, fluorouracil or tegafur in people with Neoplasms as compared to genotype CC. CC 26603945
rs3918290 T Allele T is associated with increased severity of Drug Toxicity when treated with fluorouracil. CC 18299612
rs3918290 T Allele T is associated with increased likelihood of Drug Toxicity when treated with capecitabine or fluorouracil in people with Neoplasms as compared to genotype CC. CC 23603345
rs3918290 CT + TT Genotypes CT + TT are associated with increased risk of Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to genotype CC. CC 17121937
rs3918290 CT Genotype CT is associated with increased severity of Drug Toxicity when treated with fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 17064846
rs4148323 AA + AG Genotypes AA + AG are associated with increased severity of Diarrhea when treated with cisplatin and irinotecan in women with Genital Neoplasms, Female as compared to genotype GG. GG 19299905
rs4148323 AA + AG Genotypes AA + AG are associated with increased severity of Neutropenia when treated with cisplatin and irinotecan in women with Genital Neoplasms, Female as compared to genotype GG. GG 19299905
rs4148323 AG Genotype AG is associated with increased risk of Hyperbilirubinemia when treated with indinavir in people with HIV as compared to genotype GG. GG 16609363
rs4148323 AA + AG Genotypes AA + AG are associated with increased severity of Thrombocytopenia when treated with cisplatin and irinotecan in women with Genital Neoplasms, Female as compared to genotype GG. GG 19299905
rs4148323 AA Genotype AA is associated with increased severity of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype GG. GG 19390945
rs4148323 AG Genotype AG is associated with increased severity of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype GG. GG 19390945
rs4148323 AA Genotype AA is associated with increased Neutropenia when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 16636344
rs4148323 AA Genotype AA is associated with increased risk of Neutropenia when treated with irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 18221820
rs4148323 A Allele A is associated with increased likelihood of Diarrhea when treated with irinotecan in people with Lung Neoplasms as compared to allele G. GG 28367249
rs4148323 AG Genotype AG is associated with increased risk of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype GG. GG 26830078
rs4148323 A Allele A is associated with increased likelihood of Neutropenia when treated with irinotecan in people with Lung Neoplasms as compared to allele G. GG 28367249
rs4148323 AA + AG Genotypes AA + AG is associated with increased risk of Neutropenia when treated with irinotecan in people with biliary tract neoplasms and Pancreatic Neoplasms as compared to genotype GG. GG 26229432
rs4148323 AA + AG Genotypes AA + AG is associated with increased likelihood of Diarrhea and Neutropenia when treated with irinotecan in people with Lung Neoplasms as compared to genotype GG. GG 28502040
rs429358 CC Genotype CC is associated with increased severity of COVID-19 as compared to genotype TT. TT 32451547
rs429358 CC + CT Genotypes CC + CT are associated with increased non-HDL cholesterol when treated with Antivirals for treatment of HIV infections, combinations and ritonavir in people with HIV Infections as compared to allele C. TT 15809899
rs429358 C Allele C is associated with increased likelihood of Hemorrhage when treated with acenocoumarol or warfarin in people with venous thromboembolism as compared to allele T. TT 29432897
rs429358 CC + CT Genotypes CC + CT is associated with increased Hypertriglyceridemia in people with Coronary Disease or Hypertension as compared to genotype TT. TT 31559922
rs429358 CC + CT Genotypes CC + CT is associated with increased likelihood of Recurrence when treated with bupropion or nicotine in people with Tobacco Use Disorder as compared to genotype TT. TT 23247396
rs429358 C Allele C is associated with increased risk of mortality after myocardial infarction, however this can be eliminated when treated with simvastatin as compared to allele T. TT 10736278
rs429358 CC + CT Genotypes CC + CT is associated with increased reduction in C-reactive protein (CRP) when treated with atorvastatin or pravastatin in people with Acute coronary syndrome. TT 19667110
rs445925 A Allele A is associated with baseline LDL cholesterol in people with Vascular Diseases. GG 21977987
rs4638843 C Allele C is associated with decreased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to allele G. CC 25829401
rs4680 AG + GG Genotypes AG + GG is associated with increased likelihood of requiring postoperative intervention with opioids in children with adenotonsillectomy as compared to genotype AA. GA 24533707
rs4680 AA + AG Genotypes AA + AG is associated with increased diastolic blood pressure and systolic blood pressure when treated with antipsychotics in children as compared to genotype GG. GA 25048416
rs4680 AA Genotype AA is associated with increased overall mean numerical rating scale (NRS) score for pain when treated with morphine as compared to genotype GG. GA 23210659
rs4680 G Allele G is associated with decreased risk of Tobacco Use Disorder due to nicotine in smokers as compared to allele A. GA 16395295
rs4680 GG Genotype GG is associated with increased severity of withdrawal in people not taking nicotine in women Tobacco Use Disorder as compared to genotypes AA + AG. GA 23459442
rs4680 GG Genotype GG is associated with increased reaction time when treated with tolcapone in abstinent smokers. GA 24095246
rs4680 AG Genotype AG is associated with increased likelihood of relapse when treated with nicotine. GA 18192898
rs4680 AA Genotype AA is associated with increased likelihood of smoking cessation when treated with nicotine as compared to genotypes AG + GG. GA 17548664
rs4680 GG Genotype GG is associated with increased likelihood of relapse when treated with nicotine. GA 18192898
rs4680 AG Genotype AG is associated with increased likelihood of Exanthema when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotypes AA + GG. GA 30549211
rs4680 AA + GG Genotypes AA + GG are associated with increased likelihood of adverse events when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotype AG. GA 30549211
rs4680 AA Genotype AA is associated with increased numerical rating scale (NRS) score for pain during painful procedure when treated with morphine as compared to genotype GG. GA 23210659
rs4680 AG Genotype AG is associated with increased likelihood of extrapyramidal symptoms when treated with haloperidol in men with Schizophrenia as compared to genotypes AA + GG. GA 23963056
rs4680 AA Genotype AA is associated with increased likelihood of cessation when treated with Drugs used in nicotine dependence in people with as compared to genotypes AG + GG. GA 26555332
rs4680 AG Genotype AG is associated with increased likelihood of somnolence due to fentanyl in healthy individuals as compared to genotype GG. GA 30281924
rs4680 AA + GG Genotypes AA + GG are associated with increased likelihood of Sexual Dysfunctions, Psychological when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotypes AG + GG. GA 30549211
rs4680 AA Genotype AA is associated with increased likelihood of Vomiting when treated with buprenorphine, fentanyl or tramadol in people with Opioid-Related Disorders as compared to genotypes AG + GG. GA 30549211
rs4680 GG Genotype GG is associated with increased blood pressure when treated with nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG. GA 23459442
rs4680 AG Genotype AG is associated with increased likelihood of Hyperalgesia due to opioids in people with Pain as compared to genotypes AA + GG. GA 31041874
rs4790694 A Allele A is not associated with increased risk of Tobacco Use Disorder due to nicotine as compared to allele C. CC 17579607
rs4790694 A Allele A is associated with increased risk of Tobacco Use Disorder due to nicotine as compared to allele C. CC 17579607
rs492338 AA Genotype AA is associated with increased risk of Peripheral Nervous System Diseases when treated with paclitaxel in women with Breast Neoplasms as compared to genotype GG. GG 24706167
rs494904 T Allele T is associated with decreased risk of Alcoholism due to ethanol as compared to allele C. TC 32451486
rs4961 TT Genotype TT is associated with increased hydrochlorothiazide induced calcium retention when treated with hydrochlorothiazide in men with Hypertension as compared to genotype GG. GT 16450155
rs4961 GT + TT Genotypes GT + TT are associated with decreased likelihood of Myocardial Infarction when treated with diuretics in people with Hypertension. GT 11926892
rs568408 A Allele A is associated with increased risk of time to anemia in patients undergoing living or deceased donor kidney transplant when treated with mycophenolate mofetil as compared to allele G. GG 21107304
rs5789 C Allele C is associated with decreased likelihood of aspirin-induced asthma when exposed to Antiinflammatory agents, non-steroids in people with Asthma as compared to allele A. CC 26067486
rs6021191 T Allele T is associated with increased risk of Hypersensitivity when treated with asparaginase in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A. AA 25987655
rs6025 T Allele T is associated with increased risk of Venous Thrombosis when treated with hormonal contraceptives for systemic use in women as compared to allele C. CC 28750087
rs6025 CT Genotype CT is associated with increased risk of Venous Thrombosis when treated with hormonal contraceptives for systemic use in women as compared to genotype CC. CC 12069454
rs6025 CT + TT Genotypes CT + TT is not associated with increased risk of venous thromboembolism when treated with hormonal contraceptives for systemic use in women as compared to genotype CC. CC 15208046
rs6025 CT + TT Genotypes CT + TT is not associated with increased risk of Stroke when treated with hormonal contraceptives for systemic use in women as compared to genotype CC. CC 15946211
rs6025 CT Genotype CT is associated with increased risk of Stroke when treated with hormonal contraceptives for systemic use in women as compared to genotype CC. CC 16769590
rs6071980 C Allele C is associated with increased risk of non-response when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T. TT 18615156
rs6130615 TT Genotype TT is associated with increased severity of Anemia when treated with docetaxel in people with Nasopharyngeal Neoplasms as compared to genotype CT. CC 24193570
rs671 AA + AG Genotypes AA + AG are associated with increased Heroin Dependence due to heroin as compared to genotype GG. GG 21723677
rs6714486 A Allele A is associated with changes in mycophenolic acid exposure-related parameters on day 7 after transplantation (treatment with 2g per day) when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to allele T. TT 16198654
rs6769511 C Allele C is associated with increased likelihood of Disease Progression when treated with epirubicin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to allele T. TT 26115082
rs683369 CG + GG Genotypes CG + GG is associated with increased overall survival when treated with cisplatin in people with Esophageal Neoplasms as compared to genotype CC. CC 32285752
rs683369 CC Genotype CC is associated with decreased severity of Drug Toxicity when treated with imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CG + GG. CC 28289867
rs683369 CG + GG Genotypes CG + GG is associated with increased risk of conjunctival hemorrhage when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC. CC 28762371
rs686 A Allele A is associated with increased risk of Tobacco Use Disorder when exposed to nicotine in smokers as compared to allele G. GG 18092181
rs7104613 T Allele T is associated with opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to allele C. CC 21622719
rs7170924 GT + TT Genotypes GT + TT are associated with increased risk of Drug Toxicity when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG. GG 27498158
rs7305534 CC + CT Genotypes CC + CT is associated with increased severity of Diarrhea, Nausea and Vomiting when treated with platinum in people with Lung Neoplasms as compared to genotype TT. TT 26358256
rs7412 T Allele T is associated with increased risk of Hypertriglyceridemia when treated with Antivirals for treatment of HIV infections, combinations and ritonavir in people with HIV Infections as compared to allele C. CC 15809899
rs7412 T Allele T is associated with LDL-C response when treated with atorvastatin in people with Coronary Disease. CC 20031582
rs7412 CT + TT Genotypes CT + TT is associated with increased Hyperuricemia in people with Coronary Disease or Hypertension as compared to genotype CC. CC 31559922
rs7412 CT + TT Genotypes CT + TT is associated with increased percent reduction in LDL-cholesterol when treated with atorvastatin or pravastatin in people with Acute coronary syndrome as compared to genotype CC. CC 19667110
rs7572857 AA + AG Genotypes AA + AG are associated with increased risk of aspirin-intolerant asthma when exposed to aspirin in people with Asthma as compared to genotype GG. GG 21072201
rs7572857 AA Genotype AA is associated with increased decline of forced expiratory volume in 1s (FEV(1)) by aspirin provocation when exposed to aspirin in people with Asthma as compared to genotypes AG + GG. GG 21072201
rs762551 AA Genotype AA is associated with decreased risk of Iron Overload when treated with deferasirox in children with Thalassemia as compared to genotypes AC + CC. AA 28346059
rs762551 AC + CC Genotypes AC + CC are associated with increased risk of Myocardial Infarction in people with increased coffee intake. AA 16522833
rs762551 AA Genotype AA is associated with decreased plasma concentrations when treated with olanzapine in people with psychiatric disorders as compared to allele C. AA 19636338
rs762551 AA + AC Genotypes AA + AC are associated with decreased on-treatment platelet reactivity when treated with clopidogrel in people with cigarette smokers as compared to genotype CC. AA 21148426
rs762551 AC + CC Genotypes AC + CC are associated with increased QT interval when treated with antipsychotics, chlorpromazine, fluphenazine, thioridazine and trifluoperazine in people with Schizophrenia as compared to genotype AA. AA 17611010
rs762551 C Allele C is associated with increased likelihood of Pulmonary Disease, Chronic Obstructive as compared to allele A. AA 20797314
rs762551 AC + CC Genotypes AC + CC are associated with increased QT interval when treated with chlorpromazine in people with Schizophrenia as compared to genotype AA. AA 17611010
rs762551 CC Genotype CC is associated with increased risk of tardive dyskinesia when treated with antipsychotics in people with Schizophrenia as compared to genotypes AA + AC. AA 16490169
rs762551 AA Genotype AA is associated with decreased likelihood of Metabolic Syndrome when treated with clozapine in people with Schizophrenia as compared to genotypes AC + CC. AA 27681143
rs762551 CC Genotype CC is associated with increased severity of tardive dyskinesia when treated with antipsychotics in people with Schizophrenia as compared to genotypes AA + AC. AA 10889552
rs7929521 GG Genotype GG is associated with increased IC50 of daunorubicin. GA 18451141
rs806374 CC Genotype CC is associated with increased likelihood of tardive dyskinesia when treated with antipsychotics in people with Schizophrenia as compared to genotypes CT + TT. TC 21266946
rs806374 CC Genotype CC is associated with increased severity of tardive dyskinesia when treated with antipsychotics in people with Schizophrenia as compared to genotypes CT + TT. TC 21266946
rs8099917 GG + GT Genotypes GG + GT are associated with increased risk of treatment failure when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT. TT 24355007
rs8099917 TT Genotype TT is associated with decreased severity of Hepatitis C when treated with peginterferon alfa-2b and ribavirin as compared to genotypes GG + GT. TT 21911885
rs8099917 GG + GT Genotypes GG + GT are associated with increased likelihood of retreatment failure when treated with direct acting antivirals, elbasvir / grazoprevir or ledipasvir / sofosbuvir in people with Hepatitis C, Chronic as compared to genotype TT. TT 31846553
rs8099917 GG + GT Genotypes GG + GT are associated with increased risk of Hypercholesterolemia when treated with asunaprevir, daclatasvir, direct acting antivirals, ledipasvir / sofosbuvir or ombitasvir / paritaprevir / ritonavir in people with Hepatitis C, Chronic as compared to genotype TT. TT 31144350
rs8176746 T Allele T is associated with increased ACE activity in people with Hypertension. GG 20066004
rs879207 AG Genotype AG is associated with increased risk of Neurotoxicity Syndromes when treated with carboplatin, docetaxel and paclitaxel in women with Ovarian Neoplasms as compared to genotypes AA + GG. GA 23963862
rs9282564 CC + CT Genotypes CC + CT is associated with increased risk of Respiratory Insufficiency when treated with morphine in children as compared to genotype TT. TT 25311385
rs9345389 G Allele G is associated with end-of-induction minimal risidual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) and is also associated with greater methotrexate clearance. when treated with methotrexate as compared to allele A. AA 19176441
rs9394992 CT + TT Genotypes CT + TT are associated with increased risk of neutropenia when treated with gemcitabine in people with Pancreatic Neoplasms as compared to genotype CC. CC 20665488
rs940052 G Allele G is associated with decreased risk of Esophagitis when treated with radiotherapy as compared to allele A. GA 25054431
rs951439 TT Genotype TT is associated with increased likelihood of response when treated with risperidone in people with Schizophrenia as compared to genotypes CC + CT. TC 17588543
rs951439 CC Genotype CC is associated with increased likelihood of positive response when treated with olanzapine and perphenazine in people with Schizophrenia as compared to genotypes CT + TT. TC 17588543
rs951439 CT Genotype CT is associated with increased likelihood of response when treated with olanzapine in people with Schizophrenia. TC 17588543
rs989692 CT + TT Genotypes CT + TT is associated with increased likelihood of Angioedema when treated with Ace Inhibitors, Plain as compared to genotype CC. TC 23838604
rs9922316 T Allele T is associated with increased dexmedetomidine ED50 values for drug-induced dorsal hand vein (DHV) constriction when exposed to dexmedetomidine in healthy individuals as compared to allele G. GG 23337848
Page:

Variants which affect drug dose, response, metabolism, etc.:

Page:
Variant Alleles Associations Genotype PMID
rs1042389 TT Genotype TT is associated with decreased metabolism of efavirenz in healthy individuals as compared to genotype CC. TC 28960269
rs1042713 AA Genotype AA is associated with decreased response to salmeterol in children with Asthma. GA 23126384
rs1042713 AA Genotype AA is associated with decreased response to salmeterol in people with Asthma as compared to genotype GG. GA 16322642
rs1042713 AA Genotype AA is associated with decreased response to methacholine in people with Asthma as compared to genotype GG. GA 23384627
rs10485058 AA Genotype AA is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG. AA 27958381
rs10494227 A Allele A is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele G. AA 27001119
rs10509681 C Allele C is associated with increased metabolism of rosiglitazone in healthy individuals as compared to allele T. TC 17178266
rs10509681 C Allele C is associated with increased metabolism of repaglinide in healthy individuals as compared to allele T. TC 14534525
rs1051740 C Allele C is associated with increased dose of carbamazepine in people with Epilepsy as compared to allele T. TC 19620853
rs1051740 TT Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotypes CC + CT. TC 23252947
rs1051740 CC Genotype CC is associated with decreased dose of phenprocoumon as compared to genotypes CT + TT. TC 21110013
rs1051740 C Allele C is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele T. TC 15692831
rs10793902 T Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele C. TC 26895070
rs10964552 AA + AC Genotypes AA + AC are associated with decreased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotype CC. CC 27150640
rs11126740 AA Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes AG + GG. GA 27670765
rs1126535 T Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C. TC 28639493
rs11265572 GT + TT Genotypes GT + TT are associated with decreased metabolism of tacrolimus in people with liver transplantation as compared to genotype GG. GG 24351870
rs1130864 AG + GG Genotypes AG + GG are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype AA. GG 27096233
rs1143634 GG Genotype GG is associated with decreased response to infliximab in people with Crohn Disease as compared to genotypes AA + AG. GA 22960943
rs1143634 A Allele A is associated with increased dose of morphine in women with Pain, Postoperative as compared to allele G. GA 27649267
rs11563250 AG + GG Genotypes AG + GG is associated with decreased concentrations of bilirubin in people with Colorectal Neoplasms as compared to genotype AA. AA 25778466
rs11574077 TT Genotype TT is associated with increased metabolism of irinotecan in people with Colorectal Neoplasms as compared to genotype CT. TT 29706892
rs11702779 AG + GG Genotypes AG + GG are associated with increased response to methacholine chloride in children with Asthma. GG 21803869
rs11869731 CC Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG. CC 21961650
rs11959113 AA Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG. AA 25615449
rs12082710 TT Genotype TT is associated with increased response to antidepressants in people with Depression as compared to genotypes CC + CT. TT 23092981
rs1232027 A Allele A is associated with increased response to methotrexate in people with Arthritis, Psoriatic as compared to allele G. GA 20472929
rs12404655 AG + GG Genotypes AG + GG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype AA. GG 30088438
rs12505410 G Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T. GT 24123600
rs12505410 GG + GT Genotypes GG + GT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT. GT 24123600
rs12505410 G Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T. GT 24123600
rs1265138 AA Genotype AA is associated with increased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotypes AG + GG. AA 24024897
rs12720066 AC + CC Genotypes AC + CC are associated with decreased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA. AA 27845419
rs12721655 G Allele G is not associated with decreased clearance of nevirapine in people with HIV Infections as compared to allele A. AA 22354160
rs1449683 CC + CT Genotypes CC + CT are associated with decreased response to fluvoxamine in people with Depressive Disorder as compared to genotype TT. TC 25710119
rs1521470 A Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G. GG 29121268
rs16969968 G Allele G is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder. GA 22648373
rs16969968 GG Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG. GA 23358500
rs16969968 A Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G. GA 26833182
rs16969968 A Allele A is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder. GA 22648373
rs16969968 A Allele A is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to allele G. GA 26010901
rs17216198 T Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C. CC 30100615
rs1741981 CC Genotype CC is associated with decreased response to corticosteroids in children with Asthma as compared to genotypes CT + TT. TC 24307847
rs1741981 CC Genotype CC is associated with decreased response to Corticosteroids For Systemic Use in people with Asthma as compared to genotypes CT + TT. TC 24307847
rs1799722 TT Genotype TT is associated with decreased response to enalapril in people with Hypertension as compared to genotypes CC + CT. TC 22706620
rs1799978 T Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C. TT 17105675
rs1799978 CC Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype TT. TT 21902500
rs1799978 TT Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype CT. TT 18855532
rs1800562 A Allele A is associated with decreased dose of epoetin alfa in people with hemodialysis treatment as compared to allele G. GG 18025780
rs1800629 GG Genotype GG is associated with decreased response to adalimumab in people with Arthritis, Rheumatoid. GA 17673491
rs1800629 G Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis or Spondylarthropathies as compared to allele A. GA 26244882
rs1800888 CT Genotype CT is associated with decreased response to terbutaline in healthy individuals as compared to genotype CC. CC 11222464
rs1801131 G Allele G is associated with increased response to fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele T. GT 20078613
rs1801131 GT + TT Genotypes GT + TT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GT 26616421
rs1801131 GG + GT Genotypes GG + GT are associated with increased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT. GT 20385995
rs1801131 TT Genotype TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes GG + GT. GT 27676277
rs1801131 GG Genotype GG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes GT + TT. GT 27992285
rs1801131 G Allele G is associated with increased response to Vitamin B-complex, Incl. Combinations in people with Depressive Disorder, Major. GT 27035272
rs1801133 AA Genotype AA is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotypes AG + GG. GA 29589488
rs1801133 A Allele A is associated with increased response to fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele G. GA 20078613
rs1801133 AA Genotype AA is associated with decreased response to capecitabine, fluorouracil, leucovorin and oxaliplatin in people with Colonic Neoplasms as compared to allele G. GA 24980946
rs1801133 AA Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AG + GG. GA 27676277
rs1801133 AG Genotype AG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + GG. GA 25618758
rs1801133 AA Genotype AA is associated with decreased response to bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin or trastuzumab in people with Stomach Neoplasms as compared to genotypes AG + GG. GA 27995989
rs1801133 AA Genotype AA is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG. GA 24637499
rs1801133 A Allele A is associated with increased response to Vitamin B-complex, Incl. Combinations in people with Depressive Disorder, Major. GA 27035272
rs1801274 A Allele A is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G. GA 25823785
rs1801274 GG Genotype GG is associated with decreased response to adalimumab, etanercept or infliximab in people with Psoriasis as compared to genotypes AA + AG. GA 24048425
rs1801278 CT + TT Genotypes CT + TT is associated with decreased response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to genotype CC. TC 28696414
rs1801394 AA + AG Genotypes AA + AG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG. GA 27676277
rs191190 CC + CT Genotypes CC + CT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype TT. TC 27977334
rs204047 GG Genotype GG is associated with increased dose of methadone as compared to genotypes GT + TT. GG 31907389
rs204047 GG Genotype GG is associated with increased concentrations of methadone as compared to genotypes GT + TT. GG 31907389
rs2075650 G Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A. AA 27045730
rs2177370 A Allele A is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G. AA 25730470
rs2230808 CC Genotype CC is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT. CC 20346718
rs2273697 A Allele A is associated with decreased exposure to mycophenolic acid in people with Kidney Transplantation as compared to allele G. GG 28624888
rs2273697 A Allele A is associated with decreased exposure to mycophenolic acid as compared to allele G. GG 28624888
rs2284922 A Allele A is associated with increased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms. GA 30071039
rs2303377 TT Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT. TT 28696415
rs2305089 TT Genotype TT is associated with increased response to flunisolide in people with Asthma as compared to genotypes CC + CT. TT 22538805
rs2305948 T Allele T is associated with decreased response to clopidogrel in people with Coronary Disease as compared to allele C. CC 25738571
rs2337980 CC Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT. CC 20231857
rs243865 T Allele T is associated with decreased response to ulinastatin in people with Pancreatitis as compared to allele C. CC 31192912
rs2461817 C Allele C is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele A. AC 23252947
rs2461817 AA Genotype AA is associated with decreased concentrations of voriconazole as compared to genotype AC. AC 31932875
rs2477134 G Allele G is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T. GT 29580174
rs2514218 T Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C. TC 26666695
rs2740204 T Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele G. GT 20196918
rs2776546 A Allele A is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C. AA 23753411
rs28371685 T Allele T is associated with decreased dose of warfarin as compared to allele C. CC 20072124
rs28399504 G Allele G is associated with decreased metabolism of mephenytoin as compared to allele A. AA 9435198
rs286913 A Allele A is associated with increased response to ziprasidone in people with Schizophrenia as compared to allele G. GA 21107309
rs2884737 AA Genotype AA is associated with increased dose of warfarin as compared to genotype AC. AA 24019055
rs2884737 C Allele C is associated with decreased dose of warfarin as compared to allele A. AA 20072124
rs2884737 CC Genotype CC is associated with decreased dose of warfarin as compared to genotype AA. AA 18322281
rs2884737 C Allele C is associated with decreased dose of warfarin as compared to allele A. AA 16611750
rs3184504 T Allele T is associated with increased response to candesartan in people with Hypertension as compared to allele C. TC 31327267
rs3212986 CC Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AC. CC 29662106
rs3212986 A Allele A is not associated with decreased response to Platinum compounds in women with Ovarian Neoplasms as compared to allele C. CC 22329723
rs3212986 AC + CC Genotypes AC + CC are associated with increased response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotype AA. CC 29177570
rs3749034 G Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele A. GA 31866536
rs3761555 TT Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CC + CT. TC 23394390
rs3785143 T Allele T is associated with decreased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C. CC 23266789
rs3787429 TT Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT. TT 21652606
rs3816877 CC Genotype CC is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotype CT. CC 27406852
rs3918290 CC Genotype CC is associated with increased response to fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CT. CC 26846104
rs3918290 CT Genotype CT is associated with decreased clearance of fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 17064846
rs3918290 CT Genotype CT is associated with decreased metabolism of fluorouracil in people with Neoplasms as compared to genotype CC. CC 18600527
rs3918290 CT Genotype CT is associated with decreased clearance of fluorouracil in people with Colorectal Neoplasms as compared to genotype CC. CC 11953843
rs3918290 CT Genotype CT is associated with decreased response to cisplatin and fluorouracil in men with Head and Neck Neoplasms as compared to genotype CC. CC 26792652
rs3918290 CT Genotype CT is associated with decreased metabolism of fluorouracil in people with Neoplasms as compared to genotype CC. CC 26216193
rs3918290 CT Genotype CT is associated with decreased dose of capecitabine in people with Colorectal Neoplasms as compared to genotype CC. CC 21498394
rs4148323 AA Genotype AA is associated with decreased metabolism of SN-38 in people with Neoplasms as compared to genotype GG. GG 17627617
rs4148323 AA Genotype AA is associated with decreased metabolism of SN-38 in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 16636344
rs4148323 AA Genotype AA is associated with decreased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 16636344
rs4148323 A Allele A is associated with decreased metabolism of carvedilol in people with Angina Pectoris as compared to allele G. GG 16849011
rs4148412 TT Genotype TT is associated with increased concentrations of morphine-3-glucuronide in children with tonsillectomy as compared to genotypes CC + CT. TT 26810133
rs429358 CC + CT Genotypes CC + CT is associated with decreased dose of warfarin as compared to genotype TT. TT 25312789
rs429358 C Allele C is associated with decreased dose of acenocoumarol in people with venous thromboembolism as compared to allele T. TT 29432897
rs429358 CT Genotype CT is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotype TT. TT 25860945
rs429358 CC + CT Genotypes CC + CT is associated with decreased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to genotype TT. TT 24951635
rs4305746 AA + AG Genotypes AA + AG are associated with increased response to aripiprazole in people with Schizophrenia as compared to genotype GG. AA 19345712
rs4364871 CT + TT Genotypes CT + TT is associated with decreased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype CC. TC 30088438
rs4645962 CT Genotype CT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype TT. TT 26249541
rs4646450 GG Genotype GG is associated with increased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AA + AG. GG 29454235
rs4680 GG Genotype GG is associated with decreased response to morphine in infants with Pain as compared to genotypes AA + AG. GA 27027462
rs4680 G Allele G is associated with increased clearance of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A. GA 18214865
rs4680 A Allele A is associated with increased response to morphine in people with Low Back Pain as compared to allele G. GA 23773341
rs4680 AA Genotype AA is associated with decreased dose of morphine in people with Pain, Postoperative as compared to genotypes AG + GG. GA 23686330
rs4680 GG Genotype GG is associated with decreased response to fluvoxamine in people with Depressive Disorder, Major as compared to allele A. GA 20619611
rs4680 AG Genotype AG is associated with decreased dose of opioids in children as compared to genotype GG. GA 30704436
rs4680 A Allele A is associated with increased response to paroxetine in people with Depressive Disorder, Major as compared to allele G. GA 18989660
rs4680 AA Genotype AA is associated with decreased dose of sufentanil in children as compared to genotypes AG + GG. GA 28006928
rs4680 G Allele G is associated with increased dose of morphine in people with Pain, Postoperative and Coronary Artery Disease as compared to allele A. GA 31967515
rs4737771 C Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T. TT 27091189
rs4986910 G Allele G is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to allele A. AA 12966368
rs5063 TT Genotype TT is associated with decreased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype CC. CC 20877298
rs5569 GG Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG. GG 21127421
rs5569 GG Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG. GG 29230023
rs5569 AG + GG Genotypes AG + GG are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA. GG 15322419
rs56113850 T Allele T is associated with decreased clearance of nicotine as compared to allele C. CC 26407342
rs5882 A Allele A is associated with increased response to simvastatin in people with Hypercholesterolemia as compared to allele G. AA 17931083
rs5934731 C Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T. TC 21635146
rs6458232 C Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele A. CC 21635146
rs646776 C Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T. TC 25350695
rs6494223 T Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C. TC 24951635
rs671 AA + AG Genotypes AA + AG is associated with decreased response to nitroglycerin in children with Heart Defects, Congenital as compared to genotype GG. GG 31250045
rs683369 CG + GG Genotypes CG + GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype CC. CC 29427770
rs683369 CC Genotype CC is associated with increased clearance of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CG + GG. CC 24589908
rs686 G Allele G is associated with increased response to clozapine in people with Schizophrenia as compared to allele A. GG 21332319
rs6920220 AA Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic or Psoriasis as compared to genotypes AG + GG. GA 30653751
rs6983267 GG + GT Genotypes GG + GT are associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotype TT. GT 26729200
rs7121 CC Genotype CC is associated with increased response to cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to genotypes CT + TT. CC 19274060
rs7405404 T Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C. TC 29121268
rs7412 CC Genotype CC is associated with increased dose of warfarin in people with Atrial Fibrillation, Pulmonary Embolism or Venous Thrombosis as compared to genotypes CT + TT. CC 31854268
rs7412 T Allele T is associated with decreased dose of warfarin in people with haplotype epsilon2. CC 21228733
rs762551 A Allele A is associated with increased dose of paroxetine in people with Depressive Disorder, Major as compared to allele C. AA 21121774
rs762551 AA Genotype AA is associated with increased metabolism of caffeine in people with heavy coffee consumption as compared to genotypes AC + CC. AA 20390257
rs762551 AA Genotype AA is associated with increased metabolism of caffeine in people with Tobacco Use Disorder as compared to genotypes AC + CC. AA 17370067
rs762551 AA Genotype AA is associated with increased clearance of carbamazepine in children with Epilepsy as compared to genotypes AC + CC. AA 26762380
rs762551 AA Genotype AA is associated with increased metabolism of caffeine as compared to genotype AC. AA 10233211
rs762551 AA + AC Genotypes AA + AC is associated with increased metabolism of caffeine as compared to genotype CC. AA 29282363
rs762551 CC Genotype CC is associated with decreased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AC. AA 30713339
rs7668282 CC + CT Genotypes CC + CT is associated with decreased metabolism of morphine in people with Anemia, Sickle Cell as compared to genotype TT. TT 17724700
rs800292 GG Genotype GG is associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype AA. GA 22594510
rs8099917 T Allele T is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in children with Hepatitis C as compared to allele G. TT 26825765
rs8099917 T Allele T is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to allele G. TT 19749757
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Hepatitis C, HIV Infections and HIV Infections as compared to genotypes GG + GT. TT 22328925
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or simeprevir in people with Hepatitis C as compared to genotypes GG + GT. TT 26264253
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21745312
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype GT. TT 21321200
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21254157
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21739446
rs8099917 GG + GT Genotypes GG + GT is associated with decreased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotype TT. TT 25278709
rs8099917 GG + GT Genotypes GG + GT is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotype TT. TT 20060832
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 25393304
rs8099917 TT Genotype TT is associated with increased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 24102823
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 22301466
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 25852275
rs8099917 GG + GT Genotypes GG + GT is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT. TT 21346780
rs8099917 T Allele T is associated with increased response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to allele G. TT 31201901
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21360545
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21112660
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21112660
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype GT. TT 21321200
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21246582
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21048934
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 23142377
rs8099917 TT Genotype TT is associated with increased response to interferon alfa-n1, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21466653
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 21911885
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C as compared to genotypes GG + GT. TT 20648473
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 20434452
rs8099917 G Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T. TT 19749758
rs8099917 GT Genotype GT is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT. TT 19749758
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 24929144
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype GT. TT 23281610
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic and Hepatitis C, Chronic as compared to genotypes GG + GT. TT 26075078
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotype GT. TT 23730840
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 21384511
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes GG + GT. TT 21907615
rs8099917 G Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to allele T. TT 21931540
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GT + TT. TT 21987611
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 26003758
rs8099917 GG Genotype GG is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT. TT 19749758
rs8099917 TT Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21503910
rs8099917 TT Genotype TT is associated with increased response to interferon alfa-n1, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 21466653
rs8099917 GG + GT Genotypes GG + GT is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C. TT 20060832
rs8099917 TT Genotype TT is associated with increased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. TT 24768758
rs9282564 C Allele C is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to allele T. TT 17178267
rs9282564 CC + CT Genotypes CC + CT is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype TT. TT 29603629
rs9332131 del Allele del is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype AA. GAGA 16220110
rs9332131 del Allele del is associated with decreased dose of warfarin. GAGA 20072124
rs933271 C Allele C is associated with decreased response to risperidone in people with Schizophrenia. TT 22935916
rs1002976 C Allele C is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T. TT 29580174
rs10248420 A Allele A is associated with decreased response to clozapine in people with Schizophrenia as compared to allele G. GA 22722500
rs1042713 A Allele A is associated with decreased response to corticosteroids and selective beta-2-adrenoreceptor agonists in children with Asthma as compared to genotype GG. GA 26774659
rs1042713 AA Genotype AA is associated with increased response to tiotropium in people with Asthma as compared to genotypes AG + GG. GA 19183167
rs1042713 AA Genotype AA is associated with increased dose of phenylephrine in women as compared to genotype GG. GA 25730298
rs1042713 GG Genotype GG is associated with increased response to propranolol in people with Liver Cirrhosis as compared to genotype AA. GA 26109805
rs1042713 AG + GG Genotypes AG + GG are associated with increased response to benazepril in people with Essential hypertension as compared to genotype AA. GA 15554460
rs1042713 AA Genotype AA is associated with increased response to atenolol or metoprolol in people with Tachycardia as compared to genotypes AG + GG. GA 31090079
rs10499563 CC + CT Genotypes CC + CT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype TT. TT 24776844
rs10514475 A Allele A is associated with increased response to Selective serotonin reuptake inhibitors in people with Depression as compared to allele G. GG 25649181
rs10517 AA Genotype AA is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes AG + GG. GG 27740732
rs10517 GG Genotype GG is associated with decreased dose of warfarin as compared to genotypes AA + AG. GG 26257249
rs1051740 CC Genotype CC is associated with increased dose of carbamazepine in people with Epilepsy as compared to genotypes CT + TT. TC 22188362
rs1051740 CT Genotype CT is associated with increased dose of carbamazepine in people with Epilepsy as compared to genotype TT. TC 22188362
rs1051740 CC Genotype CC is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotypes CT + TT. TC 26555147
rs1059513 CC + CT Genotypes CC + CT are associated with increased response to esomeprazole in children with eosinophilic esophagitis as compared to genotype TT. TT 31490856
rs10841753 CT + TT Genotypes CT + TT are associated with decreased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC. TT 28525903
rs10954732 GG Genotype GG is associated with increased concentrations of voriconazole as compared to genotype AA. GA 31932875
rs1143634 A Allele A is associated with decreased dose of morphine in women with Pain, Postoperative as compared to allele G. GA 27649267
rs11591147 T Allele T is associated with increased response to hmg coa reductase inhibitors in people with Hypercholesterolemia as compared to genotype GG. GG 26902539
rs11702779 AA Genotype AA is associated with increased response to methacholine chloride in children with Asthma as compared to genotypes AG + GG. GG 21803869
rs11716445 A Allele A is associated with decreased response to pravastatin or simvastatin in people with Hypercholesterolemia as compared to allele G. AA 23166513
rs11960832 TT Genotype TT is associated with decreased response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT. TT 23886675
rs12067645 AA + AG Genotypes AA + AG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype GG. GA 30088438
rs12081765 G Allele G is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A. AA 33124499
rs1229984 CT Genotype CT is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotypes CC + TT. CC 31002879
rs12456693 T Allele T is associated with increased response to clopidogrel in people with Coronary Artery Disease as compared to allele C. CC 30487649
rs12505410 GG Genotype GG is associated with increased clearance of methotrexate in people with Osteosarcoma as compared to genotypes GT + TT. GT 29791011
rs12566888 TT Genotype TT is associated with increased response to ticagrelor in healthy individuals as compared to genotype GT. GG 27937053
rs1277733 TT Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC. CC 30032160
rs13181 GG Genotype GG is associated with increased response to bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin or trastuzumab in people with Stomach Neoplasms as compared to genotypes GT + TT. GT 27995989
rs1412125 CC Genotype CC is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CT + TT. TC 24684392
rs1611115 CT + TT Genotypes CT + TT are associated with increased response to levodopa in people with Cocaine-Related Disorders as compared to genotype CC. CC 24809448
rs1611115 CT + TT Genotypes CT + TT is associated with increased response to naltrexone in men with Alcoholism as compared to genotype CC. CC 24724887
rs16873129 C Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T. CC 27091189
rs16969968 AA + AG Genotypes AA + AG are associated with increased response to bupropion, nicotine or varenicline in women with Tobacco Use Disorder as compared to genotype GG. GA 29621993
rs16969968 AA + AG Genotypes AA + AG are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype GG. GA 26142345
rs17180299 AG + GG Genotypes AG + GG are associated with increased concentrations of methadone in people with Opioid-Related Disorders as compared to genotype AA. AA 27010727
rs17268282 T Allele T is associated with increased response to furosemide in people with Heart Failure as compared to allele G. GG 26927285
rs17461620 C Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T. TC 19749758
rs17584499 CC Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT. TC 23147557
rs17798800 T Allele T is associated with decreased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C. TC 23374588
rs1799722 CT Genotype CT is associated with increased exposure to atorvastatin in healthy individuals as compared to genotypes CC + TT. TC 29250329
rs1800629 A Allele A is associated with decreased response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G. GA 19365401
rs1800629 A Allele A is associated with decreased response to etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G. GA 16909270
rs1800629 GG Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AG. GA 15834068
rs1800629 GG Genotype GG is associated with increased response to adalimumab, etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG. GA 16720636
rs1800629 AG + GG Genotypes AG + GG is associated with increased response to adalimumab, etanercept and infliximab in people with Arthritis, Rheumatoid as compared to genotype AA. GA 22760475
rs1800629 GG Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AG. GA 18050183
rs1800629 GG Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotypes AA + AG. GA 12759288
rs1800629 GG Genotype GG is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotype AG. GA 17343250
rs1800629 AG + GG Genotypes AG + GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AA. GA 18713756
rs1800629 GG Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG. GA 12847678
rs1800629 GG Genotype GG is associated with increased response to adalimumab or infliximab in people with Spondylitis, Ankylosing as compared to genotype AG. GA 16720636
rs1800629 GG Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes AA + AG. GA 24192118
rs1801131 GT Genotype GT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT. GT 25618758
rs1801131 G Allele G is associated with decreased response to benazepril in people with Hypertension. GT 16081343
rs1801133 AG + GG Genotypes AG + GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA. GA 24967362
rs1801133 AA + AG Genotypes AA + AG is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 21644011
rs1801133 AA + AG Genotypes AA + AG are associated with increased response to disulfiram in people with Cocaine-Related Disorders as compared to genotype GG. GA 23335901
rs1801133 AA Genotype AA is associated with increased response to benazepril in people with Hypertension as compared to genotypes AG + GG. GA 15226090
rs1801133 GG Genotype GG is associated with increased exposure to capecitabine in people with Neoplasms as compared to genotypes AA + AG. GA 26242222
rs1801133 G Allele G is associated with decreased response to benazepril in people with Hypertension. GA 16081343
rs1801133 AA + AG Genotypes AA + AG is associated with increased concentrations of methotrexate in people with Burkitt Lymphoma, Lymphoma, T-Cell or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. GA 25303299
rs1801133 AA Genotype AA is associated with increased concentrations of methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG. GA 17180579
rs1801133 AA + AG Genotypes AA + AG is associated with increased response to fluorouracil in people with Colorectal Neoplasms as compared to genotype GG. GA 29134491
rs1801274 AA Genotype AA is associated with increased response to cyclophosphamide, doxorubicin, paclitaxel and trastuzumab in women with Breast Neoplasms as compared to genotypes AG + GG. GA 21109570
rs1801274 G Allele G is associated with decreased response to infliximab in people with Arthritis, Rheumatoid as compared to allele A. GA 24667440
rs1801274 AG + GG Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis and Spondylitis, Ankylosing as compared to genotype AA. GA 27490376
rs1801274 GG Genotype GG is associated with increased response to cetuximab in people with Head and Neck Neoplasms as compared to genotypes AA + AG. GA 28719596
rs1801274 AA Genotype AA is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AG + GG. GA 30318772
rs1801274 AA Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG. GA 30457672
rs1801394 A Allele A is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G. GA 29743634
rs1801394 AG + GG Genotypes AG + GG is associated with increased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotype AA. GA 29589488
rs1803545 A Allele A is associated with increased response to glibenclamide in people with as compared to allele G. GG 27403931
rs1883112 AA Genotype AA is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG. GA 28485375
rs1975974 AG + GG Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA. GA 27977334
rs2003569 A Allele A is associated with increased response to simvastatin as compared to allele G. GG 25493567
rs2071303 CC + CT Genotypes CC + CT are associated with increased response to adalimumab in people with Crohn Disease as compared to genotype TT. TC 27115882
rs2071427 TT Genotype TT is associated with increased response to lithium in people with Bipolar Disorder. CC 21781277
rs2162145 T Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C. CC 29650774
rs2229109 CT Genotype CT is associated with increased resistance to doxorubicin, methotrexate, prednisolone and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC. CC 25582575
rs2246709 AG + GG Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA. GA 19907160
rs2273697 AG Genotype AG is associated with increased exposure to deferasirox in children with beta-Thalassemia as compared to genotype GG. GG 28346059
rs2273697 AA + AG Genotypes AA + AG are associated with increased metabolism of irinotecan in people with Colorectal Neoplasms as compared to genotype GG. GG 18981587
rs2273697 AA + AG Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG. GG 23252947
rs2273697 AG Genotype AG is associated with increased concentrations of deferasirox in people with beta-Thalassemia as compared to genotype GG. GG 25348619
rs2291858 G Allele G is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele A. AA 27001119
rs2298805 AA Genotype AA is associated with increased response to desloratadine and mizolastine in people with Urticaria as compared to genotypes AG + GG. GG 25412950
rs2303070 T Allele T is associated with increased response to glibenclamide in people with as compared to allele G. GG 27403931
rs2305948 CT + TT Genotypes CT + TT is associated with increased response to carfilzomib, dexamethasone and lenalidomide in people with Multiple Myeloma as compared to genotype CC. CC 28488026
rs2501873 TT Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT. CC 25356900
rs2514218 CC Genotype CC is associated with increased response to aripiprazole or risperidone in people with Psychotic Disorders, schizoaffective disorder or Schizophrenia as compared to genotypes CT + TT. TC 26320194
rs2532560 G Allele G is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele A. AA 27091189
rs2535629 AA Genotype AA is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AG + GG. GG 27396837
rs254271 C Allele C is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G. GC 29650774
rs261316 T Allele T is associated with decreased response to atenolol and hydrochlorothiazide in people with Hypertension as compared to allele C. TT 29097388
rs28371685 T Allele T is associated with increased metabolism of phenytoin in people with no disease as compared to genotype CC. CC 16220110
rs28371759 AA Genotype AA are associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype AG. AA 28079798
rs2860905 A Allele A is associated with decreased dose of warfarin as compared to allele G. GA 19752777
rs2873804 CC Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT. TC 22947179
rs28898617 G Allele G is associated with increased concentrations of valproic acid in children with Epilepsy as compared to allele A. AA 28763744
rs3025000 CT + TT Genotypes CT + TT are associated with increased response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to genotype CC. CC 23149126
rs3025000 CT + TT Genotypes CT + TT are associated with increased response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to genotype CC. CC 23149126
rs339097 G Allele G is associated with increased dose of warfarin. AA 20200517
rs339097 G Allele G is associated with increased dose of warfarin. AA 20200517
rs339097 G Allele G is associated with increased dose of warfarin. AA 20200517
rs3731722 G Allele G is associated with dose of allopurinol or febuxostat in people with Gout as compared to allele A. AA 27798726
rs3746544 GG + GT Genotypes GG + GT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT. TT 28871191
rs3761847 G Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A. GG 25834819
rs3768652 AA + AC Genotypes AA + AC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC. CC 30032160
rs3787430 TT Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT. TC 21652606
rs405509 TT Genotype TT is associated with increased response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes GG + GT. GT 32795354
rs4086116 T Allele T is associated with decreased dose of acenocoumarol as compared to allele C. TC 19578179
rs4086116 T Allele T is associated with decreased dose of phenprocoumon maintenance dosage by 2.2 mg/week as compared to allele C. TC 21063236
rs4148323 AA Genotype AA is associated with increased concentrations of SN-38 in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. GG 18221820
rs4148323 AA + AG Genotypes AA + AG are associated with increased exposure to letermovir as compared to genotype GG. GG 31022310
rs4148386 AA + AG Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG. GA 23252947
rs4149118 G Allele G is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms. GA 21995462
rs429358 CC Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Alzheimer Disease as compared to genotypes CT + TT. TT 28212683
rs429358 T Allele T is associated with decreased dose of warfarin in people with haplotype epsilon2. TT 21228733
rs4420638 G Allele G is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases or Hypercholesterolemia as compared to allele A. GA 27648687
rs445925 A Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G. GG 25350695
rs4646450 A Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G. GG 29318894
rs4680 GG Genotype GG is associated with increased dose of opioids in women with Breast Neoplasms and Pain, Postoperative as compared to genotypes AA + AG. GA 27729204
rs4680 AA + AG Genotypes AA + AG is associated with increased concentrations of glucose in children as compared to genotype GG. GA 25048416
rs4680 AG + GG Genotypes AG + GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotype AA. GA 32459054
rs4680 AA + AG Genotypes AA + AG are associated with increased response to opioids in children as compared to genotype GG. GA 30704436
rs4680 AA + AG Genotypes AA + AG is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype GG. GA 23856854
rs4680 GG Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG. GA 29230023
rs4680 AA Genotype AA is associated with increased response to remifentanil in infants with Pain as compared to genotypes AG + GG. GA 27027462
rs4680 GG Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA. GA 18214865
rs4680 AG + GG Genotypes AG + GG are associated with increased dose of morphine as compared to genotype AA. GA 17156920
rs4680 AA + AG Genotypes AA + AG are associated with increased response to venlafaxine in people with Anxiety Disorders as compared to genotype GG. GA 22417933
rs4680 A Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G. GA 19094200
rs4680 GG Genotype GG is associated with increased response to venlafaxine in people with Depressive Disorder, Major as compared to genotypes AA + AG. GA 23706899
rs4680 GG Genotype GG is associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG. GA 22695756
rs4680 GG Genotype GG is associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotypes AA + AG. GA 28745577
rs4680 GG Genotype GG is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AA + AG. GA 25560469
rs4680 AA + AG Genotypes AA + AG are associated with increased response to morphine or remifentanil in infants with Pain as compared to genotype GG. GA 27027462
rs4680 AA + AG Genotypes AA + AG are associated with increased response to oxycodone as compared to genotype GG. GA 31493434
rs4680 GG Genotype GG is associated with increased response to entacapone in people with Parkinson Disease as compared to genotype AA. GA 21280081
rs4680 GG Genotype GG is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotype AA. GA 25185591
rs4680 GG Genotype GG is associated with increased response to modafinil in people with methamphetamine dependence as compared to genotypes AA + AG. GA 22217949
rs4795893 AA + AG Genotypes AA + AG is associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG. GA 24495780
rs4795893 G Allele G is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele A. GA 26788534
rs4910008 CC Genotype CC is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT. TC 27339827
rs49411 C Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T. TC 27091189
rs4961 TT Genotype TT is associated with increased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype GG. GT 20877298
rs4986910 AG Genotype AG is associated with increased response to fluvastatin as compared to genotype AA. AA 16103896
rs5326 CT + TT Genotypes CT + TT are associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype CC. CC 23856854
rs585719 CT Genotype CT is associated with increased response to citalopram in people with Depression as compared to genotype CC. TC 23158458
rs5993883 T Allele T is associated with decreased response to quetiapine in people with Schizophrenia as compared to allele G. GT 26282453
rs671 AA + AG Genotypes AA + AG are associated with increased concentrations of nitroglycerin in children with Heart Defects, Congenital and Hypertension, Pulmonary as compared to genotype GG. GG 31250045
rs671 AG Genotype AG is associated with increased exposure to ethanol in men as compared to genotype GG. GG 25365528
rs671 AG Genotype AG is associated with increased concentrations of ethanol in healthy individuals as compared to genotype GG. GG 31002879
rs671 AG Genotype AG is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotype GG. GG 31002879
rs6806020 C Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T. TC 19749758
rs683369 CC Genotype CC is associated with decreased concentrations of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CG + GG. CC 24589908
rs683369 CC Genotype CC is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CG + GG. CC 28289867
rs689466 CC Genotype CC is associated with increased response to celecoxib in healthy individuals as compared to genotypes CT + TT. TT 29066864
rs6908425 CT + TT Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC. TC 27670765
rs6961071 GG Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG. GA 29502940
rs7412 CT Genotype CT is associated with increased response to atorvastatin as compared to genotype CC. CC 16103896
rs7412 C Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele T. CC 20031551
rs7412 CT + TT Genotypes CT + TT are associated with increased response to rosuvastatin as compared to genotype CC. CC 22331829
rs7412 CC Genotype CC is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype CT. CC 28079798
rs7412 CT Genotype CT is associated with increased response to fluvastatin as compared to genotype CC. CC 30363031
rs7412 CT + TT Genotypes CT + TT is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC. CC 12042669
rs760370 GG Genotype GG is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AG. GA 20812847
rs760370 A Allele A is associated with decreased response to gemcitabine and paclitaxel in women Breast Neoplasms as compared to allele G. GA 24361227
rs760370 AG + GG Genotypes AG + GG is associated with increased response to tipiracil hydrochloride and trifluridine in people with Colorectal Neoplasms as compared to genotype AA. GA 28992563
rs7606603 C Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T. CC 29650764
rs762551 AC + CC Genotypes AC + CC is associated with increased concentrations of deferasirox in people with beta-Thalassemia as compared to genotype AA. AA 25348619
rs762551 CC Genotype CC is associated with increased response to nevirapine in people with HIV Infections as compared to genotypes AA + AC. AA 26348712
rs762551 AA Genotype AA is associated with decreased concentrations of olanzapine in people with Schizophrenia as compared to genotypes AC + CC. AA 25090458
rs7750468 G Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele A. GG 19749758
rs7772821 GG Genotype GG is associated with increased response to corticosteroids in people with Asthma as compared to genotypes GT + TT. TT 25919112
rs7968606 CC Genotype CC is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CT + TT. TC 28332719
rs8099917 GG + GT Genotypes GG + GT are associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype TT. TT 21503910
rs8099917 GG Genotype GG is associated with increased response to interferons and ribavirin in people with Hepatitis C as compared to genotypes GT + TT. TT 26334898
rs8187692 A Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G. GG 30100615
rs833069 CC + CT Genotypes CC + CT are associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype TT. TT 23559864
rs9282564 CT Genotype CT is associated with increased concentrations of cyclosporine in people with heart transplantation as compared to genotype TT. TT 26107754
rs9282564 C Allele C is associated with increased concentrations of methotrexate in children with as compared to allele T. TT 27566582
rs928655 AG + GG Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA. AA 28470127
rs933271 CC + CT Genotypes CC + CT are associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotype TT. TT 32407152
rs9394992 CT + TT Genotypes CT + TT is associated with increased response to tipiracil hydrochloride and trifluridine in people with Colorectal Neoplasms as compared to genotype CC. CC 28992563
rs964184 G Allele G is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to allele C. CC 23119086
rs9939609 AA + AT Genotypes AA + AT is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic and HIV Infections as compared to genotype TT. AA 25367448
Page:

Variants which have in vitro functional analysis-type associations:

Page:
Variant Alleles Associations Genotype PMID
rs1043657 T Allele T is associated with decreased enzyme activity of AKR7A2 when assayed with daunorubicin or doxorubicin as compared to allele C. CC 20837989
rs1800629 AG Genotype AG is associated with decreased steady-state level of TNF when exposed to adalimumab as compared to genotype GG. GA 17343250
rs1801131 GT Genotype GT is associated with increased catalytic activity of TYMS when treated with methotrexate in lymphoblasts from pediatric ALL patients. GT 15797993
rs1801131 GG + GT Genotypes GG + GT is associated with increased sensitivity to gemcitabine as compared to genotype TT. GT 25560468
rs1804645 T Allele T is associated with decreased activity of NCOA1 when exposed to tamoxifen. CC 22174377
rs2168047 T Allele T is associated with increased expression of UGT2B4 in normal breast tissue. TT 21358749
rs2229109 T Allele T is associated with decreased transport of ABCB1 when assayed with amisulpride, aripiprazole, olanzapine or risperidone in LLC-PK1 cells as compared to allele C. CC 29443543
rs35350960 A Allele A is associated with decreased enzyme activity of UGT1A1 when assayed with SN-38. CC 12181437
rs3918290 CT Genotype CT is associated with decreased clearance of fluorouracil in peripheral blood mononuclear cells as compared to genotype CC. CC 26967565
rs3918290 CT Genotype CT is associated with decreased activity of DPYD in peripheral blood mononuclear cells as compared to genotype CC. CC 28295243
rs3918290 CT Genotype CT is associated with decreased activity of DPYD as compared to genotype CC. CC 26804652
rs3918290 CT Genotype CT is associated with decreased activity of DPYD as compared to genotype CC. CC 8698850
rs4148323 A Allele A is associated with decreased enzyme activity of UGT1A1 when assayed with SN-38. GG 12181437
rs4148323 AG Genotype AG is associated with decreased clearance of SN-38 in human liver microsomes as compared to genotype GG. GG 24897286
rs4148323 AG Genotype AG is associated with decreased formation of UGT1A1 in human liver microsomes as compared to genotype GG. GG 24897286
rs4557343 T Allele T is associated with increased expression of UGT2B15 in normal breast tissue. TT 21358749
rs4898439 A Allele A is associated with increased expression of ABCD1 in HapMap cells. AC 21383772
rs56113850 CC + CT Genotypes CC + CT are associated with increased activity of CYP2A6 when assayed with nicotine as compared to genotype TT. CC 29232328
rs6962291 AA Genotype AA is associated with decreased steady-state level of TBX2 in plasma. TT 21449675
rs6962291 AA Genotype AA is associated with decreased expression of TBXAS1 in PBMCs. TT 21449675
rs762551 A Allele A is associated with increased activity of CYP1A2. AA 21593735
rs9999111 C Allele C is associated with decreased expression of ABCG2 in human umbilical cord and T cells as compared to allele A. AA 28930109
rs9999111 C Allele C is associated with decreased expression of ABCG2 in HepG2 and HEK293 cells as compared to allele A. AA 28930109
rs1130169 T Allele T is associated with decreased expression of CD38. TC 20470215
rs11971167 T Allele T is associated with activity of CFTR when treated with ivacaftor in FRT cell lines. GG 23891399
rs1229984 CT + TT Genotypes CT + TT are associated with increased enzyme activity of ADH1B when exposed to ethanol as compared to genotype CC. CC 26863581
rs12701634 CC Genotype CC is associated with increased transcription of ABCB1 as compared to genotypes CT + TT. TT 28601971
rs17091297 C Allele C is associated with increased expression of ABCD1 in HapMap cells. GG 21383772
rs1800629 AA + AG Genotypes AA + AG is associated with increased activity of TNF as compared to genotype GG. GA 18438841
rs1801394 AG + GG Genotypes AG + GG are associated with increased catalytic activity of TYMS when treated with methotrexate in lymphoblasts from pediatric ALL patients. GA 15797993
rs1804645 T Allele T is associated with increased half-life of NCOA1. CC 22174377
rs2515629 G Allele G is associated with increased expression of ABCA1 in HapMap cells. AA 21383772
rs304400 AA Genotype AA is associated with increased transcription of ABCB1 as compared to genotypes AG + GG. GG 28601971
rs4773866 T Allele T is associated with increased expression of ABCC4 in HapMap cells. CC 21383772
rs6021191 T Allele T is associated with increased expression of NFATC2 as compared to allele A. AA 25987655
rs6569487 AA Genotype AA is associated with increased transcription of ABCB1 as compared to genotypes AG + GG. GA 28601971
rs731780 G Allele G is associated with increased expression of SLC29A1 as compared to allele C. CC 16609362
rs841698 T Allele T is associated with increased expression of ABCD3 in HapMap cells. CC 21383772
rs9357155 A Allele A is associated with increased expression of TAP2 in HapMap cells. GG 21383772
Page:

Third-party DB

Page:
snp phewas phenotype p-value odds-ratio gene_name gwas-associations
rs10033900 Colorectal cancer 0.005395 0.813 CFI Age-related macular degeneration
rs10033900 Poisoning by other anti-infectives 0.00507 0.8071 CFI Age-related macular degeneration
rs10033900 Convulsions 1.595e-05 0.7423 CFI Age-related macular degeneration
rs10033900 Epilepsy, recurrent seizures, convulsions 3.18e-05 0.7614 CFI Age-related macular degeneration
rs10033900 Sulfonamides 0.0005884 0.7419 CFI Age-related macular degeneration
rs10033900 Abnormal mammogram 0.0005789 0.8096 CFI Age-related macular degeneration
rs10033900 Aseptic necrosis of bone 0.005044 0.6275 CFI Age-related macular degeneration
rs10033900 Alcoholism 0.001593 0.7903 CFI Age-related macular degeneration
rs10033900 Polyneuropathy in diabetes 0.005194 1.196 CFI Age-related macular degeneration
rs10033900 Colon cancer 0.004222 0.7967 CFI Age-related macular degeneration
rs10033900 Alcohol-related disorders 0.001194 0.8088 CFI Age-related macular degeneration
rs10033900 Osteoporosis 0.006733 0.8851 CFI Age-related macular degeneration
rs10033900 Open wounds of head; neck; and trunk 0.01125 0.8775 CFI Age-related macular degeneration
rs10033900 Diseases of the tongue 0.009885 0.7238 CFI Age-related macular degeneration
rs10033900 Osteoporosis, NOS or other 0.00807 0.8903 CFI Age-related macular degeneration
rs10033900 Other hemoglobinopathies 0.0106 0.502 CFI Age-related macular degeneration
rs10033900 Adverse effects of cardiac rhythm regulators 0.005963 0.5641 CFI Age-related macular degeneration
rs10033900 Poisoning by agents affecting the cardiovascular system 0.008446 0.7698 CFI Age-related macular degeneration
rs10033900 Epilepsy 0.001148 0.6924 CFI Age-related macular degeneration
rs10033900 Lipoid metabolism disorder NOS 0.0009218 0.7521 CFI Age-related macular degeneration
rs10033900 Generalized convulsive epilepsy 0.004709 0.6007 CFI Age-related macular degeneration
rs10033900 Bacterial enteritis 0.009951 1.305 CFI Age-related macular degeneration
rs10045431 Cellulitis and abscess of leg 0.008008 1.171 IL12B Crohn's disease
rs10045431 Mechanical complications of cardiac/vascular device, implant, and graft 0.002691 1.284 IL12B Crohn's disease
rs10045431 Anal and rectal conditions 0.005696 1.159 IL12B Crohn's disease
rs10045431 Thyroid cancer 0.01021 1.476 IL12B Crohn's disease
rs10045431 Abnormal sputum 0.003597 0.7034 IL12B Crohn's disease
rs10045431 Obstructive sleep apnea 0.00357 0.8477 IL12B Crohn's disease
rs10045431 Myalgia and myositis NOS 0.005783 0.8816 IL12B Crohn's disease
rs10045431 Blister 0.00145 0.3544 IL12B Crohn's disease
rs10045431 Sleep apnea 0.008115 0.8862 IL12B Crohn's disease
rs10045431 Diseases of esophagus 0.00257 0.9059 IL12B Crohn's disease
rs10045431 Esophagitis, GERD and related diseases 0.00337 0.9061 IL12B Crohn's disease
rs10045431 Hypertrophy of female genital organs 0.01087 0.5245 IL12B Crohn's disease
rs10045431 Infertility, male 0.008549 0.4266 IL12B Crohn's disease
rs10045431 Other open wound of head and face 0.009868 1.214 IL12B Crohn's disease
rs10045431 Wheezing and painful respiration 0.004513 0.8691 IL12B Crohn's disease
rs10045431 Stomach cancer 0.00147 0.4099 IL12B Crohn's disease
rs10088262 Benign neoplasm of uterus 0.01098 1.211 FAM91A1 Pancreatic cancer
rs10088262 Cancer of other female genital organs 0.009138 1.887 FAM91A1 Pancreatic cancer
rs10088262 Diffuse diseases of connective tissue 0.001544 0.7225 FAM91A1 Pancreatic cancer
rs10088262 Eustachian tube disorders 0.009453 1.252 FAM91A1 Pancreatic cancer
rs10088262 Discoid lupus erythematosus 0.001307 0.5744 FAM91A1 Pancreatic cancer
rs10088262 Renal osteodystrophy 0.0052 0.5918 FAM91A1 Pancreatic cancer
rs10088262 Infections involving bone 0.003132 0.7451 FAM91A1 Pancreatic cancer
rs10088262 Pain in limb 0.01006 0.9155 FAM91A1 Pancreatic cancer
rs10088262 Derangement of joint, non-traumatic 0.004486 0.7662 FAM91A1 Pancreatic cancer
rs10088262 Open wounds of head; neck; and trunk 0.005784 0.8496 FAM91A1 Pancreatic cancer
rs10088262 Nonrheumatic pulmonary valve disorders 0.005686 0.5424 FAM91A1 Pancreatic cancer
rs10088262 Breast cancer 0.0006859 1.235 FAM91A1 Pancreatic cancer
rs10088262 Arthralgia/ankylosis of temporomandibular joint 0.007356 1.584 FAM91A1 Pancreatic cancer
rs10088262 Hematemesis 0.007889 1.584 FAM91A1 Pancreatic cancer
rs10088262 Breast cancer, including in situ 0.001212 1.225 FAM91A1 Pancreatic cancer
rs10088262 Eustachian tube disorders 0.002595 1.15 FAM91A1 Pancreatic cancer
rs10088262 Open wounds of extremities 0.002209 0.8684 FAM91A1 Pancreatic cancer
rs10088262 Unspecified osteomyelitis 0.001005 0.6587 FAM91A1 Pancreatic cancer
rs10088262 Osteomyelitis 0.001277 0.6983 FAM91A1 Pancreatic cancer
rs10088262 Breast cancer 0.0022 1.215 FAM91A1 Pancreatic cancer
rs10088262 Chronic osteomyelitis 0.008128 0.5743 FAM91A1 Pancreatic cancer
rs10088262 Systemic lupus erythematosus 0.004757 0.5983 FAM91A1 Pancreatic cancer
rs10088262 Other open wound of head and face 0.002539 0.7805 FAM91A1 Pancreatic cancer
rs10088262 Other pulmonary inflamation or edema 0.007447 0.7238 FAM91A1 Pancreatic cancer
rs10108954 Diseases of sebaceous glands 0.00697 1.328 MFHAS1 Prion diseases
rs10108954 Type 1 diabetic ketoacidosis 0.002179 2.305 MFHAS1 Prion diseases
rs10108954 Endometrial hyperplasia 0.008014 2.162 MFHAS1 Prion diseases
rs10108954 Osteoarthrosis; localized, secondary 0.001684 2.997 MFHAS1 Prion diseases
rs10108954 Inflammatory diseases of prostate 0.01068 0.5122 MFHAS1 Prion diseases
rs10108954 Malignant neoplasm of renal pelvis 0.001616 4.243 MFHAS1 Prion diseases
rs10108954 Decubitus ulcer 0.004701 1.683 MFHAS1 Prion diseases
rs10108954 Sebaceous cyst 0.003224 1.44 MFHAS1 Prion diseases
rs10108954 Prostatitis 0.001207 0.2639 MFHAS1 Prion diseases
rs1011970 Pain, swelling or discharge of eye 0.009409 0.6391 CDKN2B-AS1 Breast cancer
rs1011970 Coagulation defects 0.002826 0.8636 CDKN2B-AS1 Breast cancer
rs1011970 Dyschromia and Vitiligo 0.0003242 0.7015 CDKN2B-AS1 Breast cancer
rs1011970 Calculus of kidney 0.004814 0.7884 CDKN2B-AS1 Breast cancer
rs1011970 Thoracic neuritis/radiculitis 4.595e-05 0.7953 CDKN2B-AS1 Breast cancer
rs1011970 Cardiac dysrhythmias 0.008813 0.9003 CDKN2B-AS1 Breast cancer
rs1011970 Cardiac arrhythmia NOS 0.003151 0.8138 CDKN2B-AS1 Breast cancer
rs1011970 Actinic keratosis 0.01025 0.8783 CDKN2B-AS1 Breast cancer
rs1011970 Atrial fibrillation 0.008967 0.8564 CDKN2B-AS1 Breast cancer
rs1011970 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.005447 0.8674 CDKN2B-AS1 Breast cancer
rs1011970 Epistaxis or throat hemorrhage 0.003898 0.7459 CDKN2B-AS1 Breast cancer
rs1011970 Chronic lymphocytic thyroiditis 0.005556 1.549 CDKN2B-AS1 Breast cancer
rs1011970 Abnormal electrocardiogram 0.0108 0.8414 CDKN2B-AS1 Breast cancer
rs1011970 Supraventricular premature beats 0.006424 0.6467 CDKN2B-AS1 Breast cancer
rs1011970 Hyperosmolality and/or hypernatremia 0.007251 1.55 CDKN2B-AS1 Breast cancer
rs1011970 Other disorders of back 0.01084 0.8246 CDKN2B-AS1 Breast cancer
rs1011970 Secondary malignant neoplasm of liver 0.01129 1.424 CDKN2B-AS1 Breast cancer
rs1011970 Rosacea 0.002521 0.7586 CDKN2B-AS1 Breast cancer
rs1011970 Other specified cardiac dysrhythmias 0.006973 0.8457 CDKN2B-AS1 Breast cancer
rs1011970 Dry eyes 0.006007 0.8359 CDKN2B-AS1 Breast cancer
rs1011970 Osteoarthritis; localized 0.001681 0.8344 CDKN2B-AS1 Breast cancer
rs1011970 Cardiac conduction disorders 0.003454 0.8571 CDKN2B-AS1 Breast cancer
rs1011970 Palpitations 0.009777 0.8482 CDKN2B-AS1 Breast cancer
rs10166942 Prolapse of vaginal walls 0.006379 0.7865 TRPM8 Migraine
rs10166942 Disorders of penis 0.000505 1.572 TRPM8 Migraine
rs10166942 Chronic prostatitis 0.009962 1.567 TRPM8 Migraine
rs10166942 Ileostomy status 0.0111 0.5064 TRPM8 Migraine
rs10166942 Disturbances of amino-acid transport 0.002742 0.2784 TRPM8 Migraine
rs10166942 Redundant prepuce and phimosis/BXO 0.006354 1.842 TRPM8 Migraine
rs10166942 Hypotension NOS 0.009278 0.8123 TRPM8 Migraine
rs10166942 Disturbances of sulphur-bearing amino-acid metabolism 0.003296 0.2848 TRPM8 Migraine
rs10166942 Aplastic anemia 0.01044 1.381 TRPM8 Migraine
rs10166942 Myeloid leukemia 0.006926 1.883 TRPM8 Migraine
rs102275 Aneurysm of artery of lower extremity 0.00599 0.6 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Bipolar 0.0009503 1.502 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Ulcerative colitis 0.01135 1.419 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Malignant neoplasm of kidney and other urinary organs 0.008437 0.5593 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Other specified diseases of the salivary glands 0.008384 0.5355 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Crohn's disease 0.0004158 1.622 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Disturbance of salivary secretion 0.007191 0.5543 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Cancer of kidney and urinary organs 0.01152 0.8292 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Vertiginous syndromes and other disorders of vestibular system 0.0005992 1.125 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Hypocalcemia 0.003373 1.474 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Abnormal heart sounds 0.006918 0.848 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Jaundice 0.0003079 1.64 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Inflammatory bowel disease 0.0002721 1.461 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Lesions of stomach and duodenum 0.008777 1.88 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Light-headedness and vertigo 0.001165 1.123 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs102275 Inflammatory disease of breast 0.008991 1.527 C11orf10 Phospholipid levels in plasma, Docosapentaenoic acid, Crohn's disease, HDL Cholesterol, Alpha-Linolenic acid
rs10237118 Major depressive disorder 0.001036 0.675 DENND2A Optic disc parameters
rs10237118 Impacted cerumen 0.005186 0.808 DENND2A Optic disc parameters
rs10237118 Benign neoplasm of unspecified sites 0.002912 2.811 DENND2A Optic disc parameters
rs10237118 Alkalosis 0.006621 2.286 DENND2A Optic disc parameters
rs10237118 Mechanical complication due to other implant and internal device 0.006528 1.601 DENND2A Optic disc parameters
rs10237118 Phosphorus metabolism disorder 0.005581 1.76 DENND2A Optic disc parameters
rs10237118 Other disorders of biliary tract 0.001525 2.022 DENND2A Optic disc parameters
rs10237118 Otitis externa 0.00299 0.6638 DENND2A Optic disc parameters
rs10237118 Other disorders of bladder 0.008791 1.295 DENND2A Optic disc parameters
rs10237118 Conductive hearing loss 0.004256 1.985 DENND2A Optic disc parameters
rs10237118 Impetigo 0.002147 2.097 DENND2A Optic disc parameters
rs10237118 Injuries to the nervous system 0.0004609 2.233 DENND2A Optic disc parameters
rs10237118 Cholangitis 0.002965 2.33 DENND2A Optic disc parameters
rs10237118 Wheezing 0.006126 1.576 DENND2A Optic disc parameters
rs1024161 Other disorders of bone and cartilage 0.002293 1.245 CTLA4 Alopecia areata, Graves' disease
rs1024161 Hypothyroidism 0.01144 1.097 CTLA4 Alopecia areata, Graves' disease
rs1024161 Chronic sinusitis 0.005705 1.123 CTLA4 Alopecia areata, Graves' disease
rs1024161 Symptomatic artificial menopause 0.006214 1.501 CTLA4 Alopecia areata, Graves' disease
rs1024161 Kyphosis (acquired) 0.01093 0.679 CTLA4 Alopecia areata, Graves' disease
rs1024161 Coronary atherosclerosis 0.006863 0.9153 CTLA4 Alopecia areata, Graves' disease
rs1024161 Extrinsic allergic alveolitis 0.001979 2.237 CTLA4 Alopecia areata, Graves' disease
rs1024161 Dental caries 0.006336 0.8297 CTLA4 Alopecia areata, Graves' disease
rs1024161 Ischemic Heart Disease 0.003839 0.9143 CTLA4 Alopecia areata, Graves' disease
rs1024161 Other alveolar and parietoalveolar pneumonopathy 0.01128 0.6032 CTLA4 Alopecia areata, Graves' disease
rs1024161 Atherosclerosis 0.00681 0.8881 CTLA4 Alopecia areata, Graves' disease
rs1024161 Large cell lymphoma 0.00794 1.91 CTLA4 Alopecia areata, Graves' disease
rs1024161 Idiopathic fibrosing alveolitis 0.01079 0.5287 CTLA4 Alopecia areata, Graves' disease
rs1024161 Aortic aneurysm 0.006306 0.8251 CTLA4 Alopecia areata, Graves' disease
rs1024161 Rotator cuff (capsule) sprain 0.003137 1.218 CTLA4 Alopecia areata, Graves' disease
rs1024161 Graves' disease 0.002473 1.538 CTLA4 Alopecia areata, Graves' disease
rs1024161 Renal dialysis 0.0104 0.7063 CTLA4 Alopecia areata, Graves' disease
rs1024161 Abdominal aortic aneurysm 0.004001 0.7909 CTLA4 Alopecia areata, Graves' disease
rs1024161 Open wound of nose and sinus 0.005732 0.4277 CTLA4 Alopecia areata, Graves' disease
rs1024161 Thyrotoxicosis 9.424e-05 1.355 CTLA4 Alopecia areata, Graves' disease
rs1024161 Unstable angina (intermediate coronary syndrome) 0.007574 0.8583 CTLA4 Alopecia areata, Graves' disease
rs1024161 Osteoarthrosis, generalized 0.009093 1.207 CTLA4 Alopecia areata, Graves' disease
rs1024161 Atherosclerosis of the extremities 0.006519 0.8731 CTLA4 Alopecia areata, Graves' disease
rs1024161 Diseases of hard tissues of teeth 0.004981 0.8294 CTLA4 Alopecia areata, Graves' disease
rs1024161 Other aneurysm 0.004168 0.8337 CTLA4 Alopecia areata, Graves' disease
rs10276619 Atrophy of edentulous alveolar ridge 0.01012 0.6588 IKZF1 Hippocampal atrophy
rs10276619 Chronic sinusitis 0.006844 1.122 IKZF1 Hippocampal atrophy
rs10276619 Disorders of parathyroid gland 0.00801 1.281 IKZF1 Hippocampal atrophy
rs10276619 Chronic osteomyelitis 0.008347 0.6159 IKZF1 Hippocampal atrophy
rs10276619 Methicillin sensitive Staphylococcus aureus 0.007986 0.7385 IKZF1 Hippocampal atrophy
rs10276619 ASCVD 0.002769 1.405 IKZF1 Hippocampal atrophy
rs10276619 Hematemesis 0.004469 0.5776 IKZF1 Hippocampal atrophy
rs10276619 Diabetic retinopathy 0.009858 0.8405 IKZF1 Hippocampal atrophy
rs10276619 Peripheral retinal degenerations 0.008706 1.287 IKZF1 Hippocampal atrophy
rs10276619 Strabismus (not specified as paralytic) 0.01046 0.8121 IKZF1 Hippocampal atrophy
rs10276619 Allergic rhinitis 0.001943 1.135 IKZF1 Hippocampal atrophy
rs10276619 Random mental disorder. Ignored for now 0.002996 0.5998 IKZF1 Hippocampal atrophy
rs10276619 Type 1 diabetes 0.006004 0.8437 IKZF1 Hippocampal atrophy
rs1033180 Other hypertrophic and atrophic conditions of skin 0.01069 0.8204 IRF4 Celiac disease
rs1033180 Nonrheumatic mitral valve disorders 0.008398 1.258 IRF4 Celiac disease
rs1033180 Bladder cancer and neoplasms 0.003541 1.503 IRF4 Celiac disease
rs1033180 Other abnormal blood chemistry 0.002143 1.25 IRF4 Celiac disease
rs1033180 Other sprains and strains 0.002481 0.4039 IRF4 Celiac disease
rs1033180 Derangement of joint, non-traumatic 0.01145 0.6317 IRF4 Celiac disease
rs1033180 Malignant neoplasm of kidney and other urinary organs 0.008762 2.05 IRF4 Celiac disease
rs1033180 Bladder cancer 0.003541 1.519 IRF4 Celiac disease
rs1033180 Cancer of kidney and urinary organs 0.003841 1.399 IRF4 Celiac disease
rs1033180 Psoriasis & related disorders 0.008392 0.636 IRF4 Celiac disease
rs1043879 Congenital anomalies of urinary system 0.01134 0.6387 C1orf63 Erythrocyte sedimentation rate
rs1043879 Abnormal sputum 0.008768 1.328 C1orf63 Erythrocyte sedimentation rate
rs1043879 Other disorders of back 0.003 1.193 C1orf63 Erythrocyte sedimentation rate
rs1043879 Other specified nonpsychotic and/or transient mental disorders 0.002277 1.274 C1orf63 Erythrocyte sedimentation rate
rs1043879 Premenstrual tension syndromes 0.008223 1.882 C1orf63 Erythrocyte sedimentation rate
rs1043879 Other disorders of the kidney and ureters 0.01105 0.8881 C1orf63 Erythrocyte sedimentation rate
rs1043879 Diaphragmatic hernia 0.007613 1.148 C1orf63 Erythrocyte sedimentation rate
rs1043879 Hallucinations 0.007229 1.82 C1orf63 Erythrocyte sedimentation rate
rs1043879 Adrenal hyperfunction 0.01031 1.776 C1orf63 Erythrocyte sedimentation rate
rs1043879 Other conditions of brain 0.003519 1.364 C1orf63 Erythrocyte sedimentation rate
rs1043879 Cystic kidney disease 0.006752 0.5474 C1orf63 Erythrocyte sedimentation rate
rs1043879 Persistent mental disorders due to other conditions 0.00612 1.178 C1orf63 Erythrocyte sedimentation rate
rs10438933 Retinal detachments and defects 0.0005208 0.6616 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Acquired deformities of finger 0.002647 1.685 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Contact dermatitis and other eczema due to plants [except food] 0.005304 1.988 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Wheezing and painful respiration 0.00808 0.8375 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Hypothyroidism 0.009487 1.14 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Macular degeneration 0.006306 0.8355 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Balanoposthitis 0.007836 1.899 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Glossitis 0.002598 2.327 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Other specified peripheral vascular diseases 0.003469 2.305 B4GALT6 Amyotrophic lateral sclerosis
rs10438933 Sinoatrial node dysfunction 0.01102 1.377 B4GALT6 Amyotrophic lateral sclerosis
rs10444502 Benign neoplasm of colon 0.004908 0.9067 KSR2 Total Cholesterol
rs10444502 Hematuria 0.009936 0.8957 KSR2 Total Cholesterol
rs10444502 Fracture of ankle and foot 0.002354 0.8446 KSR2 Total Cholesterol
rs10444502 Chronic cystitis 0.008675 0.6346 KSR2 Total Cholesterol
rs10444502 Secondary malignant neoplasm 0.003785 1.177 KSR2 Total Cholesterol
rs10444502 Male infertility and abnormal spermatozoa 0.002069 1.794 KSR2 Total Cholesterol
rs10444502 Infertility, male 0.005632 1.909 KSR2 Total Cholesterol
rs10444502 Ankylosing spondylitis 0.00683 0.3096 KSR2 Total Cholesterol
rs10444502 Emphysema 0.006796 0.767 KSR2 Total Cholesterol
rs10444502 Abnormal heart sounds 0.009046 1.167 KSR2 Total Cholesterol
rs10444502 Abnormal findings on radiological examination intrathoracic organs 0.00503 1.224 KSR2 Total Cholesterol
rs10444502 Disease of tricuspid valve 0.009377 0.7808 KSR2 Total Cholesterol
rs10444502 Melanoma 0.0095 1.263 KSR2 Total Cholesterol
rs10444502 Prurigo 0.002119 1.334 KSR2 Total Cholesterol
rs10444502 Angina pectoris 0.008152 1.133 KSR2 Total Cholesterol
rs10444502 Open-angle glaucoma 0.0006343 1.222 KSR2 Total Cholesterol
rs10444502 Dysuria 0.003059 0.8397 KSR2 Total Cholesterol
rs10466868 Gastroparesis 0.01054 1.917 GPR133 Erythropoietin
rs10466868 Valvular heart disease/ heart chambers 0.009581 1.997 GPR133 Erythropoietin
rs10466868 Cellulitis and abscess of trunk 0.01147 1.426 GPR133 Erythropoietin
rs10466868 Hemorrhage or hematoma complicating a procedure 0.009831 1.324 GPR133 Erythropoietin
rs10466868 Epilepsy, recurrent seizures, convulsions 0.01047 1.286 GPR133 Erythropoietin
rs10466868 Heart transplant/surgery 0.004582 1.679 GPR133 Erythropoietin
rs10466868 Inflammatory spondylopathies 0.008595 1.732 GPR133 Erythropoietin
rs10466868 Arthropathy NOS 0.008652 1.284 GPR133 Erythropoietin
rs10466868 Postoperative infection 0.00485 1.334 GPR133 Erythropoietin
rs10466868 Unspecified local infection of skin and subcutaneous tissue 0.003785 1.439 GPR133 Erythropoietin
rs10466868 Abnormal heart sounds 0.0003431 1.363 GPR133 Erythropoietin
rs10466868 Peripheral autonomic neuropathy 0.007332 1.559 GPR133 Erythropoietin
rs10466868 Venous embolism & thrombosis 0.004849 0.7675 GPR133 Erythropoietin
rs10466868 Noninfectious disorders of lymphatic channels 0.009535 0.5656 GPR133 Erythropoietin
rs10466868 Rotator cuff (capsule) sprain 0.003323 1.345 GPR133 Erythropoietin
rs10466868 Postnasal drip 0.009435 2.014 GPR133 Erythropoietin
rs10466868 Localized adiposity 0.0007145 2.625 GPR133 Erythropoietin
rs10466868 Open wounds of head; neck; and trunk 0.01022 1.233 GPR133 Erythropoietin
rs10466868 Other arthropathies 0.001589 1.228 GPR133 Erythropoietin
rs10466868 Cyst or abscess of Bartholin's gland 0.001001 2.602 GPR133 Erythropoietin
rs10466868 Posttraumatic wound infection 0.003564 2.182 GPR133 Erythropoietin
rs10466868 Nephritis and nephropathy in diseases classified elsewhere 0.007359 1.431 GPR133 Erythropoietin
rs10466868 Ill-defined descriptions and complications of heart disease 0.002304 1.213 GPR133 Erythropoietin
rs10466868 Convulsions 0.002768 1.354 GPR133 Erythropoietin
rs10486567 Congenital anomalies of face and neck 0.001984 2.415 JAZF1 Prostate cancer
rs10486567 Nephritis & nephropathy 0.006057 0.488 JAZF1 Prostate cancer
rs10486567 Stomatitis and mucositis 0.009818 0.6627 JAZF1 Prostate cancer
rs10486567 Peritonitis and retroperitoneal infections 0.00191 0.5776 JAZF1 Prostate cancer
rs10486567 Nontoxic uninodular goiter 0.005946 0.7695 JAZF1 Prostate cancer
rs10486567 Neurological disorders due to brain damage 0.01041 0.8662 JAZF1 Prostate cancer
rs10486567 Precordial pain 0.008066 1.332 JAZF1 Prostate cancer
rs10486567 Respiratory failure 0.002591 1.336 JAZF1 Prostate cancer
rs10486567 Urethritis and urethral syndrome 0.001967 1.925 JAZF1 Prostate cancer
rs10486567 Prolapse of vaginal walls 0.009788 0.803 JAZF1 Prostate cancer
rs10486567 Pruritus and related conditions 0.004199 1.237 JAZF1 Prostate cancer
rs10486567 Sialoadenitis 0.006257 0.5845 JAZF1 Prostate cancer
rs10486567 Ulcerative stomatitis & mucositis 0.01144 0.4271 JAZF1 Prostate cancer
rs10494067 Disorders of binocular eye movements 0.002919 0.5956 NTNG1 Anorexia nervosa
rs10494067 Lymphadenitis 0.006993 0.6613 NTNG1 Anorexia nervosa
rs10494067 Rosacea 0.00892 1.382 NTNG1 Anorexia nervosa
rs10494067 Chronic lymphocytic thyroiditis 0.007268 0.2084 NTNG1 Anorexia nervosa
rs10494067 Gangrene 0.001445 2.358 NTNG1 Anorexia nervosa
rs10494067 Other abnormality of urination 0.008646 0.6317 NTNG1 Anorexia nervosa
rs10494067 Reflux esophagitis 0.008196 1.437 NTNG1 Anorexia nervosa
rs10494067 Strabismus (not specified as paralytic) 0.006491 0.5681 NTNG1 Anorexia nervosa
rs10494067 Secondary malignancy of lung 0.006391 1.742 NTNG1 Anorexia nervosa
rs10494067 Chronic glomerulonephritis 0.004249 3.096 NTNG1 Anorexia nervosa
rs10500991 Rheumatoid arthritis 0.002207 1.329 LUZP2 Serum transferrin
rs10500991 Noninflammatory female genital disorders 0.007699 0.7757 LUZP2 Serum transferrin
rs10500991 Unspecified polyarthropathy or polyarthritis 0.008388 1.604 LUZP2 Serum transferrin
rs10500991 Inflammation of eyelids 0.003979 1.199 LUZP2 Serum transferrin
rs10500991 Disturbance of salivary secretion 0.00447 0.304 LUZP2 Serum transferrin
rs10500991 Chronic kidney disease, Stage I or II 0.003067 1.537 LUZP2 Serum transferrin
rs10500991 Conjunctivitis, infectious 0.002231 1.266 LUZP2 Serum transferrin
rs10500991 Other disorders of the nervous system 0.0007137 1.852 LUZP2 Serum transferrin
rs10500991 Abnormal reflex 0.00377 2.408 LUZP2 Serum transferrin
rs10500991 Infection of the eye 0.0016 1.247 LUZP2 Serum transferrin
rs10500991 Prurigo 0.00488 0.6671 LUZP2 Serum transferrin
rs10500991 Nerve root lesions 0.004786 1.782 LUZP2 Serum transferrin
rs10500991 Prostatitis 0.0005245 1.527 LUZP2 Serum transferrin
rs10500991 Rheumatoid arthritis & related inflammatory polyarthropathies 0.009609 1.244 LUZP2 Serum transferrin
rs10500991 Sarcoidosis 0.01151 0.4343 LUZP2 Serum transferrin
rs10502868 Allergy to serum or vaccine 0.0005339 2.673 SLC14A2 Albumin levels
rs10502868 Antisocial/borderline personality disorder 0.01146 1.977 SLC14A2 Albumin levels
rs10502868 Heart transplant/surgery 0.002724 1.895 SLC14A2 Albumin levels
rs10502868 Heart valve replaced 0.00298 1.599 SLC14A2 Albumin levels
rs10502868 Speech and language disorder 0.004294 1.76 SLC14A2 Albumin levels
rs10502868 Hypotony of eye 0.005312 2.849 SLC14A2 Albumin levels
rs10502868 Chronic obstructive asthma 0.004141 1.562 SLC14A2 Albumin levels
rs10502868 Disorders of the autonomic nervous system 0.006639 1.567 SLC14A2 Albumin levels
rs10502868 Atrial flutter 0.0114 1.411 SLC14A2 Albumin levels
rs10502868 Appendicitis 0.007009 1.708 SLC14A2 Albumin levels
rs10502868 Hx of malignant neoplasm of oral cavity and pharynx 0.0101 1.998 SLC14A2 Albumin levels
rs10502868 Staphylococcus infections 0.004476 1.489 SLC14A2 Albumin levels
rs10502868 Conjunctivitis, noninfectious 0.00247 1.562 SLC14A2 Albumin levels
rs10502868 Exophthalmos 0.003372 2.519 SLC14A2 Albumin levels
rs10502868 Methicillin sensitive Staphylococcus aureus 0.005391 1.623 SLC14A2 Albumin levels
rs10502868 Ptosis of eyelid 0.007296 1.405 SLC14A2 Albumin levels
rs10502868 Ill-defined descriptions and complications of heart disease 0.003668 1.244 SLC14A2 Albumin levels
rs10502868 Other disorders of circulatory system 0.00116 1.342 SLC14A2 Albumin levels
rs10502868 Localized superficial swelling, mass, or lump 0.003148 1.538 SLC14A2 Albumin levels
rs10502868 Allergic conjunctivitis 0.003269 1.598 SLC14A2 Albumin levels
rs10502868 Hyposmolality and/or hyponatremia 0.006789 1.327 SLC14A2 Albumin levels
rs10502868 Vascular disorders of penis 0.008806 3.177 SLC14A2 Albumin levels
rs10502868 Posterior pituitary disorders 0.009386 2.103 SLC14A2 Albumin levels
rs10502868 Dermatophytosis 0.01133 1.205 SLC14A2 Albumin levels
rs10502868 Circulatory disease NEC 0.001683 1.368 SLC14A2 Albumin levels
rs10502868 Renal colic 0.004687 2.162 SLC14A2 Albumin levels
rs10502868 Cyst of kidney, acquired 0.007493 1.554 SLC14A2 Albumin levels
rs10502868 Calculus of lower urinary tract 0.008337 2.036 SLC14A2 Albumin levels
rs10502868 Patellar fracture 0.008784 1.718 SLC14A2 Albumin levels
rs10502868 Asthma 0.0005259 1.313 SLC14A2 Albumin levels
rs10502868 Other local infections of skin and subcutaneous tissue 0.005492 1.329 SLC14A2 Albumin levels
rs10502868 Nephritis and nephropathy in diseases classified elsewhere 0.008735 1.514 SLC14A2 Albumin levels
rs10503019 Schizophrenia 0.002106 1.845 ATP8B1 Vitiligo
rs10503019 Hypoglycemia 0.008738 1.505 ATP8B1 Vitiligo
rs10503019 Osteoporosis, NOS or other 0.007432 0.8632 ATP8B1 Vitiligo
rs10503019 Renal failure NOS 0.002306 0.6446 ATP8B1 Vitiligo
rs10503019 Deviated nasal septum 0.007266 0.8116 ATP8B1 Vitiligo
rs10503019 Acquired deformities of limbs 0.006224 0.7687 ATP8B1 Vitiligo
rs10503019 Other local infections of skin and subcutaneous tissue 0.008052 0.8233 ATP8B1 Vitiligo
rs10503019 Chronic pharyngitis and nasopharyngitis 0.006153 0.8212 ATP8B1 Vitiligo
rs10503019 Vitamin B12 deficiency anemia 0.002648 1.68 ATP8B1 Vitiligo
rs10503019 Other disorders of back 0.006173 0.8324 ATP8B1 Vitiligo
rs10503019 Unspecified local infection of skin and subcutaneous tissue 0.008383 0.743 ATP8B1 Vitiligo
rs10503019 Dementia with cerebral degenerations 0.0002449 0.3823 ATP8B1 Vitiligo
rs10503019 Nonsenile Cataract 0.005673 0.6497 ATP8B1 Vitiligo
rs10503019 Swelling, mass, or lump in head and neck 0.008592 0.7658 ATP8B1 Vitiligo
rs10503253 Breast disorder NOS 0.01135 0.1581 CSMD1 Schizophrenia
rs10503253 Hemiplegia 0.00473 0.6502 CSMD1 Schizophrenia
rs10503253 Mixed hyperlipidemia 0.009826 0.8232 CSMD1 Schizophrenia
rs10503253 Paroxysmal ventricular tachycardia 0.001803 0.6746 CSMD1 Schizophrenia
rs10503253 Disturbances of sulphur-bearing amino-acid metabolism 0.003504 1.954 CSMD1 Schizophrenia
rs10503253 Adverse effects of adrenal cortical steroids 0.006098 0.5108 CSMD1 Schizophrenia
rs10503253 Chronic kidney disease, Stage I or II 0.00922 0.6436 CSMD1 Schizophrenia
rs10503253 Unequal leg length (acquired) 0.01042 0.597 CSMD1 Schizophrenia
rs10503253 Genitourinary congenital anomalies 0.00301 0.6032 CSMD1 Schizophrenia
rs10503253 Adverse drug events and drug allergies 0.005236 0.8113 CSMD1 Schizophrenia
rs10503253 Viral Enteritis 0.00352 1.594 CSMD1 Schizophrenia
rs10503253 Heartburn 0.007933 1.421 CSMD1 Schizophrenia
rs10503253 Fracture of vertebral column without mention of spinal cord injury 0.004569 1.283 CSMD1 Schizophrenia
rs10503253 Disorders of synovium, tendon, and bursa 0.01148 0.8784 CSMD1 Schizophrenia
rs10503253 Other signs and symptoms in breast 0.004438 1.442 CSMD1 Schizophrenia
rs10503253 Pelvic inflammatory disease 0.002087 0.1625 CSMD1 Schizophrenia
rs10503253 Swelling of limb 0.001174 0.7817 CSMD1 Schizophrenia
rs10503253 Senile dementia 0.003579 1.301 CSMD1 Schizophrenia
rs10503253 Disturbances of amino-acid transport 0.005238 1.891 CSMD1 Schizophrenia
rs10503253 Atherosclerosis 0.01085 0.8723 CSMD1 Schizophrenia
rs10503253 Macular puckering of retina 0.0002164 1.376 CSMD1 Schizophrenia
rs10508503 Traumatic arthropathy 0.001501 2.087 PTER Obesity
rs10508503 Cancer of the upper aerodigestive tract 0.01105 0.5096 PTER Obesity
rs10508503 Adverse effects of antirheumatics 0.01143 1.932 PTER Obesity
rs10508503 Other specified peripheral vascular diseases 0.01075 2.249 PTER Obesity
rs10508503 Other disorders of prostate 0.008246 0.6119 PTER Obesity
rs10508503 Other hypertensive complications 0.005434 0.6308 PTER Obesity
rs10508503 Pseudomonal pneumonia 0.01043 2.465 PTER Obesity
rs10508503 Hidradenitis 0.01054 2.439 PTER Obesity
rs10510102 Psychogenic and somatoform disorders 0.009836 1.321 ATE1 Breast cancer
rs10510102 Congenital anomalies of the eye 0.003897 1.314 ATE1 Breast cancer
rs10510102 Orchitis and epididymitis 0.01125 0.6097 ATE1 Breast cancer
rs10510102 Mechanical complication due to other implant and internal device 0.01147 0.667 ATE1 Breast cancer
rs10510102 Peripheral or central vertigo 0.00298 1.287 ATE1 Breast cancer
rs10510102 Other disorders of the kidney and ureters 0.00473 0.8573 ATE1 Breast cancer
rs10510102 Failure to thrive 0.01113 0.6268 ATE1 Breast cancer
rs10510102 Open wound of eye or eyelid 0.0001119 2.804 ATE1 Breast cancer
rs10510102 Psychogenic disorder 0.0002677 1.757 ATE1 Breast cancer
rs10510102 Allergic reaction to food 0.008207 1.936 ATE1 Breast cancer
rs10510102 Empyema and pneumothorax 0.008261 1.351 ATE1 Breast cancer
rs10510102 Gastrointestinal malfunction arising from mental factors 0.003113 2.334 ATE1 Breast cancer
rs10510102 Purpura and other hemorrhagic conditions 0.009942 0.8259 ATE1 Breast cancer
rs10510102 Alkalosis 0.008037 1.9 ATE1 Breast cancer
rs10510102 Infections involving bone 0.005669 0.714 ATE1 Breast cancer
rs10510102 Cyst of kidney, acquired 0.01011 0.7054 ATE1 Breast cancer
rs10516430 Malignant neoplasm of ovary 0.001978 1.799 RAP1GDS1 Triglycerides
rs10516430 Poisoning by hormones and synthetic substitutes 0.009046 0.6933 RAP1GDS1 Triglycerides
rs10516430 Adverse effects of cardiac rhythm regulators 0.01122 1.692 RAP1GDS1 Triglycerides
rs10516430 Congenital cataract and lens anomalies 0.01042 1.851 RAP1GDS1 Triglycerides
rs10516430 Diverticulosis and diverticulitis 0.01097 1.112 RAP1GDS1 Triglycerides
rs10516430 Bronchopneumonia and lung abscess 0.006058 1.77 RAP1GDS1 Triglycerides
rs10516430 Swelling, mass, or lump in head and neck 0.009221 0.7924 RAP1GDS1 Triglycerides
rs10516430 Cervical cancer 0.0005225 2.185 RAP1GDS1 Triglycerides
rs10516430 Clotting factor deficiency 0.007321 2.047 RAP1GDS1 Triglycerides
rs10516430 Hypercoagulable state 0.01096 1.478 RAP1GDS1 Triglycerides
rs10516430 Corneal opacity 0.002775 1.42 RAP1GDS1 Triglycerides
rs10516430 Cyst or abscess of Bartholin's gland 0.006463 1.945 RAP1GDS1 Triglycerides
rs10516430 Symptoms associated with female genital organs 0.003936 1.218 RAP1GDS1 Triglycerides
rs10516430 Cancer of other female genital organs 0.000343 1.663 RAP1GDS1 Triglycerides
rs10516430 Ovarian cancer 0.0002133 1.828 RAP1GDS1 Triglycerides
rs10518025 Leukoplakia of oral mucosa 0.001894 2.129 CENPC1 Multiple sclerosis
rs10518025 Mastodynia 0.009463 1.352 CENPC1 Multiple sclerosis
rs10518025 Primary/intrinsic cardiomyopathies 0.01122 0.7852 CENPC1 Multiple sclerosis
rs10518025 Cellulitis and abscess of face 0.005262 1.487 CENPC1 Multiple sclerosis
rs10518025 Cardiomyopathy 0.01055 0.7894 CENPC1 Multiple sclerosis
rs10518025 Other acute and subacute forms of ischemic heart disease 0.0005549 2.337 CENPC1 Multiple sclerosis
rs10518025 Sialoadenitis 0.004464 1.63 CENPC1 Multiple sclerosis
rs10518025 Melanoma 0.008837 1.344 CENPC1 Multiple sclerosis
rs10518025 Other aneurysm 0.0007918 0.7359 CENPC1 Multiple sclerosis
rs10518025 Fracture of unspecified bones 0.0008159 0.7608 CENPC1 Multiple sclerosis
rs10518025 Dry eyes 0.007969 1.192 CENPC1 Multiple sclerosis
rs10518025 Fibroadenosis of breast 0.0003446 3.189 CENPC1 Multiple sclerosis
rs10518025 Cancer of other female genital organs 0.008915 2.08 CENPC1 Multiple sclerosis
rs10518025 Alopecia Areata 0.004589 2.262 CENPC1 Multiple sclerosis
rs10518025 Contact and allergic dermatitis of eyelid 0.01073 1.851 CENPC1 Multiple sclerosis
rs10518025 Gastrointestinal complications 0.006792 1.353 CENPC1 Multiple sclerosis
rs10518025 Abnormal kidney function 0.007524 2.145 CENPC1 Multiple sclerosis
rs10518025 Aortic aneurysm 0.002786 0.7389 CENPC1 Multiple sclerosis
rs10518025 Cellulitis and abscess of trunk 0.00151 1.462 CENPC1 Multiple sclerosis
rs10518765 Microscopic hematuria 0.004421 0.5227 UNC13C Alkaline phosphatase
rs10518765 Pain in joint 0.00573 0.9034 UNC13C Alkaline phosphatase
rs10518765 Pleurisy; pleural effusion 0.01151 0.8544 UNC13C Alkaline phosphatase
rs10518765 Chronic cystitis 0.008057 1.553 UNC13C Alkaline phosphatase
rs10518765 Benign neoplasm of brain and other parts of nervous system 0.00673 1.449 UNC13C Alkaline phosphatase
rs10518765 Bipolar 0.005614 0.6135 UNC13C Alkaline phosphatase
rs10518765 Cystitis and urethritis 0.01062 1.227 UNC13C Alkaline phosphatase
rs10518765 Other disorders of urethra and urinary tract 0.007939 1.242 UNC13C Alkaline phosphatase
rs10518765 Mucous polyp of cervix 0.006876 0.6338 UNC13C Alkaline phosphatase
rs10518765 Inflammatory conditions of jaw 0.009415 0.5423 UNC13C Alkaline phosphatase
rs10518765 Ankylosing spondylitis 0.01036 2.14 UNC13C Alkaline phosphatase
rs10518765 Urethritis and urethral syndrome 0.008549 1.766 UNC13C Alkaline phosphatase
rs10518765 Other specified diseases of the salivary glands 0.003621 0.3786 UNC13C Alkaline phosphatase
rs10521222 Disorders of esophageal motility 0.004501 2.094 SALL1 C-reactive protein
rs10521222 Osteoarthrosis; localized, primary 0.00455 0.4996 SALL1 C-reactive protein
rs10521222 Sepsis and SIRS 0.01073 1.543 SALL1 C-reactive protein
rs10521222 Dry eyes 0.005173 0.7158 SALL1 C-reactive protein
rs10521222 Other infectious diseases 0.0005891 2.934 SALL1 C-reactive protein
rs10521222 Shock 0.006006 1.83 SALL1 C-reactive protein
rs10521222 Malignant neoplasm of renal pelvis 0.0006622 3.763 SALL1 C-reactive protein
rs10521222 Atrial fibrillation 0.01093 1.299 SALL1 C-reactive protein
rs1059513 Periodontitis (acute or chronic) 0.006328 1.358 STAT6 IgE levels
rs1059513 Personality disorders 0.005954 1.414 STAT6 IgE levels
rs1059513 Type 2 diabetic peripheral circulatory disorders 0.0003597 1.782 STAT6 IgE levels
rs1059513 Chronic periodontitis 0.004382 1.428 STAT6 IgE levels
rs1059513 Anomalies of tooth position/malocclusion 0.001182 2.118 STAT6 IgE levels
rs1059513 Phosphorus metabolism disorder 0.006973 1.63 STAT6 IgE levels
rs1059513 Dentofacial anomalies, including malocclusion 0.0003886 2.062 STAT6 IgE levels
rs1059513 Vascular disorders of kidney/hypertrophy 0.003478 2.58 STAT6 IgE levels
rs1059513 Cystic kidney disease 0.00576 1.822 STAT6 IgE levels
rs1059513 Prostatitis 0.01112 1.457 STAT6 IgE levels
rs1059513 Gingival and periodontal diseases 0.004483 1.324 STAT6 IgE levels
rs1059513 Primary/intrinsic cardiomyopathies 0.001185 1.362 STAT6 IgE levels
rs1059513 Jaundice 0.004649 1.696 STAT6 IgE levels
rs1059513 Symptoms involving urinary system 0.007619 1.394 STAT6 IgE levels
rs1059513 Cardiomyopathy 0.000748 1.366 STAT6 IgE levels
rs1059513 Type 2 diabetic neuropathy 0.00695 1.278 STAT6 IgE levels
rs1059513 Cholelithiasis with acute cholecystitis 0.006356 1.789 STAT6 IgE levels
rs10748128 Peritoneal or intestinal adhesions 0.003367 1.673 FRS2 Height
rs10748128 Polycythemia vera 0.009937 1.712 FRS2 Height
rs10748128 Stomach cancer 0.004415 1.762 FRS2 Height
rs10748128 Microscopic hematuria 0.006912 0.628 FRS2 Height
rs10748128 Dupuytren's disease 0.0009479 1.481 FRS2 Height
rs10748128 Hypercoagulable state 0.009146 0.6399 FRS2 Height
rs10748128 Congenital anomalies of great vessels 0.004915 0.4108 FRS2 Height
rs10748128 Polymyalgia Rheumatica 0.005432 1.283 FRS2 Height
rs10758593 Adverse effects of antineoplastic and immunosuppressive drugs 0.004382 1.333 GLIS3 Type 1 diabetes
rs10758593 Viral hepatitis 0.002299 0.7508 GLIS3 Type 1 diabetes
rs10758593 Intracerebral hemorrhage 0.006007 1.603 GLIS3 Type 1 diabetes
rs10758593 Cystitis 0.006467 1.219 GLIS3 Type 1 diabetes
rs10758593 Acute, but ill-defined cerebrovascular disease 0.004181 1.202 GLIS3 Type 1 diabetes
rs10758593 Cystitis and urethritis 0.00522 1.211 GLIS3 Type 1 diabetes
rs10758593 Mental disorders due to brain damage 0.008368 1.219 GLIS3 Type 1 diabetes
rs10758593 Nodular lymphoma 0.009398 1.558 GLIS3 Type 1 diabetes
rs10758593 Known or suspected fetal abnormality 0.006558 1.655 GLIS3 Type 1 diabetes
rs10758593 Cholelithiasis with other cholecystitis 0.009065 0.7796 GLIS3 Type 1 diabetes
rs10758593 Cardiac congenital anomalies 0.003785 1.344 GLIS3 Type 1 diabetes
rs10758593 Diseases of the tongue 0.001066 1.491 GLIS3 Type 1 diabetes
rs10758593 Cardiac shunt/ heart septal defect 0.006668 1.445 GLIS3 Type 1 diabetes
rs10758593 Poisoning by primarily systemic agents 0.005633 1.312 GLIS3 Type 1 diabetes
rs10758593 Seborheic dermatitis 0.006666 0.8433 GLIS3 Type 1 diabetes
rs10758593 Esophageal cancer 0.01139 1.702 GLIS3 Type 1 diabetes
rs10758593 Late effects of cerebrovascular disease 0.0009311 1.217 GLIS3 Type 1 diabetes
rs10758593 Inflammatory diseases of female pelvic organs 0.01065 0.8618 GLIS3 Type 1 diabetes
rs10776612 Acquired absence of breast 0.003951 0.7382 ARHGAP22 Conduct disorder
rs10776612 Tachycardia NOS 0.0007473 0.8015 ARHGAP22 Conduct disorder
rs10776612 Symptoms involving urinary system 0.005382 0.7878 ARHGAP22 Conduct disorder
rs10776612 Other abnormality of urination 0.008105 0.8276 ARHGAP22 Conduct disorder
rs10776612 Cholelithiasis 0.00322 0.8678 ARHGAP22 Conduct disorder
rs10776612 Carditis 0.0101 0.8172 ARHGAP22 Conduct disorder
rs10776612 Cardiac conduction disorders 0.007863 0.8997 ARHGAP22 Conduct disorder
rs10776612 Functional disorders of bladder 0.003591 0.7454 ARHGAP22 Conduct disorder
rs10776612 Cholelithiasis and cholecystitis 0.001854 0.8692 ARHGAP22 Conduct disorder
rs10776612 Cholelithiasis with acute cholecystitis 0.0009707 0.5675 ARHGAP22 Conduct disorder
rs10776612 Abnormal kidney function 0.002985 0.4209 ARHGAP22 Conduct disorder
rs10776612 Chorioretinal scars 0.006457 1.448 ARHGAP22 Conduct disorder
rs10776612 Cardiac dysrhythmias 0.0001013 0.8887 ARHGAP22 Conduct disorder
rs10781380 Methicillin sensitive Staphylococcus aureus 0.006625 1.356 PRUNE2 Hippocampal atrophy
rs10781380 Other sprains and strains 0.01034 0.7154 PRUNE2 Hippocampal atrophy
rs10781380 Abdominal pain 0.01001 1.086 PRUNE2 Hippocampal atrophy
rs10781380 Muscular dystrophies and other myopathies 0.008921 0.636 PRUNE2 Hippocampal atrophy
rs10781380 Subjective visual disturbances 0.007486 1.219 PRUNE2 Hippocampal atrophy
rs10781380 Lower gastrointestinal congenital anomalies 0.002558 0.3469 PRUNE2 Hippocampal atrophy
rs10781380 Thyrotoxicosis 0.00617 1.251 PRUNE2 Hippocampal atrophy
rs10781380 Acquired spondylolisthesis 0.001991 1.36 PRUNE2 Hippocampal atrophy
rs10781380 Altered mental status 0.004157 1.311 PRUNE2 Hippocampal atrophy
rs10794720 Other cardiac conduction disorders 0.007831 2.129 WDR37 Serum creatinine
rs10794720 Adverse effects of antibacterials (not penicillins) 0.002093 2.321 WDR37 Serum creatinine
rs10794720 Other cells and casts in urine 0.005301 1.881 WDR37 Serum creatinine
rs10794720 Other acquired musculoskeletal deformity 0.008491 0.6352 WDR37 Serum creatinine
rs10794720 Peripheral retinal degenerations 0.01118 0.5779 WDR37 Serum creatinine
rs10794720 Acquired spondylolisthesis 0.00463 0.512 WDR37 Serum creatinine
rs10794720 Obsessive-compulsive disorder 0.006726 2.143 WDR37 Serum creatinine
rs10794720 Dry eyes 0.009581 0.7917 WDR37 Serum creatinine
rs10794720 Dyschromia and Vitiligo 0.004639 0.6636 WDR37 Serum creatinine
rs10794720 Viral warts & HPV 0.007214 0.7482 WDR37 Serum creatinine
rs10794720 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.004977 2.717 WDR37 Serum creatinine
rs10794720 Inguinal hernia 0.01009 1.268 WDR37 Serum creatinine
rs10794720 Cancer of other female genital organs 0.003474 2.508 WDR37 Serum creatinine
rs10794720 Inflammatory and toxic neuropathy 2.664e-06 2.066 WDR37 Serum creatinine
rs10829156 Renal colic 0.006805 1.722 ARL5B Sudden cardiac arrest
rs10829156 Chronic obstructive asthma 0.005966 1.339 ARL5B Sudden cardiac arrest
rs10829156 Emphysema 0.007059 1.31 ARL5B Sudden cardiac arrest
rs10829156 Obstructive chronic bronchitis 0.005005 1.262 ARL5B Sudden cardiac arrest
rs10829156 Asthma 0.0001056 1.216 ARL5B Sudden cardiac arrest
rs10829156 Type 1 diabetic neuropathy 0.00659 0.5928 ARL5B Sudden cardiac arrest
rs10829156 Impetigo 0.00822 1.596 ARL5B Sudden cardiac arrest
rs10829156 Chronic bronchitis 0.005684 1.23 ARL5B Sudden cardiac arrest
rs10829156 Type 1 diabetic peripheral circulatory disorders 0.002442 0.1664 ARL5B Sudden cardiac arrest
rs10829156 Other rheumatic heart disease 0.009294 0.2614 ARL5B Sudden cardiac arrest
rs10829156 Mitral valve stenosis and/or aortic valve stenosis 0.007361 0.7642 ARL5B Sudden cardiac arrest
rs10829156 Asthma with exacerbation 0.01011 1.407 ARL5B Sudden cardiac arrest
rs10829156 Chronic airway obstruction 0.001123 1.164 ARL5B Sudden cardiac arrest
rs10829156 Poisoning by hormones and synthetic substitutes 0.01074 1.413 ARL5B Sudden cardiac arrest
rs10841496 Idiopathic fibrosing alveolitis 0.01115 1.788 PDE3A Azoospermia
rs10841496 Sleep disorders 4.312e-05 0.8582 PDE3A Azoospermia
rs10841496 Cardiac dysrhythmias 0.006993 0.9221 PDE3A Azoospermia
rs10841496 Electrolyte imbalance 0.002106 0.8985 PDE3A Azoospermia
rs10841496 Muscular wasting and disuse atrophy 0.0006477 0.5329 PDE3A Azoospermia
rs10841496 Disorders of fluid, electrolyte, and acid-base balance 0.002716 0.9122 PDE3A Azoospermia
rs10841496 Hypopotassemia 0.004154 0.8766 PDE3A Azoospermia
rs10841496 Chronic ischemic heart disease 0.0009502 0.8535 PDE3A Azoospermia
rs10841496 Malaise and fatigue 0.004231 0.9173 PDE3A Azoospermia
rs10841496 Type 2 diabetic retinopathy 0.0113 0.8435 PDE3A Azoospermia
rs10841496 Persistent mental disorders due to other conditions 0.007418 0.8662 PDE3A Azoospermia
rs10841496 Alzheimer's disease 0.002553 0.8309 PDE3A Azoospermia
rs10841496 Multiple myeloma 0.0006565 1.792 PDE3A Azoospermia
rs10841496 Hypovolemia 0.0006205 0.8636 PDE3A Azoospermia
rs10841496 Failure to thrive 0.007734 0.7189 PDE3A Azoospermia
rs10841496 Acidosis 0.002373 0.6988 PDE3A Azoospermia
rs10841496 Superficial cellulitis and abscess 0.004901 0.9077 PDE3A Azoospermia
rs10841496 Ileostomy status 0.005991 0.614 PDE3A Azoospermia
rs10841496 Insomnia 0.002908 0.8468 PDE3A Azoospermia
rs10841496 Leukemia 0.001235 1.404 PDE3A Azoospermia
rs10841496 Other specified nonpsychotic and/or transient mental disorders 0.008026 0.8215 PDE3A Azoospermia
rs10841496 Acid-base balance disorder 0.005901 0.7611 PDE3A Azoospermia
rs10841496 Toxic multinodular goiter 0.004438 1.937 PDE3A Azoospermia
rs10873876 Gingival and periodontal diseases 0.004087 1.272 ST6GALNAC3 Acute lymphoblastic leukemia
rs10873876 Other symptoms involving abdomen and pelvis 0.007976 0.831 ST6GALNAC3 Acute lymphoblastic leukemia
rs10873876 Trigeminal nerve disorders 0.003171 1.602 ST6GALNAC3 Acute lymphoblastic leukemia
rs10873876 Early complications of trauma or procedure 0.01001 1.757 ST6GALNAC3 Acute lymphoblastic leukemia
rs10873876 Hepatomegaly 0.00372 0.2622 ST6GALNAC3 Acute lymphoblastic leukemia
rs10882272 Fracture of lower limb 0.00958 0.8713 O3FAR1 Vitamin A
rs10882272 Adverse effects of antirheumatics 0.0107 0.564 O3FAR1 Vitamin A
rs10882272 Aseptic necrosis of bone 0.006732 1.553 O3FAR1 Vitamin A
rs10882272 Osteoporosis 0.008036 1.131 O3FAR1 Vitamin A
rs10882272 Hemorrhage NOS 0.003378 1.74 O3FAR1 Vitamin A
rs10882272 Voice disturbance 0.009404 1.202 O3FAR1 Vitamin A
rs10882272 Fracture of upper limb 0.008313 0.8711 O3FAR1 Vitamin A
rs10882272 Abnormal chest sounds 0.0083 1.43 O3FAR1 Vitamin A
rs10882272 Diseases of the larynx and vocal cords 0.002485 1.205 O3FAR1 Vitamin A
rs10882272 Atopic or contact dermatitis 0.004255 0.8988 O3FAR1 Vitamin A
rs10882272 Abnormal cytological, histological, immunological and DNA test findings 0.005636 1.813 O3FAR1 Vitamin A
rs10882272 Labyrinthitis 0.007388 0.7141 O3FAR1 Vitamin A
rs10882272 Disturbances of amino-acid transport 0.009121 0.5285 O3FAR1 Vitamin A
rs10882272 Umbilical hernia 0.007597 0.7756 O3FAR1 Vitamin A
rs10882272 Respiratory failure 0.005255 1.279 O3FAR1 Vitamin A
rs10882272 Back pain 8.473e-05 1.127 O3FAR1 Vitamin A
rs10882272 Glossitis 0.01066 1.875 O3FAR1 Vitamin A
rs10882272 Emphysema 0.01124 1.25 O3FAR1 Vitamin A
rs10898392 Muscle weakness 0.005104 0.7581 DLG2 Height
rs10898392 Viral Enteritis 0.01129 1.449 DLG2 Height
rs10898392 Peyronie's disease 0.003078 1.946 DLG2 Height
rs10898392 Secondary malignant neoplasm of liver 0.008981 0.7336 DLG2 Height
rs10898392 Chronic kidney disease, Stage I or II 0.0001364 0.6268 DLG2 Height
rs10898392 Photodermatitis & sunburn 0.00152 1.21 DLG2 Height
rs10898392 Other disorders of testis 0.007073 1.378 DLG2 Height
rs10898392 Other headache syndromes 0.002651 0.8973 DLG2 Height
rs10898392 Benign neoplasm of unspecified sites 0.00135 2.489 DLG2 Height
rs10898392 Actinic keratosis 0.003094 1.118 DLG2 Height
rs10898392 Anal and rectal conditions 0.007686 0.8751 DLG2 Height
rs10898392 Disorders of adrenal glands 0.006413 1.327 DLG2 Height
rs10898392 Subarachnoid hemorrhage 0.002666 2.124 DLG2 Height
rs10898392 Rash and other nonspecific skin eruption 0.00832 1.154 DLG2 Height
rs10898392 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.008742 0.8542 DLG2 Height
rs10898392 Abnormal glucose 0.00319 1.124 DLG2 Height
rs10898392 Hypertensive heart and/or renal disease 0.006159 1.174 DLG2 Height
rs10898392 Obesity 0.01004 1.088 DLG2 Height
rs10898392 Secondary malignancy of brain/spine 0.0009536 0.5368 DLG2 Height
rs10937275 Pulmonary collapse; interstitial/compensatory emphysema 0.001476 1.293 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Graves' disease 0.00582 0.4378 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Phobia 0.0103 2.19 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Synoviopathy 0.005851 1.452 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Contact dermatitis and other eczema due to plants [except food] 2.686e-05 2.684 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Gastrointestinal complications 0.00291 0.6229 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Abnormal chest sounds 0.002318 1.691 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Nodular lymphoma 0.005593 1.807 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Photodermatitis & sunburn 0.01087 1.24 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937275 Inflammation of the eye 0.006456 0.8451 ST6GAL1 Drug-induced liver injury (flucloxacillin)
rs10937405 Plasma protein metabolism disorder 0.008339 0.7732 TP63 Lung adenocarcinoma
rs10937405 Cyst and pseudocyst of pancreas 0.006826 1.597 TP63 Lung adenocarcinoma
rs10937405 Hemoptysis 0.009069 0.7503 TP63 Lung adenocarcinoma
rs10937405 Breast disorder NOS 0.007027 0.405 TP63 Lung adenocarcinoma
rs10937405 Antihypertensive agents causing adverse effects 0.00977 1.516 TP63 Lung adenocarcinoma
rs10937405 Lipoma 0.008787 1.192 TP63 Lung adenocarcinoma
rs10937405 Impacted cerumen 0.008749 1.105 TP63 Lung adenocarcinoma
rs10953541 Absent or infrequent menstruation 0.00274 0.541 BCAP29 Coronary heart disease
rs10953541 Alcohol-related disorders 0.0005849 1.28 BCAP29 Coronary heart disease
rs10953541 Prostate cancer 0.00588 1.218 BCAP29 Coronary heart disease
rs10953541 Congenital cataract and lens anomalies 0.00129 2.197 BCAP29 Coronary heart disease
rs10953541 Secondary malignant neoplasm of digestive systems 0.0045 0.5593 BCAP29 Coronary heart disease
rs10953541 Inflammatory diseases of prostate 0.003663 1.296 BCAP29 Coronary heart disease
rs10953541 Abdominal aortic aneurysm 0.005118 1.277 BCAP29 Coronary heart disease
rs10953541 progressive myopia 0.005386 1.797 BCAP29 Coronary heart disease
rs10953541 Orchitis and epididymitis 0.001675 1.601 BCAP29 Coronary heart disease
rs10953541 Alcoholism 0.0002363 1.345 BCAP29 Coronary heart disease
rs10953541 Abnormal function study of cardiovascular system 0.006882 1.198 BCAP29 Coronary heart disease
rs10953541 Malignant neoplasm of brain and nervous system 0.007605 0.6363 BCAP29 Coronary heart disease
rs10953541 Chronic glomerulonephritis 0.001597 2.429 BCAP29 Coronary heart disease
rs10993994 Other disorders of bone and cartilage 0.0005931 1.279 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Symptoms involving urinary system 0.009352 0.7975 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Prostate cancer 4.951e-05 1.288 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Muscular dystrophies and other myopathies 0.001939 1.525 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Fracture of hand or wrist 0.0008949 1.214 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Anomalies of pupillary function 0.008336 0.4968 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Acquired toe deformities 0.003009 1.187 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Abnormal findings on radiological breast exam 0.009814 1.532 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Other headache syndromes 0.001523 1.122 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Renal colic 0.00948 1.609 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Rotator cuff (capsule) sprain 0.001487 1.234 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Premature beats 0.00495 0.8365 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Acute sinusitis 0.0102 1.132 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Hammer toe 0.01104 1.184 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Urethral stricture (not specified as infectious) 0.003605 1.453 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs10993994 Inflammatory spondylopathies 0.006114 1.503 MSMB Prostate cancer, Prostate-specific antigen levels (men w/out prostate cancer)
rs11013962 Ankylosis of joint 0.006849 1.424 KIAA1217 Earlobes
rs11013962 Disorders of cornea 0.01037 1.182 KIAA1217 Earlobes
rs11013962 Essential hypertension 0.004281 1.089 KIAA1217 Earlobes
rs11013962 Mucous polyp of cervix 0.001168 1.499 KIAA1217 Earlobes
rs11013962 Open wound of toe(s) 0.0112 0.5781 KIAA1217 Earlobes
rs11013962 Dermatophytosis / Dermatomycosis 0.01013 1.101 KIAA1217 Earlobes
rs11013962 Hypertension 0.004967 1.087 KIAA1217 Earlobes
rs11013962 Eosinophilia 0.009667 0.5558 KIAA1217 Earlobes
rs11013962 Adverse effects of cardiac rhythm regulators 0.008606 0.568 KIAA1217 Earlobes
rs11013962 Eye infection, viral 0.009939 1.367 KIAA1217 Earlobes
rs11013962 Cholelithiasis and cholecystitis 0.009395 0.8908 KIAA1217 Earlobes
rs11013962 Develomental delays and disorders 0.006192 1.279 KIAA1217 Earlobes
rs11057830 Colostomy and enterostomy complication 0.000644 2.216 SCARB1 Vitamin E
rs11057830 Deficiency of humoral immunity 0.004765 2.3 SCARB1 Vitamin E
rs11057830 Complication of amputation stump 0.001077 2.257 SCARB1 Vitamin E
rs11057830 Hirsutism 0.009085 1.774 SCARB1 Vitamin E
rs11057830 Chronic obstructive asthma with exacerbation 0.004629 0.3291 SCARB1 Vitamin E
rs11057830 Eustachian tube disorders 0.008035 0.848 SCARB1 Vitamin E
rs11057830 Diaphragmatic hernia 0.007976 1.182 SCARB1 Vitamin E
rs11057830 Immunity deficiency 0.0101 1.756 SCARB1 Vitamin E
rs11057830 Cancer of larynx 0.009032 0.4946 SCARB1 Vitamin E
rs11057830 Prostatitis 0.0006235 1.515 SCARB1 Vitamin E
rs11057830 Other specified gastritis 0.00269 1.399 SCARB1 Vitamin E
rs11057830 Memory loss 0.006162 0.7208 SCARB1 Vitamin E
rs11057830 Generalized anxiety disorder 0.008018 0.6683 SCARB1 Vitamin E
rs11057830 Otitis media 0.01123 0.8331 SCARB1 Vitamin E
rs11057830 Chronic obstructive asthma 0.0006173 0.5876 SCARB1 Vitamin E
rs11062040 Obstruction of bile duct 0.01005 1.559 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Blood vessel replaced 0.004043 1.613 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Benign neoplasm of ovary 0.002351 0.6034 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Abnormal findings examination of lungs 0.0107 1.157 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Nerve root lesions 0.006443 1.622 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Exophthalmos 0.003764 2.006 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Open wound of lip and mouth 0.006007 0.5588 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Generalized hyperhidrosis 0.002301 1.383 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Noninflammatory disorders of ovary, fallopian tube, & broad ligament 0.001918 0.571 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Other pulmonary inflamation or edema 0.00138 1.385 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Other hypertrophic and atrophic conditions of skin 0.01143 1.104 DCP1B Response to gemcitabine in pancreatic cancer
rs11062040 Cerebral atherosclerosis 0.008596 0.6207 DCP1B Response to gemcitabine in pancreatic cancer
rs11064994 Other specified diseases of nail 0.005006 0.7362 CCDC64 Cognitive performance
rs11064994 Intestinal infection due to C. difficile 0.0002771 1.877 CCDC64 Cognitive performance
rs11064994 Urinary obstruction 0.01075 1.643 CCDC64 Cognitive performance
rs11064994 Peritonitis and retroperitoneal infections 0.006722 1.703 CCDC64 Cognitive performance
rs11064994 Hyperparathyroidism 0.008489 1.509 CCDC64 Cognitive performance
rs11064994 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.001134 1.671 CCDC64 Cognitive performance
rs11064994 Fracture of tibia and fibula 0.008033 0.5705 CCDC64 Cognitive performance
rs11064994 Other specified nonpsychotic and/or transient mental disorders 0.01011 1.382 CCDC64 Cognitive performance
rs11064994 Cervical cancer and dysplasia 0.001855 1.583 CCDC64 Cognitive performance
rs11064994 Bacterial enteritis 0.006509 1.56 CCDC64 Cognitive performance
rs11064994 Diseases of nail 0.01005 0.764 CCDC64 Cognitive performance
rs11064994 Idiopathic fibrosing alveolitis 0.0001437 2.862 CCDC64 Cognitive performance
rs11064994 Clotting factor deficiency 0.003452 2.821 CCDC64 Cognitive performance
rs11064994 Acute pancreatitis 0.003822 1.533 CCDC64 Cognitive performance
rs11064994 Congenital coagulation defects 0.003936 2.416 CCDC64 Cognitive performance
rs11064994 Benign neoplasm of lip, oral cavity, and pharynx 0.008658 1.845 CCDC64 Cognitive performance
rs11064994 Other alveolar and parietoalveolar pneumonopathy 0.001539 2.196 CCDC64 Cognitive performance
rs11064994 Duodenitis 0.001063 1.834 CCDC64 Cognitive performance
rs11082304 Pulmonary collapse; interstitial/compensatory emphysema 0.008523 0.8607 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Abnormal findings examination of lungs 0.001408 0.8339 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Chronic ulcer of skin 0.005919 0.8855 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Parkinson's disease 0.008821 1.275 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Type 2 diabetic retinopathy 0.006342 0.8327 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Contact dermatitis and other eczema due to plants [except food] 0.009701 1.7 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Psychogenic and somatoform disorders 0.005583 0.782 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Morbid obesity 0.01064 0.8664 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Other immunological findings 0.005054 0.7486 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Chronic ulcer of unspecified site 0.0001771 0.7123 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Fracture of tibia and fibula 0.009469 0.7918 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Congenital anomalies of face and neck 0.002619 2.525 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Neutropenia 0.008171 0.8154 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Leukemia 0.009316 0.7634 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Gastritis and duodenitis 0.007031 0.8769 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Decreased white blood cell count 0.004622 0.8108 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Acute pharyngitis 0.009153 0.8748 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Varicose veins of lower extremity, symptomtic 0.009183 0.8286 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Other specified gastritis 0.005138 0.7867 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Septicemia 0.00494 0.8459 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs11082304 Other disorders of bone and cartilage 0.0003868 0.777 CABLES1 Platelet counts, Smoking behavior (age of initiation)
rs1109670 Pernicious anemia 0.00511 0.5993 ASAP2 Multiple sclerosis
rs1109670 Ovarian cancer 0.0103 1.544 ASAP2 Multiple sclerosis
rs1109670 Neurological disorders due to brain damage 0.004657 0.8574 ASAP2 Multiple sclerosis
rs1109670 Calculus of kidney 0.004261 1.205 ASAP2 Multiple sclerosis
rs1109670 Abdominal aortic aneurysm 0.01032 0.7831 ASAP2 Multiple sclerosis
rs1109670 progressive myopia 0.006716 0.4446 ASAP2 Multiple sclerosis
rs1109670 Anxiety, phobic and dissociative disorders 0.002285 1.136 ASAP2 Multiple sclerosis
rs1109670 Fractur of unspecified part of femur 0.004199 1.473 ASAP2 Multiple sclerosis
rs1109670 Fracture of unspecified bones 0.003234 1.191 ASAP2 Multiple sclerosis
rs1109670 Known or suspected fetal abnormality 0.00881 1.702 ASAP2 Multiple sclerosis
rs1109670 Osteopenia 0.005382 1.148 ASAP2 Multiple sclerosis
rs1109670 Other disorders of prostate 0.001168 1.469 ASAP2 Multiple sclerosis
rs1109670 Cancer of other female genital organs 0.009297 1.469 ASAP2 Multiple sclerosis
rs1109670 Carbuncle and furuncle 0.004685 0.5662 ASAP2 Multiple sclerosis
rs1109670 Dermatosis NOS 0.006984 1.122 ASAP2 Multiple sclerosis
rs1109670 Malaise and fatigue 0.01067 1.092 ASAP2 Multiple sclerosis
rs11129295 Psoriasis & related disorders 0.01122 0.8135 EOMES Multiple sclerosis
rs11129295 Sicca syndrome 0.004759 0.633 EOMES Multiple sclerosis
rs11129295 Type 1 diabetic retinopathy 0.01107 1.385 EOMES Multiple sclerosis
rs11129295 Hypotension 0.008533 1.131 EOMES Multiple sclerosis
rs11129295 Psoriasis 0.01123 0.8038 EOMES Multiple sclerosis
rs11129295 Intervertebral disc disorder with myelopathy 0.009204 1.681 EOMES Multiple sclerosis
rs11129295 Umbilical hernia 0.0002798 1.382 EOMES Multiple sclerosis
rs11129295 Other acquired musculoskeletal deformity 0.01092 0.8086 EOMES Multiple sclerosis
rs11129295 Hepatomegaly 0.003837 1.795 EOMES Multiple sclerosis
rs11129295 Other anemias 0.006414 1.089 EOMES Multiple sclerosis
rs11129295 Symptoms involving digestive system 0.01128 0.8214 EOMES Multiple sclerosis
rs11129295 Type 1 diabetes nephropathy 0.01142 1.576 EOMES Multiple sclerosis
rs11129295 Overweight 0.01094 1.085 EOMES Multiple sclerosis
rs11129295 Gastritis and duodenitis 0.0005445 1.189 EOMES Multiple sclerosis
rs11129295 Lesions of stomach and duodenum 0.001729 2.172 EOMES Multiple sclerosis
rs11129295 Psoriasis vulgaris 0.01091 0.7987 EOMES Multiple sclerosis
rs11129640 Obstructive sleep apnea 0.006552 1.171 ARPP21 Entorhinal cortical thickness
rs11129640 Type 2 diabetes 0.007727 0.9054 ARPP21 Entorhinal cortical thickness
rs11129640 Megaloblastic anemia 0.0108 1.365 ARPP21 Entorhinal cortical thickness
rs11129640 Otitis externa 0.008499 1.209 ARPP21 Entorhinal cortical thickness
rs11129640 Iron deficiency anemia secondary to blood loss 0.001297 1.451 ARPP21 Entorhinal cortical thickness
rs11129640 Behcet's syndrome 0.003496 0.5106 ARPP21 Entorhinal cortical thickness
rs11129640 Other aneurysm 0.009929 1.199 ARPP21 Entorhinal cortical thickness
rs11129640 Chronic interstitial cystitis 0.006236 2.13 ARPP21 Entorhinal cortical thickness
rs11129640 Sleep apnea 0.009223 1.132 ARPP21 Entorhinal cortical thickness
rs11129640 Hirsutism 0.01039 1.651 ARPP21 Entorhinal cortical thickness
rs11129640 Nevus, non-neoplastic 0.003347 1.787 ARPP21 Entorhinal cortical thickness
rs11129640 Heart valve replaced 0.009139 1.311 ARPP21 Entorhinal cortical thickness
rs11129640 Pathologic fracture 0.004201 1.248 ARPP21 Entorhinal cortical thickness
rs11129640 Aortic aneurysm 0.001182 1.283 ARPP21 Entorhinal cortical thickness
rs11130874 Hyperosmolality and/or hypernatremia 0.009605 1.513 PTPRG Schizophrenia
rs11130874 Cardiac arrest & ventricular fibrillation 0.00655 0.613 PTPRG Schizophrenia
rs11130874 Urethritis and urethral syndrome 0.01145 1.742 PTPRG Schizophrenia
rs11130874 Gingivitis 7.127e-05 2.424 PTPRG Schizophrenia
rs11130874 Adverse effects of hormones and synthetic substitutes 0.009896 2.258 PTPRG Schizophrenia
rs11130874 Lung cancer 0.005843 0.7417 PTPRG Schizophrenia
rs11130874 Sepsis 0.01109 1.302 PTPRG Schizophrenia
rs11130874 Abnormal loss of weight and underweight 0.005547 1.341 PTPRG Schizophrenia
rs11130874 Dysuria 0.001214 1.241 PTPRG Schizophrenia
rs11130874 Phosphorus metabolism disorder 0.002227 1.583 PTPRG Schizophrenia
rs11130874 Frequency of urination and polyuria 0.006607 1.16 PTPRG Schizophrenia
rs11130874 Symptoms/disorders of the urinary system 0.005171 1.114 PTPRG Schizophrenia
rs11130874 Protein-calorie malnutrition 0.00761 1.201 PTPRG Schizophrenia
rs11130874 Cancer within the respiratory system 0.004892 0.7402 PTPRG Schizophrenia
rs11130874 Other disorders of eyelids 0.001823 1.21 PTPRG Schizophrenia
rs11130874 Simple goiter 0.008311 0.7585 PTPRG Schizophrenia
rs11130874 Hepatomegaly 0.002619 1.952 PTPRG Schizophrenia
rs11130874 Secondary malignant neoplasm 0.004618 0.8159 PTPRG Schizophrenia
rs11141915 Immune disorders 0.001694 1.353 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Hypertensive heart and/or renal disease 0.00971 0.8281 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Concussion 0.006358 1.553 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Cervical radiculitis 0.001393 1.251 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Localized adiposity 0.009375 1.921 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Hypothyroidism 0.004528 1.129 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Disorders of esophageal motility 0.01103 0.588 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Thyroid cancer 0.003042 0.5153 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Urinary incontinence 0.004403 1.167 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Prolapse of vaginal walls 0.003654 1.259 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Genital prolapse 0.008456 1.197 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Thyroiditis 0.004528 1.429 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 severe protein-calorie malnutrition 0.001511 0.4466 DAPK1 Response to gemcitabine in pancreatic cancer
rs11141915 Myopia 0.007799 1.151 DAPK1 Response to gemcitabine in pancreatic cancer
rs11143230 Pulmonary collapse; interstitial/compensatory emphysema 0.0002604 1.242 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Nontoxic nodular goiter 0.005004 1.196 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Protein plasma/amino-acid transport and metabolism disorder 0.002445 1.307 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Vaginal enterocele, congenital or acquired 0.01085 1.463 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Hypertension complicating pregnancy 0.0009324 0.3098 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Plasma protein metabolism disorder 0.0001924 1.433 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Nerve root and plexus disorders 0.009203 1.302 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Oral aphthae 0.01071 1.596 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Other specified diseases of sebaceous glands 0.003727 0.7919 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Other specified osteoporosis 0.003262 1.735 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Stomatitis and mucositis 0.003657 1.422 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Hemorrhoids 0.009504 1.113 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Diseases of pulp and periapical tissues 0.01078 1.194 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Sepsis and SIRS 0.006628 1.267 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Thyrotoxicosis 0.005552 1.247 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Nontoxic multinodular goiter 0.00384 1.283 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11143230 Prolapse of vaginal vault after hysterectomy 0.009543 1.456 GDA Suicidal ideation and SSRI class antidepressant Escitalopram, Suicidal ideation
rs11144134 Thrombocytopenia 0.001797 0.6711 TRPM6 Magnesium levels
rs11144134 Mood disorders 0.01082 0.8511 TRPM6 Magnesium levels
rs11144134 Abnormal reflex 0.001276 2.967 TRPM6 Magnesium levels
rs11144134 Benign neoplasm of colon 0.009647 1.16 TRPM6 Magnesium levels
rs11144134 Purpura and other hemorrhagic conditions 0.008421 0.7492 TRPM6 Magnesium levels
rs11144134 Symptoms affecting skin 0.008636 0.8516 TRPM6 Magnesium levels
rs11144134 Balanoposthitis 0.009302 2.201 TRPM6 Magnesium levels
rs11144134 Pain, swelling or discharge of eye 0.003963 0.4465 TRPM6 Magnesium levels
rs11144134 Congenital anomalies of urinary system 0.009778 1.689 TRPM6 Magnesium levels
rs11144134 Vitamin deficiency 0.001431 0.6821 TRPM6 Magnesium levels
rs11144134 Hydrocele 0.005035 1.962 TRPM6 Magnesium levels
rs11144134 Viral Enteritis 0.01099 0.348 TRPM6 Magnesium levels
rs11172113 Chronic periodontitis 0.004828 0.7808 LRP1 Pulmonary function, Migraine
rs11172113 Abnormal function study of cardiovascular system 0.004637 0.8407 LRP1 Pulmonary function, Migraine
rs11172113 Mechanical complication due to other implant and internal device 0.003944 1.365 LRP1 Pulmonary function, Migraine
rs11172113 Symptoms associated with female genital organs 0.006851 0.8402 LRP1 Pulmonary function, Migraine
rs11172113 End stage renal disease 0.00784 1.392 LRP1 Pulmonary function, Migraine
rs11172113 Fracture of pelvis 0.003732 1.366 LRP1 Pulmonary function, Migraine
rs11172113 Cardiac defibrillator in situ 0.004402 1.449 LRP1 Pulmonary function, Migraine
rs11172113 Early complications of trauma or procedure 0.006659 1.655 LRP1 Pulmonary function, Migraine
rs11172113 Aplastic anemia 0.001001 1.437 LRP1 Pulmonary function, Migraine
rs11172113 Acute reaction to stress 0.001894 0.7646 LRP1 Pulmonary function, Migraine
rs11172113 Fracture of ribs 0.005592 1.248 LRP1 Pulmonary function, Migraine
rs11172113 Chronic ulcer of unspecified site 0.006673 0.7755 LRP1 Pulmonary function, Migraine
rs11172113 Diseases of the jaws 0.00283 0.8182 LRP1 Pulmonary function, Migraine
rs11172113 Dermatomycoses 0.002053 0.5168 LRP1 Pulmonary function, Migraine
rs11172113 Other abnormality of urination 0.0005745 0.7778 LRP1 Pulmonary function, Migraine
rs11172113 Poisoning by agents affecting the cardiovascular system 0.004701 0.7409 LRP1 Pulmonary function, Migraine
rs11172113 Fracture of ankle and foot 0.01044 1.139 LRP1 Pulmonary function, Migraine
rs11172113 Acute bronchitis and bronchiolitis 0.008704 0.8919 LRP1 Pulmonary function, Migraine
rs11172113 Infection/inflammation of internal prosthetic device, implant or graft 0.006796 1.274 LRP1 Pulmonary function, Migraine
rs11172113 Fracture of upper limb 0.002421 1.164 LRP1 Pulmonary function, Migraine
rs11172113 Temporomandibular joint disorder NOS 0.0004462 0.5065 LRP1 Pulmonary function, Migraine
rs11172113 Temporomandibular joint disorders 0.0007857 0.732 LRP1 Pulmonary function, Migraine
rs11203203 Other disorders of back 0.001229 1.199 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Chronic interstitial cystitis 0.007913 2.033 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Idiopathic fibrosing alveolitis 0.002517 0.4382 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Tension headache 0.007067 1.243 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Chronic sinusitis 0.007792 1.123 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Other endocrine disorders 0.01152 1.497 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Back pain 0.0001058 1.125 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Nonallopathic lesions NEC 0.002476 1.147 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Thoracic neuritis/radiculitis 0.003143 1.131 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Disorders of coccyx 0.004627 1.351 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Other disorders of bone and cartilage 0.01038 1.205 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Malunion fracture 0.005954 1.434 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Intervertebral disc disorders 3.455e-05 1.16 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Spondylosis without myelopathy 0.01069 1.107 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Obsessive-compulsive disorder 0.0104 1.674 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Acute sinusitis 0.006648 1.145 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Other hypertensive complications 0.0005854 1.342 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Functional digestive disorders 0.01121 1.137 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Hyperventilation 0.003607 1.76 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Chronic pharyngitis and nasopharyngitis 0.002048 1.199 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Other disorders of pancreatic internal secretion 0.01005 0.5682 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11203203 Degeneration of intervertebral disc 7.834e-05 1.182 UBASH3A Vitiligo, Type 1 diabetes, Celiac disease or Rheumatoid arthritis, Rheumatoid arthritis
rs11204538 Schizophrenia 0.008957 0.6021 TRIM58 Mean corpuscular volume
rs11204538 Prostate cancer 0.009377 0.8509 TRIM58 Mean corpuscular volume
rs11204538 Swelling, mass, or lump in head and neck 0.0007572 0.7664 TRIM58 Mean corpuscular volume
rs11204538 Ulcerative stomatitis & mucositis 0.003142 0.5053 TRIM58 Mean corpuscular volume
rs11204538 Irregular menstrual bleeding 0.009469 1.637 TRIM58 Mean corpuscular volume
rs11206510 Rhabdomyolysis 0.01068 1.835 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Stress fracture 0.005591 0.242 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Abnormal weight gain 0.004094 1.425 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Cardiac arrest & ventricular fibrillation 0.007312 1.473 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Hemorrhage or hematoma complicating a procedure 0.005158 0.7547 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Spontaneous ecchymoses 0.002117 0.3899 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Ascites (non malignant) 0.006818 0.6005 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Diplopia and disorders of binocular vision 0.002681 0.6644 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Respiratory failure 0.006323 1.324 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Toxic multinodular goiter 0.004587 1.963 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Thyroiditis 0.0004481 1.557 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Poisoning by other anti-infectives 0.007824 1.285 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11206510 Hemorrhoids 0.01082 1.136 PCSK9 LDL Cholesterol, Early onset myocardial infarction, Coronary heart disease
rs11214606 Diseases of respiratory system 0.007101 0.6737 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Cholesteatoma 9.689e-05 3.179 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Other disorders of middle ear and mastoid 0.0005852 2.195 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Deep vein thrombosis 0.0066 1.576 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Immune disorders 0.002456 1.601 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Fracture of radius and ulna 0.01008 1.385 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Diseases of hair and hair follicles 0.003381 0.5445 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Mycoses 0.009217 1.987 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Dysthymic disorder 0.001419 0.628 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Peripheral autonomic neuropathy 0.006894 1.797 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Congenital anomalies of great vessels 0.004541 2.796 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Type 1 diabetic neuropathy 0.004196 1.95 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Complication of amputation stump 0.00109 2.907 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Aneurysm of iliac artery 0.003166 2.497 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Postlaminectomy syndrome 0.0007134 1.997 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Methicillin resistant Staphylococcus aureus 0.004804 2.628 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Symptoms involving respiratory system 0.002879 0.5473 DRD2 Working memory and antipsychotic drug olanzapine
rs11214606 Other immunological findings 0.002087 1.745 DRD2 Working memory and antipsychotic drug olanzapine
rs11221332 Superficial cellulitis and abscess 0.003528 0.8851 ETS1 Celiac disease
rs11221332 Paralytic strabismus 0.004072 1.577 ETS1 Celiac disease
rs11221332 Posterior pituitary disorders 0.001695 1.891 ETS1 Celiac disease
rs11221332 Cerebrovascular disease 0.002413 0.8842 ETS1 Celiac disease
rs11221332 Cardiac defibrillator in situ 0.007053 0.614 ETS1 Celiac disease
rs11221332 Symptoms involving cardiovascular system 0.006471 0.8339 ETS1 Celiac disease
rs11221332 Hypertension 0.001071 0.8916 ETS1 Celiac disease
rs11221332 Open wounds of head; neck; and trunk 0.005175 0.8386 ETS1 Celiac disease
rs11221332 Osteoarthrosis NOS 0.005983 0.8992 ETS1 Celiac disease
rs11221332 Aneurysm of artery of lower extremity 0.005158 0.5068 ETS1 Celiac disease
rs11221332 Gross hematuria 0.0009977 0.4066 ETS1 Celiac disease
rs11221332 Other conditions of brain, NOS 0.002899 1.647 ETS1 Celiac disease
rs11221332 Osteoarthrosis 0.005174 0.9046 ETS1 Celiac disease
rs11221332 Malignant neoplasm of brain and nervous system 0.0033 1.51 ETS1 Celiac disease
rs11221332 Seborheic dermatitis 0.003019 1.23 ETS1 Celiac disease
rs11221332 Essential hypertension 0.001259 0.8929 ETS1 Celiac disease
rs11221332 Symptoms/disorders of the urinary system 0.0001749 0.8689 ETS1 Celiac disease
rs11221332 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.0007108 0.6369 ETS1 Celiac disease
rs11221332 Osteoarthritis; localized 0.008838 0.8745 ETS1 Celiac disease
rs11221332 Abnormal findings on study of brain, nervous system 0.008007 1.547 ETS1 Celiac disease
rs11221332 Pituitary hypofunction 0.009257 1.829 ETS1 Celiac disease
rs11221332 Open wounds of extremities 0.009341 0.8802 ETS1 Celiac disease
rs11221332 Other disorders of eye 0.01065 1.13 ETS1 Celiac disease
rs11221332 Occlusion and stenosis of precerebral arteries 0.0009581 0.8275 ETS1 Celiac disease
rs11221332 Cervical cancer and dysplasia 0.0001415 0.6225 ETS1 Celiac disease
rs11221332 Hypersomnia 0.01052 0.6035 ETS1 Celiac disease
rs11221332 Claw toe 0.01128 0.3374 ETS1 Celiac disease
rs11221332 Abnormal Papanicolaou smear of cervix and cervical HPV 0.006984 0.7781 ETS1 Celiac disease
rs11221332 Allergy to serum or vaccine 0.01113 1.712 ETS1 Celiac disease
rs11243676 Anomalies of jaw size/symmetry 0.003767 2.73 NTNG2 Systemic lupus erythematosus
rs11243676 Uveitis 0.01048 1.497 NTNG2 Systemic lupus erythematosus
rs11243676 Develomental delays and disorders 0.009603 1.456 NTNG2 Systemic lupus erythematosus
rs11243676 Symptoms involving respiratory system 0.002437 0.616 NTNG2 Systemic lupus erythematosus
rs11243676 Other disorders of arteries and arterioles 0.001645 0.5322 NTNG2 Systemic lupus erythematosus
rs11243676 AV block 0.01103 0.725 NTNG2 Systemic lupus erythematosus
rs11243676 Cervical radiculitis 0.003516 1.33 NTNG2 Systemic lupus erythematosus
rs11243676 Congenital musculoskeletal deformities of spine 0.006721 1.672 NTNG2 Systemic lupus erythematosus
rs11243676 Stricture of artery 0.01004 0.5396 NTNG2 Systemic lupus erythematosus
rs11243676 Carbuncle and furuncle 0.0008375 2.027 NTNG2 Systemic lupus erythematosus
rs11243676 Insect bite 0.001335 0.5571 NTNG2 Systemic lupus erythematosus
rs11243676 Ptosis of eyelid 0.001758 1.437 NTNG2 Systemic lupus erythematosus
rs11465804 Disorders of vitreous body 0.009976 0.7832 IL23R Crohn's disease
rs11465804 Unspecified erythematous condition 0.008822 0.154 IL23R Crohn's disease
rs11465804 Mechanical complication due to other implant and internal device 0.007207 1.654 IL23R Crohn's disease
rs11465804 Other disorders of eye 0.005382 0.7837 IL23R Crohn's disease
rs11465804 Hypercholesterolemia 0.00873 0.7989 IL23R Crohn's disease
rs11465804 Cervical cancer 0.004013 2.621 IL23R Crohn's disease
rs11465804 Dental caries 0.008656 1.399 IL23R Crohn's disease
rs11465804 Allergy to serum or vaccine 0.0007702 2.801 IL23R Crohn's disease
rs11465804 Other peripheral nerve disorders 0.0109 0.8189 IL23R Crohn's disease
rs11465804 Genitourinary congenital anomalies 0.01132 1.661 IL23R Crohn's disease
rs11465804 Atrophy of edentulous alveolar ridge 3.18e-05 2.638 IL23R Crohn's disease
rs11465804 Fracture of foot 0.007313 0.6203 IL23R Crohn's disease
rs11465804 Osteoarthrosis; localized, primary 0.004315 0.5636 IL23R Crohn's disease
rs11465804 Other diseases of the teeth and supporting structures 2.428e-05 1.816 IL23R Crohn's disease
rs11465804 Abnormal reflex 0.007996 2.868 IL23R Crohn's disease
rs11465804 Osteochondropathies 0.004789 2.594 IL23R Crohn's disease
rs1150754 Stress fracture 0.007701 2.004 TNXB Systemic lupus erythematosus
rs1150754 Nephritis and nephropathy in diseases classified elsewhere 0.004008 1.401 TNXB Systemic lupus erythematosus
rs1150754 Disorders of the autonomic nervous system 0.0008045 1.501 TNXB Systemic lupus erythematosus
rs1150754 Celiac disease 6.711e-06 2.822 TNXB Systemic lupus erythematosus
rs1150754 Type 1 diabetes 0.0003616 1.313 TNXB Systemic lupus erythematosus
rs1150754 Type 1 diabetic retinopathy 8.379e-05 1.799 TNXB Systemic lupus erythematosus
rs1150754 Type 1 diabetic neuropathy 1.725e-08 2.287 TNXB Systemic lupus erythematosus
rs1150754 Ovarian dysfunction 0.009312 0.2627 TNXB Systemic lupus erythematosus
rs1150754 Lupus erythematosus 0.0005656 2.396 TNXB Systemic lupus erythematosus
rs1150754 Type 1 diabetes nephropathy 0.0001004 2.168 TNXB Systemic lupus erythematosus
rs1150754 Other specified peripheral vascular diseases 0.002116 2.366 TNXB Systemic lupus erythematosus
rs1150754 Peripheral autonomic neuropathy 0.0003163 1.663 TNXB Systemic lupus erythematosus
rs1150754 Immune disorders 0.004881 1.352 TNXB Systemic lupus erythematosus
rs1150754 Nephritis and nephropathy without mention of glomerulonephritis 0.005348 1.346 TNXB Systemic lupus erythematosus
rs1150754 Adrenal hypofunction 0.006902 1.752 TNXB Systemic lupus erythematosus
rs1150754 Rosacea 0.0005574 0.712 TNXB Systemic lupus erythematosus
rs1150754 Adverse effects of insulins and antidiabetic agents 0.0001532 2.468 TNXB Systemic lupus erythematosus
rs1150754 Urticaria 0.005234 0.7053 TNXB Systemic lupus erythematosus
rs1150754 Abnormal mammogram 0.006263 0.7838 TNXB Systemic lupus erythematosus
rs1150754 Diabetic retinopathy 0.008961 1.251 TNXB Systemic lupus erythematosus
rs1150754 Inflammatory disease of cervix, vagina, and vulva 0.009757 0.7933 TNXB Systemic lupus erythematosus
rs1150754 Prostatitis 0.003974 0.6584 TNXB Systemic lupus erythematosus
rs1150754 Stricture and stenosis of esophagus 0.007385 0.6873 TNXB Systemic lupus erythematosus
rs1150754 Keratitis, infectious 0.001117 0.4812 TNXB Systemic lupus erythematosus
rs1150754 Celiac or tropical sprue 1.889e-06 2.92 TNXB Systemic lupus erythematosus
rs1150754 Congenital anomalies of intestine 0.002779 2.513 TNXB Systemic lupus erythematosus
rs1150754 Type 1 diabetic peripheral circulatory disorders 0.0001084 2.712 TNXB Systemic lupus erythematosus
rs1150754 Poisoning by psychotropic agents 0.00886 1.878 TNXB Systemic lupus erythematosus
rs1150754 Hematuria 0.001119 0.8271 TNXB Systemic lupus erythematosus
rs1150754 Atrophic gastritis 0.01088 1.567 TNXB Systemic lupus erythematosus
rs1150754 Disorders of lipoid metabolism 0.01132 0.8933 TNXB Systemic lupus erythematosus
rs1150754 Seborheic dermatitis 0.01086 0.7887 TNXB Systemic lupus erythematosus
rs1150754 Discoid lupus erythematosus 0.000417 1.762 TNXB Systemic lupus erythematosus
rs1150754 Pilonidal cyst 0.007682 2.247 TNXB Systemic lupus erythematosus
rs1150754 Decreased libido 0.0105 2.041 TNXB Systemic lupus erythematosus
rs1150754 Cyst of kidney, acquired 0.0004346 1.528 TNXB Systemic lupus erythematosus
rs1150754 Peritoneal or intestinal adhesions 0.006571 1.76 TNXB Systemic lupus erythematosus
rs11574637 Disorders of parathyroid gland 0.005538 1.364 ITGAX Systemic lupus erythematosus
rs11574637 Acne 0.003341 0.6728 ITGAX Systemic lupus erythematosus
rs11574637 Benign neoplasm of unspecified sites 0.01147 0.162 ITGAX Systemic lupus erythematosus
rs11574637 Migrain with aura 0.002359 1.624 ITGAX Systemic lupus erythematosus
rs11574637 E. coli 0.003269 0.6342 ITGAX Systemic lupus erythematosus
rs11574637 Bladder cancer 0.01032 1.314 ITGAX Systemic lupus erythematosus
rs11574637 Streptococcus infection 0.01064 0.6653 ITGAX Systemic lupus erythematosus
rs11574637 Arterial embolism and thrombosis of lower extremity artery 0.006578 1.421 ITGAX Systemic lupus erythematosus
rs11574637 Subjective visual disturbances 0.006444 1.265 ITGAX Systemic lupus erythematosus
rs11574637 Cellulitis and abscess of foot/toes 0.008372 1.336 ITGAX Systemic lupus erythematosus
rs11574637 Anemia of chronic disease 0.009621 0.7831 ITGAX Systemic lupus erythematosus
rs11574637 Atherosclerosis of renal artery 0.001516 1.435 ITGAX Systemic lupus erythematosus
rs11574637 Bacterial infection NOS 0.008417 0.8449 ITGAX Systemic lupus erythematosus
rs11574637 Other hypertensive complications 0.002547 1.366 ITGAX Systemic lupus erythematosus
rs11574637 Joint/ligament sprain 0.008831 1.38 ITGAX Systemic lupus erythematosus
rs11602954 Type 2 diabetic peripheral circulatory disorders 0.01116 0.6674 BET1L Mean platelet volume
rs11602954 Sicca syndrome 0.003189 1.591 BET1L Mean platelet volume
rs11602954 Ankylosis of joint 0.002308 0.5617 BET1L Mean platelet volume
rs11602954 Irritable Bowel Syndrome 0.006564 0.8217 BET1L Mean platelet volume
rs11602954 Chronic hepatitis 0.01132 0.4259 BET1L Mean platelet volume
rs11602954 Personality disorders 0.0006735 0.7013 BET1L Mean platelet volume
rs11602954 Type 1 diabetes 0.005352 0.8086 BET1L Mean platelet volume
rs11602954 Bacteremia 0.004575 0.6987 BET1L Mean platelet volume
rs11602954 Muscle weakness 0.002194 0.6683 BET1L Mean platelet volume
rs11602954 Anxiety, phobic and dissociative disorders 2.357e-06 0.808 BET1L Mean platelet volume
rs11602954 Colles' fracture 0.00721 1.42 BET1L Mean platelet volume
rs11602954 Mood disorders 1.341e-05 0.8348 BET1L Mean platelet volume
rs11602954 Acute reaction to stress 0.001489 0.7113 BET1L Mean platelet volume
rs11602954 Labyrinthitis 0.004172 0.638 BET1L Mean platelet volume
rs11602954 Other disorders of peritoneum 0.006069 1.498 BET1L Mean platelet volume
rs11602954 Depression 3.992e-05 0.8402 BET1L Mean platelet volume
rs11602954 Anxiety disorder 0.0002238 0.8272 BET1L Mean platelet volume
rs11602954 Adjustment reaction 0.002841 0.8258 BET1L Mean platelet volume
rs11602954 Back & neck sprains 0.00243 0.8533 BET1L Mean platelet volume
rs11602954 Non-melanoma skin cancer 0.0108 0.8905 BET1L Mean platelet volume
rs11602954 Dysthymic disorder 0.001063 0.7899 BET1L Mean platelet volume
rs11602954 Macular degeneration, wet 0.002632 0.6494 BET1L Mean platelet volume
rs11611208 Chondrocalcinosis 0.003031 1.814 PDE3A Height
rs11611208 Other disorders of metabolic, endocrine, immunity disorders 0.0102 2.521 PDE3A Height
rs11611208 Crystal arthropathies 0.002217 1.832 PDE3A Height
rs11611208 Hyperbilirubinemia 0.0003887 2.981 PDE3A Height
rs11611208 Other specified disorders of liver 0.01147 0.4416 PDE3A Height
rs11611208 Other diseases of the teeth and supporting structures 0.008428 0.5428 PDE3A Height
rs11611208 Pruritus and related conditions 0.003678 1.448 PDE3A Height
rs11611208 Erectile dysfunction 0.002083 1.453 PDE3A Height
rs11611647 Scoliosis 0.001897 1.407 CCND2 Red blood cell count
rs11611647 Cellulitis and abscess of face 0.005084 1.43 CCND2 Red blood cell count
rs11611647 Valvular heart disease/ heart chambers 0.006086 1.852 CCND2 Red blood cell count
rs11611647 Symptoms involving head and neck 0.001212 0.7596 CCND2 Red blood cell count
rs11611647 Vascular dementia 0.005198 0.633 CCND2 Red blood cell count
rs11611647 Appendiceal conditions 0.005631 1.46 CCND2 Red blood cell count
rs11611647 Hypertensive heart and/or renal disease 0.005872 1.211 CCND2 Red blood cell count
rs11611647 Speech and language disorder 0.002299 0.5707 CCND2 Red blood cell count
rs11611647 Idiopathic fibrosing alveolitis 0.007807 0.3479 CCND2 Red blood cell count
rs11611647 Heart failure NOS 0.002478 1.379 CCND2 Red blood cell count
rs11611647 Hypertensive heart disease 0.001578 1.443 CCND2 Red blood cell count
rs11611647 Heart failure 0.008316 1.139 CCND2 Red blood cell count
rs11611647 Hemangioma and lymphangioma, any site 0.00937 1.321 CCND2 Red blood cell count
rs11611647 Peripheral angiopathy in diseases classified elsewhere 0.003684 1.735 CCND2 Red blood cell count
rs11611647 Disorders of the autonomic nervous system 0.008605 1.346 CCND2 Red blood cell count
rs11611647 Respiratory insufficiency 0.008043 1.328 CCND2 Red blood cell count
rs11618202 Retinal disorders 0.005932 0.8205 HMGB1 Total hippocampal volume
rs11618202 Obstructive sleep apnea 0.002774 0.7365 HMGB1 Total hippocampal volume
rs11618202 Ischemic stroke 0.01077 1.329 HMGB1 Total hippocampal volume
rs11618202 Stomach cancer 0.002228 2.266 HMGB1 Total hippocampal volume
rs11618202 Known or suspected fetal abnormality 0.003132 2.195 HMGB1 Total hippocampal volume
rs11618202 Osteoporosis, NOS or other 0.008108 0.8019 HMGB1 Total hippocampal volume
rs11618202 Polyneuropathy in diabetes 0.005772 0.6801 HMGB1 Total hippocampal volume
rs11618202 Abnormal results of function study of liver 0.008103 1.362 HMGB1 Total hippocampal volume
rs11618202 Retinal detachments and defects 0.005345 0.655 HMGB1 Total hippocampal volume
rs11618202 ASCVD 0.007269 1.638 HMGB1 Total hippocampal volume
rs11618202 Sleep apnea 0.009383 0.8135 HMGB1 Total hippocampal volume
rs11618202 Behcet's syndrome 0.003406 0.2211 HMGB1 Total hippocampal volume
rs11618202 Retinal drusen 0.001845 0.6177 HMGB1 Total hippocampal volume
rs11712165 Eating disorder 0.009309 1.597 ARHGAP31 Celiac disease
rs11712165 Fracture of lower limb 0.0003032 0.828 ARHGAP31 Celiac disease
rs11712165 Other disorders of peritoneum 0.002462 0.6391 ARHGAP31 Celiac disease
rs11712165 Anemia of chronic disease 0.005743 0.8231 ARHGAP31 Celiac disease
rs11712165 Pathologic fracture 0.009386 0.8339 ARHGAP31 Celiac disease
rs11712165 Osteoporosis 0.004118 0.8754 ARHGAP31 Celiac disease
rs11712165 Symptoms involving female genital tract 0.009056 1.348 ARHGAP31 Celiac disease
rs11712165 Osteopenia 0.003682 0.8783 ARHGAP31 Celiac disease
rs11712165 Tuberculosis 0.009822 0.4881 ARHGAP31 Celiac disease
rs11712165 Other diseases of respiratory system 0.007998 0.7178 ARHGAP31 Celiac disease
rs11712165 Hemorrhage of gastrointestinal tract 0.006153 0.8472 ARHGAP31 Celiac disease
rs11712165 Fracture of neck of femur 0.000121 0.7587 ARHGAP31 Celiac disease
rs11712165 Fracture of pelvis 0.000101 0.6369 ARHGAP31 Celiac disease
rs11712165 Osteoporosis, osteopenia, & pathological fractures 0.000694 0.8878 ARHGAP31 Celiac disease
rs11712165 Lymphadenitis 0.004048 0.8339 ARHGAP31 Celiac disease
rs11712165 Circumscribed scleroderma 0.009882 1.375 ARHGAP31 Celiac disease
rs11712165 Peritoneal adhesions (postoperative) (postinfection) 0.003249 0.5873 ARHGAP31 Celiac disease
rs11712165 Peptic ulcer 0.004238 0.8467 ARHGAP31 Celiac disease
rs11712165 Other disorders of the nervous system 0.01042 0.6439 ARHGAP31 Celiac disease
rs11712165 Osteoporosis, NOS or other 0.001438 0.8658 ARHGAP31 Celiac disease
rs11712165 Pseudoexfoliation glaucoma 0.009795 0.626 ARHGAP31 Celiac disease
rs11712165 Anemia in neoplastic disease 0.004922 0.6816 ARHGAP31 Celiac disease
rs11712165 Congenital musculoskeletal deformities of spine 0.01151 1.382 ARHGAP31 Celiac disease
rs1175000 Neutropenia 0.00175 1.269 CDCA7L Height
rs1175000 Complication of amputation stump 0.00785 1.869 CDCA7L Height
rs1175000 Emphysema 0.006171 0.7839 CDCA7L Height
rs1175000 Reticulosarcoma 0.003111 1.726 CDCA7L Height
rs1175000 Toxic effect of venom 0.008116 0.6608 CDCA7L Height
rs1175000 Viral warts & HPV 0.01008 0.873 CDCA7L Height
rs1175000 Iatrogenic hypothyroidism 0.01066 1.31 CDCA7L Height
rs1175000 Hypersomnia 0.002763 0.6449 CDCA7L Height
rs1175000 Otorrhea 0.006267 1.975 CDCA7L Height
rs1175000 Chronic lymphocytic thyroiditis 0.006552 1.435 CDCA7L Height
rs1175000 Abnormal pulmonary function 0.007247 0.4196 CDCA7L Height
rs1175000 Amblyopia 0.008942 0.7499 CDCA7L Height
rs1175000 Decreased white blood cell count 0.004679 1.229 CDCA7L Height
rs1175000 Morbid obesity 0.01016 0.8646 CDCA7L Height
rs11754661 Other specified disorders of liver 0.009361 1.55 MTHFD1L Alzheimer's disease
rs11754661 Other specified diseases of hair and hair follicles 0.001336 1.68 MTHFD1L Alzheimer's disease
rs11754661 Scoliosis 0.009273 1.517 MTHFD1L Alzheimer's disease
rs11754661 Infertility, female 0.007205 2.508 MTHFD1L Alzheimer's disease
rs11754661 Fracture of foot 0.001923 1.442 MTHFD1L Alzheimer's disease
rs11754661 Anisometropia 0.008866 1.532 MTHFD1L Alzheimer's disease
rs11754661 Postinflammatory pulmonary fibrosis 0.003798 1.506 MTHFD1L Alzheimer's disease
rs11754661 Heart transplant/surgery 0.01028 0.3705 MTHFD1L Alzheimer's disease
rs11754661 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.006136 2.853 MTHFD1L Alzheimer's disease
rs11754661 Anorexia 0.01136 0.4401 MTHFD1L Alzheimer's disease
rs11754661 Other disorders of the nervous system 0.007072 1.887 MTHFD1L Alzheimer's disease
rs11754661 Type 2 diabetic ketoacidosis 0.001195 1.315 MTHFD1L Alzheimer's disease
rs11754661 Other disorders of bone and cartilage 0.007881 1.386 MTHFD1L Alzheimer's disease
rs11775334 Dyspareunia 0.007913 0.5861 MSRA Hypertension
rs11775334 Pain in limb 0.004952 1.096 MSRA Hypertension
rs11775334 Congenital anomalies of limbs 0.005219 0.7622 MSRA Hypertension
rs11775334 Cancer of the digestive organs and peritoneum 0.009815 1.44 MSRA Hypertension
rs11775334 Hypertension 0.002738 1.099 MSRA Hypertension
rs11775334 Disorders resulting from impaired renal function 0.006547 1.296 MSRA Hypertension
rs11775334 Extrapyramidal disease and abnormal movement disorders 0.003167 1.204 MSRA Hypertension
rs11775334 Essential hypertension 0.003089 1.097 MSRA Hypertension
rs11775334 Chronic nonalcoholic liver disease 0.005054 0.7841 MSRA Hypertension
rs11775334 Thoracic neuritis/radiculitis 0.01092 1.112 MSRA Hypertension
rs11775334 Primary pulmonary hypertension 0.003616 1.616 MSRA Hypertension
rs11775334 Hypertensive chronic kidney disease 0.001433 1.242 MSRA Hypertension
rs11775334 Anemia of chronic disease 0.001522 1.245 MSRA Hypertension
rs11775334 Bronchitis 0.000511 0.8377 MSRA Hypertension
rs11775334 Chronic liver disease and cirrhosis 0.00206 0.7761 MSRA Hypertension
rs11775334 Type 2 diabetic nephropathy 0.01123 1.203 MSRA Hypertension
rs11775334 Alkalosis 0.007192 1.792 MSRA Hypertension
rs11775334 Congenital deformities of feet 0.006343 0.7382 MSRA Hypertension
rs11775334 Type 2 diabetic retinopathy 0.008601 1.198 MSRA Hypertension
rs11775334 Malunion fracture 0.005261 1.441 MSRA Hypertension
rs11775334 Anemia in chronic kidney disease 0.008989 1.297 MSRA Hypertension
rs11775334 Pulmonary congestion and hypostasis 0.001747 1.428 MSRA Hypertension
rs11775334 Nephritis and nephropathy in diseases classified elsewhere 0.01037 1.268 MSRA Hypertension
rs11775334 Other open wound of head and face 0.001515 0.7852 MSRA Hypertension
rs11775334 Hypertensive heart and/or renal disease 0.005267 1.185 MSRA Hypertension
rs11842874 Anomalies of pupillary function 0.006922 2.39 MCF2L Osteoarthritis
rs11842874 Systolic/diastolic heart failure 0.006287 1.236 MCF2L Osteoarthritis
rs11842874 Cardiomyopathy 0.002331 1.381 MCF2L Osteoarthritis
rs11842874 Disturbances of sulphur-bearing amino-acid metabolism 0.00755 2.281 MCF2L Osteoarthritis
rs11842874 Hyperosmolality and/or hypernatremia 0.006622 1.796 MCF2L Osteoarthritis
rs11842874 Primary/intrinsic cardiomyopathies 0.005869 1.353 MCF2L Osteoarthritis
rs11842874 Nonallopathic lesions NEC 0.008629 0.7928 MCF2L Osteoarthritis
rs11842874 Other disorders of back 0.009436 0.75 MCF2L Osteoarthritis
rs11842874 Disturbances of amino-acid transport 0.009627 2.219 MCF2L Osteoarthritis
rs11856323 Abnormal sputum 0.005807 1.522 CORO2B Cognitive performance
rs11856323 Anomalies of tooth position/malocclusion 0.006806 2.014 CORO2B Cognitive performance
rs11856323 Peripheral angiopathy in diseases classified elsewhere 0.006636 1.938 CORO2B Cognitive performance
rs11856323 Diseases of lips 0.000973 1.927 CORO2B Cognitive performance
rs11856323 Suppurative and unspecified otitis media 0.002542 1.324 CORO2B Cognitive performance
rs11856323 Cholelithiasis with other cholecystitis 0.01088 0.6037 CORO2B Cognitive performance
rs11856323 Ascites (non malignant) 0.001599 1.736 CORO2B Cognitive performance
rs11856323 Chronic pharyngitis and nasopharyngitis 0.009534 1.272 CORO2B Cognitive performance
rs11856323 Chronic sinusitis 0.01143 1.196 CORO2B Cognitive performance
rs11856323 Periostitis 0.01067 2.144 CORO2B Cognitive performance
rs11856323 Primary open angle glaucoma 0.004958 0.6422 CORO2B Cognitive performance
rs11856323 Kyphosis (acquired) 0.001225 1.87 CORO2B Cognitive performance
rs11856323 Eosinophilia 0.001146 2.438 CORO2B Cognitive performance
rs11856323 Fever of unknown origin 0.002796 1.214 CORO2B Cognitive performance
rs11880198 Breast conditions, congenital or relating to hormones 0.009122 1.373 GNA15 Heart failure
rs11880198 Open wound of hand except finger(s) 0.005541 1.349 GNA15 Heart failure
rs11880198 Labyrinthitis 0.002643 1.478 GNA15 Heart failure
rs11880198 Inflammatory and toxic neuropathy 0.002526 1.468 GNA15 Heart failure
rs11880198 Colles' fracture 0.0008353 1.564 GNA15 Heart failure
rs11880198 Fracture of upper limb 0.006086 1.184 GNA15 Heart failure
rs11880198 Fracture of radius and ulna 0.003297 1.245 GNA15 Heart failure
rs11880198 Cramp of limb 0.003678 1.393 GNA15 Heart failure
rs11880198 Periapical abscess 0.00195 1.298 GNA15 Heart failure
rs11880198 Open wound of nose and sinus 0.004353 2.163 GNA15 Heart failure
rs11880198 Pityriasis 0.001354 2.546 GNA15 Heart failure
rs11880198 Frequency of urination and polyuria 0.009332 1.153 GNA15 Heart failure
rs11880198 Diseases of pulp and periapical tissues 0.003206 1.27 GNA15 Heart failure
rs11880198 Corneal dystrophy 0.0009915 1.444 GNA15 Heart failure
rs11880198 Dystrophy of female genital tract 0.003401 2.135 GNA15 Heart failure
rs11898505 Corneal opacity 0.01127 1.333 SPTBN1 Bone mineral density
rs11898505 Depression 0.0008858 0.8861 SPTBN1 Bone mineral density
rs11898505 Fracture of humerus 0.000363 0.7225 SPTBN1 Bone mineral density
rs11898505 Hemangioma and lymphangioma, any site 0.001044 0.7121 SPTBN1 Bone mineral density
rs11898505 Dysmetabolic syndrome X 0.002398 1.514 SPTBN1 Bone mineral density
rs11898505 Psoriasis & related disorders 0.01091 1.221 SPTBN1 Bone mineral density
rs11898505 Pelvic inflammatory disease 0.01103 0.4828 SPTBN1 Bone mineral density
rs11898505 Mood disorders 0.0007651 0.8872 SPTBN1 Bone mineral density
rs11898505 Psoriatic arthropathy 0.00486 1.864 SPTBN1 Bone mineral density
rs11898505 Diseases of lips 0.004964 1.504 SPTBN1 Bone mineral density
rs11898505 Scoliosis 0.01037 1.291 SPTBN1 Bone mineral density
rs11898505 Symptoms involving female genital tract 0.01117 0.7264 SPTBN1 Bone mineral density
rs11898505 Keratoderma, acquired 0.0008561 1.211 SPTBN1 Bone mineral density
rs11957313 Arthropathy associated with infections 0.006998 1.696 KCNIP1 Multiple sclerosis
rs11957313 Precordial pain 0.008596 1.404 KCNIP1 Multiple sclerosis
rs11957313 Congenital anomalies of genital organs 0.007002 2.138 KCNIP1 Multiple sclerosis
rs11957313 Infertility, male 0.006035 2.17 KCNIP1 Multiple sclerosis
rs11957313 Arthralgia/ankylosis of temporomandibular joint 0.004389 1.775 KCNIP1 Multiple sclerosis
rs11957313 CNS infection and poliomyelitis 0.00412 0.2986 KCNIP1 Multiple sclerosis
rs11957313 Other diseases of the teeth and supporting structures 0.00246 1.376 KCNIP1 Multiple sclerosis
rs11957313 Diseases of pancreas 0.004549 0.729 KCNIP1 Multiple sclerosis
rs11957313 Neurological disorders due to brain damage 0.005224 1.19 KCNIP1 Multiple sclerosis
rs11957313 Swelling of limb 0.01097 1.214 KCNIP1 Multiple sclerosis
rs11957313 Male infertility and abnormal spermatozoa 0.006109 1.906 KCNIP1 Multiple sclerosis
rs11957313 Type 2 diabetic nephropathy 0.0115 0.7568 KCNIP1 Multiple sclerosis
rs11957313 Partial epilepsy 0.009134 1.513 KCNIP1 Multiple sclerosis
rs11984075 Elevated prostate specific antigen 0.003694 1.329 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Sensorineural hearing loss 0.002891 1.191 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Secondary malignancy of brain/spine 0.004832 1.912 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Glomerulonephritis 0.0003997 2.249 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Parkinson's disease 0.001387 0.5448 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Benign neoplasm of other parts of digestive system 0.002478 0.5318 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Iron metabolism disorder 0.001663 2.395 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Toxic effect of venom 0.00988 1.706 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Pituitary hyperfunction 0.00278 2.626 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Depression 0.009294 1.153 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Arthropathy NOS involving multiple sites 0.008244 1.837 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Bundle branch block 0.002533 1.366 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Eustachian tube disorders 0.0115 1.356 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Other disorders of metabolic, endocrine, immunity disorders 0.002199 2.403 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Benign neoplasm of breast 0.009804 1.776 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Asthma with exacerbation 0.00311 1.616 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Spondylosis with myelopathy 0.009788 1.519 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Impaction of intestine 0.01041 2.323 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Major depressive disorder 0.008689 1.245 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Other hypertrophic and atrophic conditions of skin 0.007194 1.182 ELMO1 Celiac disease or Rheumatoid arthritis
rs11984075 Chronic prostatitis 0.01059 1.756 ELMO1 Celiac disease or Rheumatoid arthritis
rs11989782 Acute laryngitis and tracheitis 0.004688 0.5991 SNTB1 Eosinophilic esophagitis
rs11989782 Other alveolar and parietoalveolar pneumonopathy 0.003789 1.727 SNTB1 Eosinophilic esophagitis
rs11989782 Cholangitis 0.005224 1.784 SNTB1 Eosinophilic esophagitis
rs11989782 Symptoms involving head and neck 0.01122 0.8214 SNTB1 Eosinophilic esophagitis
rs11989782 Upper gastrointestinal congenital anomalies 0.005521 1.607 SNTB1 Eosinophilic esophagitis
rs11989782 Restless legs syndrome 0.005569 0.7243 SNTB1 Eosinophilic esophagitis
rs11989782 Esophageal atresia/tracheoesophageal fistula 0.006192 1.738 SNTB1 Eosinophilic esophagitis
rs11989782 Cardiac defibrillator in situ 0.001252 0.5649 SNTB1 Eosinophilic esophagitis
rs11989782 Other signs and symptoms in breast 0.002866 0.6463 SNTB1 Eosinophilic esophagitis
rs11989782 Osteoporosis 0.008491 0.8698 SNTB1 Eosinophilic esophagitis
rs11989782 Atrophy of edentulous alveolar ridge 0.006333 1.526 SNTB1 Eosinophilic esophagitis
rs11989782 Diverticulitis 0.004399 1.261 SNTB1 Eosinophilic esophagitis
rs11989782 Amblyopia 0.001651 1.444 SNTB1 Eosinophilic esophagitis
rs11989782 Osteoporosis, NOS or other 0.006812 0.8694 SNTB1 Eosinophilic esophagitis
rs1202199 Viral hepatitis 0.008388 1.434 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Other cerebral degenerations 0.008161 0.4392 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Hodgkin's disease 0.007458 2.112 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Facial nerve disorders 0.002898 1.686 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Cancer of other lymphoid, histiocytic tissue 0.009393 1.41 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Vascular disorders of penis 0.002695 3.094 MBOAT1 Hyperactive-impulsive symptoms
rs1202199 Congenital anomalies of genital organs 0.01111 2.218 MBOAT1 Hyperactive-impulsive symptoms
rs12075 Postmenopausal atrophic vaginitis 0.01105 0.8154 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Blood vessel replaced 0.01043 1.509 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Fracture of ribs 0.005626 1.243 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Deep vein thrombosis 0.005533 1.269 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Fracture of humerus 0.005997 1.25 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Chronic obstructive asthma 0.006249 0.7736 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Swelling of limb 0.006359 0.8541 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Abnormal pulmonary function 0.001779 0.3299 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Osteoarthrosis, generalized 0.01091 1.192 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12075 Acquired hemolytic anemias 0.009433 0.4916 DARC White blood cell count, Monocyte chemoattractant protein-1
rs12141391 Mechanical complication due to other implant and internal device 0.009949 1.901 NEGR1 Systemic lupus erythematosus
rs12141391 Other diseases of respiratory system 0.001988 2.259 NEGR1 Systemic lupus erythematosus
rs12141391 Premature beats 0.01079 1.574 NEGR1 Systemic lupus erythematosus
rs12141391 Atrial fibrillation 0.003756 1.46 NEGR1 Systemic lupus erythematosus
rs12141391 Osteoarthrosis NOS 0.01083 1.282 NEGR1 Systemic lupus erythematosus
rs12141391 Traumatic arthropathy 0.006235 2.653 NEGR1 Systemic lupus erythematosus
rs12141391 Lung involvement in conditions classified elsewhere 0.001438 4.298 NEGR1 Systemic lupus erythematosus
rs12141391 Abnormal electrocardiogram 0.01074 1.469 NEGR1 Systemic lupus erythematosus
rs12141391 Respiratory insufficiency 0.009869 0.2713 NEGR1 Systemic lupus erythematosus
rs12141391 Hemorrhage of rectum and anus 0.0008837 1.752 NEGR1 Systemic lupus erythematosus
rs12141391 Atrial fibrillation & flutter 0.003216 1.462 NEGR1 Systemic lupus erythematosus
rs12141391 Other congenital anomalies of skin 0.004142 2.279 NEGR1 Systemic lupus erythematosus
rs12141391 Blindness and low vision 0.00875 1.871 NEGR1 Systemic lupus erythematosus
rs12141391 Conjunctivitis, infectious 0.005763 1.537 NEGR1 Systemic lupus erythematosus
rs12141391 Ingrowing nail 0.007017 1.507 NEGR1 Systemic lupus erythematosus
rs12141391 Other specified diseases of sebaceous glands 0.004092 1.706 NEGR1 Systemic lupus erythematosus
rs12141391 Fracture of clavicle or scapula 0.007142 2.112 NEGR1 Systemic lupus erythematosus
rs12141391 Cystoid macular degeneration of retina 0.003886 2.001 NEGR1 Systemic lupus erythematosus
rs12141391 Vitamin deficiency 0.008013 0.5416 NEGR1 Systemic lupus erythematosus
rs12203592 Vitamin B-complex deficiencies 0.004681 1.311 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Seborrheic keratosis 3.296e-05 1.23 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Diseases of sebaceous glands 0.002376 1.169 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other specified nonpsychotic and/or transient mental disorders 0.00306 1.354 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Carcinoma in situ of skin 2.068e-10 1.874 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Melanoma 0.001373 1.425 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other specified erythematous conditions 0.009986 1.406 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other acquired musculoskeletal deformity 0.000281 1.433 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Skin cancer 1.106e-16 1.457 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Celiac disease 0.008204 0.2596 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Celiac or tropical sprue 0.005924 0.2458 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Erythematous conditions 0.002257 1.201 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Open wounds of extremities 0.005778 1.167 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Patellar fracture 0.003461 0.5029 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Sebaceous cyst 0.008181 1.18 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Disorders of the autonomic nervous system 0.00642 0.6435 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Non-melanoma skin cancer 3.818e-17 1.495 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Benign neoplasm of eye 1.734e-05 1.544 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Personal history of allergy to medicinal agents 0.004581 1.392 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Rosacea 0.00112 1.312 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Frequency of urination and polyuria 0.006087 1.176 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other specified diseases of sebaceous glands 0.006917 1.316 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Osteopenia 6.837e-05 1.271 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Skin neoplasm of uncertain behavior 1.029e-06 1.487 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Congenital anomalies of intestine 0.007945 2.302 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Mental disorders due to brain damage 0.0007803 1.42 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other disorders of intestine 0.009831 1.236 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Actinic keratosis 4.141e-26 1.691 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Gastrointestinal complications 0.01093 1.321 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Chronic tonsillitis and adenoiditis 0.003334 1.948 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Other dermatoses 1.825e-10 1.327 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Inflammation of the eye 0.004008 1.172 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Benign neoplasm of skin 0.0002758 0.8237 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Osteoporosis, osteopenia, & pathological fractures 0.0001521 1.195 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Voice disturbance 0.004223 1.297 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Neoplasm of uncertain behavior 0.0004348 1.317 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Photodermatitis & sunburn 6.352e-06 1.44 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12203592 Brain cancer 0.006601 0.4067 IRF4 Eye color, Hair color, Freckling, Progressive supranuclear palsy
rs12210050 Viral warts & HPV 0.0005464 1.264 EXOC2 Basal cell carcinoma, Tanning
rs12210050 H. pylori 0.00491 1.655 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Skin cancer 1.156e-09 1.315 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Other dermatoses 0.0003925 1.168 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Other symptoms referable to back 0.003584 0.6891 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Rosacea 0.002618 1.274 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Lipoid metabolism disorder NOS 0.009263 1.349 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Carcinoma in situ of skin 3.348e-08 1.713 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Open wound of nose and sinus 0.008493 2.11 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Failure to thrive 0.002362 1.554 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Actinic keratosis 1.937e-08 1.318 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Non-melanoma skin cancer 5.952e-09 1.318 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Diseases of the larynx and vocal cords 0.004636 1.243 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Chronic obstructive asthma 0.01089 1.339 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Photodermatitis & sunburn 0.01142 1.218 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Seborheic dermatitis 0.003478 1.262 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Osteopenia 0.0001865 1.242 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Voice disturbance 0.008658 1.26 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Skin neoplasm of uncertain behavior 0.0008494 1.322 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Disorders of mineral metabolism 0.004047 1.2 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Allergy/adverse effect of penicillin 0.006033 1.305 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Hypercalcemia 0.0007001 1.419 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Osteoporosis, osteopenia, & pathological fractures 0.008136 1.129 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Lack of normal physiological development 0.009643 1.424 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Melanoma 0.00025 1.475 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Herpes simplex 0.004098 1.41 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Benign neoplasm of skin 0.001212 0.8476 EXOC2 Basal cell carcinoma, Tanning
rs12210050 Neoplasm of uncertain behavior 0.003933 1.252 EXOC2 Basal cell carcinoma, Tanning
rs12212193 Complications of transplants and reattached limbs 0.006691 0.614 BACH2 Multiple sclerosis
rs12212193 Tuberculosis 0.008879 0.5053 BACH2 Multiple sclerosis
rs12212193 Otorrhea 0.009137 0.5016 BACH2 Multiple sclerosis
rs12212193 Hypertrophy of female genital organs 0.01099 0.5868 BACH2 Multiple sclerosis
rs12212193 Hypothyroidism 0.002722 1.113 BACH2 Multiple sclerosis
rs12212193 Gouty arthropathy 0.002098 1.346 BACH2 Multiple sclerosis
rs12212193 Cramp of limb 0.009361 0.7685 BACH2 Multiple sclerosis
rs12212193 Nonrheumatic pulmonary valve disorders 0.003177 0.5785 BACH2 Multiple sclerosis
rs12212193 Aneurysm of artery of lower extremity 0.007234 1.53 BACH2 Multiple sclerosis
rs12212193 Other anemias 0.005751 1.088 BACH2 Multiple sclerosis
rs12212193 Anemia NOS 0.002672 1.103 BACH2 Multiple sclerosis
rs12251307 Peritonitis and retroperitoneal infections 0.009657 1.543 IL2RA Type 1 diabetes
rs12251307 Acute laryngitis and tracheitis 0.003309 1.752 IL2RA Type 1 diabetes
rs12251307 Atopic or contact dermatitis 1.436e-05 1.265 IL2RA Type 1 diabetes
rs12251307 Dyshidrosis 0.0001473 2.257 IL2RA Type 1 diabetes
rs12251307 Other disorders of soft tissues 0.007441 1.572 IL2RA Type 1 diabetes
rs12251307 Anisometropia 0.0005892 0.5047 IL2RA Type 1 diabetes
rs12251307 Congenital anomalies of genital organs 0.008604 2.148 IL2RA Type 1 diabetes
rs12251307 Diverticulosis and diverticulitis 0.003525 1.189 IL2RA Type 1 diabetes
rs12251307 Diverticulosis 0.00821 1.181 IL2RA Type 1 diabetes
rs12251307 Influenza 0.002002 1.542 IL2RA Type 1 diabetes
rs12251307 Seborheic dermatitis 0.006841 1.278 IL2RA Type 1 diabetes
rs12279261 Nerve plexus lesions 0.006389 1.53 NCAM1 Entorhinal cortical thickness
rs12279261 Benign neoplasm of unspecified sites 0.008078 2.152 NCAM1 Entorhinal cortical thickness
rs12279261 Cancer of oropharynx 0.004983 2.205 NCAM1 Entorhinal cortical thickness
rs12279261 Polyarteritis nodosa and allied conditions 0.0029 1.466 NCAM1 Entorhinal cortical thickness
rs12279261 Benign neoplasm of colon 0.0004711 1.162 NCAM1 Entorhinal cortical thickness
rs12279261 Renal colic 0.001031 1.958 NCAM1 Entorhinal cortical thickness
rs12279261 Abnormal findings on study of brain, nervous system 0.009693 0.5068 NCAM1 Entorhinal cortical thickness
rs12279261 Peritoneal or intestinal adhesions 0.00199 1.841 NCAM1 Entorhinal cortical thickness
rs12279261 Hydronephrosis 0.006255 1.412 NCAM1 Entorhinal cortical thickness
rs12279261 Giant cell arteritis 0.002178 1.712 NCAM1 Entorhinal cortical thickness
rs12279261 Abnormal cytological, histological, immunological and DNA test findings 0.002668 2.029 NCAM1 Entorhinal cortical thickness
rs12279261 Ileostomy status 0.009083 1.671 NCAM1 Entorhinal cortical thickness
rs12279261 Symptoms involving respiratory system 0.007122 0.7624 NCAM1 Entorhinal cortical thickness
rs12279261 Cervical cancer and dysplasia 0.003715 1.402 NCAM1 Entorhinal cortical thickness
rs12279261 Diseases of spleen 0.001776 2.119 NCAM1 Entorhinal cortical thickness
rs12279261 Polycystic ovaries 0.009025 2.133 NCAM1 Entorhinal cortical thickness
rs12279261 Abnormal tumor markers, elevated CEA or CA 125 0.0006471 2.543 NCAM1 Entorhinal cortical thickness
rs12279261 Pituitary hyperfunction 0.0006351 2.621 NCAM1 Entorhinal cortical thickness
rs12279261 Stricture/obstruction of ureter 0.002027 1.649 NCAM1 Entorhinal cortical thickness
rs12279261 Osteoarthrosis, generalized 0.0009477 0.7169 NCAM1 Entorhinal cortical thickness
rs12279261 Hypovolemia 0.01132 0.861 NCAM1 Entorhinal cortical thickness
rs12279261 Disorders of fluid, electrolyte, and acid-base balance 0.004491 0.8881 NCAM1 Entorhinal cortical thickness
rs12279261 Oliguria and anuria 0.008738 2.234 NCAM1 Entorhinal cortical thickness
rs12295638 Acquired foot deformities 0.004183 0.8129 ANO3 Extreme obesity
rs12295638 Atrophic gastritis 0.008329 1.683 ANO3 Extreme obesity
rs12295638 Infections of kidney 0.0004113 1.693 ANO3 Extreme obesity
rs12295638 Schizophrenia and other psychotic disorders 0.009516 1.298 ANO3 Extreme obesity
rs12295638 E. coli 0.0005413 1.653 ANO3 Extreme obesity
rs12295638 Skin neoplasm of uncertain behavior 0.004805 0.6878 ANO3 Extreme obesity
rs12295638 Pituitary hypofunction 0.0106 2.084 ANO3 Extreme obesity
rs12295638 Cystitis and urethritis 0.005881 1.337 ANO3 Extreme obesity
rs12295638 Male genital disorders 0.001627 0.5315 ANO3 Extreme obesity
rs12295638 Cornea replaced by transplant 0.0006231 2.47 ANO3 Extreme obesity
rs12295638 Lesions of stomach and duodenum 0.008739 2.233 ANO3 Extreme obesity
rs12295638 Acquired deformities of ankle and foot 0.009301 0.6965 ANO3 Extreme obesity
rs12295638 Cystitis 0.005688 1.363 ANO3 Extreme obesity
rs12413409 Fluid overload 0.00605 1.449 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Aplastic anemia 0.003108 1.621 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Calculus of bile duct 0.01014 1.526 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Hemorrhage from gastrointestinal ulcer 0.008573 0.48 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Cholelithiasis 0.002114 1.266 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Fracture of vertebral column without mention of spinal cord injury 0.001373 1.443 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Acute pericarditis 0.0008842 2.895 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Arthropathy associated with infections 0.0015 2.016 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Nontoxic uninodular goiter 0.009767 1.363 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Other specified osteoporosis 0.003042 2.101 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Cholelithiasis and cholecystitis 0.00924 1.209 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Other abnormal blood chemistry 0.01019 1.193 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Inflammatory spondylopathies 0.00197 1.905 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Strabismus (not specified as paralytic) 0.004401 0.6331 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Aneurysm of iliac artery 0.002835 2.207 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Hypotony of eye 0.005063 2.643 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Blood vessel replaced 0.01049 0.2711 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Cardiomyopathy 0.0102 0.733 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Hemangioma and lymphangioma, any site 0.003919 1.504 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12413409 Alopecia 0.01009 1.484 CNNM2 Intracranial aneurysm, Coronary heart disease
rs12418204 Fracture of clavicle or scapula 0.008135 1.774 PDE2A Optic disc parameters
rs12418204 Disorders resulting from impaired renal function 0.00748 1.603 PDE2A Optic disc parameters
rs12418204 Chronic glomerulonephritis 0.001699 3.494 PDE2A Optic disc parameters
rs12418204 Lower gastrointestinal congenital anomalies 0.009735 2.416 PDE2A Optic disc parameters
rs12418204 Osteoarthrosis, generalized 0.003289 0.59 PDE2A Optic disc parameters
rs12418204 Nephritis & nephropathy 0.001678 2.413 PDE2A Optic disc parameters
rs12418204 Dentofacial anomalies, including malocclusion 0.009606 2.011 PDE2A Optic disc parameters
rs12418204 Osteomyelitis 0.008532 1.574 PDE2A Optic disc parameters
rs12418204 Osteoarthritis; localized 0.01063 0.7795 PDE2A Optic disc parameters
rs12418204 Thrombocytopenia 0.006571 0.6556 PDE2A Optic disc parameters
rs12418204 Psychogenic and somatoform disorders 0.008863 1.527 PDE2A Optic disc parameters
rs12418204 Anomalies of tooth position/malocclusion 0.0078 2.233 PDE2A Optic disc parameters
rs12420464 Anisometropia 0.001737 1.631 EIF3F Depression
rs12420464 Eye infection, viral 0.002174 1.778 EIF3F Depression
rs12420464 Other disorders of adrenal glands 0.01095 1.803 EIF3F Depression
rs12420464 Congenital anomalies of face and neck 0.001321 3.241 EIF3F Depression
rs12420464 Stiffness of joint 0.007638 1.356 EIF3F Depression
rs12420464 Diverticulosis and diverticulitis 0.008156 1.204 EIF3F Depression
rs12423712 Epilepsy 0.003954 1.663 NCOR2 Cognitive performance
rs12423712 Stiffness of joint 0.009931 1.348 NCOR2 Cognitive performance
rs12423712 Congenital cataract and lens anomalies 7.535e-05 3.263 NCOR2 Cognitive performance
rs12423712 Urinary obstruction 0.00296 1.791 NCOR2 Cognitive performance
rs12423712 Encounter for long-term use of antiplatelets/antithrombotics 0.008917 2.719 NCOR2 Cognitive performance
rs12423712 Seborheic dermatitis 0.01073 0.6978 NCOR2 Cognitive performance
rs12423712 Mitral valve stenosis and/or aortic valve stenosis 0.003523 0.5954 NCOR2 Cognitive performance
rs12423712 Open wound of hand except finger(s) 0.01151 1.474 NCOR2 Cognitive performance
rs12423712 Trigeminal nerve disorders 0.00138 1.93 NCOR2 Cognitive performance
rs12423712 Essential hypertension 0.006833 0.8573 NCOR2 Cognitive performance
rs12423712 Partial epilepsy 0.009608 1.689 NCOR2 Cognitive performance
rs12423712 Secondary malignant neoplasm of digestive systems 0.008113 0.2135 NCOR2 Cognitive performance
rs12423712 Inflammatory and toxic neuropathy 0.005593 1.653 NCOR2 Cognitive performance
rs12423712 Subarachnoid hemorrhage 0.0004281 2.98 NCOR2 Cognitive performance
rs12423712 Hallux valgus (Bunion) 0.008342 1.345 NCOR2 Cognitive performance
rs12423712 Multiple sclerosis 0.01115 1.834 NCOR2 Cognitive performance
rs12423712 Hypertension 0.005088 0.8528 NCOR2 Cognitive performance
rs12423712 Large cell lymphoma 0.002815 2.635 NCOR2 Cognitive performance
rs12447690 Macular degeneration, wet 0.004178 0.7261 ZNF469 Central corneal thickness
rs12447690 Adverse effects of hormones and synthetic substitutes 0.008422 0.3764 ZNF469 Central corneal thickness
rs12447690 Glossitis 0.01143 0.467 ZNF469 Central corneal thickness
rs12447690 Excessive or frequent menstruation 0.01111 0.7709 ZNF469 Central corneal thickness
rs12447690 Other specified osteoporosis 0.00313 0.5343 ZNF469 Central corneal thickness
rs12447690 Crystal arthropathies 0.005734 0.7118 ZNF469 Central corneal thickness
rs12447690 Umbilical hernia 0.001563 1.328 ZNF469 Central corneal thickness
rs12447690 Premenstrual tension syndromes 0.005189 0.528 ZNF469 Central corneal thickness
rs12447690 Calcium/phosphorus disorders 0.002786 0.8092 ZNF469 Central corneal thickness
rs12447690 Disorders of choroid 0.001068 0.7124 ZNF469 Central corneal thickness
rs12447690 Chondrocalcinosis 0.004989 0.7045 ZNF469 Central corneal thickness
rs12447690 Abnormal function study of cardiovascular system 0.002618 0.8266 ZNF469 Central corneal thickness
rs12483205 Chronic pain syndrome 0.00714 0.4749 DYRK1A HIV-1 progression
rs12483205 Retinal vascular changes and abnomalities 0.005329 0.7738 DYRK1A HIV-1 progression
rs12483205 Abnormal findings on examination of urine 0.009419 0.8329 DYRK1A HIV-1 progression
rs12483205 Memory loss 0.00858 1.254 DYRK1A HIV-1 progression
rs12483205 Cardiomyopathy 0.00469 0.8058 DYRK1A HIV-1 progression
rs12483205 Congenital musculoskeletal deformities of spine 0.005595 0.6183 DYRK1A HIV-1 progression
rs12483205 Symptoms involving female genital tract 0.002263 1.472 DYRK1A HIV-1 progression
rs12483205 Intestinal malabsorption 0.003505 1.442 DYRK1A HIV-1 progression
rs12483205 Lymphadenitis 0.005321 1.209 DYRK1A HIV-1 progression
rs12483205 Primary/intrinsic cardiomyopathies 0.001924 0.7821 DYRK1A HIV-1 progression
rs12483205 Peripheral or central vertigo 0.005088 1.242 DYRK1A HIV-1 progression
rs12483205 Acute cystitis 0.008367 0.658 DYRK1A HIV-1 progression
rs12483205 Psoriasis vulgaris 0.008541 1.275 DYRK1A HIV-1 progression
rs12483205 Respiratory failure; insufficiency; arrest 0.003464 0.7923 DYRK1A HIV-1 progression
rs12483205 Viral warts & HPV 0.00817 1.171 DYRK1A HIV-1 progression
rs12483205 Infertility, male 0.005105 2.003 DYRK1A HIV-1 progression
rs12483205 Celiac disease 0.007278 1.798 DYRK1A HIV-1 progression
rs12483205 Retinal detachments and defects 0.007271 1.25 DYRK1A HIV-1 progression
rs12483205 Other nonspecific findings on examination of urine 0.001201 0.767 DYRK1A HIV-1 progression
rs12531488 Left bundle branch block 0.0002537 0.6706 LOC643308 Grey matter density
rs12531488 Somatoform disorder 0.003426 1.39 LOC643308 Grey matter density
rs12531488 Calculus of kidney 0.002383 1.209 LOC643308 Grey matter density
rs12531488 Cancer of other male genital organs 0.004635 1.801 LOC643308 Grey matter density
rs12531488 Open wound of eye or eyelid 0.00544 2.019 LOC643308 Grey matter density
rs12531488 Peripheral retinal degenerations 0.004068 1.342 LOC643308 Grey matter density
rs12531488 Myalgia and myositis NOS 0.0081 1.124 LOC643308 Grey matter density
rs12531488 Psychogenic and somatoform disorders 0.005336 1.29 LOC643308 Grey matter density
rs12531488 Bundle branch block 0.007678 0.8169 LOC643308 Grey matter density
rs12531488 Abnormal movement 0.007148 0.89 LOC643308 Grey matter density
rs12531488 Angina pectoris 0.009771 1.138 LOC643308 Grey matter density
rs12531488 Malignant neoplasm of brain and nervous system 0.0004201 0.5526 LOC643308 Grey matter density
rs12531488 Paroxysmal ventricular tachycardia 0.007962 0.7546 LOC643308 Grey matter density
rs12531488 Glaucoma 0.005099 1.132 LOC643308 Grey matter density
rs12559632 Synoviopathy 0.01048 0.7037 PHEX Fetal hemoglobin
rs12559632 Glomerulonephritis 0.004487 1.922 PHEX Fetal hemoglobin
rs12559632 Swelling, mass, or lump in head and neck 0.008488 1.281 PHEX Fetal hemoglobin
rs12559632 Sleep related movement disorders 0.005928 0.7368 PHEX Fetal hemoglobin
rs12559632 Blood in stool 0.01042 0.8347 PHEX Fetal hemoglobin
rs12559632 Renal cell carcinoma 0.002876 1.518 PHEX Fetal hemoglobin
rs12559632 Hemorrhoids 0.001766 0.8509 PHEX Fetal hemoglobin
rs12559632 Type 2 diabetic peripheral circulatory disorders 0.0003294 1.694 PHEX Fetal hemoglobin
rs12559632 Mastoiditis 0.0019 2.581 PHEX Fetal hemoglobin
rs12559632 Cancer of kidney and renal pelvis 0.00169 1.546 PHEX Fetal hemoglobin
rs12559632 Osteoarthrosis, generalized 0.001689 0.75 PHEX Fetal hemoglobin
rs12559632 Magnesium metabolism disorder 0.003173 1.428 PHEX Fetal hemoglobin
rs12559632 Obesity 0.00809 0.8938 PHEX Fetal hemoglobin
rs12559632 Thyrotoxicosis 0.0004571 0.7007 PHEX Fetal hemoglobin
rs12559632 Restless legs syndrome 0.01123 0.7221 PHEX Fetal hemoglobin
rs12569163 Throat pain 0.0004422 1.924 WDR64 Radiation response
rs12569163 Thyrotoxicosis 0.01005 1.258 WDR64 Radiation response
rs12569163 Spondylosis with myelopathy 0.008678 1.414 WDR64 Radiation response
rs12569163 Renal colic 0.0008711 1.921 WDR64 Radiation response
rs12569163 Other forms of chronic heart disease 0.006201 1.23 WDR64 Radiation response
rs12569163 Premature beats 0.007863 1.212 WDR64 Radiation response
rs12569163 Septicemia 0.005178 1.217 WDR64 Radiation response
rs12569163 Esophageal atresia/tracheoesophageal fistula 0.001356 1.929 WDR64 Radiation response
rs12569163 Hematemesis 0.005168 1.67 WDR64 Radiation response
rs12569163 Muscular wasting and disuse atrophy 0.009454 1.636 WDR64 Radiation response
rs12569163 Erectile dysfunction 0.0003188 1.28 WDR64 Radiation response
rs12569163 Noninflammatory female genital disorders 0.00537 0.7934 WDR64 Radiation response
rs12569163 Pallor and flushing 0.009736 1.441 WDR64 Radiation response
rs12569163 Other conditions of the mother complicating pregnancy 0.007506 1.72 WDR64 Radiation response
rs12569163 Supraventricular premature beats 0.007182 1.398 WDR64 Radiation response
rs12569163 Disorders of external ear 0.004096 0.4272 WDR64 Radiation response
rs12576239 Gouty arthropathy 0.001848 1.462 KCNQ1 QT interval
rs12576239 Cerebral atherosclerosis 0.00834 1.802 KCNQ1 QT interval
rs12576239 Poisoning by primarily systemic agents 0.01093 1.384 KCNQ1 QT interval
rs12576239 Adverse effects of antineoplastic and immunosuppressive drugs 0.01087 1.395 KCNQ1 QT interval
rs12576239 Contracture of joint 0.008848 0.568 KCNQ1 QT interval
rs12576239 Scar conditions and fibrosis of skin 0.002154 1.47 KCNQ1 QT interval
rs12576239 Urethral hypermobility/ISD 0.004367 1.808 KCNQ1 QT interval
rs12576239 Other symptoms referable to back 0.009245 0.7197 KCNQ1 QT interval
rs12576239 Paralysis/spasm of vocal cords or larynx 0.0006975 1.968 KCNQ1 QT interval
rs12576239 Thoracic neuritis/radiculitis 0.006734 0.8519 KCNQ1 QT interval
rs12608932 Althete's foot 8.592e-05 0.689 UNC13A Amyotrophic lateral sclerosis
rs12608932 Tachycardia NOS 0.007242 0.8311 UNC13A Amyotrophic lateral sclerosis
rs12608932 Hemangioma and lymphangioma, any site 0.002266 1.338 UNC13A Amyotrophic lateral sclerosis
rs12608932 Other disorders of arteries and arterioles 0.0009968 1.323 UNC13A Amyotrophic lateral sclerosis
rs12608932 Cancer of larynx 0.01023 1.451 UNC13A Amyotrophic lateral sclerosis
rs12608932 Cancer of connective tissue 0.00217 0.5115 UNC13A Amyotrophic lateral sclerosis
rs12608932 Frequency of urination and polyuria 0.003902 0.8745 UNC13A Amyotrophic lateral sclerosis
rs12608932 Stricture of artery 0.0002466 1.454 UNC13A Amyotrophic lateral sclerosis
rs12608932 Lymphadenitis 0.007198 0.8388 UNC13A Amyotrophic lateral sclerosis
rs12608932 Abnormal loss of weight and underweight 0.007706 0.768 UNC13A Amyotrophic lateral sclerosis
rs12608932 Seborheic dermatitis 0.004393 0.8272 UNC13A Amyotrophic lateral sclerosis
rs12608932 Abnormal movement 0.00479 0.8912 UNC13A Amyotrophic lateral sclerosis
rs12608932 Adrenal hypofunction 0.01116 1.577 UNC13A Amyotrophic lateral sclerosis
rs12608932 Noninfectious disorders of lymphatic channels 0.004538 0.7208 UNC13A Amyotrophic lateral sclerosis
rs12608932 Malignant neoplasm of ovary 0.002285 0.5005 UNC13A Amyotrophic lateral sclerosis
rs12608932 Left bundle branch block 0.009791 1.272 UNC13A Amyotrophic lateral sclerosis
rs12608932 Bacteremia 0.001054 0.7087 UNC13A Amyotrophic lateral sclerosis
rs12608932 Obsessive-compulsive disorder 0.006559 0.5163 UNC13A Amyotrophic lateral sclerosis
rs12608932 Early or threatened labor; hemorrhage in early pregnancy 0.003086 1.711 UNC13A Amyotrophic lateral sclerosis
rs12608932 Secondary malignant neoplasm of liver 0.008655 0.7115 UNC13A Amyotrophic lateral sclerosis
rs12608932 Prurigo 0.0107 0.7774 UNC13A Amyotrophic lateral sclerosis
rs12608932 Vascular disorders of penis 0.008888 0.3858 UNC13A Amyotrophic lateral sclerosis
rs12608932 Anterior pituitary disorders 0.0007754 1.873 UNC13A Amyotrophic lateral sclerosis
rs12608932 Nephritis and nephropathy in diseases classified elsewhere 0.008629 0.768 UNC13A Amyotrophic lateral sclerosis
rs12608932 Anisometropia 0.0101 0.7567 UNC13A Amyotrophic lateral sclerosis
rs12643654 Diseases of respiratory system 0.0002842 1.358 UNC5C Phosphorylated tau
rs12643654 Gouty arthropathy 0.009337 1.46 UNC5C Phosphorylated tau
rs12643654 Hemorrhage NOS 0.002131 2.085 UNC5C Phosphorylated tau
rs12643654 Disorders of esophageal motility 0.002339 1.792 UNC5C Phosphorylated tau
rs12643654 Noninflammatory disorders of vulva and perineum 0.01024 1.71 UNC5C Phosphorylated tau
rs12643654 Symptoms involving respiratory system 0.00116 1.397 UNC5C Phosphorylated tau
rs12643654 Allergic conjunctivitis 0.002383 1.502 UNC5C Phosphorylated tau
rs12643654 Bronchitis 0.004372 1.255 UNC5C Phosphorylated tau
rs12643654 Lung cancer 0.0006083 1.479 UNC5C Phosphorylated tau
rs12643654 Cataract 0.001198 0.8165 UNC5C Phosphorylated tau
rs12643654 Lower gastrointestinal congenital anomalies 0.01127 2.082 UNC5C Phosphorylated tau
rs12643654 Urticaria 0.001106 1.482 UNC5C Phosphorylated tau
rs12643654 Salicylates causing adverse effects in therapeutic use 0.004916 2.373 UNC5C Phosphorylated tau
rs12643654 Acute upper respiratory infections 0.005313 1.174 UNC5C Phosphorylated tau
rs12643654 Spinal stenosis of lumbar region 0.004122 1.251 UNC5C Phosphorylated tau
rs12643654 Spontaneous ecchymoses 0.004136 1.938 UNC5C Phosphorylated tau
rs12643654 Cholelithiasis and cholecystitis 0.003861 0.7928 UNC5C Phosphorylated tau
rs12643654 Nasal polyps 0.0008247 1.692 UNC5C Phosphorylated tau
rs12643654 Cancer within the respiratory system 0.0006836 1.467 UNC5C Phosphorylated tau
rs12643654 Other specified disorders of pancreatic internal secretion 0.01095 1.913 UNC5C Phosphorylated tau
rs12643654 Cholelithiasis 0.003701 0.7777 UNC5C Phosphorylated tau
rs12643654 Acute pharyngitis 0.006391 1.263 UNC5C Phosphorylated tau
rs12644284 Periodontitis (acute or chronic) 0.005224 1.246 TRIM2 Multiple sclerosis (severity)
rs12644284 Myeloproliferative disease 0.007692 1.367 TRIM2 Multiple sclerosis (severity)
rs12644284 Hypersomnia 0.005662 0.6053 TRIM2 Multiple sclerosis (severity)
rs12644284 Chronic tonsillitis and adenoiditis 0.008729 1.669 TRIM2 Multiple sclerosis (severity)
rs12644284 Sacroiliitis NEC 0.01009 0.4696 TRIM2 Multiple sclerosis (severity)
rs12644284 Paralytic strabismus 0.001182 1.636 TRIM2 Multiple sclerosis (severity)
rs12644284 Cholangitis 0.002933 0.4163 TRIM2 Multiple sclerosis (severity)
rs12644284 Abnormality of red blood cells 0.005331 1.983 TRIM2 Multiple sclerosis (severity)
rs12644284 Other disorders of the nervous system 0.001354 1.653 TRIM2 Multiple sclerosis (severity)
rs12644284 Gram negative septicemia 0.004916 0.6468 TRIM2 Multiple sclerosis (severity)
rs12644284 Mastodynia 0.01014 1.272 TRIM2 Multiple sclerosis (severity)
rs12658202 Asthma with exacerbation 0.003962 0.7086 GRIA1 Height
rs12658202 Reticulosarcoma 0.003716 1.706 GRIA1 Height
rs12658202 Inflammatory disease of cervix, vagina, and vulva 0.006182 0.8451 GRIA1 Height
rs12658202 Acquired toe deformities 0.007742 0.8567 GRIA1 Height
rs12658202 Mucous polyp of cervix 0.01017 1.37 GRIA1 Height
rs12658202 Vaginitis and vulvovaginitis 0.009936 0.8362 GRIA1 Height
rs12658202 Bladder cancer 0.004707 1.284 GRIA1 Height
rs12658202 Polyp of female genital organs 0.002258 1.293 GRIA1 Height
rs12658202 Polyp of corpus uteri 0.004914 1.397 GRIA1 Height
rs12658202 Adverse effects of antilipemic and antiarteriosclerotic drugs 0.01137 0.4677 GRIA1 Height
rs12658202 Bladder cancer and neoplasms 0.008312 1.255 GRIA1 Height
rs12658202 Other rheumatic heart disease 0.01138 1.867 GRIA1 Height
rs12658202 Nonrheumatic aortic valve disorders 0.009452 1.15 GRIA1 Height
rs12658202 Deficiency of humoral immunity 0.01019 2.014 GRIA1 Height
rs12658202 Heart transplant/surgery 0.01049 1.405 GRIA1 Height
rs12658202 Hallux rigidus 0.005851 0.7056 GRIA1 Height
rs12658202 Gastritis and duodenitis, NOS 0.004862 1.23 GRIA1 Height
rs12720356 Throat pain 0.002114 2.096 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Ileostomy status 0.00504 1.934 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Disorders of binocular eye movements 0.009563 0.7065 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Dyspareunia 0.009175 1.911 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Respiratory failure; insufficiency; arrest 0.0004713 1.419 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Electrolyte imbalance 0.004446 1.185 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Atrophic gastritis 0.004887 1.782 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Polyp of corpus uteri 0.007218 1.622 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Neck pain 0.0007905 1.221 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Hyperpotassemia 0.00144 1.387 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Disorders of fluid, electrolyte, and acid-base balance 0.009556 1.147 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Respiratory failure 0.005926 1.451 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Septicemia 0.007053 1.299 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Pneumonia 0.005838 1.193 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Benign neoplasm of other endocrine glands 0.001243 0.2893 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Cancer of oropharynx 0.004373 2.544 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Other conditions of brain 0.007609 1.514 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Hypovolemia 0.006767 1.214 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Sexually transmitted infections 0.0006784 2.824 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Localized adiposity 0.008083 2.297 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 E. coli 0.009151 1.508 TYK2 Psoriasis vulgaris, Crohn's disease
rs12720356 Aphakia and other disorders of lens 0.003716 0.5441 TYK2 Psoriasis vulgaris, Crohn's disease
rs12797755 Sicca syndrome 0.004244 1.953 GRIK4 Cognitive performance
rs12797755 Blood vessel replaced 0.01032 1.975 GRIK4 Cognitive performance
rs12797755 Edema 0.01142 0.8177 GRIK4 Cognitive performance
rs12797755 Candidiasis 0.01028 1.359 GRIK4 Cognitive performance
rs12797755 Vascular disorders of kidney/hypertrophy 0.004558 2.817 GRIK4 Cognitive performance
rs12797755 Peripheral enthesopathies 0.002746 0.8099 GRIK4 Cognitive performance
rs12797755 Random mental disorder. Ignored for now 0.007969 1.958 GRIK4 Cognitive performance
rs12797755 Swelling of limb 0.0008719 0.625 GRIK4 Cognitive performance
rs12807809 Ill-defined descriptions and complications of heart disease 0.003972 0.8584 NRGN Schizophrenia
rs12807809 Conjunctivitis, infectious 0.004605 0.8045 NRGN Schizophrenia
rs12807809 Symptoms/disorders of the urinary system 0.0005583 0.8685 NRGN Schizophrenia
rs12807809 Alzheimer's disease 0.00968 0.803 NRGN Schizophrenia
rs12807809 Cardiac pacemaker in situ 0.01069 0.7635 NRGN Schizophrenia
rs12807809 Cardiac pacemaker/device in situ 0.009728 0.7751 NRGN Schizophrenia
rs12807809 Mechanical complication of nervous system device, implant, and graft 0.003126 2.23 NRGN Schizophrenia
rs12807809 Hypertension 0.003648 0.894 NRGN Schizophrenia
rs12807809 Systolic/diastolic heart failure 0.00251 0.8452 NRGN Schizophrenia
rs12807809 Heart failure 0.004431 0.8586 NRGN Schizophrenia
rs12807809 Myocardial infarction 0.002597 0.8318 NRGN Schizophrenia
rs12807809 Essential hypertension 0.003432 0.8932 NRGN Schizophrenia
rs12807809 Insomnia 0.009989 1.195 NRGN Schizophrenia
rs12807809 Dementias 0.007731 0.8271 NRGN Schizophrenia
rs12807809 Retention of urine 0.003914 0.824 NRGN Schizophrenia
rs12821256 Allergy to serum or vaccine 0.01058 1.983 KITLG Hair color
rs12821256 Epiphora 0.009177 0.5731 KITLG Hair color
rs12821256 Disorders of lacrimal system 0.0005731 0.7783 KITLG Hair color
rs12821256 Skin neoplasm of uncertain behavior 0.01038 0.7401 KITLG Hair color
rs12821256 Ill-defined descriptions and complications of heart disease 0.002331 0.8243 KITLG Hair color
rs12821256 Hyperglyceridemia 0.007765 0.6942 KITLG Hair color
rs12821256 Benign neoplasm of eye 0.0002035 1.503 KITLG Hair color
rs12821256 Appendicitis 0.01043 1.545 KITLG Hair color
rs12821256 Dry eyes 0.001009 0.7796 KITLG Hair color
rs12821256 Angina pectoris 0.00263 0.8003 KITLG Hair color
rs12821256 Other congenital anomalies of skin 0.002333 0.4145 KITLG Hair color
rs12821256 Other forms of chronic heart disease 0.008388 0.7475 KITLG Hair color
rs12821256 Diseases of the salivary glands 0.00879 0.6357 KITLG Hair color
rs12821256 Benign neoplasm of brain and other parts of nervous system 0.006072 0.4905 KITLG Hair color
rs12821256 Acute appendicitis 0.004273 1.721 KITLG Hair color
rs12915189 H. pylori 0.01084 1.468 CRTC3 Cognitive performance
rs12915189 Osteoporosis, NOS or other 0.0009343 1.167 CRTC3 Cognitive performance
rs12915189 Generalized anxiety disorder 0.008791 1.287 CRTC3 Cognitive performance
rs12915189 Prostate cancer 0.007836 1.194 CRTC3 Cognitive performance
rs12915189 Polycystic ovaries 0.01117 1.925 CRTC3 Cognitive performance
rs12915189 Primary pulmonary hypertension 0.00856 0.5881 CRTC3 Cognitive performance
rs12915189 Pathologic fracture 0.007909 1.211 CRTC3 Cognitive performance
rs12915189 Nasal polyps 0.003662 1.376 CRTC3 Cognitive performance
rs12915189 Herpes zoster with nervous system complications 0.00486 0.5869 CRTC3 Cognitive performance
rs12915189 Pervasive developmental disorders 0.0008592 1.716 CRTC3 Cognitive performance
rs12915189 Osteoporosis, osteopenia, & pathological fractures 0.006244 1.105 CRTC3 Cognitive performance
rs12915189 Chronic obstructive asthma 0.006426 1.297 CRTC3 Cognitive performance
rs12915189 Attention deficit hyperactivity disorder 0.0002436 1.978 CRTC3 Cognitive performance
rs12915189 Fracture of ankle and foot 0.01001 1.148 CRTC3 Cognitive performance
rs12915189 Osteoporosis 0.004403 1.147 CRTC3 Cognitive performance
rs12915189 Ovarian dysfunction 0.005771 1.875 CRTC3 Cognitive performance
rs12989701 Genitourinary congenital anomalies 0.003504 1.529 BIN1 Alzheimer's disease
rs12989701 Viral Enteritis 0.007425 1.618 BIN1 Alzheimer's disease
rs12989701 Stricture of artery 0.003525 0.6255 BIN1 Alzheimer's disease
rs12989701 Optic atrophy 0.005774 0.4927 BIN1 Alzheimer's disease
rs12989701 Bullous dermatoses 0.002437 2.109 BIN1 Alzheimer's disease
rs12989701 Dementia with cerebral degenerations 0.01057 1.648 BIN1 Alzheimer's disease
rs12989701 Nephrotic syndrome without mention of glomerulonephritis 0.01093 2.023 BIN1 Alzheimer's disease
rs12989701 Joint/ligament sprain 0.0113 0.6644 BIN1 Alzheimer's disease
rs12989701 Hypoglycemia 0.006557 1.587 BIN1 Alzheimer's disease
rs12989701 Impetigo 0.008704 1.667 BIN1 Alzheimer's disease
rs12989701 Abnormal kidney function 0.006662 2.192 BIN1 Alzheimer's disease
rs12989701 Valvular heart disease/ heart chambers 0.008573 1.892 BIN1 Alzheimer's disease
rs12989701 Benign neoplasm of brain and other parts of nervous system 0.008155 1.497 BIN1 Alzheimer's disease
rs13088462 Hyperlipidemia 0.006986 0.8214 DOCK3 Height
rs13088462 Other disorders of eyelids 0.005795 0.7308 DOCK3 Height
rs13088462 Intervertebral disc disorder with myelopathy 0.008194 2.265 DOCK3 Height
rs13088462 Inguinal hernia 0.002862 0.6642 DOCK3 Height
rs13088462 Musculoskeletal symptoms referable to limbs 0.01025 1.523 DOCK3 Height
rs13088462 Paralytic ileus 0.01032 0.4635 DOCK3 Height
rs13088462 Essential hypertension 0.0001705 0.7836 DOCK3 Height
rs13088462 Disorders of lipoid metabolism 0.009792 0.8293 DOCK3 Height
rs13088462 Hypertension 0.0002191 0.7873 DOCK3 Height
rs13088462 Ingrowing nail 0.004604 0.6721 DOCK3 Height
rs13088462 Mixed hyperlipidemia 0.001487 0.6201 DOCK3 Height
rs13088462 Dermatomycoses 0.0001168 2.901 DOCK3 Height
rs13088462 Chronic lymphocytic thyroiditis 0.01146 0.2292 DOCK3 Height
rs13088462 Benign neoplasm of eye 0.0006463 1.645 DOCK3 Height
rs13088462 Anomalies of pupillary function 0.005295 2.69 DOCK3 Height
rs13129697 stress incontinence, female 0.002022 1.229 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Corneal edema 0.005952 1.672 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Other sprains and strains 0.001239 0.6488 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Retinal vascular changes and abnomalities 0.002977 1.265 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Dupuytren's disease 0.008395 0.6864 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Gout and other crystal arthropathies 4.971e-06 0.7627 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Costochondritis 0.001116 0.3328 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Muscular dystrophies and other myopathies 0.002503 0.5833 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Pleurisy; pleural effusion 0.004878 0.8537 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Tinnitus 0.006338 1.222 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Spontaneous ecchymoses 0.01118 0.5698 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Gouty arthropathy 0.009714 0.7425 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs13129697 Gout 2.414e-07 0.716 SLC2A9 Serum uric acid, Uric acid levels, Serum Urate, Gout
rs1317209 Sprains and strains 0.006542 1.142 RNF186 Ulcerative colitis
rs1317209 Elevated levels of transaminase or lactic acid dehydrogenase 0.004009 0.7662 RNF186 Ulcerative colitis
rs1317209 Acute, but ill-defined cerebrovascular disease 0.009444 0.7939 RNF186 Ulcerative colitis
rs1317209 Other alveolar and parietoalveolar pneumonopathy 0.004791 1.786 RNF186 Ulcerative colitis
rs1317209 Lung disease due to external agents 0.008025 1.627 RNF186 Ulcerative colitis
rs1317209 Other hemoglobinopathies 0.003684 2.245 RNF186 Ulcerative colitis
rs1317209 Pain in joint 0.006763 1.112 RNF186 Ulcerative colitis
rs1317209 Back & neck sprains 0.000987 1.203 RNF186 Ulcerative colitis
rs1317209 Hemorrhage of rectum and anus 0.001081 1.3 RNF186 Ulcerative colitis
rs1317209 Erectile dysfunction 0.004801 1.231 RNF186 Ulcerative colitis
rs1317209 Benign neoplasm of thyroid glands 0.01052 1.824 RNF186 Ulcerative colitis
rs1317209 Neck pain 0.006796 1.128 RNF186 Ulcerative colitis
rs1317209 Chronic laryngitis 0.01089 1.974 RNF186 Ulcerative colitis
rs1317209 Back pain 0.002516 1.121 RNF186 Ulcerative colitis
rs1317209 Skin neoplasm of uncertain behavior 0.00636 1.26 RNF186 Ulcerative colitis
rs1317209 Other headache syndromes 0.009919 1.126 RNF186 Ulcerative colitis
rs1317209 Acute prostatitis 0.0007848 2.022 RNF186 Ulcerative colitis
rs1317209 Thoracic neuritis/radiculitis 0.008883 1.144 RNF186 Ulcerative colitis
rs13194491 Iron deficiency anemias 0.003409 0.7403 HIST1H2BJ Transferrin saturation
rs13194491 Fractur of unspecified part of femur 0.0107 1.636 HIST1H2BJ Transferrin saturation
rs13194491 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.00791 0.7268 HIST1H2BJ Transferrin saturation
rs13194491 Peripheral vascular disease 0.005205 0.7965 HIST1H2BJ Transferrin saturation
rs13194491 Discoid lupus erythematosus 0.01128 1.749 HIST1H2BJ Transferrin saturation
rs13194491 Peripheral arterial disease 0.0008221 0.7416 HIST1H2BJ Transferrin saturation
rs13194491 Secondary malignancy of bone 0.01065 1.521 HIST1H2BJ Transferrin saturation
rs13194491 Malignant neoplasm of kidney and other urinary organs 0.004521 2.065 HIST1H2BJ Transferrin saturation
rs13194491 Flat foot 0.007046 1.515 HIST1H2BJ Transferrin saturation
rs13194491 Iron deficiency anemias NOS 0.003885 0.7591 HIST1H2BJ Transferrin saturation
rs13194491 Urinary incontinence 0.007625 1.244 HIST1H2BJ Transferrin saturation
rs13194491 Iron metabolism disorder 3.76e-16 7.795 HIST1H2BJ Transferrin saturation
rs13194491 Atherosclerosis 0.002765 0.7745 HIST1H2BJ Transferrin saturation
rs13194491 Atherosclerosis of the extremities 0.0007135 0.7173 HIST1H2BJ Transferrin saturation
rs13194491 Chronic lymphoid leukemia 0.007584 1.896 HIST1H2BJ Transferrin saturation
rs13194491 Bacteremia 0.00585 0.5229 HIST1H2BJ Transferrin saturation
rs13194491 Lupus erythematosus 0.007535 2.407 HIST1H2BJ Transferrin saturation
rs13194491 Adrenal hypofunction 0.008525 1.948 HIST1H2BJ Transferrin saturation
rs13194491 Lymphoid leukemia 0.008482 1.85 HIST1H2BJ Transferrin saturation
rs13194491 Dystrophy of female genital tract 0.00351 2.607 HIST1H2BJ Transferrin saturation
rs13194491 Disorders of binocular eye movements 0.008754 0.6824 HIST1H2BJ Transferrin saturation
rs13194984 Iron metabolism disorder 5.821e-09 4.109 BTN1A1 Transferrin saturation
rs13194984 Fracture of tibia and fibula 0.003042 1.421 BTN1A1 Transferrin saturation
rs13194984 Acute pancreatitis 0.007897 0.6499 BTN1A1 Transferrin saturation
rs13194984 Non-melanoma skin cancer 0.002119 1.175 BTN1A1 Transferrin saturation
rs13194984 Poisoning by hormones and synthetic substitutes 0.003387 0.5167 BTN1A1 Transferrin saturation
rs13194984 Disorders of penis 0.0005132 0.5096 BTN1A1 Transferrin saturation
rs13194984 Carbuncle and furuncle 0.006385 1.684 BTN1A1 Transferrin saturation
rs13194984 Fracture of lower limb 0.002446 1.24 BTN1A1 Transferrin saturation
rs13194984 Other local infections of skin and subcutaneous tissue 0.009424 1.241 BTN1A1 Transferrin saturation
rs13194984 Age-related macular degeneration 0.009419 0.761 BTN1A1 Transferrin saturation
rs13194984 Atrial flutter 0.005735 0.7108 BTN1A1 Transferrin saturation
rs13194984 Multiple sclerosis 0.004263 1.732 BTN1A1 Transferrin saturation
rs13194984 Disorders of binocular eye movements 0.003817 0.7254 BTN1A1 Transferrin saturation
rs13194984 Other specified cardiac dysrhythmias 0.008608 0.8297 BTN1A1 Transferrin saturation
rs13194984 Breast conditions, congenital or relating to hormones 0.007519 0.6188 BTN1A1 Transferrin saturation
rs13194984 Diseases of the oral soft tissues 0.008177 0.7838 BTN1A1 Transferrin saturation
rs13194984 Genu valgum or varum (acquired) 0.007971 0.4974 BTN1A1 Transferrin saturation
rs13194984 Biliary cirrhosis 0.001163 2.845 BTN1A1 Transferrin saturation
rs13194984 Chronic lymphoid leukemia 0.006902 1.728 BTN1A1 Transferrin saturation
rs13194984 Bacteremia 0.000246 0.5187 BTN1A1 Transferrin saturation
rs13194984 Skin cancer 0.004782 1.152 BTN1A1 Transferrin saturation
rs13194984 Abnormal findings on radiological examination intrathoracic organs 0.0106 0.7435 BTN1A1 Transferrin saturation
rs13194984 Hypertrophy of breast (Gynecomastia) 0.005563 0.5682 BTN1A1 Transferrin saturation
rs13194984 Urinary complications 0.01054 0.4915 BTN1A1 Transferrin saturation
rs13230047 Otitis media 0.003049 0.5953 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Noninflammatory female genital disorders 0.007727 0.5083 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Gastrointestinal malfunction arising from mental factors 0.009419 3.565 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Alopecia Areata 0.001809 4.089 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Other hypertrophic and atrophic conditions of skin 0.007423 0.6996 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Adjustment reaction 0.005868 1.512 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Suppurative and unspecified otitis media 0.003673 0.5438 ELMO1 Anticoagulant levels (Protein C)
rs13230047 Pathological, developmental or recurrent dislocation 0.0001351 4.398 ELMO1 Anticoagulant levels (Protein C)
rs13278062 Other hemoglobinopathies 0.01063 0.4972 TNFRSF10A Age-related macular degeneration
rs13278062 Diaphragmatic hernia 0.01031 1.127 TNFRSF10A Age-related macular degeneration
rs13278062 Pneumonia 0.005678 1.109 TNFRSF10A Age-related macular degeneration
rs13278062 Herpes simplex 0.004196 1.318 TNFRSF10A Age-related macular degeneration
rs13278062 Congenital anomalies of urinary system 0.007084 0.6826 TNFRSF10A Age-related macular degeneration
rs13278062 Ectropion or entropion 0.007341 0.7933 TNFRSF10A Age-related macular degeneration
rs13278062 Kidney replaced by transpant 0.005192 0.6804 TNFRSF10A Age-related macular degeneration
rs13278062 Other open wound of head and face 0.01105 1.197 TNFRSF10A Age-related macular degeneration
rs13278062 Open wounds of head; neck; and trunk 0.002679 1.167 TNFRSF10A Age-related macular degeneration
rs13278062 Disturbance of skin sensation 0.01067 1.113 TNFRSF10A Age-related macular degeneration
rs13278062 Symptoms affecting skin 0.002278 1.107 TNFRSF10A Age-related macular degeneration
rs13278062 Circumscribed scleroderma 0.002845 0.6892 TNFRSF10A Age-related macular degeneration
rs13278062 Bronchiectasis 0.006436 1.391 TNFRSF10A Age-related macular degeneration
rs13278062 Hereditary hemolytic anemias 0.009954 0.6047 TNFRSF10A Age-related macular degeneration
rs13278062 Hyperosmolality and/or hypernatremia 0.002188 0.6426 TNFRSF10A Age-related macular degeneration
rs13278062 Megaloblastic anemia 0.001671 1.411 TNFRSF10A Age-related macular degeneration
rs13278062 Aneurysm of other specified artery 0.00976 1.784 TNFRSF10A Age-related macular degeneration
rs13278062 Eating disorder 0.001766 1.78 TNFRSF10A Age-related macular degeneration
rs13278062 Bullous dermatoses 0.009603 1.805 TNFRSF10A Age-related macular degeneration
rs1329428 Bundle branch block 0.003238 1.218 CFH Age-related macular degeneration
rs1329428 Type 2 diabetic ketoacidosis 0.005678 1.138 CFH Age-related macular degeneration
rs1329428 Age-related macular degeneration 7.157e-20 0.514 CFH Age-related macular degeneration
rs1329428 Type 1 diabetes 0.0001105 1.258 CFH Age-related macular degeneration
rs1329428 Retinal disorders 3.004e-07 0.8172 CFH Age-related macular degeneration
rs1329428 Conjunctivitis, noninfectious 0.008553 1.233 CFH Age-related macular degeneration
rs1329428 Osteoarthrosis; localized, secondary 0.0008799 1.724 CFH Age-related macular degeneration
rs1329428 Other specified osteoporosis 0.007802 0.5904 CFH Age-related macular degeneration
rs1329428 Type 2 diabetes 6.374e-06 1.15 CFH Age-related macular degeneration
rs1329428 Sarcoidosis 0.004161 1.634 CFH Age-related macular degeneration
rs1329428 Retinal vascular changes and abnomalities 2.802e-05 0.7319 CFH Age-related macular degeneration
rs1329428 Partial epilepsy 0.005695 0.6872 CFH Age-related macular degeneration
rs1329428 Encounter for long-term use of aspirin 0.001615 1.349 CFH Age-related macular degeneration
rs1329428 Type 1 diabetic neuropathy 0.006959 1.423 CFH Age-related macular degeneration
rs1329428 Shock 0.008697 1.37 CFH Age-related macular degeneration
rs1329428 Nerve root and plexus disorders 0.001418 1.372 CFH Age-related macular degeneration
rs1329428 Macular degeneration 7.679e-13 0.7212 CFH Age-related macular degeneration
rs1329428 Encounter for long-term use of anticoagulants/antithrombotics 0.006078 1.265 CFH Age-related macular degeneration
rs1329428 Macular degeneration, wet 4.895e-12 0.4418 CFH Age-related macular degeneration
rs1329428 Endometrial hyperplasia 0.0008203 1.554 CFH Age-related macular degeneration
rs1329428 Fracture of vertebral column without mention of spinal cord injury 0.009076 0.8204 CFH Age-related macular degeneration
rs1329428 Left bundle branch block 0.000674 1.363 CFH Age-related macular degeneration
rs1329428 Osteomyelitis 0.006309 1.287 CFH Age-related macular degeneration
rs1329428 Retinal drusen 3.168e-06 0.6987 CFH Age-related macular degeneration
rs1329428 First degree AV block 0.00933 1.227 CFH Age-related macular degeneration
rs1329428 Diabetes mellitus 3.447e-06 1.153 CFH Age-related macular degeneration
rs1329428 Allergic conjunctivitis 0.01058 1.252 CFH Age-related macular degeneration
rs1329428 Type 2 diabetic retinopathy 0.004349 1.208 CFH Age-related macular degeneration
rs1329428 Diabetic retinopathy 0.002648 1.211 CFH Age-related macular degeneration
rs1329428 Macular degeneration, dry 1.542e-09 0.627 CFH Age-related macular degeneration
rs13314993 Acute osteomyelitis 0.002993 1.705 CCR4 Celiac disease
rs13314993 Migrain with aura 0.008233 1.438 CCR4 Celiac disease
rs13314993 Other symptoms involving abdomen and pelvis 0.01012 0.8837 CCR4 Celiac disease
rs13314993 Testicular dysfunction 0.01033 0.7299 CCR4 Celiac disease
rs13314993 Anaphylactic shock NOS 0.00951 1.456 CCR4 Celiac disease
rs13314993 Drug-resistant infection 0.0005734 1.495 CCR4 Celiac disease
rs13314993 Chronic prostatitis 0.004999 1.54 CCR4 Celiac disease
rs13314993 Wheezing 0.009406 1.306 CCR4 Celiac disease
rs13314993 Cancer of other male genital organs 0.009176 0.5703 CCR4 Celiac disease
rs13314993 Gram positive septicemia 0.008808 1.571 CCR4 Celiac disease
rs13314993 Abnormal findings on radiological examination intrathoracic organs 0.005135 1.213 CCR4 Celiac disease
rs13314993 Other cerebral degenerations 0.006494 1.412 CCR4 Celiac disease
rs13314993 Testicular hypofunction 0.007255 0.7135 CCR4 Celiac disease
rs13314993 Ventral hernia 0.001714 1.33 CCR4 Celiac disease
rs13333226 Rheumatoid arthritis 0.002612 1.305 UMOD Hypertension
rs13333226 Restless legs syndrome 0.01009 0.7064 UMOD Hypertension
rs13333226 Sleep related movement disorders 0.009949 0.7484 UMOD Hypertension
rs13333226 Chronic pharyngitis and nasopharyngitis 0.003488 0.8013 UMOD Hypertension
rs13333226 Rheumatoid arthritis & related inflammatory polyarthropathies 0.006818 1.241 UMOD Hypertension
rs13333226 Encounter for long-term use of anticoagulants/antithrombotics 0.002008 0.6761 UMOD Hypertension
rs13333226 Noninflammatory female genital disorders 0.006836 1.24 UMOD Hypertension
rs13333226 Abnormal involuntary movements 0.005423 0.7263 UMOD Hypertension
rs13333226 Other abnormal glucose 0.007161 1.18 UMOD Hypertension
rs13333226 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.004477 1.703 UMOD Hypertension
rs13333226 Circumscribed scleroderma 0.006178 1.472 UMOD Hypertension
rs13333226 E. coli 0.00605 1.391 UMOD Hypertension
rs13333226 Disorders of lacrimal system 0.006507 0.849 UMOD Hypertension
rs13333226 Miscarriage; stillbirth 0.01014 1.886 UMOD Hypertension
rs13333226 Prolapse of vaginal vault after hysterectomy 0.001911 0.4701 UMOD Hypertension
rs13333226 Noninflammatory disorders of cervix 0.001839 1.894 UMOD Hypertension
rs13333226 Pyogenic arthritis 0.008109 0.415 UMOD Hypertension
rs13333226 Arthropathy associated with infections 0.004603 0.45 UMOD Hypertension
rs13333226 Diseases of spleen 0.00907 1.888 UMOD Hypertension
rs13333226 Hereditary and idiopathic peripheral neuropathy 0.006587 0.828 UMOD Hypertension
rs13333226 Renal failure 0.002187 0.8624 UMOD Hypertension
rs13333226 Optic atrophy 0.01073 0.5888 UMOD Hypertension
rs13333226 Testicular hypofunction 4.459e-05 0.4163 UMOD Hypertension
rs13333226 Testicular dysfunction 0.0001011 0.4539 UMOD Hypertension
rs1335532 Retinal detachments and defects 0.007403 1.31 CD58 Multiple sclerosis
rs1335532 Nerve root lesions 0.002181 1.948 CD58 Multiple sclerosis
rs1335532 Hereditary and idiopathic peripheral neuropathy 0.0006694 0.7494 CD58 Multiple sclerosis
rs1335532 Respiratory complications 0.01086 0.3422 CD58 Multiple sclerosis
rs1335532 Benign neoplasm of colon 0.008701 1.134 CD58 Multiple sclerosis
rs1335532 Dysmetabolic syndrome X 0.001176 1.749 CD58 Multiple sclerosis
rs1335532 Multiple myeloma 0.004289 0.3306 CD58 Multiple sclerosis
rs1335532 Astigmatism 0.007245 1.205 CD58 Multiple sclerosis
rs1335532 Diseases of the tongue 0.002282 1.636 CD58 Multiple sclerosis
rs1335532 Aphakia and other disorders of lens 0.006154 1.428 CD58 Multiple sclerosis
rs1335532 ASCVD 0.009489 1.483 CD58 Multiple sclerosis
rs13429458 Adverse effects of opiates and related narcotics in therapeutic use 0.003795 1.462 THADA Polycystic ovary syndrome
rs13429458 Nonrheumatic pulmonary valve disorders 0.006477 1.887 THADA Polycystic ovary syndrome
rs13429458 Other specified peripheral vascular diseases 0.009024 2.257 THADA Polycystic ovary syndrome
rs13429458 Cholecystitis without cholelithiasis 0.01123 0.6304 THADA Polycystic ovary syndrome
rs13429458 Salicylates causing adverse effects in therapeutic use 0.01023 2.085 THADA Polycystic ovary syndrome
rs13429458 Known or suspected fetal abnormality 0.004956 1.996 THADA Polycystic ovary syndrome
rs13429458 Erectile dysfunction 0.01032 0.7882 THADA Polycystic ovary syndrome
rs13429458 Endocarditis 0.0003896 1.649 THADA Polycystic ovary syndrome
rs13429458 Diseases of hard tissues of teeth 0.009311 0.7522 THADA Polycystic ovary syndrome
rs13429458 Noninfectious dermatoses of eyelid 0.01115 1.829 THADA Polycystic ovary syndrome
rs13429458 Atrophy of edentulous alveolar ridge 0.001529 0.3162 THADA Polycystic ovary syndrome
rs13429458 Acute osteomyelitis 0.006868 1.836 THADA Polycystic ovary syndrome
rs13429458 Symptoms involving digestive system 0.002753 1.373 THADA Polycystic ovary syndrome
rs13429458 Hallux valgus (Bunion) 0.005543 1.288 THADA Polycystic ovary syndrome
rs13429458 Other disorders of arteries and arterioles 0.01103 1.368 THADA Polycystic ovary syndrome
rs13429458 Noninflammatory disorders of cervix 0.007056 1.898 THADA Polycystic ovary syndrome
rs13438327 Infertility, male 4.129e-05 3.467 OCM2 Sudden cardiac arrest
rs13438327 Male infertility and abnormal spermatozoa 0.002382 2.266 OCM2 Sudden cardiac arrest
rs13438327 Disturbances in tooth eruption 0.007772 1.575 OCM2 Sudden cardiac arrest
rs13438327 Acquired spondylolisthesis 0.001253 1.608 OCM2 Sudden cardiac arrest
rs13438327 Other disorders of pancreatic internal secretion 0.007011 1.999 OCM2 Sudden cardiac arrest
rs13438327 Prostate cancer 0.001533 1.404 OCM2 Sudden cardiac arrest
rs13438327 Periostitis 0.01122 2.121 OCM2 Sudden cardiac arrest
rs13438327 Chronic lymphocytic thyroiditis 0.01013 0.4138 OCM2 Sudden cardiac arrest
rs13438327 Other specified disorders of pancreatic internal secretion 0.005499 2.043 OCM2 Sudden cardiac arrest
rs13438327 Cystitis and urethritis 0.01041 1.344 OCM2 Sudden cardiac arrest
rs13438327 Abnormal weight gain 0.009367 1.538 OCM2 Sudden cardiac arrest
rs1354034 Thrombocytopenia 0.0006659 1.235 ARHGEF3 Platelet counts
rs1354034 Other specified diseases of nail 0.0002147 1.215 ARHGEF3 Platelet counts
rs1354034 Diverticulosis 0.01033 1.112 ARHGEF3 Platelet counts
rs1354034 Purpura and other hemorrhagic conditions 0.001391 1.195 ARHGEF3 Platelet counts
rs1354034 Peripheral or central vertigo 0.00686 1.208 ARHGEF3 Platelet counts
rs1354034 Other conditions of brain, NOS 0.009519 0.6368 ARHGEF3 Platelet counts
rs1354034 Diffuse diseases of connective tissue 0.004107 1.29 ARHGEF3 Platelet counts
rs1354034 Dermatophytosis / Dermatomycosis 0.0107 1.102 ARHGEF3 Platelet counts
rs1354034 Overweight 0.01128 1.084 ARHGEF3 Platelet counts
rs1354034 Derangement of joint, non-traumatic 0.009443 1.233 ARHGEF3 Platelet counts
rs1354034 Abnormal weight gain 0.009701 1.322 ARHGEF3 Platelet counts
rs1354034 Anterior pituitary disorders 0.004997 1.686 ARHGEF3 Platelet counts
rs1354034 Postoperative infection 0.01072 1.194 ARHGEF3 Platelet counts
rs1354034 Hydronephrosis 0.008031 1.319 ARHGEF3 Platelet counts
rs1354034 Diverticulitis 0.01144 1.21 ARHGEF3 Platelet counts
rs1354034 Hereditary and idiopathic peripheral neuropathy 0.0101 1.143 ARHGEF3 Platelet counts
rs1354034 Diseases of nail 0.0002392 1.207 ARHGEF3 Platelet counts
rs1354034 Diverticulosis and diverticulitis 0.009965 1.107 ARHGEF3 Platelet counts
rs1354034 Poisoning by analgesics, antipyretics, and antirheumatics 0.007869 1.324 ARHGEF3 Platelet counts
rs1354034 Diseases of respiratory system 0.005132 1.17 ARHGEF3 Platelet counts
rs1354034 Symptoms involving respiratory system 0.006747 1.207 ARHGEF3 Platelet counts
rs1354034 Urticaria 0.006772 0.7951 ARHGEF3 Platelet counts
rs1354034 Hyperosmolality and/or hypernatremia 0.008259 1.457 ARHGEF3 Platelet counts
rs1354034 Poisoning by agents affecting the cardiovascular system 0.004929 1.331 ARHGEF3 Platelet counts
rs1354034 Conjunctivitis, infectious 0.009388 1.162 ARHGEF3 Platelet counts
rs1354034 Microscopic hematuria 0.006184 0.636 ARHGEF3 Platelet counts
rs1394125 Chronic lymphocytic thyroiditis 0.009949 1.414 UBE2Q2 Serum creatinine
rs1394125 Decreased white blood cell count 0.002489 1.253 UBE2Q2 Serum creatinine
rs1394125 Reticulosarcoma 0.001645 0.5028 UBE2Q2 Serum creatinine
rs1394125 Thyroiditis 0.006326 1.357 UBE2Q2 Serum creatinine
rs1394125 Abnormal coagulation profile 0.002068 1.428 UBE2Q2 Serum creatinine
rs1394125 Rheumatoid arthritis 0.006366 0.806 UBE2Q2 Serum creatinine
rs1394125 Thrombocytopenia 0.0007112 1.238 UBE2Q2 Serum creatinine
rs1394125 Spontaneous ecchymoses 0.00405 1.657 UBE2Q2 Serum creatinine
rs1394125 Bacterial enteritis 0.003627 1.353 UBE2Q2 Serum creatinine
rs1394125 Nonsenile Cataract 0.003799 0.6921 UBE2Q2 Serum creatinine
rs1394125 Rheumatoid arthritis & related inflammatory polyarthropathies 0.00594 0.8247 UBE2Q2 Serum creatinine
rs1394125 Other specified gastritis 0.007529 0.7783 UBE2Q2 Serum creatinine
rs1394125 Purpura and other hemorrhagic conditions 0.0001733 1.238 UBE2Q2 Serum creatinine
rs1394125 Rheumatic fever / chorea 0.009521 1.92 UBE2Q2 Serum creatinine
rs1394125 Temporomandibular joint disorders 0.009065 1.269 UBE2Q2 Serum creatinine
rs1394125 Other specified disorders of breast 0.007217 0.7904 UBE2Q2 Serum creatinine
rs1394125 Intestinal infection due to C. difficile 0.005364 1.389 UBE2Q2 Serum creatinine
rs1394125 Supraventricular premature beats 0.001738 1.406 UBE2Q2 Serum creatinine
rs1395479 Cardiac dysrhythmias 0.01112 0.9188 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Pseudoexfoliation glaucoma 0.00993 1.555 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Reticulosarcoma 0.00145 1.786 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.007182 1.59 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Cellulitis and abscess of foot/toes 0.001505 0.7046 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Cerebral ischemia 0.006706 0.8581 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Cystoid macular degeneration of retina 0.009284 1.314 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Transient cerebral ischemia 0.008831 0.8595 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Hydrocele 0.003749 1.58 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Other specified disorders of liver 0.008908 1.324 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Gastritis and duodenitis, NOS 0.009073 1.231 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Alcoholic liver damage 0.009846 1.616 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Cancer of connective tissue 0.007376 0.5206 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Cachexia 0.00583 2.038 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Disorders of liver 0.002156 1.137 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Noninflammatory disorders of cervix 0.005317 0.4948 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Other disorders of lipoid metabolism and hyperalimentation 0.004594 0.7406 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1395479 Palpitations 0.002155 0.8514 NEIL3 Heart rate (ratio of low frequency to high frequency power)
rs1405069 Plasma protein metabolism disorder 0.008044 1.288 PI16 Chemerin levels
rs1405069 Chronic ulcer of unspecified site 0.004507 1.291 PI16 Chemerin levels
rs1405069 Secondary malignancy of brain/spine 0.004956 0.5886 PI16 Chemerin levels
rs1405069 Cardiac arrhythmia NOS 0.01091 1.14 PI16 Chemerin levels
rs1405069 Hallucinations 0.0007647 2.155 PI16 Chemerin levels
rs1405069 Ileostomy status 0.0004943 0.519 PI16 Chemerin levels
rs1405069 Unspecified local infection of skin and subcutaneous tissue 0.007467 1.26 PI16 Chemerin levels
rs1405069 Gram negative septicemia 0.006903 1.398 PI16 Chemerin levels
rs1405069 Poisoning by psychotropic agents 0.003073 1.88 PI16 Chemerin levels
rs1405069 Emphysema 0.007736 1.259 PI16 Chemerin levels
rs1405069 Alcoholism 0.004229 1.241 PI16 Chemerin levels
rs1405069 Alcohol-related disorders 0.003932 1.21 PI16 Chemerin levels
rs1405069 Urethral stricture (not specified as infectious) 0.003623 1.457 PI16 Chemerin levels
rs1412444 Arteritis NOS 0.0049 1.594 LIPA Coronary heart disease
rs1412444 Cholelithiasis 0.009606 1.134 LIPA Coronary heart disease
rs1412444 Menopausal & postmenopausal disorders 0.001151 0.8577 LIPA Coronary heart disease
rs1412444 Symptomatic menopause 0.0005515 0.824 LIPA Coronary heart disease
rs1412444 Calculus of bile duct 0.00158 1.418 LIPA Coronary heart disease
rs1412444 Symptoms involving urinary system 0.001283 1.31 LIPA Coronary heart disease
rs1412444 Other pulmonary inflamation or edema 0.004191 1.34 LIPA Coronary heart disease
rs1412444 Postmenopausal bleeding 0.006462 0.8096 LIPA Coronary heart disease
rs1412444 Cholelithiasis and cholecystitis 0.002842 1.146 LIPA Coronary heart disease
rs1412444 Osteopenia 0.001949 0.8672 LIPA Coronary heart disease
rs1412444 Althete's foot 0.005683 1.264 LIPA Coronary heart disease
rs1412444 Other hypertensive complications 0.006778 1.262 LIPA Coronary heart disease
rs1412444 Polymyalgia Rheumatica 0.00834 0.7764 LIPA Coronary heart disease
rs1412444 Benign neoplasm of breast 0.007836 0.6039 LIPA Coronary heart disease
rs1436900 Behcet's syndrome 0.003873 1.564 ESRRG Optic disc parameters
rs1436900 Other unspecified back disorders 0.001124 1.684 ESRRG Optic disc parameters
rs1436900 Esophagitis, GERD and related diseases 0.009593 0.9222 ESRRG Optic disc parameters
rs1436900 Other nonmalignant breast conditions 0.000225 0.8167 ESRRG Optic disc parameters
rs1436900 Other disorders of the nervous system 0.00812 1.514 ESRRG Optic disc parameters
rs1436900 Torticollis 0.009548 1.506 ESRRG Optic disc parameters
rs1436900 Cystitis 0.006006 0.8114 ESRRG Optic disc parameters
rs1436900 Sleep apnea 0.001272 0.8718 ESRRG Optic disc parameters
rs1436900 Hematuria 0.003459 0.8858 ESRRG Optic disc parameters
rs1436900 Diseases of esophagus 0.008165 0.9224 ESRRG Optic disc parameters
rs1436900 Labyrinthitis 0.008364 0.7303 ESRRG Optic disc parameters
rs1436900 Macular puckering of retina 0.00832 0.8186 ESRRG Optic disc parameters
rs1436900 Urinary tract infection 0.005249 0.9043 ESRRG Optic disc parameters
rs1436900 Hypothyroidism 0.00538 0.9026 ESRRG Optic disc parameters
rs1436900 Postnasal drip 0.004375 0.4991 ESRRG Optic disc parameters
rs1436900 Dermatophytosis of nail 0.006828 0.8845 ESRRG Optic disc parameters
rs1436900 Seborrheic keratosis 0.006424 0.9035 ESRRG Optic disc parameters
rs1436900 Obstructive sleep apnea 1.506e-05 0.795 ESRRG Optic disc parameters
rs1436900 Other diseases of lung 0.008698 0.8837 ESRRG Optic disc parameters
rs1436900 Nausea and vomiting 0.009142 0.9051 ESRRG Optic disc parameters
rs1436900 Dislocation 0.01107 1.111 ESRRG Optic disc parameters
rs1436900 Restless legs syndrome 0.005418 0.759 ESRRG Optic disc parameters
rs1436900 Vertiginous syndromes and other disorders of vestibular system 0.00645 0.9117 ESRRG Optic disc parameters
rs1436900 Other specified disorders of breast 0.003567 0.7821 ESRRG Optic disc parameters
rs1436900 Cystitis and urethritis 0.002219 0.8038 ESRRG Optic disc parameters
rs1436900 Blood in stool 0.01101 0.8699 ESRRG Optic disc parameters
rs1436900 Disorders of lacrimal system 0.008895 0.8854 ESRRG Optic disc parameters
rs1436900 Other disorders of eyelids 0.009143 0.8753 ESRRG Optic disc parameters
rs1436900 Secondary thrombocytopenia 0.008736 0.5947 ESRRG Optic disc parameters
rs1437898 Acute appendicitis 0.01148 0.6715 NCKAP5 Multiple sclerosis
rs1437898 Urethral hypermobility/ISD 0.003614 1.646 NCKAP5 Multiple sclerosis
rs1437898 Intestinal infection due to C. difficile 0.01057 1.348 NCKAP5 Multiple sclerosis
rs1437898 Bacterial enteritis 0.01126 1.298 NCKAP5 Multiple sclerosis
rs1437898 Hyperplasia of prostate 0.01042 0.8756 NCKAP5 Multiple sclerosis
rs1437898 Benign neoplasm of thyroid glands 0.007397 1.758 NCKAP5 Multiple sclerosis
rs1437898 Nonspecific findings on examination of blood 0.006672 0.7532 NCKAP5 Multiple sclerosis
rs1437898 Cervical radiculitis 0.0105 0.8532 NCKAP5 Multiple sclerosis
rs1437898 Viral hepatitis 0.004614 1.295 NCKAP5 Multiple sclerosis
rs1445898 Candidiasis 0.01029 0.8495 CAPSL Type 1 diabetes
rs1445898 Pancreatic cancer 0.001572 0.5888 CAPSL Type 1 diabetes
rs1445898 Symptoms involving female genital tract 0.01025 0.7395 CAPSL Type 1 diabetes
rs1445898 Diplopia and disorders of binocular vision 0.003257 0.7546 CAPSL Type 1 diabetes
rs1445898 Benign neoplasm of thyroid glands 0.001694 1.953 CAPSL Type 1 diabetes
rs1445898 Other derangement of joint 0.00684 1.28 CAPSL Type 1 diabetes
rs1445898 Neuralgia, neuritis, and radiculitis NOS 0.008948 1.194 CAPSL Type 1 diabetes
rs1445898 Dermatomycoses 0.005951 0.5759 CAPSL Type 1 diabetes
rs1445898 Secondary malignant neoplasm of liver 0.003107 0.7005 CAPSL Type 1 diabetes
rs1445898 Drug-resistant infection 0.00862 1.355 CAPSL Type 1 diabetes
rs1445898 Atopic or contact dermatitis 0.006268 0.9063 CAPSL Type 1 diabetes
rs1445898 Acquired hemolytic anemias 0.003591 2.072 CAPSL Type 1 diabetes
rs1445898 Corneal edema 0.000298 0.4843 CAPSL Type 1 diabetes
rs1457451 Osteoarthrosis; localized, primary 0.008246 1.365 LOC100131818 Transferrin saturation
rs1457451 Malignant neoplasm, other 0.009444 1.344 LOC100131818 Transferrin saturation
rs1457451 Glossodynia 0.005335 2.217 LOC100131818 Transferrin saturation
rs1457451 Jaw disease NOS 0.01003 1.706 LOC100131818 Transferrin saturation
rs1457451 Intervertebral disc disorders 0.008113 0.8563 LOC100131818 Transferrin saturation
rs1457451 Abnormal mammogram 0.009583 0.7665 LOC100131818 Transferrin saturation
rs1457451 Disorders of sweat glands 0.006577 1.414 LOC100131818 Transferrin saturation
rs1457451 Polycythemia vera, secondary 0.01146 1.81 LOC100131818 Transferrin saturation
rs1457451 Methicillin sensitive Staphylococcus aureus 0.01095 0.5685 LOC100131818 Transferrin saturation
rs1457451 Degeneration of intervertebral disc 0.006864 0.8281 LOC100131818 Transferrin saturation
rs1457451 Other hereditary hemolytic anemias 0.01119 2.41 LOC100131818 Transferrin saturation
rs1471403 Chronic cystitis 0.004328 1.544 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Pathologic fracture 0.007176 0.8228 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Pathologic fracture of vertebrae 0.004155 0.7731 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Mycoses 0.008796 1.526 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Spontaneous ecchymoses 0.009515 1.582 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Sexual and gender identity disorders 0.006037 1.388 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Pneumococcal pneumonia 0.009619 1.785 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Epilepsy, recurrent seizures, convulsions 0.004168 0.8173 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Fracture of humerus 0.004748 0.7769 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Supraventricular premature beats 0.004753 0.7078 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Carcinoma in situ of skin 0.00324 0.7673 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Adverse effects of antilipemic and antiarteriosclerotic drugs 0.01079 2.043 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Convulsions 0.001465 0.7889 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Decreased libido 0.001962 2.133 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Dysuria 0.01014 1.156 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Salicylates causing adverse effects in therapeutic use 0.01019 1.834 MEPE Bone mineral density (hip), Bone mineral density
rs1471403 Protein plasma/amino-acid transport and metabolism disorder 0.01025 1.256 MEPE Bone mineral density (hip), Bone mineral density
rs1484170 Left bundle branch block 0.005084 0.697 NRG3 Cardiac hypertrophy
rs1484170 Bacterial infection NOS 0.009155 1.16 NRG3 Cardiac hypertrophy
rs1484170 Type 1 diabetic retinopathy 0.009381 0.6104 NRG3 Cardiac hypertrophy
rs1484170 Hepatomegaly 0.002163 1.956 NRG3 Cardiac hypertrophy
rs1484170 Male infertility and abnormal spermatozoa 0.008862 0.4296 NRG3 Cardiac hypertrophy
rs1484170 Crystal arthropathies 0.009806 1.397 NRG3 Cardiac hypertrophy
rs1484170 Allergy/adverse effect of penicillin 0.01001 1.26 NRG3 Cardiac hypertrophy
rs1484170 Poisoning by antibiotics 0.009996 1.229 NRG3 Cardiac hypertrophy
rs1484170 Graves' disease 0.001882 1.632 NRG3 Cardiac hypertrophy
rs1484170 Methicillin sensitive Staphylococcus aureus 0.006793 1.398 NRG3 Cardiac hypertrophy
rs1484170 Nerve root and plexus disorders 0.01038 0.6937 NRG3 Cardiac hypertrophy
rs1484170 Exophthalmos 0.0002211 2.396 NRG3 Cardiac hypertrophy
rs1484170 Atrophic gastritis 0.01088 1.519 NRG3 Cardiac hypertrophy
rs1484170 Staphylococcus infections 0.009872 1.289 NRG3 Cardiac hypertrophy
rs1484170 Sebaceous cyst 0.009964 0.8568 NRG3 Cardiac hypertrophy
rs1484170 Somatoform disorder 0.008994 1.394 NRG3 Cardiac hypertrophy
rs1497546 Mental retardation 0.001392 4.117 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Macular puckering of retina 0.008954 0.5192 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Open wound of ear 0.009373 3.15 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Diabetes mellitus 0.008026 1.262 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Osteoarthrosis 0.00184 0.752 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Type 2 diabetes 0.008102 1.266 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Fracture of hand or wrist 0.01077 0.5824 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Hemorrhage or hematoma complicating a procedure 0.008627 0.4451 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Osteoarthrosis NOS 0.009995 0.777 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Joint/ligament sprain 0.007816 1.853 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Neoplasm of unspecified nature of digestive system 0.008413 2.106 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Pleurisy; pleural effusion 0.01048 1.41 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1497546 Cerebral atherosclerosis 0.001679 3.128 OR5H2 Drug-induced liver injury (flucloxacillin)
rs1512268 Reticulosarcoma 0.005449 1.66 NKX3-1 Prostate cancer
rs1512268 Altered mental status 0.002089 0.7487 NKX3-1 Prostate cancer
rs1512268 Arthropathy NOS 0.01127 0.8543 NKX3-1 Prostate cancer
rs1512268 Prostate cancer 0.00586 1.187 NKX3-1 Prostate cancer
rs1512268 Type 2 diabetes 0.006781 0.9187 NKX3-1 Prostate cancer
rs1512268 Nephritis and nephropathy in diseases classified elsewhere 0.003713 0.7611 NKX3-1 Prostate cancer
rs1512268 Type 1 diabetes 0.00281 0.8328 NKX3-1 Prostate cancer
rs1512268 Deep vein thrombosis 0.002907 0.7655 NKX3-1 Prostate cancer
rs1512268 Cerebrovascular disease 0.006967 0.9136 NKX3-1 Prostate cancer
rs1512268 Malaise and fatigue 0.01012 0.9247 NKX3-1 Prostate cancer
rs1512268 Rash and other nonspecific skin eruption 0.005393 0.8566 NKX3-1 Prostate cancer
rs1512268 Venous embolism & thrombosis 0.005742 0.859 NKX3-1 Prostate cancer
rs1512268 Bacterial infection NOS 0.009511 0.8847 NKX3-1 Prostate cancer
rs1512268 Diabetes mellitus 0.007264 0.9203 NKX3-1 Prostate cancer
rs1512268 Trigeminal nerve disorders 0.004523 0.6702 NKX3-1 Prostate cancer
rs1512268 Elevated prostate specific antigen 0.004165 1.201 NKX3-1 Prostate cancer
rs1512268 Type 1 diabetic peripheral circulatory disorders 0.00888 0.4946 NKX3-1 Prostate cancer
rs1512268 First degree AV block 0.007499 0.8082 NKX3-1 Prostate cancer
rs1512268 Chronic pharyngitis and nasopharyngitis 0.008429 0.8603 NKX3-1 Prostate cancer
rs1512268 Fracture of hand or wrist 0.002299 0.8355 NKX3-1 Prostate cancer
rs1512268 Dentofacial anomalies, including malocclusion 0.00867 1.531 NKX3-1 Prostate cancer
rs153091 Occlusion of cerebral arteries 0.003426 0.791 SHISA9 Response to antipsychotic treatment
rs153091 Symptoms and disorders of the joints 0.01008 0.879 SHISA9 Response to antipsychotic treatment
rs153091 Posterior pituitary disorders 0.002212 0.36 SHISA9 Response to antipsychotic treatment
rs153091 Hearing loss 0.005308 1.11 SHISA9 Response to antipsychotic treatment
rs153091 Somatoform disorder 0.01109 1.368 SHISA9 Response to antipsychotic treatment
rs153091 Chronic kidney disease, Stage I or II 0.005024 1.449 SHISA9 Response to antipsychotic treatment
rs153091 Mitral valve stenosis and/or aortic valve stenosis 0.004792 0.7612 SHISA9 Response to antipsychotic treatment
rs153091 Cyst or abscess of Bartholin's gland 0.00702 0.282 SHISA9 Response to antipsychotic treatment
rs153091 Respiratory failure 0.002487 0.7054 SHISA9 Response to antipsychotic treatment
rs153091 Ischemic stroke 0.001955 0.7696 SHISA9 Response to antipsychotic treatment
rs153091 Pathologic fracture of vertebrae 0.008572 1.285 SHISA9 Response to antipsychotic treatment
rs153091 Thyrotoxicosis 0.007153 1.266 SHISA9 Response to antipsychotic treatment
rs153091 Other cerebral degenerations 0.00552 0.6129 SHISA9 Response to antipsychotic treatment
rs1532085 Disorders of cornea 0.005818 1.198 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Thoracic neuritis/radiculitis 0.004718 0.8888 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Type 2 diabetic nephropathy 0.004697 0.81 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Secondary malignant neoplasm of liver 0.006145 1.371 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Insect bite 0.009999 0.8048 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Corneal opacity 0.009417 1.34 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Sebaceous cyst 0.005842 0.8789 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 stress incontinence, female 0.00852 1.18 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Abnormal mammogram 0.003387 1.198 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1532085 Abnormal findings on mammogram or breast exam 0.009362 1.119 LIPC Total Cholesterol, HDL Cholesterol, Triglycerides
rs1534166 Subdural hemorrhage (injury) 0.001124 1.833 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Hypertension 0.009169 1.089 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Intracranial hemorrhage (injury) 0.0002763 1.683 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Anomalies of pupillary function 0.009593 1.819 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Biliary cirrhosis 0.00327 2.254 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Elevated blood pressure reading 0.001515 1.183 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Symptoms affecting skin 0.003518 1.111 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Chronic pancreatitis 0.002425 1.738 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Type 2 diabetic ketoacidosis 0.002141 1.166 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 H. pylori 0.006304 1.509 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Carcinoma in situ of skin 0.005286 1.269 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Mood disorders 0.01099 0.9101 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Urinary complications 0.009784 1.464 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Postmenopausal hormone replacement 0.007902 1.307 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Acquired hypothyroidism 0.007575 1.772 SRPRB Carbohydrate-deficient transferrin concentration
rs1534166 Depression 0.005888 0.9008 SRPRB Carbohydrate-deficient transferrin concentration
rs153734 Osteomyelitis 0.007202 1.323 PRICKLE2 Folate levels
rs153734 Disease of tricuspid valve 0.003837 1.324 PRICKLE2 Folate levels
rs153734 Noninfectious disorders of lymphatic channels 0.0099 0.6942 PRICKLE2 Folate levels
rs153734 Extrinsic allergic alveolitis 0.00261 2.201 PRICKLE2 Folate levels
rs153734 Sprains and strains 0.009726 1.123 PRICKLE2 Folate levels
rs153734 Fracture of tibia and fibula 0.01026 0.7332 PRICKLE2 Folate levels
rs153734 Benign neoplasm of uterus 0.01037 1.234 PRICKLE2 Folate levels
rs153734 Spondylosis with myelopathy 0.006723 1.427 PRICKLE2 Folate levels
rs153734 Oliguria and anuria 0.002159 2.342 PRICKLE2 Folate levels
rs153734 Psychogenic disorder 0.0007665 1.645 PRICKLE2 Folate levels
rs153734 Chronic lymphocytic thyroiditis 0.009076 1.473 PRICKLE2 Folate levels
rs153734 Neck pain 0.00276 1.133 PRICKLE2 Folate levels
rs153734 Abnormal loss of weight and underweight 0.0002369 1.452 PRICKLE2 Folate levels
rs153734 Disorders of liver 0.01137 1.121 PRICKLE2 Folate levels
rs153734 Elevated C-reactive protein 0.009445 1.923 PRICKLE2 Folate levels
rs153734 Anemia NOS 0.009016 1.107 PRICKLE2 Folate levels
rs153734 Primary angle-closure glaucoma 0.01041 0.7887 PRICKLE2 Folate levels
rs153734 Spasm of muscle 0.001907 1.294 PRICKLE2 Folate levels
rs153734 Psychogenic and somatoform disorders 0.008653 1.302 PRICKLE2 Folate levels
rs153734 Strabismus (not specified as paralytic) 0.005445 1.283 PRICKLE2 Folate levels
rs153734 Althete's foot 0.001979 1.344 PRICKLE2 Folate levels
rs1547374 Multiple myeloma 0.001593 0.5154 TFF1 Pancreatic cancer
rs1547374 Diverticulosis and diverticulitis 0.004917 0.8909 TFF1 Pancreatic cancer
rs1547374 Other specified diseases of hair and hair follicles 0.008202 1.316 TFF1 Pancreatic cancer
rs1547374 Cerebral aneurysm 0.01006 0.5558 TFF1 Pancreatic cancer
rs1547374 Nonrheumatic tricuspid valve disorders 0.003927 1.489 TFF1 Pancreatic cancer
rs1547374 Cholecystitis without cholelithiasis 0.005527 0.7364 TFF1 Pancreatic cancer
rs1547374 Pulmonary collapse; interstitial/compensatory emphysema 0.002701 0.8273 TFF1 Pancreatic cancer
rs1547374 Herpes zoster with nervous system complications 0.009382 0.6168 TFF1 Pancreatic cancer
rs1547374 Diverticulosis 0.008272 0.892 TFF1 Pancreatic cancer
rs1547374 Joint/ligament sprain 0.005196 1.334 TFF1 Pancreatic cancer
rs1547374 Anemia of chronic disease 0.01141 0.8275 TFF1 Pancreatic cancer
rs1547374 Blindness and low vision 0.0004335 0.6719 TFF1 Pancreatic cancer
rs1547374 Bladder cancer 0.006842 1.281 TFF1 Pancreatic cancer
rs1547374 Abnormality of red blood cells 0.003767 2.044 TFF1 Pancreatic cancer
rs1547374 Bladder cancer and neoplasms 0.0104 1.257 TFF1 Pancreatic cancer
rs1547374 Hemiplegia 0.003927 0.702 TFF1 Pancreatic cancer
rs1550976 Cataract 0.007398 1.116 NTM Asperger disorder
rs1550976 Osteomyelitis 0.007643 1.294 NTM Asperger disorder
rs1550976 Dry eyes 0.01052 1.138 NTM Asperger disorder
rs1550976 Voice disturbance 0.0003659 1.296 NTM Asperger disorder
rs1550976 Nonsenile Cataract 0.009277 1.394 NTM Asperger disorder
rs1550976 Nonallopathic lesions NEC 0.005402 0.8724 NTM Asperger disorder
rs1550976 Failure to thrive 0.0005552 0.5974 NTM Asperger disorder
rs1550976 Raynaud's syndrome 0.008239 1.316 NTM Asperger disorder
rs1550976 Lack of normal physiological development 0.003745 0.679 NTM Asperger disorder
rs1550976 Duodenal ulcer 0.007034 0.722 NTM Asperger disorder
rs1564348 Mixed hyperlipidemia 0.001174 1.289 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Acquired spondylolisthesis 0.005647 0.6537 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Diplopia and disorders of binocular vision 0.001436 1.453 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Cancer of oropharynx 0.0004719 2.672 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Pulmonary embolism and infarction 0.003026 1.362 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Duodenitis 0.0004331 1.661 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Fracture of ribs 0.009837 0.7327 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Other disorders of back 0.008498 0.8147 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Cysts of the jaws 0.00986 2.318 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Glaucoma 0.005533 0.8565 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Cancer of mouth 0.005219 1.663 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Postlaminectomy syndrome 0.005822 0.5674 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 Mammographic microcalcification 0.01005 1.629 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1564348 pulmonary heart disease 0.0002502 1.292 SLC22A1 Total Cholesterol, LDL Cholesterol
rs1566039 Infestation 0.009054 0.5516 PAPD7 Sphingolipid levels
rs1566039 Dentofacial anomalies, including malocclusion 0.003622 1.601 PAPD7 Sphingolipid levels
rs1566039 Effects of radiation NOS 0.003032 1.529 PAPD7 Sphingolipid levels
rs1566039 Polyarteritis nodosa and allied conditions 0.0103 1.321 PAPD7 Sphingolipid levels
rs1566039 Polycythemia vera 0.002466 1.897 PAPD7 Sphingolipid levels
rs1566039 Systemic sclerosis 0.0005653 0.5268 PAPD7 Sphingolipid levels
rs1566039 Somatoform disorder 0.0003603 1.494 PAPD7 Sphingolipid levels
rs1566039 Tension headache 0.01076 1.225 PAPD7 Sphingolipid levels
rs1566039 Contact dermatitis and other eczema due to plants [except food] 0.007869 1.742 PAPD7 Sphingolipid levels
rs1566039 Anomalies of tooth position/malocclusion 0.00478 1.685 PAPD7 Sphingolipid levels
rs1566039 Other sprains and strains 0.01022 0.737 PAPD7 Sphingolipid levels
rs1566039 Swelling, mass, or lump in head and neck 0.004755 1.251 PAPD7 Sphingolipid levels
rs1566039 Psychogenic and somatoform disorders 0.003187 1.306 PAPD7 Sphingolipid levels
rs1568679 Suicidal ideation or attempt 0.005794 2.136 MEIS2 Response to antipsychotic treatment
rs1568679 Cancer of bone & connective tissue 0.01045 0.3723 MEIS2 Response to antipsychotic treatment
rs1568679 Spasm of muscle 0.008143 1.364 MEIS2 Response to antipsychotic treatment
rs1568679 Cystic mastopathy 0.006019 0.7497 MEIS2 Response to antipsychotic treatment
rs1568679 Benign mammary dysplasias 0.00828 0.7662 MEIS2 Response to antipsychotic treatment
rs1568679 Diseases of nail 0.009256 0.7715 MEIS2 Response to antipsychotic treatment
rs1568679 Cancer of the upper aerodigestive tract 0.007692 0.4527 MEIS2 Response to antipsychotic treatment
rs1568679 Blood vessel replaced 0.01086 0.2722 MEIS2 Response to antipsychotic treatment
rs1568679 Myoneural disorders 0.009559 2.212 MEIS2 Response to antipsychotic treatment
rs1568679 Elevated prostate specific antigen 0.001184 1.438 MEIS2 Response to antipsychotic treatment
rs1568679 Urinary tract infection 0.005042 1.192 MEIS2 Response to antipsychotic treatment
rs1568679 Other unspecified back disorders 0.00587 1.88 MEIS2 Response to antipsychotic treatment
rs1568679 Congenital anomalies of lower limb, including pelvic girdle 9.934e-05 2.922 MEIS2 Response to antipsychotic treatment
rs1648707 severe protein-calorie malnutrition 0.001373 0.5404 ADIPOQ Adiponectin levels
rs1648707 Mammographic microcalcification 0.01073 1.514 ADIPOQ Adiponectin levels
rs1648707 Impaction of intestine 0.006627 2.106 ADIPOQ Adiponectin levels
rs1648707 Pseudoexfoliation glaucoma 0.001649 0.5407 ADIPOQ Adiponectin levels
rs1648707 Nontoxic multinodular goiter 0.005188 1.274 ADIPOQ Adiponectin levels
rs1648707 Poisoning by psychotropic agents 0.007502 0.5089 ADIPOQ Adiponectin levels
rs1648707 Other specified intestinal malabsorption 0.005449 1.664 ADIPOQ Adiponectin levels
rs1648707 Other aneurysm 0.009438 1.179 ADIPOQ Adiponectin levels
rs1648707 Atrophic gastritis 0.008901 0.6505 ADIPOQ Adiponectin levels
rs1648707 Nonsenile Cataract 0.0024 0.674 ADIPOQ Adiponectin levels
rs1648707 Hypermetropia 0.008225 0.8771 ADIPOQ Adiponectin levels
rs1648707 Other disorders of stomach and duodenum 0.0002897 0.6927 ADIPOQ Adiponectin levels
rs1668871 Intestinal infection due to C. difficile 0.004348 1.392 TMCC2 Platelet counts
rs1668871 Cancer within the respiratory system 0.01146 0.8147 TMCC2 Platelet counts
rs1668871 Nontoxic uninodular goiter 0.005446 1.233 TMCC2 Platelet counts
rs1668871 Biliary cirrhosis 0.0008583 2.599 TMCC2 Platelet counts
rs1668871 Osteoarthrosis 0.006321 1.087 TMCC2 Platelet counts
rs1668871 Male genital disorders 0.0004251 1.422 TMCC2 Platelet counts
rs1668871 Osteoarthrosis NOS 0.005275 1.096 TMCC2 Platelet counts
rs1668871 Eating disorder 0.005275 1.643 TMCC2 Platelet counts
rs1668871 Cirrhosis of liver without mention of alcohol 0.001033 1.532 TMCC2 Platelet counts
rs1668871 Symptoms involving respiratory system 0.004915 0.8184 TMCC2 Platelet counts
rs1668871 Carcinoma in situ of skin 0.0006356 0.7438 TMCC2 Platelet counts
rs1668871 Neck pain 0.004719 1.105 TMCC2 Platelet counts
rs1668871 Endometriosis 0.001163 1.455 TMCC2 Platelet counts
rs1668871 Adverse effects of insulins and antidiabetic agents 0.0001238 0.3452 TMCC2 Platelet counts
rs1668871 Other benign neoplasm of connective and other soft tissue 0.01042 1.439 TMCC2 Platelet counts
rs1668871 Diseases of respiratory system 0.004001 0.8484 TMCC2 Platelet counts
rs1668871 Cancer, suspected or other 0.001256 0.8005 TMCC2 Platelet counts
rs1668871 Erectile dysfunction 0.004471 1.182 TMCC2 Platelet counts
rs1668871 Malignant neoplasm, other 0.004162 0.7971 TMCC2 Platelet counts
rs1668871 Asthma with exacerbation 0.007698 0.7192 TMCC2 Platelet counts
rs16826658 Angina pectoris 0.01151 0.8877 WNT4 Endometriosis
rs16826658 Abnormal sputum 0.005946 0.743 WNT4 Endometriosis
rs16826658 Erythematous conditions 0.007442 0.8864 WNT4 Endometriosis
rs16826658 Absent or infrequent menstruation 0.01141 0.6522 WNT4 Endometriosis
rs16826658 Other open wound of head and face 0.009457 1.203 WNT4 Endometriosis
rs16826658 Lesions of stomach and duodenum 0.008791 0.4576 WNT4 Endometriosis
rs16826658 Fracture of tibia and fibula 0.005195 1.288 WNT4 Endometriosis
rs16826658 Cornea replaced by transplant 0.008585 1.716 WNT4 Endometriosis
rs16826658 Glomerulonephritis 0.0009122 1.849 WNT4 Endometriosis
rs16826658 Eating disorder 0.00233 0.537 WNT4 Endometriosis
rs16826658 Nonrheumatic mitral valve disorders 0.01109 0.8768 WNT4 Endometriosis
rs16826658 Derangement of joint, non-traumatic 0.007448 0.8006 WNT4 Endometriosis
rs16826658 Secondary/extrinsic cardiomyopathies 0.009902 1.723 WNT4 Endometriosis
rs16826658 Dysmenorrhea 0.00314 0.6157 WNT4 Endometriosis
rs16826658 Osteoporosis 0.007876 1.129 WNT4 Endometriosis
rs16826658 Acquired deformities of finger 0.006395 0.6703 WNT4 Endometriosis
rs16826658 Skin neoplasm of uncertain behavior 0.004915 0.8218 WNT4 Endometriosis
rs16861990 Mitral valve stenosis and/or aortic valve stenosis 0.006453 0.6231 NME7 D-dimer levels
rs16861990 Phlebitis and thrombophlebitis of lower extremities 0.005728 1.453 NME7 D-dimer levels
rs16861990 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.003753 1.227 NME7 D-dimer levels
rs16861990 Alkalosis 0.0103 2.227 NME7 D-dimer levels
rs16861990 Light-headedness and vertigo 0.00543 1.203 NME7 D-dimer levels
rs16861990 Insect bite 0.008303 1.445 NME7 D-dimer levels
rs16861990 Fracture of ribs 0.005535 1.464 NME7 D-dimer levels
rs16861990 Coagulation defects 0.0005116 1.263 NME7 D-dimer levels
rs16861990 Uterine/Uterovaginal prolapse 0.002571 1.568 NME7 D-dimer levels
rs16861990 Venous embolism & thrombosis 0.001037 1.369 NME7 D-dimer levels
rs16861990 Phlebitis and thrombophlebitis 0.002011 1.446 NME7 D-dimer levels
rs16861990 Hypercoagulable state 2e-12 3.709 NME7 D-dimer levels
rs16861990 Congenital coagulation defects 2.069e-11 5.429 NME7 D-dimer levels
rs16861990 Clotting factor deficiency 1.523e-09 6.02 NME7 D-dimer levels
rs16886165 Complication of amputation stump 0.005658 2.012 MAP3K1 Breast cancer
rs16886165 Ankylosis of joint 0.001917 1.61 MAP3K1 Breast cancer
rs16886165 Inflammation of eyelids 0.001928 1.205 MAP3K1 Breast cancer
rs16886165 Dyspepsia and disorders of function of stomach 0.01047 1.199 MAP3K1 Breast cancer
rs16886165 Open wound of foot except toe(s) alone 0.008004 1.608 MAP3K1 Breast cancer
rs16886165 Mitral stenosis/insufficiency 0.01106 0.2713 MAP3K1 Breast cancer
rs16886165 Disorders of esophageal motility 0.002152 1.675 MAP3K1 Breast cancer
rs16886165 Other disorders of back 0.005962 0.8103 MAP3K1 Breast cancer
rs16886165 Seborrheic keratosis 0.007964 1.137 MAP3K1 Breast cancer
rs16886165 Disorders of penis 0.002588 1.488 MAP3K1 Breast cancer
rs16886165 Schizophrenia and other psychotic disorders 0.004554 1.262 MAP3K1 Breast cancer
rs16886165 Inflammation of the eye 0.01003 1.15 MAP3K1 Breast cancer
rs16886165 Peritoneal adhesions (postoperative) (postinfection) 0.0115 1.623 MAP3K1 Breast cancer
rs16892766 Ankylosing spondylitis 0.009873 2.582 EIF3H Colorectal cancer
rs16892766 Acute and chronic tonsillitis 0.01081 1.68 EIF3H Colorectal cancer
rs16892766 Neuralgia, neuritis, and radiculitis NOS 0.01023 1.337 EIF3H Colorectal cancer
rs16892766 Benign neoplasm of other parts of digestive system 0.0003235 1.72 EIF3H Colorectal cancer
rs16892766 Inflammatory spondylopathies 0.007386 1.801 EIF3H Colorectal cancer
rs16892766 Umbilical hernia 0.007606 1.471 EIF3H Colorectal cancer
rs16892766 Chronic tonsillitis and adenoiditis 0.007839 2.062 EIF3H Colorectal cancer
rs16892766 Respiratory failure; insufficiency; arrest 0.009411 0.7077 EIF3H Colorectal cancer
rs16892766 Injuries to the nervous system 0.01148 1.809 EIF3H Colorectal cancer
rs16892766 Protein-calorie malnutrition 0.002273 0.6915 EIF3H Colorectal cancer
rs16892766 Chronic venous hypertension 0.005815 2.632 EIF3H Colorectal cancer
rs16892766 Disorders of the pituitary gland and its hypothalamic control 0.01104 1.554 EIF3H Colorectal cancer
rs16928809 Polyneuropathy in diabetes 0.01101 0.7366 SLC22A18 Serum bilirubin levels
rs16928809 Seborrhea 0.008 2.228 SLC22A18 Serum bilirubin levels
rs16928809 Neoplasm of unspecified nature of digestive system 0.005862 1.635 SLC22A18 Serum bilirubin levels
rs16928809 Chronic nonalcoholic liver disease 0.0002762 0.5311 SLC22A18 Serum bilirubin levels
rs16928809 Costochondritis 0.005696 2.143 SLC22A18 Serum bilirubin levels
rs16928809 Torticollis 0.005481 1.855 SLC22A18 Serum bilirubin levels
rs16928809 Asthma with exacerbation 0.004928 1.591 SLC22A18 Serum bilirubin levels
rs16928809 Cervical cancer 0.01024 2.109 SLC22A18 Serum bilirubin levels
rs16928809 Benign neoplasm of other parts of digestive system 0.01029 0.5815 SLC22A18 Serum bilirubin levels
rs16928809 Chronic liver disease and cirrhosis 0.0003976 0.5678 SLC22A18 Serum bilirubin levels
rs16928809 Acquired deformities of finger 0.005258 1.684 SLC22A18 Serum bilirubin levels
rs16928809 Cerebral aneurysm 5.207e-05 2.534 SLC22A18 Serum bilirubin levels
rs16944141 Discoid lupus erythematosus 0.008903 1.807 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Asthma 0.0006431 1.309 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Chronic prostatitis 0.005304 1.974 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Benign neoplasm of skin 0.009097 0.8214 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Dyschromia and Vitiligo 0.009427 0.6686 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Excessive or frequent menstruation 0.008985 0.5981 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Unspecified monoarthritis 0.00949 1.991 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Stress fracture 0.005813 2.388 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Chronic laryngitis 0.008406 2.465 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Emphysema 0.011 1.461 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Abnormal pulmonary function 0.01003 2.756 MIR622 Prostate cancer (gene x gene interaction)
rs16944141 Prurigo 0.007677 1.521 MIR622 Prostate cancer (gene x gene interaction)
rs16991615 Deficiency of humoral immunity 0.00834 2.665 MCM8 Menopause
rs16991615 Osteitis deformans and osteopathies associated with other disorders 0.007037 2.14 MCM8 Menopause
rs16991615 Hydrocele 0.009997 1.909 MCM8 Menopause
rs16991615 Intestinal malabsorption NOS 0.01047 2.049 MCM8 Menopause
rs16991615 Viral Enteritis 0.001201 2.066 MCM8 Menopause
rs16991615 Cerebral ischemia 0.01035 1.274 MCM8 Menopause
rs16991615 Transient cerebral ischemia 0.007039 1.295 MCM8 Menopause
rs16991615 Alopecia 0.004729 1.632 MCM8 Menopause
rs16991615 Intracerebral hemorrhage 0.004037 2.147 MCM8 Menopause
rs16991615 Venous embolism & thrombosis 0.004174 0.7127 MCM8 Menopause
rs16991615 Chronic cystitis 0.01124 1.893 MCM8 Menopause
rs16991615 Elevated levels of transaminase or lactic acid dehydrogenase 0.005949 1.405 MCM8 Menopause
rs16991615 Localized adiposity 0.004673 2.571 MCM8 Menopause
rs16991615 Exostosis of jaw 0.00266 2.959 MCM8 Menopause
rs16991615 Other disorders of testis 0.006667 1.748 MCM8 Menopause
rs16991615 Other abnormality of urination 0.005026 1.435 MCM8 Menopause
rs17066096 Cirrhosis of liver without mention of alcohol 0.006985 1.459 IL22RA2 Multiple sclerosis
rs17066096 Hemorrhage of gastrointestinal tract 0.01054 1.183 IL22RA2 Multiple sclerosis
rs17066096 Rheumatoid arthritis 0.003025 1.271 IL22RA2 Multiple sclerosis
rs17066096 Retinal detachment with retinal defect 0.006982 1.424 IL22RA2 Multiple sclerosis
rs17066096 Liver abscess and sequelae of chronic liver disease 0.008834 1.552 IL22RA2 Multiple sclerosis
rs17066096 Other paralytic syndromes 0.004714 1.539 IL22RA2 Multiple sclerosis
rs17066096 Hemoptysis 0.003212 1.406 IL22RA2 Multiple sclerosis
rs17066096 Chronic liver disease and cirrhosis 0.00422 1.263 IL22RA2 Multiple sclerosis
rs17066096 Respiratory failure; insufficiency; arrest 0.01013 1.203 IL22RA2 Multiple sclerosis
rs17066096 Retinal vascular changes and abnomalities 0.0102 1.234 IL22RA2 Multiple sclerosis
rs17066096 Rheumatoid arthritis & related inflammatory polyarthropathies 0.002885 1.241 IL22RA2 Multiple sclerosis
rs17066096 Other symptoms involving abdomen and pelvis 0.005744 1.161 IL22RA2 Multiple sclerosis
rs17066096 Portal hypertension 0.01118 1.675 IL22RA2 Multiple sclerosis
rs17066096 Pulmonary collapse; interstitial/compensatory emphysema 0.001325 1.227 IL22RA2 Multiple sclerosis
rs17066096 Peripheral or central vertigo 0.003077 1.257 IL22RA2 Multiple sclerosis
rs17066096 Age-related macular degeneration 0.006957 1.228 IL22RA2 Multiple sclerosis
rs17066096 Abnormal sputum 0.001804 1.409 IL22RA2 Multiple sclerosis
rs17066096 Respiratory abnormalities 6.109e-05 1.535 IL22RA2 Multiple sclerosis
rs17066096 Eye infection, viral 0.007761 1.428 IL22RA2 Multiple sclerosis
rs17111394 Other disorders of gallbladder 0.01038 1.631 TSHR Optic disc parameters
rs17111394 Skin cancer 0.005905 0.8796 TSHR Optic disc parameters
rs17111394 Pulmonary congestion and hypostasis 0.007712 0.6289 TSHR Optic disc parameters
rs17111394 Abnormal weight gain 0.001452 1.501 TSHR Optic disc parameters
rs17111394 Non-melanoma skin cancer 0.009137 0.8799 TSHR Optic disc parameters
rs17111394 Retinoschisis and retinal cysts 0.005901 2.215 TSHR Optic disc parameters
rs17111394 Abnormal results of function study of liver 0.005795 1.273 TSHR Optic disc parameters
rs17111394 Diseases of spleen 0.008828 1.91 TSHR Optic disc parameters
rs17111394 Nonsenile Cataract 0.008807 1.453 TSHR Optic disc parameters
rs17111394 Bundle branch block 0.01071 0.7955 TSHR Optic disc parameters
rs17111394 Symptoms involving digestive system 0.01073 1.259 TSHR Optic disc parameters
rs17111394 Delirium due to conditions classified elsewhere 0.01117 0.6443 TSHR Optic disc parameters
rs17277546 Periapical abscess 0.01028 1.457 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Malignant neoplasm, other 0.003915 1.578 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Aplastic anemia 0.01151 0.3509 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Impaired fasting glucose 0.006982 1.407 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Fibroadenosis of breast 0.008292 3.207 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Fractur of unspecified part of femur 0.006238 1.878 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Cancer of kidney and urinary organs 0.01018 0.5927 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Polymyalgia Rheumatica 0.0008098 1.736 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Bladder cancer 0.003702 0.4074 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Bladder cancer and neoplasms 0.001894 0.3831 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Hemorrhage or hematoma complicating a procedure 0.0006496 1.596 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Malunion fracture 0.01052 1.859 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Fracture of pelvis 0.003816 1.778 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17277546 Diseases of pulp and periapical tissues 0.009044 1.446 TRIM4 Dehydroepiandrosterone sulphate levels, Androsterone sulfate
rs17291650 Other derangement of joint 0.003471 0.5697 ATF1 Sudden cardiac arrest
rs17291650 Hypovolemia 0.007208 0.8155 ATF1 Sudden cardiac arrest
rs17291650 Fracture of unspecified bones 0.005722 0.7717 ATF1 Sudden cardiac arrest
rs17291650 Inflammatory conditions of jaw 0.0041 1.893 ATF1 Sudden cardiac arrest
rs17291650 Fracture of radius and ulna 0.004104 0.7286 ATF1 Sudden cardiac arrest
rs17291650 Fracture of ribs 0.008905 0.6779 ATF1 Sudden cardiac arrest
rs17291650 Fracture of hand or wrist 0.009486 0.7645 ATF1 Sudden cardiac arrest
rs17291650 Fracture of lower limb 0.003931 0.7741 ATF1 Sudden cardiac arrest
rs17291650 Colles' fracture 0.009174 0.5406 ATF1 Sudden cardiac arrest
rs17291650 Fracture of foot 0.009953 0.7244 ATF1 Sudden cardiac arrest
rs17291650 Phosphorus metabolism disorder 0.007451 1.642 ATF1 Sudden cardiac arrest
rs17291650 Ankylosis of joint 0.0006208 0.2903 ATF1 Sudden cardiac arrest
rs17291650 Acute pericarditis 0.00657 2.424 ATF1 Sudden cardiac arrest
rs17291650 Rheumatoid arthritis 0.0081 0.6885 ATF1 Sudden cardiac arrest
rs17291650 progressive myopia 0.01002 1.984 ATF1 Sudden cardiac arrest
rs17291650 Rheumatoid arthritis & related inflammatory polyarthropathies 0.001091 0.6592 ATF1 Sudden cardiac arrest
rs17291650 Genu valgum or varum (acquired) 0.003074 0.4195 ATF1 Sudden cardiac arrest
rs17291650 Fracture of upper limb 0.0002088 0.718 ATF1 Sudden cardiac arrest
rs17415853 E. coli 0.005473 1.84 EPS8 Serum ferritin levels
rs17415853 Varicose veins 0.007507 0.6538 EPS8 Serum ferritin levels
rs17415853 Other disorders of pancreatic internal secretion 0.0007193 3.081 EPS8 Serum ferritin levels
rs17415853 Symptoms involving head and neck 0.007905 1.524 EPS8 Serum ferritin levels
rs17415853 Other specified disorders of pancreatic internal secretion 0.0005846 3.142 EPS8 Serum ferritin levels
rs17415853 Osteoarthrosis; localized, secondary 0.003099 2.525 EPS8 Serum ferritin levels
rs17415853 Allergies, other 0.00365 1.745 EPS8 Serum ferritin levels
rs17415853 Esophageal bleeding 0.004138 2.717 EPS8 Serum ferritin levels
rs17415853 Other forms of chronic heart disease 0.00563 1.542 EPS8 Serum ferritin levels
rs17415853 Complications of transplants and reattached limbs 0.003653 2.504 EPS8 Serum ferritin levels
rs17415853 Colles' fracture 0.006726 2.045 EPS8 Serum ferritin levels
rs17415853 Cervical cancer and dysplasia 0.003943 1.818 EPS8 Serum ferritin levels
rs174570 Abnormal loss of weight and underweight 0.007752 0.6712 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Vertiginous syndromes and other disorders of vestibular system 0.006411 1.139 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Acute periodontitis 0.009569 1.485 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Celiac disease 0.006707 1.969 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Genitourinary congenital anomalies 0.0009525 1.612 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Light-headedness and vertigo 0.006284 1.145 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Cyst of kidney, acquired 0.002403 1.459 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Celiac or tropical sprue 0.005255 1.98 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Other specified diseases of sebaceous glands 0.01018 1.293 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Open wound of eye or eyelid 0.01055 2.107 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Infertility, female 0.007218 0.3159 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Pleurisy; pleural effusion 0.009189 0.8239 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs174570 Protein-calorie malnutrition 0.005215 0.7774 FADS2 Total Cholesterol, LDL Cholesterol, HDL Cholesterol
rs17525472 Circumscribed scleroderma 0.009693 1.537 SCG3 Asthma
rs17525472 Type 1 diabetic ketoacidosis 0.008222 0.5142 SCG3 Asthma
rs17525472 Cancer of the lower GI tract 0.003296 1.551 SCG3 Asthma
rs17525472 Acute bronchospasm 0.005176 2.51 SCG3 Asthma
rs17525472 Periodontitis (acute or chronic) 0.001854 1.372 SCG3 Asthma
rs17525472 Diseases of hard tissues of teeth 0.0004614 1.369 SCG3 Asthma
rs17525472 Carcinoma in situ of skin 0.009132 1.34 SCG3 Asthma
rs17525472 Abnormal coagulation profile 0.007619 1.493 SCG3 Asthma
rs17525472 Gingival and periodontal diseases 0.007376 1.278 SCG3 Asthma
rs17525472 Abnormal results of function studies 0.0001375 2.2 SCG3 Asthma
rs17525472 Viral warts & HPV 0.01009 1.215 SCG3 Asthma
rs17525472 Abnormal sputum 0.008627 1.442 SCG3 Asthma
rs17525472 Dental caries 0.0009077 1.359 SCG3 Asthma
rs17525472 Hemoptysis 0.008111 1.472 SCG3 Asthma
rs17525472 Intestinal malabsorption 0.01035 1.496 SCG3 Asthma
rs17525472 Chronic periodontitis 6.318e-05 1.559 SCG3 Asthma
rs17525472 Symptoms involving digestive system 0.01126 1.307 SCG3 Asthma
rs17525472 Allergic reaction to food 0.009987 2.051 SCG3 Asthma
rs17525472 Atherosclerosis of aorta 0.008869 1.371 SCG3 Asthma
rs17525472 Retinal vascular changes and abnomalities 0.001702 1.381 SCG3 Asthma
rs17525472 Optic atrophy 0.004119 1.667 SCG3 Asthma
rs17525472 Arthropathy NOS involving multiple sites 0.00491 1.841 SCG3 Asthma
rs1755289 Varicose veins 0.009134 1.147 SH3GL2 Multiple sclerosis
rs1755289 Aseptic necrosis of bone 7.35e-05 1.907 SH3GL2 Multiple sclerosis
rs1755289 Develomental delays and disorders 0.003267 0.7558 SH3GL2 Multiple sclerosis
rs1755289 Lupus erythematosus 0.003519 1.949 SH3GL2 Multiple sclerosis
rs1755289 Dermatomycoses 0.00332 1.737 SH3GL2 Multiple sclerosis
rs1755289 Pulmonary collapse; interstitial/compensatory emphysema 0.003926 1.181 SH3GL2 Multiple sclerosis
rs1755289 Benign neoplasm of bone and articular cartilage 0.003388 1.759 SH3GL2 Multiple sclerosis
rs1755289 Varicose veins of lower extremity 0.006078 1.162 SH3GL2 Multiple sclerosis
rs1755289 Acquired absence of breast 0.005707 0.7407 SH3GL2 Multiple sclerosis
rs1755289 Disturbances in tooth eruption 0.008238 0.7352 SH3GL2 Multiple sclerosis
rs1755289 Scoliosis 0.00785 0.7605 SH3GL2 Multiple sclerosis
rs1755289 Disorders of cervical region 0.007378 0.7319 SH3GL2 Multiple sclerosis
rs17584499 Urticaria 0.007303 0.7524 PTPRD Type 2 diabetes
rs17584499 Intracranial hemorrhage 0.007321 0.6753 PTPRD Type 2 diabetes
rs17584499 Ischemic Heart Disease 0.008935 0.9045 PTPRD Type 2 diabetes
rs17584499 Liver abscess and sequelae of chronic liver disease 0.007552 1.614 PTPRD Type 2 diabetes
rs17584499 Coronary atherosclerosis 0.01042 0.9014 PTPRD Type 2 diabetes
rs17584499 Acute bronchospasm 0.002386 2.451 PTPRD Type 2 diabetes
rs17584499 Pleurisy; pleural effusion 0.001205 1.21 PTPRD Type 2 diabetes
rs17584499 Portal hypertension 0.001145 1.983 PTPRD Type 2 diabetes
rs17584499 Posttraumatic wound infection 0.00658 0.3412 PTPRD Type 2 diabetes
rs17584499 Myocardial infarction 0.006576 0.8553 PTPRD Type 2 diabetes
rs17584499 Microscopic hematuria 0.002993 0.5037 PTPRD Type 2 diabetes
rs17584499 Congenital anomalies of great vessels 0.004277 2.096 PTPRD Type 2 diabetes
rs17584499 Esophageal bleeding 0.0102 1.732 PTPRD Type 2 diabetes
rs17584499 Photodermatitis & sunburn 0.00416 0.8001 PTPRD Type 2 diabetes
rs17584499 Gastrointestinal hemorrhage 0.007917 1.129 PTPRD Type 2 diabetes
rs17638629 Disorders of binocular eye movements 0.007476 0.5566 ZNF788 Cognitive performance
rs17638629 Candidiasis 0.009611 0.6023 ZNF788 Cognitive performance
rs17638629 Chronic ulcer of unspecified site 0.009629 0.3951 ZNF788 Cognitive performance
rs17638629 Strabismus (not specified as paralytic) 0.009399 0.5036 ZNF788 Cognitive performance
rs17638629 Congenital anomalies of great vessels 0.009083 2.841 ZNF788 Cognitive performance
rs17646946 Cardiac arrest 0.001761 1.763 TCHHL1 Hair morphology
rs17646946 Heart valve replaced 0.0007095 1.433 TCHHL1 Hair morphology
rs17646946 Stomatitis and mucositis 0.01119 0.6537 TCHHL1 Hair morphology
rs17646946 Degeneration of intervertebral disc 0.005125 0.8657 TCHHL1 Hair morphology
rs17646946 Subdural hemorrhage (injury) 0.00478 1.754 TCHHL1 Hair morphology
rs17646946 Depression 0.0109 0.8961 TCHHL1 Hair morphology
rs17646946 Acid-base balance disorder 0.009158 1.341 TCHHL1 Hair morphology
rs17646946 Spinal stenosis 0.003173 0.8452 TCHHL1 Hair morphology
rs17646946 Parasomnia 0.0114 1.651 TCHHL1 Hair morphology
rs17646946 Megaloblastic anemia 0.0006547 1.531 TCHHL1 Hair morphology
rs17646946 Bullous dermatoses 0.001046 2.169 TCHHL1 Hair morphology
rs17646946 Alopecia Areata 0.006284 2.065 TCHHL1 Hair morphology
rs17646946 Diseases of the oral soft tissues 0.007554 0.8231 TCHHL1 Hair morphology
rs17646946 Intracranial hemorrhage (injury) 0.009332 1.505 TCHHL1 Hair morphology
rs17646946 Injuries to the nervous system 0.009361 1.582 TCHHL1 Hair morphology
rs17646946 Valvular heart disease/ heart chambers 0.0005515 2.095 TCHHL1 Hair morphology
rs17646946 Back pain 0.01086 0.912 TCHHL1 Hair morphology
rs17646946 Acidosis 0.01071 1.4 TCHHL1 Hair morphology
rs17646946 Other dyschromia 0.004592 1.311 TCHHL1 Hair morphology
rs17646946 Cerebral atherosclerosis 0.006886 0.4693 TCHHL1 Hair morphology
rs17662626 Idiopathic fibrosing alveolitis 0.002455 2.501 PCGEM1 Schizophrenia
rs17662626 Other alveolar and parietoalveolar pneumonopathy 0.01112 1.974 PCGEM1 Schizophrenia
rs17662626 Irregular menstrual bleeding 0.01012 2.03 PCGEM1 Schizophrenia
rs17662626 Vitamin deficiency 0.008176 0.7175 PCGEM1 Schizophrenia
rs17662626 Acute osteomyelitis 0.01007 1.959 PCGEM1 Schizophrenia
rs17662626 Malaise and fatigue 0.006595 0.8541 PCGEM1 Schizophrenia
rs17662626 Dermatosis NOS 0.005948 0.8183 PCGEM1 Schizophrenia
rs17662626 Photodermatitis & sunburn 0.008769 0.7238 PCGEM1 Schizophrenia
rs17662626 Sleep apnea 0.00474 0.79 PCGEM1 Schizophrenia
rs17662626 Renal failure NOS 0.008119 0.4819 PCGEM1 Schizophrenia
rs17696736 Aortic aneurysm 0.005149 1.212 NAA25 Type 1 diabetes
rs17696736 Impaired fasting glucose 0.007954 0.8462 NAA25 Type 1 diabetes
rs17696736 Anal and rectal polyp 0.008345 0.8028 NAA25 Type 1 diabetes
rs17696736 Type 2 diabetic nephropathy 0.003832 0.81 NAA25 Type 1 diabetes
rs17696736 Retinoschisis and retinal cysts 0.001274 2.43 NAA25 Type 1 diabetes
rs17696736 Atherosclerosis of the extremities 0.002635 1.159 NAA25 Type 1 diabetes
rs17696736 Abnormal findings on mammogram or breast exam 0.008056 1.12 NAA25 Type 1 diabetes
rs17696736 Mechanical complications of cardiac/vascular device, implant, and graft 0.0002792 1.335 NAA25 Type 1 diabetes
rs17696736 Other aneurysm 0.00711 1.182 NAA25 Type 1 diabetes
rs17696736 Mastodynia 0.005788 1.283 NAA25 Type 1 diabetes
rs17696736 Ventricular fibrillation & flutter 0.001522 0.5496 NAA25 Type 1 diabetes
rs17696736 Hypothyroidism 0.0006531 1.131 NAA25 Type 1 diabetes
rs17696736 Atherosclerosis 0.006844 1.124 NAA25 Type 1 diabetes
rs17696736 Peripheral arterial disease 0.005652 1.131 NAA25 Type 1 diabetes
rs17696736 Insomnia 0.006256 0.8562 NAA25 Type 1 diabetes
rs17696736 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.0005808 1.234 NAA25 Type 1 diabetes
rs17696736 Abdominal aortic aneurysm 0.006319 1.242 NAA25 Type 1 diabetes
rs17696736 Endometriosis 0.005688 0.7172 NAA25 Type 1 diabetes
rs17696736 Peyronie's disease 0.003004 1.938 NAA25 Type 1 diabetes
rs17760296 Keloid scar 0.008878 1.709 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Hypovolemia 0.006588 1.162 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Chronic sinusitis 0.002203 1.184 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Acute pericarditis 0.0009342 2.505 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Intracerebral hemorrhage 0.01148 0.4663 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Rheumatic fever / chorea 0.0006327 2.41 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Chronic venous hypertension 0.009675 2.02 NOG Nonsyndromic cleft lip with or without cleft palate
rs17760296 Other disorders of biliary tract 0.008536 1.579 NOG Nonsyndromic cleft lip with or without cleft palate
rs17763373 Uterine cancer 0.0104 1.74 CPEB4 Prion diseases
rs17763373 Secondary malignancy of lymph nodes 0.001742 1.588 CPEB4 Prion diseases
rs17763373 Arterial embolism and thrombosis 0.003878 0.5507 CPEB4 Prion diseases
rs17763373 Aphasia/speech disturbance 0.007681 1.448 CPEB4 Prion diseases
rs17763373 Inflammation of the eye 0.01099 0.8042 CPEB4 Prion diseases
rs17763373 Abnormal tumor markers, elevated CEA or CA 125 0.006017 2.766 CPEB4 Prion diseases
rs17763373 Contact and allergic dermatitis of eyelid 0.005346 2.374 CPEB4 Prion diseases
rs17763373 Arthropathy NOS 0.009937 1.345 CPEB4 Prion diseases
rs17763373 Adverse effects of antibacterials (not penicillins) 0.003108 2.298 CPEB4 Prion diseases
rs17763373 Inflammation of eyelids 0.01001 0.7816 CPEB4 Prion diseases
rs17763373 Pathological, developmental or recurrent dislocation 0.008111 2.494 CPEB4 Prion diseases
rs17763373 Other arthropathies 0.002414 1.272 CPEB4 Prion diseases
rs17763373 Secondary malignant neoplasm 0.01128 1.295 CPEB4 Prion diseases
rs17774966 Hypertension complicating pregnancy 0.002259 2.332 TUSC1 Entorhinal cortical thickness
rs17774966 Hypertensive heart and/or renal disease 0.001057 0.7759 TUSC1 Entorhinal cortical thickness
rs17774966 Chronic ulcer of skin 0.002683 0.8384 TUSC1 Entorhinal cortical thickness
rs17774966 Vitamin B-complex deficiencies 0.002933 0.7318 TUSC1 Entorhinal cortical thickness
rs17774966 Chronic ulcer of leg or foot 0.00306 0.8146 TUSC1 Entorhinal cortical thickness
rs17774966 Cancer of the digestive organs and peritoneum 0.01034 1.509 TUSC1 Entorhinal cortical thickness
rs17774966 Rotator cuff (capsule) sprain 0.01038 1.23 TUSC1 Entorhinal cortical thickness
rs17774966 Osteoarthrosis; localized, secondary 0.01083 1.627 TUSC1 Entorhinal cortical thickness
rs17774966 Cervicocranial/Cervicobrachial syndrome 0.004695 1.329 TUSC1 Entorhinal cortical thickness
rs17774966 Anal and rectal polyp 0.008625 0.7435 TUSC1 Entorhinal cortical thickness
rs17774966 Disorders of sacrum 0.005215 1.316 TUSC1 Entorhinal cortical thickness
rs17774966 Fasciitis 0.004428 1.218 TUSC1 Entorhinal cortical thickness
rs17774966 Urinary tract infection 0.006185 0.8838 TUSC1 Entorhinal cortical thickness
rs17774966 Disorders of muscle, ligament, and fascia 0.003619 1.217 TUSC1 Entorhinal cortical thickness
rs17774966 Symptoms and disorders of the joints 0.003629 1.16 TUSC1 Entorhinal cortical thickness
rs17774966 Lipoid metabolism disorder NOS 0.00149 1.423 TUSC1 Entorhinal cortical thickness
rs17774966 Hypertensive chronic kidney disease 0.004446 0.7808 TUSC1 Entorhinal cortical thickness
rs17774966 Disorders of synovium, tendon, and bursa 0.00621 1.148 TUSC1 Entorhinal cortical thickness
rs17774966 Cervicitis and endocervicitis 0.006101 1.704 TUSC1 Entorhinal cortical thickness
rs17774966 Ischemic Heart Disease 0.009655 0.904 TUSC1 Entorhinal cortical thickness
rs17774966 Altered mental status 0.009636 0.7221 TUSC1 Entorhinal cortical thickness
rs17774966 End stage renal disease 0.01067 0.6225 TUSC1 Entorhinal cortical thickness
rs17793829 Renal dialysis 0.009005 0.6214 TTC7B Cytomegalovirus antibody response
rs17793829 Retinal hemorrhage/ischemia 0.00211 1.507 TTC7B Cytomegalovirus antibody response
rs17793829 Other disorders of circulatory system 0.001697 0.8208 TTC7B Cytomegalovirus antibody response
rs17793829 Other dermatoses 0.003742 1.122 TTC7B Cytomegalovirus antibody response
rs17793829 Immunity deficiency 0.003741 0.3998 TTC7B Cytomegalovirus antibody response
rs17793829 Seborrheic keratosis 0.0007058 1.158 TTC7B Cytomegalovirus antibody response
rs17793829 Circulatory disease NEC 0.002247 0.806 TTC7B Cytomegalovirus antibody response
rs17793829 Other cardiac conduction disorders 0.009307 1.741 TTC7B Cytomegalovirus antibody response
rs17793829 Atrophic gastritis 0.001398 1.636 TTC7B Cytomegalovirus antibody response
rs17793829 Gastritis and duodenitis 9.808e-05 1.249 TTC7B Cytomegalovirus antibody response
rs17793829 Gastritis and duodenitis, NOS 0.003456 1.28 TTC7B Cytomegalovirus antibody response
rs17793829 Hemangioma and lymphangioma, any site 0.0008682 1.417 TTC7B Cytomegalovirus antibody response
rs17793829 Anomalies of jaw size/symmetry 0.004628 2.161 TTC7B Cytomegalovirus antibody response
rs17793829 Retinal disorders 0.003234 1.149 TTC7B Cytomegalovirus antibody response
rs17793829 Meningitis 0.002636 1.889 TTC7B Cytomegalovirus antibody response
rs17793829 Benign neoplasm of skin 0.0008573 1.155 TTC7B Cytomegalovirus antibody response
rs17793829 Kidney replaced by transpant 0.005397 0.5784 TTC7B Cytomegalovirus antibody response
rs17793829 Testicular hypofunction 0.008506 1.442 TTC7B Cytomegalovirus antibody response
rs1800562 Disorders of cervical region 6.737e-05 2.015 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Adrenal hypofunction 0.007443 2.052 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Disorders of refraction and accommodation 0.00175 1.259 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Iron deficiency anemias NOS 0.001527 0.7151 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Edema 0.007657 1.211 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Traumatic arthropathy 0.01109 2.024 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 CNS infection and poliomyelitis 0.005992 2.132 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Iron deficiency anemias 0.001725 0.7008 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.007556 2.913 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Other disorders of bone and cartilage 0.003854 1.456 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Disorders of sweat glands 0.001038 1.639 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Hypermetropia 0.0005697 1.403 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Polycythemia vera, secondary 0.004248 2.165 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Skin cancer 0.0003708 1.27 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Eosinophilia 0.0001859 3.002 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Diseases of sebaceous glands 0.004228 1.235 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Other abnormality of urination 0.0007062 1.527 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Other congenital anomalies of skin 0.0007272 2.067 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Frequency of urination and polyuria 0.009871 1.25 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Retinoschisis and retinal cysts 0.009263 2.574 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Non-melanoma skin cancer 0.001005 1.262 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Torticollis 0.0005442 2.321 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Other specified diseases of sebaceous glands 0.00453 1.48 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800562 Iron metabolism disorder 3.409e-25 12.27 HFE Mean corpuscular hemoglobin, Glycated hemoglobin, LDL Cholesterol, Transferrin saturation, Serum iron, Hematocrit, Total Transferrin, Mean corpuscular volume, Total Cholesterol, Serum transferrin, Ferritin concentration, Serum ferritin
rs1800775 Cerebral aneurysm 0.005014 0.5831 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Macular degeneration 0.003263 1.139 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Pervasive developmental disorders 0.006321 0.6371 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Esophageal atresia/tracheoesophageal fistula 0.001229 1.915 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Mucous polyp of cervix 0.008911 0.7262 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Inflammatory bowel disease 0.007505 1.319 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Chronic lymphocytic thyroiditis 0.00714 0.6972 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Swelling of limb 0.01038 1.156 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Lesions of stomach and duodenum 0.0101 1.905 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Other disorders of urethra and urinary tract 0.01111 0.8361 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Congenital deformities of feet 0.01104 0.774 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Polyarteritis nodosa and allied conditions 0.002284 1.388 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Retinal disorders 0.008095 1.107 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800775 Other disorders of middle ear and mastoid 0.0006579 1.61 CETP HDL Cholesterol, Apolipoprotein A-1
rs1800961 Extrinsic allergic alveolitis 0.001435 3.656 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Other cerebral degenerations 0.002351 2.146 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Malignant neoplasm of renal pelvis 0.002245 3.731 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Symptomatic artificial menopause 0.007998 2.42 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Acidosis 0.001798 2.106 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Hypocalcemia 0.01042 1.994 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Cachexia 0.0005511 4.02 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Sinoatrial node dysfunction 0.007842 0.3716 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Spirochetal infection 0.005994 2.312 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Acid-base balance disorder 0.004196 1.838 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Intracerebral hemorrhage 0.004918 2.45 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Optic atrophy 0.007916 2.115 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Polyp of female genital organs 0.003143 1.749 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Polyp of corpus uteri 0.003843 2.043 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Lyme disease 0.004394 2.389 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1800961 Prurigo 0.002142 1.84 HNF4A HDL Cholesterol, C-reactive protein, Total Cholesterol
rs1801133 Alzheimer's disease 0.01097 1.178 MTHFR Homocysteine levels
rs1801133 Insect bite 0.00328 1.268 MTHFR Homocysteine levels
rs1801133 Dementias 0.0006514 1.206 MTHFR Homocysteine levels
rs1801133 Dystrophy of female genital tract 0.004088 0.3913 MTHFR Homocysteine levels
rs1801133 Gastrointestinal hemorrhage 0.01048 1.105 MTHFR Homocysteine levels
rs1801133 Acute bronchitis and bronchiolitis 0.01085 1.122 MTHFR Homocysteine levels
rs1801133 Senile dementia 0.004151 1.256 MTHFR Homocysteine levels
rs1801133 Delirium dementia and amnestic disorders 0.0008675 1.171 MTHFR Homocysteine levels
rs1801133 Angina pectoris 0.007287 1.136 MTHFR Homocysteine levels
rs1801133 Hyperventilation 0.01038 0.5446 MTHFR Homocysteine levels
rs1801133 Diffuse diseases of connective tissue 0.004595 1.287 MTHFR Homocysteine levels
rs1801239 Phosphorus metabolism disorder 0.009053 1.609 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Benign neoplasm of uterus 0.005338 1.832 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Other disorders of eyelids 0.005396 0.7886 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Diseases of blood and blood-forming organs 0.003802 0.6499 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Diseases of the salivary glands 0.0001792 1.635 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Sacroiliitis NEC 0.00945 2.039 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Mental retardation 0.0005282 2.948 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Schizoid personality disorder 0.006412 1.972 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Second degree AV block 0.00783 0.3877 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Acute bronchitis and bronchiolitis 0.001147 0.7875 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Acute posthemorrhagic anemia 0.007967 1.266 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Cardiomyopathy 0.008455 0.7436 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Hallux rigidus 0.004116 1.635 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Sialoadenitis 0.0002518 1.962 CUBN Urinary albumin-to-creatinine ratio
rs1801239 Ptosis of eyelid 0.003772 0.7043 CUBN Urinary albumin-to-creatinine ratio
rs1801274 Abnormal kidney function 0.00712 2 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Cyst and pseudocyst of pancreas 0.006484 0.6138 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Symptoms involving urinary system 0.001643 0.7716 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Reflux esophagitis 0.003342 0.8142 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Occlusion and stenosis of precerebral arteries 0.005725 1.135 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Cellulitis and abscess of face 0.006335 0.7295 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Acquired hypothyroidism 0.001865 1.999 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Duodenitis 0.004851 0.7113 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Other alveolar and parietoalveolar pneumonopathy 0.004566 1.697 FCGR2A Kawasaki disease, Ulcerative colitis
rs1801274 Otitis externa 0.008962 0.8469 FCGR2A Kawasaki disease, Ulcerative colitis
rs1816002 Cancer of the digestive organs and peritoneum 0.0007172 0.6056 ADAMTS14 Weight
rs1816002 Alzheimer's disease 0.005636 0.8454 ADAMTS14 Weight
rs1816002 Nervous system congenital anomalies 0.002044 0.6643 ADAMTS14 Weight
rs1816002 Megaloblastic anemia 0.004532 0.7271 ADAMTS14 Weight
rs1816002 Gestational diabetes 0.01123 0.4785 ADAMTS14 Weight
rs1816002 Chronic pain syndrome 0.008522 0.6014 ADAMTS14 Weight
rs1816002 Neoplasm of unspecified nature of digestive system 0.002856 0.6714 ADAMTS14 Weight
rs1816002 Abnormal thyroid function 0.005029 0.7791 ADAMTS14 Weight
rs1816002 Anomalies of pupillary function 0.00569 1.917 ADAMTS14 Weight
rs1816002 Senile dementia 0.003049 0.8046 ADAMTS14 Weight
rs1816002 Chronic airway obstruction 0.008105 1.109 ADAMTS14 Weight
rs1816002 Abdominal pain 0.007697 1.08 ADAMTS14 Weight
rs1816002 Other specified erythematous conditions 0.005171 0.7558 ADAMTS14 Weight
rs1816002 Secondary malignancy of lymph nodes 0.008074 0.7962 ADAMTS14 Weight
rs183266 Gastroparesis 8.746e-06 2.691 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Abnormal pulmonary function 0.00769 2.469 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Type 1 diabetic neuropathy 0.00153 1.749 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Other disorders of bone and cartilage 0.005169 1.332 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Osteopenia 0.008626 1.193 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Hyperosmolality and/or hypernatremia 0.009651 1.622 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Anemia in chronic kidney disease 0.0004849 0.4857 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Acute appendicitis 0.009954 1.637 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Type 1 diabetic retinopathy 0.003159 1.664 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Iron deficiency anemia secondary to blood loss 0.008198 0.573 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Raynaud's syndrome 0.002172 1.51 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Allergy to serum or vaccine 0.004428 2.113 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Secondary hyperparathyroidism (of renal origin) 0.006541 0.5347 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Renal osteodystrophy 0.009292 0.4088 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Disorders of function of stomach 0.004817 1.248 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Type 1 diabetes nephropathy 0.0006462 2.13 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Disorders resulting from impaired renal function 0.002108 0.5589 IRF2BPL Adverse response to lamotrigine and phenytoin
rs183266 Noninfectious dermatoses of eyelid 0.007222 0.2056 IRF2BPL Adverse response to lamotrigine and phenytoin
rs1837253 Symptoms and disorders of the joints 0.0005815 1.169 TSLP Asthma
rs1837253 Stiffness of joint 0.001602 1.26 TSLP Asthma
rs1837253 Symptoms affecting skin 0.009018 1.102 TSLP Asthma
rs1837253 Cancer of the lower GI tract 0.003754 1.422 TSLP Asthma
rs1837253 Colorectal cancer 0.0004683 1.32 TSLP Asthma
rs1837253 Hypoventilation 0.009498 0.4905 TSLP Asthma
rs1837253 Adjustment reaction 0.0009504 1.215 TSLP Asthma
rs1837253 Colon cancer 0.000848 1.326 TSLP Asthma
rs1837253 Rash and other nonspecific skin eruption 0.001032 1.216 TSLP Asthma
rs1837253 Infestation 0.00371 0.4538 TSLP Asthma
rs1837253 Torsion dystonia 0.008454 1.601 TSLP Asthma
rs1837253 Hypertrophy of breast (Gynecomastia) 0.006161 1.38 TSLP Asthma
rs1853665 Open wound of nose and sinus 0.0005241 2.551 ULBP1 Radiation response
rs1853665 Bipolar 0.009544 1.452 ULBP1 Radiation response
rs1853665 Anal and rectal conditions 0.01042 1.177 ULBP1 Radiation response
rs1853665 Chronic venous hypertension 0.000428 2.693 ULBP1 Radiation response
rs1853665 Primary pulmonary hypertension 0.0006301 1.89 ULBP1 Radiation response
rs1853665 Loss of teeth or edentulism 0.01132 0.6303 ULBP1 Radiation response
rs1853665 Peripheral autonomic neuropathy 0.01016 0.614 ULBP1 Radiation response
rs1853665 Other disorders of gallbladder 0.006698 0.4274 ULBP1 Radiation response
rs1853665 Hyperlipidemia 0.009912 1.119 ULBP1 Radiation response
rs1853665 Joint effusions 0.008421 1.27 ULBP1 Radiation response
rs1853665 Respiratory complications 0.007599 1.733 ULBP1 Radiation response
rs1853665 Osteoarthrosis of multiple sites 0.01105 0.7757 ULBP1 Radiation response
rs1853665 Disorders of the autonomic nervous system 0.001279 0.5977 ULBP1 Radiation response
rs1853665 Nevus, non-neoplastic 0.001082 1.955 ULBP1 Radiation response
rs1853665 Other disorders of testis 0.001459 1.595 ULBP1 Radiation response
rs1869901 Alopecia 0.003003 1.345 PLCB2 Schizophrenia
rs1869901 Skin neoplasm of uncertain behavior 0.008106 1.194 PLCB2 Schizophrenia
rs1869901 Localized superficial swelling, mass, or lump 0.0092 1.251 PLCB2 Schizophrenia
rs1869901 Diseases of the larynx and vocal cords 0.00784 1.173 PLCB2 Schizophrenia
rs1869901 Gingivitis 0.007284 1.763 PLCB2 Schizophrenia
rs1869901 Chronic bronchitis 0.006137 1.189 PLCB2 Schizophrenia
rs1869901 Palpitations 0.009847 1.128 PLCB2 Schizophrenia
rs1869901 Early or threatened labor; hemorrhage in early pregnancy 0.002324 0.5371 PLCB2 Schizophrenia
rs1869901 Attention deficit hyperactivity disorder 0.00536 0.5606 PLCB2 Schizophrenia
rs1869901 Myeloid leukemia 0.002404 1.961 PLCB2 Schizophrenia
rs1869901 Vascular disorders of penis 0.005359 0.3842 PLCB2 Schizophrenia
rs1869901 Peritoneal adhesions (postoperative) (postinfection) 0.01096 1.504 PLCB2 Schizophrenia
rs1869901 Fracture of pelvis 0.006776 1.332 PLCB2 Schizophrenia
rs1869901 Fracture of ribs 0.009435 1.228 PLCB2 Schizophrenia
rs1869901 Multiple sclerosis 0.006375 1.54 PLCB2 Schizophrenia
rs1869901 Other disorders of peritoneum 0.006632 1.438 PLCB2 Schizophrenia
rs1888414 Seborheic dermatitis 0.01144 1.171 FDPSP6 Hippocampal atrophy
rs1888414 Sleep apnea 0.005856 1.119 FDPSP6 Hippocampal atrophy
rs1888414 Inflammatory diseases of female pelvic organs 0.01005 1.164 FDPSP6 Hippocampal atrophy
rs1888414 Personality disorders 0.006833 1.251 FDPSP6 Hippocampal atrophy
rs1888414 Other specified erythematous conditions 0.002363 1.353 FDPSP6 Hippocampal atrophy
rs1888414 Redundant prepuce and phimosis/BXO 0.01003 1.665 FDPSP6 Hippocampal atrophy
rs1888414 Abnormal findings on radiological exam of musculoskeletal system 0.007651 1.568 FDPSP6 Hippocampal atrophy
rs1888414 Adjustment reaction 0.002416 1.175 FDPSP6 Hippocampal atrophy
rs1888414 Diseases of lips 0.006137 1.479 FDPSP6 Hippocampal atrophy
rs1888414 Deviated nasal septum 0.01128 0.853 FDPSP6 Hippocampal atrophy
rs1888414 Breast disorder NOS 0.005141 2.286 FDPSP6 Hippocampal atrophy
rs1888414 Inflammatory disease of cervix, vagina, and vulva 0.007843 1.181 FDPSP6 Hippocampal atrophy
rs1888414 Pyogenic arthritis 0.0113 1.596 FDPSP6 Hippocampal atrophy
rs1888414 Bronchiectasis 0.011 0.723 FDPSP6 Hippocampal atrophy
rs1888414 Other disorders of lipoid metabolism and hyperalimentation 0.006277 0.7744 FDPSP6 Hippocampal atrophy
rs1923775 Colostomy and enterostomy complication 0.004233 1.846 POLN Alzheimer's disease
rs1923775 Diseases of the jaws 0.009082 1.202 POLN Alzheimer's disease
rs1923775 Vaginitis and vulvovaginitis 0.002859 1.243 POLN Alzheimer's disease
rs1923775 Fractur of unspecified part of femur 0.01078 1.401 POLN Alzheimer's disease
rs1923775 Benign neoplasm of uterus 0.007586 1.555 POLN Alzheimer's disease
rs1923775 Visual field defects 0.01006 0.767 POLN Alzheimer's disease
rs1923775 Decubitus ulcer 0.005408 1.247 POLN Alzheimer's disease
rs1923775 Pilonidal cyst 0.005943 2.15 POLN Alzheimer's disease
rs1923775 Diverticulum of esophagus, acquired 0.0006513 2.28 POLN Alzheimer's disease
rs1926203 Graves' disease 0.007328 0.6453 ACTA2 Lung cancer
rs1926203 Hypertensive chronic kidney disease 0.005127 0.8205 ACTA2 Lung cancer
rs1926203 Premature beats 0.01114 0.8472 ACTA2 Lung cancer
rs1926203 Abnormal findings on radiological exam of musculoskeletal system 7.197e-05 1.949 ACTA2 Lung cancer
rs1926203 Renal dialysis 0.006395 0.6727 ACTA2 Lung cancer
rs1926203 End stage renal disease 0.01055 0.6963 ACTA2 Lung cancer
rs1926203 Intracerebral hemorrhage 0.003979 0.5529 ACTA2 Lung cancer
rs1926203 Benign neoplasm of bone and articular cartilage 0.003572 0.4925 ACTA2 Lung cancer
rs1927745 Other unspecified back disorders 0.005392 1.604 FAM155A Depression
rs1927745 Abdominal pain 0.000678 1.12 FAM155A Depression
rs1927745 Open wound of toe(s) 0.0007496 2.005 FAM155A Depression
rs1927745 Ileostomy status 0.009931 1.597 FAM155A Depression
rs1927745 Plasma protein metabolism disorder 0.00893 1.314 FAM155A Depression
rs1927745 Cervical radiculitis 0.002414 1.225 FAM155A Depression
rs1927745 Bronchitis 0.007499 1.159 FAM155A Depression
rs1927745 Subdural hemorrhage 0.01059 0.5537 FAM155A Depression
rs1927745 Keratoconjunctivitis sicca 0.005866 1.666 FAM155A Depression
rs1927745 Urethral stricture (not specified as infectious) 0.009045 1.431 FAM155A Depression
rs1927745 Other signs and symptoms in breast 0.004624 0.6553 FAM155A Depression
rs1980493 Graves' disease 0.004545 1.612 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Celiac or tropical sprue 9.001e-06 2.703 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Disorders of the pituitary gland and its hypothalamic control 0.004338 1.481 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Varicose veins of lower extremity 0.005606 1.219 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Vaginitis and vulvovaginitis 0.005346 0.7519 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Ingrowing nail 0.002992 1.234 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Allergic rhinitis 0.00585 0.8557 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Urinary calculus 0.003082 0.8005 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Type 1 diabetic ketoacidosis 0.007371 1.504 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Calculus of kidney 0.007585 0.795 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Other immunological findings 0.001189 1.494 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Lupus erythematosus 2.914e-05 2.79 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Postmenopausal atrophic vaginitis 0.001043 0.6866 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Varicose veins of lower extremity, symptomtic 0.008209 1.28 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Other specified peripheral vascular diseases 0.000801 2.448 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Varicose veins 0.003624 1.221 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Type 1 diabetic retinopathy 0.01062 1.485 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Disorders of external ear 0.009116 1.741 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Osteoarthrosis; localized, secondary 0.00932 1.691 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Type 1 diabetic neuropathy 0.0005468 1.705 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Systemic lupus erythematosus 0.0005181 1.822 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Rosacea 0.01036 0.7886 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Other infectious diseases 0.01001 0.3384 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Type 1 diabetes nephropathy 0.0002289 2.088 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Aneurysm of iliac artery 0.000348 2.192 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Thyrotoxicosis 0.003406 1.331 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Retinoschisis and retinal cysts 5.049e-05 3.006 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Adverse effects of insulins and antidiabetic agents 0.001068 2.162 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Polycythemia vera, secondary 0.005948 1.735 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Immune disorders 0.00156 1.39 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Gastrointestinal complications 0.006086 1.352 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Myeloid leukemia 0.001783 2.124 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Peritoneal or intestinal adhesions 0.006031 1.71 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Discoid lupus erythematosus 3.056e-05 1.937 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Ectropion or entropion 0.006496 1.353 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1980493 Celiac disease 3.115e-05 2.607 BTNL2 Anti-cyclic Citrullinated Peptide Antibody
rs1983891 Inflammation of the eye 0.0005615 1.171 FOXP4 Prostate cancer
rs1983891 Corneal edema 0.002094 1.765 FOXP4 Prostate cancer
rs1983891 Acute pharyngitis 0.003818 1.179 FOXP4 Prostate cancer
rs1983891 Delirium dementia and amnestic disorders 0.007541 1.143 FOXP4 Prostate cancer
rs1983891 Hypotony of eye 0.002391 2.314 FOXP4 Prostate cancer
rs1983891 Cardiac pacemaker/device in situ 0.002624 0.7874 FOXP4 Prostate cancer
rs1983891 Loss of teeth or edentulism 0.008825 1.371 FOXP4 Prostate cancer
rs1983891 Uveitis 0.008003 1.314 FOXP4 Prostate cancer
rs1983891 Cardiac conduction disorders 0.0008882 0.8627 FOXP4 Prostate cancer
rs1983891 Sexual and gender identity disorders 0.00468 1.419 FOXP4 Prostate cancer
rs1983891 Abnormal electrocardiogram 0.007577 0.8595 FOXP4 Prostate cancer
rs1983891 Blood in stool 0.007131 0.8473 FOXP4 Prostate cancer
rs1983891 Conjunctivitis, noninfectious 0.001959 1.322 FOXP4 Prostate cancer
rs1983891 Paroxysmal ventricular tachycardia 0.005446 0.7426 FOXP4 Prostate cancer
rs1983891 Trigeminal nerve disorders 0.00324 0.5938 FOXP4 Prostate cancer
rs1983891 Incisional hernia 0.01095 1.298 FOXP4 Prostate cancer
rs1983891 Abnormal coagulation profile 0.00991 0.6982 FOXP4 Prostate cancer
rs1992950 Adverse effects of hormones and synthetic substitutes 0.00215 2.441 SATB2 Ulcerative colitis
rs1992950 Bipolar 0.004069 1.449 SATB2 Ulcerative colitis
rs1992950 Chronic pharyngitis and nasopharyngitis 0.005651 0.8304 SATB2 Ulcerative colitis
rs1992950 Cancer of brain and nervous system 0.002922 1.703 SATB2 Ulcerative colitis
rs1992950 Brain cancer 0.002345 1.772 SATB2 Ulcerative colitis
rs1992950 Lack of coordination 3.314e-05 1.442 SATB2 Ulcerative colitis
rs1992950 Other conditions of brain, NOS 5.504e-05 1.906 SATB2 Ulcerative colitis
rs1992950 Periapical abscess 0.007705 0.795 SATB2 Ulcerative colitis
rs1992950 Inflammatory and toxic neuropathy 0.009094 0.6935 SATB2 Ulcerative colitis
rs1992950 Acute sinusitis 0.01077 0.8685 SATB2 Ulcerative colitis
rs1992950 Malignant neoplasm of brain and nervous system 0.007287 1.443 SATB2 Ulcerative colitis
rs1992950 Diseases of pulp and periapical tissues 0.001348 0.7661 SATB2 Ulcerative colitis
rs1992950 Neutropenia 0.009636 0.7871 SATB2 Ulcerative colitis
rs1992950 Acute laryngitis and tracheitis 0.003792 0.5966 SATB2 Ulcerative colitis
rs2000999 Idiopathic fibrosing alveolitis 0.01088 1.844 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Acute upper respiratory infections 0.005434 1.127 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Thyroiditis 0.0005357 1.539 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Hemoptysis 0.001484 1.482 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Abnormal thyroid function 0.006292 1.331 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Chronic hepatitis 0.009536 1.798 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Mammographic microcalcification 7.128e-05 1.982 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Bladder cancer and neoplasms 0.008147 1.306 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Chronic lymphocytic thyroiditis 0.003268 1.552 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Other disorders of metabolic, endocrine, immunity disorders 0.0003333 2.378 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Abnormal sputum 0.004466 1.402 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2000999 Blindness and low vision 0.01067 0.7053 HPR Total Cholesterol, LDL Cholesterol, Haptoglobin levels
rs2002030 Pulmonary embolism and infarction 0.008585 1.432 C8orf12 Cognitive performance
rs2002030 Acquired deformities of finger 0.01135 1.706 C8orf12 Cognitive performance
rs2002030 Torsion dystonia 0.005581 2.007 C8orf12 Cognitive performance
rs2002030 Carcinoma in situ of skin 0.002153 1.519 C8orf12 Cognitive performance
rs2002030 Essential tremor 0.006926 1.54 C8orf12 Cognitive performance
rs2002030 Wheezing 0.004743 1.593 C8orf12 Cognitive performance
rs2002030 Acquired deformities of limbs 0.006488 1.404 C8orf12 Cognitive performance
rs2002030 Abnormal findings examination of lungs 0.001527 1.376 C8orf12 Cognitive performance
rs2073643 Other disorders of the kidney and ureters 0.004578 1.122 SLC22A5 Asthma
rs2073643 Chronic obstructive asthma with exacerbation 0.008655 0.5966 SLC22A5 Asthma
rs2073643 Chronic venous insufficiency 0.002492 0.8225 SLC22A5 Asthma
rs2073643 Lower gastrointestinal congenital anomalies 0.008592 1.815 SLC22A5 Asthma
rs2073643 Intracranial hemorrhage 0.005852 1.333 SLC22A5 Asthma
rs2073643 Dermatosis NOS 0.01045 0.9081 SLC22A5 Asthma
rs2073643 Skin cancer 0.0006228 0.886 SLC22A5 Asthma
rs2073643 Viral warts & HPV 0.007331 0.8666 SLC22A5 Asthma
rs2073643 Non-melanoma skin cancer 0.001473 0.8882 SLC22A5 Asthma
rs2073643 Hyperbilirubinemia 0.008394 0.5463 SLC22A5 Asthma
rs2073643 Bronchiectasis 0.008063 1.378 SLC22A5 Asthma
rs2073643 Excessive or frequent menstruation 0.0108 1.279 SLC22A5 Asthma
rs2073643 Parasomnia 0.005647 0.5849 SLC22A5 Asthma
rs2073643 Late effects of cerebrovascular disease 0.001332 1.211 SLC22A5 Asthma
rs2074404 Abnormal coagulation profile 0.007325 1.396 WNT3 Celiac disease
rs2074404 Visual disturbances 0.00195 1.152 WNT3 Celiac disease
rs2074404 Chronic periodontitis 0.004423 1.303 WNT3 Celiac disease
rs2074404 Anisometropia 0.0005536 1.449 WNT3 Celiac disease
rs2074404 Conjunctivitis, infectious 0.007218 1.191 WNT3 Celiac disease
rs2074404 Infection of the eye 0.001333 1.206 WNT3 Celiac disease
rs2074404 Psoriasis vulgaris 0.005256 1.293 WNT3 Celiac disease
rs2074404 Psychogenic disorder 0.01106 1.432 WNT3 Celiac disease
rs2074404 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.0003772 1.462 WNT3 Celiac disease
rs2074404 Ulceration of intestine 0.003826 1.729 WNT3 Celiac disease
rs2074404 Polycythemia vera, secondary 0.003677 1.704 WNT3 Celiac disease
rs2074404 Spontaneous ecchymoses 0.008441 1.634 WNT3 Celiac disease
rs2074404 Testicular dysfunction 0.00862 1.408 WNT3 Celiac disease
rs2074404 Unequal leg length (acquired) 0.008682 1.488 WNT3 Celiac disease
rs2075650 Macular degeneration, wet 0.001038 0.5817 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Aseptic necrosis of bone 0.01092 0.4498 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Mental disorders due to brain damage 6.257e-06 1.566 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Chronic pharyngitis and nasopharyngitis 0.002009 0.7767 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Schizophrenia and other psychotic disorders 4.897e-05 1.41 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Neurological disorders due to brain damage 4.329e-09 1.452 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Persistent mental disorders due to other conditions 9.183e-16 1.775 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Acute osteomyelitis 0.004168 1.826 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Other peripheral nerve disorders 0.005864 0.8692 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Diseases of sebaceous glands 0.00117 0.8384 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Type 2 diabetic ketoacidosis 0.009998 0.8385 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Asthma 0.006971 0.8465 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Schizoid personality disorder 0.006963 0.3412 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Open-angle glaucoma 0.008523 0.8091 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Delirium dementia and amnestic disorders 8.027e-24 1.841 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Atopic or contact dermatitis 0.00197 0.8538 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Sebaceous cyst 0.006628 0.8351 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Other specified nonpsychotic and/or transient mental disorders 7.334e-06 1.546 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Dementias 2.409e-26 2.114 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Optic atrophy 0.0002892 0.3729 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Wheezing and painful respiration 0.00815 0.8433 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Deviated nasal septum 0.004151 0.775 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Retinal drusen 0.009525 0.7533 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Disorders of lacrimal system 0.000856 0.8025 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Allergic rhinitis 0.0001426 0.7998 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Glaucoma 0.007839 0.8602 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Develomental delays and disorders 0.001176 1.448 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Neoplasm of unspecified nature of digestive system 0.008922 1.517 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Vascular dementia 0.001199 1.682 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Age-related macular degeneration 6.704e-05 0.6658 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Diseases of respiratory system 6.682e-05 0.7078 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Senile dementia 1.887e-12 2.037 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Abnormal findings on mammogram or breast exam 0.001891 0.8279 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Macular degeneration, dry 0.0007954 0.6921 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Diabetes mellitus 0.00757 0.8897 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Visual disturbances 0.001152 0.8281 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Conduct disorders 0.004435 1.741 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Symptoms involving respiratory system 0.0008009 0.6943 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Chronic sinusitis 0.00057 0.8134 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Macular degeneration 0.001732 0.8178 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Hyperlipidemia 0.01129 1.124 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Dyspepsia and disorders of function of stomach 0.008148 0.8081 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Mild cognitive impairment 0.0005436 2.194 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Known or suspected fetal abnormality 0.004355 1.926 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Dry eyes 0.0006323 0.7909 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Memory loss 4.677e-09 1.796 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Alzheimer's disease 5.237e-28 2.41 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Subjective visual disturbances 0.00365 0.7349 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Impaction of intestine 0.003732 2.389 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Reticulosarcoma 0.003455 1.858 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Acute posthemorrhagic anemia 0.003282 1.255 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Epistaxis or throat hemorrhage 0.003292 0.7371 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2075650 Delirium due to conditions classified elsewhere 0.003037 1.58 TOMM40 Alzheimer's disease, Alzheimer's disease biomarkers, Amyloid Beta Peptide 1-42, LDL Cholesterol, C-reactive protein, Total Cholesterol, Grey matter density
rs2084385 Complex regional/central pain syndrome 0.00215 2.112 PAK2 Total ventricular volume
rs2084385 Myoclonus 0.001314 2.057 PAK2 Total ventricular volume
rs2084385 Mental retardation 0.007954 2.358 PAK2 Total ventricular volume
rs2084385 Astigmatism 0.006872 0.8307 PAK2 Total ventricular volume
rs2084385 Osteoarthritis; localized 0.007644 1.184 PAK2 Total ventricular volume
rs2084385 Develomental delays and disorders 0.0001879 1.565 PAK2 Total ventricular volume
rs2084385 Internal derangement of knee 0.009501 1.209 PAK2 Total ventricular volume
rs2084385 Diseases of the larynx and vocal cords 0.00439 0.7541 PAK2 Total ventricular volume
rs2084385 Other cerebral degenerations 0.003577 1.622 PAK2 Total ventricular volume
rs2084385 Other arthropathies 0.008915 1.17 PAK2 Total ventricular volume
rs2084385 Bullous dermatoses 0.002165 2.26 PAK2 Total ventricular volume
rs2084385 Voice disturbance 0.005476 0.7258 PAK2 Total ventricular volume
rs2114039 Symptoms associated with female genital organs 0.007995 0.8216 PDGFRA Corneal curvature
rs2114039 Cardiac pacemaker in situ 0.001216 1.295 PDGFRA Corneal curvature
rs2114039 Other disorders of urethra and urinary tract 0.001323 1.274 PDGFRA Corneal curvature
rs2114039 Urethral stricture (not specified as infectious) 0.0001167 1.666 PDGFRA Corneal curvature
rs2114039 progressive myopia 0.006057 0.4575 PDGFRA Corneal curvature
rs2114039 Primary pulmonary hypertension 0.004244 1.634 PDGFRA Corneal curvature
rs2114039 Inguinal hernia 0.008781 1.162 PDGFRA Corneal curvature
rs2114039 Cardiac pacemaker/device in situ 0.00432 1.239 PDGFRA Corneal curvature
rs2114039 Graves' disease 0.002158 0.5699 PDGFRA Corneal curvature
rs2114039 Strabismus (not specified as paralytic) 0.001319 0.7387 PDGFRA Corneal curvature
rs2114039 Inflammatory spondylopathies 0.009024 0.6041 PDGFRA Corneal curvature
rs2114039 Sinoatrial node dysfunction 0.002933 1.353 PDGFRA Corneal curvature
rs2114039 Primary angle-closure glaucoma 0.009113 0.7976 PDGFRA Corneal curvature
rs2114039 Acquired absence of breast 0.007737 0.7249 PDGFRA Corneal curvature
rs2114039 Nonspecific findings on examination of blood 0.003351 1.362 PDGFRA Corneal curvature
rs2114039 Disorders of binocular eye movements 0.00496 0.7996 PDGFRA Corneal curvature
rs2114039 Disorders of the globe 0.001919 0.5766 PDGFRA Corneal curvature
rs2121433 Allergy/adverse effect of penicillin 0.00397 1.265 EPC2 Alzheimer's disease biomarkers
rs2121433 Postmenopausal atrophic vaginitis 0.004972 0.7743 EPC2 Alzheimer's disease biomarkers
rs2121433 Immunity deficiency 0.001848 1.796 EPC2 Alzheimer's disease biomarkers
rs2121433 Spasm of muscle 0.001082 0.7525 EPC2 Alzheimer's disease biomarkers
rs2121433 Dermatomycoses 0.008739 1.656 EPC2 Alzheimer's disease biomarkers
rs2121433 Immune disorders 0.001177 1.339 EPC2 Alzheimer's disease biomarkers
rs2121433 Open wound of hand except finger(s) 0.004928 1.31 EPC2 Alzheimer's disease biomarkers
rs2121433 Peripheral autonomic neuropathy 0.002838 0.647 EPC2 Alzheimer's disease biomarkers
rs2121433 Fracture of pelvis 0.003671 0.6826 EPC2 Alzheimer's disease biomarkers
rs2121433 Fractur of unspecified part of femur 0.00806 0.6612 EPC2 Alzheimer's disease biomarkers
rs2121433 Poisoning by antibiotics 0.006314 1.22 EPC2 Alzheimer's disease biomarkers
rs2121433 Abnormal results of function studies 0.008515 1.601 EPC2 Alzheimer's disease biomarkers
rs2150702 Dystrophy of female genital tract 0.001351 2.374 MLANA Multiple sclerosis
rs2150702 Peripheral angiopathy in diseases classified elsewhere 0.009129 1.594 MLANA Multiple sclerosis
rs2150702 Apnea 0.001235 2.344 MLANA Multiple sclerosis
rs2150702 Behcet's syndrome 0.001943 0.6094 MLANA Multiple sclerosis
rs2150702 Dermatomyositis and Polymyositis 0.005867 0.4578 MLANA Multiple sclerosis
rs2150702 Known or suspected fetal abnormality 0.004825 1.693 MLANA Multiple sclerosis
rs2150702 Temporomandibular joint disorder NOS 0.005919 0.6151 MLANA Multiple sclerosis
rs2150702 Hydrocele 0.00538 0.661 MLANA Multiple sclerosis
rs2150702 Iron deficiency anemia secondary to blood loss 0.008323 1.319 MLANA Multiple sclerosis
rs2150702 Congenital anomalies of face and neck 0.0004142 0.3106 MLANA Multiple sclerosis
rs2150702 Peripheral vascular disease 0.008627 1.111 MLANA Multiple sclerosis
rs2150702 Heartburn 0.006781 1.378 MLANA Multiple sclerosis
rs2150702 Arterial embolism and thrombosis 0.003417 1.259 MLANA Multiple sclerosis
rs2150702 Myopia 0.00164 0.8726 MLANA Multiple sclerosis
rs2150702 Astigmatism 0.008828 0.8881 MLANA Multiple sclerosis
rs2150702 Arterial embolism and thrombosis of lower extremity artery 0.000376 1.483 MLANA Multiple sclerosis
rs2150702 Allergy/adverse effect of penicillin 0.007109 1.227 MLANA Multiple sclerosis
rs2166706 Abnormal glucose 0.0002139 1.159 MTNR1B Fasting plasma glucose
rs2166706 Polycythemia vera, secondary 0.01062 0.6132 MTNR1B Fasting plasma glucose
rs2166706 Poisoning by primarily systemic agents 0.002661 1.345 MTNR1B Fasting plasma glucose
rs2166706 Type 2 diabetes 0.0004154 1.118 MTNR1B Fasting plasma glucose
rs2166706 Other abnormal glucose 0.001566 1.167 MTNR1B Fasting plasma glucose
rs2166706 Lipoid metabolism disorder NOS 0.001912 1.318 MTNR1B Fasting plasma glucose
rs2166706 Pain, swelling or discharge of eye 0.008723 0.733 MTNR1B Fasting plasma glucose
rs2166706 Miscarriage; stillbirth 0.01055 1.755 MTNR1B Fasting plasma glucose
rs2166706 Prolapse of vaginal vault after hysterectomy 0.00922 0.669 MTNR1B Fasting plasma glucose
rs2166706 Impaired fasting glucose 0.00684 1.181 MTNR1B Fasting plasma glucose
rs2166706 Exostosis of jaw 0.008836 0.4546 MTNR1B Fasting plasma glucose
rs2166706 Diabetes mellitus 0.0002749 1.12 MTNR1B Fasting plasma glucose
rs2166706 Periodontitis (acute or chronic) 0.009849 1.208 MTNR1B Fasting plasma glucose
rs2166706 Hyperglyceridemia 1.159e-05 1.425 MTNR1B Fasting plasma glucose
rs2166706 Keratitis 0.003229 0.7371 MTNR1B Fasting plasma glucose
rs2166706 Acute pericarditis 0.006304 0.4127 MTNR1B Fasting plasma glucose
rs2166706 Intracranial hemorrhage (injury) 0.005052 1.487 MTNR1B Fasting plasma glucose
rs2166706 Adverse effects of antineoplastic and immunosuppressive drugs 0.001792 1.371 MTNR1B Fasting plasma glucose
rs2236313 Noninflammatory female genital disorders 0.008351 1.186 RNASET2 Vitiligo
rs2236313 Wheezing 0.002735 1.359 RNASET2 Vitiligo
rs2236313 Ovarian cancer 0.007825 1.542 RNASET2 Vitiligo
rs2236313 Abnormal findings on radiological exam of musculoskeletal system 0.005638 1.591 RNASET2 Vitiligo
rs2236313 Altered mental status 0.00205 1.328 RNASET2 Vitiligo
rs2236313 Acute upper respiratory infections 0.001749 1.116 RNASET2 Vitiligo
rs2236313 Alopecia Areata 0.002329 0.3864 RNASET2 Vitiligo
rs2236313 Gastroparesis 0.0008963 1.922 RNASET2 Vitiligo
rs2236313 Retinal vascular changes and abnomalities 0.004675 1.23 RNASET2 Vitiligo
rs2236313 Cancer of other female genital organs 0.007423 1.458 RNASET2 Vitiligo
rs2236313 Other symptoms referable to back 0.00172 1.298 RNASET2 Vitiligo
rs2236313 Other unspecified back disorders 2.69e-05 1.98 RNASET2 Vitiligo
rs2236313 Other hypertrophic and atrophic conditions of skin 0.006327 1.115 RNASET2 Vitiligo
rs2236313 Other disorders of back 0.001764 1.185 RNASET2 Vitiligo
rs2236313 Pain in joint 0.009756 1.082 RNASET2 Vitiligo
rs2236313 Blood in stool 0.006943 1.154 RNASET2 Vitiligo
rs2236313 Spondylolisthesis, congenital 0.00651 1.545 RNASET2 Vitiligo
rs2237886 Hammer toe 0.003745 0.7071 KCNQ1 Height
rs2237886 Alopecia 0.005466 1.502 KCNQ1 Height
rs2237886 Esophageal atresia/tracheoesophageal fistula 0.007891 1.978 KCNQ1 Height
rs2237886 Symptoms involving respiratory system 0.0009024 1.397 KCNQ1 Height
rs2237886 Diseases of respiratory system 0.0006816 1.326 KCNQ1 Height
rs2237886 Bladder cancer and neoplasms 0.001346 1.475 KCNQ1 Height
rs2237886 Vascular dementia 0.009268 1.554 KCNQ1 Height
rs2237886 Generalized convulsive epilepsy 0.007519 1.827 KCNQ1 Height
rs2237886 Bladder cancer 0.001438 1.486 KCNQ1 Height
rs2237886 Age-related macular degeneration 0.002676 0.7032 KCNQ1 Height
rs2237886 Keratitis, infectious 0.006926 1.588 KCNQ1 Height
rs2237886 Hemoptysis 0.003046 1.569 KCNQ1 Height
rs2237886 Diseases of hair and hair follicles 0.0004976 1.45 KCNQ1 Height
rs2237886 Liver abscess and sequelae of chronic liver disease 0.004518 1.801 KCNQ1 Height
rs2237886 Chronic airway obstruction 0.002879 1.2 KCNQ1 Height
rs2237886 Chronic bronchitis 0.00451 1.313 KCNQ1 Height
rs2237886 Obstructive chronic bronchitis 0.003656 1.358 KCNQ1 Height
rs2237886 Abnormal sputum 0.003436 1.531 KCNQ1 Height
rs2237886 Secondary thrombocytopenia 0.004742 1.896 KCNQ1 Height
rs2237886 Extrinsic allergic alveolitis 0.008297 2.302 KCNQ1 Height
rs2242073 Osteoarthrosis of multiple sites 0.004917 1.326 CRYGC Attention deficit hyperactivity disorder
rs2242073 Optic atrophy 0.004211 1.602 CRYGC Attention deficit hyperactivity disorder
rs2242073 Cyst of kidney, acquired 0.009204 0.6811 CRYGC Attention deficit hyperactivity disorder
rs2242073 Displacement of intervertebral disc 0.005854 0.8072 CRYGC Attention deficit hyperactivity disorder
rs2242073 Mental retardation 0.009809 2.195 CRYGC Attention deficit hyperactivity disorder
rs2242073 Early complications of trauma or procedure 0.004714 1.815 CRYGC Attention deficit hyperactivity disorder
rs2242073 Herpes zoster with nervous system complications 0.003715 1.695 CRYGC Attention deficit hyperactivity disorder
rs2242073 Abnormal findings on mammogram or breast exam 0.001964 1.194 CRYGC Attention deficit hyperactivity disorder
rs2242073 Enthesopathy 0.006927 1.159 CRYGC Attention deficit hyperactivity disorder
rs2242073 Fuchs' dystrophy 0.002557 1.653 CRYGC Attention deficit hyperactivity disorder
rs2242073 Spermatocele 0.002362 2.019 CRYGC Attention deficit hyperactivity disorder
rs2242073 Chronic tonsillitis and adenoiditis 0.006749 1.822 CRYGC Attention deficit hyperactivity disorder
rs2242073 Unspecified polyarthropathy or polyarthritis 0.004502 1.664 CRYGC Attention deficit hyperactivity disorder
rs2242073 Iron deficiency anemias 0.007426 1.189 CRYGC Attention deficit hyperactivity disorder
rs2242073 Iron deficiency anemias NOS 0.001957 1.208 CRYGC Attention deficit hyperactivity disorder
rs2242073 Symptomatic artificial menopause 0.001159 1.832 CRYGC Attention deficit hyperactivity disorder
rs2242073 Generalized hyperhidrosis 0.008897 0.6417 CRYGC Attention deficit hyperactivity disorder
rs2242073 Herpes zoster 0.007777 1.244 CRYGC Attention deficit hyperactivity disorder
rs2242073 Peritoneal or intestinal adhesions 0.003662 1.817 CRYGC Attention deficit hyperactivity disorder
rs2242073 Other diseases of respiratory system 0.006368 1.481 CRYGC Attention deficit hyperactivity disorder
rs2242073 Lump or mass in breast 0.00483 1.227 CRYGC Attention deficit hyperactivity disorder
rs2242073 Disorders of optic nerve and visual pathways 0.002537 1.385 CRYGC Attention deficit hyperactivity disorder
rs2242944 Open wound of ear 0.004222 1.998 PSMG1 Ankylosing spondylitis
rs2242944 Malignant neoplasm of renal pelvis 0.008219 2.092 PSMG1 Ankylosing spondylitis
rs2242944 Nevus, non-neoplastic 0.01049 1.61 PSMG1 Ankylosing spondylitis
rs2242944 Ectropion or entropion 0.002393 0.7545 PSMG1 Ankylosing spondylitis
rs2242944 Irritable Bowel Syndrome 0.01119 0.8592 PSMG1 Ankylosing spondylitis
rs2242944 Chronic interstitial cystitis 0.00736 2.03 PSMG1 Ankylosing spondylitis
rs2242944 Hypercholesterolemia 0.006965 1.118 PSMG1 Ankylosing spondylitis
rs2242944 Hallux rigidus 0.00554 1.403 PSMG1 Ankylosing spondylitis
rs2242944 Unspecified polyarthropathy or polyarthritis 0.002943 0.603 PSMG1 Ankylosing spondylitis
rs2242944 Mammographic microcalcification 0.001082 0.5411 PSMG1 Ankylosing spondylitis
rs2242944 Open-angle glaucoma 0.01082 0.8623 PSMG1 Ankylosing spondylitis
rs2242944 Adverse effects of insulins and antidiabetic agents 0.007177 0.5055 PSMG1 Ankylosing spondylitis
rs2242944 Pervasive developmental disorders 0.001199 1.684 PSMG1 Ankylosing spondylitis
rs2242944 Attention deficit hyperactivity disorder 0.0006125 1.892 PSMG1 Ankylosing spondylitis
rs2242944 Paroxysmal supraventricular tachycardia 0.004154 0.759 PSMG1 Ankylosing spondylitis
rs2242944 Eating disorder 0.00778 0.5768 PSMG1 Ankylosing spondylitis
rs2242944 Respiratory abnormalities 0.006412 0.7418 PSMG1 Ankylosing spondylitis
rs2242944 Lyme disease 0.009891 1.502 PSMG1 Ankylosing spondylitis
rs2242944 Bronchitis 0.008431 0.876 PSMG1 Ankylosing spondylitis
rs2242944 Polyarthropathy or polyarthritis involving multiple sites NOS 0.002907 0.5362 PSMG1 Ankylosing spondylitis
rs2242944 Functional digestive disorders 0.009834 0.8768 PSMG1 Ankylosing spondylitis
rs2252521 Genitourinary congenital anomalies 0.007066 0.6808 CPVL Cognitive performance
rs2252521 Abnormal serum enzyme levels 0.00116 1.193 CPVL Cognitive performance
rs2252521 Cancer of oropharynx 0.003335 2.188 CPVL Cognitive performance
rs2252521 Cholelithiasis with other cholecystitis 0.00499 0.7266 CPVL Cognitive performance
rs2252521 Cystic kidney disease 0.008898 0.5717 CPVL Cognitive performance
rs2252521 Disorders of conjunctiva 0.01027 0.7853 CPVL Cognitive performance
rs2252521 Symptomatic artificial menopause 0.01068 0.6472 CPVL Cognitive performance
rs2252521 Iron deficiency anemia secondary to blood loss 0.001623 0.6633 CPVL Cognitive performance
rs2274089 CNS infection and poliomyelitis 0.01003 1.937 LRRC16A Serum transferrin, Serum iron levels, Transferrin saturation
rs2274089 Nontoxic multinodular goiter 0.009979 0.6245 LRRC16A Serum transferrin, Serum iron levels, Transferrin saturation
rs2274089 Disorders of cervical region 0.006401 1.59 LRRC16A Serum transferrin, Serum iron levels, Transferrin saturation
rs2274089 Iron metabolism disorder 7.032e-14 6.178 LRRC16A Serum transferrin, Serum iron levels, Transferrin saturation
rs2274089 Eosinophilia 0.003617 2.286 LRRC16A Serum transferrin, Serum iron levels, Transferrin saturation
rs2275215 Arterial embolism and thrombosis 0.008738 1.246 LAMA2 Body mass index
rs2275215 Althete's foot 0.007771 0.7679 LAMA2 Body mass index
rs2275215 Sepsis 0.003364 1.314 LAMA2 Body mass index
rs2275215 Sepsis and SIRS 0.003407 1.302 LAMA2 Body mass index
rs2275215 Breast disorder NOS 0.003549 2.331 LAMA2 Body mass index
rs2275215 Other arthropathies 0.00233 1.145 LAMA2 Body mass index
rs2275215 Vitamin B12 deficiency anemia 0.004403 1.58 LAMA2 Body mass index
rs2275215 Open wound of finger(s) 0.0004499 0.787 LAMA2 Body mass index
rs2275215 Corneal dystrophy 0.008652 0.7399 LAMA2 Body mass index
rs2277339 Aseptic necrosis of bone 0.01083 1.753 PRIM1 Menopause
rs2277339 Cancer of the digestive organs and peritoneum 0.006006 1.701 PRIM1 Menopause
rs2277339 Other disorders of gallbladder 0.002765 1.944 PRIM1 Menopause
rs2277339 Hypercoagulable state 0.003759 1.807 PRIM1 Menopause
rs2277339 Atherosclerosis of aorta 0.008321 1.423 PRIM1 Menopause
rs2277339 Bipolar 0.01112 1.564 PRIM1 Menopause
rs2277339 Meningitis 0.001118 2.279 PRIM1 Menopause
rs2277339 Other disorders of adrenal glands 0.00703 1.75 PRIM1 Menopause
rs2277339 Other disorders of arteries and arterioles 0.009712 1.396 PRIM1 Menopause
rs2277339 Macular degeneration, wet 0.005713 1.563 PRIM1 Menopause
rs2277339 Diseases of blood and blood-forming organs 0.007013 1.371 PRIM1 Menopause
rs2277339 Cataract 0.001808 0.8234 PRIM1 Menopause
rs2277912 Infertility, male 0.000849 2.382 FASTKD2 Height
rs2277912 Otalgia 0.01123 0.7311 FASTKD2 Height
rs2277912 Chronic tonsillitis and adenoiditis 0.006544 0.366 FASTKD2 Height
rs2277912 Chronic sinusitis 0.003573 0.8482 FASTKD2 Height
rs2277912 Symptomatic artificial menopause 0.001338 0.511 FASTKD2 Height
rs2277912 Other specified intestinal malabsorption 0.007329 0.4059 FASTKD2 Height
rs2277912 Magnesium metabolism disorder 0.005736 0.65 FASTKD2 Height
rs2277912 Disorders of menstruation 0.005396 0.7794 FASTKD2 Height
rs2277912 Other disorders of bone and cartilage 0.007596 0.7624 FASTKD2 Height
rs2277912 Dysphagia 0.004986 0.8485 FASTKD2 Height
rs2277912 Lymphadenitis 0.0009825 0.7502 FASTKD2 Height
rs2277912 Dyspepsia and disorders of function of stomach 0.003157 0.8008 FASTKD2 Height
rs2277912 Acquired hemolytic anemias 0.01121 1.986 FASTKD2 Height
rs2277912 Stricture and stenosis of esophagus 0.0108 0.7248 FASTKD2 Height
rs2277912 Noninflammatory disorders of vagina 0.002644 0.5897 FASTKD2 Height
rs2277912 Urticaria 0.008754 0.7406 FASTKD2 Height
rs2277912 Disorders of function of stomach 0.006971 0.8252 FASTKD2 Height
rs2279434 Elevated prostate specific antigen 0.0102 1.335 MARCH8 Mean corpuscular hemoglobin
rs2279434 Myalgia and myositis NOS 0.01058 0.8134 MARCH8 Mean corpuscular hemoglobin
rs2279434 Retinal drusen 0.001729 0.6114 MARCH8 Mean corpuscular hemoglobin
rs2279434 Cystitis 0.006636 0.6512 MARCH8 Mean corpuscular hemoglobin
rs2279434 Corneal degenerations 0.0009277 0.3811 MARCH8 Mean corpuscular hemoglobin
rs2279434 Disorders of cornea 0.00217 0.668 MARCH8 Mean corpuscular hemoglobin
rs2279434 Genital prolapse 0.007577 1.305 MARCH8 Mean corpuscular hemoglobin
rs2279434 Macular degeneration 0.01145 0.8082 MARCH8 Mean corpuscular hemoglobin
rs2281680 Other specified cardiac dysrhythmias 0.00148 1.201 AP1G2 Sudden cardiac arrest
rs2281680 Scar conditions and fibrosis of skin 0.005628 1.37 AP1G2 Sudden cardiac arrest
rs2281680 Chronic cystitis 0.01103 0.5474 AP1G2 Sudden cardiac arrest
rs2281680 Urinary obstruction 0.01067 1.433 AP1G2 Sudden cardiac arrest
rs2281680 Infertility, male 0.006833 2.076 AP1G2 Sudden cardiac arrest
rs2281680 Dyshidrosis 0.008753 1.667 AP1G2 Sudden cardiac arrest
rs2281680 AV block 0.007767 1.237 AP1G2 Sudden cardiac arrest
rs2281680 Cystoid macular degeneration of retina 0.007542 0.6951 AP1G2 Sudden cardiac arrest
rs2281680 Glycosuria or Acetonuria 0.01095 2.128 AP1G2 Sudden cardiac arrest
rs2281680 Abnormal weight gain 0.004106 1.426 AP1G2 Sudden cardiac arrest
rs2281680 Meniere's disease 0.009681 0.4569 AP1G2 Sudden cardiac arrest
rs2281680 Balanoposthitis 0.008287 1.814 AP1G2 Sudden cardiac arrest
rs2281680 Infestation 0.006378 0.3859 AP1G2 Sudden cardiac arrest
rs2290416 Elevated white blood cell count 0.007422 1.472 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Open-angle glaucoma 0.00382 0.7395 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Pneumonitis due to inhalation of food or vomitus 0.009037 1.523 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Congenital anomalies of urinary system 0.004218 1.766 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Abnormal loss of weight and underweight 0.006029 1.468 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Rheumatoid arthritis 0.004091 0.6414 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Choroidal degenerations 0.006413 0.4447 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Pallor and flushing 0.0008359 1.807 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Glaucoma 0.001561 0.7961 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Disorders of choroid 0.001053 0.5142 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Cystic kidney disease 0.006852 1.873 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Secondary thrombocytopenia 0.0004861 2.283 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Mechanical complication due to other implant and internal device 0.004618 1.592 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Cervicocranial/Cervicobrachial syndrome 0.00767 0.6379 NAPRT1 Attention deficit hyperactivity disorder
rs2290416 Genitourinary congenital anomalies 0.001212 1.721 NAPRT1 Attention deficit hyperactivity disorder
rs2292354 Other specified erythematous conditions 0.0008588 0.6615 GIT2 HDL Cholesterol
rs2292354 Type 2 diabetic peripheral circulatory disorders 0.005046 0.6638 GIT2 HDL Cholesterol
rs2292354 Pancreatic cancer 0.007348 1.544 GIT2 HDL Cholesterol
rs2292354 Chronic periodontitis 0.004133 0.7484 GIT2 HDL Cholesterol
rs2292354 Hyperglyceridemia 0.009552 0.7833 GIT2 HDL Cholesterol
rs2292354 Periodontitis (acute or chronic) 0.009334 0.7969 GIT2 HDL Cholesterol
rs2292354 Disorders of coccyx 0.01082 0.7235 GIT2 HDL Cholesterol
rs2292354 Random mental disorder. Ignored for now 0.002187 0.5303 GIT2 HDL Cholesterol
rs2292354 Other disorders of thyroid 0.007593 1.329 GIT2 HDL Cholesterol
rs2292354 Polyneuropathy in diabetes 0.005348 0.8085 GIT2 HDL Cholesterol
rs2294008 Other derangement of joint 0.008387 0.7817 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Pyogenic granuloma 0.001387 0.4628 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Bacterial infection NOS 0.0005492 0.8491 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Abnormal function study of cardiovascular system 0.001431 0.8277 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Prostate cancer 0.003843 1.197 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Chronic sinusitis 0.005792 0.8901 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Tension headache 0.009837 0.8196 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Hyperpotassemia 0.005981 0.8348 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Sciatica 0.002065 0.8383 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Appendiceal conditions 0.006297 0.7092 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Acute reaction to stress 0.01022 0.8039 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Generalized convulsive epilepsy 0.007758 0.6129 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Disorders of function of stomach 0.004743 0.8619 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Rheumatoid arthritis 0.007598 0.819 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Cellulitis and abscess of foot/toes 0.007215 0.7793 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Reflux esophagitis 0.009712 0.832 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Diseases of esophagus 0.007232 0.9229 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Cystitis and urethritis 0.003581 0.8155 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Stricture and stenosis of esophagus 0.002246 0.7586 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Inflammatory disease of breast 0.001971 1.65 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Elevated prostate specific antigen 0.005016 1.196 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Diaphragmatic hernia 0.006785 0.8806 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Other congenital anomalies 0.008011 0.5487 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 E. coli 0.007173 0.7537 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Cystitis 0.00493 0.8106 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Acute cystitis 0.006189 0.7106 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Esophagitis, GERD and related diseases 0.003294 0.9139 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Peptic ulcer 0.006217 0.856 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Rheumatoid arthritis & related inflammatory polyarthropathies 0.004615 0.8283 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Age-related macular degeneration 0.004181 0.8239 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Gastric ulcer 0.00157 0.7485 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Bladder cancer and neoplasms 0.01029 1.248 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Disorders of adrenal glands 0.004286 0.7378 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 GERD 0.001452 0.9027 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Other nonmalignant breast conditions 0.005512 1.159 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Bladder cancer 0.0114 1.252 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Dyspepsia and disorders of function of stomach 0.005928 0.8591 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294008 Cancer of kidney and urinary organs 0.009563 1.198 PSCA Duodenal ulcer, Bladder cancer, Urinary bladder cancer
rs2294015 Subarachnoid hemorrhage 0.004061 0.4518 ANXA13 Event-related brain oscillations
rs2294015 Congenital deformities of feet 0.008592 0.7572 ANXA13 Event-related brain oscillations
rs2294015 Pain in limb 0.006267 1.089 ANXA13 Event-related brain oscillations
rs2294015 Hammer toe 0.009214 0.8396 ANXA13 Event-related brain oscillations
rs2294015 Fracture of unspecified bones 0.009956 1.145 ANXA13 Event-related brain oscillations
rs2294015 Peripheral arterial disease 0.00295 1.139 ANXA13 Event-related brain oscillations
rs2294015 Congenital anomalies of limbs 0.009077 0.7854 ANXA13 Event-related brain oscillations
rs2294015 Congenital anomalies of face and neck 0.002287 0.3421 ANXA13 Event-related brain oscillations
rs2294015 Urethral stricture (not specified as infectious) 0.001647 0.6492 ANXA13 Event-related brain oscillations
rs2294015 Acquired deformities of limbs 0.007051 0.8184 ANXA13 Event-related brain oscillations
rs2294015 Chronic ulcer of unspecified site 0.0005603 1.359 ANXA13 Event-related brain oscillations
rs2294015 Allergic reaction to food 0.01121 1.777 ANXA13 Event-related brain oscillations
rs2304130 Joint/ligament sprain 0.003539 0.5212 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Deep vein thrombosis 0.00514 0.592 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Nonsenile Cataract 0.00711 0.5144 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Abnormal cytological, histological, immunological and DNA test findings 0.004522 2.273 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Arthropathy NOS 0.0007714 0.6546 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Cervicitis and endocervicitis 0.002375 2.057 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Myeloproliferative disease 0.005799 1.592 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Renal osteodystrophy 0.004043 1.83 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Hemorrhoids 0.008686 0.8274 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Other arthropathies 0.006601 0.8108 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Other specified diseases of hair and hair follicles 0.004196 0.5049 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2304130 Colles' fracture 0.004595 0.4611 ZNF101 Total Cholesterol, LDL Cholesterol, Triglycerides, Sphingolipid levels
rs2326679 Cerebrovascular disease 0.003737 1.112 LRRN4 Menopause
rs2326679 Appendiceal conditions 0.009985 1.391 LRRN4 Menopause
rs2326679 Essential tremor 0.002402 1.362 LRRN4 Menopause
rs2326679 Polycythemia vera, secondary 0.009488 0.5555 LRRN4 Menopause
rs2326679 Cancer of the digestive organs and peritoneum 0.00375 0.59 LRRN4 Menopause
rs2326679 Symptoms of the muscles 0.004959 1.278 LRRN4 Menopause
rs2326679 Oral aphthae 0.002824 1.746 LRRN4 Menopause
rs2326679 Polyp of corpus uteri 0.007023 0.6755 LRRN4 Menopause
rs2326679 Premature beats 0.003532 0.815 LRRN4 Menopause
rs2326679 Multiple sclerosis 0.003415 1.597 LRRN4 Menopause
rs233100 Plasma protein metabolism disorder 0.002685 0.7403 DDAH1 Multiple sclerosis
rs233100 Herpes simplex 0.004034 0.7473 DDAH1 Multiple sclerosis
rs233100 Paraproteinemia 0.004642 0.7063 DDAH1 Multiple sclerosis
rs233100 Altered mental status 0.0004205 0.7158 DDAH1 Multiple sclerosis
rs233100 Heart failure NOS 0.01139 0.7846 DDAH1 Multiple sclerosis
rs233100 Protein plasma/amino-acid transport and metabolism disorder 0.0004204 0.7256 DDAH1 Multiple sclerosis
rs233100 Spirochetal infection 0.00224 1.61 DDAH1 Multiple sclerosis
rs233100 Chronic prostatitis 0.00702 1.518 DDAH1 Multiple sclerosis
rs233100 Pathologic fracture of vertebrae 0.004335 0.7816 DDAH1 Multiple sclerosis
rs233100 Adjustment reaction 0.001888 0.8476 DDAH1 Multiple sclerosis
rs233100 Neck pain 0.008958 0.9112 DDAH1 Multiple sclerosis
rs233100 Benign neoplasm of unspecified sites 0.003124 0.3965 DDAH1 Multiple sclerosis
rs233100 Hereditary and idiopathic peripheral neuropathy 0.003504 0.8577 DDAH1 Multiple sclerosis
rs233100 Premature menopause and other ovarian failure 0.003369 0.4997 DDAH1 Multiple sclerosis
rs233100 Edema 0.01143 0.9108 DDAH1 Multiple sclerosis
rs233100 Nonrheumatic mitral valve disorders 0.008403 0.8738 DDAH1 Multiple sclerosis
rs233100 Hemoptysis 0.01041 0.7477 DDAH1 Multiple sclerosis
rs233100 Hyperventilation 0.004094 0.5384 DDAH1 Multiple sclerosis
rs233100 Lyme disease 0.001427 1.66 DDAH1 Multiple sclerosis
rs233100 Gastritis and duodenitis, NOS 0.001879 0.7891 DDAH1 Multiple sclerosis
rs233100 Bacterial pneumonia 0.001448 0.732 DDAH1 Multiple sclerosis
rs2363956 Heart transplant/surgery 0.002435 0.6616 ANKLE1 Ovarian cancer
rs2363956 Other aneurysm 0.003697 1.195 ANKLE1 Ovarian cancer
rs2363956 Urinary complications 0.005729 1.497 ANKLE1 Ovarian cancer
rs2363956 Cancer, suspected or other 0.008735 1.191 ANKLE1 Ovarian cancer
rs2363956 Paget's disease of bone 0.003742 0.4088 ANKLE1 Ovarian cancer
rs2363956 Substance addiction and disorders 0.0005029 0.7226 ANKLE1 Ovarian cancer
rs2363956 Acute pancreatitis 0.003142 0.7588 ANKLE1 Ovarian cancer
rs2363956 Diverticulum of esophagus, acquired 0.00886 0.5192 ANKLE1 Ovarian cancer
rs2363956 Malignant neoplasm, other 0.001527 1.274 ANKLE1 Ovarian cancer
rs2363956 Neoplasm of uncertain behavior 0.008706 1.18 ANKLE1 Ovarian cancer
rs2363956 Osteopenia 0.008508 1.121 ANKLE1 Ovarian cancer
rs2363956 Alcoholism 0.001136 0.7835 ANKLE1 Ovarian cancer
rs2363956 Redundant prepuce and phimosis/BXO 0.005711 0.5872 ANKLE1 Ovarian cancer
rs2363956 Endometriosis 0.0006099 0.6637 ANKLE1 Ovarian cancer
rs2363956 Aortic aneurysm 0.005315 1.208 ANKLE1 Ovarian cancer
rs2363956 Urinary calculus 0.006827 0.8696 ANKLE1 Ovarian cancer
rs2363956 Spondylolisthesis, congenital 0.003042 1.626 ANKLE1 Ovarian cancer
rs2363956 Other disorders of urethra and urinary tract 0.001069 1.261 ANKLE1 Ovarian cancer
rs2363956 Other paralytic syndromes 0.006073 1.499 ANKLE1 Ovarian cancer
rs2363956 Gross hematuria 0.005279 0.6112 ANKLE1 Ovarian cancer
rs2363956 Disorders of esophageal motility 0.01147 0.6895 ANKLE1 Ovarian cancer
rs2363956 Posttraumatic wound infection 0.006729 0.545 ANKLE1 Ovarian cancer
rs2363956 Primary open angle glaucoma 0.0003216 1.347 ANKLE1 Ovarian cancer
rs2363956 Dementia with cerebral degenerations 0.01012 0.6509 ANKLE1 Ovarian cancer
rs2363956 Alcohol-related disorders 0.0002246 0.7842 ANKLE1 Ovarian cancer
rs2363956 Open-angle glaucoma 0.006692 1.164 ANKLE1 Ovarian cancer
rs2395029 Psoriasis 4.759e-08 2.383 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Voice disturbance 0.0007985 1.682 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Psoriatic arthropathy 0.002383 3.089 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Psoriasis & related disorders 4.113e-07 2.203 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Retinal disorders 0.00593 1.334 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Chronic hepatitis 0.008182 2.725 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Mitral valve stenosis and/or aortic valve stenosis 0.006833 1.598 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Neurological disorders due to brain damage 0.005282 0.6794 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Keratoconjunctivitis, noninfectious 0.0027 2.295 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Acute sinusitis 0.005616 1.413 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Acute laryngitis and tracheitis 0.005621 2.331 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Respiratory failure; insufficiency; arrest 0.00617 0.5394 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Fracture of hand or wrist 0.009025 0.6133 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Pseudoexfoliation glaucoma 0.01111 2.299 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Disorders of cornea 0.006856 1.54 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Psoriasis vulgaris 1.939e-07 2.344 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Acute upper respiratory infections 0.00378 1.307 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Cystic mastopathy 0.0106 1.444 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Keratoconjunctivitis sicca 0.01039 2.37 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Male genital disorders 0.004361 1.872 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Other specified erythematous conditions 0.011 1.756 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Torticollis 0.004129 2.408 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Substance addiction and disorders 0.009114 0.3411 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Macular degeneration 0.008251 1.373 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2395029 Disorders of cervical region 0.006257 1.886 HCP5 Psoriasis, HIV-1 progression, AIDS progression, Drug-induced liver injury (flucloxacillin)
rs2413583 Pancytopenia 0.002965 0.4074 TAB1 Crohn's disease
rs2413583 Decreased white blood cell count 0.01051 0.7559 TAB1 Crohn's disease
rs2413583 Aplastic anemia 0.004684 0.6064 TAB1 Crohn's disease
rs2413583 Suppurative and unspecified otitis media 0.005864 1.228 TAB1 Crohn's disease
rs2413583 Congenital anomalies of posterior segment of eye 0.01116 1.347 TAB1 Crohn's disease
rs2413583 Thoracic neuritis/radiculitis 0.003137 1.171 TAB1 Crohn's disease
rs2413583 Strabismus (not specified as paralytic) 0.002845 1.348 TAB1 Crohn's disease
rs2413583 Other disorders of ear 0.008575 1.362 TAB1 Crohn's disease
rs2413583 Jaundice 0.00654 0.526 TAB1 Crohn's disease
rs2413583 Salicylates causing adverse effects in therapeutic use 0.004092 2.14 TAB1 Crohn's disease
rs2413583 Otorrhea 0.009171 2.039 TAB1 Crohn's disease
rs2413583 Neck pain 0.001533 1.158 TAB1 Crohn's disease
rs2413583 Postlaminectomy syndrome 0.00413 1.541 TAB1 Crohn's disease
rs2413583 Right bundle branch block 0.008642 0.7041 TAB1 Crohn's disease
rs2413583 Mastoiditis 0.0001248 2.971 TAB1 Crohn's disease
rs2413583 Congenital anomalies of urinary system 0.003578 1.606 TAB1 Crohn's disease
rs2413583 Simple goiter 0.005664 1.312 TAB1 Crohn's disease
rs2413583 Cerebral atherosclerosis 0.00974 0.4207 TAB1 Crohn's disease
rs2413583 Migrain with aura 0.001674 0.4557 TAB1 Crohn's disease
rs2413583 Type 2 diabetic peripheral circulatory disorders 0.003264 0.5671 TAB1 Crohn's disease
rs2413583 Other disorders of middle ear and mastoid 0.007822 1.564 TAB1 Crohn's disease
rs2413583 Secondary malignancy of lung 0.01014 0.602 TAB1 Crohn's disease
rs2413583 Eustachian tube disorders 0.005186 1.171 TAB1 Crohn's disease
rs2413583 Diabetic retinopathy 0.0008239 0.7253 TAB1 Crohn's disease
rs2413583 Hyperparathyroidism 0.007157 0.6619 TAB1 Crohn's disease
rs2413583 Cardiac pacemaker/device in situ 0.01127 0.7805 TAB1 Crohn's disease
rs2413583 Neutropenia 0.01117 0.7483 TAB1 Crohn's disease
rs2413583 Complications of transplants and reattached limbs 0.007699 0.4301 TAB1 Crohn's disease
rs2413583 Type 2 diabetic retinopathy 0.00141 0.7288 TAB1 Crohn's disease
rs2413583 Dislocation 0.00583 1.159 TAB1 Crohn's disease
rs242557 Adverse effects of insulins and antidiabetic agents 0.009056 0.5166 MAPT Progressive supranuclear palsy
rs242557 Other disorders of back 0.003089 0.847 MAPT Progressive supranuclear palsy
rs242557 Other hypertrophic and atrophic conditions of skin 0.009479 0.8994 MAPT Progressive supranuclear palsy
rs242557 Otalgia 0.01085 0.7937 MAPT Progressive supranuclear palsy
rs242557 Decreased libido 0.00288 2.07 MAPT Progressive supranuclear palsy
rs242557 Subdural hemorrhage (injury) 0.0104 1.614 MAPT Progressive supranuclear palsy
rs242557 Symptoms involving head and neck 0.004786 1.203 MAPT Progressive supranuclear palsy
rs242557 Elevated levels of transaminase or lactic acid dehydrogenase 0.0105 1.189 MAPT Progressive supranuclear palsy
rs242557 Trigeminal nerve disorders 0.007878 0.6718 MAPT Progressive supranuclear palsy
rs242557 Conduct disorders 0.005829 1.566 MAPT Progressive supranuclear palsy
rs242557 Mechanical complications of cardiac/vascular device, implant, and graft 0.009142 0.8039 MAPT Progressive supranuclear palsy
rs242557 Osteoarthrosis, generalized 0.009315 0.8237 MAPT Progressive supranuclear palsy
rs242557 Eustachian tube disorders 0.01051 0.8022 MAPT Progressive supranuclear palsy
rs242557 Pain in limb 0.003048 0.9091 MAPT Progressive supranuclear palsy
rs242557 Diseases of hard tissues of teeth 0.001662 1.23 MAPT Progressive supranuclear palsy
rs242557 Superficial cellulitis and abscess 0.005398 0.9057 MAPT Progressive supranuclear palsy
rs242557 Alcohol-related disorders 0.000489 1.258 MAPT Progressive supranuclear palsy
rs242557 Subdural hemorrhage 0.01025 1.544 MAPT Progressive supranuclear palsy
rs242557 Cardiomyopathy 0.007457 1.182 MAPT Progressive supranuclear palsy
rs242557 Shock 0.01133 0.7159 MAPT Progressive supranuclear palsy
rs242557 Diabetic retinopathy 0.00244 0.8109 MAPT Progressive supranuclear palsy
rs242557 Schizophrenia and other psychotic disorders 0.0004327 1.262 MAPT Progressive supranuclear palsy
rs242557 Alcoholism 0.002608 1.253 MAPT Progressive supranuclear palsy
rs242557 Nonrheumatic mitral valve disorders 0.003797 1.158 MAPT Progressive supranuclear palsy
rs242557 Intracranial hemorrhage (injury) 0.00334 1.52 MAPT Progressive supranuclear palsy
rs242557 Keratitis, infectious 0.0006616 0.6269 MAPT Progressive supranuclear palsy
rs242557 Other disorders of soft tissues 0.01144 0.7132 MAPT Progressive supranuclear palsy
rs242557 Chronic pain syndrome 0.009249 0.5823 MAPT Progressive supranuclear palsy
rs242557 Dental caries 0.001387 1.241 MAPT Progressive supranuclear palsy
rs242557 Mental disorders due to brain damage 0.008543 1.224 MAPT Progressive supranuclear palsy
rs242557 Chronic venous hypertension 0.004473 0.3857 MAPT Progressive supranuclear palsy
rs242557 Ankylosis of joint 0.006136 0.6759 MAPT Progressive supranuclear palsy
rs243021 Other abnormal glucose 0.008745 1.136 BCL11A Type 2 diabetes
rs243021 Retinal drusen 0.002649 0.7946 BCL11A Type 2 diabetes
rs243021 Polycythemia vera, secondary 0.005764 0.609 BCL11A Type 2 diabetes
rs243021 Herpes zoster 0.006857 1.183 BCL11A Type 2 diabetes
rs243021 Gross hematuria 0.007128 0.6197 BCL11A Type 2 diabetes
rs243021 ASCVD 0.006694 1.367 BCL11A Type 2 diabetes
rs243021 Aortic aneurysm 0.00679 0.8308 BCL11A Type 2 diabetes
rs243021 Abnormal glucose 0.003096 1.123 BCL11A Type 2 diabetes
rs243021 Acute bronchospasm 0.002832 0.3842 BCL11A Type 2 diabetes
rs243021 Acute upper respiratory infections 0.009274 1.094 BCL11A Type 2 diabetes
rs243021 Absent or infrequent menstruation 0.0009403 1.706 BCL11A Type 2 diabetes
rs2430212 Non-healing surgical wound 0.004207 1.796 KLHL13 Serum transferrin
rs2430212 Tachycardia NOS 0.005244 0.7955 KLHL13 Serum transferrin
rs2430212 Diseases of the larynx and vocal cords 0.003928 0.7967 KLHL13 Serum transferrin
rs2430212 Adverse effects of hormones and synthetic substitutes 0.008461 0.2542 KLHL13 Serum transferrin
rs2430212 Vaginitis and vulvovaginitis 0.003257 1.24 KLHL13 Serum transferrin
rs2430212 Ovarian dysfunction 0.002533 0.3847 KLHL13 Serum transferrin
rs2430212 Ectropion or entropion 0.004383 0.72 KLHL13 Serum transferrin
rs2430212 Arthropathy associated with infections 0.009414 0.528 KLHL13 Serum transferrin
rs2430212 Rheumatoid arthritis & related inflammatory polyarthropathies 0.006636 0.802 KLHL13 Serum transferrin
rs2430212 Fracture of humerus 0.0003679 0.6852 KLHL13 Serum transferrin
rs2430212 Rheumatoid arthritis 0.004712 0.7716 KLHL13 Serum transferrin
rs2430212 Eating disorder 0.0114 1.636 KLHL13 Serum transferrin
rs2430212 Other alveolar and parietoalveolar pneumonopathy 0.002492 0.3926 KLHL13 Serum transferrin
rs2430212 Voice disturbance 0.005848 0.7781 KLHL13 Serum transferrin
rs2430212 Visual disturbances 0.0008402 1.174 KLHL13 Serum transferrin
rs2430212 Plasma protein metabolism disorder 0.001877 0.6613 KLHL13 Serum transferrin
rs2430212 Polycystic ovaries 0.003749 0.3475 KLHL13 Serum transferrin
rs2476601 Macular degeneration, dry 0.002992 1.444 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Chronic lymphocytic thyroiditis 0.0004169 1.909 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Primary open angle glaucoma 0.006086 1.415 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Jaundice 0.00866 1.66 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Ovarian dysfunction 0.00424 2.367 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Open-angle glaucoma 0.008166 1.269 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Graves' disease 0.0004271 1.97 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Hypothyroidism 4.02e-07 1.334 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Disorders of tooth development 0.006815 1.521 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Hypotony of eye 0.003949 2.638 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Glaucoma 0.009954 1.185 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Rheumatoid arthritis & related inflammatory polyarthropathies 0.009674 1.297 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Other hypertensive complications 0.009023 1.403 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Hypocalcemia 0.004849 1.674 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Other disorders of gallbladder 0.004858 1.873 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Congenital deformities of feet 0.01006 1.478 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Decreased white blood cell count 0.002305 1.4 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Retinal edema and hypertensive retinopathy 0.01085 1.48 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Vitamin D deficiency 0.01035 1.437 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Thyrotoxicosis 0.008105 1.367 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Disorders of liver 0.002959 1.201 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Neutropenia 0.006896 1.368 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Thyroiditis 0.0007339 1.703 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Urinary calculus 0.01121 0.7873 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Supraventricular premature beats 0.007937 1.53 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Malignant neoplasm of renal pelvis 0.007431 2.505 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Polycystic ovaries 0.0005011 3.149 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Pernicious anemia 0.006919 1.673 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2476601 Congenital anomalies of limbs 0.005418 1.453 PTPN22 Type 1 diabetes, Type 1 diabetes autoantibodies, Vitiligo, Rheumatoid arthritis, Crohn's disease
rs2484873 Perforation of tympanic membrane 0.008245 1.984 KIAA1217 Cognitive performance
rs2484873 Malaise and fatigue 0.00736 1.202 KIAA1217 Cognitive performance
rs2484873 Other anemias 0.001584 1.24 KIAA1217 Cognitive performance
rs2484873 Cardiac defibrillator in situ 0.005462 1.995 KIAA1217 Cognitive performance
rs2484873 Hematemesis 0.001469 2.375 KIAA1217 Cognitive performance
rs2484873 Anemia NOS 0.0006997 1.281 KIAA1217 Cognitive performance
rs2484873 Miscarriage; stillbirth 0.00607 2.521 KIAA1217 Cognitive performance
rs2484873 Elevated levels of transaminase or lactic acid dehydrogenase 0.006783 0.6133 KIAA1217 Cognitive performance
rs2484873 Type 1 diabetic peripheral circulatory disorders 0.003815 2.9 KIAA1217 Cognitive performance
rs2484873 Other aneurysm 0.003711 1.444 KIAA1217 Cognitive performance
rs2484873 Other forms of chronic heart disease 0.01057 1.413 KIAA1217 Cognitive performance
rs2484873 Sexually transmitted infections 0.01074 2.661 KIAA1217 Cognitive performance
rs2484873 Other disorders of arteries and arterioles 0.006808 1.57 KIAA1217 Cognitive performance
rs2505083 Disturbances of sulphur-bearing amino-acid metabolism 0.005529 1.839 KIAA1462 Coronary heart disease
rs2505083 Allergic reaction to food 0.0065 1.863 KIAA1462 Coronary heart disease
rs2505083 Scoliosis 0.006274 0.7632 KIAA1462 Coronary heart disease
rs2505083 Respiratory insufficiency 0.01022 0.7811 KIAA1462 Coronary heart disease
rs2505083 Muscular wasting and disuse atrophy 0.003846 0.5814 KIAA1462 Coronary heart disease
rs2505083 Thyrotoxicosis 0.003759 1.25 KIAA1462 Coronary heart disease
rs2505083 Abnormal findings examination of lungs 0.002547 0.8391 KIAA1462 Coronary heart disease
rs2505083 Aneurysm of artery of lower extremity 0.002463 1.624 KIAA1462 Coronary heart disease
rs2505083 Disorders of mineral metabolism 0.003543 0.866 KIAA1462 Coronary heart disease
rs2505083 Aplastic anemia 0.0005463 0.6723 KIAA1462 Coronary heart disease
rs2505083 Herpes zoster with nervous system complications 0.003633 1.552 KIAA1462 Coronary heart disease
rs2505083 Other benign neoplasm of connective and other soft tissue 0.0008136 0.5993 KIAA1462 Coronary heart disease
rs2505083 Disturbances of amino-acid transport 0.00996 1.745 KIAA1462 Coronary heart disease
rs2505083 Empyema and pneumothorax 0.01047 0.7787 KIAA1462 Coronary heart disease
rs2505083 Labyrinthitis 0.008247 1.344 KIAA1462 Coronary heart disease
rs2515629 Thrombocytopenia 0.003235 0.7753 ABCA1 HDL Cholesterol
rs2515629 Hemorrhage or hematoma complicating a procedure 0.002554 0.7266 ABCA1 HDL Cholesterol
rs2515629 Glaucoma 0.01115 1.139 ABCA1 HDL Cholesterol
rs2515629 Secondary malignant neoplasm 0.00133 1.243 ABCA1 HDL Cholesterol
rs2515629 Fracture of upper limb 0.007045 0.8327 ABCA1 HDL Cholesterol
rs2515629 Candidiasis 0.003405 0.7707 ABCA1 HDL Cholesterol
rs2515629 Malignant neoplasm, other 0.004304 1.308 ABCA1 HDL Cholesterol
rs2515629 Type 2 diabetes 0.0007318 0.8702 ABCA1 HDL Cholesterol
rs2515629 Diabetic retinopathy 0.008229 0.7891 ABCA1 HDL Cholesterol
rs2515629 Colles' fracture 0.001623 0.5582 ABCA1 HDL Cholesterol
rs2515629 Secondary malignant neoplasm of liver 0.004913 1.472 ABCA1 HDL Cholesterol
rs2515629 Type 2 diabetic retinopathy 0.006304 0.7745 ABCA1 HDL Cholesterol
rs2515629 Altered mental status 0.0004352 0.6092 ABCA1 HDL Cholesterol
rs2515629 Diabetes mellitus 0.0006046 0.8698 ABCA1 HDL Cholesterol
rs2515629 Antihypertensive agents causing adverse effects 0.00502 1.68 ABCA1 HDL Cholesterol
rs2515629 Cancer, suspected or other 0.0005484 1.326 ABCA1 HDL Cholesterol
rs2515629 Neoplasm of uncertain behavior 0.001615 1.278 ABCA1 HDL Cholesterol
rs2515629 Poisoning by primarily systemic agents 0.001097 1.464 ABCA1 HDL Cholesterol
rs2515629 Overweight 0.004019 0.8881 ABCA1 HDL Cholesterol
rs2515629 Adverse effects of antineoplastic and immunosuppressive drugs 0.001205 1.474 ABCA1 HDL Cholesterol
rs2515629 Arterial embolism and thrombosis 0.002346 1.35 ABCA1 HDL Cholesterol
rs2515629 Poisoning by other anti-infectives 0.01091 1.277 ABCA1 HDL Cholesterol
rs2515629 Obesity 0.001578 0.8712 ABCA1 HDL Cholesterol
rs2517388 Retinal detachments and defects 0.007526 1.277 ASH2L Menopause
rs2517388 Varicose veins of lower extremity 0.006438 0.8183 ASH2L Menopause
rs2517388 Diseases of respiratory system 0.01006 0.8212 ASH2L Menopause
rs2517388 Secondary malignant neoplasm 0.008831 1.192 ASH2L Menopause
rs2517388 Varicose veins 0.008565 0.8318 ASH2L Menopause
rs2517388 Bronchopneumonia and lung abscess 0.007704 0.3468 ASH2L Menopause
rs2523946 Congenital anomalies of peripheral vascular system 0.006391 1.801 HCG9 IgA nephropathy
rs2523946 Rheumatoid arthritis & related inflammatory polyarthropathies 0.0008209 1.242 HCG9 IgA nephropathy
rs2523946 Polyarteritis nodosa and allied conditions 0.009866 1.313 HCG9 IgA nephropathy
rs2523946 Myalgia and myositis NOS 0.009668 1.112 HCG9 IgA nephropathy
rs2523946 Other congenital anomalies of skin 0.009035 0.6982 HCG9 IgA nephropathy
rs2523946 Atrial fibrillation & flutter 0.008069 1.121 HCG9 IgA nephropathy
rs2523946 Blood in stool 0.0008289 1.192 HCG9 IgA nephropathy
rs2523946 Other and unspecified disc disorder 0.01029 1.441 HCG9 IgA nephropathy
rs2523946 Prurigo 0.005712 0.7724 HCG9 IgA nephropathy
rs2523946 Viral warts & HPV 0.002938 0.8531 HCG9 IgA nephropathy
rs2523946 Conductive hearing loss 0.006175 0.64 HCG9 IgA nephropathy
rs2523946 Herpes zoster 0.01108 0.8518 HCG9 IgA nephropathy
rs2523946 Hidradenitis 0.001209 0.3268 HCG9 IgA nephropathy
rs2523946 Atrial fibrillation 0.007812 1.124 HCG9 IgA nephropathy
rs2523946 Rheumatoid arthritis 0.000787 1.277 HCG9 IgA nephropathy
rs2523946 Arteritis NOS 0.00168 1.69 HCG9 IgA nephropathy
rs2523946 Obstructive sleep apnea 0.001267 0.85 HCG9 IgA nephropathy
rs25422 Decubitus ulcer 0.01115 1.261 C6orf204 Renal cell carcinoma
rs25422 Disorders of fluid, electrolyte, and acid-base balance 0.007599 1.11 C6orf204 Renal cell carcinoma
rs25422 Osteoarthrosis; localized, secondary 0.005803 1.68 C6orf204 Renal cell carcinoma
rs25422 Macular degeneration, dry 0.001802 1.352 C6orf204 Renal cell carcinoma
rs25422 Wheezing and painful respiration 0.01086 0.8614 C6orf204 Renal cell carcinoma
rs25422 Lesions of stomach and duodenum 0.004705 2.104 C6orf204 Renal cell carcinoma
rs25422 Electrolyte imbalance 0.005624 1.131 C6orf204 Renal cell carcinoma
rs25422 Cervical cancer and dysplasia 0.004379 1.371 C6orf204 Renal cell carcinoma
rs25422 Hypovolemia 0.004039 1.168 C6orf204 Renal cell carcinoma
rs25422 Wheezing 0.0007981 0.5954 C6orf204 Renal cell carcinoma
rs2544390 Neoplasm of unspecified nature of digestive system 0.003421 1.459 LRP2 Serum urate
rs2544390 Other disorders of intestine 0.01087 1.176 LRP2 Serum urate
rs2544390 Gastrointestinal complications 0.01104 1.25 LRP2 Serum urate
rs2544390 Abnormal chest sounds 0.008957 0.6805 LRP2 Serum urate
rs2544390 Stiffness of joint 0.005614 0.8215 LRP2 Serum urate
rs2544390 Hypertension 0.003677 1.093 LRP2 Serum urate
rs2544390 Congenital anomalies of face and neck 0.007242 2.14 LRP2 Serum urate
rs2544390 Unstable angina (intermediate coronary syndrome) 0.009963 1.157 LRP2 Serum urate
rs2544390 Essential hypertension 0.005537 1.088 LRP2 Serum urate
rs2544390 Tinnitus 0.001451 1.242 LRP2 Serum urate
rs2544390 Injuries to the nervous system 0.006041 0.6046 LRP2 Serum urate
rs2544390 Elevated blood pressure reading 4.067e-05 1.228 LRP2 Serum urate
rs255052 Type 1 diabetic neuropathy 0.005562 1.582 DPEP2 HDL Cholesterol
rs255052 Heart valve replaced 0.01145 1.354 DPEP2 HDL Cholesterol
rs255052 Osteopenia 0.004463 1.184 DPEP2 HDL Cholesterol
rs255052 Other disorders of the nervous system 0.01115 1.618 DPEP2 HDL Cholesterol
rs255052 Balanoposthitis 0.007714 0.3815 DPEP2 HDL Cholesterol
rs255052 Fibroadenosis of breast 0.006911 2.426 DPEP2 HDL Cholesterol
rs255052 Vitamin deficiency 0.005379 1.24 DPEP2 HDL Cholesterol
rs255052 Other hypertrophic and atrophic conditions of skin 0.007788 0.86 DPEP2 HDL Cholesterol
rs255052 Herpes zoster 0.007952 1.247 DPEP2 HDL Cholesterol
rs2562519 Heart failure NOS 0.008241 0.7415 POLR3G Nevirapine-induced rash
rs2562519 Osteochondropathies 0.009033 1.891 POLR3G Nevirapine-induced rash
rs2562519 Atrial fibrillation & flutter 0.008552 0.8741 POLR3G Nevirapine-induced rash
rs2562519 Acute tonsillitis 0.008243 1.629 POLR3G Nevirapine-induced rash
rs2562519 Benign neoplasm of other endocrine glands 0.004916 1.461 POLR3G Nevirapine-induced rash
rs2562519 Disorders of the pituitary gland and its hypothalamic control 0.007886 1.393 POLR3G Nevirapine-induced rash
rs2562519 Atrial fibrillation 0.006422 0.8677 POLR3G Nevirapine-induced rash
rs2562519 Neoplasm of unspecified nature of digestive system 0.003737 1.507 POLR3G Nevirapine-induced rash
rs2562519 Balanoposthitis 0.004335 0.4764 POLR3G Nevirapine-induced rash
rs2562784 Sacroiliitis NEC 0.00601 0.3969 SH3GL3 Height
rs2562784 Pneumonia 0.01131 1.117 SH3GL3 Height
rs2562784 Fractur of unspecified part of femur 0.001224 0.5628 SH3GL3 Height
rs2562784 Other congenital anomalies of skin 0.002734 1.54 SH3GL3 Height
rs2562784 Hallux valgus (Bunion) 0.002651 1.24 SH3GL3 Height
rs2562784 Speech and language disorder 0.009224 1.427 SH3GL3 Height
rs2562784 Urinary calculus 0.01007 1.163 SH3GL3 Height
rs2562784 Disorders of cornea 0.00687 1.222 SH3GL3 Height
rs2562784 Intestinal malabsorption 0.002455 1.461 SH3GL3 Height
rs2562784 Bullous dermatoses 0.002933 2.014 SH3GL3 Height
rs2562784 Cancer of connective tissue 0.00112 1.864 SH3GL3 Height
rs2562784 Other disorders of bladder 0.007758 1.185 SH3GL3 Height
rs2562784 Hematuria 0.0002749 1.183 SH3GL3 Height
rs2562784 Intestinal malabsorption NOS 0.009014 1.673 SH3GL3 Height
rs2562784 Ventral hernia 0.003288 1.349 SH3GL3 Height
rs2562784 Other specified peripheral vascular diseases 0.004909 2.054 SH3GL3 Height
rs2562784 Cancer of bone & connective tissue 0.01023 1.477 SH3GL3 Height
rs2562784 Abdominal hernia 0.0008838 1.138 SH3GL3 Height
rs2562784 Schizophrenia 0.007957 1.674 SH3GL3 Height
rs2562784 Cancer, suspected or other 0.00294 1.25 SH3GL3 Height
rs2562784 Random mental disorder. Ignored for now 0.002856 1.614 SH3GL3 Height
rs2562784 progressive myopia 0.01141 1.731 SH3GL3 Height
rs2575876 Lupus erythematosus 0.005514 1.923 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Primary angle-closure glaucoma 0.0007063 1.323 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Urethritis and urethral syndrome 0.007397 0.4602 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Angina pectoris 0.006518 0.8633 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Adverse effects of adrenal cortical steroids 0.005816 1.592 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Cellulitis and abscess of trunk 0.002326 0.6901 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Proteinuria 0.01122 1.29 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Anomalies of jaw size/symmetry 0.009715 1.962 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Other peripheral nerve disorders 0.01114 0.9001 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Cardiac defibrillator in situ 0.006504 1.476 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Other infectious diseases 0.003179 0.4027 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Diverticulum of esophagus, acquired 0.009858 0.396 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Hypoparathyroidism 0.007189 2.121 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2575876 Labyrinthitis 5.501e-05 0.5299 ABCA1 Total cholesterol to Esterified cholesterol ratio
rs2597513 Lung cancer 0.002612 1.412 HDAC11 Height
rs2597513 Chronic ischemic heart disease 0.002102 1.258 HDAC11 Height
rs2597513 Peripheral autonomic neuropathy 0.006188 1.56 HDAC11 Height
rs2597513 Type 2 diabetic peripheral circulatory disorders 0.008129 1.535 HDAC11 Height
rs2597513 Irritable Bowel Syndrome 0.004704 0.7521 HDAC11 Height
rs2597513 Temporomandibular joint disorders 0.007965 0.6294 HDAC11 Height
rs2597513 Arthralgia/ankylosis of temporomandibular joint 0.008107 0.2982 HDAC11 Height
rs2597513 Acute laryngitis and tracheitis 0.01115 0.4598 HDAC11 Height
rs2597513 Hypotension NOS 0.001447 1.337 HDAC11 Height
rs2597513 Primary angle-closure glaucoma 0.006601 0.7078 HDAC11 Height
rs2597513 Otalgia 0.001111 0.5674 HDAC11 Height
rs2597513 Hypovolemia 0.000939 1.247 HDAC11 Height
rs2597513 Cancer within the respiratory system 0.002994 1.4 HDAC11 Height
rs2597513 Claw toe 0.0001125 3.057 HDAC11 Height
rs2597513 Known or suspected fetal abnormality 0.006491 0.238 HDAC11 Height
rs2597513 Acidosis 0.01095 1.517 HDAC11 Height
rs2597513 Urethral stricture (not specified as infectious) 0.005133 1.654 HDAC11 Height
rs2619566 Chronic lymphoid leukemia 0.002816 1.846 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Viral Enteritis 0.003639 1.724 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Erythematous conditions 0.009337 0.8327 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Myeloproliferative disease 0.007584 1.5 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Conjunctivitis, infectious 0.004472 0.7662 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Angina pectoris 0.002507 0.8003 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Ischemic Heart Disease 0.0004788 0.8457 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Fracture of unspecified bones 0.004441 1.251 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Hypercholesterolemia 0.01073 0.852 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Coronary atherosclerosis 0.004506 0.8667 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Heart valve disorders 0.009972 0.8545 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Acquired spondylolisthesis 0.004087 0.5918 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Infection of the eye 0.006559 0.7986 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Diffuse diseases of connective tissue 0.008861 0.6679 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Cancer of other female genital organs 0.008321 2.137 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Lymphoid leukemia 0.0004918 1.967 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Ectropion or entropion 0.001554 0.6164 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Colostomy and enterostomy complication 0.01134 1.946 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Leukemia 0.005699 1.479 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Other disorders of back 0.006982 0.7849 CNTN4 Amyotrophic lateral sclerosis
rs2619566 Seborheic dermatitis 0.006101 0.752 CNTN4 Amyotrophic lateral sclerosis
rs2651899 Pyogenic granuloma 0.006027 0.5072 PRDM16 Migraine
rs2651899 Cervical cancer and dysplasia 0.006404 0.7706 PRDM16 Migraine
rs2651899 Synoviopathy 0.006271 0.7477 PRDM16 Migraine
rs2651899 Otalgia 0.006522 0.7838 PRDM16 Migraine
rs2651899 Gram negative septicemia 0.009643 0.7123 PRDM16 Migraine
rs2651899 Toxic erythema 0.006601 2.13 PRDM16 Migraine
rs2651899 Methicillin sensitive Staphylococcus aureus 0.00103 0.6882 PRDM16 Migraine
rs2651899 Iatrogenic hypotension 0.006514 1.585 PRDM16 Migraine
rs2651899 Atrophy of edentulous alveolar ridge 0.005239 0.6418 PRDM16 Migraine
rs2651899 Type 1 diabetic neuropathy 0.005028 1.454 PRDM16 Migraine
rs2651899 Diverticulum of esophagus, acquired 0.007093 0.4899 PRDM16 Migraine
rs2651899 Testicular hypofunction 0.01094 1.368 PRDM16 Migraine
rs2651899 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.008857 0.7626 PRDM16 Migraine
rs2651899 Chronic pancreatitis 0.003409 0.5572 PRDM16 Migraine
rs2651899 Heart transplant/surgery 0.004742 0.6722 PRDM16 Migraine
rs2651899 Prostatitis 0.009366 0.7766 PRDM16 Migraine
rs2651899 Renal colic 0.008933 0.5888 PRDM16 Migraine
rs2651899 Absent or infrequent menstruation 0.01045 0.6615 PRDM16 Migraine
rs2651899 Drug-resistant infection 0.005704 0.7103 PRDM16 Migraine
rs2711721 Appendicitis 0.0004454 1.596 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Deviated nasal septum 0.006185 1.213 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Spondylosis without myelopathy 0.001622 1.152 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Macular degeneration 0.004333 1.164 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Cystic kidney disease 0.002041 0.4619 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Abnormal function study of cardiovascular system 0.01134 0.8333 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Appendiceal conditions 0.0003871 1.586 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Spinal stenosis 0.0005507 1.195 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Spinal stenosis of lumbar region 0.004846 1.176 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Microscopic hematuria 0.003738 1.604 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Degeneration of intervertebral disc 0.005521 1.142 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Urethral hypermobility/ISD 0.001653 0.4203 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Alcoholic liver damage 0.009183 1.645 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Abnormal movement 0.004745 1.137 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Allergies, other 0.0002106 1.419 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Cancer of mouth 0.006651 0.5501 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Congenital anomalies of urinary system 0.006089 0.5918 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Fluid overload 0.008901 0.7428 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Osteoarthrosis, generalized 0.008091 1.241 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Spondylosis and allied disorders 0.001392 1.149 AMIGO2 Prostate cancer (gene x gene interaction)
rs2711721 Hodgkin's disease 0.005391 0.3781 AMIGO2 Prostate cancer (gene x gene interaction)
rs2731672 Early or threatened labor; hemorrhage in early pregnancy 0.002205 1.82 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Inguinal hernia 0.01141 0.8543 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Benign neoplasm of other parts of digestive system 0.009053 0.7175 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Keratoconjunctivitis sicca 0.006667 1.653 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Other conditions of brain 0.0005574 0.6347 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Excessive or frequent menstruation 0.005196 1.355 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Known or suspected fetal abnormality 0.005593 1.732 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Gingival and periodontal diseases 0.008028 0.8137 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Dysmenorrhea 0.004975 1.591 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Cystic kidney disease 0.00811 0.5471 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Uterine leiomyoma 0.0007545 1.324 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Abnormal findings on radiological examination intrathoracic organs 0.01047 0.8067 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Infertility, female 0.001173 2.063 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Abnormal results of function study of liver 0.00586 0.7844 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Benign neoplasm of uterus 0.0001215 1.353 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Insect bite 0.002292 1.306 F12 Activated partial thromboplastin time, Factor XII levels
rs2731672 Malignant neoplasm of brain and nervous system 0.005273 0.6213 F12 Activated partial thromboplastin time, Factor XII levels
rs2744148 Male genital disorders 0.003081 0.6528 SOX8 Multiple sclerosis
rs2744148 Known or suspected fetal abnormality 0.003002 1.898 SOX8 Multiple sclerosis
rs2744148 Macular degeneration 0.00505 0.8446 SOX8 Multiple sclerosis
rs2744148 Congenital anomalies of the eye 0.009451 0.7446 SOX8 Multiple sclerosis
rs2744148 Cholangitis 0.009404 0.3818 SOX8 Multiple sclerosis
rs2744148 Other conditions of the mother complicating pregnancy 0.008268 1.758 SOX8 Multiple sclerosis
rs2744148 Bone cancer 0.004474 1.811 SOX8 Multiple sclerosis
rs2744148 Nevus, non-neoplastic 0.005419 0.3769 SOX8 Multiple sclerosis
rs2744148 Spasm of muscle 0.003333 1.303 SOX8 Multiple sclerosis
rs2744148 Atrophy of edentulous alveolar ridge 0.006236 1.604 SOX8 Multiple sclerosis
rs2744148 Optic atrophy 0.008927 1.536 SOX8 Multiple sclerosis
rs2744148 Personal history of allergy to medicinal agents 0.004432 1.358 SOX8 Multiple sclerosis
rs2744148 Parasomnia 0.004719 1.802 SOX8 Multiple sclerosis
rs2744148 Ulcerative stomatitis & mucositis 0.006022 1.932 SOX8 Multiple sclerosis
rs2744148 Early or threatened labor; hemorrhage in early pregnancy 0.0101 1.731 SOX8 Multiple sclerosis
rs2755237 Neck pain 0.00285 1.154 FOXO1 Central corneal thickness
rs2755237 Other disorders of stomach and duodenum 0.001794 1.433 FOXO1 Central corneal thickness
rs2755237 Infection/inflammation of internal prosthetic device, implant or graft 0.000892 0.6069 FOXO1 Central corneal thickness
rs2755237 pulmonary heart disease 0.007085 1.213 FOXO1 Central corneal thickness
rs2755237 Megaloblastic anemia 0.0008538 0.5186 FOXO1 Central corneal thickness
rs2755237 Alcoholism 0.007629 0.7358 FOXO1 Central corneal thickness
rs2755237 Magnesium metabolism disorder 0.001465 0.5698 FOXO1 Central corneal thickness
rs2755237 Displacement of intervertebral disc 0.00365 1.233 FOXO1 Central corneal thickness
rs2755237 Early or threatened labor; hemorrhage in early pregnancy 0.01098 0.4554 FOXO1 Central corneal thickness
rs2755237 Degenerative disease of the spinal cord 0.008379 1.563 FOXO1 Central corneal thickness
rs2755237 Phobia 0.009051 2.165 FOXO1 Central corneal thickness
rs2755237 Noninfectious dermatoses of eyelid 0.005339 1.823 FOXO1 Central corneal thickness
rs2755237 Other disorders of bladder 0.002711 1.251 FOXO1 Central corneal thickness
rs2755237 Chronic pancreatitis 0.008008 1.766 FOXO1 Central corneal thickness
rs2755237 Vitamin D deficiency 0.005906 0.6618 FOXO1 Central corneal thickness
rs2807278 Other specified erythematous conditions 0.0002548 0.6363 ARG1 Waist hip ratio
rs2807278 Coagulation defects 0.01047 0.901 ARG1 Waist hip ratio
rs2807278 Sleep related movement disorders 0.01041 1.246 ARG1 Waist hip ratio
rs2807278 Cancer of connective tissue 0.006076 0.5037 ARG1 Waist hip ratio
rs2807278 Chronic glomerulonephritis 0.006783 2.142 ARG1 Waist hip ratio
rs2807278 Blister 0.006632 1.823 ARG1 Waist hip ratio
rs2807278 Parkinson's disease 0.009717 0.7497 ARG1 Waist hip ratio
rs2807278 Hematuria 0.003174 0.8737 ARG1 Waist hip ratio
rs2807278 Myeloproliferative disease 0.009572 1.358 ARG1 Waist hip ratio
rs2807278 Ulceration of intestine 0.008528 0.5347 ARG1 Waist hip ratio
rs2807278 Ulceration of the lower GI tract 0.003828 0.5426 ARG1 Waist hip ratio
rs2807278 Congenital anomalies of the eye 0.002509 0.7526 ARG1 Waist hip ratio
rs2807278 Postnasal drip 0.005053 1.811 ARG1 Waist hip ratio
rs2823455 Hallux valgus (Bunion) 0.002631 0.7077 USP25 Panic disorder
rs2823455 Atopic or contact dermatitis 0.00577 0.8421 USP25 Panic disorder
rs2823455 Disorders of cervical region 0.00714 0.5407 USP25 Panic disorder
rs2823455 Gouty arthropathy 0.0108 1.45 USP25 Panic disorder
rs2823455 Sensorineural hearing loss 0.003169 0.8264 USP25 Panic disorder
rs2823455 Macular degeneration, dry 0.004979 0.6771 USP25 Panic disorder
rs2823455 Other disorders of tympanic membrane 0.01123 1.624 USP25 Panic disorder
rs2823455 Acute bronchitis and bronchiolitis 0.01126 0.8268 USP25 Panic disorder
rs2823455 Hammer toe 0.002066 0.679 USP25 Panic disorder
rs2823455 Acquired foot deformities 0.0003448 0.7629 USP25 Panic disorder
rs2823455 Other disorders of bone and cartilage 0.003203 0.6597 USP25 Panic disorder
rs2823455 Acquired toe deformities 0.0002232 0.6673 USP25 Panic disorder
rs2836878 Attention deficit hyperactivity disorder 0.00153 1.816 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Paroxysmal supraventricular tachycardia 0.006037 0.7496 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Hypercholesterolemia 0.004137 1.134 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Hallux rigidus 0.005998 1.412 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Sciatica 0.007254 0.8415 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Adverse effects of antirheumatics 0.002622 0.4487 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Influenza 0.01022 0.724 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Lyme disease 0.001768 1.653 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Hemorrhage or hematoma complicating a procedure 0.002618 0.7764 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Asthma with exacerbation 0.006987 0.6854 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Open-angle glaucoma 0.005438 0.8395 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Palpitations 0.008184 0.8713 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Disorders of tooth development 0.01131 0.7253 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Disturbances in tooth eruption 0.00752 0.7041 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Other disorders of back 0.01032 0.8546 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Neoplasm of unspecified nature of digestive system 0.00583 1.445 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Respiratory abnormalities 0.002695 0.6938 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Dysmenorrhea 0.01139 0.6449 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Mammographic microcalcification 0.002519 0.524 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Poisoning by analgesics, antipyretics, and antirheumatics 0.009798 0.7281 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Other specified diseases of hair and hair follicles 0.00764 0.7238 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Bronchitis 0.008686 0.8683 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Pervasive developmental disorders 0.01149 1.521 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Glaucoma 0.005487 0.8834 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Spirochetal infection 0.002991 1.6 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2836878 Polyarthropathy or polyarthritis involving multiple sites NOS 0.006408 0.5278 PSMG1 Inflammatory bowel disease, Ulcerative colitis, C-reactive protein
rs2838815 Abnormal mammogram 0.002495 1.2 ADARB1 Pulmonary function
rs2838815 Contracture of joint 0.003842 1.426 ADARB1 Pulmonary function
rs2838815 Hydronephrosis 0.005028 0.7412 ADARB1 Pulmonary function
rs2838815 Traumatic arthropathy 0.005693 1.647 ADARB1 Pulmonary function
rs2838815 Urinary complications 0.007715 1.461 ADARB1 Pulmonary function
rs2838815 Abnormal findings on radiological breast exam 0.01002 1.539 ADARB1 Pulmonary function
rs2839619 Calcaneal spur; Exostosis NOS 0.01136 1.237 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Visual field defects 0.002464 1.304 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Pallor and flushing 0.004285 0.6869 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Ulcerative colitis 0.006172 1.458 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Dyspepsia and disorders of function of stomach 0.007456 1.157 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Personal history of allergy to medicinal agents 0.002515 0.768 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Disorders of function of stomach 0.003007 1.167 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Hemorrhage or hematoma complicating a procedure 0.002699 1.239 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Fasciitis 0.002438 1.182 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Disorders of muscle, ligament, and fascia 0.004664 1.164 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Oliguria and anuria 0.006024 2.178 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Nasal polyps 0.007441 1.323 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2839619 Swelling, mass, or lump in head and neck 0.01058 0.8189 PKNOX1 Total Cholesterol, LDL Cholesterol
rs2853676 Costochondritis 0.002931 1.901 TERT Glioma
rs2853676 Other dermatoses 0.001125 0.887 TERT Glioma
rs2853676 Herpes zoster with nervous system complications 0.004709 0.5674 TERT Glioma
rs2853676 Retinal drusen 0.005417 1.262 TERT Glioma
rs2853676 Neoplasm of unspecified nature of digestive system 0.006993 0.6425 TERT Glioma
rs2853676 Balanoposthitis 0.009542 1.661 TERT Glioma
rs2853676 Leukoplakia of oral mucosa 0.0001572 2.28 TERT Glioma
rs2853676 Paroxysmal ventricular tachycardia 0.01115 0.7582 TERT Glioma
rs2853676 Congenital anomalies of intestine 0.009352 0.2911 TERT Glioma
rs2853676 Dysmetabolic syndrome X 0.008192 1.451 TERT Glioma
rs2853676 Altered mental status 0.009799 0.7546 TERT Glioma
rs2853676 Other hypertrophic and atrophic conditions of skin 0.002504 0.8735 TERT Glioma
rs2853676 Seborrheic keratosis 1.563e-07 0.804 TERT Glioma
rs2853676 Postmenopausal hormone replacement 0.007312 1.323 TERT Glioma
rs2853676 Other forms of chronic heart disease 0.01123 0.8241 TERT Glioma
rs2853676 Stricture and stenosis of esophagus 0.005221 1.306 TERT Glioma
rs2853676 Fracture of foot 0.008273 0.805 TERT Glioma
rs2853676 Cardiac defibrillator in situ 0.007326 0.6502 TERT Glioma
rs2853676 Eye infection, viral 0.008703 0.6729 TERT Glioma
rs2853676 Cholelithiasis with acute cholecystitis 0.003358 0.5366 TERT Glioma
rs2853676 Central/nonobstroctive sleep apnea 0.008223 0.5215 TERT Glioma
rs2857595 Ectropion or entropion 0.007973 1.324 NCR3 Pulmonary function
rs2857595 Bullous dermatoses 0.002251 2.088 NCR3 Pulmonary function
rs2857595 Retinoschisis and retinal cysts 0.005845 2.159 NCR3 Pulmonary function
rs2857595 Thyrotoxicosis 0.01033 1.26 NCR3 Pulmonary function
rs2857595 Other specified peripheral vascular diseases 0.001371 2.28 NCR3 Pulmonary function
rs2857595 Hyperplasia of prostate 0.000119 0.7836 NCR3 Pulmonary function
rs2857595 Celiac or tropical sprue 3.342e-05 2.451 NCR3 Pulmonary function
rs2857595 Disorders of the pituitary gland and its hypothalamic control 0.00862 1.407 NCR3 Pulmonary function
rs2857595 Varicose veins of lower extremity 0.0002174 1.275 NCR3 Pulmonary function
rs2857595 Adverse effects of insulins and antidiabetic agents 0.003067 1.939 NCR3 Pulmonary function
rs2857595 Other disorders of lipoid metabolism and hyperalimentation 0.004536 1.344 NCR3 Pulmonary function
rs2857595 Lymphosarcoma 0.008797 0.1515 NCR3 Pulmonary function
rs2857595 Colon cancer 0.004484 0.7333 NCR3 Pulmonary function
rs2857595 Poisoning by antibiotics 0.005472 0.7859 NCR3 Pulmonary function
rs2857595 Prostatitis 0.001212 0.6612 NCR3 Pulmonary function
rs2857595 Cardiac shunt/ heart septal defect 0.002352 0.5295 NCR3 Pulmonary function
rs2857595 Type 1 diabetic retinopathy 0.0002628 1.671 NCR3 Pulmonary function
rs2857595 Celiac disease 8.504e-05 2.385 NCR3 Pulmonary function
rs2857595 Venous embolism & thrombosis 0.007405 1.193 NCR3 Pulmonary function
rs2857595 Type 1 diabetes nephropathy 0.01011 1.65 NCR3 Pulmonary function
rs2857595 Peripheral autonomic neuropathy 0.000128 1.647 NCR3 Pulmonary function
rs2857595 Inflammatory disease of cervix, vagina, and vulva 0.005928 0.8055 NCR3 Pulmonary function
rs2857595 Disorders of the autonomic nervous system 0.002434 1.406 NCR3 Pulmonary function
rs2857595 Varicose veins 0.0002379 1.261 NCR3 Pulmonary function
rs2857595 Lack of coordination 0.001541 1.353 NCR3 Pulmonary function
rs2857595 Lipoprotein disorders 0.00728 1.409 NCR3 Pulmonary function
rs2858331 Adverse effects of insulins and antidiabetic agents 0.003292 0.48 HLA-DQA2 IgE levels
rs2858331 Type 1 diabetes nephropathy 6.189e-05 0.4113 HLA-DQA2 IgE levels
rs2858331 Infections involving bone 0.007797 0.79 HLA-DQA2 IgE levels
rs2858331 Male infertility and abnormal spermatozoa 0.002949 1.8 HLA-DQA2 IgE levels
rs2858331 Fractur of unspecified part of femur 0.003753 0.6733 HLA-DQA2 IgE levels
rs2858331 Multiple sclerosis 0.000626 0.5377 HLA-DQA2 IgE levels
rs2858331 Male genital disorders 0.003596 1.34 HLA-DQA2 IgE levels
rs2858331 Claw toe 0.005153 1.975 HLA-DQA2 IgE levels
rs2858331 Toxic erythema 0.005248 0.3908 HLA-DQA2 IgE levels
rs2858331 Type 1 diabetic neuropathy 0.001554 0.626 HLA-DQA2 IgE levels
rs2858331 Type 1 diabetic ketoacidosis 0.0001121 0.572 HLA-DQA2 IgE levels
rs2858331 Ventral hernia 0.001532 1.334 HLA-DQA2 IgE levels
rs2858331 Chronic pancreatitis 0.0008376 1.826 HLA-DQA2 IgE levels
rs2858331 Chronic liver disease and cirrhosis 0.003031 1.249 HLA-DQA2 IgE levels
rs2858331 Type 1 diabetes 0.001715 0.8223 HLA-DQA2 IgE levels
rs2858331 Hyperpotassemia 0.009667 0.8419 HLA-DQA2 IgE levels
rs2858331 Breast conditions, congenital or relating to hormones 0.006095 1.324 HLA-DQA2 IgE levels
rs2858331 Sicca syndrome 0.005764 0.6451 HLA-DQA2 IgE levels
rs2858331 Deficiency anemias NOS 0.004491 1.428 HLA-DQA2 IgE levels
rs2858331 Substance addiction and disorders 0.002973 0.7483 HLA-DQA2 IgE levels
rs2858331 Other disorders of lipoid metabolism and hyperalimentation 0.003337 0.7581 HLA-DQA2 IgE levels
rs2858331 Diseases of the tongue 0.003062 1.441 HLA-DQA2 IgE levels
rs2858331 Benign neoplasm of uterus 0.01113 1.199 HLA-DQA2 IgE levels
rs2858331 Disturbances of amino-acid transport 0.01107 1.709 HLA-DQA2 IgE levels
rs2858331 Occlusion of cerebral arteries, with cerebral infarction 0.003528 0.6268 HLA-DQA2 IgE levels
rs2858331 Open wound of finger(s) 0.005865 0.8489 HLA-DQA2 IgE levels
rs2858331 Acute laryngitis and tracheitis 0.009516 1.44 HLA-DQA2 IgE levels
rs2859631 Cystic mastopathy 0.008417 0.5579 WWOX Radiation response
rs2859631 Peptic ulcer 0.006426 1.668 WWOX Radiation response
rs2859631 Chronic periodontitis 3.855e-05 2.493 WWOX Radiation response
rs2859631 Abnormal findings on radiological examination intrathoracic organs 0.001913 1.985 WWOX Radiation response
rs2859631 Periodontitis (acute or chronic) 0.0005143 2.084 WWOX Radiation response
rs2859631 Other disorders of the kidney and ureters 0.001191 1.571 WWOX Radiation response
rs2859631 Hyposmolality and/or hyponatremia 0.005685 1.672 WWOX Radiation response
rs2859631 Sleep apnea 0.009329 1.415 WWOX Radiation response
rs2859631 Unstable angina (intermediate coronary syndrome) 0.006083 1.689 WWOX Radiation response
rs2859631 Poisoning by psychotropic agents 0.002337 3.844 WWOX Radiation response
rs2859631 Light-headedness and vertigo 0.009642 1.388 WWOX Radiation response
rs2859631 Vascular dementia 1.127e-06 4.531 WWOX Radiation response
rs2859631 Hemorrhage from gastrointestinal ulcer 0.0002506 3.191 WWOX Radiation response
rs2859631 Hydronephrosis 0.002746 2.301 WWOX Radiation response
rs2859631 Skin neoplasm of uncertain behavior 0.001238 1.935 WWOX Radiation response
rs2859631 Gingival and periodontal diseases 0.0001162 2.071 WWOX Radiation response
rs2859631 Angina pectoris 0.0006836 1.732 WWOX Radiation response
rs2859631 Methicillin resistant Staphylococcus aureus 0.005388 3.771 WWOX Radiation response
rs2859631 Peripheral or central vertigo 0.0052 1.847 WWOX Radiation response
rs2859631 Peyronie's disease 0.00515 4.182 WWOX Radiation response
rs2859631 Viral pneumonia 0.005238 4.568 WWOX Radiation response
rs2859631 Vertiginous syndromes and other disorders of vestibular system 0.01071 1.363 WWOX Radiation response
rs2859631 Glomerulonephritis 0.01068 2.956 WWOX Radiation response
rs286913 Apnea 0.005771 2.68 EHF Response to antipsychotic treatment
rs286913 Diseases of hard tissues of teeth 0.0112 1.405 EHF Response to antipsychotic treatment
rs286913 Antihypertensive agents causing adverse effects 0.006465 2.117 EHF Response to antipsychotic treatment
rs286913 Costochondritis 0.009114 2.465 EHF Response to antipsychotic treatment
rs286913 Poisoning by agents primarily affecting blood constituents 0.00668 2.194 EHF Response to antipsychotic treatment
rs286913 Althete's foot 0.001591 0.4315 EHF Response to antipsychotic treatment
rs286913 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.002013 3.734 EHF Response to antipsychotic treatment
rs286913 Chronic venous hypertension 0.009642 2.743 EHF Response to antipsychotic treatment
rs286913 Immune disorders 0.003965 0.4548 EHF Response to antipsychotic treatment
rs286913 Appendicitis 0.005801 1.848 EHF Response to antipsychotic treatment
rs286913 Allergies, other 0.009671 1.547 EHF Response to antipsychotic treatment
rs286913 Dental caries 0.006079 1.452 EHF Response to antipsychotic treatment
rs286913 Sleep disorders 0.01115 1.225 EHF Response to antipsychotic treatment
rs286913 Type 1 diabetic peripheral circulatory disorders 0.006266 2.64 EHF Response to antipsychotic treatment
rs286913 Mechanical complication due to other implant and internal device 0.006715 1.701 EHF Response to antipsychotic treatment
rs2870946 Raynaud's syndrome 0.000973 1.721 IL26 Ulcerative colitis
rs2870946 Infestation 0.009302 2.112 IL26 Ulcerative colitis
rs2870946 Allergic conjunctivitis 0.004404 0.5335 IL26 Ulcerative colitis
rs2870946 Other headache syndromes 0.01107 1.194 IL26 Ulcerative colitis
rs2870946 Central/nonobstroctive sleep apnea 0.002273 2.308 IL26 Ulcerative colitis
rs2870946 Abnormal findings on exam of gastrointestinal tract/abdominal area 0.008879 1.638 IL26 Ulcerative colitis
rs2870946 Osteoporosis 0.01066 1.25 IL26 Ulcerative colitis
rs2870946 Paralytic ileus 0.006043 1.649 IL26 Ulcerative colitis
rs2870946 Hyperlipidemia 0.001985 1.23 IL26 Ulcerative colitis
rs2870946 Psychogenic disorder 0.001334 1.956 IL26 Ulcerative colitis
rs2870946 Postmenopausal hormone replacement 0.00375 1.701 IL26 Ulcerative colitis
rs2870946 Obsessive-compulsive disorder 8.316e-05 2.912 IL26 Ulcerative colitis
rs2870946 Hyposmolality and/or hyponatremia 0.01146 1.321 IL26 Ulcerative colitis
rs2870946 Gastric ulcer 0.008141 1.536 IL26 Ulcerative colitis
rs2870946 Anemia in neoplastic disease 0.0006841 1.966 IL26 Ulcerative colitis
rs2870946 Congenital anomalies of intestine 0.009928 2.687 IL26 Ulcerative colitis
rs2870946 Hypopotassemia 0.003183 1.301 IL26 Ulcerative colitis
rs2870946 Psychogenic and somatoform disorders 0.008005 1.508 IL26 Ulcerative colitis
rs2870946 Gastrointestinal malfunction arising from mental factors 0.0001116 3.523 IL26 Ulcerative colitis
rs2870946 Pathologic fracture 0.01034 1.375 IL26 Ulcerative colitis
rs2870946 Disorders of fluid, electrolyte, and acid-base balance 0.001354 1.219 IL26 Ulcerative colitis
rs2870946 Electrolyte imbalance 0.0009436 1.256 IL26 Ulcerative colitis
rs2870946 Nausea and vomiting 0.0004139 1.284 IL26 Ulcerative colitis
rs2870946 Osteochondropathies 0.006603 2.453 IL26 Ulcerative colitis
rs2870946 Anomalies of jaw size/symmetry 0.007764 2.687 IL26 Ulcerative colitis
rs2870946 Intestinal obstruction without mention of hernia 0.002048 1.433 IL26 Ulcerative colitis
rs2870946 Conjunctivitis, noninfectious 0.007277 0.6049 IL26 Ulcerative colitis
rs2870946 Pancytopenia 0.001637 2.159 IL26 Ulcerative colitis
rs2870946 Disorders of lipoid metabolism 0.001244 1.239 IL26 Ulcerative colitis
rs2870946 Pathologic fracture of vertebrae 0.004558 1.524 IL26 Ulcerative colitis
rs2870946 Hypercholesterolemia 0.001848 1.285 IL26 Ulcerative colitis
rs2895811 Testicular hypofunction 0.003838 1.428 HHIPL1 Coronary heart disease
rs2895811 Other forms of chronic heart disease 0.00306 0.8205 HHIPL1 Coronary heart disease
rs2895811 Renal failure NOS 0.007223 0.7476 HHIPL1 Coronary heart disease
rs2895811 Other and unspecified disc disorder 0.003827 0.6462 HHIPL1 Coronary heart disease
rs2895811 severe protein-calorie malnutrition 0.009246 0.6433 HHIPL1 Coronary heart disease
rs2895811 Claw toe 0.0008288 0.3742 HHIPL1 Coronary heart disease
rs2895811 Fracture of radius and ulna 0.01056 1.171 HHIPL1 Coronary heart disease
rs2895811 Femoral hernia 0.009216 0.5237 HHIPL1 Coronary heart disease
rs2895811 Elevated C-reactive protein 0.003362 2.048 HHIPL1 Coronary heart disease
rs2895811 Protein-calorie malnutrition 0.009594 0.8605 HHIPL1 Coronary heart disease
rs2895811 Gram negative septicemia 0.005449 1.413 HHIPL1 Coronary heart disease
rs2895811 Hereditary and idiopathic peripheral neuropathy 0.009122 0.8734 HHIPL1 Coronary heart disease
rs2895811 ASCVD 0.0006843 0.6593 HHIPL1 Coronary heart disease
rs2895811 Pruritus and related conditions 0.00389 0.8243 HHIPL1 Coronary heart disease
rs2895811 Hypertensive heart disease 0.004111 0.7337 HHIPL1 Coronary heart disease
rs2901331 Secondary thrombocytopenia 0.003443 1.683 CNTNAP5 Response to statin therapy
rs2901331 Tobacco use disorder 0.009482 1.104 CNTNAP5 Response to statin therapy
rs2901331 Reticulosarcoma 0.001572 1.775 CNTNAP5 Response to statin therapy
rs2901331 Essential tremor 0.009373 1.295 CNTNAP5 Response to statin therapy
rs2901331 Other congenital anomalies 0.006507 1.771 CNTNAP5 Response to statin therapy
rs2901331 Gastrointestinal hemorrhage 0.01059 1.106 CNTNAP5 Response to statin therapy
rs2901331 Disturbances of amino-acid transport 0.003828 1.887 CNTNAP5 Response to statin therapy
rs2901331 Disturbances of sulphur-bearing amino-acid metabolism 0.009054 1.789 CNTNAP5 Response to statin therapy
rs2901331 Chronic airway obstruction 0.01115 1.11 CNTNAP5 Response to statin therapy
rs2901331 Disorders of muscle, ligament, and fascia 0.009687 0.8572 CNTNAP5 Response to statin therapy
rs2901331 Congenital musculoskeletal deformities of spine 0.011 0.6852 CNTNAP5 Response to statin therapy
rs29232 Protein plasma/amino-acid transport and metabolism disorder 0.001316 1.32 GABBR1 Nasopharyngeal carcinoma
rs29232 Paraproteinemia 0.01069 1.344 GABBR1 Nasopharyngeal carcinoma
rs29232 Sleep apnea 0.004254 1.126 GABBR1 Nasopharyngeal carcinoma
rs29232 Circumscribed scleroderma 0.001121 1.478 GABBR1 Nasopharyngeal carcinoma
rs29232 Palpitations 0.007366 1.134 GABBR1 Nasopharyngeal carcinoma
rs29232 Essential tremor 0.002694 1.339 GABBR1 Nasopharyngeal carcinoma
rs29232 Paroxysmal supraventricular tachycardia 0.003805 1.293 GABBR1 Nasopharyngeal carcinoma
rs29232 Peripheral vascular disease 0.006981 1.117 GABBR1 Nasopharyngeal carcinoma
rs29232 Other specified erythematous conditions 0.00122 1.372 GABBR1 Nasopharyngeal carcinoma
rs29232 Other disorders of arteries and arterioles 0.004179 1.275 GABBR1 Nasopharyngeal carcinoma
rs29232 Extrapyramidal disease and abnormal movement disorders 0.004028 1.194 GABBR1 Nasopharyngeal carcinoma
rs29232 Stricture of artery 0.001317 1.388 GABBR1 Nasopharyngeal carcinoma
rs29232 Dentofacial anomalies, including malocclusion 0.009204 1.506 GABBR1 Nasopharyngeal carcinoma
rs29232 Second degree AV block 0.001789 1.621 GABBR1 Nasopharyngeal carcinoma
rs29232 Suppurative and unspecified otitis media 0.00614 0.8511 GABBR1 Nasopharyngeal carcinoma
rs29232 Plasma protein metabolism disorder 0.001999 1.342 GABBR1 Nasopharyngeal carcinoma
rs29232 Other acute and subacute forms of ischemic heart disease 0.001814 2.007 GABBR1 Nasopharyngeal carcinoma
rs29232 Peripheral arterial disease 0.00454 1.135 GABBR1 Nasopharyngeal carcinoma
rs2925979 Gout 0.007902 0.8506 CMIP HDL Cholesterol
rs2925979 Plasma protein metabolism disorder 0.003195 0.7192 CMIP HDL Cholesterol
rs2925979 Chronic renal failure 0.005572 0.8807 CMIP HDL Cholesterol
rs2925979 Early complications of trauma or procedure 0.01111 1.621 CMIP HDL Cholesterol
rs2925979 Diaphragmatic hernia 0.009063 0.8732 CMIP HDL Cholesterol
rs2925979 Renal dialysis 0.01009 0.6767 CMIP HDL Cholesterol
rs2925979 Dermatophytosis of nail 0.009571 0.8816 CMIP HDL Cholesterol
rs2925979 Carbuncle and furuncle 0.009017 0.6265 CMIP HDL Cholesterol
rs2925979 Disorders resulting from impaired renal function 0.0107 0.7579 CMIP HDL Cholesterol
rs2925979 Hypothyroidism 0.002134 0.8853 CMIP HDL Cholesterol
rs2925979 Degenerative disease of the spinal cord 0.008044 0.6453 CMIP HDL Cholesterol
rs2925979 Hyperparathyroidism 0.002822 0.7101 CMIP HDL Cholesterol
rs2925979 Crystal arthropathies 0.00178 0.6585 CMIP HDL Cholesterol
rs2925979 Calcium/phosphorus disorders 0.0003548 0.7613 CMIP HDL Cholesterol
rs2925979 Protein plasma/amino-acid transport and metabolism disorder 0.003681 0.7471 CMIP HDL Cholesterol
rs2925979 Hemorrhage of rectum and anus 0.005944 0.8154 CMIP HDL Cholesterol
rs2925979 Osteoporosis, osteopenia, & pathological fractures 0.002245 0.8916 CMIP HDL Cholesterol
rs2925979 Chondrocalcinosis 0.004078 0.68 CMIP HDL Cholesterol
rs2925979 Umbilical hernia 0.01132 0.7749 CMIP HDL Cholesterol
rs2925979 Paraproteinemia 0.002154 0.651 CMIP HDL Cholesterol
rs2925979 Other local infections of skin and subcutaneous tissue 0.005208 0.8348 CMIP HDL Cholesterol
rs2925979 Disorders of parathyroid gland 0.005097 0.7369 CMIP HDL Cholesterol
rs2925979 Graves' disease 0.01092 0.6489 CMIP HDL Cholesterol
rs2925979 Renal failure 0.004296 0.8911 CMIP HDL Cholesterol
rs2925979 Disorders of diaphragm 0.004337 0.3921 CMIP HDL Cholesterol
rs2925979 Gout and other crystal arthropathies 0.001456 0.8341 CMIP HDL Cholesterol
rs2925979 Other disorders of the kidney and ureters 0.002912 0.8742 CMIP HDL Cholesterol
rs2925979 Disorders of mineral metabolism 0.01099 0.8698 CMIP HDL Cholesterol
rs2934442 Other disorders of peritoneum 0.0111 1.458 CGNL1 Bipolar disorder
rs2934442 Hydrocele 0.01069 0.5876 CGNL1 Bipolar disorder
rs2934442 Peritoneal adhesions (postoperative) (postinfection) 0.004632 1.638 CGNL1 Bipolar disorder
rs2934442 Hemorrhage NOS 0.00168 0.3526 CGNL1 Bipolar disorder
rs2934442 Hidradenitis 0.004548 2.331 CGNL1 Bipolar disorder
rs2934442 Age-related macular degeneration 0.003196 1.268 CGNL1 Bipolar disorder
rs2934442 Disorders of mineral metabolism 0.001121 1.206 CGNL1 Bipolar disorder
rs2934442 Disorders of choroid 0.007143 1.348 CGNL1 Bipolar disorder
rs2934442 Macular degeneration, wet 0.01041 1.373 CGNL1 Bipolar disorder
rs2934442 Anisometropia 0.00226 0.6615 CGNL1 Bipolar disorder
rs2934442 Iron metabolism disorder 0.004874 1.941 CGNL1 Bipolar disorder
rs2934442 Disorders of coccyx 0.001581 1.452 CGNL1 Bipolar disorder
rs2934442 Ovarian cyst 0.009072 0.7034 CGNL1 Bipolar disorder
rs2934442 Glaucoma 0.009283 1.134 CGNL1 Bipolar disorder
rs2934442 Hepatic cancer, primary 0.007318 2.047 CGNL1 Bipolar disorder
rs2957128 Hypercalcemia 0.007172 0.7939 TNFRSF11A Paget's disease
rs2957128 Carbohydrate transport and metabolism disorder 0.007156 1.171 TNFRSF11A Paget's disease
rs2957128 Speech and language disorder 0.01073 0.7175 TNFRSF11A Paget's disease
rs2957128 Carbuncle and furuncle 0.00967 0.6681 TNFRSF11A Paget's disease
rs2957128 Urinary complications 0.0108 1.441 TNFRSF11A Paget's disease
rs2957128 Gestational diabetes 0.0009648 2.673 TNFRSF11A Paget's disease
rs2957128 Fracture of tibia and fibula 0.009249 1.262 TNFRSF11A Paget's disease
rs2957128 Other conditions of the mother complicating pregnancy 0.001154 1.836 TNFRSF11A Paget's disease
rs2957128 Acute renal failure 0.006821 1.158 TNFRSF11A Paget's disease
rs2957128 Chronic pain syndrome 0.009071 1.619 TNFRSF11A Paget's disease
rs2957128 Cataract 0.0007919 0.8818 TNFRSF11A Paget's disease
rs2957128 Localized superficial swelling, mass, or lump 0.00372 0.774 TNFRSF11A Paget's disease
rs2957128 Morbid obesity 0.001417 1.196 TNFRSF11A Paget's disease
rs2957128 severe protein-calorie malnutrition 0.005022 1.574 TNFRSF11A Paget's disease
rs2957128 Elevated prostate specific antigen 0.003359 0.8278 TNFRSF11A Paget's disease
rs296547 Secondary malignancy of lung 0.01021 1.369 C1orf81 Celiac disease
rs296547 Stomach cancer 0.003594 1.78 C1orf81 Celiac disease
rs296547 Other upper respiratory disease 0.006939 1.157 C1orf81 Celiac disease
rs296547 Muscle weakness 0.005955 0.7525 C1orf81 Celiac disease
rs296547 Cholesteatoma 0.003811 0.5049 C1orf81 Celiac disease
rs296547 Anaphylactic shock NOS 0.0004205 1.665 C1orf81 Celiac disease
rs296547 Secondary malignant neoplasm of digestive systems 0.0001622 1.756 C1orf81 Celiac disease
rs296547 Poisoning by agents affecting the cardiovascular system 0.00257 1.356 C1orf81 Celiac disease
rs296547 Symptoms involving cardiovascular system 0.00381 0.8479 C1orf81 Celiac disease
rs296547 Bronchiectasis 1.797e-05 1.671 C1orf81 Celiac disease
rs296547 Other cerebral degenerations 0.005455 0.677 C1orf81 Celiac disease
rs296547 Hypercalcemia 0.002066 1.295 C1orf81 Celiac disease
rs2979481 Diplopia and disorders of binocular vision 0.007839 1.289 RBPMS Heart rate training response
rs2979481 Oral aphthae 0.002823 1.718 RBPMS Heart rate training response
rs2979481 Disorders of conjunctiva 0.002353 1.281 RBPMS Heart rate training response
rs2979481 Loss of teeth or edentulism 0.002593 1.419 RBPMS Heart rate training response
rs2979481 Delirium due to conditions classified elsewhere 0.003574 1.414 RBPMS Heart rate training response
rs2979481 Hemorrhage NOS 0.008302 0.5562 RBPMS Heart rate training response
rs2979481 Other diseases of the teeth and supporting structures 0.007702 1.248 RBPMS Heart rate training response
rs2979481 Otalgia 0.005751 0.774 RBPMS Heart rate training response
rs2979481 Hx of malignant neoplasm of oral cavity and pharynx 0.007572 1.623 RBPMS Heart rate training response
rs2979481 Cervical radiculitis 0.004181 1.193 RBPMS Heart rate training response
rs2979481 Stomatitis and mucositis 0.001684 1.46 RBPMS Heart rate training response
rs2979481 Acute bronchitis and bronchiolitis 0.002127 1.15 RBPMS Heart rate training response
rs2979481 Anomalies of pupillary function 0.009711 1.823 RBPMS Heart rate training response
rs2979481 Cystic kidney disease 0.008565 1.546 RBPMS Heart rate training response
rs3016539 Alcohol-related disorders 0.007649 1.301 PARK2 Pancreatic cancer
rs3016539 Alcoholism 0.008446 1.34 PARK2 Pancreatic cancer
rs3016539 Acquired spondylolisthesis 0.002936 1.501 PARK2 Pancreatic cancer
rs3016539 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.006819 0.6143 PARK2 Pancreatic cancer
rs3016539 Palpitations 0.007825 1.217 PARK2 Pancreatic cancer
rs3016539 Irregular menstrual bleeding 0.005518 0.252 PARK2 Pancreatic cancer
rs3016539 Hepatic cancer, primary 0.008311 2.294 PARK2 Pancreatic cancer
rs3016539 Abnormal electrocardiogram 0.006962 1.245 PARK2 Pancreatic cancer
rs3016539 Impaired fasting glucose 0.008017 1.278 PARK2 Pancreatic cancer
rs3016539 Bundle branch block 0.009845 1.316 PARK2 Pancreatic cancer
rs3016539 Postlaminectomy syndrome 0.002182 1.662 PARK2 Pancreatic cancer
rs3016539 Stomach cancer 0.004952 2.03 PARK2 Pancreatic cancer
rs3016539 Chronic kidney disease, Stage I or II 0.003735 1.595 PARK2 Pancreatic cancer
rs3027409 Dysmenorrhea 0.0008892 3.031 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Nerve plexus lesions 0.00898 1.985 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Cyst and pseudocyst of pancreas 0.001672 2.787 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Abnormal findings on mammogram or breast exam 0.002595 1.354 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Irregular menstrual cycle 0.002813 2.095 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Cardiac arrest 0.009138 2.524 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Adverse effects of antibacterials (not penicillins) 0.0003913 3.468 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Open-angle glaucoma 0.001803 1.543 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Poisoning by water, mineral, and uric acid metabolism drugs 0.002379 2.956 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Leukoplakia of oral mucosa 0.002722 3.198 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Eating disorder 0.004345 2.576 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Other acute and subacute forms of ischemic heart disease 5.536e-05 4.716 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Irregular menstrual cycle/bleeding 0.008991 1.542 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Glaucoma 0.001568 1.396 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Bursitis 0.004379 1.586 MAOA Smoking behavior (10+ cigarettes per day)
rs3027409 Poisoning by agents primarily affecting blood constituents 0.0105 2.426 MAOA Smoking behavior (10+ cigarettes per day)
rs3099950 Appendiceal conditions 0.0005632 1.693 MORN2 Amyotrophic lateral sclerosis
rs3099950 Acute appendicitis 0.001742 1.754 MORN2 Amyotrophic lateral sclerosis
rs3099950 Fracture of hand or wrist 0.01014 1.232 MORN2 Amyotrophic lateral sclerosis
rs3099950 Congenital musculoskeletal anomalies 0.009246 2.329 MORN2 Amyotrophic lateral sclerosis
rs3099950 Rheumatoid arthritis 0.001623 1.364 MORN2 Amyotrophic lateral sclerosis
rs3099950 Polymyalgia Rheumatica 0.004648 1.39 MORN2 Amyotrophic lateral sclerosis
rs3099950 Other abnormality of urination 0.009785 1.28 MORN2 Amyotrophic lateral sclerosis
rs3099950 Muscular wasting and disuse atrophy 0.005731 0.3158 MORN2 Amyotrophic lateral sclerosis
rs3099950 Cancer of other male genital organs 0.008376 0.1516 MORN2 Amyotrophic lateral sclerosis
rs3099950 Appendicitis 0.001633 1.644 MORN2 Amyotrophic lateral sclerosis
rs3099950 Other infectious diseases 0.006946 1.917 MORN2 Amyotrophic lateral sclerosis
rs3099950 Corneal edema 0.007623 1.807 MORN2 Amyotrophic lateral sclerosis
rs3099950 Other congenital anomalies of skin 0.00443 1.619 MORN2 Amyotrophic lateral sclerosis
rs3129882 Type 2 diabetes 0.00283 0.9105 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Pericarditis 0.001954 0.6798 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetic neuropathy 2.876e-05 0.5453 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Disorders of the autonomic nervous system 0.00036 0.6931 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Symptoms involving respiratory system 0.004677 0.8194 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Celiac or tropical sprue 0.00546 0.5271 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Lack of coordination 0.002721 0.779 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Insulin pump user 0.002551 0.774 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Hypoglycemia 0.0003534 0.5849 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetes nephropathy 0.000184 0.4721 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Peripheral autonomic neuropathy 0.001604 0.6763 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Non-Hodgkins lymphoma 0.01066 0.7878 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Breast conditions, congenital or relating to hormones 0.00478 1.336 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Pernicious anemia 0.00095 1.583 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Cancer of other lymphoid, histiocytic tissue 0.009819 0.79 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 2 diabetic ketoacidosis 0.000201 0.8372 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Rheumatoid arthritis & related inflammatory polyarthropathies 6.048e-07 0.7126 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Diabetic retinopathy 0.002614 0.8199 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetic ketoacidosis 1.91e-06 0.5052 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Secondary/extrinsic cardiomyopathies 0.006969 0.5352 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetic retinopathy 0.001645 0.6555 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Asthma 0.004009 0.883 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Diseases of respiratory system 0.00146 0.8353 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Vascular insufficiency of intestine 0.001303 0.6526 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Rosacea 0.004203 1.198 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Rheumatoid arthritis 2.796e-06 0.6987 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Paraproteinemia 0.01147 0.737 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Hypertrophy of breast (Gynecomastia) 0.006619 1.357 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Celiac disease 0.007223 0.5323 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Obstructive chronic bronchitis 0.005899 0.8213 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Pneumonia 0.007601 0.904 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Respiratory abnormalities 0.007821 0.7578 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetes 3.836e-06 0.751 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Diabetes mellitus 0.00321 0.9128 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Liver replaced by transplant 0.005138 0.4105 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 2 diabetic retinopathy 0.009657 0.838 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Cancer of bone & connective tissue 0.009467 1.434 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Type 1 diabetic peripheral circulatory disorders 0.006086 0.4722 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3129882 Cancer of connective tissue 0.005126 1.661 HLA-DRA Systemic sclerosis, Parkinson's disease
rs3130573 Uterine leiomyoma 0.01029 0.8147 PSORS1C1 Systemic sclerosis
rs3130573 Stricture/obstruction of ureter 0.0007004 1.62 PSORS1C1 Systemic sclerosis
rs3130573 Acute prostatitis 0.002817 0.5259 PSORS1C1 Systemic sclerosis
rs3130573 Prostate cancer 0.0009955 0.8032 PSORS1C1 Systemic sclerosis
rs3130573 Psoriasis 2.516e-05 1.41 PSORS1C1 Systemic sclerosis
rs3130573 Sarcoidosis 0.002197 1.702 PSORS1C1 Systemic sclerosis
rs3130573 Psoriasis & related disorders 0.0002078 1.333 PSORS1C1 Systemic sclerosis
rs3130573 Inflammatory diseases of prostate 0.007808 0.801 PSORS1C1 Systemic sclerosis
rs3130573 Cancer of other female genital organs 0.002065 1.529 PSORS1C1 Systemic sclerosis
rs3130573 Psoriasis vulgaris 3.463e-05 1.414 PSORS1C1 Systemic sclerosis
rs3130573 Noninflammatory disorders of ovary, fallopian tube, & broad ligament 0.001916 1.717 PSORS1C1 Systemic sclerosis
rs3130573 Memory loss 0.00116 0.7598 PSORS1C1 Systemic sclerosis
rs3130573 Bullous dermatoses 0.001419 2.033 PSORS1C1 Systemic sclerosis
rs3130573 Acidosis 0.007753 1.367 PSORS1C1 Systemic sclerosis
rs3130573 Hydronephrosis 0.007125 1.327 PSORS1C1 Systemic sclerosis
rs3130573 Benign neoplasm of uterus 0.009113 0.8215 PSORS1C1 Systemic sclerosis
rs3130573 Acid-base balance disorder 0.01034 1.293 PSORS1C1 Systemic sclerosis
rs3130573 Ovarian cancer 0.005584 1.554 PSORS1C1 Systemic sclerosis
rs3130573 Benign neoplasm of uterus 0.009044 0.624 PSORS1C1 Systemic sclerosis
rs3130573 Graves' disease 0.00818 1.454 PSORS1C1 Systemic sclerosis
rs3130573 Gastroparesis 0.006909 0.5363 PSORS1C1 Systemic sclerosis
rs3130573 Renal failure NOS 0.007062 1.328 PSORS1C1 Systemic sclerosis
rs3130573 Neoplasm of uncertain behavior 0.00584 1.193 PSORS1C1 Systemic sclerosis
rs3130573 Chronic bronchitis 0.01123 0.8408 PSORS1C1 Systemic sclerosis
rs3130573 Other disorders of intestine 0.003221 1.21 PSORS1C1 Systemic sclerosis
rs3130573 Prostatitis 0.005541 0.7544 PSORS1C1 Systemic sclerosis
rs3131296 Congenital anomalies of intestine 0.00175 2.657 NOTCH4 Schizophrenia
rs3131296 Stricture and stenosis of esophagus 0.006982 0.6791 NOTCH4 Schizophrenia
rs3131296 Adverse effects of insulins and antidiabetic agents 0.0001046 2.545 NOTCH4 Schizophrenia
rs3131296 Poisoning by hormones and synthetic substitutes 0.006505 1.502 NOTCH4 Schizophrenia
rs3131296 Multiple sclerosis 0.01121 1.623 NOTCH4 Schizophrenia
rs3131296 Rosacea 0.0004692 0.6984 NOTCH4 Schizophrenia
rs3131296 Hematuria 0.002582 0.8369 NOTCH4 Schizophrenia
rs3131296 Discoid lupus erythematosus 0.0004842 1.767 NOTCH4 Schizophrenia
rs3131296 Celiac disease 3.647e-07 3.185 NOTCH4 Schizophrenia
rs3131296 Celiac or tropical sprue 7.517e-08 3.309 NOTCH4 Schizophrenia
rs3131296 Hypoglycemia 0.002659 1.661 NOTCH4 Schizophrenia
rs3131296 Varicose veins 0.006375 1.219 NOTCH4 Schizophrenia
rs3131296 Type 1 diabetes nephropathy 0.0001135 2.184 NOTCH4 Schizophrenia
rs3131296 Other specified peripheral vascular diseases 0.001256 2.449 NOTCH4 Schizophrenia
rs3131296 Type 1 diabetic neuropathy 1.605e-05 1.952 NOTCH4 Schizophrenia
rs3131296 Benign neoplasm of brain and other parts of nervous system 0.008106 0.5538 NOTCH4 Schizophrenia
rs3131296 Vascular insufficiency of intestine 0.004101 1.571 NOTCH4 Schizophrenia
rs3131296 Abnormal weight gain 0.00252 0.5711 NOTCH4 Schizophrenia
rs3131296 Abnormal mammogram 0.01131 0.7974 NOTCH4 Schizophrenia
rs3131296 Anterior pituitary disorders 0.006487 1.831 NOTCH4 Schizophrenia
rs3131296 Hyperlipidemia 0.001415 0.8618 NOTCH4 Schizophrenia
rs3131296 Cyst of kidney, acquired 0.001231 1.484 NOTCH4 Schizophrenia
rs3131296 Adrenal hypofunction 0.006614 1.781 NOTCH4 Schizophrenia
rs3131296 Prostatitis 0.002896 0.6407 NOTCH4 Schizophrenia
rs3131296 Posttraumatic wound infection 0.01142 1.877 NOTCH4 Schizophrenia
rs3131296 Testicular hypofunction 0.008602 1.511 NOTCH4 Schizophrenia
rs3131296 Disorders of lipoid metabolism 0.001294 0.8617 NOTCH4 Schizophrenia
rs3131296 Cystic mastopathy 0.004662 0.7932 NOTCH4 Schizophrenia
rs3131296 Aplastic anemia 0.01038 1.437 NOTCH4 Schizophrenia
rs3131296 Benign mammary dysplasias 0.005418 0.8037 NOTCH4 Schizophrenia
rs3131296 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.005083 1.421 NOTCH4 Schizophrenia
rs3131296 Diseases of sebaceous glands 0.01049 0.8676 NOTCH4 Schizophrenia
rs3131296 Peripheral autonomic neuropathy 0.0002516 1.694 NOTCH4 Schizophrenia
rs3131296 Systemic lupus erythematosus 0.005399 1.642 NOTCH4 Schizophrenia
rs3131296 Diabetic retinopathy 0.002288 1.302 NOTCH4 Schizophrenia
rs3131296 Peripheral angiopathy in diseases classified elsewhere 0.0106 1.733 NOTCH4 Schizophrenia
rs3131296 Disorders of the autonomic nervous system 0.001969 1.471 NOTCH4 Schizophrenia
rs3131296 Type 1 diabetic retinopathy 0.0002125 1.764 NOTCH4 Schizophrenia
rs3131296 Immune disorders 0.004789 1.364 NOTCH4 Schizophrenia
rs3131296 Type 1 diabetic peripheral circulatory disorders 0.001351 2.351 NOTCH4 Schizophrenia
rs3131296 Other hereditary hemolytic anemias 0.007103 2.351 NOTCH4 Schizophrenia
rs3131296 Bullous dermatoses 0.001939 2.266 NOTCH4 Schizophrenia
rs3131296 Testicular dysfunction 0.004899 1.538 NOTCH4 Schizophrenia
rs3131296 Hypercholesterolemia 0.00214 0.8371 NOTCH4 Schizophrenia
rs3131296 Sarcoidosis 0.005101 1.805 NOTCH4 Schizophrenia
rs3131296 Lupus erythematosus 0.0005329 2.405 NOTCH4 Schizophrenia
rs3131296 Complication of amputation stump 0.001337 2.258 NOTCH4 Schizophrenia
rs3184504 Dentofacial anomalies, including malocclusion 0.01059 0.6601 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Arterial embolism and thrombosis 0.00126 1.292 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.00686 1.296 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Hypertension 0.01107 1.078 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Other congenital anomalies of skin 0.006306 1.439 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Open wound of finger(s) 0.008962 0.8594 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Peyronie's disease 0.01067 1.784 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.001846 1.204 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Atherosclerosis of the extremities 0.002085 1.16 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Mastodynia 0.00819 1.264 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Peripheral arterial disease 0.004773 1.132 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Acute bronchospasm 0.009458 0.4545 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Ischemic Heart Disease 0.007575 1.084 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Empyema and pneumothorax 0.009123 1.284 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Other rheumatic heart disease 0.005213 2.073 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Myocardial infarction 0.0004043 1.171 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Other disorders of gallbladder 0.001266 0.5683 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Peripheral vascular disease 0.008122 1.113 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Anomalies of tooth position/malocclusion 0.004609 0.5834 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Arterial embolism and thrombosis of lower extremity artery 0.007384 1.342 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Abdominal aortic aneurysm 0.01139 1.22 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Coronary atherosclerosis 0.006473 1.091 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Morbid obesity 0.008289 0.862 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Cancer of the upper aerodigestive tract 0.006314 0.7217 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Mechanical complications of cardiac/vascular device, implant, and graft 0.003074 1.264 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Benign neoplasm of uterus 0.001902 0.802 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Anal and rectal polyp 0.01057 0.8123 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Endometriosis 0.002769 0.7068 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Ventricular fibrillation & flutter 0.01004 0.6286 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Osteoporosis 0.006226 1.132 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Phlebitis and thrombophlebitis of lower extremities 0.0111 1.222 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Aortic aneurysm 0.008784 1.195 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Paranoid disorders 0.01142 1.773 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Atherosclerosis 0.001489 1.145 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Essential hypertension 0.009907 1.08 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Hypothyroidism 7.655e-06 1.174 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Osteoporosis, NOS or other 0.005418 1.13 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Retinoschisis and retinal cysts 0.003572 2.251 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Abnormal findings on mammogram or breast exam 0.007769 1.119 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs3184504 Uterine leiomyoma 0.006447 0.8148 SH2B3 Diastolic blood pressure, Type 1 diabetes, Coronary heart disease, Eosinophil counts, Systolic blood pressure, Type 1 diabetes autoantibodies, Rheumatoid arthritis
rs337847 Aplastic anemia 0.007494 1.544 ARSB Hippocampal atrophy
rs337847 Hereditary and idiopathic peripheral neuropathy 0.003629 1.27 ARSB Hippocampal atrophy
rs337847 Cellulitis and abscess of trunk 0.006405 1.464 ARSB Hippocampal atrophy
rs337847 Poisoning by water, mineral, and uric acid metabolism drugs 0.001299 2.217 ARSB Hippocampal atrophy
rs337847 Inguinal hernia 0.002576 0.7438 ARSB Hippocampal atrophy
rs337847 Circumscribed scleroderma 0.006207 0.427 ARSB Hippocampal atrophy
rs337847 Esophageal cancer 0.01091 2.002 ARSB Hippocampal atrophy
rs337847 Psychogenic disorder 0.0009769 1.862 ARSB Hippocampal atrophy
rs337847 Thyroid cancer 0.01119 1.698 ARSB Hippocampal atrophy
rs337847 Hyperventilation 0.001574 2.195 ARSB Hippocampal atrophy
rs337847 Lipoid metabolism disorder NOS 0.005597 1.535 ARSB Hippocampal atrophy
rs337847 Cyst or abscess of Bartholin's gland 0.001457 2.635 ARSB Hippocampal atrophy
rs363512 Spondylosis and allied disorders 0.009657 0.8172 GRIK1 Hyperactive-impulsive symptoms
rs363512 Pernicious anemia 0.007887 1.765 GRIK1 Hyperactive-impulsive symptoms
rs363512 Abnormal thyroid function 0.008638 1.511 GRIK1 Hyperactive-impulsive symptoms
rs363512 Symptoms involving urinary system 0.002759 1.558 GRIK1 Hyperactive-impulsive symptoms
rs363512 Disorders resulting from impaired renal function 0.003628 1.586 GRIK1 Hyperactive-impulsive symptoms
rs363512 Empyema and pneumothorax 0.00719 1.55 GRIK1 Hyperactive-impulsive symptoms
rs363512 Acute, but ill-defined cerebrovascular disease 0.01007 1.344 GRIK1 Hyperactive-impulsive symptoms
rs363512 Other pulmonary inflamation or edema 0.003437 1.644 GRIK1 Hyperactive-impulsive symptoms
rs363512 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.008747 2.765 GRIK1 Hyperactive-impulsive symptoms
rs363512 Pneumonitis due to inhalation of food or vomitus 0.006951 1.614 GRIK1 Hyperactive-impulsive symptoms
rs363512 Fracture of humerus 0.0021 1.547 GRIK1 Hyperactive-impulsive symptoms
rs363512 Mental disorders due to brain damage 0.00689 1.456 GRIK1 Hyperactive-impulsive symptoms
rs363512 Macular degeneration, dry 0.007688 1.483 GRIK1 Hyperactive-impulsive symptoms
rs363512 Vitamin B12 deficiency anemia 0.01114 1.838 GRIK1 Hyperactive-impulsive symptoms
rs363512 Secondary hyperparathyroidism (of renal origin) 0.005469 1.679 GRIK1 Hyperactive-impulsive symptoms
rs363512 Vascular dementia 0.002348 1.824 GRIK1 Hyperactive-impulsive symptoms
rs363512 Lupus erythematosus 0.009867 2.334 GRIK1 Hyperactive-impulsive symptoms
rs368331 Digestive congenital anomalies 0.00299 1.866 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Esophageal atresia/tracheoesophageal fistula 0.008269 2.186 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Labyrinthitis 0.004109 0.3727 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Mechanical complication of nervous system device, implant, and graft 0.006324 2.599 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Macular degeneration 0.00646 1.282 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Diaphragmatic hernia 0.007445 1.263 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Glaucoma 0.0003801 1.326 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Poisoning by agents primarily affecting blood constituents 0.007023 2 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Open-angle glaucoma 0.004812 1.358 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Other conditions of the mother complicating pregnancy 0.006307 2.319 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Torsion dystonia 0.004619 2.076 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Upper gastrointestinal congenital anomalies 0.00134 2.209 DNAH11 Total ventricular volume, Whole-brain volume
rs368331 Substance addiction and disorders 0.01029 0.5447 DNAH11 Total ventricular volume, Whole-brain volume
rs3736228 Fracture of humerus 0.007888 1.335 LRP5 Bone mineral density (lumbar spine)
rs3736228 Stricture and stenosis of esophagus 0.002798 1.417 LRP5 Bone mineral density (lumbar spine)
rs3736228 Subdural hemorrhage 0.00344 1.784 LRP5 Bone mineral density (lumbar spine)
rs3736228 Congenital cataract and lens anomalies 0.0009981 2.439 LRP5 Bone mineral density (lumbar spine)
rs3736228 Other conditions of brain 0.0007325 1.531 LRP5 Bone mineral density (lumbar spine)
rs3736228 Glycosuria or Acetonuria 0.0005421 2.939 LRP5 Bone mineral density (lumbar spine)
rs3736228 Skin neoplasm of uncertain behavior 0.00474 1.286 LRP5 Bone mineral density (lumbar spine)
rs3736228 Raynaud's syndrome 0.01121 1.39 LRP5 Bone mineral density (lumbar spine)
rs3736228 Disaccharide malabsorption 0.001194 0.7337 LRP5 Bone mineral density (lumbar spine)
rs3736228 Carbohydrate transport and metabolism disorder 0.001623 0.7427 LRP5 Bone mineral density (lumbar spine)
rs3736228 Type 1 diabetic retinopathy 0.00704 1.535 LRP5 Bone mineral density (lumbar spine)
rs3736228 Cystic mastopathy 0.002402 1.273 LRP5 Bone mineral density (lumbar spine)
rs3736228 Benign mammary dysplasias 0.003014 1.255 LRP5 Bone mineral density (lumbar spine)
rs3736228 Leukoplakia of oral mucosa 0.0075 1.962 LRP5 Bone mineral density (lumbar spine)
rs3736228 Type 2 diabetic peripheral circulatory disorders 0.01111 1.453 LRP5 Bone mineral density (lumbar spine)
rs3736228 Congenital anomalies of the eye 0.006579 1.329 LRP5 Bone mineral density (lumbar spine)
rs3743200 Dentofacial anomalies, including malocclusion 0.005454 0.5498 RASGRF1 RR interval (heart rate)
rs3743200 Menopausal & postmenopausal disorders 0.0112 1.141 RASGRF1 RR interval (heart rate)
rs3743200 Neurological disorders due to brain damage 0.0008965 0.8326 RASGRF1 RR interval (heart rate)
rs3743200 Jaw disease NOS 0.005098 0.5611 RASGRF1 RR interval (heart rate)
rs3743200 Periodontitis (acute or chronic) 0.009941 0.7945 RASGRF1 RR interval (heart rate)
rs3743200 Intracerebral hemorrhage 0.003571 0.4895 RASGRF1 RR interval (heart rate)
rs3743200 Benign neoplasm of eye 0.005564 1.277 RASGRF1 RR interval (heart rate)
rs3743200 Early complications of trauma or procedure 0.0005802 0.3608 RASGRF1 RR interval (heart rate)
rs3743200 Type 2 diabetic ketoacidosis 0.002405 0.8442 RASGRF1 RR interval (heart rate)
rs3743200 Gingival and periodontal diseases 0.0008792 0.7685 RASGRF1 RR interval (heart rate)
rs3743200 Persistent mental disorders due to other conditions 0.001186 0.8116 RASGRF1 RR interval (heart rate)
rs3743200 Claw toe 0.004232 2.072 RASGRF1 RR interval (heart rate)
rs3743200 Aphasia/speech disturbance 0.001378 0.7424 RASGRF1 RR interval (heart rate)
rs3744064 Diabetic retinopathy 0.0003262 1.786 SEC14L1 Cognitive performance
rs3744064 Other local infections of skin and subcutaneous tissue 0.001983 0.4989 SEC14L1 Cognitive performance
rs3744064 Primary open angle glaucoma 0.000415 2.017 SEC14L1 Cognitive performance
rs3744064 Disorders of refraction and accommodation 0.006386 0.7449 SEC14L1 Cognitive performance
rs3744064 Benign neoplasm of lip, oral cavity, and pharynx 0.008214 2.408 SEC14L1 Cognitive performance
rs3744064 Type 2 diabetic nephropathy 0.00562 1.671 SEC14L1 Cognitive performance
rs3744064 Type 2 diabetes 0.002695 1.309 SEC14L1 Cognitive performance
rs3744064 Hypermetropia 0.001894 0.6367 SEC14L1 Cognitive performance
rs3744064 Primary angle-closure glaucoma 0.0008337 1.994 SEC14L1 Cognitive performance
rs3744064 Type 2 diabetic ketoacidosis 0.0006928 1.541 SEC14L1 Cognitive performance
rs3744064 Diabetes mellitus 0.00391 1.292 SEC14L1 Cognitive performance
rs3744064 Type 2 diabetic retinopathy 5.223e-05 1.946 SEC14L1 Cognitive performance
rs3744064 Disorders of the globe 0.0005863 2.724 SEC14L1 Cognitive performance
rs3744064 Femoral hernia 0.009101 3.061 SEC14L1 Cognitive performance
rs3744064 Retinal edema and hypertensive retinopathy 2.029e-05 2.576 SEC14L1 Cognitive performance
rs3745516 Sacroiliitis NEC 0.0097 1.77 SPIB Primary biliary cirrhosis
rs3745516 Open wound of lip and mouth 0.007484 1.779 SPIB Primary biliary cirrhosis
rs3745516 Nephritis and nephropathy without mention of glomerulonephritis 0.005512 1.292 SPIB Primary biliary cirrhosis
rs3745516 Other disorders of urethra and urinary tract 0.007355 0.7877 SPIB Primary biliary cirrhosis
rs3745516 Type 2 diabetic neuropathy 0.004478 1.212 SPIB Primary biliary cirrhosis
rs3745516 Type 1 diabetes 0.008952 1.195 SPIB Primary biliary cirrhosis
rs3745516 Type 2 diabetic nephropathy 0.0003054 1.331 SPIB Primary biliary cirrhosis
rs3745516 Respiratory failure 0.003866 1.321 SPIB Primary biliary cirrhosis
rs3745516 Deficiency of humoral immunity 0.002976 2.22 SPIB Primary biliary cirrhosis
rs3745516 Occlusion and stenosis of precerebral arteries 0.006509 1.157 SPIB Primary biliary cirrhosis
rs3745516 Polyneuropathy in diabetes 0.003006 1.242 SPIB Primary biliary cirrhosis
rs3745516 Cardiac complications, not elsewhere classified 0.0062 1.426 SPIB Primary biliary cirrhosis
rs3745516 Nephritis and nephropathy in diseases classified elsewhere 0.001012 1.392 SPIB Primary biliary cirrhosis
rs3745516 Derangement of joint, non-traumatic 0.002179 1.319 SPIB Primary biliary cirrhosis
rs3745516 Antisocial/borderline personality disorder 0.005609 0.488 SPIB Primary biliary cirrhosis
rs3757840 Polymyalgia Rheumatica 0.0009764 1.341 GCK Glucose
rs3757840 Angina pectoris 0.0008328 0.8577 GCK Glucose
rs3757840 Ulcer of esophagus 0.005914 0.6959 GCK Glucose
rs3757840 Anterior pituitary disorders 0.01139 0.6145 GCK Glucose
rs3757840 Other abnormal glucose 0.003763 0.8683 GCK Glucose
rs3757840 Other cells and casts in urine 0.009316 1.407 GCK Glucose
rs3757840 Alopecia 0.00705 0.759 GCK Glucose
rs3757840 Ingrowing nail 0.003697 0.8526 GCK Glucose
rs3757840 Alopecia Areata 0.007736 0.4811 GCK Glucose
rs3757840 Malignant neoplasm, other 0.01046 1.216 GCK Glucose
rs3757840 Rheumatoid arthritis 0.0109 0.8283 GCK Glucose
rs3757840 Morbid obesity 0.0113 1.152 GCK Glucose
rs3757840 Delirium due to conditions classified elsewhere 0.005482 1.387 GCK Glucose
rs3761847 Occlusion and stenosis of precerebral arteries 0.004511 1.141 TRAF1 Rheumatoid arthritis
rs3761847 Chronic ischemic heart disease 0.006746 1.141 TRAF1 Rheumatoid arthritis
rs3761847 Acquired foot deformities 0.01015 1.116 TRAF1 Rheumatoid arthritis
rs3761847 Unspecified osteomyelitis 0.01032 1.306 TRAF1 Rheumatoid arthritis
rs3761847 Malunion fracture 0.0006047 0.6185 TRAF1 Rheumatoid arthritis
rs3761847 Disorders of esophageal motility 0.003891 0.6425 TRAF1 Rheumatoid arthritis
rs3761847 Fracture of clavicle or scapula 0.002317 0.6691 TRAF1 Rheumatoid arthritis
rs3761847 Testicular hypofunction 0.007693 1.385 TRAF1 Rheumatoid arthritis
rs3761847 Hammer toe 0.008102 1.194 TRAF1 Rheumatoid arthritis
rs3761847 Right bundle branch block 0.002508 1.321 TRAF1 Rheumatoid arthritis
rs3761847 Testicular dysfunction 0.00433 1.407 TRAF1 Rheumatoid arthritis
rs3761847 Bundle branch block 0.005257 1.208 TRAF1 Rheumatoid arthritis
rs3761847 Althete's foot 0.009179 1.245 TRAF1 Rheumatoid arthritis
rs3761847 Diseases of the tongue 0.004787 0.6906 TRAF1 Rheumatoid arthritis
rs3761847 Infestation 0.01061 0.5874 TRAF1 Rheumatoid arthritis
rs3761847 Cerebrovascular disease 0.005419 1.098 TRAF1 Rheumatoid arthritis
rs3761847 Infections involving bone 0.01132 1.24 TRAF1 Rheumatoid arthritis
rs3761847 Toxic effect of venom 0.0004227 0.5572 TRAF1 Rheumatoid arthritis
rs3761847 Congenital anomalies of great vessels 0.006914 0.4729 TRAF1 Rheumatoid arthritis
rs3761847 Acquired toe deformities 0.008111 1.167 TRAF1 Rheumatoid arthritis
rs3761847 Hallux valgus (Bunion) 0.005208 1.195 TRAF1 Rheumatoid arthritis
rs3761847 Muscular dystrophies and other myopathies 0.003807 1.49 TRAF1 Rheumatoid arthritis
rs3761847 Rheumatoid arthritis & related inflammatory polyarthropathies 0.01113 1.182 TRAF1 Rheumatoid arthritis
rs3761959 Chronic pancreatitis 0.01085 0.6098 FCRL3 Graves' disease
rs3761959 Astigmatism 0.005498 1.135 FCRL3 Graves' disease
rs3761959 Urethral stricture (not specified as infectious) 0.002242 0.6605 FCRL3 Graves' disease
rs3761959 Hypermetropia 0.003339 1.149 FCRL3 Graves' disease
rs3761959 Hypothyroidism 0.01017 1.097 FCRL3 Graves' disease
rs3761959 Other disorders of adrenal glands 0.005641 0.6394 FCRL3 Graves' disease
rs3761959 Psychogenic and somatoform disorders 0.001332 0.7507 FCRL3 Graves' disease
rs3761959 Otitis externa 0.006037 1.191 FCRL3 Graves' disease
rs3761959 Tension headache 0.001752 0.7829 FCRL3 Graves' disease
rs3761959 Costochondritis 0.001246 0.4617 FCRL3 Graves' disease
rs3761959 Disorders of coccyx 0.008632 0.7569 FCRL3 Graves' disease
rs3761959 Disturbance of skin sensation 0.01093 0.8966 FCRL3 Graves' disease
rs3761959 Agorophobia, social phobia, and panic disorder 0.001323 0.6751 FCRL3 Graves' disease
rs3761959 Abnormal mammogram 0.003495 0.8366 FCRL3 Graves' disease
rs3761959 Inflammatory spondylopathies 0.01022 1.474 FCRL3 Graves' disease
rs3764640 Other open wound of head and face 0.004161 1.259 STK11 Alzheimer's disease with psychosis
rs3764640 Abnormal reflex 0.01139 2.049 STK11 Alzheimer's disease with psychosis
rs3764640 Sialoadenitis 0.003489 0.5475 STK11 Alzheimer's disease with psychosis
rs3764640 Glycosuria or Acetonuria 0.01013 2.099 STK11 Alzheimer's disease with psychosis
rs3764640 Abnormal Papanicolaou smear of cervix and cervical HPV 0.004973 1.272 STK11 Alzheimer's disease with psychosis
rs3764640 Viral hepatitis C 0.009671 1.512 STK11 Alzheimer's disease with psychosis
rs3764640 Immune disorders 0.003596 1.315 STK11 Alzheimer's disease with psychosis
rs3764640 Electrolyte imbalance 0.007636 1.117 STK11 Alzheimer's disease with psychosis
rs3764640 Cardiac shunt/ heart septal defect 0.002197 0.5468 STK11 Alzheimer's disease with psychosis
rs3764640 Urethritis and urethral syndrome 0.007621 1.76 STK11 Alzheimer's disease with psychosis
rs3764640 Anemia NOS 0.01106 0.9043 STK11 Alzheimer's disease with psychosis
rs3764640 Plasma protein metabolism disorder 0.009357 1.318 STK11 Alzheimer's disease with psychosis
rs3764640 Patellar fracture 0.002757 1.512 STK11 Alzheimer's disease with psychosis
rs3764640 Nontoxic multinodular goiter 0.01003 0.7583 STK11 Alzheimer's disease with psychosis
rs3764640 Fracture of lower limb 0.005029 1.177 STK11 Alzheimer's disease with psychosis
rs3780792 Chronic pain syndrome 0.004839 1.665 VAV2 Multiple sclerosis
rs3780792 Ischemic stroke 0.01135 1.187 VAV2 Multiple sclerosis
rs3780792 Bacteremia 0.008251 0.7594 VAV2 Multiple sclerosis
rs3780792 Edema 0.005375 0.8987 VAV2 Multiple sclerosis
rs3780792 Disorders resulting from impaired renal function 0.0034 1.326 VAV2 Multiple sclerosis
rs3780792 Hematuria 0.008725 1.115 VAV2 Multiple sclerosis
rs3780792 Type 1 diabetic retinopathy 0.007643 1.403 VAV2 Multiple sclerosis
rs3780792 Abnormal chest sounds 0.002103 0.6264 VAV2 Multiple sclerosis
rs3780792 Cramp of limb 0.01038 1.291 VAV2 Multiple sclerosis
rs3780792 Anal and rectal polyp 0.009709 1.236 VAV2 Multiple sclerosis
rs3780792 Poisoning by water, mineral, and uric acid metabolism drugs 0.01064 1.588 VAV2 Multiple sclerosis
rs3780792 Back & neck sprains 0.008225 0.8883 VAV2 Multiple sclerosis
rs3782181 Chronic hepatitis 0.004934 1.913 KITLG Testicular germ cell cancer
rs3782181 Disorders of esophageal motility 0.002719 1.636 KITLG Testicular germ cell cancer
rs3782181 Hypersomnia 0.003585 1.589 KITLG Testicular germ cell cancer
rs3782181 Fracture of unspecified bones 0.007684 0.8302 KITLG Testicular germ cell cancer
rs3782181 Chronic interstitial cystitis 0.001306 2.421 KITLG Testicular germ cell cancer
rs3782181 Nevus, non-neoplastic 0.01021 0.4652 KITLG Testicular germ cell cancer
rs3782181 Gram positive septicemia 0.005328 1.701 KITLG Testicular germ cell cancer
rs3782181 H. pylori 0.008181 1.563 KITLG Testicular germ cell cancer
rs3782181 Congenital musculoskeletal deformities of spine 0.01063 0.6203 KITLG Testicular germ cell cancer
rs3782181 Hyperventilation 0.006181 1.791 KITLG Testicular germ cell cancer
rs3782181 Swelling of limb 0.001073 1.251 KITLG Testicular germ cell cancer
rs3782181 Obstruction of bile duct 0.00171 1.79 KITLG Testicular germ cell cancer
rs3782181 Dyschromia and Vitiligo 0.008253 1.235 KITLG Testicular germ cell cancer
rs3782181 Prostate cancer 0.001264 0.7703 KITLG Testicular germ cell cancer
rs3782181 Paroxysmal tachycardia, unspecified 0.006177 0.7869 KITLG Testicular germ cell cancer
rs3782181 Poisoning by analgesics, antipyretics, and antirheumatics 0.0003047 1.536 KITLG Testicular germ cell cancer
rs3782181 Choroidal degenerations 0.008934 1.49 KITLG Testicular germ cell cancer
rs3803662 Breast cancer 8.379e-05 1.279 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Breast cancer 3.446e-05 1.301 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Other benign neoplasm of connective and other soft tissue 0.001702 0.5482 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Breast cancer, including in situ 4.317e-05 1.294 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Disorders of esophageal motility 0.008754 1.488 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Skin neoplasm of uncertain behavior 0.003886 0.7954 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Acute bronchospasm 0.008189 2.131 TOX3 Breast cancer, ER+ Breast cancer
rs3803662 Postoperative infection 0.004332 0.7927 TOX3 Breast cancer, ER+ Breast cancer
rs3803800 Lymphosarcoma 0.002169 2.317 TNFSF13 IgA nephropathy
rs3803800 Sepsis and SIRS 0.01107 1.28 TNFSF13 IgA nephropathy
rs3803800 Exophthalmos 0.006389 0.3135 TNFSF13 IgA nephropathy
rs3803800 Major depressive disorder 0.002436 1.213 TNFSF13 IgA nephropathy
rs3803800 Suppurative and unspecified otitis media 0.006158 0.824 TNFSF13 IgA nephropathy
rs3803800 Vitamin deficiency 0.01078 1.19 TNFSF13 IgA nephropathy
rs3803800 Otitis media 0.01091 0.8564 TNFSF13 IgA nephropathy
rs3803800 Acidosis 0.001146 1.519 TNFSF13 IgA nephropathy
rs3803800 Depression 0.002257 1.135 TNFSF13 IgA nephropathy
rs3803800 Eustachian tube disorders 0.004502 0.8597 TNFSF13 IgA nephropathy
rs3803800 Deep vein thrombosis 0.009877 1.291 TNFSF13 IgA nephropathy
rs3803800 Swelling, mass, or lump in head and neck 0.01025 1.255 TNFSF13 IgA nephropathy
rs3803800 Diseases of the tongue 0.003299 1.496 TNFSF13 IgA nephropathy
rs3803800 Protein-calorie malnutrition 0.001646 1.231 TNFSF13 IgA nephropathy
rs3803800 Acid-base balance disorder 0.005278 1.364 TNFSF13 IgA nephropathy
rs3803800 Agorophobia, social phobia, and panic disorder 0.006113 1.439 TNFSF13 IgA nephropathy
rs3803800 Pathological, developmental or recurrent dislocation 0.009272 1.879 TNFSF13 IgA nephropathy
rs3803800 Shock 0.004542 1.463 TNFSF13 IgA nephropathy
rs3803800 Acute laryngitis and tracheitis 0.008767 0.6027 TNFSF13 IgA nephropathy
rs3803800 Mood disorders 0.007724 1.114 TNFSF13 IgA nephropathy
rs3803800 Generalized anxiety disorder 0.01044 1.316 TNFSF13 IgA nephropathy
rs3803800 Hypercalcemia 0.006009 0.7371 TNFSF13 IgA nephropathy
rs3806156 Hypoglycemia 0.008412 1.439 BTNL2 Vitiligo
rs3806156 Postmenopausal atrophic vaginitis 0.005083 1.254 BTNL2 Vitiligo
rs3806156 Atrophy of edentulous alveolar ridge 0.006682 1.482 BTNL2 Vitiligo
rs3806156 Thyrotoxicosis 0.008399 0.804 BTNL2 Vitiligo
rs3806156 Eosinophilia 0.001347 1.98 BTNL2 Vitiligo
rs3806156 Urethritis and urethral syndrome 0.00726 1.721 BTNL2 Vitiligo
rs3806156 Atherosclerosis of the extremities 0.008996 1.139 BTNL2 Vitiligo
rs3806156 Discoid lupus erythematosus 0.009324 0.6744 BTNL2 Vitiligo
rs3806156 Intracerebral hemorrhage 0.007691 1.582 BTNL2 Vitiligo
rs3806156 Cellulitis and abscess of leg 0.01028 0.8595 BTNL2 Vitiligo
rs3806156 Degenerative disease of the spinal cord 0.00969 1.426 BTNL2 Vitiligo
rs3806156 Shock 0.004713 1.408 BTNL2 Vitiligo
rs3806156 Ulceration of intestine 0.01077 1.577 BTNL2 Vitiligo
rs3806156 Polyarteritis nodosa and allied conditions 0.002931 1.377 BTNL2 Vitiligo
rs3806156 Pneumoconiosis 0.001134 0.3714 BTNL2 Vitiligo
rs3806156 Lupus erythematosus 0.001441 0.3884 BTNL2 Vitiligo
rs3806156 Acquired deformities of ankle and foot 0.006846 1.229 BTNL2 Vitiligo
rs3806932 Chronic lymphoid leukemia 0.00136 0.5792 TSLP Eosinophilic esophagitis
rs3806932 Delirium dementia and amnestic disorders 0.0004243 1.17 TSLP Eosinophilic esophagitis
rs3806932 Dementias 0.009078 1.144 TSLP Eosinophilic esophagitis
rs3806932 Fracture of clavicle or scapula 0.003156 0.6833 TSLP Eosinophilic esophagitis
rs3806932 Other symptoms referable to back 0.009231 0.804 TSLP Eosinophilic esophagitis
rs3806932 Paroxysmal tachycardia, unspecified 0.002014 0.8165 TSLP Eosinophilic esophagitis
rs3806932 Skin cancer 0.01108 0.9153 TSLP Eosinophilic esophagitis
rs3806932 Congenital anomalies of genital organs 0.01147 0.5099 TSLP Eosinophilic esophagitis
rs3806932 Other diseases of respiratory system 0.002783 1.42 TSLP Eosinophilic esophagitis
rs3806932 Cancer of the lower GI tract 0.0065 1.362 TSLP Eosinophilic esophagitis
rs3806932 Hereditary and idiopathic peripheral neuropathy 0.006523 0.8701 TSLP Eosinophilic esophagitis
rs3806932 Paroxysmal ventricular tachycardia 0.006004 0.776 TSLP Eosinophilic esophagitis
rs3806932 Prostate cancer 0.01118 0.8522 TSLP Eosinophilic esophagitis
rs3806932 Skin neoplasm of uncertain behavior 0.01024 0.8402 TSLP Eosinophilic esophagitis
rs3806932 Open wound of eye or eyelid 0.009591 0.4859 TSLP Eosinophilic esophagitis
rs3806932 Other disorders of ear 0.009304 0.7893 TSLP Eosinophilic esophagitis
rs3806932 Chronic pharyngitis and nasopharyngitis 0.00906 0.8615 TSLP Eosinophilic esophagitis
rs3806932 Other specified cardiac dysrhythmias 0.001494 0.8648 TSLP Eosinophilic esophagitis
rs3806932 Lymphoid leukemia 0.004278 0.6295 TSLP Eosinophilic esophagitis
rs3806932 Otosclerosis 0.005555 0.661 TSLP Eosinophilic esophagitis
rs3806932 Cardiac dysrhythmias 0.007603 0.9233 TSLP Eosinophilic esophagitis
rs3806932 Cerebral aneurysm 0.009811 1.607 TSLP Eosinophilic esophagitis
rs3806932 Lymphadenitis 0.007438 0.8493 TSLP Eosinophilic esophagitis
rs3806932 Other disorders of back 0.003675 0.8542 TSLP Eosinophilic esophagitis
rs3806932 Cancer of oropharynx 0.007241 2.047 TSLP Eosinophilic esophagitis
rs3806932 Posttraumatic wound infection 0.01008 0.5549 TSLP Eosinophilic esophagitis
rs3806932 Disorders of sacrum 0.00561 0.797 TSLP Eosinophilic esophagitis
rs3806932 Peyronie's disease 0.007743 0.5314 TSLP Eosinophilic esophagitis
rs3807989 Hepatomegaly 0.001555 1.913 CAV1 PR interval
rs3807989 Other conditions of the mother complicating pregnancy 0.002789 0.5683 CAV1 PR interval
rs3807989 Abnormal chest sounds 0.003593 0.6587 CAV1 PR interval
rs3807989 Iatrogenic hypothyroidism 0.004178 1.351 CAV1 PR interval
rs3807989 Glossitis 0.009806 0.4822 CAV1 PR interval
rs3807989 Nephritis and nephropathy in diseases classified elsewhere 0.003611 1.302 CAV1 PR interval
rs3807989 Nonspecific findings on examination of blood 0.006557 1.305 CAV1 PR interval
rs3807989 Posttraumatic stress disorder 0.01073 1.509 CAV1 PR interval
rs3807989 Muscular wasting and disuse atrophy 0.0006231 0.5134 CAV1 PR interval
rs3807989 Stricture/obstruction of ureter 0.01049 1.433 CAV1 PR interval
rs3807989 Phobia 0.007839 2.016 CAV1 PR interval
rs3807989 Lump or mass in breast 0.008309 0.8622 CAV1 PR interval
rs3807989 Secondary thrombocytopenia 0.009235 1.581 CAV1 PR interval
rs3807989 Intervertebral disc disorder with myelopathy 0.00898 0.5635 CAV1 PR interval
rs3807989 Other disorders of metabolic, endocrine, immunity disorders 0.002712 0.436 CAV1 PR interval
rs3807989 Adverse effects of opiates and related narcotics in therapeutic use 0.007821 1.291 CAV1 PR interval
rs3815087 Mood disorders 0.009784 1.114 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Althete's foot 0.000908 1.38 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Corneal edema 0.005093 1.713 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Psoriasis 5.549e-07 1.571 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Depression 0.006715 1.122 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Adverse effects of cardiac rhythm regulators 0.002743 0.3266 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Psoriasis & related disorders 1.415e-05 1.457 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Biliary cirrhosis 0.006508 2.211 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Seborheic dermatitis 0.0007983 1.277 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Fuchs' dystrophy 0.0102 1.513 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Corneal degenerations 0.0002124 1.572 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Psoriasis vulgaris 2.448e-07 1.608 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Malunion fracture 0.009862 1.462 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Prostate cancer 0.004508 0.7924 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Iron deficiency anemia secondary to blood loss 0.006844 1.381 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Orchitis and epididymitis 0.007434 0.6147 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Anemia of chronic disease 0.001312 0.7476 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Partial epilepsy 0.01036 0.6239 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Esophageal cancer 0.006612 1.859 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3815087 Disorders of cornea 0.003563 1.249 PSORS1C1 HIV-1 progression, Stevens-Johnson syndrome and toxic epidermal necrolysis
rs3816995 Diverticulitis 0.007515 1.214 SDK2 Panic disorder
rs3816995 Acquired toe deformities 0.002212 0.8397 SDK2 Panic disorder
rs3816995 Respiratory insufficiency 0.0006222 0.721 SDK2 Panic disorder
rs3816995 Anomalies of pupillary function 0.0009165 0.4312 SDK2 Panic disorder
rs3816995 Disorders of cervical region 0.003496 1.372 SDK2 Panic disorder
rs3816995 Torticollis 0.003718 1.593 SDK2 Panic disorder
rs3816995 Other sprains and strains 0.002289 1.389 SDK2 Panic disorder
rs3816995 Cardiomegaly 0.01036 0.8743 SDK2 Panic disorder
rs3816995 Hammer toe 0.008324 0.8411 SDK2 Panic disorder
rs3816995 Secondary malignant neoplasm 0.009643 1.148 SDK2 Panic disorder
rs3816995 Perforation of tympanic membrane 0.007536 0.6633 SDK2 Panic disorder
rs3818361 Senile dementia 0.008335 1.273 CR1 Alzheimer's disease
rs3818361 Posttraumatic wound infection 0.008176 1.825 CR1 Alzheimer's disease
rs3818361 Inflammatory conditions of jaw 0.007862 1.625 CR1 Alzheimer's disease
rs3818361 Myopia 0.007542 0.8648 CR1 Alzheimer's disease
rs3818361 Loose body in joint 0.008381 0.1494 CR1 Alzheimer's disease
rs3818361 Systolic/diastolic heart failure 0.007576 1.149 CR1 Alzheimer's disease
rs3818361 Brain cancer 0.001152 1.911 CR1 Alzheimer's disease
rs3818361 Other aneurysm 0.002818 1.246 CR1 Alzheimer's disease
rs3818361 Symptoms/disorders of the urinary system 0.009284 1.106 CR1 Alzheimer's disease
rs3818361 Reticulosarcoma 0.006953 0.4385 CR1 Alzheimer's disease
rs3818361 Cerebral edema and compression of brain 0.008551 1.91 CR1 Alzheimer's disease
rs3818361 Heart valve disorders 0.0093 1.129 CR1 Alzheimer's disease
rs3818361 Neutropenia 0.008149 0.7607 CR1 Alzheimer's disease
rs3818361 Poisoning by anticonvulsants and anti-Parkinsonism drugs 0.007775 0.3485 CR1 Alzheimer's disease
rs3818361 Personality disorders 0.009632 1.287 CR1 Alzheimer's disease
rs3818361 Aortic aneurysm 0.007273 1.244 CR1 Alzheimer's disease
rs3818361 Shock 0.0104 1.426 CR1 Alzheimer's disease
rs3818361 Diseases of pancreas 0.002091 1.294 CR1 Alzheimer's disease
rs3818361 Other abnormality of urination 0.002216 1.294 CR1 Alzheimer's disease
rs3818361 Urinary obstruction 0.002122 1.556 CR1 Alzheimer's disease
rs3818361 Congenital anomalies of peripheral vascular system 0.002923 1.98 CR1 Alzheimer's disease
rs3818361 Dyschromia and Vitiligo 0.01079 1.225 CR1 Alzheimer's disease
rs3818361 Palpitations 0.005655 1.171 CR1 Alzheimer's disease
rs3818361 Decreased white blood cell count 0.002488 0.7384 CR1 Alzheimer's disease
rs385893 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.005694 0.4159 AK3 Platelet counts
rs385893 Chronic ulcer of unspecified site 0.00156 1.33 AK3 Platelet counts
rs385893 Cyst or abscess of Bartholin's gland 0.009205 1.966 AK3 Platelet counts
rs385893 Myopia 0.004188 1.131 AK3 Platelet counts
rs385893 Hypermetropia 0.007591 1.133 AK3 Platelet counts
rs385893 Herpes zoster with nervous system complications 0.009865 0.6659 AK3 Platelet counts
rs385893 Symptoms of the muscles 0.001289 0.7649 AK3 Platelet counts
rs385893 Unspecified polyarthropathy or polyarthritis 0.003784 0.643 AK3 Platelet counts
rs385893 Miscarriage; stillbirth 0.006612 1.851 AK3 Platelet counts
rs385893 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.008267 1.305 AK3 Platelet counts
rs385893 Hirsutism 0.007201 1.664 AK3 Platelet counts
rs385893 Genu valgum or varum (acquired) 0.007622 0.7002 AK3 Platelet counts
rs385893 Astigmatism 0.009969 1.123 AK3 Platelet counts
rs385893 Other disorders of metabolic, endocrine, immunity disorders 0.009217 1.892 AK3 Platelet counts
rs385893 Polyarthropathy or polyarthritis involving multiple sites NOS 0.002512 0.5722 AK3 Platelet counts
rs385893 Cervical cancer and dysplasia 0.005091 1.299 AK3 Platelet counts
rs3885683 Carbuncle and furuncle 0.004173 1.696 DLG2 Monocyte chemoattractant protein-1
rs3885683 Cardiac defibrillator in situ 0.01032 1.558 DLG2 Monocyte chemoattractant protein-1
rs3885683 Chronic pancreatitis 0.008298 1.813 DLG2 Monocyte chemoattractant protein-1
rs3885683 Dental caries 0.01001 1.268 DLG2 Monocyte chemoattractant protein-1
rs3885683 Personal history of allergy to medicinal agents 0.006094 0.6684 DLG2 Monocyte chemoattractant protein-1
rs3885683 Diseases of pancreas 0.005878 1.307 DLG2 Monocyte chemoattractant protein-1
rs3885683 Paroxysmal tachycardia, unspecified 0.01149 1.26 DLG2 Monocyte chemoattractant protein-1
rs3885683 Dysmenorrhea 0.005266 1.755 DLG2 Monocyte chemoattractant protein-1
rs3885683 Other disorders of thyroid 0.007556 0.6174 DLG2 Monocyte chemoattractant protein-1
rs3885683 Acute pancreatitis 0.004662 1.413 DLG2 Monocyte chemoattractant protein-1
rs3885683 Vascular disorders of penis 0.001506 2.79 DLG2 Monocyte chemoattractant protein-1
rs3885683 Microscopic hematuria 0.0008606 1.846 DLG2 Monocyte chemoattractant protein-1
rs3885683 Fracture of radius and ulna 0.004002 1.277 DLG2 Monocyte chemoattractant protein-1
rs3885683 Atrial fibrillation & flutter 0.0102 1.178 DLG2 Monocyte chemoattractant protein-1
rs3885683 Hemorrhage NOS 0.005955 1.871 DLG2 Monocyte chemoattractant protein-1
rs3885683 Paroxysmal ventricular tachycardia 0.007333 1.391 DLG2 Monocyte chemoattractant protein-1
rs3885683 Multiple myeloma 0.008602 1.713 DLG2 Monocyte chemoattractant protein-1
rs3923809 Mood disorders 0.005768 0.9041 BTBD9 Restless legs syndrome
rs3923809 Traumatic arthropathy 0.003637 1.693 BTBD9 Restless legs syndrome
rs3923809 Nonrheumatic aortic valve disorders 0.003677 1.179 BTBD9 Restless legs syndrome
rs3923809 Depression 0.006716 0.9039 BTBD9 Restless legs syndrome
rs3923809 Extrapyramidal disease and abnormal movement disorders 0.001653 0.806 BTBD9 Restless legs syndrome
rs3923809 Other disorders of biliary tract 0.001921 0.5641 BTBD9 Restless legs syndrome
rs3923809 Other diseases of the teeth and supporting structures 0.005914 0.7774 BTBD9 Restless legs syndrome
rs3923809 Malignant neoplasm of ovary 0.002316 1.77 BTBD9 Restless legs syndrome
rs3923809 Iron deficiency anemias NOS 0.01012 0.8805 BTBD9 Restless legs syndrome
rs3923809 Idiopathic fibrosing alveolitis 0.003053 1.916 BTBD9 Restless legs syndrome
rs3923809 Chronic pancreatitis 0.004237 0.515 BTBD9 Restless legs syndrome
rs3923809 Incisional hernia 0.005495 1.314 BTBD9 Restless legs syndrome
rs3923809 Acute bronchospasm 0.006919 2.156 BTBD9 Restless legs syndrome
rs3923809 Adverse drug events and drug allergies 0.004887 0.8368 BTBD9 Restless legs syndrome
rs3923809 Other alveolar and parietoalveolar pneumonopathy 9.832e-05 2.022 BTBD9 Restless legs syndrome
rs398652 Hallux valgus (Bunion) 0.008305 1.248 PELI2 Telomere length
rs398652 Varicose veins of lower extremity 0.001043 1.272 PELI2 Telomere length
rs398652 Subjective visual disturbances 0.001818 1.334 PELI2 Telomere length
rs398652 Osteoarthrosis; localized, primary 0.001516 1.384 PELI2 Telomere length
rs398652 Osteoarthritis; localized 0.007789 1.17 PELI2 Telomere length
rs398652 Osteoarthrosis NOS 0.01092 1.124 PELI2 Telomere length
rs398652 Disorders of the autonomic nervous system 0.009562 1.389 PELI2 Telomere length
rs398652 Postnasal drip 0.009507 1.893 PELI2 Telomere length
rs398652 Second degree AV block 0.007397 1.682 PELI2 Telomere length
rs398652 Neoplasm of unspecified nature of digestive system 0.01009 1.52 PELI2 Telomere length
rs398652 Congenital anomalies of great vessels 0.008167 2.104 PELI2 Telomere length
rs398652 Varicose veins 0.0001513 1.304 PELI2 Telomere length
rs398652 Anomalies of jaw size/symmetry 0.007244 2.185 PELI2 Telomere length
rs4086116 Sprains and strains 0.007189 1.135 CYP2C9 Warfarin maintenance dose
rs4086116 Corneal degenerations 0.005327 0.6504 CYP2C9 Warfarin maintenance dose
rs4086116 Barrett's esophagus 0.002944 1.488 CYP2C9 Warfarin maintenance dose
rs4086116 Anal and rectal conditions 0.004318 1.188 CYP2C9 Warfarin maintenance dose
rs4086116 Congenital deformities of feet 0.01033 1.357 CYP2C9 Warfarin maintenance dose
rs4086116 Elevated prostate specific antigen 0.01086 0.8102 CYP2C9 Warfarin maintenance dose
rs4086116 Nervous system congenital anomalies 0.007939 1.475 CYP2C9 Warfarin maintenance dose
rs4086116 Other disorders of pancreatic internal secretion 0.002217 0.3254 CYP2C9 Warfarin maintenance dose
rs4086116 Open wound of lip and mouth 0.007902 1.805 CYP2C9 Warfarin maintenance dose
rs4086116 Infection/inflammation of internal prosthetic device, implant or graft 0.002968 1.36 CYP2C9 Warfarin maintenance dose
rs4086116 Acute reaction to stress 0.0001331 1.45 CYP2C9 Warfarin maintenance dose
rs4086116 Shock 0.009594 1.429 CYP2C9 Warfarin maintenance dose
rs4086116 Functional disorders of bladder 0.008576 1.346 CYP2C9 Warfarin maintenance dose
rs4086116 Hypotension NOS 0.006367 1.224 CYP2C9 Warfarin maintenance dose
rs4086116 Other specified disorders of pancreatic internal secretion 0.002662 0.3318 CYP2C9 Warfarin maintenance dose
rs4086116 Spontaneous ecchymoses 0.0009734 1.892 CYP2C9 Warfarin maintenance dose
rs4086116 Calcaneal spur; Exostosis NOS 0.006637 1.317 CYP2C9 Warfarin maintenance dose
rs4086116 Atrial flutter 0.00986 1.262 CYP2C9 Warfarin maintenance dose
rs4086116 Leukoplakia of oral mucosa 0.00545 1.899 CYP2C9 Warfarin maintenance dose
rs4132509 Joint/ligament sprain 0.008064 0.6881 AKT3 RR interval (heart rate)
rs4132509 Sacroiliitis NEC 0.00832 0.3522 AKT3 RR interval (heart rate)
rs4132509 Benign neoplasm of eye 0.007167 1.294 AKT3 RR interval (heart rate)
rs4132509 Other arthropathies 0.006479 0.862 AKT3 RR interval (heart rate)
rs4132509 Inflammatory spondylopathies 0.007822 0.5224 AKT3 RR interval (heart rate)
rs4132509 Hemiplegia 0.0073 0.6584 AKT3 RR interval (heart rate)
rs4132509 Viral Enteritis 0.001015 1.702 AKT3 RR interval (heart rate)
rs4132509 Impetigo 0.002789 1.714 AKT3 RR interval (heart rate)
rs4132509 Bursitis 0.01019 0.802 AKT3 RR interval (heart rate)
rs4132509 Osteoarthrosis NOS 0.002842 0.8824 AKT3 RR interval (heart rate)
rs4132509 Fracture of humerus 0.006998 0.7322 AKT3 RR interval (heart rate)
rs4132509 Osteoarthrosis 0.007005 0.9004 AKT3 RR interval (heart rate)
rs4141463 Myasthenia gravis 0.00527 0.4382 MACROD2 Autism
rs4141463 Pulmonary embolism and infarction 0.007813 0.8006 MACROD2 Autism
rs4141463 Sulfonamides 0.001797 0.7559 MACROD2 Autism
rs4141463 Atherosclerosis of the extremities 0.008411 1.138 MACROD2 Autism
rs4141463 Anomalies of tooth position/malocclusion 0.003148 1.732 MACROD2 Autism
rs4141463 Muscular wasting and disuse atrophy 0.006082 0.5955 MACROD2 Autism
rs4141463 Muscle weakness 0.007046 0.7642 MACROD2 Autism
rs4141463 Disorders of the autonomic nervous system 0.004452 1.321 MACROD2 Autism
rs4141463 Poisoning by other anti-infectives 0.005433 0.8031 MACROD2 Autism
rs4141463 Chronic sinusitis 0.009532 0.8955 MACROD2 Autism
rs4141463 Gout 0.007836 0.8636 MACROD2 Autism
rs4141463 Other specified disorders of liver 0.009817 0.7605 MACROD2 Autism
rs4141463 Mastoiditis 0.001649 2.349 MACROD2 Autism
rs4141463 Thyroiditis 0.0104 0.7432 MACROD2 Autism
rs4141463 Streptococcus infection 0.00533 0.7323 MACROD2 Autism
rs4141463 Acquired deformities of limbs 0.003372 0.8027 MACROD2 Autism
rs4148441 Diseases of nail 0.001539 0.7383 ABCC4 Platelet counts
rs4148441 Other congenital anomalies 0.007841 2.099 ABCC4 Platelet counts
rs4148441 Adverse effects of antilipemic and antiarteriosclerotic drugs 0.00112 2.864 ABCC4 Platelet counts
rs4148441 Acute sinusitis 0.006261 0.7828 ABCC4 Platelet counts
rs4148441 Primary angle-closure glaucoma 0.01033 1.374 ABCC4 Platelet counts
rs4148441 Nonspecific findings on examination of blood 5.24e-05 0.3614 ABCC4 Platelet counts
rs4148441 Synoviopathy 0.01144 1.511 ABCC4 Platelet counts
rs4148441 Bone cancer 0.003345 2.09 ABCC4 Platelet counts
rs4148441 Osteoarthrosis NOS 0.0108 0.8662 ABCC4 Platelet counts
rs4148441 Phlebitis and thrombophlebitis of lower extremities 0.008666 0.6818 ABCC4 Platelet counts
rs4148441 Phlebitis and thrombophlebitis 0.009332 0.7187 ABCC4 Platelet counts
rs4148441 Other specified diseases of nail 0.001319 0.7283 ABCC4 Platelet counts
rs4148441 Anal and rectal polyp 0.003254 1.457 ABCC4 Platelet counts
rs4148441 Polyp of corpus uteri 0.006863 1.608 ABCC4 Platelet counts
rs4148441 Chronic ulcer of skin 0.008226 0.804 ABCC4 Platelet counts
rs4148441 Ingrowing nail 0.005147 0.7474 ABCC4 Platelet counts
rs4149268 Dysmenorrhea 0.00596 0.6453 ABCA1 HDL Cholesterol
rs4149268 Delirium dementia and amnestic disorders 0.00773 1.13 ABCA1 HDL Cholesterol
rs4149268 Sensorineural hearing loss 0.002958 0.8916 ABCA1 HDL Cholesterol
rs4149268 Acquired hypothyroidism 0.001073 0.4262 ABCA1 HDL Cholesterol
rs4149268 Light-headedness and vertigo 0.003644 0.901 ABCA1 HDL Cholesterol
rs4149268 Diverticulum of esophagus, acquired 0.003017 0.4276 ABCA1 HDL Cholesterol
rs4149268 Congenital anomalies of urinary system 0.003134 1.505 ABCA1 HDL Cholesterol
rs4149268 Malignant neoplasm of ovary 0.00919 0.5716 ABCA1 HDL Cholesterol
rs4149268 Late effects of cerebrovascular disease 0.002325 0.8271 ABCA1 HDL Cholesterol
rs4149268 Cancer of other female genital organs 0.001357 0.6036 ABCA1 HDL Cholesterol
rs4149268 Vertiginous syndromes and other disorders of vestibular system 0.003112 0.9036 ABCA1 HDL Cholesterol
rs4149268 Symptoms associated with female genital organs 0.004418 0.8242 ABCA1 HDL Cholesterol
rs4149268 Chondrocalcinosis 0.005723 1.369 ABCA1 HDL Cholesterol
rs4149268 Crystal arthropathies 0.006279 1.36 ABCA1 HDL Cholesterol
rs4149268 Myeloid leukemia 0.006614 1.816 ABCA1 HDL Cholesterol
rs4149268 Benign neoplasm of bone and articular cartilage 0.001179 0.4683 ABCA1 HDL Cholesterol
rs4149268 Labyrinthitis 0.0001292 0.6121 ABCA1 HDL Cholesterol
rs4149268 Facial nerve disorders 0.004807 1.412 ABCA1 HDL Cholesterol
rs4149268 Ovarian cancer 0.004677 0.5964 ABCA1 HDL Cholesterol
rs4149268 Cardiac defibrillator in situ 0.005247 1.454 ABCA1 HDL Cholesterol
rs4149268 Constipation 0.00143 1.167 ABCA1 HDL Cholesterol
rs4149268 Ovarian cyst 0.004149 0.7426 ABCA1 HDL Cholesterol
rs4149268 Keloid scar 0.0007647 1.866 ABCA1 HDL Cholesterol
rs4149268 Other disorders of eyelids 0.0111 0.8787 ABCA1 HDL Cholesterol
rs4233356 Keratoconjunctivitis sicca 0.002035 0.5218 DUSP23 Interstitial lung disease
rs4233356 Sicca syndrome 0.0001718 1.739 DUSP23 Interstitial lung disease
rs4233356 Lymphosarcoma 0.002898 2.215 DUSP23 Interstitial lung disease
rs4233356 Internal derangement of knee 0.009669 0.8714 DUSP23 Interstitial lung disease
rs4233356 Benign neoplasm of other parts of digestive system 0.002006 0.707 DUSP23 Interstitial lung disease
rs4233356 Menopausal & postmenopausal disorders 0.005933 1.138 DUSP23 Interstitial lung disease
rs4233356 Keratoconjunctivitis, noninfectious 0.008908 0.662 DUSP23 Interstitial lung disease
rs4233356 Postmenopausal bleeding 0.006331 1.234 DUSP23 Interstitial lung disease
rs4233356 Urethral stricture (not specified as infectious) 0.004709 1.449 DUSP23 Interstitial lung disease
rs4233356 Pneumococcal pneumonia 0.005761 1.842 DUSP23 Interstitial lung disease
rs4238010 Premature beats 0.008158 1.258 CCND2 Major depressive disorder (recurrent)
rs4238010 Pituitary hypofunction 0.00251 2.175 CCND2 Major depressive disorder (recurrent)
rs4238010 Chronic hepatitis 0.01041 1.9 CCND2 Major depressive disorder (recurrent)
rs4238010 Bladder neck obstruction 0.001209 1.451 CCND2 Major depressive disorder (recurrent)
rs4238010 Alcohol-related disorders 0.008517 1.265 CCND2 Major depressive disorder (recurrent)
rs4238010 Dermatophytosis of the body 0.005924 1.483 CCND2 Major depressive disorder (recurrent)
rs4238010 stress incontinence, female 0.001716 1.309 CCND2 Major depressive disorder (recurrent)
rs4238010 Benign neoplasm of respiratory and intrathoracic organs 0.004237 1.998 CCND2 Major depressive disorder (recurrent)
rs4295627 Dysphagia 0.009846 1.151 CCDC26 Glioma
rs4295627 Cardiac arrest & ventricular fibrillation 0.01093 0.6101 CCDC26 Glioma
rs4295627 Noninfectious gastroenteritis 0.005909 1.206 CCDC26 Glioma
rs4295627 Diseases of hair and hair follicles 0.001939 1.312 CCDC26 Glioma
rs4295627 Intracerebral hemorrhage 0.006102 1.698 CCDC26 Glioma
rs4295627 Calculus of kidney 0.006116 1.219 CCDC26 Glioma
rs4295627 Aphasia/speech disturbance 0.01028 1.271 CCDC26 Glioma
rs4295627 Nephritis & nephropathy 0.0007761 1.904 CCDC26 Glioma
rs4295627 Spondylosis with myelopathy 0.008389 0.6187 CCDC26 Glioma
rs4295627 Bacterial enteritis 0.01019 1.368 CCDC26 Glioma
rs4295627 Speech and language disorder 0.004791 1.512 CCDC26 Glioma
rs4295627 Paroxysmal tachycardia, unspecified 0.007101 0.7831 CCDC26 Glioma
rs4295627 Urinary calculus 0.002658 1.211 CCDC26 Glioma
rs4295627 Seborrhea 0.008535 1.96 CCDC26 Glioma
rs4295627 Acute sinusitis 0.00667 1.183 CCDC26 Glioma
rs4295627 Type 1 diabetic peripheral circulatory disorders 0.00878 1.991 CCDC26 Glioma
rs4295627 Diseases of the tongue 0.001773 1.56 CCDC26 Glioma
rs4295627 Neurological disorders due to brain damage 0.01065 1.162 CCDC26 Glioma
rs4295627 Benign neoplasm of colon 0.007497 1.117 CCDC26 Glioma
rs4295627 Fluid overload 0.006308 1.335 CCDC26 Glioma
rs4299376 Cancer within the respiratory system 0.005354 0.7835 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Cholelithiasis with other cholecystitis 0.0004307 0.6828 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Hyperlipidemia 0.009822 1.094 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Open wounds of extremities 0.005969 1.126 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Lung cancer 0.004026 0.7738 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Cellulitis and abscess of hand/fingers 0.005287 0.8232 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Mammographic microcalcification 0.00697 0.5875 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Phobia 0.001748 0.2786 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Disorders of lipoid metabolism 0.008687 1.095 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Meniere's disease 0.004909 1.663 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Contracture of joint 0.002715 1.452 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Malunion fracture 0.0006441 1.563 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Constipation 0.006202 0.8683 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Calculus of bile duct 0.005144 0.7002 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Balanoposthitis 0.00594 1.693 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Cholelithiasis 0.0002329 0.8246 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 pulmonary heart disease 0.004486 0.8438 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Fracture of hand or wrist 0.005193 1.187 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Cholelithiasis and cholecystitis 6.913e-05 0.8227 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Secondary malignant neoplasm 0.001148 0.8233 ABCG8 Total Cholesterol, LDL Cholesterol
rs4299376 Pulmonary embolism and infarction 0.002084 0.7515 ABCG8 Total Cholesterol, LDL Cholesterol
rs4410871 Other specified diseases of sebaceous glands 0.01055 0.802 PVT1 Multiple sclerosis
rs4410871 Fuchs' dystrophy 0.004518 1.521 PVT1 Multiple sclerosis
rs4410871 Congenital anomalies of limbs 0.001694 0.7155 PVT1 Multiple sclerosis
rs4410871 Rheumatoid arthritis 0.005831 0.7894 PVT1 Multiple sclerosis
rs4410871 Hypotony of eye 0.006896 0.2811 PVT1 Multiple sclerosis
rs4410871 Corneal dystrophy 0.006763 1.317 PVT1 Multiple sclerosis
rs4410871 Congenital deformities of feet 0.000637 0.653 PVT1 Multiple sclerosis
rs4410871 Arthropathy NOS involving multiple sites 0.007147 0.5522 PVT1 Multiple sclerosis
rs4410871 Viral warts & HPV 0.00901 0.8553 PVT1 Multiple sclerosis
rs4410871 Rheumatoid arthritis & related inflammatory polyarthropathies 0.0005546 0.7669 PVT1 Multiple sclerosis
rs4410871 Allergic conjunctivitis 0.007134 1.291 PVT1 Multiple sclerosis
rs4410871 Other disorders of bone and cartilage 0.005267 1.237 PVT1 Multiple sclerosis
rs4410871 Cardiomyopathy 0.004642 1.207 PVT1 Multiple sclerosis
rs4410871 Ascites (non malignant) 0.003835 1.441 PVT1 Multiple sclerosis
rs4410871 Primary/intrinsic cardiomyopathies 0.007767 1.2 PVT1 Multiple sclerosis
rs4430796 Pain, swelling or discharge of eye 0.0009046 0.6748 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Lipoid metabolism disorder NOS 0.007868 0.7879 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Back & neck sprains 0.002733 0.8789 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Symptoms involving head and neck 0.01008 0.8452 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Congenital musculoskeletal deformities of spine 0.003467 0.6793 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Immune disorders 0.0003148 0.733 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Myocardial infarction 0.008184 1.127 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Drug-resistant infection 0.01125 0.7358 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Nerve root and plexus disorders 0.01004 1.297 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Other immunological findings 0.002555 0.729 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Bladder neck obstruction 0.004413 0.7792 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Other acquired musculoskeletal deformity 0.004052 0.7947 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Internal derangement of knee 0.01133 0.8784 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Diplopia and disorders of binocular vision 0.003212 1.322 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Prostate cancer 0.001525 0.8192 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Carbuncle and furuncle 0.01113 0.6771 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Periostitis 0.001938 2.003 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs4430796 Other disorders of peritoneum 0.00683 0.6866 HNF1B Prostate-specific antigen levels (men w/out prostate cancer), Endometrial cancer, Prostate cancer, Type 2 diabetes
rs443198 Infertility, female 0.01049 0.5679 NOTCH4 Systemic sclerosis
rs443198 Prostatitis 0.001497 0.7271 NOTCH4 Systemic sclerosis
rs443198 Liver replaced by transplant 0.002693 2.247 NOTCH4 Systemic sclerosis
rs443198 Atherosclerosis of the extremities 0.01143 1.134 NOTCH4 Systemic sclerosis
rs443198 Aneurysm of artery of lower extremity 0.001994 1.639 NOTCH4 Systemic sclerosis
rs443198 Abdominal hernia 0.002258 1.11 NOTCH4 Systemic sclerosis
rs443198 Stomatitis and mucositis 0.01003 0.7149 NOTCH4 Systemic sclerosis
rs443198 Inflammatory diseases of prostate 0.002448 0.7807 NOTCH4 Systemic sclerosis
rs443198 Celiac disease 3.545e-05 2.478 NOTCH4 Systemic sclerosis
rs443198 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.006928 1.181 NOTCH4 Systemic sclerosis
rs443198 Dental caries 0.01106 1.185 NOTCH4 Systemic sclerosis
rs443198 Lymphadenitis 0.009123 1.173 NOTCH4 Systemic sclerosis
rs443198 Hemorrhage of gastrointestinal tract 0.01076 1.163 NOTCH4 Systemic sclerosis
rs443198 Abnormal tumor markers, elevated CEA or CA 125 0.0007364 2.424 NOTCH4 Systemic sclerosis
rs443198 Aneurysm of iliac artery 0.00402 1.777 NOTCH4 Systemic sclerosis
rs443198 Stress fracture 0.004655 1.909 NOTCH4 Systemic sclerosis
rs443198 Macular degeneration, dry 0.0004992 1.312 NOTCH4 Systemic sclerosis
rs443198 Keratitis 0.001102 0.7097 NOTCH4 Systemic sclerosis
rs443198 Other benign neoplasm of connective and other soft tissue 0.005554 1.49 NOTCH4 Systemic sclerosis
rs443198 Chronic prostatitis 0.00682 0.6266 NOTCH4 Systemic sclerosis
rs443198 Cervicocranial/Cervicobrachial syndrome 0.005079 0.7776 NOTCH4 Systemic sclerosis
rs443198 Cellulitis and abscess of face 0.003281 0.6932 NOTCH4 Systemic sclerosis
rs443198 Stiffness of joint 0.004576 1.212 NOTCH4 Systemic sclerosis
rs443198 Celiac or tropical sprue 1.197e-05 2.566 NOTCH4 Systemic sclerosis
rs443198 Acute tonsillitis 0.008783 0.6178 NOTCH4 Systemic sclerosis
rs443198 Mitral valve stenosis and/or aortic valve stenosis 0.0007132 1.295 NOTCH4 Systemic sclerosis
rs443198 Abnormality of red blood cells 0.01148 0.4664 NOTCH4 Systemic sclerosis
rs4444235 Keratitis, infectious 0.00267 1.449 BMP4 Colorectal cancer
rs4444235 Ileostomy status 0.005513 1.623 BMP4 Colorectal cancer
rs4444235 Cerebral edema and compression of brain 0.00734 1.882 BMP4 Colorectal cancer
rs4444235 Superficial cellulitis and abscess 0.001866 1.114 BMP4 Colorectal cancer
rs4444235 Nerve root lesions 0.005469 0.6018 BMP4 Colorectal cancer
rs4444235 Epilepsy, recurrent seizures, convulsions 0.007482 1.189 BMP4 Colorectal cancer
rs4444235 Fracture of pelvis 0.01068 1.316 BMP4 Colorectal cancer
rs4444235 Anal and rectal conditions 0.0005056 1.187 BMP4 Colorectal cancer
rs4444235 Temporomandibular joint disorder NOS 0.0008509 0.538 BMP4 Colorectal cancer
rs4444235 Other disorders of prostate 0.004617 0.7471 BMP4 Colorectal cancer
rs4444235 Ulceration of the lower GI tract 0.004628 1.57 BMP4 Colorectal cancer
rs4444235 Other conditions of brain 0.0009686 1.396 BMP4 Colorectal cancer
rs4444235 Convulsions 0.01116 1.189 BMP4 Colorectal cancer
rs4444235 Viral Enteritis 0.0043 0.6516 BMP4 Colorectal cancer
rs4444235 Acute reaction to stress 0.003858 0.7808 BMP4 Colorectal cancer
rs445 Cerebrovascular disease 0.006187 1.157 CDK6 White blood cell count, Neutrophil count
rs445 Keratoderma, acquired 0.002489 0.7419 CDK6 White blood cell count, Neutrophil count
rs445 Arthropathy associated with infections 0.008869 1.757 CDK6 White blood cell count, Neutrophil count
rs445 Acne 0.001394 1.526 CDK6 White blood cell count, Neutrophil count
rs445 Photodermatitis & sunburn 0.005656 0.7454 CDK6 White blood cell count, Neutrophil count
rs445 Polymyalgia Rheumatica 0.008885 0.6415 CDK6 White blood cell count, Neutrophil count
rs445 Secondary hyperparathyroidism (of renal origin) 0.006204 1.57 CDK6 White blood cell count, Neutrophil count
rs4516970 Disorders of cervical region 0.001669 2.25 WTAP Serum ferritin
rs4516970 Congenital cataract and lens anomalies 0.001265 3.989 WTAP Serum ferritin
rs4516970 Muscular wasting and disuse atrophy 0.001319 2.859 WTAP Serum ferritin
rs4516970 Spinal stenosis 0.003469 1.456 WTAP Serum ferritin
rs4516970 Aneurysm of iliac artery 0.009261 3.346 WTAP Serum ferritin
rs4516970 Sexual and gender identity disorders 0.005419 2.213 WTAP Serum ferritin
rs4516970 Chronic ischemic heart disease 0.0001755 1.68 WTAP Serum ferritin
rs4516970 Light-headedness and vertigo 0.002115 1.388 WTAP Serum ferritin
rs4516970 Other disorders of gallbladder 0.002492 2.862 WTAP Serum ferritin
rs4516970 Precordial pain 0.001992 2.148 WTAP Serum ferritin
rs4516970 Dentofacial anomalies, including malocclusion 0.006756 2.62 WTAP Serum ferritin
rs4516970 Sarcoidosis 0.002498 2.816 WTAP Serum ferritin
rs4516970 Spinal stenosis of lumbar region 0.001692 1.553 WTAP Serum ferritin
rs4516970 Occlusion of cerebral arteries 0.00968 1.558 WTAP Serum ferritin
rs4516970 Hypocalcemia 0.003359 2.324 WTAP Serum ferritin
rs4516970 Congenital anomalies of peripheral vascular system 0.001627 3.377 WTAP Serum ferritin
rs4516970 Postmenopausal hormone replacement 0.00153 2.406 WTAP Serum ferritin
rs4516970 Coronary atherosclerosis 0.01031 1.297 WTAP Serum ferritin
rs4516970 Degeneration of intervertebral disc 0.01036 1.372 WTAP Serum ferritin
rs4516970 Disorders of liver 0.007416 1.353 WTAP Serum ferritin
rs4516970 Other acute and subacute forms of ischemic heart disease 0.0009088 4.244 WTAP Serum ferritin
rs4516970 Ischemic Heart Disease 0.007942 1.291 WTAP Serum ferritin
rs4516970 Myocardial infarction 0.003639 1.478 WTAP Serum ferritin
rs4516970 Angina pectoris 0.01047 1.438 WTAP Serum ferritin
rs4516970 Mastodynia 0.008235 1.921 WTAP Serum ferritin
rs4528684 Noninflammatory disorders of vulva and perineum 0.00715 1.754 LPHN1 Mortality among heart failure patients
rs4528684 Uterine/Uterovaginal prolapse 0.001519 1.54 LPHN1 Mortality among heart failure patients
rs4528684 Chronic renal failure 0.007049 0.8182 LPHN1 Mortality among heart failure patients
rs4528684 Pervasive developmental disorders 0.0005345 2.095 LPHN1 Mortality among heart failure patients
rs4528684 Acute periodontitis 0.01109 0.516 LPHN1 Mortality among heart failure patients
rs4528684 Dementia with cerebral degenerations 0.008054 1.811 LPHN1 Mortality among heart failure patients
rs4528684 Coagulation defects 0.007026 0.8437 LPHN1 Mortality among heart failure patients
rs4528684 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.0007754 0.7993 LPHN1 Mortality among heart failure patients
rs4528684 Hypertrophy of female genital organs 0.001268 2.22 LPHN1 Mortality among heart failure patients
rs4528684 Attention deficit hyperactivity disorder 0.002645 2.108 LPHN1 Mortality among heart failure patients
rs4528684 Curvature of spine 0.005877 0.6418 LPHN1 Mortality among heart failure patients
rs4528684 Primary pulmonary hypertension 0.007917 0.2596 LPHN1 Mortality among heart failure patients
rs4528684 Other hypertensive complications 0.006924 0.6281 LPHN1 Mortality among heart failure patients
rs4528684 Allergy/adverse effect of penicillin 0.01089 0.688 LPHN1 Mortality among heart failure patients
rs4528684 Excessive or frequent menstruation 0.006501 1.525 LPHN1 Mortality among heart failure patients
rs4528684 Infection/inflammation of internal prosthetic device, implant or graft 0.006211 0.5943 LPHN1 Mortality among heart failure patients
rs4528684 Poisoning by antibiotics 0.01142 0.7258 LPHN1 Mortality among heart failure patients
rs4528684 Type 2 diabetic peripheral circulatory disorders 0.008459 0.4941 LPHN1 Mortality among heart failure patients
rs4528684 Phlebitis and thrombophlebitis 0.007079 0.7126 LPHN1 Mortality among heart failure patients
rs4528684 Peptic ulcer 0.003065 0.7312 LPHN1 Mortality among heart failure patients
rs4528684 Cyst or abscess of Bartholin's gland 0.002311 2.52 LPHN1 Mortality among heart failure patients
rs4537545 Somatoform disorder 0.00312 1.378 IL6R C-reactive protein
rs4537545 Cerebral edema and compression of brain 0.003606 1.943 IL6R C-reactive protein
rs4537545 Arthropathy NOS 0.004482 1.189 IL6R C-reactive protein
rs4537545 Diseases of the tongue 0.005594 1.406 IL6R C-reactive protein
rs4537545 Constipation 0.001219 1.166 IL6R C-reactive protein
rs4537545 Bipolar 0.01095 1.363 IL6R C-reactive protein
rs4537545 Disease of capillaries 0.007804 0.7349 IL6R C-reactive protein
rs4537545 Polycythemia vera, secondary 0.001701 1.72 IL6R C-reactive protein
rs4537545 Morbid obesity 0.004567 1.173 IL6R C-reactive protein
rs4537545 Dystrophy of female genital tract 0.003714 2.073 IL6R C-reactive protein
rs4537545 Dementia with cerebral degenerations 0.005672 1.552 IL6R C-reactive protein
rs4537545 Iron deficiency anemia secondary to blood loss 0.003672 1.35 IL6R C-reactive protein
rs4537545 Renal cell carcinoma 0.01129 0.7484 IL6R C-reactive protein
rs4537545 Vitamin B12 deficiency anemia 0.001118 1.662 IL6R C-reactive protein
rs4537545 Keloid scar 0.00797 0.5823 IL6R C-reactive protein
rs4537545 Other specified intestinal malabsorption 0.005915 1.709 IL6R C-reactive protein
rs4537545 Cancer of the upper aerodigestive tract 0.007393 1.366 IL6R C-reactive protein
rs4537545 Bladder cancer 0.003144 1.297 IL6R C-reactive protein
rs4537545 Malignant neoplasm of renal pelvis 0.005581 0.391 IL6R C-reactive protein
rs4537545 Cancer of larynx 0.004356 1.496 IL6R C-reactive protein
rs4537545 Psychogenic and somatoform disorders 0.007786 1.258 IL6R C-reactive protein
rs454305 Intestinal infection due to C. difficile 0.009541 1.364 TGFA Neutrophil count
rs454305 Abnormal findings on exam of gastrointestinal tract/abdominal area 0.01089 1.33 TGFA Neutrophil count
rs454305 Disorders of other cranial nerves 0.008775 0.7697 TGFA Neutrophil count
rs454305 Deep vein thrombosis 0.008907 1.267 TGFA Neutrophil count
rs454305 Sicca syndrome 0.003847 1.526 TGFA Neutrophil count
rs454305 Peritoneal or intestinal adhesions 0.001483 1.734 TGFA Neutrophil count
rs454305 Subarachnoid hemorrhage (injury) 0.005634 2.133 TGFA Neutrophil count
rs454305 Occlusion of cerebral arteries, with cerebral infarction 0.01011 1.477 TGFA Neutrophil count
rs454305 Stomach cancer 0.0003054 2.052 TGFA Neutrophil count
rs454305 Postmenopausal bleeding 0.003858 1.251 TGFA Neutrophil count
rs454305 Nerve plexus lesions 0.008167 1.424 TGFA Neutrophil count
rs454305 Other biliary tract disease 0.007369 1.269 TGFA Neutrophil count
rs454305 Corneal degenerations 0.006039 1.366 TGFA Neutrophil count
rs454305 Hyperosmolality and/or hypernatremia 0.001888 1.552 TGFA Neutrophil count
rs454305 Other disorders of gallbladder 0.005606 1.606 TGFA Neutrophil count
rs454305 Epistaxis or throat hemorrhage 0.005983 0.8089 TGFA Neutrophil count
rs454305 Trigeminal nerve disorders 0.003451 0.6281 TGFA Neutrophil count
rs454305 Functional disorders of bladder 0.001488 1.373 TGFA Neutrophil count
rs454305 Vascular insufficiency of intestine 0.007803 1.41 TGFA Neutrophil count
rs454305 Hypertensive heart disease 0.005534 1.344 TGFA Neutrophil count
rs454305 Valvular heart disease/ heart chambers 0.009776 0.5184 TGFA Neutrophil count
rs454305 Premature menopause and other ovarian failure 0.00469 1.929 TGFA Neutrophil count
rs4649203 Renal colic 0.004719 0.4834 IL28RA Psoriasis vulgaris
rs4649203 Congenital musculoskeletal deformities of spine 0.009175 1.424 IL28RA Psoriasis vulgaris
rs4649203 stress incontinence, female 0.002176 1.23 IL28RA Psoriasis vulgaris
rs4649203 Cardiomegaly 0.009264 1.162 IL28RA Psoriasis vulgaris
rs4649203 Syncope and collapse 0.004206 1.139 IL28RA Psoriasis vulgaris
rs4649203 Cyst and pseudocyst of pancreas 0.007696 1.617 IL28RA Psoriasis vulgaris
rs4649203 Lupus erythematosus 0.01054 0.4327 IL28RA Psoriasis vulgaris
rs4650608 Other abnormal glucose 0.005284 0.8634 PTGFR Bipolar disorder
rs4650608 Posttraumatic stress disorder 0.00633 0.5924 PTGFR Bipolar disorder
rs4650608 Other disorders of bone and cartilage 0.001266 0.7751 PTGFR Bipolar disorder
rs4650608 Acidosis 0.00184 0.6584 PTGFR Bipolar disorder
rs4650608 Other specified disorders of breast 0.0004519 1.341 PTGFR Bipolar disorder
rs4650608 Dysthymic disorder 0.005749 0.84 PTGFR Bipolar disorder
rs4650608 Lack of normal physiological development 0.01129 0.7225 PTGFR Bipolar disorder
rs4650608 Failure to thrive 0.009219 0.6958 PTGFR Bipolar disorder
rs4650608 Type 2 diabetic neuropathy 0.0111 0.8497 PTGFR Bipolar disorder
rs4650608 Diabetes mellitus 0.01046 0.9196 PTGFR Bipolar disorder
rs4650608 Symptoms involving cardiovascular system 0.006541 1.167 PTGFR Bipolar disorder
rs4650608 Type 2 diabetes 0.007024 0.9145 PTGFR Bipolar disorder
rs4650608 Genu valgum or varum (acquired) 0.00286 1.484 PTGFR Bipolar disorder
rs4650608 Labyrinthitis 0.0002808 1.517 PTGFR Bipolar disorder
rs4650608 Gastroparesis 0.00357 0.4927 PTGFR Bipolar disorder
rs4650608 Polyneuropathy in diabetes 0.0009243 0.7915 PTGFR Bipolar disorder
rs4650608 Bladder neck obstruction 0.001552 1.325 PTGFR Bipolar disorder
rs4650608 Acid-base balance disorder 0.009097 0.7502 PTGFR Bipolar disorder
rs4650608 Corneal dystrophy 0.008343 1.306 PTGFR Bipolar disorder
rs4650608 Hematemesis 0.002197 0.5246 PTGFR Bipolar disorder
rs4650608 Keratoderma, acquired 0.005149 0.8443 PTGFR Bipolar disorder
rs4650608 Althete's foot 0.00278 0.7566 PTGFR Bipolar disorder
rs4656461 Allergic conjunctivitis 0.001744 1.478 TMCO1 Glaucoma
rs4656461 Appendicitis 0.005743 1.574 TMCO1 Glaucoma
rs4656461 Benign neoplasm of unspecified sites 0.004004 2.433 TMCO1 Glaucoma
rs4656461 Breast disorder NOS 0.003761 2.651 TMCO1 Glaucoma
rs4656461 Dermatophytosis of the body 0.009616 0.5792 TMCO1 Glaucoma
rs4656461 Ankylosis of joint 0.004355 0.4632 TMCO1 Glaucoma
rs4656461 Eating disorder 0.009317 1.811 TMCO1 Glaucoma
rs4656461 Ventral hernia 0.005013 0.6312 TMCO1 Glaucoma
rs4656461 Heartburn 0.009822 1.502 TMCO1 Glaucoma
rs4656461 Conjunctivitis, noninfectious 0.003271 1.402 TMCO1 Glaucoma
rs4656461 Heart valve disorders 0.009751 0.8569 TMCO1 Glaucoma
rs4656461 Other hypertrophic and atrophic conditions of skin 0.00611 0.8444 TMCO1 Glaucoma
rs4656461 Cancer of larynx 0.01065 1.604 TMCO1 Glaucoma
rs4656461 Noninflammatory disorders of vagina 0.00707 1.487 TMCO1 Glaucoma
rs4656461 Back pain 0.007638 0.8873 TMCO1 Glaucoma
rs4656461 Intestinal obstruction without mention of hernia 0.007237 0.7531 TMCO1 Glaucoma
rs4656461 Acute pancreatitis 0.009797 1.382 TMCO1 Glaucoma
rs4656461 Paralytic ileus 0.008707 0.6087 TMCO1 Glaucoma
rs4657178 Spondylosis with myelopathy 0.003484 1.445 NOS1AP QT interval
rs4657178 Ovarian cancer 0.008385 0.5585 NOS1AP QT interval
rs4657178 Septicemia 0.004198 0.8128 NOS1AP QT interval
rs4657178 Lymphosarcoma 0.002982 0.2131 NOS1AP QT interval
rs4657178 Symptoms involving urinary system 0.008506 1.271 NOS1AP QT interval
rs4657178 Cancer of other lymphoid, histiocytic tissue 0.0009112 0.6885 NOS1AP QT interval
rs4657178 Malignant neoplasm of ovary 0.003137 0.4375 NOS1AP QT interval
rs4657178 Degeneration of intervertebral disc 0.007678 1.132 NOS1AP QT interval
rs4657178 Hypertensive heart disease 0.0007945 1.473 NOS1AP QT interval
rs4657178 Adverse effects of hormones and synthetic substitutes 0.008993 0.255 NOS1AP QT interval
rs4657178 Hallux rigidus 0.00885 1.417 NOS1AP QT interval
rs4657178 Disaccharide malabsorption 0.01005 1.187 NOS1AP QT interval
rs4657178 Non-Hodgkins lymphoma 0.0003084 0.6562 NOS1AP QT interval
rs4657178 Disorders of choroid 0.009449 0.7361 NOS1AP QT interval
rs4657178 Elevated prostate specific antigen 0.005001 1.226 NOS1AP QT interval
rs4657178 Hallucinations 0.001428 2.08 NOS1AP QT interval
rs4676406 Right bundle branch block 0.007062 1.281 GPR35 Ulcerative colitis
rs4676406 Nonrheumatic tricuspid valve disorders 0.007452 1.441 GPR35 Ulcerative colitis
rs4676406 Abnormal Papanicolaou smear of cervix and cervical HPV 0.002677 0.7998 GPR35 Ulcerative colitis
rs4676406 Anomalies of tooth position/malocclusion 0.005245 1.672 GPR35 Ulcerative colitis
rs4676406 Labyrinthitis 0.003291 1.402 GPR35 Ulcerative colitis
rs4676406 Late effects of cerebrovascular disease 0.009645 1.166 GPR35 Ulcerative colitis
rs4676406 Pruritus and related conditions 0.009164 1.186 GPR35 Ulcerative colitis
rs4676406 Open wound of foot except toe(s) alone 0.003012 0.63 GPR35 Ulcerative colitis
rs4676406 Chronic prostatitis 0.002429 1.611 GPR35 Ulcerative colitis
rs4676406 Unspecified monoarthritis 0.007319 1.626 GPR35 Ulcerative colitis
rs4676406 Aneurysm of other specified artery 0.005288 1.892 GPR35 Ulcerative colitis
rs4676406 Lump or mass in breast 0.005704 0.8614 GPR35 Ulcerative colitis
rs4676406 Pneumonitis due to inhalation of food or vomitus 0.0002181 0.6727 GPR35 Ulcerative colitis
rs4701252 Other immunological findings 0.008614 1.383 CDH12 Waist circumference
rs4701252 Osteoporosis, osteopenia, & pathological fractures 0.006279 1.129 CDH12 Waist circumference
rs4701252 Chronic obstructive asthma with exacerbation 0.005296 1.798 CDH12 Waist circumference
rs4701252 Fracture of radius and ulna 0.003816 1.248 CDH12 Waist circumference
rs4701252 Abdominal aortic aneurysm 0.005425 0.7383 CDH12 Waist circumference
rs4701252 Nephritis & nephropathy 0.007313 0.429 CDH12 Waist circumference
rs4701252 Type 2 diabetic neuropathy 0.006198 0.7977 CDH12 Waist circumference
rs4701252 Aortic aneurysm 0.003249 0.7597 CDH12 Waist circumference
rs4701252 Agorophobia, social phobia, and panic disorder 0.006155 0.6079 CDH12 Waist circumference
rs4701252 Other aneurysm 0.002689 0.7781 CDH12 Waist circumference
rs4701252 Behcet's syndrome 0.006824 1.67 CDH12 Waist circumference
rs4701252 Diseases of lips 0.008027 1.561 CDH12 Waist circumference
rs4701252 Nontoxic multinodular goiter 0.007647 0.7216 CDH12 Waist circumference
rs4701252 Polyarthropathy or polyarthritis involving multiple sites NOS 0.008267 0.4335 CDH12 Waist circumference
rs4704970 Arthropathy NOS involving multiple sites 0.008042 1.651 SGCD Multiple sclerosis
rs4704970 Heart valve replaced 0.006915 1.34 SGCD Multiple sclerosis
rs4704970 Personal history of allergy to medicinal agents 0.005505 1.322 SGCD Multiple sclerosis
rs4704970 Essential tremor 0.00653 0.6864 SGCD Multiple sclerosis
rs4704970 Elevated levels of transaminase or lactic acid dehydrogenase 0.00792 1.231 SGCD Multiple sclerosis
rs4704970 Open-angle glaucoma 0.01046 0.8332 SGCD Multiple sclerosis
rs4704970 Unspecified local infection of skin and subcutaneous tissue 0.001281 1.373 SGCD Multiple sclerosis
rs4704970 Valvular heart disease/ heart chambers 0.01103 1.764 SGCD Multiple sclerosis
rs4704970 Other acute and subacute forms of ischemic heart disease 0.01044 1.838 SGCD Multiple sclerosis
rs4713693 Secondary malignancy of lymph nodes 0.006291 0.7917 HLA-E Graves' disease
rs4713693 Late effects of cerebrovascular disease 0.006263 1.173 HLA-E Graves' disease
rs4713693 Viral Enteritis 0.009568 0.6808 HLA-E Graves' disease
rs4713693 Heart transplant/surgery 0.002646 1.487 HLA-E Graves' disease
rs4713693 Cystitis and urethritis 0.00907 0.8351 HLA-E Graves' disease
rs4713693 Osteochondropathies 0.007917 0.5109 HLA-E Graves' disease
rs4713693 Other hypertrophic and atrophic conditions of skin 0.0008197 1.138 HLA-E Graves' disease
rs4713693 Genital prolapse 0.009546 1.157 HLA-E Graves' disease
rs4713693 Vascular insufficiency of intestine 0.007236 0.7073 HLA-E Graves' disease
rs4713693 Psoriasis & related disorders 0.00986 0.8192 HLA-E Graves' disease
rs4713693 Gastrointestinal complications 0.01059 1.246 HLA-E Graves' disease
rs4713693 Plasma protein metabolism disorder 0.01056 1.271 HLA-E Graves' disease
rs4713693 Urethral stricture (not specified as infectious) 0.01039 0.7076 HLA-E Graves' disease
rs4732812 Generalized anxiety disorder 0.003146 1.34 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Arthropathy NOS 0.007834 1.189 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Symptoms involving urinary system 0.0005292 1.359 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Chronic periodontitis 0.006648 1.272 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Exophthalmos 0.000282 2.286 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Mastoiditis 1.927e-06 3.685 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Periodontitis (acute or chronic) 0.00261 1.265 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Disorders of parathyroid gland 0.002589 1.346 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Keratitis, infectious 0.009175 0.6832 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Hyperparathyroidism 0.008556 1.31 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Occlusion of cerebral arteries 0.0005604 1.261 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Speech and language disorder 0.004268 1.451 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Mucous polyp of cervix 0.003077 1.46 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Hematuria 0.01103 1.118 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Dysphagia 0.002476 1.152 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Abnormal findings on radiological breast exam 0.002358 1.664 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Gingival and periodontal diseases 0.001838 1.241 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Allergic conjunctivitis 0.00392 0.7441 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Nonspecific findings on examination of blood 0.01078 1.304 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Peripheral enthesopathies 0.004598 1.109 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Polyp of female genital organs 0.005818 1.282 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Hemiplegia 0.002727 1.392 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Acute periodontitis 0.00155 1.469 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Senile dementia 0.007047 1.247 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Develomental delays and disorders 0.004398 1.311 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Influenza 0.008465 1.353 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Lipoid metabolism disorder NOS 0.0006649 0.705 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Other disorders of middle ear and mastoid 0.0007011 1.62 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Late effects of cerebrovascular disease 0.001831 1.218 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Aphasia/speech disturbance 0.009055 1.235 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Acute, but ill-defined cerebrovascular disease 0.009917 1.196 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Ischemic stroke 0.0008945 1.264 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Blood vessel replaced 0.008289 0.5796 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Hallucinations 0.01147 1.778 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4732812 Intracranial hemorrhage (injury) 0.001721 1.584 C8orf80 Suicidal ideation and SSRI class antidepressant Escitalopram
rs4764043 Jaw disease NOS 0.007498 1.826 GRIN2B Aging
rs4764043 Abnormal glucose 0.003081 0.7935 GRIN2B Aging
rs4764043 Diabetes mellitus 0.01105 0.8572 GRIN2B Aging
rs4764043 Wheezing and painful respiration 0.001061 0.7423 GRIN2B Aging
rs4764043 Pallor and flushing 0.01088 1.65 GRIN2B Aging
rs4764043 Congenital musculoskeletal anomalies 0.006508 2.691 GRIN2B Aging
rs4764043 Retinal detachment with retinal defect 0.001617 1.849 GRIN2B Aging
rs4764043 Type 2 diabetes 0.005528 0.8427 GRIN2B Aging
rs4764043 Gastrointestinal complications 0.005568 1.487 GRIN2B Aging
rs4764043 Schizophrenia and other psychotic disorders 0.001403 0.6285 GRIN2B Aging
rs4789939 Spinal stenosis of lumbar region 0.005828 1.194 TIMP2 Dupuytren's disease
rs4789939 Acquired spondylolisthesis 0.003753 1.414 TIMP2 Dupuytren's disease
rs4789939 Abnormal kidney function 0.008781 2.075 TIMP2 Dupuytren's disease
rs4789939 Chronic ulcer of skin 0.002307 1.189 TIMP2 Dupuytren's disease
rs4789939 Mastodynia 0.008119 0.7089 TIMP2 Dupuytren's disease
rs4789939 Hyposmolality and/or hyponatremia 0.001882 1.257 TIMP2 Dupuytren's disease
rs4789939 Heart failure 0.003185 1.17 TIMP2 Dupuytren's disease
rs4789939 Adverse effects of opiates and related narcotics in therapeutic use 0.0003853 1.531 TIMP2 Dupuytren's disease
rs4789939 Carbuncle and furuncle 0.01047 1.571 TIMP2 Dupuytren's disease
rs4789939 Neoplasm of uncertain behavior 0.0009312 0.7384 TIMP2 Dupuytren's disease
rs4789939 Chronic nonalcoholic liver disease 0.0008139 1.388 TIMP2 Dupuytren's disease
rs4789939 Other cerebral degenerations 0.008044 0.5744 TIMP2 Dupuytren's disease
rs4789939 Other acquired musculoskeletal deformity 0.0006204 1.397 TIMP2 Dupuytren's disease
rs4789939 Chronic ulcer of leg or foot 0.01103 1.183 TIMP2 Dupuytren's disease
rs4789939 Other nonspecific findings on examination of urine 0.01067 1.245 TIMP2 Dupuytren's disease
rs4789939 Spinal stenosis 0.008535 1.166 TIMP2 Dupuytren's disease
rs4789939 Anemia of chronic disease 0.0002829 1.356 TIMP2 Dupuytren's disease
rs4789939 Complications of gastrostomy, colostomy and enterostomy 0.0006032 2.408 TIMP2 Dupuytren's disease
rs4789939 Abnormal heart sounds 0.0009693 1.272 TIMP2 Dupuytren's disease
rs4789939 Decreased libido 0.001089 2.448 TIMP2 Dupuytren's disease
rs4789939 Malaise and fatigue 0.008185 0.8977 TIMP2 Dupuytren's disease
rs4789939 Type 2 diabetic retinopathy 0.004156 1.275 TIMP2 Dupuytren's disease
rs4789939 Systolic/diastolic heart failure 0.003679 1.174 TIMP2 Dupuytren's disease
rs4789939 Chronic liver disease and cirrhosis 0.0002251 1.406 TIMP2 Dupuytren's disease
rs4789939 Anemia in chronic kidney disease 0.002773 1.426 TIMP2 Dupuytren's disease
rs4789939 Abnormal findings examination of lungs 0.003263 1.244 TIMP2 Dupuytren's disease
rs4789939 Open wound of eye or eyelid 0.003158 2.317 TIMP2 Dupuytren's disease
rs4795067 Other disorders of soft tissues 0.01115 1.362 NOS2 Psoriasis vulgaris
rs4795067 Central/nonobstroctive sleep apnea 0.007201 0.5617 NOS2 Psoriasis vulgaris
rs4795067 Peritoneal or intestinal adhesions 0.0076 0.5913 NOS2 Psoriasis vulgaris
rs4795067 Gingival and periodontal diseases 0.00166 1.231 NOS2 Psoriasis vulgaris
rs4795067 Eye infection, viral 0.006636 1.402 NOS2 Psoriasis vulgaris
rs4795067 Ulcerative stomatitis & mucositis 0.007092 1.776 NOS2 Psoriasis vulgaris
rs4795067 Benign neoplasm of respiratory and intrathoracic organs 5.476e-05 0.3127 NOS2 Psoriasis vulgaris
rs4795067 First degree AV block 0.006896 1.245 NOS2 Psoriasis vulgaris
rs4795067 Calculus of bile duct 0.00732 0.7225 NOS2 Psoriasis vulgaris
rs4795067 Dermatomycoses 0.004875 0.5318 NOS2 Psoriasis vulgaris
rs4795067 Other hemoglobinopathies 0.005945 0.4104 NOS2 Psoriasis vulgaris
rs4815868 Cancer of kidney and renal pelvis 0.008592 1.41 C20orf196 Cognitive performance
rs4815868 Torsion dystonia 0.0114 1.641 C20orf196 Cognitive performance
rs4815868 Dyspareunia 0.008375 1.683 C20orf196 Cognitive performance
rs4815868 Perforation of tympanic membrane 0.004137 1.643 C20orf196 Cognitive performance
rs4815868 Plasma protein metabolism disorder 0.005614 1.376 C20orf196 Cognitive performance
rs4815868 Cardiac arrhythmia NOS 0.006197 0.829 C20orf196 Cognitive performance
rs4815868 Tinnitus 0.01145 1.242 C20orf196 Cognitive performance
rs4815868 Nerve root lesions 0.008099 1.718 C20orf196 Cognitive performance
rs4815868 Paraproteinemia 0.005719 1.465 C20orf196 Cognitive performance
rs4815868 Paroxysmal tachycardia, unspecified 0.004369 0.7691 C20orf196 Cognitive performance
rs4815868 Malignant neoplasm of renal pelvis 6.331e-05 3.148 C20orf196 Cognitive performance
rs4815868 Pruritus and related conditions 0.01012 0.7869 C20orf196 Cognitive performance
rs4815868 Facial nerve disorders 0.01142 1.457 C20orf196 Cognitive performance
rs4815868 Postmenopausal atrophic vaginitis 0.009616 1.297 C20orf196 Cognitive performance
rs4815868 Disorders of coccyx 0.008167 0.6618 C20orf196 Cognitive performance
rs4820268 Ovarian dysfunction 0.001634 0.462 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Keratoconjunctivitis sicca 0.005631 0.6077 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Superficial cellulitis and abscess 0.01058 1.091 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Functional digestive disorders 0.002635 1.157 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Abnormal findings on exam of gastrointestinal tract/abdominal area 0.003314 1.371 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Noninfectious gastroenteritis 0.0001486 1.223 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Scar conditions and fibrosis of skin 0.006442 1.294 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Anemia NOS 0.003312 1.1 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Deficiency anemias NOS 0.002055 1.474 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Other intestinal obstruction 0.007002 1.243 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Iron deficiency anemias 0.0006038 1.178 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Other anemias 0.007442 1.084 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Iron deficiency anemias NOS 0.0006182 1.167 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Nontoxic uninodular goiter 0.009928 0.8227 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Polycystic ovaries 0.003577 0.4373 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4820268 Poisoning by water, mineral, and uric acid metabolism drugs 0.002273 1.781 TMPRSS6 Serum iron concentration, Iron levels, Mean corpuscular volume, Mean corpuscular hemoglobin concentra­tion, Mean corpuscular hemoglobin, Serum iron levels
rs4838605 Osteoporosis, osteopenia, & pathological fractures 0.007129 1.099 ARHGAP22 Diabetic retinopathy
rs4838605 Sacroiliitis NEC 0.006789 0.5079 ARHGAP22 Diabetic retinopathy
rs4838605 Gout 0.00672 0.8564 ARHGAP22 Diabetic retinopathy
rs4838605 Mastoiditis 0.006568 0.4009 ARHGAP22 Diabetic retinopathy
rs4838605 Polycystic ovaries 0.008473 0.451 ARHGAP22 Diabetic retinopathy
rs4838605 Thrombocytopenia 0.007818 1.18 ARHGAP22 Diabetic retinopathy
rs4838605 Other biliary tract disease 0.01012 1.249 ARHGAP22 Diabetic retinopathy
rs4838605 Pallor and flushing 0.005063 0.6741 ARHGAP22 Diabetic retinopathy
rs4838605 Ovarian dysfunction 0.007584 0.4981 ARHGAP22 Diabetic retinopathy
rs4838605 Senile dementia 0.00665 1.226 ARHGAP22 Diabetic retinopathy
rs4838605 Insulin pump user 0.008954 0.7939 ARHGAP22 Diabetic retinopathy
rs4838605 Benign neoplasm of colon 0.005343 0.9101 ARHGAP22 Diabetic retinopathy
rs4838605 Gout and other crystal arthropathies 0.006556 0.8653 ARHGAP22 Diabetic retinopathy
rs4902642 Cellulitis and abscess of arm 0.0009029 0.7561 ZFP36L1 Crohn's disease
rs4902642 Ptosis of eyelid 0.009669 0.8379 ZFP36L1 Crohn's disease
rs4902642 Cancer of the lower GI tract 0.009481 1.344 ZFP36L1 Crohn's disease
rs4902642 Other congenital anomalies of skin 0.0008059 1.556 ZFP36L1 Crohn's disease
rs4902642 Poisoning by analgesics, antipyretics, and antirheumatics 0.004131 0.7331 ZFP36L1 Crohn's disease
rs4902642 Circumscribed scleroderma 0.007965 0.714 ZFP36L1 Crohn's disease
rs4902642 Other immunological findings 0.007842 1.313 ZFP36L1 Crohn's disease
rs4902642 Psychogenic and somatoform disorders 0.009567 0.7937 ZFP36L1 Crohn's disease
rs4902642 Other specified diseases of hair and hair follicles 0.00139 1.384 ZFP36L1 Crohn's disease
rs4902642 Heart failure NOS 0.005187 0.7652 ZFP36L1 Crohn's disease
rs4902642 Congenital anomalies of limbs 0.003665 1.296 ZFP36L1 Crohn's disease
rs4902642 Sinoatrial node dysfunction 0.004996 0.7595 ZFP36L1 Crohn's disease
rs4902642 Congenital deformities of feet 0.001674 1.376 ZFP36L1 Crohn's disease
rs4902642 Meningitis 0.0001116 2.225 ZFP36L1 Crohn's disease
rs4902642 Multiple sclerosis 0.01085 0.6545 ZFP36L1 Crohn's disease
rs4902642 Intestinal malabsorption 0.004517 0.7118 ZFP36L1 Crohn's disease
rs4902642 Cardiac pacemaker in situ 0.009572 0.8232 ZFP36L1 Crohn's disease
rs4902642 Immune disorders 0.006565 1.257 ZFP36L1 Crohn's disease
rs4917014 Symptoms/disorders of the urinary system 0.004528 0.9106 IKZF1 Systemic lupus erythematosus
rs4917014 Stomach cancer 0.0112 0.5354 IKZF1 Systemic lupus erythematosus
rs4917014 Breast disorder NOS 0.0006827 0.1924 IKZF1 Systemic lupus erythematosus
rs4917014 Chronic ischemic heart disease 0.006277 0.8674 IKZF1 Systemic lupus erythematosus
rs4917014 Cornea replaced by transplant 0.007342 0.5047 IKZF1 Systemic lupus erythematosus
rs4917014 Encounter for long-term use of antiplatelets/antithrombotics 0.001147 0.2666 IKZF1 Systemic lupus erythematosus
rs4917014 Coronary atherosclerosis 0.00211 0.8999 IKZF1 Systemic lupus erythematosus
rs4917014 Ischemic Heart Disease 0.001521 0.902 IKZF1 Systemic lupus erythematosus
rs4917014 Premenstrual tension syndromes 0.005987 0.5187 IKZF1 Systemic lupus erythematosus
rs4917014 Hallux rigidus 0.00888 1.387 IKZF1 Systemic lupus erythematosus
rs4917014 Pulmonary congestion and hypostasis 0.007123 0.7047 IKZF1 Systemic lupus erythematosus
rs4917014 Fever of unknown origin 0.01127 0.8974 IKZF1 Systemic lupus erythematosus
rs4935969 Allergic rhinitis 0.005195 1.121 KIRREL3 Hair color
rs4935969 Duodenal ulcer 0.01009 1.302 KIRREL3 Hair color
rs4935969 Cholecystitis without cholelithiasis 0.01079 0.7703 KIRREL3 Hair color
rs4935969 Congenital anomalies of peripheral vascular system 0.0103 1.731 KIRREL3 Hair color
rs4935969 Vascular complications of surgery and medical procedures 0.002377 1.639 KIRREL3 Hair color
rs4935969 Nonrheumatic aortic valve disorders 0.007598 1.155 KIRREL3 Hair color
rs4935969 Cancer of the upper aerodigestive tract 0.001215 1.461 KIRREL3 Hair color
rs4935969 Other and unspecified disc disorder 0.001023 1.596 KIRREL3 Hair color
rs4935969 Cancer of oropharynx 0.001918 2.257 KIRREL3 Hair color
rs4935969 Arteritis NOS 0.00559 1.58 KIRREL3 Hair color
rs4935969 Insulin pump user 0.009209 1.241 KIRREL3 Hair color
rs4935969 Anomalies of pupillary function 0.004024 0.4532 KIRREL3 Hair color
rs4935969 Protein plasma/amino-acid transport and metabolism disorder 0.008878 1.253 KIRREL3 Hair color
rs4935969 Neutropenia 0.007999 1.226 KIRREL3 Hair color
rs4935969 Acquired deformities of limbs 0.009249 1.21 KIRREL3 Hair color
rs4935969 Abnormal reflex 0.01151 2.018 KIRREL3 Hair color
rs4935969 Chronic sinusitis 0.007823 1.119 KIRREL3 Hair color
rs4935969 Retinal detachments and defects 0.01113 0.8244 KIRREL3 Hair color
rs4935969 Varicose veins of lower extremity, symptomtic 0.006422 1.219 KIRREL3 Hair color
rs4935969 Hypermetropia 0.0089 0.8828 KIRREL3 Hair color
rs4935969 Unequal leg length (acquired) 0.001946 1.539 KIRREL3 Hair color
rs4935969 Drug-resistant infection 0.008583 1.358 KIRREL3 Hair color
rs4935969 Nontoxic nodular goiter 0.001721 0.8175 KIRREL3 Hair color
rs4935969 Type 2 diabetic ketoacidosis 0.004126 1.146 KIRREL3 Hair color
rs494620 Seborheic dermatitis 0.01055 1.171 SLC44A4 Menopause
rs494620 Bacteremia 0.0004042 1.392 SLC44A4 Menopause
rs494620 Fracture of hand or wrist 0.0006194 1.219 SLC44A4 Menopause
rs494620 Pulmonary collapse; interstitial/compensatory emphysema 0.001802 1.195 SLC44A4 Menopause
rs494620 Hyperlipidemia 0.01045 1.088 SLC44A4 Menopause
rs494620 Osteoarthrosis 0.006941 1.085 SLC44A4 Menopause
rs494620 Colon cancer 0.007274 1.235 SLC44A4 Menopause
rs494620 Dermatomyositis and Polymyositis 0.005836 0.4196 SLC44A4 Menopause
rs494620 Second degree AV block 0.008453 1.487 SLC44A4 Menopause
rs494620 Other specified peripheral vascular diseases 0.006979 0.4551 SLC44A4 Menopause
rs494620 Benign neoplasm of colon 0.002033 1.106 SLC44A4 Menopause
rs494620 Esophageal cancer 0.001345 1.95 SLC44A4 Menopause
rs494620 Lymphosarcoma 0.01047 1.985 SLC44A4 Menopause
rs494620 Rheumatoid arthritis 0.002713 1.247 SLC44A4 Menopause
rs494620 Septicemia 0.001539 1.208 SLC44A4 Menopause
rs494620 Adverse effects of adrenal cortical steroids 0.006425 1.553 SLC44A4 Menopause
rs494620 Stomach cancer 0.0003761 2.05 SLC44A4 Menopause
rs494620 Disorders of lipoid metabolism 0.005162 1.096 SLC44A4 Menopause
rs494620 Corneal degenerations 0.002898 1.387 SLC44A4 Menopause
rs494620 Personal history of allergy to medicinal agents 0.001868 1.31 SLC44A4 Menopause
rs494620 Joint effusions 0.003457 1.235 SLC44A4 Menopause
rs4952590 Other disorders of testis 0.003672 1.596 PKDCC Atopy
rs4952590 Osteoarthrosis NOS 0.003867 0.8712 PKDCC Atopy
rs4952590 Chronic obstructive asthma with exacerbation 0.004406 1.874 PKDCC Atopy
rs4952590 Myeloproliferative disease 0.0007342 1.615 PKDCC Atopy
rs4952590 Otitis externa 0.005445 0.7526 PKDCC Atopy
rs4952590 Disorders of vitreous body 0.01137 0.8471 PKDCC Atopy
rs4952590 Pruritus and related conditions 0.009335 0.7564 PKDCC Atopy
rs4952590 Hydrocele 0.0002061 2.028 PKDCC Atopy
rs4952590 Temporomandibular joint disorder NOS 0.008709 0.3594 PKDCC Atopy
rs4952590 Pseudomonal pneumonia 0.009014 2.333 PKDCC Atopy
rs4952590 Corneal degenerations 0.01041 1.457 PKDCC Atopy
rs4952590 Pneumoconiosis 0.007481 2.159 PKDCC Atopy
rs4952590 Peripheral enthesopathies 0.01023 0.8831 PKDCC Atopy
rs4952590 Polycythemia vera 0.0009457 2.227 PKDCC Atopy
rs4952590 Iron deficiency anemias 0.01097 1.193 PKDCC Atopy
rs4952590 Pleurisy; pleural effusion 0.008875 1.201 PKDCC Atopy
rs4952590 Lung disease due to external agents 0.01132 1.692 PKDCC Atopy
rs495366 Herpes zoster with nervous system complications 0.007687 0.5819 MMP3 Matrix metalloproteinase-1 levels
rs495366 Other disorders of gallbladder 0.006796 1.61 MMP3 Matrix metalloproteinase-1 levels
rs495366 Eye infection, viral 0.0008221 1.544 MMP3 Matrix metalloproteinase-1 levels
rs495366 Corneal edema 0.004206 0.4937 MMP3 Matrix metalloproteinase-1 levels
rs495366 Respiratory complications 0.0007254 1.866 MMP3 Matrix metalloproteinase-1 levels
rs495366 Disorders of adrenal glands 0.01034 1.329 MMP3 Matrix metalloproteinase-1 levels
rs495366 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.005518 1.34 MMP3 Matrix metalloproteinase-1 levels
rs495366 Disorders of other cranial nerves 0.009795 0.7541 MMP3 Matrix metalloproteinase-1 levels
rs495366 Spondylosis and allied disorders 0.008982 0.8936 MMP3 Matrix metalloproteinase-1 levels
rs495366 Nerve plexus lesions 0.009235 0.6427 MMP3 Matrix metalloproteinase-1 levels
rs495366 Chronic pain syndrome 0.004445 1.715 MMP3 Matrix metalloproteinase-1 levels
rs495366 Throat pain 0.003768 1.701 MMP3 Matrix metalloproteinase-1 levels
rs495366 Benign neoplasm of ovary 0.004355 1.61 MMP3 Matrix metalloproteinase-1 levels
rs495366 Voice disturbance 0.005912 1.231 MMP3 Matrix metalloproteinase-1 levels
rs495366 Cholecystitis without cholelithiasis 0.007751 1.32 MMP3 Matrix metalloproteinase-1 levels
rs4959235 Conjunctivitis, noninfectious 0.001777 1.536 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Bronchitis 0.002463 1.324 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Pernicious anemia 0.003072 1.872 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Sensorineural hearing loss 0.007918 1.213 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Intervertebral disc disorder with myelopathy 0.004078 2.306 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Poisoning by analgesics, antipyretics, and antirheumatics 0.006428 1.613 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Influenza 0.001782 1.725 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Asthma 0.004822 1.26 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Osteochondropathies 0.005101 2.448 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4959235 Noninfectious disorders of lymphatic channels 0.01084 1.557 SLC22A23 Antipsychotic-induced QTc interval prolongation (Quetiapine)
rs4964469 Cervicocranial/Cervicobrachial syndrome 0.001704 0.7576 LOC100287944 Parkinson's disease
rs4964469 Hypercholesterolemia 0.008947 1.111 LOC100287944 Parkinson's disease
rs4964469 Posttraumatic wound infection 0.002149 1.927 LOC100287944 Parkinson's disease
rs4964469 Noninflammatory disorders of vagina 0.005035 0.72 LOC100287944 Parkinson's disease
rs4964469 Aneurysm of artery of lower extremity 0.002403 1.619 LOC100287944 Parkinson's disease
rs4964469 Paranoid disorders 0.006146 1.802 LOC100287944 Parkinson's disease
rs4964469 Other specified diseases of the salivary glands 0.005088 0.5304 LOC100287944 Parkinson's disease
rs4964469 Acute posthemorrhagic anemia 0.001227 1.207 LOC100287944 Parkinson's disease
rs4964469 Pneumonia 0.01017 0.9061 LOC100287944 Parkinson's disease
rs4964469 Seborrhea 0.00669 0.4695 LOC100287944 Parkinson's disease
rs4964469 Gouty arthropathy 0.004227 1.321 LOC100287944 Parkinson's disease
rs4964469 Otorrhea 0.004143 0.4293 LOC100287944 Parkinson's disease
rs4964469 Noninflammatory female genital disorders 0.003741 0.8237 LOC100287944 Parkinson's disease
rs4964469 Abnormal findings on exam of gastrointestinal tract/abdominal area 0.01066 0.7451 LOC100287944 Parkinson's disease
rs4977574 Type 2 diabetic nephropathy 0.0003253 1.296 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Other forms of chronic heart disease 0.001179 1.236 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cerebrovascular disease 0.00161 1.111 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Costochondritis 0.002352 0.4994 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cardiac dysrhythmias 0.004224 1.09 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Type 1 diabetic ketoacidosis 0.005221 1.435 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Myocardial infarction 4.003e-08 1.28 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Abdominal aortic aneurysm 0.001384 1.289 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Hemorrhoids 0.0005759 0.8736 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Central/nonobstroctive sleep apnea 0.005889 1.681 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Ill-defined descriptions and complications of heart disease 0.001024 1.137 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Hypotension 0.001051 1.162 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cardiac conduction disorders 0.002514 1.126 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Abnormal electrocardiogram 0.004546 1.154 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Angina pectoris 4.924e-05 1.203 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Disorders of penis 0.007013 0.7483 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Polyneuropathy in diabetes 0.0002201 1.273 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Atrial flutter 0.01122 1.209 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Chronic ischemic heart disease 7.667e-06 1.239 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cystitis and urethritis 0.009029 1.197 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Occlusion and stenosis of precerebral arteries 5.597e-05 1.205 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Ventricular fibrillation & flutter 0.007578 1.612 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Other infectious diseases 0.005661 1.773 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Aortic aneurysm 0.008855 1.197 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Ulcerative colitis 0.008605 0.6942 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Symptoms involving cardiovascular system 0.006124 1.158 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Primary thrombocytopenia 0.009887 0.6255 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Type 2 diabetic peripheral circulatory disorders 0.004353 1.408 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Pseudomonal pneumonia 0.009758 0.4471 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Nephritis; nephrosis; renal sclerosis 0.002849 1.249 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cardiac complications, not elsewhere classified 0.002296 1.433 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.003054 1.196 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Coronary atherosclerosis 1.002e-12 1.258 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Hypotension NOS 0.002286 1.207 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cardiac arrest & ventricular fibrillation 0.005456 1.421 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Neurological disorders due to brain damage 0.005108 1.138 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Acne 0.003665 0.764 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Paraproteinemia 0.007277 0.7271 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Symptoms involving digestive system 0.00818 0.8235 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Acute, but ill-defined cerebrovascular disease 0.007128 1.19 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Unstable angina (intermediate coronary syndrome) 2.164e-09 1.396 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Other aneurysm 0.003168 1.201 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 stress incontinence, female 0.007042 0.8469 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Type 2 diabetic neuropathy 0.003474 1.191 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Renal failure NOS 0.005621 1.336 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cardiac pacemaker/device in situ 0.007091 1.204 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Ischemic Heart Disease 6.335e-10 1.207 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Mild cognitive impairment 0.01135 1.613 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4977574 Cystitis 0.008031 1.214 CDKN2B-AS1 Early onset myocardial infarction, Coronary heart disease
rs4979906 Respiratory failure; insufficiency; arrest 0.002749 1.255 KCNMA1 Mortality among heart failure patients
rs4979906 Hemorrhage NOS 0.008112 1.73 KCNMA1 Mortality among heart failure patients
rs4979906 Pain in limb 0.01123 1.104 KCNMA1 Mortality among heart failure patients
rs4979906 Heartburn 0.01148 1.421 KCNMA1 Mortality among heart failure patients
rs4979906 Respiratory failure 0.0005051 1.414 KCNMA1 Mortality among heart failure patients
rs4979906 Prostate cancer 0.01065 1.214 KCNMA1 Mortality among heart failure patients
rs4979906 Neck pain 0.005454 1.128 KCNMA1 Mortality among heart failure patients
rs4979906 Otosclerosis 0.0009807 0.4521 KCNMA1 Mortality among heart failure patients
rs4979906 Retinal disorders 0.009923 1.134 KCNMA1 Mortality among heart failure patients
rs4979906 Optic neuritis/neuropathy 0.005318 1.426 KCNMA1 Mortality among heart failure patients
rs4979906 Anemia in neoplastic disease 0.01141 0.6212 KCNMA1 Mortality among heart failure patients
rs4979906 Osteopenia 0.001966 1.182 KCNMA1 Mortality among heart failure patients
rs4979906 Coronary atherosclerosis 0.008337 1.112 KCNMA1 Mortality among heart failure patients
rs4979906 Arthropathy NOS involving multiple sites 0.000336 1.942 KCNMA1 Mortality among heart failure patients
rs4979906 Respiratory insufficiency 0.001798 1.405 KCNMA1 Mortality among heart failure patients
rs4979906 Viral hepatitis C 0.01005 1.542 KCNMA1 Mortality among heart failure patients
rs4979906 Osteoporosis, osteopenia, & pathological fractures 0.004714 1.129 KCNMA1 Mortality among heart failure patients
rs4986172 Poisoning by anticonvulsants and anti-Parkinsonism drugs 0.00543 1.831 ACBD4 Height
rs4986172 Dementias 0.002335 0.8445 ACBD4 Height
rs4986172 Hyperventilation 0.001595 0.4617 ACBD4 Height
rs4986172 Optic neuritis/neuropathy 0.005076 1.362 ACBD4 Height
rs4986172 Gout and other crystal arthropathies 0.0004108 1.2 ACBD4 Height
rs4986172 Aneurysm of artery of lower extremity 0.006454 1.554 ACBD4 Height
rs4986172 Abnormal results of function study of liver 0.006834 1.219 ACBD4 Height
rs4986172 Lichen 0.005842 0.6161 ACBD4 Height
rs4986172 Unequal leg length (acquired) 0.0108 1.434 ACBD4 Height
rs4986172 Substance addiction and disorders 0.007527 1.285 ACBD4 Height
rs4986172 Essential tremor 0.009729 0.7598 ACBD4 Height
rs4986172 Respiratory abnormalities 0.005016 0.7305 ACBD4 Height
rs4986172 Random mental disorder. Ignored for now 0.009228 1.498 ACBD4 Height
rs4986172 Cystic mastopathy 0.007459 0.8523 ACBD4 Height
rs4986172 Alzheimer's disease 0.004731 0.8319 ACBD4 Height
rs4986172 Ankylosis of joint 0.01072 1.402 ACBD4 Height
rs4986172 Vascular dementia 0.005272 0.6933 ACBD4 Height
rs4986172 Mitral stenosis/insufficiency 0.009819 0.4939 ACBD4 Height
rs4986172 Joint effusions 0.006893 1.224 ACBD4 Height
rs4986172 Gout 0.0002388 1.225 ACBD4 Height
rs4986172 Gastritis and duodenitis 0.006877 1.146 ACBD4 Height
rs4986172 Elevated blood pressure reading 0.009968 1.141 ACBD4 Height
rs499697 Symptoms and disorders of the joints 0.0002037 0.8404 LCE3E Hair morphology
rs499697 Decreased libido 0.009028 0.3864 LCE3E Hair morphology
rs499697 Fracture of foot 0.00295 0.787 LCE3E Hair morphology
rs499697 Temporomandibular joint disorder NOS 0.005193 0.53 LCE3E Hair morphology
rs499697 Herpes zoster 0.007064 0.8217 LCE3E Hair morphology
rs499697 Known or suspected fetal abnormality 0.005684 0.5193 LCE3E Hair morphology
rs499697 Paralysis/spasm of vocal cords or larynx 0.003228 1.655 LCE3E Hair morphology
rs499697 H. pylori 0.0003308 1.743 LCE3E Hair morphology
rs499697 Acquired spondylolisthesis 0.003311 1.351 LCE3E Hair morphology
rs499697 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.00119 0.6756 LCE3E Hair morphology
rs499697 Cervical cancer and dysplasia 0.006046 0.74 LCE3E Hair morphology
rs499697 Stiffness of joint 0.00508 0.8043 LCE3E Hair morphology
rs499697 Abnormal Papanicolaou smear of cervix and cervical HPV 0.01126 0.8036 LCE3E Hair morphology
rs499697 Amblyopia 0.002468 0.6665 LCE3E Hair morphology
rs5015480 Poisoning by primarily systemic agents 0.003448 0.7383 HHEX Type 2 diabetes
rs5015480 Diabetes mellitus 0.0006201 0.8993 HHEX Type 2 diabetes
rs5015480 Peripheral enthesopathies 0.007593 0.9153 HHEX Type 2 diabetes
rs5015480 Hypercholesterolemia 0.004465 0.8917 HHEX Type 2 diabetes
rs5015480 Lipoid metabolism disorder NOS 3.396e-05 0.6934 HHEX Type 2 diabetes
rs5015480 Renal failure 0.004645 0.9009 HHEX Type 2 diabetes
rs5015480 Postlaminectomy syndrome 0.009516 1.373 HHEX Type 2 diabetes
rs5015480 Type 2 diabetic retinopathy 0.0002704 0.7756 HHEX Type 2 diabetes
rs5015480 Type 2 diabetes 0.0004393 0.8955 HHEX Type 2 diabetes
rs5015480 Enthesopathy 0.005141 0.8917 HHEX Type 2 diabetes
rs5015480 Type 1 diabetic retinopathy 0.004661 0.682 HHEX Type 2 diabetes
rs5015480 Disorders of parathyroid gland 0.001433 0.7308 HHEX Type 2 diabetes
rs5015480 Hyperlipidemia 0.006061 0.9138 HHEX Type 2 diabetes
rs5015480 Epiphora 0.01118 1.347 HHEX Type 2 diabetes
rs5015480 Hyperparathyroidism 0.001488 0.7217 HHEX Type 2 diabetes
rs5015480 Intervertebral disc disorders 0.005254 1.103 HHEX Type 2 diabetes
rs5015480 Diabetic retinopathy 0.001266 0.8063 HHEX Type 2 diabetes
rs5015480 Chronic glomerulonephritis 0.00962 2.073 HHEX Type 2 diabetes
rs5015480 Type 1 diabetes 0.0006206 0.8098 HHEX Type 2 diabetes
rs5015480 Back pain 0.004757 1.087 HHEX Type 2 diabetes
rs5015480 Disorders of lipoid metabolism 0.004905 0.9124 HHEX Type 2 diabetes
rs5015480 Type 2 diabetic ketoacidosis 0.0005544 0.8476 HHEX Type 2 diabetes
rs5015480 Diseases of nail 0.008335 0.8725 HHEX Type 2 diabetes
rs5015480 Adverse effects of antineoplastic and immunosuppressive drugs 0.001289 0.7078 HHEX Type 2 diabetes
rs5015480 Glomerulonephritis 0.007899 1.624 HHEX Type 2 diabetes
rs5015480 Type 2 diabetic neuropathy 0.001707 0.826 HHEX Type 2 diabetes
rs5015480 Superficial cellulitis and abscess 0.008787 0.9126 HHEX Type 2 diabetes
rs5015480 Other specified diseases of nail 0.003006 0.8539 HHEX Type 2 diabetes
rs5031002 Cornea replaced by transplant 0.008677 3.24 AR LDL Cholesterol
rs5031002 Fluid overload 0.001472 2.15 AR LDL Cholesterol
rs5031002 Altered mental status 0.009851 1.959 AR LDL Cholesterol
rs5031002 Abnormal findings on study of brain, nervous system 0.007808 2.568 AR LDL Cholesterol
rs5031002 Pneumonitis due to inhalation of food or vomitus 0.004286 2.221 AR LDL Cholesterol
rs5031002 Other acute and subacute forms of ischemic heart disease 0.009918 3.49 AR LDL Cholesterol
rs5031002 Acute pancreatitis 0.0003742 2.291 AR LDL Cholesterol
rs531676 Anticoagulants causing adverse effects 0.006844 1.639 CRTAC1 Type 2 diabetes
rs531676 Endometriosis 0.00896 1.357 CRTAC1 Type 2 diabetes
rs531676 Intestinal infection 0.007695 1.21 CRTAC1 Type 2 diabetes
rs531676 Elevated sedimentation rate 0.01035 0.7359 CRTAC1 Type 2 diabetes
rs531676 Abnormal coagulation profile 0.009595 1.341 CRTAC1 Type 2 diabetes
rs531676 Jaundice 0.006278 0.6803 CRTAC1 Type 2 diabetes
rs531676 Acidosis 0.004528 1.39 CRTAC1 Type 2 diabetes
rs531676 Anxiety, phobic and dissociative disorders 0.009169 1.099 CRTAC1 Type 2 diabetes
rs531676 Schizophrenia 0.002497 1.753 CRTAC1 Type 2 diabetes
rs531676 Anxiety disorder 0.001401 1.141 CRTAC1 Type 2 diabetes
rs531676 Derangement of joint, non-traumatic 0.008039 1.233 CRTAC1 Type 2 diabetes
rs544368 Peritonitis and retroperitoneal infections 0.0005454 1.737 SIAE Bipolar disorder
rs544368 Iron deficiency anemias NOS 0.008096 1.188 SIAE Bipolar disorder
rs544368 Retinal drusen 0.008775 1.337 SIAE Bipolar disorder
rs544368 Bacterial infection NOS 2.454e-05 1.316 SIAE Bipolar disorder
rs544368 Acute renal failure 0.00915 1.221 SIAE Bipolar disorder
rs544368 Lung disease due to external agents 0.0005663 1.97 SIAE Bipolar disorder
rs544368 Late effects of cerebrovascular disease 0.005114 1.263 SIAE Bipolar disorder
rs544368 Tachycardia NOS 0.003218 1.302 SIAE Bipolar disorder
rs544368 Generalized anxiety disorder 0.002687 1.458 SIAE Bipolar disorder
rs544368 Eosinophilia 0.001134 2.248 SIAE Bipolar disorder
rs544368 Open wounds of extremities 0.009457 1.167 SIAE Bipolar disorder
rs544368 Bacteremia 0.0005032 1.54 SIAE Bipolar disorder
rs544368 Phosphorus metabolism disorder 0.006481 1.588 SIAE Bipolar disorder
rs544368 Hepatic cancer 0.00757 1.888 SIAE Bipolar disorder
rs544368 Urinary tract infection 0.00115 1.182 SIAE Bipolar disorder
rs544368 Wheezing 0.00411 1.474 SIAE Bipolar disorder
rs544368 Deficiency of humoral immunity 0.008419 2.266 SIAE Bipolar disorder
rs544368 Fracture of radius and ulna 0.005029 1.275 SIAE Bipolar disorder
rs544368 Other disorders of ear 0.008991 1.384 SIAE Bipolar disorder
rs544368 Atherosclerosis of the extremities 0.009983 1.204 SIAE Bipolar disorder
rs544368 E. coli 3.436e-05 1.72 SIAE Bipolar disorder
rs544368 Nervous system congenital anomalies 0.007459 1.556 SIAE Bipolar disorder
rs544368 Hemiplegia 0.01085 1.432 SIAE Bipolar disorder
rs544368 AV block 0.01148 1.268 SIAE Bipolar disorder
rs544368 Joint/ligament sprain 0.005827 0.6124 SIAE Bipolar disorder
rs544368 Urinary incontinence 0.01128 1.185 SIAE Bipolar disorder
rs544368 Other infectious diseases 0.008885 1.886 SIAE Bipolar disorder
rs544368 Electrolyte imbalance 0.001381 1.178 SIAE Bipolar disorder
rs544368 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.0003512 1.606 SIAE Bipolar disorder
rs544368 Open wound of eye or eyelid 0.00809 2.245 SIAE Bipolar disorder
rs544368 Protein-calorie malnutrition 0.0004058 1.319 SIAE Bipolar disorder
rs544368 Pneumoconiosis 0.01087 2.07 SIAE Bipolar disorder
rs544368 Colles' fracture 0.005223 1.542 SIAE Bipolar disorder
rs544368 Symptoms/disorders of the urinary system 2.405e-05 1.212 SIAE Bipolar disorder
rs544368 Hyperparathyroidism 0.004762 0.6063 SIAE Bipolar disorder
rs544368 Cellulitis and abscess of foot/toes 0.008818 1.383 SIAE Bipolar disorder
rs544368 Mechanical complication due to other implant and internal device 0.004424 1.492 SIAE Bipolar disorder
rs544368 Cellulitis and abscess of arm 0.001151 1.425 SIAE Bipolar disorder
rs5498 Complication of amputation stump 0.003917 1.953 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Hematemesis 0.008849 1.574 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Blood vessel replaced 0.008787 1.532 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Calculus of lower urinary tract 0.01141 0.611 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Disorders of menstruation 0.0009807 0.7988 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Irregular menstrual cycle/bleeding 0.002706 0.8056 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Otosclerosis 0.008949 0.6693 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Congenital anomalies of posterior segment of eye 0.007021 1.291 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Unspecified polyarthropathy or polyarthritis 0.00207 1.595 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Hemorrhage NOS 0.004723 0.5631 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Irregular menstrual cycle 0.002041 0.6936 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Cardiac complications, not elsewhere classified 0.00915 0.7259 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Adverse effects of antirheumatics 0.01104 1.657 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Seborheic dermatitis 0.01065 1.174 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Prostate cancer 0.00928 0.848 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs5498 Phobia 0.001303 2.447 ICAM1 Soluble Intercellular Adhesion Molecule 1
rs603424 Dermatomycoses 0.01013 1.713 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Chronic nonalcoholic liver disease 0.004944 1.303 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Hammer toe 0.0008791 0.7355 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Complications of transplants and reattached limbs 0.004043 1.722 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Hyperlipidemia 0.0008354 1.151 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Chronic liver disease and cirrhosis 0.003667 1.296 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Thyroid cancer 0.01007 1.539 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Hallux valgus (Bunion) 0.006218 0.7933 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Acquired toe deformities 0.0002295 0.7456 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Secondary thrombocytopenia 0.004699 1.748 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Respiratory failure 0.002894 1.36 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Disorders of lipoid metabolism 0.000928 1.149 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Miscarriage; stillbirth 0.01025 1.838 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Torticollis 0.001939 0.426 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Corns and callosities 0.00413 0.8109 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs603424 Cardiac complications, not elsewhere classified 0.001893 1.526 PKD2L1 Phospholipid levels in plasma, Myristate / Myristoleate
rs6051520 Internal derangement of knee 0.008034 1.166 TRIB3 Cognitive performance
rs6051520 Atherosclerosis of the extremities 0.0007311 1.213 TRIB3 Cognitive performance
rs6051520 Esophageal cancer 0.003608 0.3606 TRIB3 Cognitive performance
rs6051520 Congenital cataract and lens anomalies 0.00215 2.165 TRIB3 Cognitive performance
rs6051520 Sarcoidosis 0.007391 1.634 TRIB3 Cognitive performance
rs6051520 Primary/intrinsic cardiomyopathies 0.008734 1.206 TRIB3 Cognitive performance
rs6051520 Atherosclerosis 0.0003399 1.197 TRIB3 Cognitive performance
rs6051520 Bone cancer 0.01132 0.4945 TRIB3 Cognitive performance
rs6051520 Other specified disorders of plasma protein metabolism 0.008994 0.2578 TRIB3 Cognitive performance
rs6051520 Disease of capillaries 0.0002595 1.557 TRIB3 Cognitive performance
rs6051520 Abdominal aortic aneurysm 0.003192 1.306 TRIB3 Cognitive performance
rs6051520 Immunity deficiency 0.004156 1.737 TRIB3 Cognitive performance
rs6051520 Femoral hernia 0.0002623 2.335 TRIB3 Cognitive performance
rs6051520 Aneurysm of artery of lower extremity 0.01065 1.587 TRIB3 Cognitive performance
rs6051520 Arterial embolism and thrombosis 0.006997 1.282 TRIB3 Cognitive performance
rs6051520 Infections involving bone 0.008096 1.285 TRIB3 Cognitive performance
rs6051520 Periostitis 0.001055 2.078 TRIB3 Cognitive performance
rs6051520 Peripheral vascular disease 0.001818 1.159 TRIB3 Cognitive performance
rs6051520 Other aneurysm 0.0005021 1.283 TRIB3 Cognitive performance
rs6051520 Pityriasis 0.008907 2.116 TRIB3 Cognitive performance
rs6051520 Disease of tricuspid valve 0.008716 1.29 TRIB3 Cognitive performance
rs6051520 Aortic aneurysm 0.002314 1.273 TRIB3 Cognitive performance
rs6051520 Disorders of the autonomic nervous system 0.01047 1.322 TRIB3 Cognitive performance
rs6051520 Decreased libido 0.002934 2.16 TRIB3 Cognitive performance
rs6051520 Nevus, non-neoplastic 0.004198 1.774 TRIB3 Cognitive performance
rs6051520 Peripheral arterial disease 0.00153 1.177 TRIB3 Cognitive performance
rs6051520 Ventral hernia 0.004763 1.333 TRIB3 Cognitive performance
rs6051520 Noninflammatory disorders of cervix 0.0008545 1.925 TRIB3 Cognitive performance
rs6080550 Other disorders of eyelids 0.009772 0.8177 LOC100289473 Non-obstructive azoospermia
rs6080550 Atopic or contact dermatitis 0.005153 0.8569 LOC100289473 Non-obstructive azoospermia
rs6080550 Large cell lymphoma 0.00744 2.15 LOC100289473 Non-obstructive azoospermia
rs6080550 Alcoholism 0.003962 0.6864 LOC100289473 Non-obstructive azoospermia
rs6080550 Other specified cardiac dysrhythmias 4.763e-05 0.7437 LOC100289473 Non-obstructive azoospermia
rs6080550 Atrial fibrillation & flutter 0.00771 0.8359 LOC100289473 Non-obstructive azoospermia
rs6080550 AV block 0.01111 0.7724 LOC100289473 Non-obstructive azoospermia
rs6080550 Unstable angina (intermediate coronary syndrome) 0.001429 0.7471 LOC100289473 Non-obstructive azoospermia
rs6080550 Alzheimer's disease 0.005111 1.282 LOC100289473 Non-obstructive azoospermia
rs6080550 Musculoskeletal symptoms referable to limbs 0.007831 0.675 LOC100289473 Non-obstructive azoospermia
rs6080550 Exostosis of jaw 0.0008252 2.652 LOC100289473 Non-obstructive azoospermia
rs6080550 Alcohol-related disorders 0.008517 0.7466 LOC100289473 Non-obstructive azoospermia
rs6080550 Cardiac dysrhythmias 0.0009902 0.8591 LOC100289473 Non-obstructive azoospermia
rs6080550 Atherosclerosis of renal artery 0.007804 0.6526 LOC100289473 Non-obstructive azoospermia
rs6080550 Abnormal electrocardiogram 0.000137 0.7393 LOC100289473 Non-obstructive azoospermia
rs6080550 Atrial fibrillation 0.00804 0.8344 LOC100289473 Non-obstructive azoospermia
rs6080550 Postmenopausal atrophic vaginitis 0.00802 0.7201 LOC100289473 Non-obstructive azoospermia
rs6080550 Atrial flutter 0.0009198 0.6584 LOC100289473 Non-obstructive azoospermia
rs6080550 Cardiac conduction disorders 0.0005179 0.8098 LOC100289473 Non-obstructive azoospermia
rs6080550 Cardiac arrhythmia NOS 0.003137 0.7895 LOC100289473 Non-obstructive azoospermia
rs6080550 Angina pectoris 0.003596 0.8091 LOC100289473 Non-obstructive azoospermia
rs6092477 Insect bite 0.007856 0.7906 RBM38 Mean corpuscular volume
rs6092477 Alcohol-related disorders 0.01132 1.189 RBM38 Mean corpuscular volume
rs6092477 Corneal degenerations 0.01096 1.334 RBM38 Mean corpuscular volume
rs6092477 Other disorders of tympanic membrane 0.003906 1.48 RBM38 Mean corpuscular volume
rs6092477 Swelling, mass, or lump in head and neck 0.007214 0.7943 RBM38 Mean corpuscular volume
rs6092477 Perforation of tympanic membrane 0.00902 1.487 RBM38 Mean corpuscular volume
rs6092477 Functional disorders of bladder 0.002757 0.7165 RBM38 Mean corpuscular volume
rs6092477 Parkinson's disease 0.01079 0.7675 RBM38 Mean corpuscular volume
rs6092477 Dermatophytosis of the body 0.00104 0.6535 RBM38 Mean corpuscular volume
rs6092477 Nevus, non-neoplastic 0.009491 1.617 RBM38 Mean corpuscular volume
rs6092477 Other disorders of bladder 0.0007349 0.8113 RBM38 Mean corpuscular volume
rs6118083 Wheezing and painful respiration 0.002883 0.8425 PLCB1 Cognitive performance
rs6118083 Gastroparesis 0.009523 1.746 PLCB1 Cognitive performance
rs6118083 Other headache syndromes 0.004988 1.133 PLCB1 Cognitive performance
rs6118083 Dislocation 0.004121 1.154 PLCB1 Cognitive performance
rs6118083 Other immunological findings 0.009674 1.361 PLCB1 Cognitive performance
rs6118083 Mitral stenosis/insufficiency 0.005241 0.2757 PLCB1 Cognitive performance
rs6118083 Symptomatic artificial menopause 0.00405 0.548 PLCB1 Cognitive performance
rs6118083 Dyspepsia and disorders of function of stomach 0.000959 1.241 PLCB1 Cognitive performance
rs6118083 Disorders of synovium, tendon, and bursa 0.009084 1.138 PLCB1 Cognitive performance
rs6118083 Other unspecified back disorders 0.01011 1.59 PLCB1 Cognitive performance
rs6118083 Noninfectious disorders of lymphatic channels 0.002318 0.6305 PLCB1 Cognitive performance
rs6118083 Mechanical complication due to other implant and internal device 0.00206 0.6088 PLCB1 Cognitive performance
rs6118083 Testicular hypofunction 0.009762 1.441 PLCB1 Cognitive performance
rs6118083 Pneumoconiosis 0.00407 2.037 PLCB1 Cognitive performance
rs6118083 Eustachian tube disorders 0.0009961 1.363 PLCB1 Cognitive performance
rs6118083 Memory loss 0.002279 1.319 PLCB1 Cognitive performance
rs6118083 Other rheumatic heart disease 0.004107 0.1272 PLCB1 Cognitive performance
rs6118083 Disorders of function of stomach 0.000401 1.247 PLCB1 Cognitive performance
rs613872 Appendiceal conditions 0.0002756 1.664 TCF4 Fuchs's corneal dystrophy
rs613872 Corneal dystrophy 3.156e-05 1.63 TCF4 Fuchs's corneal dystrophy
rs613872 Hemorrhage NOS 0.006209 1.8 TCF4 Fuchs's corneal dystrophy
rs613872 Enthesopathy 0.008243 0.8643 TCF4 Fuchs's corneal dystrophy
rs613872 Umbilical hernia 0.005277 0.694 TCF4 Fuchs's corneal dystrophy
rs613872 Cervical radiculitis 0.006032 0.7927 TCF4 Fuchs's corneal dystrophy
rs613872 Acute appendicitis 6.013e-06 2.045 TCF4 Fuchs's corneal dystrophy
rs613872 Conjunctivitis, infectious 0.00411 0.7999 TCF4 Fuchs's corneal dystrophy
rs613872 Appendicitis 0.0005255 1.647 TCF4 Fuchs's corneal dystrophy
rs613872 Cornea replaced by transplant 0.005965 1.927 TCF4 Fuchs's corneal dystrophy
rs613872 Type 2 diabetic retinopathy 0.007472 0.7743 TCF4 Fuchs's corneal dystrophy
rs613872 Decreased libido 0.005864 2.149 TCF4 Fuchs's corneal dystrophy
rs613872 Poisoning by antibiotics 0.009504 0.786 TCF4 Fuchs's corneal dystrophy
rs613872 Nephritis and nephropathy in diseases classified elsewhere 0.008845 0.6993 TCF4 Fuchs's corneal dystrophy
rs613872 Sialoadenitis 0.008187 1.552 TCF4 Fuchs's corneal dystrophy
rs613872 Open wound of toe(s) 0.003413 1.933 TCF4 Fuchs's corneal dystrophy
rs613872 Subarachnoid hemorrhage 0.003304 2.131 TCF4 Fuchs's corneal dystrophy
rs613872 Corneal edema 0.00704 1.75 TCF4 Fuchs's corneal dystrophy
rs613872 Fuchs' dystrophy 2.891e-09 2.609 TCF4 Fuchs's corneal dystrophy
rs619865 Prostatitis 0.004198 1.511 EIF6 Freckling
rs619865 Iron metabolism disorder 0.002726 2.393 EIF6 Freckling
rs619865 Skin cancer 5.812e-05 1.251 EIF6 Freckling
rs619865 Hyperlipidemia 0.007508 0.8661 EIF6 Freckling
rs619865 Non-melanoma skin cancer 0.0001073 1.254 EIF6 Freckling
rs619865 Osteoarthrosis; localized, secondary 0.01082 1.866 EIF6 Freckling
rs619865 Actinic keratosis 0.000184 1.252 EIF6 Freckling
rs619865 Disorders of lipoid metabolism 0.009332 0.8705 EIF6 Freckling
rs619865 Hypercholesterolemia 0.00325 0.8203 EIF6 Freckling
rs619865 Angina pectoris 0.006075 0.8008 EIF6 Freckling
rs619865 Pancreatic cancer 0.002638 1.84 EIF6 Freckling
rs619865 Other endocrine disorders 0.003666 1.845 EIF6 Freckling
rs619865 Phlebitis and thrombophlebitis 0.006349 0.7099 EIF6 Freckling
rs619865 Cancer of other female genital organs 0.009289 2.15 EIF6 Freckling
rs619865 First degree AV block 0.006132 0.6619 EIF6 Freckling
rs619865 Elevated sedimentation rate 0.00989 1.557 EIF6 Freckling
rs619865 Other dermatoses 0.007435 1.155 EIF6 Freckling
rs6437740 Dermatophytosis 0.00534 0.882 BBX Smoking behavior (cigarettes per day)
rs6437740 Other nonspecific findings on examination of urine 0.006351 0.8034 BBX Smoking behavior (cigarettes per day)
rs6437740 Diseases of nail 0.007003 0.8504 BBX Smoking behavior (cigarettes per day)
rs6437740 Schizophrenia 0.007871 0.4825 BBX Smoking behavior (cigarettes per day)
rs6437740 Fracture of clavicle or scapula 0.001502 0.5831 BBX Smoking behavior (cigarettes per day)
rs6437740 Fracture of unspecified bones 0.01032 0.8489 BBX Smoking behavior (cigarettes per day)
rs6437740 Dermatophytosis / Dermatomycosis 0.006349 0.8868 BBX Smoking behavior (cigarettes per day)
rs6437740 Other specified diseases of nail 0.004193 0.8374 BBX Smoking behavior (cigarettes per day)
rs6437740 Dermatophytosis of nail 0.004883 0.8637 BBX Smoking behavior (cigarettes per day)
rs6437740 Neuralgia, neuritis, and radiculitis NOS 0.002196 0.7685 BBX Smoking behavior (cigarettes per day)
rs6437740 Adverse effects of adrenal cortical steroids 0.007243 1.555 BBX Smoking behavior (cigarettes per day)
rs6457617 Type 1 diabetes 0.001502 1.209 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Hearing loss 0.0004866 1.115 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Keratoderma, acquired 0.01083 1.154 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Rheumatoid arthritis 4.538e-05 1.354 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Lupus erythematosus 0.01132 0.5451 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Congenital anomalies of great vessels 0.008309 0.5043 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Skin cancer 0.00741 1.098 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Diseases of the larynx and vocal cords 0.01132 1.164 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Hyperplasia of prostate 0.007619 1.143 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Systemic lupus erythematosus 0.007172 0.6707 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Adverse effects of insulins and antidiabetic agents 0.0008516 0.4637 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Polymyalgia Rheumatica 0.0001792 1.394 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Photodermatitis & sunburn 0.006967 1.172 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Non-melanoma skin cancer 0.003482 1.114 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Rheumatoid arthritis & related inflammatory polyarthropathies 5.685e-05 1.304 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Infertility, female 0.003302 1.926 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Hyperglyceridemia 0.00644 1.243 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Acute upper respiratory infections 0.003449 1.106 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Male genital disorders 0.002398 1.351 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Celiac disease 0.004203 0.5232 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Hematuria 0.00217 1.131 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Acute sinusitis 0.005204 1.143 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Discoid lupus erythematosus 0.00178 0.6468 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Toxic multinodular goiter 0.008756 1.813 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Psoriasis & related disorders 0.01093 1.214 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Abnormal electrocardiogram 0.01027 1.137 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Hypothyroidism 0.007327 1.1 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Elevated prostate specific antigen 0.007034 1.185 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Celiac or tropical sprue 0.001385 0.4885 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Multiple sclerosis 0.000949 0.5818 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Conjunctivitis, infectious 0.01014 1.157 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Varicose veins 0.01127 0.8779 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs6457617 Sensorineural hearing loss 0.008088 1.103 HLA-DQB1 Graves' disease, Rheumatoid arthritis, Systemic sclerosis
rs646776 Osteoarthrosis, generalized 0.01058 1.236 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Chronic renal failure 0.00481 0.867 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Hypertensive chronic kidney disease 0.008289 0.8062 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Acute reaction to stress 0.009428 1.283 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Renal failure 0.005301 0.8829 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Hypocalcemia 0.003179 1.531 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Hypercholesterolemia 1.043e-07 0.7725 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Hyperlipidemia 1.743e-08 0.8015 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 ASCVD 0.007436 0.6651 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Scar conditions and fibrosis of skin 0.01068 0.7252 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Early or threatened labor; hemorrhage in early pregnancy 0.002246 1.878 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Mixed hyperlipidemia 0.001525 0.7957 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Disorders of lipoid metabolism 1.189e-08 0.8008 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Atherosclerosis 0.002304 0.8527 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Calcium/phosphorus disorders 0.009375 1.218 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.008534 0.8234 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs646776 Unstable angina (intermediate coronary syndrome) 0.009855 0.8371 CELSR2 LDL Cholesterol, Total Cholesterol, Progranulin levels, Early onset myocardial infarction, Response to statin therapy, Coronary heart disease
rs6499188 Bladder cancer 0.01021 0.754 ZFP90 Ulcerative colitis
rs6499188 Secondary malignant neoplasm 0.009313 1.171 ZFP90 Ulcerative colitis
rs6499188 Irregular menstrual cycle/bleeding 0.002074 1.28 ZFP90 Ulcerative colitis
rs6499188 Benign neoplasm of uterus 0.01076 1.225 ZFP90 Ulcerative colitis
rs6499188 Polycystic ovaries 0.00294 2.188 ZFP90 Ulcerative colitis
rs6499188 Acid-base balance disorder 0.005501 0.7072 ZFP90 Ulcerative colitis
rs6499188 Strabismus (not specified as paralytic) 0.01063 1.25 ZFP90 Ulcerative colitis
rs6499188 Pulmonary congestion and hypostasis 0.01002 0.6911 ZFP90 Ulcerative colitis
rs6499188 Other paralytic syndromes 0.003721 0.5599 ZFP90 Ulcerative colitis
rs6499188 Personal history of allergy to medicinal agents 0.00855 1.284 ZFP90 Ulcerative colitis
rs6499188 Malignant neoplasm of kidney and other urinary organs 0.0001476 2.069 ZFP90 Ulcerative colitis
rs6499188 Other nonspecific findings on examination of urine 0.001977 0.7775 ZFP90 Ulcerative colitis
rs6499188 Behcet's syndrome 0.001708 0.5233 ZFP90 Ulcerative colitis
rs6499188 Attention deficit hyperactivity disorder 0.004043 1.743 ZFP90 Ulcerative colitis
rs6499188 Melanoma 0.0003239 1.41 ZFP90 Ulcerative colitis
rs6499188 Bladder cancer and neoplasms 0.009095 0.7572 ZFP90 Ulcerative colitis
rs6499188 Myocardial infarction 0.002462 0.851 ZFP90 Ulcerative colitis
rs6499188 Unstable angina (intermediate coronary syndrome) 0.002252 0.8164 ZFP90 Ulcerative colitis
rs6499188 Subarachnoid hemorrhage 0.008122 1.899 ZFP90 Ulcerative colitis
rs6499188 Disorders of menstruation 0.00216 1.262 ZFP90 Ulcerative colitis
rs6499188 Abnormal findings on examination of urine 0.001066 0.7945 ZFP90 Ulcerative colitis
rs6499188 Uterine leiomyoma 0.003104 1.281 ZFP90 Ulcerative colitis
rs6499640 Gingivitis 0.001483 0.4508 FTO Body mass index, Weight
rs6499640 Aneurysm of iliac artery 0.009358 0.573 FTO Body mass index, Weight
rs6499640 End stage renal disease 0.004562 0.6818 FTO Body mass index, Weight
rs6499640 Frequency of urination and polyuria 0.004099 0.8773 FTO Body mass index, Weight
rs6499640 Non-Hodgkins lymphoma 0.009113 0.7785 FTO Body mass index, Weight
rs6499640 Adverse effects of insulins and antidiabetic agents 0.008263 0.5224 FTO Body mass index, Weight
rs6499640 Shock 0.0005104 0.6315 FTO Body mass index, Weight
rs6499640 Althete's foot 0.009963 1.245 FTO Body mass index, Weight
rs6499640 Abdominal aortic aneurysm 0.004234 0.7921 FTO Body mass index, Weight
rs6499640 Cancer of other lymphoid, histiocytic tissue 0.004358 0.7647 FTO Body mass index, Weight
rs651164 Periostitis 0.006529 1.796 SLC22A1 Prostate cancer
rs651164 Type 2 diabetic peripheral circulatory disorders 0.0001671 0.5877 SLC22A1 Prostate cancer
rs651164 Mixed hyperlipidemia 0.009225 0.8457 SLC22A1 Prostate cancer
rs651164 Other hereditary hemolytic anemias 0.008584 0.3434 SLC22A1 Prostate cancer
rs651164 Type 2 diabetic nephropathy 0.0005723 0.7586 SLC22A1 Prostate cancer
rs651164 Oral aphthae 0.01047 1.596 SLC22A1 Prostate cancer
rs651164 Pain, swelling or discharge of eye 0.00418 1.387 SLC22A1 Prostate cancer
rs651164 Trigeminal nerve disorders 0.0007351 1.589 SLC22A1 Prostate cancer
rs651164 Aneurysm of other specified artery 0.002104 1.969 SLC22A1 Prostate cancer
rs651164 Osteoporosis, osteopenia, & pathological fractures 0.007793 0.9072 SLC22A1 Prostate cancer
rs651164 Vascular insufficiency of intestine 0.01032 0.687 SLC22A1 Prostate cancer
rs651164 Symptoms associated with female genital organs 0.004743 1.208 SLC22A1 Prostate cancer
rs651164 Open wound of lip and mouth 0.0008366 1.938 SLC22A1 Prostate cancer
rs651164 Acquired foot deformities 0.008229 1.124 SLC22A1 Prostate cancer
rs651164 Essential tremor 0.008177 0.7467 SLC22A1 Prostate cancer
rs651164 Keloid scar 0.000513 1.883 SLC22A1 Prostate cancer
rs651164 Peripheral angiopathy in diseases classified elsewhere 0.004579 0.5337 SLC22A1 Prostate cancer
rs6511720 Other arthropathies 0.004869 1.193 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Cardiac arrhythmia NOS 0.007568 1.237 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Diseases of white blood cells 0.01138 1.263 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Allergy/adverse effect of penicillin 0.003232 1.4 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Congenital musculoskeletal anomalies 0.0002646 3.172 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Mechanical complications of cardiac/vascular device, implant, and graft 0.004911 0.6592 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Mixed hyperlipidemia 0.00471 0.7639 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Retinal edema and hypertensive retinopathy 0.004468 1.495 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Pain in limb 0.001092 1.174 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Diverticulitis 0.004986 1.37 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Other peripheral nerve disorders 0.00484 1.17 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Hyperlipidemia 6.739e-06 0.7948 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Hypercholesterolemia 2.492e-06 0.7387 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Diseases of the jaws 0.006082 0.7238 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Corneal edema 0.008885 0.2643 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Abnormal results of function studies 0.01072 1.814 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Disorders of lipoid metabolism 4.148e-06 0.7919 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Allergy to serum or vaccine 0.0002801 2.505 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Reflux esophagitis 0.01018 1.31 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Poisoning by antibiotics 0.002142 1.368 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs6511720 Temporomandibular joint disorders 0.002623 0.59 LDLR Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Carotid plaque
rs652889 Hemorrhage or hematoma complicating a procedure 0.003932 1.241 PTPRG QT interval
rs652889 Symptoms involving cardiovascular system 0.007493 1.166 PTPRG QT interval
rs652889 Atrial fibrillation 0.003374 1.152 PTPRG QT interval
rs652889 Pyogenic granuloma 0.009351 0.4662 PTPRG QT interval
rs652889 Palpitations 0.01052 1.136 PTPRG QT interval
rs652889 Dyshidrosis 0.005466 0.533 PTPRG QT interval
rs652889 Cerebral edema and compression of brain 0.001437 2.054 PTPRG QT interval
rs652889 Allergies, other 0.009609 0.7825 PTPRG QT interval
rs652889 Other specified cardiac dysrhythmias 0.003315 1.156 PTPRG QT interval
rs652889 Atrial fibrillation & flutter 0.007333 1.136 PTPRG QT interval
rs652889 Disorders of optic nerve and visual pathways 0.009887 0.7785 PTPRG QT interval
rs652889 Cellulitis and abscess of arm 0.0009428 0.7298 PTPRG QT interval
rs652889 Arthropathy associated with neurological disorders 0.005681 1.865 PTPRG QT interval
rs652889 Cholecystitis without cholelithiasis 0.002191 1.356 PTPRG QT interval
rs652889 Cardiac dysrhythmias 0.00764 1.091 PTPRG QT interval
rs652889 Hyperventilation 0.009978 1.656 PTPRG QT interval
rs652889 Other disorders of metabolism 0.0004326 0.4359 PTPRG QT interval
rs652889 Optic neuritis/neuropathy 0.009147 0.7196 PTPRG QT interval
rs653178 Myocardial infarction 0.0004842 1.169 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.01043 1.279 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Peyronie's disease 0.01148 1.772 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Open wound of finger(s) 0.008721 0.8589 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Arterial embolism and thrombosis 0.003545 1.261 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Acute bronchospasm 0.008823 0.4516 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Atherosclerosis 0.001768 1.142 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.001173 1.214 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Hypothyroidism 4.031e-06 1.18 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Peripheral vascular disease 0.01039 1.109 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Osteoporosis 0.007409 1.129 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Atherosclerosis of the extremities 0.002111 1.16 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Cancer of the upper aerodigestive tract 0.005419 0.7174 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Retinoschisis and retinal cysts 0.004073 2.223 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Mechanical complications of cardiac/vascular device, implant, and graft 0.006289 1.241 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Other disorders of gallbladder 0.001089 0.5639 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Hypertension 0.007377 1.083 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Peripheral arterial disease 0.006118 1.128 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Osteoporosis, NOS or other 0.005962 1.129 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Other rheumatic heart disease 0.005799 2.053 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Coronary atherosclerosis 0.006311 1.091 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Essential hypertension 0.006539 1.084 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Uterine leiomyoma 0.006187 0.8137 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Morbid obesity 0.01029 0.8655 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Ischemic Heart Disease 0.008778 1.082 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Disease of tricuspid valve 0.008312 1.247 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Endometriosis 0.003504 0.7128 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Atherosclerosis of renal artery 0.009476 1.275 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Mastodynia 0.01011 1.256 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Ventricular fibrillation & flutter 0.008967 0.6252 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Abnormal findings on mammogram or breast exam 0.006219 1.123 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Anomalies of tooth position/malocclusion 0.00667 0.5976 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Aortic aneurysm 0.01004 1.191 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Other congenital anomalies of skin 0.004834 1.457 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs653178 Benign neoplasm of uterus 0.001757 0.8004 ATXN2 Celiac disease, Celiac disease or Rheumatoid arthritis, Serum cystatin C, Diastolic blood pressure, Mean Arterial Pressure
rs6544713 Calculus of bile duct 0.007952 0.7138 ABCG8 LDL Cholesterol
rs6544713 Balanoposthitis 0.009255 1.644 ABCG8 LDL Cholesterol
rs6544713 pulmonary heart disease 0.009898 0.8573 ABCG8 LDL Cholesterol
rs6544713 Pulmonary embolism and infarction 0.001559 0.7445 ABCG8 LDL Cholesterol
rs6544713 Cholelithiasis 0.00023 0.8242 ABCG8 LDL Cholesterol
rs6544713 Cancer within the respiratory system 0.006127 0.7864 ABCG8 LDL Cholesterol
rs6544713 Lung cancer 0.00462 0.7766 ABCG8 LDL Cholesterol
rs6544713 Cholelithiasis and cholecystitis 8.515e-05 0.8245 ABCG8 LDL Cholesterol
rs6544713 Fracture of hand or wrist 0.004027 1.193 ABCG8 LDL Cholesterol
rs6544713 Hyperlipidemia 0.008437 1.096 ABCG8 LDL Cholesterol
rs6544713 Constipation 0.006136 0.8679 ABCG8 LDL Cholesterol
rs6544713 Meniere's disease 0.008345 1.614 ABCG8 LDL Cholesterol
rs6544713 Contracture of joint 0.001021 1.503 ABCG8 LDL Cholesterol
rs6544713 Cellulitis and abscess of hand/fingers 0.005621 0.824 ABCG8 LDL Cholesterol
rs6544713 Cholelithiasis with other cholecystitis 0.000489 0.6853 ABCG8 LDL Cholesterol
rs6544713 Diseases of the oral soft tissues 0.009239 0.8498 ABCG8 LDL Cholesterol
rs6544713 Malunion fracture 0.0003264 1.601 ABCG8 LDL Cholesterol
rs6544713 Mammographic microcalcification 0.004132 0.5645 ABCG8 LDL Cholesterol
rs6544713 Phobia 0.004104 0.3306 ABCG8 LDL Cholesterol
rs6544713 Secondary malignant neoplasm 0.000967 0.8205 ABCG8 LDL Cholesterol
rs6544713 Disorders of lipoid metabolism 0.0068 1.098 ABCG8 LDL Cholesterol
rs6554809 Other specified intestinal malabsorption 0.004232 1.883 DNAH5 IgE grass sensitization
rs6554809 Pityriasis 0.01043 2.218 DNAH5 IgE grass sensitization
rs6554809 Type 2 diabetic ketoacidosis 0.004451 0.8266 DNAH5 IgE grass sensitization
rs6554809 Hyperpotassemia 0.01083 0.7875 DNAH5 IgE grass sensitization
rs6554809 Other disorders of eye 0.01017 1.151 DNAH5 IgE grass sensitization
rs6554809 Joint/ligament sprain 0.008877 1.397 DNAH5 IgE grass sensitization
rs6554809 Paralytic strabismus 0.00326 1.674 DNAH5 IgE grass sensitization
rs6554809 Gross hematuria 0.01083 1.66 DNAH5 IgE grass sensitization
rs6554809 Diabetes mellitus 0.008727 0.8957 DNAH5 IgE grass sensitization
rs6554809 Asthma 0.004919 1.169 DNAH5 IgE grass sensitization
rs6554809 Type 2 diabetes 0.007661 0.8927 DNAH5 IgE grass sensitization
rs6554809 Disorders of vitreous body 0.005403 1.179 DNAH5 IgE grass sensitization
rs6554809 Acute posthemorrhagic anemia 0.008646 0.7993 DNAH5 IgE grass sensitization
rs6554809 Myeloid leukemia 0.005969 1.973 DNAH5 IgE grass sensitization
rs6563943 Lower gastrointestinal congenital anomalies 0.003741 0.4478 CDH13 Height
rs6563943 Atrophic gastritis 0.006521 0.6493 CDH13 Height
rs6563943 Systemic sclerosis 0.01035 0.643 CDH13 Height
rs6563943 Macular degeneration, wet 0.01066 0.7537 CDH13 Height
rs6563943 Other disorders of back 0.007407 0.8597 CDH13 Height
rs6563943 Viral pneumonia 0.001407 2.329 CDH13 Height
rs6563943 Secondary malignancy of lymph nodes 0.005906 0.7797 CDH13 Height
rs6563943 Elevated levels of transaminase or lactic acid dehydrogenase 0.008892 0.8336 CDH13 Height
rs6563943 Other arthropathies 0.002388 0.8786 CDH13 Height
rs6563943 Arthropathy NOS 0.004595 0.8331 CDH13 Height
rs6563943 Retinal drusen 0.004668 0.8002 CDH13 Height
rs6563943 Abnormal findings on radiological exam of musculoskeletal system 0.003352 1.635 CDH13 Height
rs6563943 Anal and rectal polyp 0.008132 1.24 CDH13 Height
rs6563943 Muscle/tendon sprain 0.005316 1.92 CDH13 Height
rs6563943 Macular degeneration, dry 0.004267 0.7992 CDH13 Height
rs6563943 Other hemoglobinopathies 0.008114 1.93 CDH13 Height
rs6563943 Other specified gastritis 0.007105 0.7793 CDH13 Height
rs6563943 Other disorders of biliary tract 0.002577 0.5965 CDH13 Height
rs6564851 Retinal detachments and defects 0.01009 1.209 BCMO1 Beta-carotene
rs6564851 Primary pulmonary hypertension 0.003216 0.6034 BCMO1 Beta-carotene
rs6564851 Scar conditions and fibrosis of skin 0.01128 0.782 BCMO1 Beta-carotene
rs6564851 Anemia NOS 0.009826 1.088 BCMO1 Beta-carotene
rs6564851 Hypertrophy of breast (Gynecomastia) 0.0109 0.7523 BCMO1 Beta-carotene
rs6564851 Peripheral autonomic neuropathy 0.009576 1.36 BCMO1 Beta-carotene
rs6564851 Bronchopneumonia and lung abscess 0.003982 0.542 BCMO1 Beta-carotene
rs6564851 Angina pectoris 0.002601 1.144 BCMO1 Beta-carotene
rs6564851 Pyogenic granuloma 0.006405 0.537 BCMO1 Beta-carotene
rs6564851 Other local infections of skin and subcutaneous tissue 0.008236 0.8592 BCMO1 Beta-carotene
rs6564851 Chronic glomerulonephritis 0.002148 0.38 BCMO1 Beta-carotene
rs6564851 Cerebral edema and compression of brain 0.005651 0.5119 BCMO1 Beta-carotene
rs6564851 Alcohol-related disorders 0.007935 1.186 BCMO1 Beta-carotene
rs6564851 Thyroiditis 0.005146 0.7347 BCMO1 Beta-carotene
rs6585827 Hypercholesterolemia 0.003578 1.121 PLEKHA1 Height
rs6585827 Congenital anomalies of lower limb, including pelvic girdle 0.01006 0.5674 PLEKHA1 Height
rs6585827 Genu valgum or varum (acquired) 0.006065 0.7003 PLEKHA1 Height
rs6585827 Mastodynia 0.007775 1.262 PLEKHA1 Height
rs6585827 Arterial embolism and thrombosis 0.001841 0.7798 PLEKHA1 Height
rs6585827 Other specified osteoporosis 0.005426 1.66 PLEKHA1 Height
rs6585827 Blister 0.005723 0.5357 PLEKHA1 Height
rs6585827 Blood vessel replaced 0.006269 0.6306 PLEKHA1 Height
rs6585827 Macular degeneration 0.008794 1.121 PLEKHA1 Height
rs6585827 Acne 0.003513 1.304 PLEKHA1 Height
rs6585827 Age-related macular degeneration 5.279e-05 1.302 PLEKHA1 Height
rs6585827 Macular degeneration, wet 4.062e-06 1.621 PLEKHA1 Height
rs6585827 Cataract 0.003069 1.116 PLEKHA1 Height
rs6585827 Benign neoplasm of other endocrine glands 0.003487 1.441 PLEKHA1 Height
rs6585827 Rheumatoid arthritis 2.319e-05 1.362 PLEKHA1 Height
rs6585827 Rheumatoid arthritis & related inflammatory polyarthropathies 2.102e-05 1.317 PLEKHA1 Height
rs6585827 Symptoms involving respiratory system 0.003524 1.218 PLEKHA1 Height
rs6585827 Arterial embolism and thrombosis of lower extremity artery 0.01062 0.7535 PLEKHA1 Height
rs6585827 Paraproteinemia 0.005943 1.374 PLEKHA1 Height
rs6585827 Corneal dystrophy 0.0005382 1.385 PLEKHA1 Height
rs6585827 Extrapyramidal disease and abnormal movement disorders 0.006973 1.178 PLEKHA1 Height
rs6585827 Aphakia and other disorders of lens 0.007296 1.283 PLEKHA1 Height
rs6585827 Type 1 diabetic ketoacidosis 0.006401 0.7041 PLEKHA1 Height
rs6585827 Asthma 0.009977 1.115 PLEKHA1 Height
rs6585827 Contracture of joint 0.004106 0.7017 PLEKHA1 Height
rs6585827 Essential tremor 0.001274 1.367 PLEKHA1 Height
rs6586282 Suppurative and unspecified otitis media 0.01135 1.197 CBS Homocysteine levels
rs6586282 Disease of tricuspid valve 0.01096 1.303 CBS Homocysteine levels
rs6586282 Noninflammatory disorders of vagina 0.007844 0.6375 CBS Homocysteine levels
rs6586282 Pyogenic arthritis 0.0009896 1.959 CBS Homocysteine levels
rs6586282 Mitral stenosis/insufficiency 0.001313 2.171 CBS Homocysteine levels
rs6586282 Keratitis 0.005564 0.6693 CBS Homocysteine levels
rs6586282 Dyspareunia 0.00353 0.3897 CBS Homocysteine levels
rs6586282 Prurigo 0.0068 1.355 CBS Homocysteine levels
rs6586282 Disorders of optic nerve and visual pathways 0.002614 0.6948 CBS Homocysteine levels
rs6586282 Optic neuritis/neuropathy 0.0009179 0.5844 CBS Homocysteine levels
rs6586282 Lichen 0.009038 1.601 CBS Homocysteine levels
rs6586282 Visual disturbances 2.3e-06 0.7697 CBS Homocysteine levels
rs6586282 Thyrotoxicosis 0.01079 1.275 CBS Homocysteine levels
rs6586282 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.007723 0.4586 CBS Homocysteine levels
rs6586282 Benign neoplasm of eye 0.006038 1.307 CBS Homocysteine levels
rs6586282 Prolapse of vaginal vault after hysterectomy 0.0003611 1.772 CBS Homocysteine levels
rs6586282 Aseptic necrosis of bone 0.008398 1.625 CBS Homocysteine levels
rs6586282 Chronic rheumatic disease of the heart valves 0.009085 1.194 CBS Homocysteine levels
rs6586282 Subjective visual disturbances 0.006147 0.764 CBS Homocysteine levels
rs6586282 Disturbances in tooth eruption 0.01001 0.6688 CBS Homocysteine levels
rs6586282 Lung involvement in conditions classified elsewhere 0.009123 2.094 CBS Homocysteine levels
rs6586282 Diseases of hard tissues of teeth 0.007596 0.788 CBS Homocysteine levels
rs660895 Conjunctivitis, infectious 0.0008296 1.259 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Other specified osteoporosis 0.003603 1.775 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Osteoarthrosis 0.002339 1.12 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Polyneuropathy in diabetes 0.0006278 1.296 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Disorders of fluid, electrolyte, and acid-base balance 0.009419 1.104 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Obstructive chronic bronchitis 0.005075 1.265 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Giant cell arteritis 6.323e-05 1.938 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Acquired deformities of ankle and foot 0.004676 1.287 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Anorexia 0.004712 1.437 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Abnormal findings examination of lungs 0.01091 1.194 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Varicose veins of lower extremity 0.006941 0.8282 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Intracerebral hemorrhage 0.007255 1.663 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Astigmatism 0.004691 1.179 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Polyarteritis nodosa and allied conditions 3.138e-05 1.639 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Pneumonia 0.000586 1.172 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Ulceration of intestine 0.003497 1.784 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Other headache syndromes 0.006336 1.127 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Bronchiectasis 0.002064 1.518 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Benign neoplasm of ovary 0.009989 0.5241 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Adverse effects of cardiac rhythm regulators 0.002911 1.951 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Type 2 diabetes 0.0006831 1.138 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Pseudomonal pneumonia 0.003345 2.393 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Congenital anomalies of posterior segment of eye 0.006511 1.349 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Diabetes mellitus 0.0006937 1.136 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Other diseases of lung 0.005994 1.162 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Viral pneumonia 0.0002655 2.728 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Glaucoma 0.003159 1.159 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Adverse effects of antirheumatics 0.005946 1.784 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Type 1 diabetes nephropathy 1.683e-05 2.228 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Infection of the eye 0.001789 1.215 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Chronic bronchitis 0.001559 1.27 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Hearing loss 0.003982 1.118 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Personal history of allergy to medicinal agents 0.007833 1.31 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Atopic or contact dermatitis 0.00366 1.137 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Varicose veins 0.007921 0.8373 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Gastroparesis 0.00193 1.911 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Sepsis 0.006638 1.32 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Toxic effect of venom 0.005457 0.5076 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Unspecified polyarthropathy or polyarthritis 0.006699 1.578 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Eustachian tube disorders 0.006702 0.7379 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Sepsis and SIRS 0.005311 1.316 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Miscarriage; stillbirth 0.008095 1.864 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Diseases of white blood cells 0.001953 1.255 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Inflammation of the eye 0.003554 1.158 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Rheumatoid arthritis 6.658e-08 1.561 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Voice disturbance 0.003952 1.271 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Type 1 diabetes 7.123e-08 1.444 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Type 1 diabetic neuropathy 2.578e-06 1.942 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Insomnia 0.004326 1.208 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Diseases of the larynx and vocal cords 0.004086 1.231 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Shock 0.0009537 1.554 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Rheumatoid arthritis & related inflammatory polyarthropathies 4.672e-08 1.501 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Type 1 diabetic ketoacidosis 3.648e-09 2.217 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Disorders of refraction and accommodation 0.004377 1.136 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Visual field defects 0.0008717 1.403 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Abnormal electrocardiogram 0.002376 1.206 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Arteritis NOS 0.002978 1.715 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs660895 Nasal polyps 0.0009302 1.498 HLA-DRB1 IgA nephropathy, Rheumatoid arthritis (anti-CCP+)
rs6610953 Nausea and vomiting 0.007462 1.154 FUNDC1 Personality dimensions
rs6610953 Other specified diseases of the salivary glands 0.01011 1.925 FUNDC1 Personality dimensions
rs6610953 Phosphorus metabolism disorder 0.007641 1.633 FUNDC1 Personality dimensions
rs6610953 Cramp of limb 0.003626 1.467 FUNDC1 Personality dimensions
rs6610953 Pneumonitis due to inhalation of food or vomitus 0.005377 1.504 FUNDC1 Personality dimensions
rs6610953 Cancer of other female genital organs 0.003678 2.13 FUNDC1 Personality dimensions
rs6610953 Carcinoma in situ of skin 6.656e-05 1.568 FUNDC1 Personality dimensions
rs6610953 Inflammatory conditions of jaw 0.01124 1.736 FUNDC1 Personality dimensions
rs6610953 Menopausal & postmenopausal disorders 0.009685 1.167 FUNDC1 Personality dimensions
rs6610953 Disorders of mineral metabolism 0.002257 1.238 FUNDC1 Personality dimensions
rs6610953 Calcium/phosphorus disorders 0.001798 1.341 FUNDC1 Personality dimensions
rs6610953 Other specified osteoporosis 0.009632 1.802 FUNDC1 Personality dimensions
rs6610953 Intestinal obstruction without mention of hernia 0.007758 1.283 FUNDC1 Personality dimensions
rs6610953 Fracture of vertebral column without mention of spinal cord injury 0.007304 1.316 FUNDC1 Personality dimensions
rs6610953 Otosclerosis 0.00247 1.784 FUNDC1 Personality dimensions
rs6610953 Endometriosis 0.005403 1.497 FUNDC1 Personality dimensions
rs6610953 Pseudomonal pneumonia 7.751e-05 4.133 FUNDC1 Personality dimensions
rs6611365 Unstable angina (intermediate coronary syndrome) 0.001808 1.272 ZNF157 Optic disc parameters
rs6611365 Peritoneal adhesions (postoperative) (postinfection) 0.006202 0.4576 ZNF157 Optic disc parameters
rs6611365 Dysmenorrhea 0.009179 0.5865 ZNF157 Optic disc parameters
rs6611365 Otorrhea 0.002066 2.381 ZNF157 Optic disc parameters
rs6611365 Benign neoplasm of colon 0.008087 0.8846 ZNF157 Optic disc parameters
rs6611365 Stricture of artery 0.01119 0.6749 ZNF157 Optic disc parameters
rs6611365 Uterine/Uterovaginal prolapse 0.007443 0.7221 ZNF157 Optic disc parameters
rs6611365 Open wound of lip and mouth 0.00651 0.2818 ZNF157 Optic disc parameters
rs6611365 Respiratory failure 0.004656 0.6734 ZNF157 Optic disc parameters
rs6611365 Seborrhea 0.005513 2.098 ZNF157 Optic disc parameters
rs6708166 Viral pneumonia 0.008753 2.018 LBH Factor VIII activity
rs6708166 Other hypertrophic and atrophic conditions of skin 4.908e-06 0.8282 LBH Factor VIII activity
rs6708166 Nevus, non-neoplastic 0.0008948 0.4784 LBH Factor VIII activity
rs6708166 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.01054 0.8509 LBH Factor VIII activity
rs6708166 Infestation 0.00989 0.5629 LBH Factor VIII activity
rs6708166 Intestinal obstruction without mention of hernia 0.009572 0.839 LBH Factor VIII activity
rs6708166 Atherosclerosis of renal artery 0.00199 0.7307 LBH Factor VIII activity
rs6708166 Suicidal ideation or attempt 0.01035 1.667 LBH Factor VIII activity
rs6708166 Other disorders of lipoid metabolism and hyperalimentation 0.0104 0.7817 LBH Factor VIII activity
rs6708166 Disease of capillaries 0.001506 0.6798 LBH Factor VIII activity
rs6708166 Renal failure 0.008308 0.904 LBH Factor VIII activity
rs6708166 Corns and callosities 0.01116 0.867 LBH Factor VIII activity
rs6708166 Other disorders of thyroid 0.006762 0.7434 LBH Factor VIII activity
rs6708166 Keratoderma, acquired 1.104e-05 0.7688 LBH Factor VIII activity
rs6708166 Personality disorders 0.003971 0.7754 LBH Factor VIII activity
rs6708166 Cervicocranial/Cervicobrachial syndrome 0.007824 0.7893 LBH Factor VIII activity
rs6708166 Cerebrovascular disease 0.002173 0.8985 LBH Factor VIII activity
rs6708166 Encounter for long-term use of antiplatelets/antithrombotics 0.01036 0.4374 LBH Factor VIII activity
rs6708166 Acquired deformities of finger 0.008652 1.431 LBH Factor VIII activity
rs6711606 Disorders of synovium, tendon, and bursa 0.003573 1.155 RNF149 Pancreatic cancer
rs6711606 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.000921 2.659 RNF149 Pancreatic cancer
rs6711606 Paroxysmal supraventricular tachycardia 0.006986 0.7192 RNF149 Pancreatic cancer
rs6711606 Gram positive septicemia 0.001032 1.848 RNF149 Pancreatic cancer
rs6711606 Glomerulonephritis 0.006733 0.4368 RNF149 Pancreatic cancer
rs6711606 Deviated nasal septum 0.008871 0.8093 RNF149 Pancreatic cancer
rs6711606 Infection of the eye 0.004009 1.198 RNF149 Pancreatic cancer
rs6711606 Abnormal results of function studies 0.006981 1.685 RNF149 Pancreatic cancer
rs6711606 Osteoarthrosis, generalized 0.0105 0.7857 RNF149 Pancreatic cancer
rs6725887 Psoriasis 0.005051 1.358 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Bacterial enteritis 0.0007579 1.562 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Upper gastrointestinal congenital anomalies 0.009801 0.4107 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Paget's disease of bone 0.0109 2.316 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Disease of tricuspid valve 0.002742 1.398 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Psoriasis vulgaris 0.005267 1.366 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Aortic aneurysm 0.005209 0.7347 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Alopecia 0.006896 1.436 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Heart transplant/surgery 0.005508 1.594 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Fracture of neck of femur 0.006685 1.308 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Benign neoplasm of colon 0.004503 0.8698 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Ischemic stroke 0.009485 1.27 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Benign neoplasm of ovary 0.005873 1.743 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Neutropenia 0.01035 1.307 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.001883 1.89 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Osteitis deformans and osteopathies associated with other disorders 0.002839 1.995 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Benign neoplasm of bone and articular cartilage 0.005938 1.91 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Unspecified erythematous condition 0.0103 1.59 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Fracture of lower limb 0.006995 1.217 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Other aneurysm 0.008377 0.7719 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Occlusion of cerebral arteries 0.007269 1.267 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Inflammatory diseases of prostate 0.003634 0.7036 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6725887 Gastritis and duodenitis, NOS 0.007505 0.7211 WDR12 Early onset myocardial infarction, Coronary heart disease
rs6782029 Chronic liver disease and cirrhosis 0.008633 0.7791 VGLL4 Anorexia nervosa
rs6782029 Disorders of cervical region 0.007096 0.6843 VGLL4 Anorexia nervosa
rs6782029 Myasthenia gravis 0.006039 2.059 VGLL4 Anorexia nervosa
rs6782029 Leukoplakia of oral mucosa 0.009419 1.802 VGLL4 Anorexia nervosa
rs6782029 Alopecia Areata 0.0002844 2.571 VGLL4 Anorexia nervosa
rs6782029 Bacterial infection NOS 0.001123 0.8293 VGLL4 Anorexia nervosa
rs6782029 Staphylococcus infections 0.0002317 0.6666 VGLL4 Anorexia nervosa
rs6782029 Drug-resistant infection 0.004362 0.6385 VGLL4 Anorexia nervosa
rs6782029 Insulin pump user 0.006776 1.283 VGLL4 Anorexia nervosa
rs6782029 Posttraumatic stress disorder 0.003641 1.649 VGLL4 Anorexia nervosa
rs6782029 Schizoid personality disorder 0.01046 0.4966 VGLL4 Anorexia nervosa
rs6782029 Lymphadenitis 0.009643 0.8248 VGLL4 Anorexia nervosa
rs6782029 Methicillin sensitive Staphylococcus aureus 0.009489 0.6959 VGLL4 Anorexia nervosa
rs6782029 Disease of tricuspid valve 0.001908 0.7099 VGLL4 Anorexia nervosa
rs6791644 AV block 0.0002882 1.421 FHIT Attention deficit hyperactivity disorder
rs6791644 Cardiac arrest & ventricular fibrillation 0.0002338 1.861 FHIT Attention deficit hyperactivity disorder
rs6791644 Congenital anomalies of the eye 0.0002848 0.5793 FHIT Attention deficit hyperactivity disorder
rs6791644 Biliary cirrhosis 0.0004131 3.116 FHIT Attention deficit hyperactivity disorder
rs6791644 First degree AV block 0.0002606 1.536 FHIT Attention deficit hyperactivity disorder
rs6791644 Retinal detachments and defects 0.01004 1.321 FHIT Attention deficit hyperactivity disorder
rs6791644 Congenital anomalies of peripheral vascular system 0.007399 2.069 FHIT Attention deficit hyperactivity disorder
rs6791644 Plasma protein metabolism disorder 0.007443 1.434 FHIT Attention deficit hyperactivity disorder
rs6791644 Cirrhosis of liver without mention of alcohol 0.005864 1.621 FHIT Attention deficit hyperactivity disorder
rs6791644 Patellar fracture 0.003294 1.649 FHIT Attention deficit hyperactivity disorder
rs6791644 Cardiac pacemaker in situ 0.003615 1.381 FHIT Attention deficit hyperactivity disorder
rs6791644 Congenital anomalies of posterior segment of eye 0.004698 0.608 FHIT Attention deficit hyperactivity disorder
rs6791644 Infestation 0.003859 2.005 FHIT Attention deficit hyperactivity disorder
rs6807064 Abnormal Papanicolaou smear of cervix and cervical HPV 0.008969 0.8025 ATP2B2 Phenylalanine
rs6807064 Plasma protein metabolism disorder 0.01126 1.29 ATP2B2 Phenylalanine
rs6807064 Herpes zoster 0.006912 1.199 ATP2B2 Phenylalanine
rs6807064 Nephritis & nephropathy 0.002468 1.717 ATP2B2 Phenylalanine
rs6807064 Posttraumatic stress disorder 0.006929 0.5738 ATP2B2 Phenylalanine
rs6807064 Renal colic 0.008716 0.5255 ATP2B2 Phenylalanine
rs6807064 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.0004113 1.804 ATP2B2 Phenylalanine
rs6807064 Chronic obstructive asthma with exacerbation 0.0003286 1.962 ATP2B2 Phenylalanine
rs6807064 Periapical abscess 0.002929 1.253 ATP2B2 Phenylalanine
rs6807064 Diseases of pulp and periapical tissues 0.001094 1.267 ATP2B2 Phenylalanine
rs6807064 Breast disorder NOS 0.004864 2.232 ATP2B2 Phenylalanine
rs6807064 Other conditions of the mother complicating pregnancy 0.00175 0.5011 ATP2B2 Phenylalanine
rs6807064 Type 2 diabetic peripheral circulatory disorders 0.01104 1.362 ATP2B2 Phenylalanine
rs6845865 Lyme disease 0.002316 1.744 ARHGAP10 QT interval
rs6845865 Disorders of tooth development 0.008774 0.6481 ARHGAP10 QT interval
rs6845865 Cervical cancer 0.01006 1.942 ARHGAP10 QT interval
rs6845865 Hematuria 0.000717 0.8283 ARHGAP10 QT interval
rs6845865 Spirochetal infection 0.00496 1.664 ARHGAP10 QT interval
rs6845865 Renal colic 0.0005439 2.035 ARHGAP10 QT interval
rs6845865 Torticollis 0.009877 1.616 ARHGAP10 QT interval
rs6845865 Polycythemia vera, secondary 0.009307 0.4399 ARHGAP10 QT interval
rs6845865 Nonrheumatic mitral valve disorders 0.01095 1.181 ARHGAP10 QT interval
rs6869388 Hyperosmolality and/or hypernatremia 0.003955 1.578 C5orf36 Gallbladder cancer
rs6869388 Hypertrophy of female genital organs 0.008697 1.757 C5orf36 Gallbladder cancer
rs6869388 Torticollis 0.006263 1.605 C5orf36 Gallbladder cancer
rs6869388 Superficial cellulitis and abscess 0.007667 1.121 C5orf36 Gallbladder cancer
rs6869388 Other acquired musculoskeletal deformity 0.003407 0.7259 C5orf36 Gallbladder cancer
rs6869388 Sensorineural hearing loss 0.003263 1.145 C5orf36 Gallbladder cancer
rs6869388 Hearing loss 0.001356 1.133 C5orf36 Gallbladder cancer
rs6869388 Melanoma 0.004799 0.7033 C5orf36 Gallbladder cancer
rs6869388 Hemorrhage from gastrointestinal ulcer 0.009558 1.453 C5orf36 Gallbladder cancer
rs6869388 Disorders of uterus, NEC 0.003707 1.956 C5orf36 Gallbladder cancer
rs690037 Intestinal infection 0.0001501 0.7572 RFTN1 Optic disc parameters
rs690037 Bacterial enteritis 3.684e-06 0.608 RFTN1 Optic disc parameters
rs690037 Intestinal infection due to C. difficile 0.0002108 0.6378 RFTN1 Optic disc parameters
rs690037 Psoriasis 0.005672 1.251 RFTN1 Optic disc parameters
rs690037 Other diseases of respiratory system 0.01097 1.351 RFTN1 Optic disc parameters
rs690037 Cardiac arrhythmia NOS 0.002986 0.8568 RFTN1 Optic disc parameters
rs690037 Retinal edema and hypertensive retinopathy 0.005349 1.329 RFTN1 Optic disc parameters
rs690037 Hydrocele 0.005189 1.489 RFTN1 Optic disc parameters
rs690037 Spondylosis with myelopathy 0.004582 1.395 RFTN1 Optic disc parameters
rs690037 Psoriasis & related disorders 0.004388 1.244 RFTN1 Optic disc parameters
rs690037 Anal and rectal polyp 0.001078 0.765 RFTN1 Optic disc parameters
rs690037 Abnormal findings on radiological examination intrathoracic organs 0.008987 0.8319 RFTN1 Optic disc parameters
rs690037 Mechanical complications of cardiac/vascular device, implant, and graft 0.008108 0.8106 RFTN1 Optic disc parameters
rs690037 Gout and other crystal arthropathies 0.009479 1.139 RFTN1 Optic disc parameters
rs690037 Mitral valve stenosis and/or aortic valve stenosis 0.0006365 0.7739 RFTN1 Optic disc parameters
rs690037 Gout 0.0107 1.148 RFTN1 Optic disc parameters
rs690037 Iatrogenic hypotension 0.006609 0.6256 RFTN1 Optic disc parameters
rs690705 Open wound of eye or eyelid 0.008435 1.939 RFC3 Alzheimer's disease
rs690705 Acute, but ill-defined cerebrovascular disease 0.00678 1.202 RFC3 Alzheimer's disease
rs690705 Dislocation 0.00163 1.145 RFC3 Alzheimer's disease
rs690705 Other disorders of back 0.002632 1.187 RFC3 Alzheimer's disease
rs690705 Disorders of sacrum 0.0003334 1.359 RFC3 Alzheimer's disease
rs690705 Traumatic arthropathy 0.01014 1.593 RFC3 Alzheimer's disease
rs690705 Benign neoplasm of colon 0.009745 0.9133 RFC3 Alzheimer's disease
rs690705 Hearing loss 0.008768 1.092 RFC3 Alzheimer's disease
rs690705 Other and unspecified disc disorder 0.008303 1.475 RFC3 Alzheimer's disease
rs690705 Loose body in joint 0.003983 2.175 RFC3 Alzheimer's disease
rs690705 Known or suspected fetal abnormality 2.278e-05 2.196 RFC3 Alzheimer's disease
rs6908425 Stomach cancer 0.002757 1.877 CDKAL1 Crohn's disease
rs6908425 Endometrial hyperplasia 0.008928 1.464 CDKAL1 Crohn's disease
rs6908425 Fibroadenosis of breast 0.002258 2.417 CDKAL1 Crohn's disease
rs6908425 Adverse drug events and drug allergies 0.008995 0.8279 CDKAL1 Crohn's disease
rs6908425 Emphysema 0.009057 0.7379 CDKAL1 Crohn's disease
rs6908425 Other rheumatic heart disease 0.002538 2.139 CDKAL1 Crohn's disease
rs6908425 Non-healing surgical wound 0.0007508 1.859 CDKAL1 Crohn's disease
rs6908425 Cyst or abscess of Bartholin's gland 0.00155 2.208 CDKAL1 Crohn's disease
rs6908425 Urinary obstruction 0.007454 0.6385 CDKAL1 Crohn's disease
rs6908425 Epiphora 0.003607 0.6216 CDKAL1 Crohn's disease
rs6908425 Poisoning by other anti-infectives 0.009496 0.7762 CDKAL1 Crohn's disease
rs6908425 End stage renal disease 0.003697 1.493 CDKAL1 Crohn's disease
rs6908425 Premenstrual tension syndromes 0.00885 1.954 CDKAL1 Crohn's disease
rs6908425 Esophageal cancer 0.004829 1.86 CDKAL1 Crohn's disease
rs6919346 Vascular insufficiency of intestine 0.002504 1.544 LPA Lipoprotein(a) levels
rs6919346 Chronic ulcer of skin 0.007671 1.161 LPA Lipoprotein(a) levels
rs6919346 Corns and callosities 0.008421 1.194 LPA Lipoprotein(a) levels
rs6919346 Contact dermatitis and other eczema due to plants [except food] 0.00605 1.851 LPA Lipoprotein(a) levels
rs6919346 Hepatomegaly 0.007022 1.836 LPA Lipoprotein(a) levels
rs6919346 Peripheral autonomic neuropathy 0.006665 1.463 LPA Lipoprotein(a) levels
rs6919346 Subdural hemorrhage 0.008117 0.4606 LPA Lipoprotein(a) levels
rs6919346 Flat foot 0.0007706 1.425 LPA Lipoprotein(a) levels
rs6919346 Gastrointestinal complications 0.003519 1.357 LPA Lipoprotein(a) levels
rs6919346 Chronic ulcer of leg or foot 0.007269 1.19 LPA Lipoprotein(a) levels
rs6919346 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.01076 1.13 LPA Lipoprotein(a) levels
rs6919346 Spontaneous ecchymoses 0.002224 1.813 LPA Lipoprotein(a) levels
rs6919346 Acquired deformities of ankle and foot 0.0001084 1.413 LPA Lipoprotein(a) levels
rs6919346 Intestinal malabsorption 0.00845 1.443 LPA Lipoprotein(a) levels
rs6922632 Conduct disorders 0.003594 1.759 NRSN1 Cognitive performance
rs6922632 Periapical abscess 0.01007 0.7631 NRSN1 Cognitive performance
rs6922632 Spondylosis without myelopathy 0.003872 0.8526 NRSN1 Cognitive performance
rs6922632 Intracerebral hemorrhage 0.003696 1.806 NRSN1 Cognitive performance
rs6922632 Dental caries 0.00184 0.7295 NRSN1 Cognitive performance
rs6922632 Edema 0.009248 0.8735 NRSN1 Cognitive performance
rs6922632 Mechanical complication due to other implant and internal device 0.008857 0.6215 NRSN1 Cognitive performance
rs6922632 Infection of the eye 0.01036 0.8292 NRSN1 Cognitive performance
rs6922632 Spondylosis and allied disorders 0.007504 0.8668 NRSN1 Cognitive performance
rs6922632 First degree AV block 0.006473 1.335 NRSN1 Cognitive performance
rs6922632 Open wound of toe(s) 0.00645 1.902 NRSN1 Cognitive performance
rs6922632 Other sprains and strains 0.003145 0.5848 NRSN1 Cognitive performance
rs6922632 Contact dermatitis and other eczema due to plants [except food] 0.003044 0.2194 NRSN1 Cognitive performance
rs6922632 Altered mental status 0.003542 0.6506 NRSN1 Cognitive performance
rs6922632 Displacement of intervertebral disc 0.01069 0.8155 NRSN1 Cognitive performance
rs6922632 Osteoporosis 0.002683 0.8237 NRSN1 Cognitive performance
rs6922632 Atopic or contact dermatitis 0.009471 0.8767 NRSN1 Cognitive performance
rs6922632 Diseases of hard tissues of teeth 0.001332 0.7285 NRSN1 Cognitive performance
rs6922632 Osteoporosis, osteopenia, & pathological fractures 0.00929 0.8817 NRSN1 Cognitive performance
rs6922632 Lump or mass in breast 0.009252 0.8159 NRSN1 Cognitive performance
rs6922632 Gout and other crystal arthropathies 0.000308 0.7566 NRSN1 Cognitive performance
rs6922632 Gout 0.0006442 0.7526 NRSN1 Cognitive performance
rs6922632 Herpes simplex 0.007937 0.6594 NRSN1 Cognitive performance
rs6922632 Benign mammary dysplasias 0.01022 0.8186 NRSN1 Cognitive performance
rs6922632 Cystic mastopathy 0.007001 0.8039 NRSN1 Cognitive performance
rs6922632 Osteoporosis, NOS or other 0.001139 0.8142 NRSN1 Cognitive performance
rs6922632 Pulmonary collapse; interstitial/compensatory emphysema 0.007102 0.794 NRSN1 Cognitive performance
rs693 Hypertensive heart and/or renal disease 0.0002992 0.81 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Insect bite 0.008525 0.8119 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Disorders of lipoid metabolism 1.813e-07 0.8457 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Localized superficial swelling, mass, or lump 0.009725 0.8004 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Ileostomy status 0.007113 1.611 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Peripheral retinal degenerations 0.01073 0.7856 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Mixed hyperlipidemia 1.348e-05 0.7735 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Paralytic strabismus 0.01076 1.461 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Hypercholesterolemia 7.419e-10 0.7838 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Cardiac arrest 0.008338 0.6358 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Tachycardia NOS 0.009035 0.8471 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Cardiac pacemaker/device in situ 0.007731 0.833 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Subdural hemorrhage (injury) 0.003603 0.5719 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Lymphosarcoma 0.005401 2.203 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Hypertensive chronic kidney disease 0.002937 0.8236 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Celiac disease 0.001706 0.4966 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Fluid overload 0.007591 0.7907 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Hearing loss 0.002005 0.9086 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Conjunctivitis, noninfectious 0.01097 1.226 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Celiac or tropical sprue 0.002167 0.5135 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Sensorineural hearing loss 0.003553 0.898 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Hyperlipidemia 8.821e-08 0.841 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Adverse effects of opiates and related narcotics in therapeutic use 0.002014 1.339 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Disturbances of sensation of smell and taste 0.001655 0.5721 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs693 Renal dialysis 0.003152 0.6845 APOB Total Cholesterol, LDL Cholesterol, Triglycerides
rs6959888 Painful respiration 0.008669 1.227 ZNF804B Anorexia nervosa
rs6959888 Hypovolemia 0.00223 1.215 ZNF804B Anorexia nervosa
rs6959888 Chronic pancreatitis 0.008748 0.2644 ZNF804B Anorexia nervosa
rs6959888 Infections of kidney 0.01094 1.451 ZNF804B Anorexia nervosa
rs6959888 Abnormal findings examination of lungs 0.006636 1.253 ZNF804B Anorexia nervosa
rs6959888 Other diseases of lung 0.004992 1.208 ZNF804B Anorexia nervosa
rs6959888 Disorders of fluid, electrolyte, and acid-base balance 0.002733 1.15 ZNF804B Anorexia nervosa
rs6959888 Disorders of menstruation 0.01091 0.7625 ZNF804B Anorexia nervosa
rs6959888 Dysmenorrhea 0.005335 0.4547 ZNF804B Anorexia nervosa
rs6959888 Alzheimer's disease 0.006078 1.281 ZNF804B Anorexia nervosa
rs6959888 Excessive or frequent menstruation 0.0003751 0.5408 ZNF804B Anorexia nervosa
rs697739 Substance addiction and disorders 0.00327 1.32 ATXN1 Amyotrophic lateral sclerosis
rs697739 Absent or infrequent menstruation 0.008554 1.508 ATXN1 Amyotrophic lateral sclerosis
rs697739 Spondylosis with myelopathy 0.009076 1.37 ATXN1 Amyotrophic lateral sclerosis
rs697739 Viral Enteritis 0.0003801 1.672 ATXN1 Amyotrophic lateral sclerosis
rs697739 Type 2 diabetic peripheral circulatory disorders 0.006348 0.6879 ATXN1 Amyotrophic lateral sclerosis
rs697739 Hyperglyceridemia 0.002717 0.7672 ATXN1 Amyotrophic lateral sclerosis
rs697739 Disorders of optic nerve and visual pathways 0.008513 0.7799 ATXN1 Amyotrophic lateral sclerosis
rs697739 Urethral stricture (not specified as infectious) 0.009476 0.6756 ATXN1 Amyotrophic lateral sclerosis
rs697739 Secondary thrombocytopenia 0.009126 1.594 ATXN1 Amyotrophic lateral sclerosis
rs697739 Rheumatoid arthritis & related inflammatory polyarthropathies 0.004561 0.8133 ATXN1 Amyotrophic lateral sclerosis
rs697739 Optic neuritis/neuropathy 0.003933 0.7009 ATXN1 Amyotrophic lateral sclerosis
rs697739 Chronic glomerulonephritis 0.0002253 2.817 ATXN1 Amyotrophic lateral sclerosis
rs697739 Glomerulonephritis 0.0009807 1.837 ATXN1 Amyotrophic lateral sclerosis
rs697739 Peripheral vascular disease 0.00497 0.8834 ATXN1 Amyotrophic lateral sclerosis
rs697739 Scoliosis 0.01066 0.7552 ATXN1 Amyotrophic lateral sclerosis
rs697739 Abnormal kidney function 0.002836 2.1 ATXN1 Amyotrophic lateral sclerosis
rs697739 Rheumatoid arthritis 0.00021 0.7321 ATXN1 Amyotrophic lateral sclerosis
rs7023329 Abnormal coagulation profile 0.002002 1.421 MTAP Melanoma
rs7023329 Coronary atherosclerosis 0.006459 1.091 MTAP Melanoma
rs7023329 Other disorders of biliary tract 0.009518 1.484 MTAP Melanoma
rs7023329 Other cells and casts in urine 0.004948 0.6871 MTAP Melanoma
rs7023329 Chronic pharyngitis and nasopharyngitis 0.006394 0.8573 MTAP Melanoma
rs7023329 Gastrointestinal malfunction arising from mental factors 0.006385 2.097 MTAP Melanoma
rs7023329 Other upper respiratory disease 0.005173 0.8636 MTAP Melanoma
rs7023329 Myocardial infarction 0.009395 1.124 MTAP Melanoma
rs7023329 Memory loss 0.001782 0.7846 MTAP Melanoma
rs7023329 Varicose veins of lower extremity, symptomtic 7.985e-05 0.7493 MTAP Melanoma
rs7023329 Complication of internal orthopedic device 0.001876 1.262 MTAP Melanoma
rs7023329 Varicose veins 0.0002104 0.8249 MTAP Melanoma
rs7023329 Cardiomyopathy 0.0111 1.169 MTAP Melanoma
rs7023329 Aneurysm of artery of lower extremity 0.008596 0.647 MTAP Melanoma
rs7023329 Major depressive disorder 0.007168 0.8645 MTAP Melanoma
rs7023329 Varicose veins of lower extremity 0.0001925 0.8172 MTAP Melanoma
rs7023329 Ischemic Heart Disease 0.004051 1.091 MTAP Melanoma
rs7023329 Diseases of pulp and periapical tissues 0.008577 0.8375 MTAP Melanoma
rs7023329 progressive myopia 0.004399 1.811 MTAP Melanoma
rs7023329 Primary/intrinsic cardiomyopathies 0.0112 1.174 MTAP Melanoma
rs7023329 Mucous polyp of cervix 0.005542 0.7137 MTAP Melanoma
rs7025486 Senile dementia 0.003066 0.7719 DAB2IP Abdominal aortic aneurysm
rs7025486 Mechanical complications of cardiac/vascular device, implant, and graft 0.004632 1.272 DAB2IP Abdominal aortic aneurysm
rs7025486 Peritonitis and retroperitoneal infections 0.008623 0.6554 DAB2IP Abdominal aortic aneurysm
rs7025486 Arterial embolism and thrombosis 0.008812 1.253 DAB2IP Abdominal aortic aneurysm
rs7025486 Sprains and strains 0.0008684 1.151 DAB2IP Abdominal aortic aneurysm
rs7025486 Persistent mental disorders due to other conditions 0.01048 0.8537 DAB2IP Abdominal aortic aneurysm
rs7025486 Dermatophytosis of the body 0.003203 1.412 DAB2IP Abdominal aortic aneurysm
rs7025486 Diverticulitis 0.008381 0.7957 DAB2IP Abdominal aortic aneurysm
rs7025486 Other pulmonary inflamation or edema 0.005744 0.709 DAB2IP Abdominal aortic aneurysm
rs7025486 Fracture of clavicle or scapula 0.001956 1.499 DAB2IP Abdominal aortic aneurysm
rs7025486 Cystoid macular degeneration of retina 0.0009133 1.42 DAB2IP Abdominal aortic aneurysm
rs7025486 Abnormal thyroid function 0.008552 0.7561 DAB2IP Abdominal aortic aneurysm
rs7025486 Abnormal chest sounds 0.004568 1.505 DAB2IP Abdominal aortic aneurysm
rs7025486 Nonrheumatic tricuspid valve disorders 0.006976 1.476 DAB2IP Abdominal aortic aneurysm
rs7025486 Arterial embolism and thrombosis of lower extremity artery 0.009655 1.358 DAB2IP Abdominal aortic aneurysm
rs7025486 Disorders of other cranial nerves 0.002475 1.333 DAB2IP Abdominal aortic aneurysm
rs7025486 Diseases of pulp and periapical tissues 0.006532 1.227 DAB2IP Abdominal aortic aneurysm
rs7025486 Acute pancreatitis 0.005876 0.7333 DAB2IP Abdominal aortic aneurysm
rs7025486 Facial nerve disorders 0.00588 1.433 DAB2IP Abdominal aortic aneurysm
rs7025486 Hyperbilirubinemia 0.007118 0.4339 DAB2IP Abdominal aortic aneurysm
rs7025486 Other alveolar and parietoalveolar pneumonopathy 0.003259 1.722 DAB2IP Abdominal aortic aneurysm
rs703842 Degenerative disease of the spinal cord 0.008507 1.444 METTL1 Multiple sclerosis
rs703842 Alcoholism 0.0108 1.219 METTL1 Multiple sclerosis
rs703842 Fasciitis 0.000465 1.224 METTL1 Multiple sclerosis
rs703842 Disorders of muscle, ligament, and fascia 0.0004954 1.217 METTL1 Multiple sclerosis
rs703842 Ulceration of intestine 0.0001018 2.021 METTL1 Multiple sclerosis
rs703842 Fracture of neck of femur 0.002259 0.7954 METTL1 Multiple sclerosis
rs703842 Postlaminectomy syndrome 0.005246 0.6736 METTL1 Multiple sclerosis
rs703842 Other signs and symptoms in breast 0.0005301 1.495 METTL1 Multiple sclerosis
rs703842 Hemoptysis 0.0001365 0.6205 METTL1 Multiple sclerosis
rs703842 Subjective visual disturbances 0.01148 1.201 METTL1 Multiple sclerosis
rs703842 Keloid scar 0.005345 0.5351 METTL1 Multiple sclerosis
rs703842 Noninflammatory disorders of vulva and perineum 0.007308 0.6208 METTL1 Multiple sclerosis
rs703842 Fracture of lower limb 0.0001158 0.8081 METTL1 Multiple sclerosis
rs703842 Fracture of tibia and fibula 0.006603 0.7616 METTL1 Multiple sclerosis
rs703842 Abnormal sputum 0.0002542 0.651 METTL1 Multiple sclerosis
rs703842 Early or threatened labor; hemorrhage in early pregnancy 0.002757 1.754 METTL1 Multiple sclerosis
rs703842 Ulceration of the lower GI tract 0.009072 1.528 METTL1 Multiple sclerosis
rs703842 Localized superficial swelling, mass, or lump 0.005963 1.274 METTL1 Multiple sclerosis
rs703842 Known or suspected fetal abnormality 0.0009498 1.877 METTL1 Multiple sclerosis
rs703842 Neurological disorders due to brain damage 0.006143 1.144 METTL1 Multiple sclerosis
rs703842 Portal hypertension 0.009038 0.5352 METTL1 Multiple sclerosis
rs703842 pulmonary heart disease 0.00594 0.851 METTL1 Multiple sclerosis
rs7072268 Aphakia and other disorders of lens 0.008044 1.28 HK1 Glycated hemoglobin levels
rs7072268 Cancer of oropharynx 0.004298 2.213 HK1 Glycated hemoglobin levels
rs7072268 Abnormal findings on radiological exam of musculoskeletal system 0.0001351 1.967 HK1 Glycated hemoglobin levels
rs7072268 Celiac or tropical sprue 0.01027 1.725 HK1 Glycated hemoglobin levels
rs7072268 Keratoderma, acquired 0.0003726 0.8195 HK1 Glycated hemoglobin levels
rs7072268 Myocardial infarction 0.001723 0.8693 HK1 Glycated hemoglobin levels
rs7072268 Celiac disease 0.009152 1.762 HK1 Glycated hemoglobin levels
rs7072268 Colostomy and enterostomy complication 0.003659 1.914 HK1 Glycated hemoglobin levels
rs7072268 Acid-base balance disorder 0.008898 1.294 HK1 Glycated hemoglobin levels
rs7072268 Nontoxic nodular goiter 0.003962 1.193 HK1 Glycated hemoglobin levels
rs7072268 Insulin pump user 0.001396 0.7677 HK1 Glycated hemoglobin levels
rs7072268 Diplopia and disorders of binocular vision 0.007189 0.7772 HK1 Glycated hemoglobin levels
rs7072268 Redundant prepuce and phimosis/BXO 0.009051 0.6048 HK1 Glycated hemoglobin levels
rs7072268 Other anemias 0.001687 1.1 HK1 Glycated hemoglobin levels
rs7072268 Anemia NOS 0.0005756 1.119 HK1 Glycated hemoglobin levels
rs7072268 Hypercalcemia 0.01017 1.242 HK1 Glycated hemoglobin levels
rs7072268 Diseases of hair and hair follicles 0.01064 0.8311 HK1 Glycated hemoglobin levels
rs7085433 Degeneration of intervertebral disc 0.001094 1.226 TIMM23 Mean corpuscular hemoglobin
rs7085433 Disorders of synovium, tendon, and bursa 0.009295 1.174 TIMM23 Mean corpuscular hemoglobin
rs7085433 Generalized hyperhidrosis 0.002175 1.565 TIMM23 Mean corpuscular hemoglobin
rs7085433 Disorders of sweat glands 0.006524 1.397 TIMM23 Mean corpuscular hemoglobin
rs7085433 Aortic aneurysm 0.005939 1.317 TIMM23 Mean corpuscular hemoglobin
rs7085433 Enthesopathy 0.002847 1.205 TIMM23 Mean corpuscular hemoglobin
rs7085433 Sepsis and SIRS 0.0001054 1.563 TIMM23 Mean corpuscular hemoglobin
rs7085433 Sepsis 0.000126 1.578 TIMM23 Mean corpuscular hemoglobin
rs7085433 Open wound of ear 0.01065 2.161 TIMM23 Mean corpuscular hemoglobin
rs7085433 Intervertebral disc disorders 0.005139 1.163 TIMM23 Mean corpuscular hemoglobin
rs7085433 Fracture of clavicle or scapula 0.01031 0.5148 TIMM23 Mean corpuscular hemoglobin
rs7085433 Dermatomyositis and Polymyositis 0.007962 2.298 TIMM23 Mean corpuscular hemoglobin
rs7085433 Synoviopathy 0.00704 1.506 TIMM23 Mean corpuscular hemoglobin
rs7085433 Anemia in chronic kidney disease 0.002404 0.5606 TIMM23 Mean corpuscular hemoglobin
rs7085433 Contact dermatitis and other eczema due to plants [except food] 0.0009842 2.327 TIMM23 Mean corpuscular hemoglobin
rs7085433 Other sprains and strains 0.001629 1.58 TIMM23 Mean corpuscular hemoglobin
rs7085433 Disorders of parathyroid gland 0.007389 0.6194 TIMM23 Mean corpuscular hemoglobin
rs7085433 Nontoxic uninodular goiter 0.00666 0.6894 TIMM23 Mean corpuscular hemoglobin
rs7085433 Muscle weakness 0.007398 0.6097 TIMM23 Mean corpuscular hemoglobin
rs712039 Poisoning by primarily systemic agents 0.008595 0.7261 DUSP14 Tuberculosis
rs712039 Partial epilepsy 0.001758 1.516 DUSP14 Tuberculosis
rs712039 Abnormal findings on mammogram or breast exam 0.01036 1.13 DUSP14 Tuberculosis
rs712039 Subarachnoid hemorrhage 0.008777 1.884 DUSP14 Tuberculosis
rs712039 Retinal vascular changes and abnomalities 0.006757 1.246 DUSP14 Tuberculosis
rs712039 Vascular insufficiency of intestine 0.01051 1.402 DUSP14 Tuberculosis
rs712039 Abnormal thyroid function 0.002771 0.7235 DUSP14 Tuberculosis
rs712039 Personal history of allergy to medicinal agents 0.001746 0.7181 DUSP14 Tuberculosis
rs712039 Other specified nonpsychotic and/or transient mental disorders 0.00159 0.7556 DUSP14 Tuberculosis
rs712039 Age-related macular degeneration 0.001228 1.276 DUSP14 Tuberculosis
rs712039 Mental disorders due to brain damage 0.001045 0.7422 DUSP14 Tuberculosis
rs712039 Nontoxic uninodular goiter 0.003079 0.7613 DUSP14 Tuberculosis
rs712039 Ptosis of eyelid 0.01064 1.214 DUSP14 Tuberculosis
rs712039 Arthropathy NOS 0.01058 0.8303 DUSP14 Tuberculosis
rs712039 Cervical cancer 0.001839 0.3104 DUSP14 Tuberculosis
rs7122539 Fracture of foot 0.009669 1.198 PC HIV-1 susceptibility
rs7122539 Viral hepatitis 0.003117 0.7429 PC HIV-1 susceptibility
rs7122539 Temporomandibular joint disorders 0.003182 0.751 PC HIV-1 susceptibility
rs7122539 Other congenital anomalies 0.0005578 0.3765 PC HIV-1 susceptibility
rs7122539 Gram negative septicemia 0.003974 1.43 PC HIV-1 susceptibility
rs7122539 Postinflammatory pulmonary fibrosis 0.008165 1.26 PC HIV-1 susceptibility
rs7122539 Dermatomycoses 0.0002423 1.995 PC HIV-1 susceptibility
rs7122539 Urinary tract infection 0.006543 0.905 PC HIV-1 susceptibility
rs7122539 Septicemia 0.0009978 1.223 PC HIV-1 susceptibility
rs7122539 Asthma 0.00808 0.887 PC HIV-1 susceptibility
rs7122539 Noninflammatory disorders of cervix 0.005464 0.5325 PC HIV-1 susceptibility
rs7122539 Cervicocranial/Cervicobrachial syndrome 0.004656 0.7772 PC HIV-1 susceptibility
rs7122539 Chronic venous hypertension 0.008603 0.4214 PC HIV-1 susceptibility
rs7136572 Symptoms involving cardiovascular system 0.002799 0.3494 USP44 Response to antidepressant treatment
rs7136572 Ulcerative stomatitis & mucositis 0.01111 3.758 USP44 Response to antidepressant treatment
rs7136572 Obsessive-compulsive disorder 0.009435 3.628 USP44 Response to antidepressant treatment
rs7136572 Functional digestive disorders 0.004377 0.4877 USP44 Response to antidepressant treatment
rs7136572 Parkinson's disease 0.003507 2.416 USP44 Response to antidepressant treatment
rs7136572 Myopia 0.005327 0.5772 USP44 Response to antidepressant treatment
rs7136572 Ileostomy status 0.004687 3.345 USP44 Response to antidepressant treatment
rs7136572 Disorders of refraction and accommodation 0.007626 0.664 USP44 Response to antidepressant treatment
rs7136572 Extrapyramidal disease and abnormal movement disorders 0.008763 1.786 USP44 Response to antidepressant treatment
rs7136572 Pneumonitis due to inhalation of food or vomitus 0.00758 2.271 USP44 Response to antidepressant treatment
rs7136572 Genital prolapse 0.01096 1.701 USP44 Response to antidepressant treatment
rs7136572 Prolapse of vaginal walls 0.005276 1.922 USP44 Response to antidepressant treatment
rs7136572 Poisoning by anticonvulsants and anti-Parkinsonism drugs 0.00916 3.966 USP44 Response to antidepressant treatment
rs7136572 Hammer toe 0.002891 2.026 USP44 Response to antidepressant treatment
rs7136572 Pseudomonal pneumonia 0.004807 5.7 USP44 Response to antidepressant treatment
rs7136572 Epilepsy, recurrent seizures, convulsions 0.004803 1.87 USP44 Response to antidepressant treatment
rs7137869 Cancer, suspected or other 0.008334 0.7978 CCDC60 Aging
rs7137869 Malignant neoplasm, other 0.009379 0.7728 CCDC60 Aging
rs7137869 Cardiac congenital anomalies 0.01117 1.343 CCDC60 Aging
rs7137869 Torsion dystonia 0.003976 1.685 CCDC60 Aging
rs7137869 Diseases of the salivary glands 0.009389 1.316 CCDC60 Aging
rs7137869 Rash and other nonspecific skin eruption 0.0112 0.8408 CCDC60 Aging
rs7137869 Sialoadenitis 0.005172 1.535 CCDC60 Aging
rs7137869 Acute pharyngitis 0.001764 0.8204 CCDC60 Aging
rs7137869 Pneumoconiosis 0.009809 1.897 CCDC60 Aging
rs7137869 Primary pulmonary hypertension 0.01019 1.588 CCDC60 Aging
rs7137869 Temporomandibular joint disorder NOS 0.007456 1.644 CCDC60 Aging
rs7137869 Malignant neoplasm of brain and nervous system 0.01139 0.6338 CCDC60 Aging
rs7137869 Angina pectoris 0.007999 1.154 CCDC60 Aging
rs7137869 Other forms of chronic heart disease 0.00527 1.233 CCDC60 Aging
rs7137869 Iatrogenic hypothyroidism 0.006721 0.6741 CCDC60 Aging
rs7140150 Calcaneal spur; Exostosis NOS 0.006952 1.26 FRMD6 Brain structure
rs7140150 Open wound of hand except finger(s) 0.009842 1.263 FRMD6 Brain structure
rs7140150 Other cerebral degenerations 0.0001451 1.624 FRMD6 Brain structure
rs7140150 Inflammatory and toxic neuropathy 0.0006224 1.459 FRMD6 Brain structure
rs7140150 Otalgia 0.008158 1.254 FRMD6 Brain structure
rs7140150 Diseases of blood and blood-forming organs 0.006334 0.8047 FRMD6 Brain structure
rs7140150 Pathologic fracture 0.004328 1.214 FRMD6 Brain structure
rs7140150 Nerve root and plexus disorders 0.001564 1.372 FRMD6 Brain structure
rs7140150 Nerve plexus lesions 0.000335 1.601 FRMD6 Brain structure
rs7140150 Secondary malignancy of brain/spine 0.006181 1.622 FRMD6 Brain structure
rs7140150 Intracranial hemorrhage 0.00946 0.7552 FRMD6 Brain structure
rs7140150 Viral warts & HPV 0.007134 1.153 FRMD6 Brain structure
rs7140150 Varicose veins of lower extremity, symptomtic 0.007007 0.8187 FRMD6 Brain structure
rs7157785 Disorders of choroid 0.009867 0.691 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Plasma protein metabolism disorder 0.001988 1.426 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Skin neoplasm of uncertain behavior 0.003959 0.7495 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Conductive hearing loss 0.001994 0.4079 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Patellar fracture 0.01113 1.472 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Bacterial enteritis 0.001704 1.47 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Other disorders of tympanic membrane 0.009589 0.5679 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Multiple sclerosis 0.005785 1.642 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Noninflammatory disorders of ovary, fallopian tube, & broad ligament 0.006085 1.726 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Uterine cancer 0.003365 0.535 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Other endocrine disorders 0.008817 0.4795 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Peripheral enthesopathies 0.0006612 0.8604 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Disorders of penis 0.008499 1.429 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Peyronie's disease 0.000789 2.312 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Cancer of oropharynx 0.002424 2.345 SGPP1 Sphingolipid levels - sphingomyelin
rs7157785 Reticulosarcoma 0.007445 0.3958 SGPP1 Sphingolipid levels - sphingomyelin
rs7158173 Cancer of other female genital organs 0.003419 0.6544 MAX Waist circumference
rs7158173 Bacterial enteritis 0.001506 0.7146 MAX Waist circumference
rs7158173 Intestinal infection due to C. difficile 0.004395 0.7091 MAX Waist circumference
rs7158173 Cancer of kidney and urinary organs 0.01001 0.8356 MAX Waist circumference
rs7158173 Cancer of bone & connective tissue 0.008412 0.6839 MAX Waist circumference
rs7158173 Perforation of tympanic membrane 0.007696 1.495 MAX Waist circumference
rs7158173 Benign neoplasm of brain and other parts of nervous system 0.005737 0.7028 MAX Waist circumference
rs7158173 Malignant neoplasm of ovary 0.006413 0.581 MAX Waist circumference
rs7158173 Immune disorders 0.008818 0.8003 MAX Waist circumference
rs7158173 Intestinal malabsorption 0.0109 1.343 MAX Waist circumference
rs7158173 Stricture/obstruction of ureter 0.005319 0.6643 MAX Waist circumference
rs7158173 Anorexia 0.009069 1.336 MAX Waist circumference
rs7158173 Ovarian cancer 0.002878 0.6032 MAX Waist circumference
rs7158173 Infertility, male 0.003538 0.47 MAX Waist circumference
rs7158173 Other disorders of tympanic membrane 0.004345 1.467 MAX Waist circumference
rs7191888 Other paralytic syndromes 0.002338 1.653 C16orf47 Multiple sclerosis
rs7191888 Anal and rectal polyp 0.008768 0.7413 C16orf47 Multiple sclerosis
rs7191888 Nonrheumatic aortic valve disorders 0.007189 0.8172 C16orf47 Multiple sclerosis
rs7191888 Other abnormal glucose 0.01138 0.8443 C16orf47 Multiple sclerosis
rs7191888 Abnormal glucose 0.009917 0.8715 C16orf47 Multiple sclerosis
rs7191888 Sialoadenitis 0.009832 1.532 C16orf47 Multiple sclerosis
rs7191888 Stricture and stenosis of esophagus 0.00411 1.358 C16orf47 Multiple sclerosis
rs7191888 Acute sinusitis 0.001828 0.8164 C16orf47 Multiple sclerosis
rs7191888 Acute pharyngitis 0.001218 0.7993 C16orf47 Multiple sclerosis
rs7191888 Varicose veins of lower extremity 0.006725 0.8177 C16orf47 Multiple sclerosis
rs7219585 AV block 0.003654 0.7529 DNAI2 Cognitive performance
rs7219585 Ingrowing nail 0.006062 0.791 DNAI2 Cognitive performance
rs7219585 Secondary malignancy of bone 1.358e-05 1.771 DNAI2 Cognitive performance
rs7219585 Subarachnoid hemorrhage 0.00179 2.299 DNAI2 Cognitive performance
rs7219585 Synoviopathy 0.001766 1.539 DNAI2 Cognitive performance
rs7219585 Adverse effects of sedatives or other central nervous system depressants and anesthetics 0.001342 1.918 DNAI2 Cognitive performance
rs7219585 Noninflammatory disorders of ovary, fallopian tube, & broad ligament 0.002824 1.864 DNAI2 Cognitive performance
rs7219585 Inguinal hernia 0.002301 0.7813 DNAI2 Cognitive performance
rs7219585 Myasthenia gravis 0.009834 2.152 DNAI2 Cognitive performance
rs7219585 Retinal edema and hypertensive retinopathy 0.004978 1.456 DNAI2 Cognitive performance
rs7219585 Nasal polyps 0.006501 1.468 DNAI2 Cognitive performance
rs7219585 Primary angle-closure glaucoma 0.004873 1.343 DNAI2 Cognitive performance
rs7219585 Complication of internal orthopedic device 0.002923 0.6861 DNAI2 Cognitive performance
rs7219585 Other disorders of urethra and urinary tract 0.01081 0.7452 DNAI2 Cognitive performance
rs7219585 Adverse drug events and drug allergies 0.01076 1.227 DNAI2 Cognitive performance
rs7219585 Premature menopause and other ovarian failure 0.003117 2.126 DNAI2 Cognitive performance
rs7219585 Cancer, suspected or other 0.01045 1.266 DNAI2 Cognitive performance
rs7219585 Malignant neoplasm, other 0.0113 1.304 DNAI2 Cognitive performance
rs7253363 Cholesteatoma 0.01132 2.333 ACP5 Multiple sclerosis
rs7253363 Primary pulmonary hypertension 0.004404 2.32 ACP5 Multiple sclerosis
rs7253363 Scleritis and episcleritis 0.003662 2.297 ACP5 Multiple sclerosis
rs7253363 Congenital anomalies of peripheral vascular system 0.007428 2.511 ACP5 Multiple sclerosis
rs7253363 Anisometropia 0.004249 1.74 ACP5 Multiple sclerosis
rs7253363 Otosclerosis 0.007092 2.015 ACP5 Multiple sclerosis
rs7253363 Acute laryngitis and tracheitis 0.005152 2.069 ACP5 Multiple sclerosis
rs7253363 Paralysis/spasm of vocal cords or larynx 0.008036 2.19 ACP5 Multiple sclerosis
rs7253363 Cramp of limb 0.01007 1.635 ACP5 Multiple sclerosis
rs7253363 Periapical abscess 0.00739 0.569 ACP5 Multiple sclerosis
rs7253363 Sacroiliitis NEC 0.01052 2.365 ACP5 Multiple sclerosis
rs7315438 Disorders resulting from impaired renal function 0.0043 1.308 MED13L Colorectal cancer
rs7315438 Neoplasm of uncertain behavior 0.001861 0.8191 MED13L Colorectal cancer
rs7315438 Keratitis, infectious 0.003243 0.6835 MED13L Colorectal cancer
rs7315438 Oliguria and anuria 0.005206 2.187 MED13L Colorectal cancer
rs7315438 Other endocrine disorders 0.002704 0.5961 MED13L Colorectal cancer
rs7315438 Nerve plexus lesions 0.006296 0.6877 MED13L Colorectal cancer
rs7315438 Hyperplasia of prostate 0.007772 0.8742 MED13L Colorectal cancer
rs7315438 Cholangitis 0.008164 0.5623 MED13L Colorectal cancer
rs7315438 Melanoma 0.0008162 0.7349 MED13L Colorectal cancer
rs7315438 Hypoparathyroidism 0.007758 0.4285 MED13L Colorectal cancer
rs735172 Allergies, other 0.002665 0.7512 EVC Prostate cancer (gene x gene interaction)
rs735172 Esophageal atresia/tracheoesophageal fistula 0.01112 1.646 EVC Prostate cancer (gene x gene interaction)
rs735172 Diseases of pulp and periapical tissues 0.01083 0.8262 EVC Prostate cancer (gene x gene interaction)
rs735172 Hepatomegaly 0.002796 0.4305 EVC Prostate cancer (gene x gene interaction)
rs735172 Adjustment reaction 0.002155 1.183 EVC Prostate cancer (gene x gene interaction)
rs735172 Conduct disorders 0.01116 0.6042 EVC Prostate cancer (gene x gene interaction)
rs735172 Other disorders of urethra and urinary tract 0.003487 1.239 EVC Prostate cancer (gene x gene interaction)
rs735172 Urethral stricture (not specified as infectious) 0.008148 1.418 EVC Prostate cancer (gene x gene interaction)
rs735172 Periostitis 0.00649 0.4711 EVC Prostate cancer (gene x gene interaction)
rs735172 Other specified disorders of pancreatic internal secretion 0.01003 0.5358 EVC Prostate cancer (gene x gene interaction)
rs735854 Enthesopathy 0.008865 0.8961 MYH9 Optic disc parameters
rs735854 Joint/ligament sprain 0.00473 0.7406 MYH9 Optic disc parameters
rs735854 Varicose veins of lower extremity 0.0001414 0.8063 MYH9 Optic disc parameters
rs735854 Ulceration of the lower GI tract 0.00121 0.549 MYH9 Optic disc parameters
rs735854 Acute posthemorrhagic anemia 0.003807 0.8368 MYH9 Optic disc parameters
rs735854 Aphasia/speech disturbance 0.01072 0.8155 MYH9 Optic disc parameters
rs735854 Benign neoplasm of respiratory and intrathoracic organs 0.005253 1.756 MYH9 Optic disc parameters
rs735854 Diseases of hard tissues of teeth 0.0004071 1.262 MYH9 Optic disc parameters
rs735854 Back & neck sprains 0.002061 0.8719 MYH9 Optic disc parameters
rs735854 Varicose veins of lower extremity, symptomtic 0.006461 0.8138 MYH9 Optic disc parameters
rs735854 Angiodysplasia of intestine 0.0003386 0.2548 MYH9 Optic disc parameters
rs735854 Sprains and strains 0.007508 0.9008 MYH9 Optic disc parameters
rs735854 Other disorders of tympanic membrane 0.002239 1.509 MYH9 Optic disc parameters
rs735854 Hypermetropia 0.007212 0.8769 MYH9 Optic disc parameters
rs735854 Nonspecific findings on examination of blood 5.266e-05 1.492 MYH9 Optic disc parameters
rs735854 Ulceration of intestine 0.003331 0.5434 MYH9 Optic disc parameters
rs735854 Diseases of pulp and periapical tissues 0.002639 1.231 MYH9 Optic disc parameters
rs735854 Chronic obstructive asthma 0.009424 1.273 MYH9 Optic disc parameters
rs735854 Hemorrhoids 0.000725 0.8705 MYH9 Optic disc parameters
rs735854 Neurological disorders due to brain damage 0.005371 0.8744 MYH9 Optic disc parameters
rs735854 Dental caries 0.001403 1.241 MYH9 Optic disc parameters
rs735854 Fractur of unspecified part of femur 0.001499 0.6385 MYH9 Optic disc parameters
rs735854 Internal derangement of knee 0.008326 0.8692 MYH9 Optic disc parameters
rs735854 Torticollis 0.001916 0.5685 MYH9 Optic disc parameters
rs735854 Osteoarthrosis of multiple sites 0.0005331 0.7695 MYH9 Optic disc parameters
rs735854 Open wound of lip and mouth 0.005092 0.5128 MYH9 Optic disc parameters
rs735854 Symptoms involving female genital tract 0.00945 0.723 MYH9 Optic disc parameters
rs735854 Varicose veins 0.0002051 0.8175 MYH9 Optic disc parameters
rs735854 Chronic venous insufficiency 0.006316 0.8371 MYH9 Optic disc parameters
rs735854 Disorders of cervical region 0.007757 0.7307 MYH9 Optic disc parameters
rs735854 Acquired deformities of ankle and foot 0.00783 0.8074 MYH9 Optic disc parameters
rs744373 Joint/ligament sprain 0.006058 0.7184 BIN1 Alzheimer's disease
rs744373 Menopausal & postmenopausal disorders 0.0105 1.134 BIN1 Alzheimer's disease
rs744373 Alopecia Areata 0.00386 2.119 BIN1 Alzheimer's disease
rs744373 Other specified diseases of hair and hair follicles 0.008096 1.328 BIN1 Alzheimer's disease
rs744373 Vaginitis and vulvovaginitis 0.01085 1.207 BIN1 Alzheimer's disease
rs744373 Adrenal hypofunction 0.005266 1.666 BIN1 Alzheimer's disease
rs744373 Postmenopausal hormone replacement 0.001673 1.374 BIN1 Alzheimer's disease
rs744373 Diseases of hair and hair follicles 0.005523 1.241 BIN1 Alzheimer's disease
rs744373 Anal and rectal conditions 0.001273 1.188 BIN1 Alzheimer's disease
rs744373 Cancer of other male genital organs 0.009824 1.727 BIN1 Alzheimer's disease
rs749005 Discoid lupus erythematosus 0.006768 0.511 F13A1 Entorhinal cortical volume
rs749005 Altered mental status 0.005241 1.393 F13A1 Entorhinal cortical volume
rs749005 Chronic bronchitis 0.01067 1.246 F13A1 Entorhinal cortical volume
rs749005 Nervous system congenital anomalies 0.004634 1.57 F13A1 Entorhinal cortical volume
rs749005 Phosphorus metabolism disorder 0.01014 0.5385 F13A1 Entorhinal cortical volume
rs749005 Other specified diseases of nail 0.01025 1.201 F13A1 Entorhinal cortical volume
rs749005 Seborrheic keratosis 0.003106 1.16 F13A1 Entorhinal cortical volume
rs749005 Systemic lupus erythematosus 0.007102 0.4823 F13A1 Entorhinal cortical volume
rs749005 Chronic prostatitis 0.01023 1.642 F13A1 Entorhinal cortical volume
rs749005 Retinal detachments and defects 0.01072 1.288 F13A1 Entorhinal cortical volume
rs749005 Ulceration of the lower GI tract 0.002165 1.808 F13A1 Entorhinal cortical volume
rs7495052 Anisometropia 0.002017 0.7284 SLCO3A1 Inattentive symptoms
rs7495052 Hypercalcemia 0.003021 0.7723 SLCO3A1 Inattentive symptoms
rs7495052 Periapical abscess 0.001731 1.254 SLCO3A1 Inattentive symptoms
rs7495052 Fracture of upper limb 0.01065 0.8788 SLCO3A1 Inattentive symptoms
rs7495052 Lymphadenitis 0.007762 1.175 SLCO3A1 Inattentive symptoms
rs7495052 Secondary malignancy of lymph nodes 0.005897 1.261 SLCO3A1 Inattentive symptoms
rs7495052 Nonrheumatic aortic valve disorders 0.003724 0.8508 SLCO3A1 Inattentive symptoms
rs7495052 Open wound of foot except toe(s) alone 0.005804 1.509 SLCO3A1 Inattentive symptoms
rs7495052 Disorders of mineral metabolism 0.0007307 0.8439 SLCO3A1 Inattentive symptoms
rs7495052 Renal colic 0.01119 1.602 SLCO3A1 Inattentive symptoms
rs7495052 Diseases of pulp and periapical tissues 0.004955 1.215 SLCO3A1 Inattentive symptoms
rs7498403 Gout and other crystal arthropathies 0.01093 1.261 MAF Height
rs7498403 Cardiac shunt/ heart septal defect 4.076e-05 2.235 MAF Height
rs7498403 Deviated nasal septum 0.009722 1.348 MAF Height
rs7498403 Cholelithiasis 0.008811 1.254 MAF Height
rs7498403 Arthropathy associated with neurological disorders 0.001419 2.66 MAF Height
rs7498403 Irritable Bowel Syndrome 0.009155 1.321 MAF Height
rs7498403 Develomental delays and disorders 0.00266 1.559 MAF Height
rs7498403 Personality disorders 0.008863 1.498 MAF Height
rs7498403 Cardiac congenital anomalies 0.001342 1.684 MAF Height
rs7498403 Osteoarthrosis of multiple sites 0.003129 1.505 MAF Height
rs7498403 Osteoarthrosis 0.008539 1.166 MAF Height
rs7498403 Other upper respiratory disease 0.0105 1.292 MAF Height
rs7498403 Other specified diseases of hair and hair follicles 0.01006 1.545 MAF Height
rs7498403 Arthropathy associated with other disorders classified elsewhere 0.005053 2.265 MAF Height
rs7498403 Cardiac and circulatory congenital anomalies 0.006922 1.507 MAF Height
rs750338 Chronic airway obstruction 0.004749 1.139 PKNOX2 Alcoholism
rs750338 Disaccharide malabsorption 0.001519 0.7881 PKNOX2 Alcoholism
rs750338 Carbohydrate transport and metabolism disorder 0.002026 0.7951 PKNOX2 Alcoholism
rs750338 Renal colic 0.004574 0.4325 PKNOX2 Alcoholism
rs750338 Urticaria 0.005699 0.7516 PKNOX2 Alcoholism
rs750338 Asthma 0.009295 1.14 PKNOX2 Alcoholism
rs750338 Pain in joint 0.008451 1.102 PKNOX2 Alcoholism
rs750338 Abnormal cytological, histological, immunological and DNA test findings 0.004171 0.3444 PKNOX2 Alcoholism
rs750338 Hypertension complicating pregnancy 0.005583 0.2664 PKNOX2 Alcoholism
rs750338 Valvular heart disease/ heart chambers 0.0007409 2.057 PKNOX2 Alcoholism
rs7517337 Lymphosarcoma 0.002892 0.3811 KCNT2 Total ventricular volume
rs7517337 Prurigo 0.009059 0.7814 KCNT2 Total ventricular volume
rs7517337 Functional disorders of bladder 0.007933 1.291 KCNT2 Total ventricular volume
rs7517337 Meniere's disease 0.009761 1.573 KCNT2 Total ventricular volume
rs7517337 Back pain 0.0005839 1.106 KCNT2 Total ventricular volume
rs7517337 Atrophic gastritis 0.001166 1.591 KCNT2 Total ventricular volume
rs7517337 Pulmonary embolism and infarction 0.001641 1.294 KCNT2 Total ventricular volume
rs7517337 Adrenal hyperfunction 0.003166 0.4751 KCNT2 Total ventricular volume
rs7517337 Hypopotassemia 0.006026 1.135 KCNT2 Total ventricular volume
rs7517337 Electrolyte imbalance 0.008596 1.096 KCNT2 Total ventricular volume
rs7517337 Pathologic fracture of vertebrae 0.000301 1.35 KCNT2 Total ventricular volume
rs7517337 Pathologic fracture 0.002097 1.232 KCNT2 Total ventricular volume
rs7517337 severe protein-calorie malnutrition 0.004892 1.559 KCNT2 Total ventricular volume
rs7517337 Osteoporosis, osteopenia, & pathological fractures 0.006422 1.098 KCNT2 Total ventricular volume
rs7517337 Other specified disorders of pancreatic internal secretion 0.01009 1.64 KCNT2 Total ventricular volume
rs7517337 Otalgia 0.009118 1.253 KCNT2 Total ventricular volume
rs755383 Calculus of ureter 0.0005033 1.319 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Jaundice 0.003429 0.64 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Chronic ulcer of unspecified site 0.006274 1.279 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Patellar fracture 0.007506 1.408 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Neuralgia, neuritis, and radiculitis NOS 0.003883 1.222 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Ileostomy status 0.00648 1.603 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Complications of gastrostomy, colostomy and enterostomy 0.000743 2.312 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Urinary calculus 0.007675 1.149 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Premature beats 0.006522 0.8385 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Ankylosing spondylitis 0.004686 2.255 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Rheumatoid arthritis & related inflammatory polyarthropathies 0.001287 1.237 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Injuries to the nervous system 0.01111 1.509 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Dental caries 0.01021 1.189 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Otorrhea 0.00918 1.897 DMRT1 Testicular germ cell cancer, Testicular cancer
rs755383 Multiple sclerosis 0.002988 1.595 DMRT1 Testicular germ cell cancer, Testicular cancer
rs7561317 Shock 0.000504 0.4814 TMEM18 Body mass index, Weight
rs7561317 Migraine 0.00129 0.7742 TMEM18 Body mass index, Weight
rs7561317 Other headache syndromes 0.008041 0.8798 TMEM18 Body mass index, Weight
rs7561317 Abnormal findings on radiological exam of musculoskeletal system 0.002766 1.767 TMEM18 Body mass index, Weight
rs7561317 Phosphorus metabolism disorder 0.006869 0.5516 TMEM18 Body mass index, Weight
rs7561317 Inflammatory disease of cervix, vagina, and vulva 0.004938 0.7875 TMEM18 Body mass index, Weight
rs7561317 Hypopotassemia 0.01114 0.8512 TMEM18 Body mass index, Weight
rs7561317 Torsion dystonia 0.008104 1.671 TMEM18 Body mass index, Weight
rs7561317 Parasomnia 0.009435 1.702 TMEM18 Body mass index, Weight
rs7561317 Nodular lymphoma 0.008278 1.675 TMEM18 Body mass index, Weight
rs7561317 Subarachnoid hemorrhage 0.007032 2.006 TMEM18 Body mass index, Weight
rs7561317 Unequal leg length (acquired) 0.002799 0.4911 TMEM18 Body mass index, Weight
rs7577851 Acquired deformities of limbs 0.003243 0.7287 AAK1 Parkinson's disease
rs7577851 Trigeminal nerve disorders 0.003157 1.608 AAK1 Parkinson's disease
rs7577851 Ulcer of esophagus 0.005831 1.557 AAK1 Parkinson's disease
rs7577851 Spinal stenosis of lumbar region 0.01112 0.8387 AAK1 Parkinson's disease
rs7577851 Other disorders of back 0.005979 0.8125 AAK1 Parkinson's disease
rs7577851 Barrett's esophagus 0.005988 1.491 AAK1 Parkinson's disease
rs7577851 Anemia of chronic disease 0.003529 1.282 AAK1 Parkinson's disease
rs7577851 Enthesopathy 0.01067 0.8699 AAK1 Parkinson's disease
rs7577851 Esophageal cancer 0.008206 1.881 AAK1 Parkinson's disease
rs7577851 Anal and rectal conditions 0.007581 0.8298 AAK1 Parkinson's disease
rs7577851 Psychogenic and somatoform disorders 0.009514 0.7213 AAK1 Parkinson's disease
rs7577851 Photodermatitis & sunburn 0.005111 0.793 AAK1 Parkinson's disease
rs7577851 Other disorders of soft tissues 0.007535 0.6138 AAK1 Parkinson's disease
rs7577851 Spinal stenosis 0.007004 0.845 AAK1 Parkinson's disease
rs7577851 Periapical abscess 0.002733 0.7373 AAK1 Parkinson's disease
rs7577851 Anemia in neoplastic disease 0.00386 1.548 AAK1 Parkinson's disease
rs7577851 Other disorders of tympanic membrane 0.004161 0.5324 AAK1 Parkinson's disease
rs7577851 Peripheral autonomic neuropathy 0.008858 0.6162 AAK1 Parkinson's disease
rs7577851 Diseases of pulp and periapical tissues 0.001267 0.7296 AAK1 Parkinson's disease
rs7577851 Neutropenia 0.000975 1.364 AAK1 Parkinson's disease
rs7577851 Edema 0.004849 0.8688 AAK1 Parkinson's disease
rs7577851 Osteoporosis, NOS or other 0.01069 1.159 AAK1 Parkinson's disease
rs7577851 Rash and other nonspecific skin eruption 0.0046 0.8025 AAK1 Parkinson's disease
rs7577851 Lymphosarcoma 0.01098 2.103 AAK1 Parkinson's disease
rs7577851 Fuchs' dystrophy 0.004583 0.5194 AAK1 Parkinson's disease
rs7577851 Unequal leg length (acquired) 0.0003571 0.4047 AAK1 Parkinson's disease
rs7577851 Decreased white blood cell count 0.001454 1.336 AAK1 Parkinson's disease
rs7577851 Other specified diseases of sebaceous glands 0.008672 0.759 AAK1 Parkinson's disease
rs7577851 Crystal arthropathies 0.01151 0.6515 AAK1 Parkinson's disease
rs7577851 Disorders of cornea 0.009326 0.7907 AAK1 Parkinson's disease
rs7577925 Inflammatory diseases of female pelvic organs 0.01086 0.8566 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Inflammatory disease of cervix, vagina, and vulva 0.007149 0.8405 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Polyneuropathy in diabetes 0.009368 1.188 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Osteoarthrosis; localized, primary 0.00613 0.7977 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Bronchitis 0.004276 1.152 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Cornea replaced by transplant 0.009918 0.5286 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Renal colic 0.009983 1.613 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Irritable Bowel Syndrome 0.007627 0.8481 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Other diseases of the teeth and supporting structures 0.008448 1.245 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Symptoms involving digestive system 0.005758 0.8065 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Iatrogenic hypotension 0.001102 1.736 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Benign neoplasm of other parts of digestive system 0.0092 1.307 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Skin neoplasm of uncertain behavior 0.009174 0.8277 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Migraine 0.005978 1.171 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Optic neuritis/neuropathy 0.008319 0.7344 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 CNS infection and poliomyelitis 0.0006833 1.877 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Noninflammatory female genital disorders 0.002052 0.8088 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Pseudoexfoliation glaucoma 0.004451 1.597 NCKAP5 Attention deficit hyperactivity disorder
rs7577925 Symptoms involving female genital tract 0.001642 0.6661 NCKAP5 Attention deficit hyperactivity disorder
rs758642 AV block 0.008983 1.188 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Congenital musculoskeletal deformities of spine 0.0002498 1.591 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Phobia 3.858e-05 3.046 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Cerebral ischemia 0.001859 0.8502 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Overweight 0.006875 1.09 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Spondylolisthesis, congenital 0.002937 1.604 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Cystic mastopathy 0.0001188 1.249 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Disorders of mineral metabolism 0.01106 1.135 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Varicose veins of lower extremity 0.002561 1.183 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Abnormal findings on mammogram or breast exam 0.002926 1.138 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Varicose veins 0.002669 1.175 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Congenital cataract and lens anomalies 0.001731 2.114 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Miscarriage; stillbirth 0.008393 0.4948 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Retinal hemorrhage/ischemia 0.01044 0.7173 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Tuberculosis 0.003695 1.99 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Mastodynia 0.002618 1.306 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Lump or mass in breast 0.0002123 1.226 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Benign mammary dysplasias 0.0003286 1.221 CAMKK1 Smoking behavior (cigarettes per day)
rs758642 Transient cerebral ischemia 0.005703 0.8632 CAMKK1 Smoking behavior (cigarettes per day)
rs7610017 Sprains and strains 0.005347 1.249 TP63 Grey matter density
rs7610017 Back & neck sprains 0.003963 1.298 TP63 Grey matter density
rs7610017 Rotator cuff (capsule) sprain 0.003704 1.465 TP63 Grey matter density
rs7610017 Spinal stenosis 0.008547 1.267 TP63 Grey matter density
rs7610017 Congenital anomalies of genital organs 0.006463 2.632 TP63 Grey matter density
rs7610017 Other specified cardiac dysrhythmias 0.008755 1.28 TP63 Grey matter density
rs7610017 Mechanical complication of nervous system device, implant, and graft 0.008756 2.712 TP63 Grey matter density
rs7610017 Symptoms involving digestive system 0.01061 1.418 TP63 Grey matter density
rs7610017 Urethral stricture (not specified as infectious) 0.003085 1.903 TP63 Grey matter density
rs7610017 Muscular wasting and disuse atrophy 0.008699 2.062 TP63 Grey matter density
rs7610017 Jaundice 0.001104 2.042 TP63 Grey matter density
rs7610017 Keratitis 0.006071 1.6 TP63 Grey matter density
rs7610017 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.01145 1.211 TP63 Grey matter density
rs7610017 Other disorders of back 0.008277 1.318 TP63 Grey matter density
rs7610017 Mixed hyperlipidemia 0.006565 0.6606 TP63 Grey matter density
rs7610017 Atrial fibrillation 0.008097 1.273 TP63 Grey matter density
rs7610017 Bacterial infection NOS 0.00623 1.286 TP63 Grey matter density
rs7610017 Other immunological findings 0.006986 1.59 TP63 Grey matter density
rs7610017 Coagulation defects 0.0106 1.205 TP63 Grey matter density
rs7672826 Inflammation of eyelids 0.002823 1.155 MGC45800 Multiple sclerosis
rs7672826 Dyspepsia and disorders of function of stomach 0.01057 0.858 MGC45800 Multiple sclerosis
rs7672826 Conductive hearing loss 0.003862 1.574 MGC45800 Multiple sclerosis
rs7672826 Hyperbilirubinemia 0.0002242 2.214 MGC45800 Multiple sclerosis
rs7672826 Symptoms of the muscles 0.003706 1.279 MGC45800 Multiple sclerosis
rs7672826 Disorders of function of stomach 0.009641 0.8627 MGC45800 Multiple sclerosis
rs7672826 Calculus of lower urinary tract 0.009856 0.5715 MGC45800 Multiple sclerosis
rs7672826 Nonallopathic lesions NEC 0.009174 1.129 MGC45800 Multiple sclerosis
rs7672826 Disorders of esophageal motility 0.0001406 1.729 MGC45800 Multiple sclerosis
rs7672826 Secondary/extrinsic cardiomyopathies 0.003044 1.865 MGC45800 Multiple sclerosis
rs7672826 Other aneurysm 0.003489 0.8224 MGC45800 Multiple sclerosis
rs7672826 Abdominal aortic aneurysm 0.004699 0.783 MGC45800 Multiple sclerosis
rs7672826 Aortic aneurysm 0.001124 0.7839 MGC45800 Multiple sclerosis
rs7672826 Peripheral or central vertigo 0.003823 1.232 MGC45800 Multiple sclerosis
rs7672826 Inflammation of the eye 0.003741 1.133 MGC45800 Multiple sclerosis
rs7672826 Thyroiditis 0.008853 1.344 MGC45800 Multiple sclerosis
rs7672826 Other disorders of urethra and urinary tract 0.00191 1.254 MGC45800 Multiple sclerosis
rs7672826 Epilepsy, recurrent seizures, convulsions 0.002547 0.8057 MGC45800 Multiple sclerosis
rs7672826 Convulsions 0.006902 0.8166 MGC45800 Multiple sclerosis
rs7672826 Noninfectious disorders of lymphatic channels 0.008838 1.32 MGC45800 Multiple sclerosis
rs7715811 Other specified disorders of breast 0.005153 0.7718 DNAH5 Ankle brachial index
rs7715811 Pathologic fracture 0.006414 0.8061 DNAH5 Ankle brachial index
rs7715811 Multiple sclerosis 0.01033 1.511 DNAH5 Ankle brachial index
rs7715811 Mucous polyp of cervix 0.001594 0.6201 DNAH5 Ankle brachial index
rs7715811 Infertility, male 0.004781 1.988 DNAH5 Ankle brachial index
rs7715811 Acute bronchospasm 0.009412 2.033 DNAH5 Ankle brachial index
rs7715811 Vitamin D deficiency 0.0105 0.7499 DNAH5 Ankle brachial index
rs7715811 Cystic mastopathy 0.002138 0.8233 DNAH5 Ankle brachial index
rs7715811 Rash and other nonspecific skin eruption 0.006372 0.8427 DNAH5 Ankle brachial index
rs7715811 Asthma 0.007527 0.8784 DNAH5 Ankle brachial index
rs7715811 Excessive or frequent menstruation 0.003672 0.7259 DNAH5 Ankle brachial index
rs7715811 Postmenopausal hormone replacement 0.001842 0.7252 DNAH5 Ankle brachial index
rs7715811 Toxic effect of venom 0.003698 0.5636 DNAH5 Ankle brachial index
rs7715811 Hypothyroidism 0.003935 0.8897 DNAH5 Ankle brachial index
rs7715811 Benign mammary dysplasias 0.002355 0.8312 DNAH5 Ankle brachial index
rs7715811 Simple goiter 0.003957 0.7724 DNAH5 Ankle brachial index
rs7742369 Nontoxic multinodular goiter 0.002203 0.6836 HMGA1 Height
rs7742369 Acute, but ill-defined cerebrovascular disease 0.001626 1.289 HMGA1 Height
rs7742369 Neuralgia, neuritis, and radiculitis NOS 0.003498 0.751 HMGA1 Height
rs7742369 Orchitis and epididymitis 0.005723 1.552 HMGA1 Height
rs7742369 Circulatory disease NEC 0.004115 1.219 HMGA1 Height
rs7742369 Ptosis of eyelid 0.01082 1.246 HMGA1 Height
rs7742369 Other disorders of circulatory system 0.003564 1.199 HMGA1 Height
rs7742369 Hypertrophy of female genital organs 0.002587 1.943 HMGA1 Height
rs7742369 Disorders of esophageal motility 0.0005785 1.747 HMGA1 Height
rs7742369 Torsion dystonia 0.01026 1.649 HMGA1 Height
rs7742369 Duodenal ulcer 0.008938 0.6642 HMGA1 Height
rs7742369 Hemorrhage NOS 0.001434 1.961 HMGA1 Height
rs7742369 Poisoning by water, mineral, and uric acid metabolism drugs 0.007016 1.764 HMGA1 Height
rs7742369 Benign neoplasm of respiratory and intrathoracic organs 0.002978 1.927 HMGA1 Height
rs7742369 Disorders of uterus, NEC 0.008388 1.877 HMGA1 Height
rs7774434 Insomnia 0.008948 1.159 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Diplopia and disorders of binocular vision 0.01028 1.274 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Rheumatoid arthritis 0.001984 1.256 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Labyrinthitis 0.01114 1.34 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Eosinophilia 0.0006764 2.074 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Allergic rhinitis 0.009658 1.112 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Multiple sclerosis 0.004638 0.6061 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Gastroparesis 0.001771 1.828 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Vitamin B-complex deficiencies 0.003554 0.7919 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Rheumatoid arthritis & related inflammatory polyarthropathies 0.004704 1.204 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Other local infections of skin and subcutaneous tissue 0.006121 0.8483 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Chronic sinusitis 0.008639 1.12 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Rheumatic fever / chorea 0.009812 0.4599 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Type 1 diabetic neuropathy 0.01003 1.411 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Other disorders of adrenal glands 0.009332 0.6447 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Retinal hemorrhage/ischemia 0.002346 1.448 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Other specified erythematous conditions 0.00652 0.7513 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Discoid lupus erythematosus 0.004498 0.6579 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Bullous dermatoses 0.003318 0.4509 HLA-DQB1 Primary biliary cirrhosis
rs7774434 Lupus erythematosus 0.003281 0.4469 HLA-DQB1 Primary biliary cirrhosis
rs7789197 Diseases of the jaws 0.01015 1.232 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Diaphragmatic hernia 0.002318 1.192 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Epilepsy 0.01139 1.401 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Throat pain 0.009417 1.687 INHBA Prostate cancer (gene x gene interaction)
rs7789197 First degree AV block 0.003654 1.322 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Adverse effects of insulins and antidiabetic agents 0.009215 1.859 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Other disorders of middle ear and mastoid 0.008451 1.528 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Dental caries 0.0009868 1.31 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Convulsions 0.001052 1.311 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Cardiac defibrillator in situ 0.001109 1.605 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Otalgia 3.507e-05 1.521 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Periostitis 0.005115 1.916 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Epilepsy, recurrent seizures, convulsions 0.00136 1.288 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Noninflammatory disorders of vagina 0.01057 0.6503 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Acute bronchospasm 0.001731 2.526 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Diseases of hard tissues of teeth 0.004686 1.256 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Gastritis and duodenitis 0.005061 1.19 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Other signs and symptoms in breast 0.01033 0.6399 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Other specified cardiac dysrhythmias 0.008679 1.165 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Primary angle-closure glaucoma 0.007229 0.7606 INHBA Prostate cancer (gene x gene interaction)
rs7789197 Poisoning by anticonvulsants and anti-Parkinsonism drugs 0.01071 1.86 INHBA Prostate cancer (gene x gene interaction)
rs7792939 Acute cystitis 0.003734 0.5444 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Cachexia 0.002491 2.385 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Mental retardation 0.007869 2.286 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Stress fracture 0.01057 1.99 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Hemiplegia 0.008644 0.6148 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Fibroadenosis of breast 0.01135 2.232 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Cystitis 0.0005567 0.6637 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Dysuria 0.007735 0.8008 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Chronic cystitis 0.008979 0.4809 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Cystitis and urethritis 0.004533 0.7354 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Chronic ulcer of skin 0.008632 0.8354 ZNF498 Weight, Hip circumference, Brachial circumference
rs7792939 Decubitus ulcer 0.01076 0.7313 ZNF498 Weight, Hip circumference, Brachial circumference
rs7804356 Abnormal loss of weight and underweight 0.01015 1.296 SKAP2 Type 1 diabetes
rs7804356 Joint/ligament sprain 0.006483 0.7011 SKAP2 Type 1 diabetes
rs7804356 Aplastic anemia 0.006076 0.6691 SKAP2 Type 1 diabetes
rs7804356 Hallux valgus (Bunion) 0.005117 1.226 SKAP2 Type 1 diabetes
rs7804356 Renal osteodystrophy 0.008136 1.53 SKAP2 Type 1 diabetes
rs7804356 Noninfectious dermatoses of eyelid 0.005505 1.77 SKAP2 Type 1 diabetes
rs7804356 Adverse drug events and drug allergies 0.001563 1.232 SKAP2 Type 1 diabetes
rs7865146 Occlusion and stenosis of precerebral arteries 0.01136 0.8841 ENG Diastolic blood pressure
rs7865146 Retinal vascular changes and abnomalities 0.0001875 0.7475 ENG Diastolic blood pressure
rs7865146 Congenital cataract and lens anomalies 0.008297 0.4675 ENG Diastolic blood pressure
rs7865146 Congenital anomalies of peripheral vascular system 0.008943 0.5208 ENG Diastolic blood pressure
rs7865146 Cardiac and circulatory congenital anomalies 0.004 0.7534 ENG Diastolic blood pressure
rs7865146 Impetigo 0.006819 0.6179 ENG Diastolic blood pressure
rs7865146 Other disorders of gallbladder 0.006972 1.576 ENG Diastolic blood pressure
rs7865146 Cardiac shunt/ heart septal defect 0.002571 0.6372 ENG Diastolic blood pressure
rs7865146 Unspecified monoarthritis 0.007151 1.629 ENG Diastolic blood pressure
rs7865146 Dermatosis NOS 0.003974 0.8942 ENG Diastolic blood pressure
rs7865146 Secondary malignancy of lymph nodes 0.01018 1.243 ENG Diastolic blood pressure
rs7865146 Abnormal pulmonary function 0.007717 2.159 ENG Diastolic blood pressure
rs7865146 Open-angle glaucoma 0.003521 0.8438 ENG Diastolic blood pressure
rs7865146 Rhabdomyolysis 0.009632 1.776 ENG Diastolic blood pressure
rs7866070 Crohn's disease 0.009215 1.429 PRRX2 Astigmatism
rs7866070 Fasciitis 0.008844 1.163 PRRX2 Astigmatism
rs7866070 Myeloproliferative disease 0.001948 1.415 PRRX2 Astigmatism
rs7866070 Ulcer of esophagus 0.0008379 1.539 PRRX2 Astigmatism
rs7866070 Pulmonary embolism and infarction 0.006773 1.251 PRRX2 Astigmatism
rs7866070 Gastric ulcer 6.299e-05 1.435 PRRX2 Astigmatism
rs7866070 Viral hepatitis C 0.001414 0.5753 PRRX2 Astigmatism
rs7866070 Sciatica 0.003328 1.186 PRRX2 Astigmatism
rs7866070 Peptic ulcer 0.0006551 1.215 PRRX2 Astigmatism
rs7866070 Abdominal hernia 0.009863 1.094 PRRX2 Astigmatism
rs7866070 Pseudoexfoliation glaucoma 0.002382 0.5526 PRRX2 Astigmatism
rs7866070 Barrett's esophagus 0.009742 1.358 PRRX2 Astigmatism
rs7866070 Viral hepatitis 0.001998 0.7322 PRRX2 Astigmatism
rs7866070 Disorders of synovium, tendon, and bursa 0.01004 1.113 PRRX2 Astigmatism
rs7866070 Scoliosis 0.007445 1.304 PRRX2 Astigmatism
rs7866070 Migraine 0.01018 0.8565 PRRX2 Astigmatism
rs7866070 Curvature of spine 0.009293 1.236 PRRX2 Astigmatism
rs786870 Vitamin B12 deficiency anemia 0.005286 1.581 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Chronic kidney disease, Stage I or II 0.003108 0.6338 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Failure to thrive 0.003099 1.468 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Disturbance of skin sensation 0.008544 1.133 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Upper gastrointestinal congenital anomalies 0.001941 1.687 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Other open wound of head and face 0.002107 0.769 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Paranoid disorders 0.001664 1.973 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Orchitis and epididymitis 0.001429 0.5714 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Iron metabolism disorder 0.006679 1.871 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Disorders of adrenal glands 0.004416 1.369 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Hereditary and idiopathic peripheral neuropathy 0.01114 1.155 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Muscular dystrophies and other myopathies 0.0113 1.448 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs786870 Elevated levels of transaminase or lactic acid dehydrogenase 0.008386 1.212 APBB1IP Response to fenofibrate treatment, Inflammatory biomarkers
rs7871764 Vitamin D deficiency 0.006313 1.308 DCAF12 Height
rs7871764 Retinal disorders 0.008983 1.116 DCAF12 Height
rs7871764 Adverse effects of insulins and antidiabetic agents 0.005575 1.818 DCAF12 Height
rs7871764 Infections involving bone 0.007358 0.7704 DCAF12 Height
rs7871764 Age-related macular degeneration 0.001637 1.258 DCAF12 Height
rs7871764 Hemorrhagic disorder due to intrinsic circulating anticoagulants 0.007289 1.114 DCAF12 Height
rs7871764 Urticaria 0.007511 0.7842 DCAF12 Height
rs7871764 Barrett's esophagus 0.008599 1.375 DCAF12 Height
rs7871764 Polycystic ovaries 0.007358 0.3874 DCAF12 Height
rs7871764 Vascular dementia 0.003768 1.436 DCAF12 Height
rs7871764 Dermatophytosis of the body 0.006701 0.696 DCAF12 Height
rs7871764 Precordial pain 0.01128 0.7464 DCAF12 Height
rs7871764 Extrinsic allergic alveolitis 0.000184 2.576 DCAF12 Height
rs7873102 Male infertility and abnormal spermatozoa 0.01104 1.618 SHB Brain structure
rs7873102 Symptoms involving nervous and musculoskeletal systems 0.007016 0.7883 SHB Brain structure
rs7873102 Fracture of unspecified bones 0.006533 1.156 SHB Brain structure
rs7873102 Chronic kidney disease, Stage I or II 0.003529 1.407 SHB Brain structure
rs7873102 Cysts of the jaws 0.001742 2.492 SHB Brain structure
rs7873102 Gram negative septicemia 0.004812 1.411 SHB Brain structure
rs7873102 Diaphragmatic hernia 0.003623 1.147 SHB Brain structure
rs7873102 Acute laryngitis and tracheitis 0.001482 1.562 SHB Brain structure
rs7873102 Optic atrophy 0.002445 0.6378 SHB Brain structure
rs7873102 Viral Enteritis 0.006066 1.482 SHB Brain structure
rs7873102 Other sprains and strains 0.005416 1.348 SHB Brain structure
rs7873102 Fasciitis 0.01039 1.15 SHB Brain structure
rs789560 Uterine leiomyoma 0.005285 1.341 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 severe protein-calorie malnutrition 0.004332 1.783 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Type 2 diabetic peripheral circulatory disorders 0.009042 1.503 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Contracture of joint 0.00112 1.664 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Hypercoagulable state 0.01145 1.629 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Emphysema 0.002829 1.426 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Develomental delays and disorders 0.009156 1.375 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs789560 Disorders of penis 0.008682 1.474 C12orf28 Attention deficit hyperactivity disorder and conduct disorder
rs7916697 Melanoma 0.006393 1.299 ATOH7 Optic disc parameters
rs7916697 Bronchiectasis 0.006573 1.414 ATOH7 Optic disc parameters
rs7916697 Nevus, non-neoplastic 0.0005633 0.3604 ATOH7 Optic disc parameters
rs7916697 Cellulitis and abscess of trunk 0.006713 0.7204 ATOH7 Optic disc parameters
rs7916697 Abnormal reflex 0.007259 2.153 ATOH7 Optic disc parameters
rs7916697 Heartburn 0.005917 1.413 ATOH7 Optic disc parameters
rs7916697 Other rheumatic heart disease 0.002711 2.084 ATOH7 Optic disc parameters
rs7916697 Crohn's disease 0.0006647 1.626 ATOH7 Optic disc parameters
rs7916697 Inflammatory conditions of jaw 0.003484 1.621 ATOH7 Optic disc parameters
rs7916697 Inflammatory bowel disease 0.008765 1.338 ATOH7 Optic disc parameters
rs7916697 Esophageal atresia/tracheoesophageal fistula 0.00407 0.4373 ATOH7 Optic disc parameters
rs7916697 Toxic erythema 0.003095 2.219 ATOH7 Optic disc parameters
rs7916697 Photodermatitis & sunburn 0.009268 0.832 ATOH7 Optic disc parameters
rs7922491 Poisoning by other anti-infectives 0.0005344 1.514 PRKG1 Asthma
rs7922491 Intestinal malabsorption NOS 0.005418 2.023 PRKG1 Asthma
rs7922491 Fracture of unspecified bones 0.00441 1.261 PRKG1 Asthma
rs7922491 Abnormal findings on radiological examination intrathoracic organs 0.01099 1.327 PRKG1 Asthma
rs7922491 Hypotension NOS 0.005857 1.297 PRKG1 Asthma
rs7922491 Hypotension 0.003752 1.231 PRKG1 Asthma
rs7922491 Fuchs' dystrophy 0.009471 1.697 PRKG1 Asthma
rs7922491 Sulfonamides 0.001313 1.533 PRKG1 Asthma
rs7922491 Herpes zoster with nervous system complications 0.003419 1.863 PRKG1 Asthma
rs7922491 Disorders of coccyx 0.005041 1.572 PRKG1 Asthma
rs7922491 Purpura and other hemorrhagic conditions 0.01102 0.7752 PRKG1 Asthma
rs7922491 Erythematous conditions 0.01055 0.8211 PRKG1 Asthma
rs7922491 Osteoarthrosis of multiple sites 0.003509 1.412 PRKG1 Asthma
rs7922491 Chronic pain syndrome 0.001564 2.108 PRKG1 Asthma
rs7922491 Spinal stenosis of lumbar region 0.007157 1.236 PRKG1 Asthma
rs7922491 Concussion 0.00973 1.688 PRKG1 Asthma
rs7922491 Spondylosis and allied disorders 0.009143 1.171 PRKG1 Asthma
rs7922491 Abnormal findings on exam of gastrointestinal tract/abdominal area 0.01144 1.51 PRKG1 Asthma
rs7922491 Syncope and collapse 0.004902 1.2 PRKG1 Asthma
rs7922491 Lump or mass in breast 0.008548 0.7804 PRKG1 Asthma
rs7922491 Cancer within the respiratory system 5.545e-05 1.551 PRKG1 Asthma
rs7922491 Lung cancer 0.0001059 1.537 PRKG1 Asthma
rs7922491 Other hereditary hemolytic anemias 0.009381 2.437 PRKG1 Asthma
rs7922491 Viral hepatitis 0.003704 1.467 PRKG1 Asthma
rs7922491 Diseases of respiratory system 0.001035 1.317 PRKG1 Asthma
rs7922491 Deficiency of humoral immunity 0.01023 2.343 PRKG1 Asthma
rs7937 Diffuse diseases of connective tissue 0.009626 1.254 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Malaise and fatigue 0.0114 1.08 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Cachexia 0.003834 2.122 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Lack of normal physiological development 0.008723 1.343 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Cramp of limb 9.811e-05 1.47 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Osteopenia 0.006506 1.127 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Viral infection 0.0003421 1.236 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Asthma 0.003651 1.133 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Seborrhea 0.0114 0.523 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7937 Deficiency of humoral immunity 0.006781 2.099 RAB4B Chronic obstructive pulmonary disease in current smokers
rs7961894 Multiple myeloma 0.004376 1.845 WDR66 Platelet counts, Mean platelet volume
rs7961894 Generalized anxiety disorder 0.008896 1.431 WDR66 Platelet counts, Mean platelet volume
rs7961894 Aplastic anemia 1.931e-05 1.85 WDR66 Platelet counts, Mean platelet volume
rs7961894 Cellulitis and abscess of foot/toes 0.005073 1.447 WDR66 Platelet counts, Mean platelet volume
rs7961894 Pseudomonal pneumonia 0.007612 2.524 WDR66 Platelet counts, Mean platelet volume
rs7961894 Peripheral autonomic neuropathy 0.007981 1.543 WDR66 Platelet counts, Mean platelet volume
rs7961894 Mental retardation 0.0007206 2.968 WDR66 Platelet counts, Mean platelet volume
rs7961894 Enthesopathy 0.01142 1.177 WDR66 Platelet counts, Mean platelet volume
rs7961894 Pancytopenia 0.000773 1.996 WDR66 Platelet counts, Mean platelet volume
rs7961894 Type 1 diabetes 0.005331 1.282 WDR66 Platelet counts, Mean platelet volume
rs7961894 Posttraumatic stress disorder 0.008248 1.796 WDR66 Platelet counts, Mean platelet volume
rs7961894 Vitamin B-complex deficiencies 0.008673 1.336 WDR66 Platelet counts, Mean platelet volume
rs7961894 Other diseases of the teeth and supporting structures 0.003651 1.412 WDR66 Platelet counts, Mean platelet volume
rs7961894 Adjustment reaction 0.004856 1.255 WDR66 Platelet counts, Mean platelet volume
rs7961894 Colon cancer 0.006707 0.6718 WDR66 Platelet counts, Mean platelet volume
rs8016947 Mycoses 0.005324 1.562 NFKBIA Psoriasis vulgaris
rs8016947 Abnormal results of function study of liver 0.004749 1.223 NFKBIA Psoriasis vulgaris
rs8016947 Other unspecified back disorders 0.007313 0.6356 NFKBIA Psoriasis vulgaris
rs8016947 Crohn's disease 0.006783 1.448 NFKBIA Psoriasis vulgaris
rs8016947 Cervical cancer 0.00687 0.5087 NFKBIA Psoriasis vulgaris
rs8016947 Diaphragmatic hernia 0.00883 0.8836 NFKBIA Psoriasis vulgaris
rs8016947 Known or suspected fetal abnormality 0.001156 0.5205 NFKBIA Psoriasis vulgaris
rs8017161 Encounter for long-term use of anticoagulants/antithrombotics 0.000219 0.7041 TNFAIP2 Primary biliary cirrhosis
rs8017161 Cervical cancer and dysplasia 0.002563 0.7427 TNFAIP2 Primary biliary cirrhosis
rs8017161 Subarachnoid hemorrhage (injury) 0.009961 0.4293 TNFAIP2 Primary biliary cirrhosis
rs8017161 Melanoma 0.01146 0.7908 TNFAIP2 Primary biliary cirrhosis
rs8017161 Encounter for long-term use of aspirin 8.282e-05 0.6558 TNFAIP2 Primary biliary cirrhosis
rs8017161 Nodular lymphoma 0.00493 0.5816 TNFAIP2 Primary biliary cirrhosis
rs8017161 Jaw disease NOS 0.0009016 1.655 TNFAIP2 Primary biliary cirrhosis
rs8017161 Cervical intraepithelial neoplasia (Cervical dysplasia) 0.003599 0.7325 TNFAIP2 Primary biliary cirrhosis
rs8017161 Other disorders of metabolism 0.01046 0.6144 TNFAIP2 Primary biliary cirrhosis
rs8017161 Disorders of parathyroid gland 0.005431 1.299 TNFAIP2 Primary biliary cirrhosis
rs8017161 Hyperparathyroidism 0.005555 1.313 TNFAIP2 Primary biliary cirrhosis
rs8017161 Bladder neck obstruction 0.00856 0.7891 TNFAIP2 Primary biliary cirrhosis
rs8017161 Herpes zoster with nervous system complications 0.004487 0.616 TNFAIP2 Primary biliary cirrhosis
rs8017161 Nephritis and nephropathy without mention of glomerulonephritis 0.007486 1.249 TNFAIP2 Primary biliary cirrhosis
rs8017161 Inguinal hernia 0.006343 1.158 TNFAIP2 Primary biliary cirrhosis
rs8017161 Testicular dysfunction 0.01016 0.7172 TNFAIP2 Primary biliary cirrhosis
rs8017161 Barrett's esophagus 0.003283 1.411 TNFAIP2 Primary biliary cirrhosis
rs8023445 Hepatomegaly 0.001031 2.268 SHC4 Major depressive disorder
rs8023445 Fracture of vertebral column without mention of spinal cord injury 0.002773 1.359 SHC4 Major depressive disorder
rs8023445 Pelvic peritoneal adhesions, female (postoperative) (postinfection) 0.001822 2.757 SHC4 Major depressive disorder
rs8023445 Purpura and other hemorrhagic conditions 0.003701 1.265 SHC4 Major depressive disorder
rs8023445 Thrombocytopenia 0.0037 1.296 SHC4 Major depressive disorder
rs8023445 Fracture of foot 0.00847 1.291 SHC4 Major depressive disorder
rs8023445 Dermatosis NOS 0.0108 0.8591 SHC4 Major depressive disorder
rs8023445 Secondary malignant neoplasm 0.007275 0.7819 SHC4 Major depressive disorder
rs8038465 Ulcerative colitis 0.006626 0.6704 CD276 Gamma-glutamyl transferase
rs8038465 Cardiomegaly 0.001205 1.187 CD276 Gamma-glutamyl transferase
rs8038465 Congenital anomalies of peripheral vascular system 0.01097 0.5377 CD276 Gamma-glutamyl transferase
rs8038465 Other hypertensive complications 0.004052 1.272 CD276 Gamma-glutamyl transferase
rs8038465 Balanoposthitis 0.00666 1.665 CD276 Gamma-glutamyl transferase
rs8038465 Spondylosis without myelopathy 0.0003026 0.8675 CD276 Gamma-glutamyl transferase
rs8038465 Iatrogenic hypothyroidism 0.002497 0.7122 CD276 Gamma-glutamyl transferase
rs8038465 Inflammatory bowel disease 0.01013 0.7564 CD276 Gamma-glutamyl transferase
rs8038465 Graves' disease 0.003289 0.6352 CD276 Gamma-glutamyl transferase
rs8038465 Ulceration of the lower GI tract 0.00881 0.6347 CD276 Gamma-glutamyl transferase
rs8038465 Femoral hernia 0.003641 0.4587 CD276 Gamma-glutamyl transferase
rs8038465 E. coli 0.004082 0.7319 CD276 Gamma-glutamyl transferase
rs8038465 Spondylosis and allied disorders 0.0004319 0.8742 CD276 Gamma-glutamyl transferase
rs8038465 Cancer of oropharynx 0.01105 1.953 CD276 Gamma-glutamyl transferase
rs8038465 Pneumonia 0.0009646 1.132 CD276 Gamma-glutamyl transferase
rs8041675 Abnormal glucose 0.005691 1.115 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Malignant neoplasm of kidney and other urinary organs 0.006375 1.678 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Malunion fracture 0.005724 1.436 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Congenital anomalies of limbs 2.989e-06 1.517 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Impaired fasting glucose 0.003994 1.192 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Chronic tonsillitis and adenoiditis 0.01059 0.595 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Congenital anomalies of lower limb, including pelvic girdle 0.008863 1.771 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Congenital deformities of feet 2.935e-05 1.528 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Disorders of uterus, NEC 0.01065 1.771 MEIS2 Hyperactive-impulsive symptoms
rs8041675 Blindness and low vision 0.01104 1.282 MEIS2 Hyperactive-impulsive symptoms
rs8042374 Peripheral vascular disease 0.006403 0.8754 CHRNA3 Lung cancer
rs8042374 Peripheral arterial disease 0.002107 0.8493 CHRNA3 Lung cancer
rs8042374 Gout 0.0006843 1.234 CHRNA3 Lung cancer
rs8042374 Cirrhosis of liver without mention of alcohol 0.004586 1.495 CHRNA3 Lung cancer
rs8042374 Gout and other crystal arthropathies 0.0006565 1.218 CHRNA3 Lung cancer
rs8042374 Disorders of parathyroid gland 0.001375 0.6701 CHRNA3 Lung cancer
rs8042374 Gouty arthropathy 0.004039 1.364 CHRNA3 Lung cancer
rs8042374 Atherosclerosis of the extremities 0.006508 0.8529 CHRNA3 Lung cancer
rs8042374 Cancer of other male genital organs 0.009007 1.747 CHRNA3 Lung cancer
rs8042374 Chronic nonalcoholic liver disease 0.005345 1.28 CHRNA3 Lung cancer
rs8042374 Pneumonia 0.005332 0.8828 CHRNA3 Lung cancer
rs8042374 Atherosclerosis of native arteries of the extremities with intermittent claudication 0.006277 0.8203 CHRNA3 Lung cancer
rs8042374 Type 2 diabetic ketoacidosis 0.001265 1.191 CHRNA3 Lung cancer
rs8042374 Hyperparathyroidism 0.002401 0.6736 CHRNA3 Lung cancer
rs8047014 Urticaria 0.003144 0.7813 HAS3 Attention deficit hyperactivity disorder
rs8047014 Cancer of kidney and urinary organs 0.008696 1.201 HAS3 Attention deficit hyperactivity disorder
rs8047014 Morbid obesity 0.0002051 0.8054 HAS3 Attention deficit hyperactivity disorder
rs8047014 Renal cell carcinoma 0.001152 1.431 HAS3 Attention deficit hyperactivity disorder
rs8047014 Mitral stenosis/insufficiency 0.003459 0.4652 HAS3 Attention deficit hyperactivity disorder
rs8047014 Abnormal findings on examination of urine 0.01103 0.8579 HAS3 Attention deficit hyperactivity disorder
rs8047014 Other biliary tract disease 0.001084 1.324 HAS3 Attention deficit hyperactivity disorder
rs8047014 Other disorders of soft tissues 0.006995 0.7057 HAS3 Attention deficit hyperactivity disorder
rs8047014 Cancer of kidney and renal pelvis 0.001569 1.415 HAS3 Attention deficit hyperactivity disorder
rs8047014 Periapical abscess 0.01087 0.8281 HAS3 Attention deficit hyperactivity disorder
rs8047014 Hemorrhage from gastrointestinal ulcer 0.004385 0.6876 HAS3 Attention deficit hyperactivity disorder
rs8062326 Intestinal malabsorption 0.001559 2.069 SYT17 Alcoholism
rs8062326 Fracture of ribs 0.001817 1.728 SYT17 Alcoholism
rs8062326 Hypoglycemia 0.006774 2.087 SYT17 Alcoholism
rs8062326 Fracture of vertebral column without mention of spinal cord injury 0.008876 1.559 SYT17 Alcoholism
rs8062326 Otorrhea 0.008101 2.889 SYT17 Alcoholism
rs8062326 Peripheral or central vertigo 0.003693 0.4785 SYT17 Alcoholism
rs8062326 Ulcerative stomatitis & mucositis 3.24e-05 3.893 SYT17 Alcoholism
rs8062326 Sprains and strains 0.01011 1.294 SYT17 Alcoholism
rs8062326 Noninflammatory female genital disorders 0.01076 1.475 SYT17 Alcoholism
rs8062326 Glossitis 0.006284 3.016 SYT17 Alcoholism
rs8062326 Rotator cuff (capsule) sprain 2.519e-05 1.893 SYT17 Alcoholism
rs8074980 Secondary malignancy of bone 0.003127 0.6106 CUEDC1 Multiple sclerosis
rs8074980 Peripheral enthesopathies 0.00909 1.119 CUEDC1 Multiple sclerosis
rs8074980 Poisoning by water, mineral, and uric acid metabolism drugs 0.005495 1.787 CUEDC1 Multiple sclerosis
rs8074980 Respiratory insufficiency 0.007309 0.6819 CUEDC1 Multiple sclerosis
rs8074980 Ventral hernia 0.0005311 1.462 CUEDC1 Multiple sclerosis
rs8074980 Prostate cancer 0.006267 0.7919 CUEDC1 Multiple sclerosis
rs8074980 Prostatitis 0.002198 0.6615 CUEDC1 Multiple sclerosis
rs8074980 Aphakia and other disorders of lens 0.007361 1.368 CUEDC1 Multiple sclerosis
rs8074980 Unspecified erythematous condition 0.01058 0.5495 CUEDC1 Multiple sclerosis
rs8074980 Attention deficit hyperactivity disorder 0.01052 1.72 CUEDC1 Multiple sclerosis
rs8074980 Calcaneal spur; Exostosis NOS 0.007386 1.336 CUEDC1 Multiple sclerosis
rs8074980 Hyperbilirubinemia 0.001524 2.09 CUEDC1 Multiple sclerosis
rs8074980 Disease of tricuspid valve 0.01074 0.7362 CUEDC1 Multiple sclerosis
rs8074980 Syncope and collapse 0.007013 0.8587 CUEDC1 Multiple sclerosis
rs8074980 Secondary malignancy of lymph nodes 0.004986 0.7004 CUEDC1 Multiple sclerosis
rs8079702 Other disorders of intestine 0.003696 0.8299 KCNJ2 Primary tooth development
rs8079702 Open wounds of head; neck; and trunk 0.006505 0.8679 KCNJ2 Primary tooth development
rs8079702 Other diseases of the teeth and supporting structures 0.002638 0.7792 KCNJ2 Primary tooth development
rs8079702 Open wound of nose and sinus 0.01044 0.4775 KCNJ2 Primary tooth development
rs8079702 Other cerebral degenerations 0.01147 1.373 KCNJ2 Primary tooth development
rs8079702 Loss of teeth or edentulism 0.003607 0.709 KCNJ2 Primary tooth development
rs8079702 Fracture of radius and ulna 0.005455 0.8419 KCNJ2 Primary tooth development
rs8079702 Fuchs' dystrophy 0.002408 0.6304 KCNJ2 Primary tooth development
rs8079702 Nerve plexus lesions 0.006641 0.6895 KCNJ2 Primary tooth development
rs8079702 Benign neoplasm of eye 0.009254 1.227 KCNJ2 Primary tooth development
rs8079702 Intestinal obstruction without mention of hernia 0.005702 0.8353 KCNJ2 Primary tooth development
rs8079702 Chronic hepatitis 0.01059 1.711 KCNJ2 Primary tooth development
rs8079702 Fracture of upper limb 0.00798 0.8763 KCNJ2 Primary tooth development
rs8079702 Disorders of liver 0.008869 0.9042 KCNJ2 Primary tooth development
rs8083432 Convulsions 0.002245 1.27 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Otitis externa 0.008155 1.22 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Bladder neck obstruction 0.009768 1.308 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Occlusion of cerebral arteries, with cerebral infarction 0.009329 0.5668 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Photodermatitis & sunburn 0.0001962 1.303 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Epilepsy, recurrent seizures, convulsions 0.00142 1.269 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Empyema and pneumothorax 0.00689 0.7014 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Dupuytren's disease 0.002948 1.497 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Peyronie's disease 0.005804 1.965 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Phobia 0.003063 2.312 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Psoriasis 0.008774 1.279 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Intestinal infection 0.01052 0.7827 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Partial epilepsy 0.009754 1.446 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Paralytic strabismus 0.0008719 1.722 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Eustachian tube disorders 0.001273 1.182 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Orchitis and epididymitis 0.002036 1.619 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Cervicitis and endocervicitis 0.000601 1.883 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Skin neoplasm of uncertain behavior 0.006763 1.242 ZNF521 Adverse response to lamotrigine and phenytoin
rs8083432 Glossodynia 0.01081 0.3625 ZNF521 Adverse response to lamotrigine and phenytoin
rs8099917 Edema 0.0104 1.122 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Chronic renal failure 0.0009885 1.182 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Conduct disorders 0.008778 0.5003 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Renal failure 0.001055 1.159 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Other paralytic syndromes 0.005266 1.571 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Complications of transplants and reattached limbs 0.003757 1.731 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Adverse effects of hormones and synthetic substitutes 0.009668 2.173 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Corneal edema 0.009356 1.662 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Anal and rectal polyp 0.008502 0.7466 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Dysmetabolic syndrome X 0.002055 1.594 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Umbilical hernia 0.009425 1.309 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Complication of internal orthopedic device 0.00766 1.268 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Stomatitis and mucositis 0.01129 1.415 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Disorders of fluid, electrolyte, and acid-base balance 0.004118 1.117 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Anemia of chronic disease 0.003413 1.267 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8099917 Arthropathy NOS 0.005483 1.228 IL28B Response to hepatitis C treatment, Chronic Hepatitis C infection
rs8101881 Conduct disorders 0.007135 0.6099 SLC7A9 Lysine/valine ratio
rs8101881 Anomalies of tooth position/malocclusion 0.00739 1.644 SLC7A9 Lysine/valine ratio
rs8101881 Insect bite 0.000445 1.331 SLC7A9 Lysine/valine ratio
rs8101881 Malignant neoplasm of renal pelvis 0.009278 0.4093 SLC7A9 Lysine/valine ratio
rs8101881 Cyst or abscess of Bartholin's gland 0.0104 1.898 SLC7A9 Lysine/valine ratio
rs8101881 Retinal vascular changes and abnomalities 0.00152 0.7833 SLC7A9 Lysine/valine ratio
rs8101881 Inflammatory spondylopathies 0.01105 0.6552 SLC7A9 Lysine/valine ratio
rs8101881 Electrolyte imbalance 0.00552 0.9039 SLC7A9 Lysine/valine ratio
rs8101881 Cholelithiasis with other cholecystitis 0.007278 1.29 SLC7A9 Lysine/valine ratio
rs8101881 Brain cancer 0.008901 0.584 SLC7A9 Lysine/valine ratio
rs8101881 Dupuytren's disease 0.001329 1.464 SLC7A9 Lysine/valine ratio
rs8101881 Bipolar 0.00446 1.421 SLC7A9 Lysine/valine ratio
rs8109578 Other benign neoplasm of connective and other soft tissue 0.0001431 1.954 ANGPTL6 Thyroid stimulating hormone
rs8109578 Cancer of connective tissue 0.01075 1.804 ANGPTL6 Thyroid stimulating hormone
rs8109578 Speech and language disorder 0.007171 1.57 ANGPTL6 Thyroid stimulating hormone
rs8109578 Cervical cancer and dysplasia 0.004683 0.6094 ANGPTL6 Thyroid stimulating hormone
rs8109578 Cerebrovascular disease 0.004418 0.8566 ANGPTL6 Thyroid stimulating hormone
rs8109578 Other disorders of the nervous system 0.005515 1.754 ANGPTL6 Thyroid stimulating hormone
rs8109578 Amblyopia 0.007176 0.5472 ANGPTL6 Thyroid stimulating hormone
rs8109578 Rosacea 0.005972 0.733 ANGPTL6 Thyroid stimulating hormone
rs8109578 Cerebral ischemia 0.009414 0.8067 ANGPTL6 Thyroid stimulating hormone
rs8109578 Magnesium metabolism disorder 0.01009 1.434 ANGPTL6 Thyroid stimulating hormone
rs8109578 Thyroiditis 0.005941 0.5298 ANGPTL6 Thyroid stimulating hormone
rs8109578 Duodenitis 0.01015 1.513 ANGPTL6 Thyroid stimulating hormone
rs8109578 Femoral hernia 0.009689 2.023 ANGPTL6 Thyroid stimulating hormone
rs8111589 Shock 0.008638 0.7191 OPA3 Depression and alcohol dependence
rs8111589 Abdominal pain 0.0006638 0.9056 OPA3 Depression and alcohol dependence
rs8111589 Inguinal hernia 0.001249 0.8418 OPA3 Depression and alcohol dependence
rs8111589 Rheumatic fever / chorea 0.007455 0.472 OPA3 Depression and alcohol dependence
rs8111589 Speech and language disorder 0.002479 1.462 OPA3 Depression and alcohol dependence
rs8111589 Develomental delays and disorders 0.002022 1.319 OPA3 Depression and alcohol dependence
rs8111589 Esophageal atresia/tracheoesophageal fistula 0.004863 0.5535 OPA3 Depression and alcohol dependence
rs8111589 Elevated white blood cell count 0.00712 0.7707 OPA3 Depression and alcohol dependence
rs8111589 Diseases of white blood cells 0.008026 0.8454 OPA3 Depression and alcohol dependence
rs8139900 Dysmenorrhea 0.006894 1.486 MYO18B Uric acid levels
rs8139900 Abnormal serum enzyme levels 0.004583 1.153 MYO18B Uric acid levels
rs8139900 Staphylococcus infections 0.003419 1.278 MYO18B Uric acid levels
rs8139900 Urethritis and urethral syndrome 0.005228 0.5493 MYO18B Uric acid levels
rs8139900 Enthesopathy 0.01117 1.107 MYO18B Uric acid levels
rs8139900 Adverse effects of antilipemic and antiarteriosclerotic drugs 0.007869 2.103 MYO18B Uric acid levels
rs8139900 Secondary malignant neoplasm of liver 0.003873 0.7116 MYO18B Uric acid levels
rs8139900 Aseptic necrosis of bone 0.001681 1.676 MYO18B Uric acid levels
rs8139900 Open wound of hand except finger(s) 0.006235 1.28 MYO18B Uric acid levels
rs8139900 Elevated levels of transaminase or lactic acid dehydrogenase 0.01111 1.184 MYO18B Uric acid levels
rs8139900 Iatrogenic hypotension 0.01051 1.542 MYO18B Uric acid levels
rs8139900 Disorders of synovium, tendon, and bursa 0.002268 1.13 MYO18B Uric acid levels
rs8139900 Infection/inflammation of internal prosthetic device, implant or graft 0.008736 1.264 MYO18B Uric acid levels
rs8139900 Secondary malignancy of lung 0.006402 0.7136 MYO18B Uric acid levels
rs8139900 Neoplasm of unspecified nature of digestive system 0.002173 1.49 MYO18B Uric acid levels
rs8139900 Hypotension 0.003874 1.141 MYO18B Uric acid levels
rs8139900 Abnormal weight gain 0.007782 1.326 MYO18B Uric acid levels
rs8139900 Hypotension NOS 0.004951 1.187 MYO18B Uric acid levels
rs8139900 Methicillin sensitive Staphylococcus aureus 0.001335 1.414 MYO18B Uric acid levels
rs8139900 Macular degeneration, dry 0.009469 1.216 MYO18B Uric acid levels
rs8139900 Polymyalgia Rheumatica 0.007164 1.267 MYO18B Uric acid levels
rs8139900 Methicillin resistant Staphylococcus aureus 0.01037 1.813 MYO18B Uric acid levels
rs8139900 Benign neoplasm of other endocrine glands 0.009365 1.384 MYO18B Uric acid levels
rs8139900 Acute reaction to stress 0.00577 1.257 MYO18B Uric acid levels
rs8176746 Other conditions of the mother complicating pregnancy 0.006168 2.187 ABO Mean corpuscular hemoglobin
rs8176746 Diseases of pancreas 0.007903 1.361 ABO Mean corpuscular hemoglobin
rs8176746 Peripheral retinal degenerations 0.002144 1.568 ABO Mean corpuscular hemoglobin
rs8176746 Arthropathy associated with neurological disorders 0.00383 2.389 ABO Mean corpuscular hemoglobin
rs8176746 Unspecified monoarthritis 0.005301 1.985 ABO Mean corpuscular hemoglobin
rs8176746 Breast cancer 0.004212 0.7017 ABO Mean corpuscular hemoglobin
rs8176746 Occlusion of cerebral arteries, with cerebral infarction 0.0006516 2.003 ABO Mean corpuscular hemoglobin
rs8176746 Back & neck sprains 0.004221 1.247 ABO Mean corpuscular hemoglobin
rs8176746 Osteitis deformans and osteopathies associated with other disorders 0.007349 2.019 ABO Mean corpuscular hemoglobin
rs8176746 Other disorders of thyroid 0.008681 1.511 ABO Mean corpuscular hemoglobin
rs8176746 Osteoarthrosis NOS 0.004135 1.182 ABO Mean corpuscular hemoglobin
rs8176746 Breast cancer, including in situ 0.004371 0.701 ABO Mean corpuscular hemoglobin
rs8176746 Depression 0.01073 1.172 ABO Mean corpuscular hemoglobin
rs8176746 Thyroiditis 0.003117 1.624 ABO Mean corpuscular hemoglobin
rs8176746 Vascular dementia 0.008358 1.668 ABO Mean corpuscular hemoglobin
rs8176746 Paget's disease of bone 0.01011 2.532 ABO Mean corpuscular hemoglobin
rs8176746 Chronic lymphocytic thyroiditis 0.01075 1.652 ABO Mean corpuscular hemoglobin
rs8176746 Chronic ulcer of leg or foot 0.003392 1.29 ABO Mean corpuscular hemoglobin
rs8176746 Pseudomonal pneumonia 0.007634 2.673 ABO Mean corpuscular hemoglobin
rs8176746 Breast cancer 0.004004 0.6957 ABO Mean corpuscular hemoglobin
rs8192917 Abnormal pulmonary function 0.01057 2.094 GZMB Vitiligo
rs8192917 Nerve root and plexus disorders 0.005887 0.7002 GZMB Vitiligo
rs8192917 Respiratory abnormalities 0.008919 1.335 GZMB Vitiligo
rs8192917 Primary thrombocytopenia 0.005753 1.669 GZMB Vitiligo
rs8192917 Calcium/phosphorus disorders 0.005639 1.228 GZMB Vitiligo
rs8192917 Fracture of pelvis 0.007454 1.364 GZMB Vitiligo
rs8192917 Abnormal thyroid function 0.002874 1.329 GZMB Vitiligo
rs8192917 Internal derangement of knee 0.01102 0.8561 GZMB Vitiligo
rs837763 Disorders of refraction and accommodation 0.005912 1.105 CDT1 Mean corpuscular hemoglobin
rs837763 Cystoid macular degeneration of retina 0.007426 1.302 CDT1 Mean corpuscular hemoglobin
rs837763 Congenital anomalies of face and neck 0.001168 2.6 CDT1 Mean corpuscular hemoglobin
rs837763 Rosacea 0.007777 1.184 CDT1 Mean corpuscular hemoglobin
rs837763 Appendicitis 0.009384 1.386 CDT1 Mean corpuscular hemoglobin
rs837763 Fuchs' dystrophy 0.0005885 1.646 CDT1 Mean corpuscular hemoglobin
rs837763 Varicose veins 0.003839 1.163 CDT1 Mean corpuscular hemoglobin
rs837763 Lack of coordination 0.003131 1.271 CDT1 Mean corpuscular hemoglobin
rs837763 Chronic venous insufficiency 0.0007046 1.243 CDT1 Mean corpuscular hemoglobin
rs837763 Corneal dystrophy 0.001966 1.35 CDT1 Mean corpuscular hemoglobin
rs837763 Rash and other nonspecific skin eruption 0.0008157 1.202 CDT1 Mean corpuscular hemoglobin
rs837763 Amblyopia 0.005978 1.351 CDT1 Mean corpuscular hemoglobin
rs837763 Cervicocranial/Cervicobrachial syndrome 0.006653 1.258 CDT1 Mean corpuscular hemoglobin
rs837763 Altered mental status 0.00934 1.265 CDT1 Mean corpuscular hemoglobin
rs837763 Lymphoid leukemia 0.003934 1.569 CDT1 Mean corpuscular hemoglobin
rs837763 Atrophy of edentulous alveolar ridge 0.003544 0.6293 CDT1 Mean corpuscular hemoglobin
rs837763 Other symptoms referable to back 0.01035 1.235 CDT1 Mean corpuscular hemoglobin
rs837763 Aneurysm of iliac artery 0.007729 0.567 CDT1 Mean corpuscular hemoglobin
rs837763 Abnormal involuntary movements 0.0005172 1.325 CDT1 Mean corpuscular hemoglobin
rs837763 Kidney replaced by transpant 0.0008554 0.6218 CDT1 Mean corpuscular hemoglobin
rs837763 Disorders of external ear 0.005102 1.68 CDT1 Mean corpuscular hemoglobin
rs837763 Adrenal hypofunction 0.01059 1.583 CDT1 Mean corpuscular hemoglobin
rs837763 Pleurisy; pleural effusion 0.005902 1.146 CDT1 Mean corpuscular hemoglobin
rs837763 Benign neoplasm of brain and other parts of nervous system 0.01048 1.372 CDT1 Mean corpuscular hemoglobin
rs837763 Other hypertrophic and atrophic conditions of skin 0.009695 1.108 CDT1 Mean corpuscular hemoglobin
rs837763 Age-related macular degeneration 0.009504 1.189 CDT1 Mean corpuscular hemoglobin
rs837763 Corneal edema 0.004171 1.668 CDT1 Mean corpuscular hemoglobin
rs837763 Chronic lymphoid leukemia 0.01112 1.507 CDT1 Mean corpuscular hemoglobin
rs837763 Varicose veins of lower extremity 0.007978 1.155 CDT1 Mean corpuscular hemoglobin
rs837763 Astigmatism 0.005956 1.136 CDT1 Mean corpuscular hemoglobin
rs855913 Toxic erythema 0.007626 2.695 ZNF746 Amyotrophic lateral sclerosis
rs855913 Coronary atherosclerosis 0.005937 0.835 ZNF746 Amyotrophic lateral sclerosis
rs855913 Ischemic Heart Disease 0.007726 0.8484 ZNF746 Amyotrophic lateral sclerosis
rs855913 Degenerative disease of the spinal cord 0.007604 1.797 ZNF746 Amyotrophic lateral sclerosis
rs855913 Scar conditions and fibrosis of skin 0.0106 1.538 ZNF746 Amyotrophic lateral sclerosis
rs855913 Cancer of other male genital organs 0.004958 2.321 ZNF746 Amyotrophic lateral sclerosis
rs855913 Effects of radiation NOS 0.0001063 2.255 ZNF746 Amyotrophic lateral sclerosis
rs855913 Fracture of ribs 0.009997 1.439 ZNF746 Amyotrophic lateral sclerosis
rs855913 Hypoglycemia 0.005995 1.837 ZNF746 Amyotrophic lateral sclerosis
rs855913 Fracture of clavicle or scapula 0.004786 1.774 ZNF746 Amyotrophic lateral sclerosis
rs855913 Elevated levels of transaminase or lactic acid dehydrogenase 0.0002453 0.5384 ZNF746 Amyotrophic lateral sclerosis
rs855913 Type 1 diabetes nephropathy 0.003758 2.152 ZNF746 Amyotrophic lateral sclerosis
rs855913 Other disorders of biliary tract 0.002992 1.975 ZNF746 Amyotrophic lateral sclerosis
rs855913 Iatrogenic hypotension 0.0001761 2.402 ZNF746 Amyotrophic lateral sclerosis
rs855913 Acute laryngitis and tracheitis 0.001971 2.035 ZNF746 Amyotrophic lateral sclerosis
rs855913 Nonallopathic lesions NEC 0.009729 0.7834 ZNF746 Amyotrophic lateral sclerosis
rs855913 Neoplasm of uncertain behavior 0.002273 1.415 ZNF746 Amyotrophic lateral sclerosis
rs855913 Blindness and low vision 0.000534 1.764 ZNF746 Amyotrophic lateral sclerosis
rs855913 Type 2 diabetic retinopathy 0.01054 1.363 ZNF746 Amyotrophic lateral sclerosis
rs855913 Antihypertensive agents causing adverse effects 0.002576 2.157 ZNF746 Amyotrophic lateral sclerosis
rs855913 Endocarditis 0.007004 0.4193 ZNF746 Amyotrophic lateral sclerosis
rs855913 Diabetic retinopathy 0.002894 1.405 ZNF746 Amyotrophic lateral sclerosis
rs855913 Nephritis; nephrosis; renal sclerosis 0.002413 1.469 ZNF746 Amyotrophic lateral sclerosis
rs873917 Degeneration of intervertebral disc 0.003123 0.8764 NT5C1A Amyotrophic lateral sclerosis
rs873917 Other disorders of pancreatic internal secretion 0.008263 0.5309 NT5C1A Amyotrophic lateral sclerosis
rs873917 Spinal stenosis 0.01069 0.8829 NT5C1A Amyotrophic lateral sclerosis
rs873917 Vascular insufficiency of intestine 0.006932 0.6721 NT5C1A Amyotrophic lateral sclerosis
rs873917 Other specified disorders of pancreatic internal secretion 0.01114 0.5434 NT5C1A Amyotrophic lateral sclerosis
rs873917 Benign neoplasm of uterus 0.006191 1.228 NT5C1A Amyotrophic lateral sclerosis
rs873917 Inflammatory bowel disease 0.01022 0.7386 NT5C1A Amyotrophic lateral sclerosis
rs873917 Ulcerative colitis 0.003605 0.6216 NT5C1A Amyotrophic lateral sclerosis
rs873917 Spinal stenosis of lumbar region 0.003559 0.8533 NT5C1A Amyotrophic lateral sclerosis
rs873917 Acute sinusitis 0.01013 0.8737 NT5C1A Amyotrophic lateral sclerosis
rs873917 Intervertebral disc disorders 0.003039 0.8937 NT5C1A Amyotrophic lateral sclerosis
rs873917 Posterior pituitary disorders 0.001094 1.902 NT5C1A Amyotrophic lateral sclerosis
rs873917 Other disorders of intestine 0.002789 0.8083 NT5C1A Amyotrophic lateral sclerosis
rs873917 Congenital anomalies of lower limb, including pelvic girdle 0.001386 0.3816 NT5C1A Amyotrophic lateral sclerosis
rs873917 Abnormal findings on radiological breast exam 0.008752 1.544 NT5C1A Amyotrophic lateral sclerosis
rs873917 Gastrointestinal complications 0.006622 0.7621 NT5C1A Amyotrophic lateral sclerosis
rs873917 Nontoxic multinodular goiter 0.003519 0.7582 NT5C1A Amyotrophic lateral sclerosis
rs908821 Cancer of the lower GI tract 0.00694 1.382 SLC25A36 Multiple sclerosis
rs908821 Gangrene 0.0101 0.5647 SLC25A36 Multiple sclerosis
rs908821 Other disorders of lipoid metabolism and hyperalimentation 0.009796 1.275 SLC25A36 Multiple sclerosis
rs908821 Nerve plexus lesions 0.00826 1.431 SLC25A36 Multiple sclerosis
rs908821 Chronic obstructive asthma 0.003352 0.7284 SLC25A36 Multiple sclerosis
rs908821 End stage renal disease 0.008574 1.403 SLC25A36 Multiple sclerosis
rs908821 Nerve root and plexus disorders 0.008554 1.316 SLC25A36 Multiple sclerosis
rs908821 Primary/intrinsic cardiomyopathies 0.008194 1.193 SLC25A36 Multiple sclerosis
rs908821 Parasomnia 0.009035 1.615 SLC25A36 Multiple sclerosis
rs908821 Calculus of lower urinary tract 0.01063 1.602 SLC25A36 Multiple sclerosis
rs908821 Toxic erythema 0.009303 2.017 SLC25A36 Multiple sclerosis
rs908821 Other specified nonpsychotic and/or transient mental disorders 0.01132 0.8099 SLC25A36 Multiple sclerosis
rs909116 Stomatitis and mucositis 0.01063 0.7343 TNNT3 Breast cancer
rs909116 Cerebrovascular disease 0.0007719 1.119 TNNT3 Breast cancer
rs909116 Cellulitis and abscess of trunk 0.007627 1.288 TNNT3 Breast cancer
rs909116 Nonspecific findings on examination of blood 0.000329 0.6976 TNNT3 Breast cancer
rs909116 Myeloid leukemia 0.01032 0.5499 TNNT3 Breast cancer
rs909116 Occlusion and stenosis of precerebral arteries 0.002158 1.153 TNNT3 Breast cancer
rs909116 Mitral valve stenosis and/or aortic valve stenosis 0.000823 1.285 TNNT3 Breast cancer
rs909116 Open wound of nose and sinus 0.009958 1.975 TNNT3 Breast cancer
rs909116 Chronic rheumatic disease of the heart valves 0.007467 1.155 TNNT3 Breast cancer
rs909116 Other diseases of the teeth and supporting structures 0.008643 1.235 TNNT3 Breast cancer
rs9282641 Abnormal function study of cardiovascular system 0.003273 1.33 CD86 Multiple sclerosis
rs9282641 Heart transplant/surgery 0.007215 1.709 CD86 Multiple sclerosis
rs9282641 Malignant neoplasm of renal pelvis 0.007151 2.675 CD86 Multiple sclerosis
rs9282641 Heart failure 0.008766 1.197 CD86 Multiple sclerosis
rs9282641 Emphysema 0.002392 1.5 CD86 Multiple sclerosis
rs9282641 Ill-defined descriptions and complications of heart disease 0.008607 1.191 CD86 Multiple sclerosis
rs9282641 Chronic lymphocytic thyroiditis 0.004363 1.698 CD86 Multiple sclerosis
rs9282641 Chronic ischemic heart disease 0.0101 1.23 CD86 Multiple sclerosis
rs9282641 Asthma 0.0003411 1.281 CD86 Multiple sclerosis
rs9282641 Polyp of female genital organs 0.006649 1.413 CD86 Multiple sclerosis
rs9282641 Chronic obstructive asthma 0.009075 1.448 CD86 Multiple sclerosis
rs9282641 Thyroiditis 0.0003746 1.73 CD86 Multiple sclerosis
rs9282641 Chronic airway obstruction 0.003855 1.207 CD86 Multiple sclerosis
rs9282641 Cardiomegaly 0.003614 1.282 CD86 Multiple sclerosis
rs9282641 Symptoms involving urinary system 0.01019 1.403 CD86 Multiple sclerosis
rs9282641 Chronic rheumatic disease of the heart valves 0.01094 1.255 CD86 Multiple sclerosis
rs9282641 Spontaneous ecchymoses 0.0001681 2.39 CD86 Multiple sclerosis
rs9282641 Subarachnoid hemorrhage (injury) 0.0103 2.413 CD86 Multiple sclerosis
rs9282641 Benign neoplasm of thyroid glands 0.007837 2.088 CD86 Multiple sclerosis
rs9282641 Nonspecific findings on examination of blood 0.0001777 1.718 CD86 Multiple sclerosis
rs9282641 Systolic/diastolic heart failure 0.008943 1.203 CD86 Multiple sclerosis
rs9282641 Mitral valve stenosis and/or aortic valve stenosis 0.0007489 1.484 CD86 Multiple sclerosis
rs9282641 Primary/intrinsic cardiomyopathies 0.005555 1.323 CD86 Multiple sclerosis
rs9303401 Retinal hemorrhage/ischemia 0.006506 1.429 PPM1E Cognitive performance
rs9303401 Memory loss 0.0008662 0.7331 PPM1E Cognitive performance
rs9303401 Bone cancer 0.002619 0.4536 PPM1E Cognitive performance
rs9303401 Persistent mental disorders due to other conditions 0.002694 0.8308 PPM1E Cognitive performance
rs9303401 Cellulitis and abscess of hand/fingers 0.01005 1.19 PPM1E Cognitive performance
rs9303401 E. coli 0.009904 0.7285 PPM1E Cognitive performance
rs9303401 Symptoms involving female genital tract 0.01047 1.362 PPM1E Cognitive performance
rs9303401 Eustachian tube disorders 0.006542 1.135 PPM1E Cognitive performance
rs9303401 Alzheimer's disease 0.003617 0.8141 PPM1E Cognitive performance
rs9303401 Cancer of bone & connective tissue 0.007752 0.6258 PPM1E Cognitive performance
rs9303401 Lung involvement in conditions classified elsewhere 0.003761 0.2873 PPM1E Cognitive performance
rs9303401 Acne 0.00994 1.283 PPM1E Cognitive performance
rs9303401 Peripheral arterial disease 0.01112 1.129 PPM1E Cognitive performance
rs9303401 Acquired spondylolisthesis 0.004138 1.34 PPM1E Cognitive performance
rs932316 Disorders of esophageal motility 0.003963 0.5068 SCGN Transferrin saturation
rs932316 Other symptoms involving abdomen and pelvis 0.008722 0.8435 SCGN Transferrin saturation
rs932316 Cholelithiasis with other cholecystitis 0.00765 0.6963 SCGN Transferrin saturation
rs932316 Iron deficiency anemias NOS 0.006995 0.8487 SCGN Transferrin saturation
rs932316 Hypertension 0.003626 1.118 SCGN Transferrin saturation
rs932316 Essential hypertension 0.00341 1.119 SCGN Transferrin saturation
rs932316 Polymyalgia Rheumatica 0.009534 0.7237 SCGN Transferrin saturation
rs932316 Iron metabolism disorder 4.153e-07 3.215 SCGN Transferrin saturation
rs933688 Obstructive sleep apnea 0.01 1.182 LOC133789 Smoking behavior (ever vs. never)
rs933688 Primary open angle glaucoma 0.008009 0.7357 LOC133789 Smoking behavior (ever vs. never)
rs933688 Other upper respiratory disease 0.007798 1.205 LOC133789 Smoking behavior (ever vs. never)
rs933688 Temporomandibular joint disorder NOS 0.00126 1.875 LOC133789 Smoking behavior (ever vs. never)
rs933688 Other disorders of bladder 0.01023 0.8147 LOC133789 Smoking behavior (ever vs. never)
rs933688 Allergic rhinitis 0.003492 1.168 LOC133789 Smoking behavior (ever vs. never)
rs933688 Nonrheumatic aortic valve disorders 0.007597 0.816 LOC133789 Smoking behavior (ever vs. never)
rs933688 Symptoms involving digestive system 0.005309 0.7498 LOC133789 Smoking behavior (ever vs. never)
rs933688 Labyrinthitis 0.003588 1.499 LOC133789 Smoking behavior (ever vs. never)
rs933688 Diseases of respiratory system 0.002113 1.24 LOC133789 Smoking behavior (ever vs. never)
rs933688 Sarcoidosis 0.01068 1.684 LOC133789 Smoking behavior (ever vs. never)
rs933688 Precordial pain 0.003677 1.422 LOC133789 Smoking behavior (ever vs. never)
rs9349379 Anorexia 0.003189 1.396 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Chronic pain syndrome 0.002228 1.749 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Subjective visual disturbances 0.008313 1.202 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Other forms of chronic heart disease 0.003718 1.211 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Epiphora 0.002547 1.432 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Uterine/Uterovaginal prolapse 0.01138 0.7862 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Hyposmolality and/or hyponatremia 0.006475 1.172 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Unstable angina (intermediate coronary syndrome) 0.0004332 1.217 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Myocardial infarction 0.0001591 1.188 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Ischemic Heart Disease 0.005244 1.09 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Pancreatic cancer 0.002941 0.6058 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Chronic ischemic heart disease 0.002944 1.156 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Coronary atherosclerosis 0.001074 1.112 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Loss of teeth or edentulism 0.007059 1.356 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Benign neoplasm of uterus 0.0008352 1.713 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9349379 Major depressive disorder 0.01014 1.15 PHACTR1 Coronary artery calcification, Coronary heart disease
rs9357155 Rheumatoid arthritis 0.001631 1.378 PSMB8 IgA nephropathy
rs9357155 Psoriasis & related disorders 0.003427 1.369 PSMB8 IgA nephropathy
rs9357155 Type 1 diabetic neuropathy 0.003863 1.652 PSMB8 IgA nephropathy
rs9357155 Arteritis NOS 0.005744 1.791 PSMB8 IgA nephropathy
rs9357155 Abnormal findings on examination of urine 0.003069 1.28 PSMB8 IgA nephropathy
rs9357155 Heartburn 0.007602 1.524 PSMB8 IgA nephropathy
rs9357155 Psoriasis vulgaris 0.004851 1.386 PSMB8 IgA nephropathy
rs9357155 Other nonspecific findings on examination of urine 0.009866 1.277 PSMB8 IgA nephropathy
rs9357155 Digestive congenital anomalies 0.01115 1.561 PSMB8 IgA nephropathy
rs9357155 Type 1 diabetes nephropathy 0.004187 1.896 PSMB8 IgA nephropathy
rs9357155 Osteomyelitis 0.008361 1.399 PSMB8 IgA nephropathy
rs9357155 Hypertrophy of female genital organs 0.0007655 2.17 PSMB8 IgA nephropathy
rs9357155 Type 1 diabetic retinopathy 0.006056 1.592 PSMB8 IgA nephropathy
rs9357155 Unspecified osteomyelitis 0.01093 1.431 PSMB8 IgA nephropathy
rs9357155 Keratitis 0.009441 1.415 PSMB8 IgA nephropathy
rs9357155 Infection/inflammation of internal prosthetic device, implant or graft 0.001271 1.472 PSMB8 IgA nephropathy
rs9357155 Upper gastrointestinal congenital anomalies 0.005564 1.784 PSMB8 IgA nephropathy
rs9357155 Glaucoma 0.004042 1.194 PSMB8 IgA nephropathy
rs9357155 Attention deficit hyperactivity disorder 0.003151 1.94 PSMB8 IgA nephropathy
rs9357155 Rheumatoid arthritis & related inflammatory polyarthropathies 0.002676 1.318 PSMB8 IgA nephropathy
rs9357155 Other intestinal obstruction 0.009584 1.341 PSMB8 IgA nephropathy
rs9357155 Vitamin D deficiency 0.0005629 0.5239 PSMB8 IgA nephropathy
rs9357155 Symptoms involving cardiovascular system 0.008615 1.232 PSMB8 IgA nephropathy
rs9357155 Pervasive developmental disorders 0.001998 1.841 PSMB8 IgA nephropathy
rs9357155 Open-angle glaucoma 0.001424 1.306 PSMB8 IgA nephropathy
rs9357155 Exophthalmos 0.01036 1.998 PSMB8 IgA nephropathy
rs9357155 Other disorders of soft tissues 0.0001737 1.832 PSMB8 IgA nephropathy
rs9357155 Psoriasis 0.002555 1.404 PSMB8 IgA nephropathy
rs9364554 Deviated nasal septum 0.0062 1.203 SLC22A3 Prostate cancer
rs9364554 Pain in joint 0.007147 1.094 SLC22A3 Prostate cancer
rs9364554 Cramp of limb 0.001612 1.386 SLC22A3 Prostate cancer
rs9364554 Elevated C-reactive protein 0.009194 1.874 SLC22A3 Prostate cancer
rs9364554 Diseases of esophagus 0.01013 1.087 SLC22A3 Prostate cancer
rs9364554 Symptoms involving cardiovascular system 0.001361 1.203 SLC22A3 Prostate cancer
rs9364554 Chronic interstitial cystitis 0.009076 0.3502 SLC22A3 Prostate cancer
rs9364554 Glycosuria or Acetonuria 0.002483 2.365 SLC22A3 Prostate cancer
rs9364554 Stiffness of joint 0.003443 1.234 SLC22A3 Prostate cancer
rs9364554 Hidradenitis 0.006637 2.166 SLC22A3 Prostate cancer
rs9364554 GERD 0.00353 1.107 SLC22A3 Prostate cancer
rs9364554 Eustachian tube disorders 0.006457 1.264 SLC22A3 Prostate cancer
rs9364554 Hyperglyceridemia 0.0005931 1.345 SLC22A3 Prostate cancer
rs9364554 Essential tremor 0.008232 1.314 SLC22A3 Prostate cancer
rs9364554 Elevated sedimentation rate 0.008987 1.39 SLC22A3 Prostate cancer
rs9364554 Benign neoplasm of skin 0.00356 1.121 SLC22A3 Prostate cancer
rs9364554 Known or suspected fetal abnormality 0.009218 1.655 SLC22A3 Prostate cancer
rs9364554 Ill-defined descriptions and complications of heart disease 0.01054 1.115 SLC22A3 Prostate cancer
rs9364554 Fracture of radius and ulna 0.009064 1.187 SLC22A3 Prostate cancer
rs9364554 Primary thrombocytopenia 0.005014 1.659 SLC22A3 Prostate cancer
rs9364554 Hodgkin's disease 0.004836 0.4396 SLC22A3 Prostate cancer
rs9364554 Peptic ulcer 0.005855 1.181 SLC22A3 Prostate cancer
rs9364554 Diseases of nail 0.009216 1.153 SLC22A3 Prostate cancer
rs9364554 Precordial pain 0.007971 1.321 SLC22A3 Prostate cancer
rs9364554 Other disorders of soft tissues 0.001985 0.6229 SLC22A3 Prostate cancer
rs9364554 Cellulitis and abscess of hand/fingers 0.00182 1.234 SLC22A3 Prostate cancer
rs9364554 Esophagitis, GERD and related diseases 0.00441 1.099 SLC22A3 Prostate cancer
rs9368699 Unspecified local infection of skin and subcutaneous tissue 0.003022 0.3636 C6orf48 HIV-1 progression
rs9368699 Acute laryngitis and tracheitis 0.004556 2.29 C6orf48 HIV-1 progression
rs9368699 Genital prolapse 0.003337 0.5943 C6orf48 HIV-1 progression
rs9368699 Psoriasis vulgaris 6.542e-06 2.101 C6orf48 HIV-1 progression
rs9368699 Stricture/obstruction of ureter 0.009058 2.043 C6orf48 HIV-1 progression
rs9368699 Abnormal findings on radiological breast exam 0.009758 2.219 C6orf48 HIV-1 progression
rs9368699 Cancer of bone & connective tissue 0.004033 2.138 C6orf48 HIV-1 progression
rs9368699 Corneal dystrophy 0.00215 1.899 C6orf48 HIV-1 progression
rs9368699 Voice disturbance 0.0009477 1.641 C6orf48 HIV-1 progression
rs9368699 Fracture of hand or wrist 0.003596 0.5864 C6orf48 HIV-1 progression
rs9368699 Vascular disorders of penis 0.004812 4.083 C6orf48 HIV-1 progression
rs9368699 Neurological disorders due to brain damage 0.007064 0.7019 C6orf48 HIV-1 progression
rs9368699 Psoriasis 2.059e-06 2.137 C6orf48 HIV-1 progression
rs9368699 Respiratory failure; insufficiency; arrest 0.007797 0.5703 C6orf48 HIV-1 progression
rs9368699 Persistent mental disorders due to other conditions 0.009801 0.6707 C6orf48 HIV-1 progression
rs9368699 Acute upper respiratory infections 0.001362 1.335 C6orf48 HIV-1 progression
rs9368699 Psoriasis & related disorders 2.557e-06 2.068 C6orf48 HIV-1 progression
rs9368699 Pseudoexfoliation glaucoma 0.004069 2.545 C6orf48 HIV-1 progression
rs9368699 Male genital disorders 0.00116 2.009 C6orf48 HIV-1 progression
rs9368699 Rosacea 0.004853 1.507 C6orf48 HIV-1 progression
rs9368699 Respiratory failure 0.008348 0.4093 C6orf48 HIV-1 progression
rs9390459 Sleep apnea 0.008433 0.8972 STXBP5 von Willebrand factor levels
rs9390459 Staphylococcus infections 0.001326 0.7568 STXBP5 von Willebrand factor levels
rs9390459 Cancer, suspected or other 0.002068 0.8114 STXBP5 von Willebrand factor levels
rs9390459 Lymphadenitis 0.002384 0.8276 STXBP5 von Willebrand factor levels
rs9390459 Chronic periodontitis 0.01023 1.24 STXBP5 von Willebrand factor levels
rs9390459 Streptococcus infection 0.004509 0.7297 STXBP5 von Willebrand factor levels
rs9390459 Malignant neoplasm, other 0.003241 0.7947 STXBP5 von Willebrand factor levels
rs9390459 Functional digestive disorders 0.007966 1.139 STXBP5 von Willebrand factor levels
rs9390459 Septicemia 0.001634 0.8235 STXBP5 von Willebrand factor levels
rs9390459 Systemic lupus erythematosus 0.01133 1.443 STXBP5 von Willebrand factor levels
rs9390459 Noninfectious dermatoses of eyelid 0.006519 1.663 STXBP5 von Willebrand factor levels
rs9390459 Infection of the eye 0.0003912 1.198 STXBP5 von Willebrand factor levels
rs9390459 Graves' disease 0.00863 0.6763 STXBP5 von Willebrand factor levels
rs9390459 Cystic mastopathy 0.01047 1.156 STXBP5 von Willebrand factor levels
rs9390459 Atrophy of edentulous alveolar ridge 0.004226 1.539 STXBP5 von Willebrand factor levels
rs9390459 Bacterial infection NOS 0.00213 0.8634 STXBP5 von Willebrand factor levels
rs9390459 Valvular heart disease/ heart chambers 0.001374 1.95 STXBP5 von Willebrand factor levels
rs9390459 Type 1 diabetic peripheral circulatory disorders 0.007633 0.4865 STXBP5 von Willebrand factor levels
rs9390459 Calculus of lower urinary tract 0.01003 0.6053 STXBP5 von Willebrand factor levels
rs9390459 Acquired deformities of finger 0.004182 1.478 STXBP5 von Willebrand factor levels
rs9390459 Cancer within the respiratory system 0.006047 0.8027 STXBP5 von Willebrand factor levels
rs9390459 Pelvic inflammatory disease 0.006474 1.969 STXBP5 von Willebrand factor levels
rs9390459 Gram negative septicemia 0.01118 0.7202 STXBP5 von Willebrand factor levels
rs9390459 Conjunctivitis, infectious 0.001434 1.197 STXBP5 von Willebrand factor levels
rs9390459 Hyposmolality and/or hyponatremia 0.01074 0.8593 STXBP5 von Willebrand factor levels
rs9390459 Benign mammary dysplasias 0.008068 1.156 STXBP5 von Willebrand factor levels
rs9390459 Psoriasis & related disorders 0.003938 1.247 STXBP5 von Willebrand factor levels
rs9395066 Epistaxis or throat hemorrhage 0.005302 0.8168 SUPT3H Height
rs9395066 Osteoporosis 0.01048 0.8882 SUPT3H Height
rs9395066 Periodontitis (acute or chronic) 0.01065 0.8243 SUPT3H Height
rs9395066 Curvature of spine 0.004969 0.7949 SUPT3H Height
rs9395066 Salicylates causing adverse effects in therapeutic use 0.006797 0.4913 SUPT3H Height
rs9395066 pulmonary heart disease 0.002002 0.8411 SUPT3H Height
rs9395066 Cholecystitis without cholelithiasis 0.001916 0.7275 SUPT3H Height
rs9395066 Lesions of stomach and duodenum 0.004621 2.028 SUPT3H Height
rs9395066 Restless legs syndrome 0.01114 1.267 SUPT3H Height
rs9395066 Hidradenitis 0.002288 0.3255 SUPT3H Height
rs9395066 Osteoporosis, NOS or other 0.007445 0.8861 SUPT3H Height
rs9395066 Adjustment reaction 0.003738 0.8554 SUPT3H Height
rs9395066 Umbilical hernia 0.002939 0.7597 SUPT3H Height
rs9395066 Bacterial pneumonia 0.004863 0.7565 SUPT3H Height
rs939876 Atherosclerosis 0.008159 0.8494 TBC1D30 Cognitive performance
rs939876 Bacterial enteritis 0.009178 1.412 TBC1D30 Cognitive performance
rs939876 Symptoms affecting skin 0.001914 1.156 TBC1D30 Cognitive performance
rs939876 Transient cerebral ischemia 0.009339 0.8197 TBC1D30 Cognitive performance
rs939876 Somatoform disorder 0.003594 1.521 TBC1D30 Cognitive performance
rs939876 Hirsutism 0.005437 1.853 TBC1D30 Cognitive performance
rs939876 Disturbance of skin sensation 0.00146 1.205 TBC1D30 Cognitive performance
rs939876 Urinary incontinence 0.009711 1.179 TBC1D30 Cognitive performance
rs939876 Ulceration of the lower GI tract 0.008716 1.664 TBC1D30 Cognitive performance
rs939876 Diseases of hair and hair follicles 0.002062 1.349 TBC1D30 Cognitive performance
rs939876 Vitamin B12 deficiency anemia 0.006116 1.705 TBC1D30 Cognitive performance
rs939876 Myoclonus 0.0004994 2.111 TBC1D30 Cognitive performance
rs939876 Seborheic dermatitis 0.001365 1.306 TBC1D30 Cognitive performance
rs939876 Eating disorder 0.0005518 2.075 TBC1D30 Cognitive performance
rs939876 Essential tremor 0.009115 1.392 TBC1D30 Cognitive performance
rs939876 Benign neoplasm of other endocrine glands 0.002774 1.586 TBC1D30 Cognitive performance
rs939876 Mastoiditis 0.00329 2.375 TBC1D30 Cognitive performance
rs939876 Diseases of sebaceous glands 0.006087 1.154 TBC1D30 Cognitive performance
rs939876 Postmenopausal atrophic vaginitis 0.005947 1.343 TBC1D30 Cognitive performance
rs939876 Dysthymic disorder 0.0001123 1.363 TBC1D30 Cognitive performance
rs939876 Cholesteatoma 0.005156 1.924 TBC1D30 Cognitive performance
rs939876 Other disorders of middle ear and mastoid 0.009452 1.561 TBC1D30 Cognitive performance
rs939876 Conductive hearing loss 7.585e-06 2.218 TBC1D30 Cognitive performance
rs939876 Intestinal infection due to C. difficile 0.00952 1.47 TBC1D30 Cognitive performance
rs939876 Dermatophytosis of nail 0.008038 1.179 TBC1D30 Cognitive performance
rs939876 Other disorders of tympanic membrane 0.01026 1.538 TBC1D30 Cognitive performance
rs939876 Neoplasm of uncertain behavior 0.006076 1.259 TBC1D30 Cognitive performance
rs939876 Mucous polyp of cervix 0.005294 0.5512 TBC1D30 Cognitive performance
rs939876 Posttraumatic wound infection 0.004766 2.017 TBC1D30 Cognitive performance
rs939876 Type 1 diabetic neuropathy 0.0008093 1.711 TBC1D30 Cognitive performance
rs939876 Generalized anxiety disorder 0.01106 1.375 TBC1D30 Cognitive performance
rs944260 Photodermatitis & sunburn 0.006035 0.83 CDH4 Sudden cardiac arrest
rs944260 Mixed hyperlipidemia 0.007162 0.8359 CDH4 Sudden cardiac arrest
rs944260 Abnormal pulmonary function 0.009351 2.108 CDH4 Sudden cardiac arrest
rs944260 Pneumoconiosis 0.008473 1.855 CDH4 Sudden cardiac arrest
rs944260 Type 1 diabetes nephropathy 0.007188 0.5285 CDH4 Sudden cardiac arrest
rs944260 Ankylosis of joint 0.00983 0.663 CDH4 Sudden cardiac arrest
rs944260 Mastoiditis 0.006769 2.037 CDH4 Sudden cardiac arrest
rs944260 Fibroadenosis of breast 0.001684 2.461 CDH4 Sudden cardiac arrest
rs944797 Type 1 diabetic ketoacidosis 0.003658 0.683 CDKN2B-AS1 Coronary heart disease
rs944797 Acne 0.006766 1.285 CDKN2B-AS1 Coronary heart disease
rs944797 Cystitis 0.004433 0.8119 CDKN2B-AS1 Coronary heart disease
rs944797 Cardiac arrest & ventricular fibrillation 0.009289 0.7185 CDKN2B-AS1 Coronary heart disease
rs944797 Abnormal electrocardiogram 0.005819 0.87 CDKN2B-AS1 Coronary heart disease
rs944797 Hemorrhoids 0.002319 1.126 CDKN2B-AS1 Coronary heart disease
rs944797 Cardiac conduction disorders 0.003856 0.8925 CDKN2B-AS1 Coronary heart disease
rs944797 Polyneuropathy in diabetes 0.0002279 0.7855 CDKN2B-AS1 Coronary heart disease
rs944797 Neurological disorders due to brain damage 0.001325 0.8623 CDKN2B-AS1 Coronary heart disease
rs944797 Cardiac complications, not elsewhere classified 0.0004845 0.6579 CDKN2B-AS1 Coronary heart disease
rs944797 Cerebral ischemia 0.01109 0.8818 CDKN2B-AS1 Coronary heart disease
rs944797 Type 2 diabetic peripheral circulatory disorders 0.003058 0.6994 CDKN2B-AS1 Coronary heart disease
rs944797 Chronic airway obstruction 0.002331 1.126 CDKN2B-AS1 Coronary heart disease
rs944797 Nephritis and nephropathy without mention of glomerulonephritis 0.005272 0.7919 CDKN2B-AS1 Coronary heart disease
rs944797 Renal failure NOS 0.009525 0.7612 CDKN2B-AS1 Coronary heart disease
rs944797 Cystitis and urethritis 0.004266 0.8214 CDKN2B-AS1 Coronary heart disease
rs944797 Type 1 diabetic neuropathy 0.00811 0.6965 CDKN2B-AS1 Coronary heart disease
rs944797 Hypotension 0.002058 0.8683 CDKN2B-AS1 Coronary heart disease
rs944797 Other forms of chronic heart disease 0.005053 0.8328 CDKN2B-AS1 Coronary heart disease
rs944797 Coronary atherosclerosis 7.283e-11 0.8108 CDKN2B-AS1 Coronary heart disease
rs944797 Type 2 diabetic neuropathy 0.008593 0.8544 CDKN2B-AS1 Coronary heart disease
rs944797 Cardiac dysrhythmias 0.003098 0.9149 CDKN2B-AS1 Coronary heart disease
rs944797 Ill-defined descriptions and complications of heart disease 0.0002053 0.8646 CDKN2B-AS1 Coronary heart disease
rs944797 Costochondritis 0.001146 2.087 CDKN2B-AS1 Coronary heart disease
rs944797 Aphasia/speech disturbance 0.006266 0.8147 CDKN2B-AS1 Coronary heart disease
rs944797 Late effects of cerebrovascular disease 0.007493 0.8538 CDKN2B-AS1 Coronary heart disease
rs944797 Ulcerative colitis 0.005244 1.472 CDKN2B-AS1 Coronary heart disease
rs944797 Unstable angina (intermediate coronary syndrome) 1.993e-08 0.7309 CDKN2B-AS1 Coronary heart disease
rs944797 Plasma protein metabolism disorder 0.01143 1.275 CDKN2B-AS1 Coronary heart disease
rs944797 Symptoms involving digestive system 0.003148 1.241 CDKN2B-AS1 Coronary heart disease
rs944797 Occlusion of cerebral arteries 0.005181 0.8377 CDKN2B-AS1 Coronary heart disease
rs944797 Nephritis; nephrosis; renal sclerosis 0.0005887 0.7729 CDKN2B-AS1 Coronary heart disease
rs944797 Angina pectoris 8.807e-05 0.8367 CDKN2B-AS1 Coronary heart disease
rs944797 Ischemic Heart Disease 9.421e-09 0.8398 CDKN2B-AS1 Coronary heart disease
rs944797 Other infectious diseases 0.002082 0.5213 CDKN2B-AS1 Coronary heart disease
rs944797 Myocardial infarction 1.104e-07 0.7874 CDKN2B-AS1 Coronary heart disease
rs944797 Primary thrombocytopenia 0.009705 1.591 CDKN2B-AS1 Coronary heart disease
rs944797 Gastrointestinal hemorrhage 0.005379 1.109 CDKN2B-AS1 Coronary heart disease
rs944797 Paraproteinemia 0.003308 1.412 CDKN2B-AS1 Coronary heart disease
rs944797 Ischemic stroke 0.01038 0.8435 CDKN2B-AS1 Coronary heart disease
rs944797 Hypotension NOS 0.002939 0.8327 CDKN2B-AS1 Coronary heart disease
rs944797 Acute, but ill-defined cerebrovascular disease 0.0008165 0.8056 CDKN2B-AS1 Coronary heart disease
rs944797 Peptic ulcer 0.004881 0.8544 CDKN2B-AS1 Coronary heart disease
rs944797 Symptoms involving cardiovascular system 0.002829 0.8519 CDKN2B-AS1 Coronary heart disease
rs944797 Type 2 diabetic nephropathy 0.0001187 0.7566 CDKN2B-AS1 Coronary heart disease
rs944797 Cerebrovascular disease 0.0007004 0.8931 CDKN2B-AS1 Coronary heart disease
rs944797 Occlusion and stenosis of precerebral arteries 0.0003023 0.846 CDKN2B-AS1 Coronary heart disease
rs944797 Mild cognitive impairment 0.00487 0.5834 CDKN2B-AS1 Coronary heart disease
rs944797 Chronic ischemic heart disease 4.12e-05 0.8212 CDKN2B-AS1 Coronary heart disease
rs9468925 Aseptic necrosis of bone 0.01026 1.507 HLA-B Vitiligo
rs9468925 Diseases of lips 0.006627 0.6533 HLA-B Vitiligo
rs9468925 Other disorders of eye 0.009658 1.111 HLA-B Vitiligo
rs9468925 Discoid lupus erythematosus 0.003996 0.6503 HLA-B Vitiligo
rs9468925 Age-related macular degeneration 0.00777 0.8345 HLA-B Vitiligo
rs9468925 Subjective visual disturbances 0.001037 0.7865 HLA-B Vitiligo
rs9468925 Systemic lupus erythematosus 0.01033 0.6649 HLA-B Vitiligo
rs9468925 Renal osteodystrophy 0.006465 1.497 HLA-B Vitiligo
rs9468925 Cancer of kidney and renal pelvis 0.004806 0.7178 HLA-B Vitiligo
rs9468925 Iron deficiency anemias NOS 0.009583 1.127 HLA-B Vitiligo
rs9468925 Blood in stool 0.01055 1.145 HLA-B Vitiligo
rs9468925 Renal cell carcinoma 0.005451 0.72 HLA-B Vitiligo
rs947583 Osteoarthrosis; localized, primary 0.007168 1.253 PDE7B Phosphorus levels
rs947583 Chronic venous hypertension 0.006176 0.3313 PDE7B Phosphorus levels
rs947583 GERD 0.009895 1.095 PDE7B Phosphorus levels
rs947583 Arteritis NOS 0.007094 0.5574 PDE7B Phosphorus levels
rs947583 Diseases of esophagus 0.00124 1.111 PDE7B Phosphorus levels
rs947583 Bladder cancer 0.002721 1.318 PDE7B Phosphorus levels
rs947583 Fracture of ribs 0.0009633 1.316 PDE7B Phosphorus levels
rs947583 Other specified peripheral vascular diseases 0.001167 2.269 PDE7B Phosphorus levels
rs947583 Ulceration of the lower GI tract 0.005889 0.5674 PDE7B Phosphorus levels
rs947583 Esophagitis, GERD and related diseases 0.00291 1.105 PDE7B Phosphorus levels
rs947583 Anisometropia 0.0003883 0.6502 PDE7B Phosphorus levels
rs947583 Chronic rheumatic disease of the heart valves 0.01124 1.159 PDE7B Phosphorus levels
rs947583 Visual disturbances 0.002944 0.8743 PDE7B Phosphorus levels
rs947583 Bladder cancer and neoplasms 0.0037 1.298 PDE7B Phosphorus levels
rs9491140 Streptococcus infection 0.006095 1.35 NKAIN2 Personality dimensions
rs9491140 Type 2 diabetic peripheral circulatory disorders 0.001714 1.455 NKAIN2 Personality dimensions
rs9491140 Type 2 diabetic neuropathy 0.006082 1.186 NKAIN2 Personality dimensions
rs9491140 Benign neoplasm of skin 0.01058 0.9046 NKAIN2 Personality dimensions
rs9491140 Obsessive-compulsive disorder 0.005044 1.753 NKAIN2 Personality dimensions
rs9491140 Renal dialysis 0.005356 1.436 NKAIN2 Personality dimensions
rs9502893 Obesity 0.008457 0.9174 FOXQ1 Pancreatic cancer
rs9502893 Impacted cerumen 0.01115 1.101 FOXQ1 Pancreatic cancer
rs9502893 Hammer toe 0.006724 1.194 FOXQ1 Pancreatic cancer
rs9502893 Dermatophytosis of nail 0.0008395 1.158 FOXQ1 Pancreatic cancer
rs9502893 Dermatophytosis / Dermatomycosis 0.003365 1.115 FOXQ1 Pancreatic cancer
rs9502893 Bacterial pneumonia 0.008056 1.282 FOXQ1 Pancreatic cancer
rs9502893 Speech and language disorder 0.001569 1.48 FOXQ1 Pancreatic cancer
rs9502893 Chronic obstructive asthma 0.01034 1.264 FOXQ1 Pancreatic cancer
rs9502893 Acquired toe deformities 0.0005214 1.219 FOXQ1 Pancreatic cancer
rs9502893 Acquired foot deformities 0.009115 1.115 FOXQ1 Pancreatic cancer
rs9502893 Abnormal findings examination of lungs 0.005787 1.168 FOXQ1 Pancreatic cancer
rs9502893 Anomalies of tooth position/malocclusion 0.01136 0.6113 FOXQ1 Pancreatic cancer
rs9502893 Infestation 0.01102 0.5949 FOXQ1 Pancreatic cancer
rs9502893 Other diseases of lung 0.003931 1.138 FOXQ1 Pancreatic cancer
rs9502893 Other disorders of eye 0.004188 0.8905 FOXQ1 Pancreatic cancer
rs9502893 Dermatophytosis 0.007056 1.108 FOXQ1 Pancreatic cancer
rs9502893 Obstructive chronic bronchitis 0.0009366 1.261 FOXQ1 Pancreatic cancer
rs9502893 Chronic bronchitis 0.001236 1.225 FOXQ1 Pancreatic cancer
rs9502893 Decubitus ulcer 0.001281 1.271 FOXQ1 Pancreatic cancer
rs9502893 Develomental delays and disorders 1.145e-05 1.478 FOXQ1 Pancreatic cancer
rs9502893 Other sprains and strains 0.00454 1.356 FOXQ1 Pancreatic cancer
rs951005 Functional disorders of bladder 0.004349 1.407 CCL21 Rheumatoid arthritis
rs951005 Ulcerative stomatitis & mucositis 0.001342 2.149 CCL21 Rheumatoid arthritis
rs951005 Spirochetal infection 0.01035 0.4949 CCL21 Rheumatoid arthritis
rs951005 Personality disorders 4.643e-05 1.545 CCL21 Rheumatoid arthritis
rs951005 Posttraumatic stress disorder 0.008745 1.668 CCL21 Rheumatoid arthritis
rs951005 Schizoid personality disorder 0.01099 1.821 CCL21 Rheumatoid arthritis
rs951005 Tachycardia NOS 0.007707 1.246 CCL21 Rheumatoid arthritis
rs951005 Generalized anxiety disorder 0.004385 1.403 CCL21 Rheumatoid arthritis
rs951005 Benign neoplasm of thyroid glands 0.007549 1.882 CCL21 Rheumatoid arthritis
rs951005 Aneurysm of artery of lower extremity 0.002625 0.4121 CCL21 Rheumatoid arthritis
rs951005 Hypotension NOS 0.007771 1.232 CCL21 Rheumatoid arthritis
rs951005 Stomach cancer 0.008044 0.3273 CCL21 Rheumatoid arthritis
rs951005 Aphakia and other disorders of lens 0.005457 1.415 CCL21 Rheumatoid arthritis
rs951005 Secondary hyperparathyroidism (of renal origin) 0.003214 1.499 CCL21 Rheumatoid arthritis
rs951005 Disorders of optic nerve and visual pathways 0.003709 1.372 CCL21 Rheumatoid arthritis
rs951005 Disorders of cervical region 0.007033 0.6273 CCL21 Rheumatoid arthritis
rs951005 Optic neuritis/neuropathy 0.0001081 1.686 CCL21 Rheumatoid arthritis
rs951005 Alopecia Areata 0.003647 2.299 CCL21 Rheumatoid arthritis
rs951005 Claw toe 0.00889 2.082 CCL21 Rheumatoid arthritis
rs951005 Adverse effects of antibacterials (not penicillins) 0.01023 1.846 CCL21 Rheumatoid arthritis
rs951005 Arthropathy associated with neurological disorders 0.01087 1.906 CCL21 Rheumatoid arthritis
rs9574199 Type 2 diabetes 0.008505 1.092 POU4F1-AS1 Total ventricular volume
rs9574199 Open wound of lip and mouth 0.005726 0.4826 POU4F1-AS1 Total ventricular volume
rs9574199 Scleritis and episcleritis 0.003754 1.657 POU4F1-AS1 Total ventricular volume
rs9574199 Fibroadenosis of breast 0.0039 2.24 POU4F1-AS1 Total ventricular volume
rs9574199 Cervical radiculitis 0.01134 0.8424 POU4F1-AS1 Total ventricular volume
rs9574199 Muscle/tendon sprain 0.007927 0.4278 POU4F1-AS1 Total ventricular volume
rs9574199 Pruritus and related conditions 0.003827 1.225 POU4F1-AS1 Total ventricular volume
rs9574199 Methicillin resistant Staphylococcus aureus 0.008145 1.822 POU4F1-AS1 Total ventricular volume
rs9574199 Spasm of muscle 0.01076 0.8085 POU4F1-AS1 Total ventricular volume
rs9574199 Infections of kidney 0.006079 0.7131 POU4F1-AS1 Total ventricular volume
rs9574199 Bursitis 0.007936 0.8231 POU4F1-AS1 Total ventricular volume
rs9574199 Obsessive-compulsive disorder 0.005036 0.4827 POU4F1-AS1 Total ventricular volume
rs9574199 Nervous system congenital anomalies 0.001716 0.6091 POU4F1-AS1 Total ventricular volume
rs9574199 Diabetes mellitus 0.009917 1.089 POU4F1-AS1 Total ventricular volume
rs958798 Pituitary hyperfunction 0.0108 2.054 KCNC4 Self-rated health
rs958798 Alopecia 0.009928 1.349 KCNC4 Self-rated health
rs958798 Abnormal sputum 0.01056 1.348 KCNC4 Self-rated health
rs958798 Adverse effects of antilipemic and antiarteriosclerotic drugs 0.003541 2.342 KCNC4 Self-rated health
rs958798 Other derangement of joint 0.005018 1.349 KCNC4 Self-rated health
rs958798 Generalized anxiety disorder 0.003206 0.6828 KCNC4 Self-rated health
rs958798 Depression 0.01058 0.8952 KCNC4 Self-rated health
rs958798 Cardiomyopathy 0.0009369 0.7607 KCNC4 Self-rated health
rs958798 Disease of tricuspid valve 0.008942 0.7457 KCNC4 Self-rated health
rs958798 Primary/intrinsic cardiomyopathies 0.001671 0.7658 KCNC4 Self-rated health
rs958798 Schizophrenia and other psychotic disorders 0.004845 0.7885 KCNC4 Self-rated health
rs958798 Polycythemia vera 0.0106 1.787 KCNC4 Self-rated health
rs958798 Cardiac dysrhythmias 0.006003 0.903 KCNC4 Self-rated health
rs958798 Benign neoplasm of other endocrine glands 0.007587 1.456 KCNC4 Self-rated health
rs958798 Malunion fracture 0.007753 1.479 KCNC4 Self-rated health
rs958798 Symptoms/disorders of the urinary system 0.006502 0.9001 KCNC4 Self-rated health
rs958798 Arthralgia/ankylosis of temporomandibular joint 0.004701 1.673 KCNC4 Self-rated health
rs9594293 Uterine leiomyoma 0.008637 1.28 FREM2 Cytomegalovirus antibody response
rs9594293 Skin neoplasm of uncertain behavior 0.0006867 1.327 FREM2 Cytomegalovirus antibody response
rs9594293 Benign neoplasm of uterus 0.007219 1.27 FREM2 Cytomegalovirus antibody response
rs9594293 Joint effusions 0.00574 1.279 FREM2 Cytomegalovirus antibody response
rs9594293 Dysthymic disorder 0.0001775 1.322 FREM2 Cytomegalovirus antibody response
rs9594293 Depression 0.00351 1.139 FREM2 Cytomegalovirus antibody response
rs9594293 Anxiety, phobic and dissociative disorders 0.007583 1.135 FREM2 Cytomegalovirus antibody response
rs9594293 Hypertensive heart disease 0.009369 0.6897 FREM2 Cytomegalovirus antibody response
rs9594293 Elevated blood pressure reading 0.003163 0.8259 FREM2 Cytomegalovirus antibody response
rs9594293 Dysuria 0.005208 1.213 FREM2 Cytomegalovirus antibody response
rs9594293 Other hypertensive complications 0.003616 0.7135 FREM2 Cytomegalovirus antibody response
rs9594293 Other specified erythematous conditions 0.003482 0.6513 FREM2 Cytomegalovirus antibody response
rs9594293 Mood disorders 0.001527 1.147 FREM2 Cytomegalovirus antibody response
rs9594293 Suicidal ideation or attempt 0.00111 2.064 FREM2 Cytomegalovirus antibody response
rs9594293 Chronic venous hypertension 0.01099 0.218 FREM2 Cytomegalovirus antibody response
rs9594293 Other disorders of middle ear and mastoid 0.008278 0.5621 FREM2 Cytomegalovirus antibody response
rs9594293 Open wound of nose and sinus 0.0004583 2.589 FREM2 Cytomegalovirus antibody response
rs9594293 Vascular disorders of penis 0.001227 2.687 FREM2 Cytomegalovirus antibody response
rs9594293 Toxic multinodular goiter 0.004646 2.013 FREM2 Cytomegalovirus antibody response
rs9594293 Postnasal drip 0.007781 1.848 FREM2 Cytomegalovirus antibody response
rs960089 Other upper respiratory disease 0.01046 0.7761 TOX Cognitive performance
rs960089 Gastrointestinal hemorrhage 0.00653 0.8249 TOX Cognitive performance
rs960089 Peripheral arterial disease 0.008268 0.8016 TOX Cognitive performance
rs960089 Chronic sinusitis 0.002363 0.7883 TOX Cognitive performance
rs960089 Epistaxis or throat hemorrhage 0.01096 0.7037 TOX Cognitive performance
rs960089 Skin cancer 0.002405 0.8175 TOX Cognitive performance
rs960089 Non-melanoma skin cancer 0.001392 0.7985 TOX Cognitive performance
rs960089 Biliary cirrhosis 0.007576 2.607 TOX Cognitive performance
rs960089 Nasal polyps 0.005 0.518 TOX Cognitive performance
rs960089 Vaginal enterocele, congenital or acquired 0.004256 1.818 TOX Cognitive performance
rs960089 Benign neoplasm of uterus 0.003155 0.6452 TOX Cognitive performance
rs960089 Other anemias 0.007661 0.8602 TOX Cognitive performance
rs960089 Stiffness of joint 0.009096 0.6949 TOX Cognitive performance
rs960089 Concussion 0.009524 1.735 TOX Cognitive performance
rs960089 Morbid obesity 0.009077 0.747 TOX Cognitive performance
rs960089 Renal failure 0.007427 0.8318 TOX Cognitive performance
rs960089 Infections involving bone 0.00869 0.608 TOX Cognitive performance
rs964184 Hypercholesterolemia 7.818e-05 1.26 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Retinal detachment with retinal defect 0.006147 1.594 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Decreased libido 0.008158 2.148 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Anxiety disorder 0.001142 1.219 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Sexual and gender identity disorders 0.004895 1.546 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Abnormal findings on radiological exam of musculoskeletal system 0.000233 2.085 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Coronary atherosclerosis 0.009791 1.13 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Disorders of lipoid metabolism 1.1e-05 1.235 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Obsessive-compulsive disorder 0.008965 1.895 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Phlebitis and thrombophlebitis of lower extremities 0.003755 0.6851 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Delirium due to conditions classified elsewhere 0.006134 1.516 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Peyronie's disease 0.001247 2.328 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Sensorineural hearing loss 0.006686 1.159 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Other disorders of urethra and urinary tract 0.004713 0.714 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Lipoid metabolism disorder NOS 0.004591 1.461 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Dysmetabolic syndrome X 0.001717 1.707 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Cataract 0.003336 1.178 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Hyperlipidemia 2.532e-05 1.226 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Mixed hyperlipidemia 0.001367 1.307 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Vaginitis and vulvovaginitis 0.009078 1.293 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Chronic ischemic heart disease 0.01069 1.197 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Tinnitus 0.008866 1.283 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Inflammatory diseases of female pelvic organs 0.002264 1.288 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Hyperglyceridemia 5.782e-13 2.216 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Urinary complications 0.008332 0.4647 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Inflammatory disease of cervix, vagina, and vulva 0.007259 1.266 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Anxiety, phobic and dissociative disorders 0.005319 1.162 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Anomalies of pupillary function 0.005881 2.15 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs964184 Lipoprotein disorders 0.01115 0.6116 ZNF259 HDL Cholesterol, Total Cholesterol, Lipoprotein-associated phospholipase A2 activity concentrations, LDL Cholesterol, Hypertriglyceridemia, Vitamin E, Triglycerides, Coronary heart disease, Phosphatidylcholines/sphingomyelins ratio
rs9642880 Other abnormal glucose 0.007558 1.138 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Cancer of the upper aerodigestive tract 0.001751 1.445 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Other local infections of skin and subcutaneous tissue 0.00261 1.19 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Secondary malignant neoplasm 0.009711 1.148 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Unspecified local infection of skin and subcutaneous tissue 0.003616 1.283 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Vertiginous syndromes and other disorders of vestibular system 0.009537 0.9181 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Epiphora 0.001829 0.6914 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Bladder cancer 0.0006372 1.352 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Other specified diseases of the salivary glands 0.005462 1.731 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Abnormal glucose 0.00345 1.121 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Hepatic cancer 0.003936 1.752 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Bladder cancer and neoplasms 0.000877 1.33 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Cancer of kidney and urinary organs 0.009604 1.195 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Cancer of larynx 0.008057 1.462 MYC Urinary bladder cancer, Bladder cancer
rs9642880 Light-headedness and vertigo 0.007893 0.9127 MYC Urinary bladder cancer, Bladder cancer
rs9649213 Contracture of joint 0.002287 1.458 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Chronic kidney disease, Stage I or II 0.00824 1.367 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Other congenital anomalies of skin 0.002313 1.498 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Dysphagia 0.002843 0.8723 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Hemorrhage of rectum and anus 0.001636 1.232 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Other disorders of stomach and duodenum 0.007897 0.7709 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Anemia in chronic kidney disease 0.006146 0.748 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Other specified diseases of hair and hair follicles 0.004488 1.336 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Other specified diseases of sebaceous glands 0.0001847 1.325 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Diseases of hair and hair follicles 0.009026 1.214 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Lack of normal physiological development 0.005193 0.7001 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Benign neoplasm of other endocrine glands 0.009097 1.385 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Muscular dystrophies and other myopathies 0.0003015 1.637 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Cirrhosis of liver without mention of alcohol 0.002555 0.6309 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Anemia of chronic disease 0.006879 0.822 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs9649213 Femoral hernia 0.0108 0.4932 BAIAP2L1 Prostate cancer (gene x gene interaction)
rs975334 Other disorders of gallbladder 0.007064 1.577 CNTN4 Gallbladder cancer
rs975334 Diseases of pancreas 0.001581 1.254 CNTN4 Gallbladder cancer
rs975334 Nervous system congenital anomalies 0.002423 0.6486 CNTN4 Gallbladder cancer
rs975334 Disorders of synovium, tendon, and bursa 0.007178 0.8945 CNTN4 Gallbladder cancer
rs975334 Sicca syndrome 0.0007751 1.615 CNTN4 Gallbladder cancer
rs975334 Pulmonary collapse; interstitial/compensatory emphysema 0.007857 1.166 CNTN4 Gallbladder cancer
rs975334 Other unspecified back disorders 0.007312 1.532 CNTN4 Gallbladder cancer
rs975334 Chronic pain syndrome 0.008342 0.5793 CNTN4 Gallbladder cancer
rs9846480 Benign neoplasm of uterus 0.002995 0.802 TXNDC6 Whole-brain volume
rs9846480 Dyschromia and Vitiligo 0.01052 0.8365 TXNDC6 Whole-brain volume
rs9846480 Chronic prostatitis 0.00204 0.5871 TXNDC6 Whole-brain volume
rs9846480 Cyst or abscess of Bartholin's gland 0.008183 0.4557 TXNDC6 Whole-brain volume
rs9846480 Other specified gastritis 0.005786 0.7746 TXNDC6 Whole-brain volume
rs9846480 Irregular menstrual bleeding 0.00731 1.646 TXNDC6 Whole-brain volume
rs9846480 Other specified disorders of liver 0.006255 0.7408 TXNDC6 Whole-brain volume
rs9846480 Seborrheic keratosis 0.007961 0.9051 TXNDC6 Whole-brain volume
rs9846480 Displacement of intervertebral disc 0.003395 1.176 TXNDC6 Whole-brain volume
rs9846480 Symptoms involving respiratory system 0.00822 0.8265 TXNDC6 Whole-brain volume
rs9846480 Uterine leiomyoma 0.003682 0.7958 TXNDC6 Whole-brain volume
rs9846480 Prostatitis 0.001339 0.725 TXNDC6 Whole-brain volume
rs9846480 Other dyschromia 0.003078 0.7691 TXNDC6 Whole-brain volume
rs991316 Impacted cerumen 0.00947 0.9059 ADH7 Hypertension
rs991316 Acute pharyngitis 0.009584 0.8748 ADH7 Hypertension
rs991316 Postmenopausal atrophic vaginitis 0.001013 0.7674 ADH7 Hypertension
rs991316 Keratoderma, acquired 0.004791 1.168 ADH7 Hypertension
rs991316 Graves' disease 0.002899 1.535 ADH7 Hypertension
rs991316 Thyrotoxicosis 0.008031 1.229 ADH7 Hypertension
rs991316 Abnormal findings on radiological examination intrathoracic organs 0.001369 1.248 ADH7 Hypertension
rs991316 Non-Hodgkins lymphoma 0.006921 1.276 ADH7 Hypertension
rs991316 Cancer of other lymphoid, histiocytic tissue 0.01039 1.254 ADH7 Hypertension
rs991316 Type 2 diabetes 0.004895 0.9162 ADH7 Hypertension
rs991316 Wheezing 0.01094 1.296 ADH7 Hypertension
rs991316 Diabetes mellitus 0.009202 0.9232 ADH7 Hypertension
rs9923451 Calculus of bile duct 0.008648 2.609 WWOX Hip circumference
rs9923451 Infestation 0.005359 4.234 WWOX Hip circumference
rs9923451 Hyperglyceridemia 0.002533 2.963 WWOX Hip circumference
rs9923451 Bacterial pneumonia 0.001324 2.75 WWOX Hip circumference
rs9923451 Injuries to the nervous system 0.01042 3.254 WWOX Hip circumference
rs9923451 Vitamin D deficiency 0.0007964 2.708 WWOX Hip circumference
rs9923451 Benign neoplasm of unspecified sites 0.01056 4.682 WWOX Hip circumference
rs9923451 Seborrheic keratosis 0.009148 1.556 WWOX Hip circumference
rs9923451 Appendiceal conditions 0.01114 2.683 WWOX Hip circumference
rs9923451 Arterial embolism and thrombosis of lower extremity artery 0.001245 3.321 WWOX Hip circumference
rs9923451 Hypertrophy of breast (Gynecomastia) 0.006785 2.779 WWOX Hip circumference
rs9923451 Vitamin deficiency 0.003332 1.925 WWOX Hip circumference
rs9929218 Sacroiliitis NEC 0.01022 0.5012 CDH1 Colorectal cancer
rs9929218 Electrolyte imbalance 0.008484 0.9036 CDH1 Colorectal cancer
rs9929218 Strabismus (not specified as paralytic) 0.005674 1.258 CDH1 Colorectal cancer
rs9929218 Other paralytic syndromes 0.001882 0.5645 CDH1 Colorectal cancer
rs9929218 Inflammatory spondylopathies 0.0109 0.6286 CDH1 Colorectal cancer
rs9929218 Psychogenic and somatoform disorders 0.01003 1.271 CDH1 Colorectal cancer
rs9929218 Cardiomegaly 0.01089 0.8626 CDH1 Colorectal cancer
rs9929218 Irregular menstrual cycle/bleeding 0.000203 1.325 CDH1 Colorectal cancer
rs9929218 Constipation 0.009887 0.8748 CDH1 Colorectal cancer
rs9929218 Attention deficit hyperactivity disorder 0.005562 1.685 CDH1 Colorectal cancer
rs9929218 Schizoid personality disorder 0.003593 1.804 CDH1 Colorectal cancer
rs9929218 Disorders of menstruation 0.000429 1.288 CDH1 Colorectal cancer
rs9929218 Diseases of respiratory system 0.009269 1.166 CDH1 Colorectal cancer
rs9929218 Bladder cancer and neoplasms 0.00874 0.7712 CDH1 Colorectal cancer
rs9943849 Secondary malignancy of bone 0.002671 0.6628 CPM Major depressive disorder
rs9943849 Open wound of toe(s) 0.008855 0.4558 CPM Major depressive disorder
rs9943849 Left bundle branch block 0.008414 0.7431 CPM Major depressive disorder
rs9943849 Disorders of fluid, electrolyte, and acid-base balance 0.007793 0.9092 CPM Major depressive disorder
rs9943849 Congenital anomalies of great vessels 0.003067 2.06 CPM Major depressive disorder
rs9943849 Abnormal findings on study of brain, nervous system 0.005302 0.559 CPM Major depressive disorder
rs9943849 Hypopotassemia 0.005709 0.8595 CPM Major depressive disorder
rs9943849 Edema 0.008792 0.8952 CPM Major depressive disorder
rs9943849 Cornea replaced by transplant 0.000492 2.123 CPM Major depressive disorder
rs9989419 Staphylococcus infections 0.003464 1.276 CETP HDL Cholesterol
rs9989419 Methicillin sensitive Staphylococcus aureus 0.006514 1.337 CETP HDL Cholesterol
rs9989419 Lesions of stomach and duodenum 0.00477 0.4442 CETP HDL Cholesterol
rs9989419 Infection/inflammation of internal prosthetic device, implant or graft 0.005616 1.28 CETP HDL Cholesterol
rs9989419 Major depressive disorder 0.00304 1.175 CETP HDL Cholesterol
rs9989419 Antisocial/borderline personality disorder 0.002832 1.708 CETP HDL Cholesterol
rs9989419 Disorders of esophageal motility 0.001424 0.607 CETP HDL Cholesterol
rs9989419 Astigmatism 0.01137 0.8907 CETP HDL Cholesterol
rs9989419 Posttraumatic stress disorder 0.002503 1.625 CETP HDL Cholesterol
rs9989419 Atherosclerosis of native arteries of the extremities with ulceration or gangrene 0.008311 1.299 CETP HDL Cholesterol
rs9989419 Cardiac congenital anomalies 0.00687 1.319 CETP HDL Cholesterol
rs9989419 Psychogenic and somatoform disorders 0.004174 1.284 CETP HDL Cholesterol
rs9989419 Anxiety, phobic and dissociative disorders 0.005667 1.108 CETP HDL Cholesterol
rs9989419 Somatoform disorder 0.002438 1.39 CETP HDL Cholesterol
rs999943 Abdominal pain 0.007678 1.088 ITPR3 Extreme obesity
rs999943 Polycystic ovaries 0.006605 0.3667 ITPR3 Extreme obesity
rs999943 Iatrogenic hypotension 0.003041 0.5256 ITPR3 Extreme obesity
rs999943 Other acquired musculoskeletal deformity 0.006801 0.783 ITPR3 Extreme obesity
rs999943 Heart transplant/surgery 0.001423 0.5902 ITPR3 Extreme obesity
rs999943 Non-healing surgical wound 0.002519 0.4993 ITPR3 Extreme obesity
rs999943 Nephritis; nephrosis; renal sclerosis 0.003786 0.7808 ITPR3 Extreme obesity
rs999943 Type 2 diabetic nephropathy 0.01128 0.8135 ITPR3 Extreme obesity
rs999943 Salicylates causing adverse effects in therapeutic use 0.006516 1.894 ITPR3 Extreme obesity
rs999943 Cystitis and urethritis 0.008749 1.216 ITPR3 Extreme obesity
rs999943 Somatoform disorder 0.008947 1.342 ITPR3 Extreme obesity
rs999943 Other disorders of peritoneum 0.009955 0.6563 ITPR3 Extreme obesity
rs999943 Arthropathy NOS involving multiple sites 0.009153 1.579 ITPR3 Extreme obesity
rs999943 Bladder cancer and neoplasms 0.003274 1.301 ITPR3 Extreme obesity
rs999943 Benign neoplasm of other endocrine glands 0.007089 1.416 ITPR3 Extreme obesity
rs999943 Nephritis and nephropathy in diseases classified elsewhere 0.006239 0.7469 ITPR3 Extreme obesity
rs999943 Electrolyte imbalance 0.005746 0.8984 ITPR3 Extreme obesity
rs999943 Postoperative infection 0.0007167 0.7637 ITPR3 Extreme obesity
rs999943 Bladder cancer 0.002103 1.326 ITPR3 Extreme obesity
rs999943 Hydronephrosis 0.007266 1.336 ITPR3 Extreme obesity
rs999943 Hyperpotassemia 0.00385 0.8098 ITPR3 Extreme obesity
Page:

5th Q

QR Code

This section allows users to specify a relatively concise list of SNPs freely and to generate a QR code. This feature is expected to facilitate genetic data transmission and encryption, while increasing the possibility to maintain individual privacy.

SNP list QR code:

SNP list QR code

User QR code:

User QR code

Decrypted user genotype:

rs970973: TC, rs1874045: CC, rs7514102: GG, rs1801274: GA, rs2274064: TT, rs2297950: CC, rs7527925: TC, rs3811445: GG, rs935172: CC, rs3739014: GG, rs1545133: TT, rs10206850: GG, rs9646748: GG, rs3732083: TC, rs6756597: TC, rs6765537: GA, rs2289247: GG, rs571391: AA, rs9851180: TC, rs6788448: TC, rs898500: AA, rs931606: GG, rs13146272: AC, rs737154: TT, rs1531545: TC, rs285599: TC, rs160632: TC, rs2304054: GG, rs315717: CC, rs1052486: GA, rs2229848: CC, rs9390459: GG, rs2236313: TT, rs7793096: GA, rs3823646: GA, rs10246939: TC, rs12919: AA, rs2301963: AC, rs1800392: GG, rs4870723: AC, rs2294008: TC, rs301430: TC, rs1539172: GA, rs1043836: TC, rs10901333: GG, rs3136618: CC, rs2185724: TC, rs3818876: GA, rs1891110: GG, rs12781609: TC, rs1025412: AA, rs1064005: TC, rs4453265: TC, rs1852450: AA, rs703842: GA, rs11558556: CC, rs495680: CC, rs4942848: GG, rs1135641: TT, rs1060570: AC, rs3825569: TC, rs863980: TC, rs4077410: GA, rs1800775: AC, rs2159132: GA, rs2586514: AA, rs1292053: GG, rs1026128: GG, rs1805034: TT, rs888930: GG, rs2363956: TT, rs3745298: TC, rs2296241: AA, rs4680: GA

Running Log

Input file:

./personal_genome/HG001.vcf.gz

Database directory:

  • ./algorithm/Qualitative/Qualitative_traits
  • ./algorithm/Quantitative/Quantitative_traits

Reference population data:

  • ['/home/sheng/Documents/pageant/population_genome/G1K.vcf.gz']

Log:

2021-10-06 21:05:56,035 - INFO: Logging start.
2021-10-06 21:05:56,037 - INFO: Recode and sex impute start
2021-10-06 21:05:56,872 - INFO: Recode and sex impute used time: 0.84s
2021-10-06 21:05:56,873 - INFO: Progress of the analysis: 5.0%
2021-10-06 21:05:57,302 - INFO: Sample QC start
2021-10-06 21:06:16,082 - INFO: Sample QC used time: 18.78s
2021-10-06 21:06:16,082 - INFO: Progress of the analysis: 14.0%
2021-10-06 21:06:16,082 - INFO: Reference data QC start
2021-10-06 21:06:22,668 - INFO: Reference data QC used time: 6.59s
2021-10-06 21:06:22,669 - INFO: Progress of the analysis: 23.0%
2021-10-06 21:06:22,669 - INFO: Initial reference data start
2021-10-06 21:06:22,669 - INFO: Get reference result data start
2021-10-06 21:06:22,789 - INFO: Get reference result data used time: 0.12s
2021-10-06 21:06:22,794 - INFO: Initial reference data used time: 0.13s
2021-10-06 21:06:22,794 - INFO: Progress of the analysis: 38.0%
2021-10-06 21:06:22,799 - INFO: Load sample vcf start
2021-10-06 21:06:22,973 - INFO: Load sample vcf used time: 0.17s
2021-10-06 21:06:22,974 - INFO: Progress of the analysis: 48.0%
2021-10-06 21:06:22,974 - INFO: Load indicator data start
2021-10-06 21:06:22,984 - WARNING: Snp (rs333) cannot be found in your genotype file!
2021-10-06 21:06:22,984 - WARNING: Snp (rs333) cannot be found in your genotype file!
2021-10-06 21:06:22,987 - WARNING: Snp (rs116503776) cannot be found in your genotype file!
2021-10-06 21:06:22,988 - WARNING: Snp (rs142450006) cannot be found in your genotype file!
2021-10-06 21:06:22,989 - WARNING: Snp (rs79037040) cannot be found in your genotype file!
2021-10-06 21:06:22,990 - WARNING: There are duplicate snps (rs11264280) when calculate the quantitative trait!
2021-10-06 21:06:22,991 - WARNING: There are duplicate snps (rs6843082) when calculate the quantitative trait!
2021-10-06 21:06:22,993 - WARNING: Snp (rs2992756) cannot be found in your genotype file! Using reference population average: 1.0334317891373774
2021-10-06 21:06:22,993 - WARNING: Snp (rs4233486) cannot be found in your genotype file! Using reference population average: 0.9589735623003371
2021-10-06 21:06:22,994 - WARNING: Snp (rs79724016) cannot be found in your genotype file! Using reference population average: 0.7260223642172805
2021-10-06 21:06:22,994 - WARNING: Snp (rs1707302) cannot be found in your genotype file! Using reference population average: 0.9628855431310027
2021-10-06 21:06:22,994 - WARNING: Snp (rs140850326) cannot be found in your genotype file! Using reference population average: 1.0
2021-10-06 21:06:22,995 - WARNING: Snp (rs17426269) cannot be found in your genotype file! Using reference population average: 1.1129035143769395
2021-10-06 21:06:22,995 - WARNING: Snp (rs7529522) cannot be found in your genotype file! Using reference population average: 1.083614217252348
2021-10-06 21:06:22,995 - WARNING: Snp (rs4971059) cannot be found in your genotype file! Using reference population average: 1.081641972843436
2021-10-06 21:06:22,995 - WARNING: Snp (rs35383942) cannot be found in your genotype file! Using reference population average: 1.1632677316294282
2021-10-06 21:06:22,996 - WARNING: Snp (rs11117758) cannot be found in your genotype file! Using reference population average: 0.9187969249201129
2021-10-06 21:06:22,996 - WARNING: Snp (rs113577745) cannot be found in your genotype file! Using reference population average: 1.155537380191719
2021-10-06 21:06:22,996 - WARNING: Snp (rs6725517) cannot be found in your genotype file! Using reference population average: 0.9511491613418529
2021-10-06 21:06:22,996 - WARNING: Snp (rs71801447) cannot be found in your genotype file!
2021-10-06 21:06:22,997 - WARNING: Snp (rs12479355) cannot be found in your genotype file! Using reference population average: 0.9069477635782623
2021-10-06 21:06:22,997 - WARNING: Snp (rs6805189) cannot be found in your genotype file! Using reference population average: 0.9451884984025519
2021-10-06 21:06:22,997 - WARNING: Snp (rs13066793) cannot be found in your genotype file! Using reference population average: 0.8367671725239362
2021-10-06 21:06:22,998 - WARNING: Snp (rs9833888) cannot be found in your genotype file! Using reference population average: 1.101887380191636
2021-10-06 21:06:22,998 - WARNING: Snp (rs34207738) cannot be found in your genotype file!
2021-10-06 21:06:22,998 - WARNING: Snp (rs58058861) cannot be found in your genotype file! Using reference population average: 1.0794668530351308
2021-10-06 21:06:22,998 - WARNING: Snp (rs6815814) cannot be found in your genotype file! Using reference population average: 1.0442362220447294
2021-10-06 21:06:22,999 - WARNING: Snp (4:84370124) cannot be found in your genotype file!
2021-10-06 21:06:22,999 - WARNING: Snp (rs10022462) cannot be found in your genotype file! Using reference population average: 1.1025896964856043
2021-10-06 21:06:22,999 - WARNING: Snp (rs77528541) cannot be found in your genotype file! Using reference population average: 0.8431771565494999
2021-10-06 21:06:22,999 - WARNING: Snp (rs116095464) cannot be found in your genotype file!
2021-10-06 21:06:23,000 - WARNING: Snp (rs72749841) cannot be found in your genotype file! Using reference population average: 0.8730825079872432
2021-10-06 21:06:23,000 - WARNING: Snp (rs35951924) cannot be found in your genotype file! Using reference population average: 0.9392945686900891
2021-10-06 21:06:23,000 - WARNING: Snp (rs6882649) cannot be found in your genotype file! Using reference population average: 0.9536480830671081
2021-10-06 21:06:23,001 - WARNING: Snp (rs6596100) cannot be found in your genotype file! Using reference population average: 0.9531382987220692
2021-10-06 21:06:23,001 - WARNING: Snp (rs4562056) cannot be found in your genotype file! Using reference population average: 1.0493833865814504
2021-10-06 21:06:23,001 - WARNING: Snp (rs2223621) cannot be found in your genotype file! Using reference population average: 1.068766972843443
2021-10-06 21:06:23,002 - WARNING: Snp (rs71557345) cannot be found in your genotype file! Using reference population average: 0.8488396166133758
2021-10-06 21:06:23,002 - WARNING: Snp (rs12207986) cannot be found in your genotype file! Using reference population average: 0.9764736421725224
2021-10-06 21:06:23,002 - WARNING: Snp (rs6569648) cannot be found in your genotype file! Using reference population average: 0.8445896964856018
2021-10-06 21:06:23,002 - WARNING: Snp (rs7971) cannot be found in your genotype file! Using reference population average: 0.9534873003195139
2021-10-06 21:06:23,003 - WARNING: Snp (rs17268829) cannot be found in your genotype file! Using reference population average: 1.1084440894568466
2021-10-06 21:06:23,003 - WARNING: Snp (rs71559437) cannot be found in your genotype file! Using reference population average: 0.9270670926517366
2021-10-06 21:06:23,004 - WARNING: Snp (rs514192) cannot be found in your genotype file! Using reference population average: 1.0632127795526785
2021-10-06 21:06:23,004 - WARNING: Snp (rs12546444) cannot be found in your genotype file! Using reference population average: 0.8936226837060419
2021-10-06 21:06:23,004 - WARNING: Snp (rs58847541) cannot be found in your genotype file! Using reference population average: 1.1283795527156582
2021-10-06 21:06:23,004 - WARNING: Snp (rs1895062) cannot be found in your genotype file! Using reference population average: 0.9566287939297338
2021-10-06 21:06:23,005 - WARNING: Snp (rs10760444) cannot be found in your genotype file! Using reference population average: 1.0753648562300204
2021-10-06 21:06:23,005 - WARNING: Snp (rs8176636) cannot be found in your genotype file!
2021-10-06 21:06:23,005 - WARNING: Snp (rs67958007) cannot be found in your genotype file! Using reference population average: 1.1121314696485036
2021-10-06 21:06:23,006 - WARNING: Snp (rs140936696) cannot be found in your genotype file! Using reference population average: 1.1059907348242641
2021-10-06 21:06:23,006 - WARNING: Snp (rs6597981) cannot be found in your genotype file! Using reference population average: 0.9753233226837154
2021-10-06 21:06:23,006 - WARNING: Snp (rs202049448) cannot be found in your genotype file! Using reference population average: 0.9557201277955363
2021-10-06 21:06:23,006 - WARNING: Snp (rs206966) cannot be found in your genotype file! Using reference population average: 1.0688996805111626
2021-10-06 21:06:23,007 - WARNING: Snp (rs10623258) cannot be found in your genotype file! Using reference population average: 1.0449779552715384
2021-10-06 21:06:23,007 - WARNING: Snp (rs28539243) cannot be found in your genotype file! Using reference population average: 1.0340764776357831
2021-10-06 21:06:23,008 - WARNING: Snp (rs2432539) cannot be found in your genotype file! Using reference population average: 1.0727875399360927
2021-10-06 21:06:23,008 - WARNING: Snp (rs4496150) cannot be found in your genotype file! Using reference population average: 0.9413840255590948
2021-10-06 21:06:23,008 - WARNING: Snp (rs72826962) cannot be found in your genotype file! Using reference population average: 0.9801434904153662
2021-10-06 21:06:23,008 - WARNING: Snp (rs2532263) cannot be found in your genotype file!
2021-10-06 21:06:23,008 - WARNING: Snp (rs117618124) cannot be found in your genotype file! Using reference population average: 0.7437507987220884
2021-10-06 21:06:23,009 - WARNING: Snp (rs78269692) cannot be found in your genotype file! Using reference population average: 1.1641597444089813
2021-10-06 21:06:23,009 - WARNING: Snp (rs2594714) cannot be found in your genotype file! Using reference population average: 0.9321204472843492
2021-10-06 21:06:23,009 - WARNING: Snp (rs2965183) cannot be found in your genotype file! Using reference population average: 1.0530301517571885
2021-10-06 21:06:23,009 - WARNING: Snp (rs71338792) cannot be found in your genotype file!
2021-10-06 21:06:23,010 - WARNING: Snp (rs6122906) cannot be found in your genotype file! Using reference population average: 1.11911693290735
2021-10-06 21:06:23,010 - WARNING: Snp (rs738321) cannot be found in your genotype file! Using reference population average: 0.9304579872204548
2021-10-06 21:06:23,010 - WARNING: Snp (rs73161324) cannot be found in your genotype file! Using reference population average: 1.2939507987220076
2021-10-06 21:06:23,011 - WARNING: Snp (rs28512361) cannot be found in your genotype file! Using reference population average: 1.1055137380191156
2021-10-06 21:06:23,011 - WARNING: Snp (rs2271616) cannot be found in your genotype file! Using reference population average: 1.3052131988818636
2021-10-06 21:06:23,012 - WARNING: Snp (rs10490770) cannot be found in your genotype file! Using reference population average: 1.315690734824335
2021-10-06 21:06:23,012 - WARNING: Snp (rs11919389) cannot be found in your genotype file! Using reference population average: 0.9177937967252382
2021-10-06 21:06:23,012 - WARNING: Snp (rs1886814) cannot be found in your genotype file! Using reference population average: 1.1869673210862484
2021-10-06 21:06:23,012 - WARNING: Snp (rs912805253) cannot be found in your genotype file!
2021-10-06 21:06:23,013 - WARNING: Snp (rs2109069) cannot be found in your genotype file! Using reference population average: 1.0788328202875401
2021-10-06 21:06:23,013 - WARNING: Snp (rs4801778) cannot be found in your genotype file! Using reference population average: 0.9080582284344927
2021-10-06 21:06:23,013 - WARNING: Snp (rs72711165) cannot be found in your genotype file! Using reference population average: 1.1523330299520391
2021-10-06 21:06:23,014 - WARNING: Snp (rs1819040) cannot be found in your genotype file! Using reference population average: 0.9240992815495079
2021-10-06 21:06:23,014 - WARNING: Snp (rs77534576) cannot be found in your genotype file! Using reference population average: 1.1687035335463538
2021-10-06 21:06:23,014 - WARNING: Snp (rs74956615) cannot be found in your genotype file! Using reference population average: 1.1114028953674755
2021-10-06 21:06:23,015 - WARNING: Snp (rs13050728) cannot be found in your genotype file! Using reference population average: 0.9739275223642436
2021-10-06 21:06:23,328 - WARNING: Snp (rs116822326) cannot be found in your genotype file!
2021-10-06 21:06:23,333 - WARNING: Snp (rs111404218) cannot be found in your genotype file!
2021-10-06 21:06:23,334 - WARNING: Snp (rs140002913) cannot be found in your genotype file!
2021-10-06 21:06:23,336 - WARNING: Snp (rs67338227) cannot be found in your genotype file!
2021-10-06 21:06:23,337 - WARNING: Snp (rs77505915) cannot be found in your genotype file!
2021-10-06 21:06:23,342 - WARNING: Snp (chr1_243881945_I) cannot be found in your genotype file!
2021-10-06 21:06:23,342 - WARNING: Snp (chr1_8424984_D) cannot be found in your genotype file!
2021-10-06 21:06:23,342 - WARNING: Snp (chr10_104957618_I) cannot be found in your genotype file!
2021-10-06 21:06:23,342 - WARNING: Snp (chr11_46350213_D) cannot be found in your genotype file!
2021-10-06 21:06:23,342 - WARNING: Snp (chr18_52749216_D) cannot be found in your genotype file!
2021-10-06 21:06:23,343 - WARNING: Snp (chr2_146436222_I) cannot be found in your genotype file!
2021-10-06 21:06:23,343 - WARNING: Snp (chr2_149429178_D) cannot be found in your genotype file!
2021-10-06 21:06:23,343 - WARNING: Snp (chr2_200825237_I) cannot be found in your genotype file!
2021-10-06 21:06:23,343 - WARNING: Snp (chr22_39987017_D) cannot be found in your genotype file!
2021-10-06 21:06:23,343 - WARNING: Snp (chr3_180594593_I) cannot be found in your genotype file!
2021-10-06 21:06:23,344 - WARNING: Snp (chr5_140143664_I) cannot be found in your genotype file!
2021-10-06 21:06:23,344 - WARNING: Snp (chr6_84280274_D) cannot be found in your genotype file!
2021-10-06 21:06:23,344 - WARNING: Snp (chr7_2025096_I) cannot be found in your genotype file!
2021-10-06 21:06:23,344 - WARNING: Snp (chr7_24747494_D) cannot be found in your genotype file!
2021-10-06 21:06:23,345 - WARNING: Snp (rs115329265) cannot be found in your genotype file!
2021-10-06 21:06:23,348 - WARNING: Snp (rs190065944) cannot be found in your genotype file!
2021-10-06 21:06:23,353 - WARNING: Snp (rs7907645) cannot be found in your genotype file!
2021-10-06 21:06:23,354 - INFO: Load indicator data used time: 0.38s
2021-10-06 21:06:23,355 - INFO: Progress of the analysis: 58.0%
2021-10-06 21:06:23,355 - INFO: Add population distribution start
2021-10-06 21:06:34,536 - INFO: Add population distribution used time: 11.18s
2021-10-06 21:06:34,536 - INFO: Progress of the analysis: 62.5%
2021-10-06 21:06:34,536 - INFO: Query database start
2021-10-06 21:06:42,278 - INFO: Progress of the analysis: 71.5%
2021-10-06 21:06:42,279 - INFO: Progress of the analysis: 80.5%
2021-10-06 21:06:42,794 - INFO: Query database used time: 8.26s
2021-10-06 21:06:42,794 - INFO: Load sample vcf start
2021-10-06 21:06:42,950 - INFO: Load sample vcf used time: 0.16s
2021-10-06 21:06:42,950 - INFO: Progress of the analysis: 90.5%
2021-10-06 21:06:42,950 - INFO: Produce QR code start
2021-10-06 21:06:43,398 - INFO: Produce QR code used time: 0.45s
2021-10-06 21:06:43,399 - INFO: Progress of the analysis: 95.0%
2021-10-06 21:06:43,399 - INFO: Export report result start
2021-10-06 21:06:43,404 - INFO: Export report result used time: 0.01s
2021-10-06 21:06:43,404 - INFO: Progress of the analysis: 105.0%
2021-10-06 21:06:43,404 - INFO: Analysis runs successfully!